Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7952329398967014,-2.1891566340565594,0.0,0.0,0.0,54/141,11.36%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;TRIR;RPL10;RPLP1;RPL7A;POP4;RPL10A;RPS19;RPL18;RPL13;RPS24;NIFK;RPL35A;RPS16;EXOSC8;RPS15;RPL8;PIH1D1;RPS28;WDR18;NOL11;EBNA1BP2;RPS7;RPL23;RPL19;DDX54;NOP56;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;NOP14;RPL34;RPL35;POP5;NOL6;RPL21;RPL11;RPL6;RPL36;RPL38;RPL4;SBDS;RPL9;RPF1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.7795638515343994,-2.1157407203298306,0.0,0.0,0.0,55/154,11.36%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;RPL10;RPLP1;RPL7A;POP4;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;EXOSC8;RPS15;RPL8;PIH1D1;RPS28;WDR18;NOL11;NHP2;EBNA1BP2;RPS7;RIOK2;RPL23;RPL19;DDX54;NOP56;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;NOP14;RPL34;RPL35;POP5;NOL6;RPL21;RPL11;RPL6;RPL36;RPL38;RPL4;SBDS;TSR3;RPL9;RPF1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.7513347271611183,-2.111328884192443,0.0,0.0,0.0,55/175,11.36%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;RPL10;RPLP1;RPL7A;POP4;RPL10A;MRPL44;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;EXOSC8;RPS15;RPL8;PIH1D1;RPS28;WDR18;NOL11;EBNA1BP2;RPS7;RPL23;RPL19;DDX54;NOP56;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;NOP14;SARS1;RPL34;RPL35;POP5;NOL6;RPL21;RPL11;RPL6;RPL36;AARS1;RPL38;RPL4;SBDS;RPL9;RPF1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.8036868753741475,-2.1087712018912446,0.0,0.0,0.0,54/94,14.26%,RPS2;SPCS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;SRP14;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;SEC61G;RPS15;RPL8;RPS28;RPS7;RPL23;RPL19;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;RPL34;RPS15A;RPL35;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;RPS11;RPL4;RPL9;GET3;RPS8;RPL30;RPS5;RPL18A;RPS26;SEC62;RPSA
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.755935046517102,-2.092060889690066,0.0,0.0,0.0,62/170,11.77%,RPS2;RPL29;RPL15;RPL23A;UTP11;IMP3;MRPL36;RPL10;RPLP1;RPL7A;RAN;POP4;RPL10A;ZNF658;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;EXOSC8;RPS15;RPL8;PIH1D1;LTV1;RPS28;WDR18;NOL11;EBNA1BP2;RPS7;RIOK2;RPL23;RPL19;DDX54;NOP56;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;METTL17;NOP14;RPL34;RPL35;POP5;NOL6;NOC2L;RPL21;RPL11;RPL6;RPL36;RPL38;RPL4;SBDS;LSG1;RPL9;RPF1;RPF2;NPM1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8044351033828214,-2.0895455579606006,0.0,0.0,0.0,52/86,14.26%,RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;SRP14;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPS15;RPL8;RPS28;RPS7;RPL23;RPL19;RPLP0;RPS9;RPL37;RPL41;UBA52;SSR2;RPL13A;RPL3;RPL31;RPL34;RPS15A;RPL35;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;RPS11;RPL4;RPL9;RPS8;RPL30;RPS5;RPL18A;RPS26;SEC62;RPSA
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8083353074217153,-2.0890646839466585,0.0,0.0,0.0,44/83,10.29%,RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;SRP14;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPS15;RPL8;RPS28;RPS7;RPL23;RPL19;RPLP0;RPS9;RPL37;RPL41;UBA52;RPL13A;RPL3;RPL31;RPL34;RPS15A;RPL35;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;SEC61B;RPS11;RPL4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7831775411424707,-2.0222035447575055,0.0,0.00384006105616911,0.03,54/102,12.78%,RPS2;RPL29;RBM8A;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;PNRC2;RPS15;RPL8;RPS28;RPS7;RPL23;RPL19;RPLP0;RPS9;RPL37;RPL41;UBA52;GSPT2;RPL13A;RPL3;RPL31;RPL34;RPS15A;RPL35;MAGOH;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;RPS11;RPL4;EIF4A3;RPL9;GSPT1;DCP1A;RPS8;RPL30;PPP2R1A;RPS5
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8016063749346639,-2.0087870797961545,0.0,0.004551183473978205,0.04,51/84,12.78%,TMA7;RPS2;RPL29;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;RPS15;RPL8;RPS28;RPS7;RPL23;RPL19;RWDD1;RPLP0;RPS9;RPL37;RPL41;UBA52;GSPT2;RPL13A;RPL3;RPL31;RPL34;RPS15A;RPL22L1;RPL35;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;RPS11;RPL4;RPL9;GSPT1;RPS8;RPL30;RPS5
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7635624217036902,-2.0069542528162083,0.0,0.0040960651265803845,0.04,40/88,15.96%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPS7;MRPL10;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MTRF1L;MRPS11;MRPL21;MRPL32;TUFM;MRPS10;MRPL48;MRPS12;MTIF3;MRPL24;MRPS18B;GATC;MRPS14;MRPS22;MRPL9;MRPS2;MRPL51;MRPL13;MRPL16;MRPL34;MRPS18A;MRPL4;ERAL1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7860227754654584,-2.0047864793083177,0.0,0.0037236955696185316,0.04,37/74,15.96%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPS7;MRPL10;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MTRF1L;MRPS11;MRPL21;MRPL32;MRPS10;MRPL48;MRPS12;MRPL24;MRPS18B;MRPS14;MRPS22;MRPL9;MRPS2;MRPL51;MRPL13;MRPL16;MRPL34;MRPS18A;MRPL4;ERAL1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.7936892906597932,-1.9901530734917534,0.0,0.004266734506854567,0.05,37/73,15.96%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPS7;MRPL10;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MRPS11;MRPL21;MRPL32;TUFM;MRPS10;MRPL48;MRPS12;MRPL24;MRPS18B;MRPS14;MRPS22;MRPL9;MRPS2;MRPL51;MRPL13;MRPL16;MRPL34;MRPS18A;MRPL4;ERAL1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7364149758005387,-1.9870620306691842,0.0,0.004726228992208136,0.05,74/136,15.32%,RPS2;RPL29;RPL15;RPL23A;MRPS33;MRPL36;RPL10;MRPL27;MRPS7;RPLP1;RPS27A;MRPL10;RPL7A;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;RPS16;EEF1A1;RPS15;RPL8;RPS28;MRPL52;RPS7;RPL23;RPL19;MRPL28;RPLP0;RPS9;RPL37;RPL41;MRPS11;GSPT2;RPL13A;RPL3;RPL31;SARS1;RPL34;RPS15A;MRPL32;RPL35;MRPS12;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;EIF4EBP2;RPS11;RPL4;RPL9;MRPL24;MRPS18B;GSPT1;FURIN;RPS8;RPL30;MRPS14;RPS5;RPL18A;MRPL9;RPS26;RPSA;MRPL51;MRPL13;MRPL34;MRPS18A;RPL5
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.7225444502550041,-1.9827977256328042,0.0,0.00512008140822548,0.06,62/174,13.42%,UQCR10;HSD17B10;ISCA1;SURF1;GPX4;IDH1;NDUFB7;ATP5MC1;NDUFA6;NDUFB1;MRPL15;OAT;TIMM8B;COX6C;COX7C;NDUFS6;ISCU;UQCRQ;ATP6V0E1;NDUFA1;ATP6V1F;COX7A2;ATP5PD;SLC25A6;COX5B;ATP5F1A;CYB5R3;ATP6V1G1;NDUFS8;NDUFA3;UQCRC1;TIMM13;PHB2;ATP5F1E;COX6B1;MRPS11;VDAC2;MRPS12;COX11;SLC25A4;COX4I1;COX17;COX5A;NDUFS3;ATP5PB;AIFM1;NDUFB2;NDUFA5;DLD;SLC25A5;ATP5F1D;NDUFAB1;ATP5ME;CYC1;PDHB;SUCLA2;GRPEL1;UQCRH;UQCRB;SLC25A20;NDUFB3;MRPS22
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6698772569800496,-1.974648800908229,0.0,0.006144097689870576,0.07,87/303,12.81%,RPS2;RPL29;RBM8A;RPL15;NOX4;SRSF7;RPL23A;MRPS33;PTMA;POLR2L;CPSF1;MRPL36;RPL10;POLR2J;MRPL27;MRPS7;RPLP1;RPS27A;MRPL10;RPL7A;RPS23;MRPS16;RPL10A;MRPL44;NUP42;RPS19;RPL18;RPL13;RPS24;RPL35A;POLR2I;POLR2G;RPS16;EEF1A1;RPS15;RPL8;RPS28;MRPL52;RPS7;RPL23;PAX8;RPL19;MRPL28;DDX54;RPLP0;RPS9;RPL37;RPL41;MRPS11;GSPT2;RPL13A;RPL3;RPL31;SARS1;RPL34;RPS15A;MRPL32;RPL35;MRPS12;MAGOH;U2AF1;RPL21;RPL11;RPL6;RBM15B;STUB1;RPL36;SLU7;RPS13;RPS3A;RPL38;EIF4EBP2;RPS11;RPL4;NUP155;EIF4A3;RPL9;MRPL24;MRPS18B;GSPT1;POLR2K;SRSF9;RPS8;RPL30;MRPS14;RPS5;NOVA1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7760005845339375,-1.9557972009279858,0.0,0.010880172992479144,0.1,41/80,15.96%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;TRMT112;MRPL27;MRPS7;MRPL10;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;MRPL52;MRPL28;MTRF1L;MRPS11;GSPT2;MRPL21;APEH;MRPL32;MRPS10;MRPL48;MRPS12;MRPL24;MRPS18B;GSPT1;MRPS14;MRPS22;MRPL9;MRPS2;MRPL51;MRPL13;MRPL16;MRPL34;MRPS18A;MRPL4;ERAL1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7936088119653077,-1.9521243359229554,0.0,0.010842525335065724,0.11,29/52,13.27%,NDUFB11;UQCR10;NDUFB7;NDUFA12;NDUFA6;NDUFB1;COX6C;COA6;COX7C;NDUFS6;UQCRQ;NDUFA1;COX5B;NDUFB10;NDUFS8;NDUFA3;UQCRC1;COX6B1;COX4I1;NDUFS5;COX5A;NDUFS3;NDUFB2;NDUFA5;NDUFAB1;CYC1;UQCRH;UQCRB;NDUFB3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.706591424424952,-1.9453487626590482,0.0,0.010809060750698235,0.12,61/154,12.78%,RPS2;RPL29;RBM8A;RPL15;RPL23A;RPL10;RPLP1;RPS27A;RPL7A;RPS23;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;POLR2G;LSM1;RPS16;PNRC2;EXOSC8;RPS15;RPL8;ZFP36L1;RPS28;RPS7;RPL23;RPL19;RPLP0;RPS9;RPL37;RPL41;UBA52;GSPT2;RPL13A;RPL3;DXO;RPL31;RPL34;RPS15A;RPL35;MAGOH;RPL21;RPL11;RPL6;RPL36;RPS13;RPS3A;RPL38;DDX5;RPS11;DCPS;RPL4;EIF4A3;RPL9;GSPT1;DCP1A;RPS8;RPL30;PPP2R1A;RPS5
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7905488882393858,-1.9313830641489869,0.0,0.014012854380406576,0.16,28/51,13.27%,NDUFB11;UQCR10;NDUFB7;NDUFA12;NDUFA6;NDUFB1;COX6C;COX7C;NDUFS6;UQCRQ;NDUFA1;COX5B;NDUFB10;NDUFS8;NDUFA3;UQCRC1;COX6B1;COX4I1;NDUFS5;COX5A;NDUFS3;NDUFB2;NDUFA5;NDUFAB1;CYC1;UQCRH;UQCRB;NDUFB3
prerank,PanglaoDB_Augmented_2021__B Cells,0.7965846308466211,1.9202827610616104,0.0,0.0,0.0,6/35,12.20%,EBF1;PTPRC;BCL11A;TRAF3IP3;CD27;PXK
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.7196691291495974,-1.8755043780825165,0.0,0.02867245588606269,0.25,32/72,15.43%,NDUFB11;NDUFAF8;SURF1;NDUFB7;NDUFA12;NDUFA6;NDUFB1;NDUFS6;NDUFA1;NDUFB10;NDUFS8;COX19;NDUFA3;SMIM20;SLC25A33;BCS1L;NDUFS5;COX17;NDUFS3;AIFM1;NDUFB2;NDUFA5;COX18;NDUFAB1;SDHAF4;TMEM126B;NDUFAF3;NDUFB3;DMAC2;TIMM21;COA5;UQCC3
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6708909752146511,-1.8707184382080335,0.0,0.029745234847786125,0.26,87/186,14.59%,TMA7;RPS2;RPL29;RPL15;RPL23A;MRPS33;MRPL36;TRMT112;RPL10;MRPL27;MRPS7;RPLP1;RPS27A;MRPL10;RPL7A;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;MRPL47;RPL35A;RPS16;EEF1A1;RPS15;RPL8;RPS28;MRPL52;EEF2;RPS7;RPL23;RPL19;MRPL28;RWDD1;FARSA;RPLP0;RPS9;RPL37;WARS2;RPL41;UBA52;MRPS11;GSPT2;RPL13A;RPL3;QARS1;RPL31;SARS1;RPL34;APEH;RPS15A;MRPL32;RPL22L1;TUFM;RPL35;MRPS12;RPL21;RPL11;RPL6;EEF1B2;RPL36;AARS1;RPS13;RPS3A;RPL38;EIF4EBP2;RPS11;RPL4;RPL9;MRPL24;MRPS18B;GSPT1;GATC;RPS8;RPL30;MRPS14;RPS5;RPL18A;MRPL9;RPS26;MRPS2;RPSA;MRPL51;MRPL13;MRPL16
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6212830176494533,-1.8527936013854898,0.0,0.04189157515820848,0.34,85/302,11.60%,RPS2;SPCS2;RPL29;RPL15;MMP2;RPL23A;MRPS33;TMEM208;UBL5;MRPL36;NCSTN;RPL10;MRPL27;SCG3;MRPS7;RPLP1;CKAP4;RPS27A;MRPL10;RPL7A;RPS23;MRPS16;NUCB1;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;ICMT;IGFBP7;RPS16;EEF1A1;RPS15;RPL8;RPS28;MRPL52;MSRB2;RPS7;RPL23;UBE2L6;RPL19;MRPL28;VWA1;RCN1;APH1A;RPLP0;RPS9;RPL37;RPL41;UBA52;MRPS11;GSPT2;RPL13A;SEC11C;CHGB;RPL3;RPL31;SARS1;RPL34;RPS15A;MRPL32;RPL35;MRPS12;RPL21;RPL11;RPL6;SEC11A;MFGE8;RPL36;RPS13;RPS3A;RPL38;RPN1;EIF4EBP2;RPS11;FN1;RPL4;HM13;CST3;RPL9;MRPL24;MRPS18B;GSPT1;FURIN
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.8325609522513762,-1.8425417534576158,0.0,0.04719379384973051,0.35,15/30,10.81%,NDUFB11;NDUFB7;NDUFA12;NDUFA6;NDUFB1;NDUFS6;NDUFA1;NDUFB10;NDUFS8;NDUFA3;NDUFS5;NDUFS3;NDUFB2;NDUFA5;NDUFAB1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.6527400219042304,-1.840967931472701,0.0,0.04522738577265841,0.35,80/176,19.13%,RPS2;SRSF7;ILF2;APEX1;PSMD8;RAN;SNRPD2;VBP1;ODC1;LSM7;EIF1AX;RPL18;RANBP1;ERH;PPIA;NHP2;PSMA7;HDGF;CCT5;KPNA2;H2AZ1;NOP56;RPLP0;PHB2;CSTF2;PA2G4;EIF3D;PRPF31;CCT3;YWHAQ;CANX;RPL34;SNRPG;TUFM;SRM;SET;U2AF1;CNBP;RPL6;COX5A;EEF1B2;EIF4H;EIF3J;HSP90AB1;NDUFAB1;CYC1;SNRPD1;MRPS18B;GSPT1;NPM1;RPS5;PCBP1;MCM4;RACK1;RSL1D1;MRPL9;SERBP1;SRPK1;DEK;SNRPB2;HNRNPA2B1;PSMC4;CCT7;PRDX3;IMPDH2;PSMB2;SRSF3;BUB3;PSMD3;EIF4G2;RUVBL2;POLD2;TRIM28;HNRNPR;SNRPA;COPS5;CBX3;RPL14;TARDBP;YWHAE
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.7582714746431223,-1.835777917468878,0.0,0.04686843750606401,0.38,21/50,13.29%,NDUFB11;NDUFAF8;NDUFB7;NDUFA12;NDUFA6;NDUFB1;NDUFS6;NDUFA1;NDUFB10;NDUFS8;NDUFA3;BCS1L;NDUFS5;NDUFS3;NDUFB2;NDUFA5;NDUFAB1;TMEM126B;NDUFAF3;NDUFB3;DMAC2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.7582714746431223,-1.835777917468878,0.0,0.04686843750606401,0.38,21/50,13.29%,NDUFB11;NDUFAF8;NDUFB7;NDUFA12;NDUFA6;NDUFB1;NDUFS6;NDUFA1;NDUFB10;NDUFS8;NDUFA3;BCS1L;NDUFS5;NDUFS3;NDUFB2;NDUFA5;NDUFAB1;TMEM126B;NDUFAF3;NDUFB3;DMAC2
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.9378211246911312,1.8306620652763885,0.0,0.06353381496042439,0.1,2/9,2.98%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.6859948055348334,-1.826482525362496,0.0,0.05461420168773846,0.48,42/111,16.51%,LSM4;RPL23A;RPL10;MRPS7;SNRPD2;SNRPB;RPS19;EIF5;RPS15;RPS28;RPLP0;NOL3;MRPS11;RPL3;PUF60;SNRPG;SF3A2;RPL11;RPL6;EIF4H;HSP90AB1;RPL38;BRIX1;COIL;SNRPD1;RPF2;DDX1;SRSF9;RPS5;DHX29;SRSF10;SNRPE;PRPF18;RPSA;PRPF19;SNRNP200;SRPK1;RPL5;SF1;PRMT5;ERAL1;CDC73
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.7294903504813934,-1.8213275810317566,0.0,0.05485801508813014,0.48,15/51,9.88%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.7936848287645955,-1.8100056475148047,0.0,0.0600285406481608,0.5,8/24,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;CTDP1;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7250486273769674,-1.7915047822220331,0.0,0.07475318856009201,0.55,24/39,17.99%,RPL23A;RPL10;MRPS7;RPS19;RPS15;RPS28;RPLP0;MRPS11;RPL3;RPL11;RPL6;BRIX1;SBDS;RPF2;NPM1;RPS5;DHX29;MRPS2;RPSA;RPL5;ERAL1;MTERF3;RPS14;RSL24D1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.7381314956902507,1.7842992683521435,0.0,0.13358391863473845,0.28,21/50,17.98%,SLC6A15;SLC6A11;SLC6A17;HCN3;SLC24A2;SCN8A;SLC4A4;HCN1;SLC6A6;SLC6A7;SLC12A1;SCN2A;NALCN;SLC6A8;SLC8A1;SLC9A9;SLC8A2;SLC4A8;SLC6A1;KCNK1;PKD2
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8948298921964133,1.77866886680922,0.0,0.10263154724376249,0.29,3/15,2.00%,CHRM3;HTR1F;HTR2C
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.8657473698466822,1.7703973585203852,0.0,0.0918796708658445,0.31,5/19,5.83%,HEY2;ROBO2;SOX9;SLIT3;EFNA1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.7334719236205339,1.752180913062755,0.0,0.0961152585298728,0.4,23/50,17.98%,SLC6A15;NEDD4L;SLC6A11;SLC6A17;HCN3;SLC24A2;SCN8A;SLC4A4;HCN1;SLC6A6;SLC9B2;SLC6A7;SLC12A1;SGK1;SCN2A;NALCN;SLC6A8;SLC8A1;SLC8A2;SLC4A8;SLC6A1;KCNK1;PKD2
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.8948774852455752,1.7323239103053907,0.0,0.12846397750239658,0.52,5/16,5.83%,HEY2;ROBO2;SOX9;SLIT3;EFNA1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.7917637770052351,1.7318750238614091,0.0,0.11362778444845133,0.53,6/27,9.85%,PTPRC;GPR18;FOXP1;DOCK8;TRAF3IP3;SLC12A1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6935063872409543,-1.7303120754226053,0.0,0.13807703410569358,0.77,19/63,9.88%,UBB;SIRT2;PSMB6;ELOB;PSMD8;RPS27A;PSMB4;UBC;STOX1;PSMA7;ELOC;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.5807193003302442,-1.729555826369763,0.0,0.13440213696591885,0.78,88/249,14.48%,RPS2;RPL29;RPL15;RPL23A;MRPS33;PTMA;POLR2L;MRPL36;RPL10;POLR2J;MRPL27;MRPS7;RPLP1;RPS27A;MRPL10;RPL7A;RPS23;MRPS16;RPL10A;RPS19;RPL18;RPL13;RPS24;RPL35A;POLR2I;POLR2G;RPS16;EEF1A1;RPS15;RPL8;RPS28;MRPL52;EEF2;RPS7;RPL23;PAX8;RPL19;MRPL28;RPLP0;RPS9;RPL37;RPL41;MRPS11;GSPT2;RPL13A;RPL3;KIN;RPL31;SARS1;RPL34;RPS15A;MRPL32;TUFM;RPL35;PIF1;MRPS12;SET;RPL21;RPL11;RPL6;PTMS;EEF1B2;RPL36;RPS13;RPS3A;RPL38;EIF4EBP2;RPS11;RPL4;RPL9;RAD17;MRPL24;MRPS18B;GSPT1;POLR2K;GAL3ST4;RPS8;RPL30;MRPS14;RPS5;MCM4;POLR2E;RPL18A;MRPL9;RPS26;RPSA;MRPL51;MRPL13
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.8267208766251254,1.7286561943337833,0.0,0.10643271566019813,0.56,9/24,7.33%,PTPRC;ITPR1;GRIN2A;HTR2C;SLC24A2;RYR3;GRIN1;RYR2;ITPR2
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.67151977936376,-1.7229688399015748,0.0,0.1415004316455042,0.79,12/50,9.88%,PSMB6;PSMD8;PSMB4;PSMA7;NABP2;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5595054297169165,1.7159210436014585,0.0,0.1182706401570977,0.64,127/354,22.63%,EEF2K;IGF1R;CTBP1;TLK1;NUAK1;NEK3;VRK1;DAPK1;ALK;MERTK;AKT2;CAMK1D;GRK4;DAPK2;RPS6KB2;RELN;PAK1;FAM20C;PRKX;CAMK2B;BCR;PRKAR1B;CDC42BPB;TSSK3;PNCK;PRKCA;CDK19;TGFBR3;LIMK1;CDKL1;TYRO3;PAK2;RIPK1;CDK14;JAK1;MAK;EPHA4;OXSR1;CDK6;MAPK10;TNKS;MAPK12;SGK1;ATM;TTBK2;CIT;MAP3K9;RARA;GRK5;PDPK1;MAST4;CAMK1;CDK7;CDK12;TOP1;PRKG1;TNIK;ERC1;STK3;AKT3;RPS6KA2;PXK;CAMK2D;MKNK1;NIM1K;TAF1;PIK3CD;ACVR1C;STK11;SIK3;LMTK2;STK17B;PRKAA2;MAP3K5;DCLK1;MASTL;VRK2;CSNK1G1;CDK17;FAM20A;PLK2;PRKCE;CDK13;CSNK1D;SRPK2;CDC7;MAPKAPK5;PRKCZ;DAPK3;NEK7;NEK4;ADAM10;PRKAA1;RYK;NEK11;EIF2AK3;FER;MAP3K11;ACVR1B;MAML1;STK17A;COQ8B;STK36;LIMK2;ABL2;EPHA3;PRKACB;CDK4;MAPK3;MAPK1;SIK2;TAOK1;STK24;NEK10;CSNK1G2;ATR;BRSK1;PRKAG2;ABI2;CDK9;MAP3K12;AATK;ERBB4;DAB2IP;ULK2;RICTOR;PDK2
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.8953844247579883,1.7145835164886352,0.0,0.11285027272690765,0.67,2/14,1.69%,HEY2;SOX9
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6820132984487955,-1.7137410883518465,0.0,0.15149417343161273,0.83,20/69,9.88%,UBB;PSMB6;ELOB;PSMD8;RPS27A;ATF4;PSMB4;UBC;STOX1;PSMA7;ELOC;BAG3;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7727456335239243,-1.7090778993003093,0.0,0.1568207791319347,0.85,8/28,11.85%,LSM4;LSM7;POLR2G;LSM1;EXOSC8;EDC3;DCPS;DCP1A
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.8000920702141783,-1.705365675744534,0.0,0.15616248295087717,0.85,3/19,1.82%,TRMT112;SMYD2;CSKMT
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.7758897883742693,-1.7016586588326335,0.0,0.1599679488623961,0.88,9/28,9.23%,UBB;SIRT2;RPS27A;UBC;CDC26;NPM2;PHB2;UBA52;ANAPC11
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.6800437486968293,-1.6999463862708704,0.0,0.15872252365498987,0.89,21/54,18.01%,PSMB6;PSMD8;CALR;PSMB4;PSMA7;PSMC3;PSMD10;HLA-B;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;IKBKB;B2M;ITGB5;PSMD4;PSMC4;PSMB2;PSMD3;PSMD11
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.6941008186325082,1.6940432022001874,0.0,0.16616536220418687,0.81,17/63,11.93%,HEY2;CORO6;FABP3;EDNRA;CKMT2;SYNPO2;ZFPM2;SORBS1;PDE1A;LAMA2;TTN;CAV3;RYR2;MYOM1;ADIPOR2;PRKG1;TPM1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.6907471591977523,-1.6895605783769132,0.02,0.17224478993825204,0.89,21/53,14.54%,PPP1R14B;EIF5A;AGRN;TUBA1C;RPL8;KDELR1;HDGF;NR2F6;HNRNPAB;SAPCD2;CCT3;TUBG1;NOC2L;GIPC1;LAMA5;SLC25A1;PYCR1;TRAF4;MRPS2;DHCR7;FKBP4
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.8314517626577766,-1.687136629514534,0.0,0.16758900609362426,0.9,4/17,3.19%,POLR2L;POLR2J;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.8314517626577766,-1.687136629514534,0.0,0.16758900609362426,0.9,4/17,3.19%,POLR2L;POLR2J;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.7638452861437905,-1.6860132599625774,0.0,0.16481785866478213,0.91,13/32,15.57%,LSM4;SNRPD2;SNRPB;PRPF8;PRPF31;SNRPG;CD2BP2;COIL;SNRPD1;SRSF10;SNRPE;PRPF19;PRMT5
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.9163923740729001,1.6848920711150963,0.0,0.17969919260995773,0.85,2/12,0.62%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.7094965442548591,-1.6837055871610398,0.0,0.16693846824028197,0.91,12/42,9.88%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,PanglaoDB_Augmented_2021__NK Cells,0.8106673858031339,1.680468784428846,0.0,0.18222335939198644,0.87,11/28,15.59%,PTPRC;AHR;ITGA2;HSD11B1;ZBTB16;TRAF3IP3;CD27;CD247;HMBOX1;AOAH;KLRD1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6952296814594443,-1.6801647460541962,0.0,0.17035907231004782,0.91,12/45,9.88%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.880179785053135,1.679456538904185,0.01639344262295082,0.17203002204668758,0.87,3/11,1.98%,PTPRC;ITGA2;SHTN1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6508963659092166,1.6778858785734379,0.0,0.16799806840496834,0.87,29/88,18.10%,ABLIM1;HOOK1;BAIAP3;RAPGEF5;KIAA1671;SORBS1;NEBL;ARFGEF3;ADCY5;SYBU;SH3BGRL2;SRCIN1;USP54;SHC2;AQP4;RAI2;NDRG2;PDE9A;SLC22A23;MTUS1;ASAP3;CHDH;PRKCZ;PPP1R13B;SPARCL1;KCNQ1;SLC6A1;ABAT;ANK3
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.7028215732380623,-1.6748943978059105,0.018867924528301886,0.17453788622706418,0.92,11/40,11.01%,BGN;BCAN;STAB2;HSPG2;AGRN;GPC4;GUSB;GALNS;CD44;SGSH;NCAN
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.623116066059431,1.6747627914510388,0.0,0.17019012876276576,0.87,27/136,9.13%,CHRM3;GABRA4;UNC13C;GABRG3;GLRA1;GLRA2;GRIN2A;SYT1;HTR1F;HTR2C;KCNQ3;KCNC4;PCDHB5;APBA2;PRKAR1B;GRM3;CHRNB3;GRIN1;NRGN;GABRB1;AKAP5;SNAP25;GABRG2;PRKAR2A;GPR176;GABRA2;DLG4
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.5877687795892331,-1.6738635242855022,0.0,0.17185664552826396,0.92,70/244,15.71%,RBM8A;LSM4;SRSF7;POLR2L;UBL5;CPSF1;SF3B5;POLR2J;PPWD1;GTF2F1;SNRPD2;SNRPB;RBM22;LSM7;DNAJC8;POLR2I;POLR2G;HNRNPA0;HSPA8;SMU1;SF3B6;ZMAT2;SCNM1;PRPF8;CSTF2;PRPF31;PUF60;CWC15;CSTF2T;SNRPG;SF3A2;CACTIN;MAGOH;U2AF1;BUD13;RBM15B;SLU7;SMNDC1;DDX5;DCPS;CD2BP2;COIL;EIF4A3;SNIP1;PDCD7;SNRPD1;POLR2K;DDX1;YBX1;SRSF9;SYF2;NOVA1;PCBP1;WBP11;SRSF10;SNRPE;POLR2E;NONO;SF3B2;BUD31;PRPF19;SNRNP35;SNRNP200;PRPF38A;SRPK1;RBM17;SF1;PRMT5;SNRPB2;HNRNPA2B1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6551403991837377,-1.6690641153915442,0.0,0.17713302914414109,0.94,17/62,9.88%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;CDC26;PSMA7;UBA52;PSMC3;PSMD10;PSME3;PSMD12;ANAPC11;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.7352875724915389,1.6666122919009472,0.0,0.1922305170597456,0.92,7/36,5.24%,AHR;GLRA1;AKR1C2;GLRA2;GRAMD1C;KLF9;ADCY5
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6708471616513805,-1.6655342994658278,0.0,0.17877617583720637,0.95,21/56,18.01%,PSMB6;PSMD8;CALR;PSMB4;PSMA7;PSMC3;PSMD10;HLA-B;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;IKBKB;B2M;ITGB5;PSMD4;PSMC4;PSMB2;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.8793247801149185,1.6640923966026198,0.0,0.19240199834169006,0.94,6/13,7.33%,PTPRC;ITPR1;HTR2C;RYR3;RYR2;ITPR2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.5921813454978614,1.662211730753947,0.0,0.18815783661356453,0.95,46/178,12.96%,CHRM3;GABRA4;UNC13C;GABRG3;GLRA1;GLRA2;GRIN2A;SYT1;HTR1F;SHISA6;HTR2C;KCNQ3;KCNC4;RAB3A;CBLN2;GRIK5;PCDHB5;APBA2;CDH8;PRKAR1B;GRM3;CHRNB3;GRIK3;SYN3;GRIN1;NRGN;GABRB1;AKAP5;SNAP25;GABRG2;LIN7A;NAAA;PRKAR2A;GPR176;SLC1A4;GABRA2;DLG4;NAPB;STX1A;CAMK1;KCNMB4;GRM1;ERC1;RPS6KA2;STXBP3;SNCA
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6685053681526847,-1.6614132642783626,0.0,0.18641275984233177,0.96,39/87,15.13%,CHCHD1;AURKAIP1;MRPL40;MRPS33;GADD45GIP1;MRPL36;MRPL27;MRPS7;MRPL10;MRPS16;MRPL44;MRPL15;MRPL47;MRPL50;MRPS26;EEF1A1;MRPL52;EEF2;MRPL28;MRPS11;MRPL21;MRPL32;TUFM;MRPS10;MRPL48;MRPS12;EEF1B2;MRPL24;MRPS18B;MRPS14;MRPS22;RACK1;MRPL9;MRPS2;MRPL51;MRPL13;MRPL16;MRPL34;MRPS18A
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7550461822260619,1.6568068766811248,0.0,0.20805578965062055,0.95,9/28,14.01%,UNC13C;SYT1;PCLO;RAB3A;SNAP25;STX1A;SYT2;SNCA;CPLX1
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.6652661873645767,-1.6543497032683574,0.0,0.1964063228195294,0.96,18/51,18.01%,PSMB6;PSMD8;ODC1;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;CAV1;PSMD4;PSMC4;PSMB2;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.9206913232596641,1.6530116755041049,0.0,0.21281606549680618,0.95,2/10,0.62%,HEY2;ROBO2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.7108581927102225,-1.6528523865438245,0.0,0.19556703104359288,0.97,8/37,9.67%,CNPPD1;CCND1;CDKN2C;ACTB;STOX1;CCNK;CDC37;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.6259373648281727,-1.650217899884609,0.0,0.19810776525672433,0.97,11/78,8.04%,CNPPD1;CCND1;CDKN2C;THY1;CALM1;ACTB;SYAP1;PIH1D1;CCNK;CALM3;CDC37
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.7311114600592278,-1.6495479617631985,0.0,0.1951427253701032,0.98,11/33,12.27%,TSR1;RPS19;RPS16;RPS28;NOL11;NGDN;RIOK2;MRPS11;NOP14;TSR3;RPS8
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.553519652363521,1.6480887522839682,0.0,0.22311205922557056,0.99,104/297,21.90%,CTBP1;TLK1;NUAK1;NEK3;VRK1;EPHA7;DAPK1;ALK;MERTK;GRK4;DAPK2;PAK1;FAM20C;CAMK2B;BCR;PRKAR1B;DGKG;CDC42BPB;TSSK3;PRKCA;CDK19;LIMK1;CDKL1;DGKZ;PAK2;CDK14;JAK1;MAK;OXSR1;CDK6;MAPK10;SGK1;ATM;MAP3K9;RARA;GRK5;PDPK1;CAMK1;CDK7;CDK12;TOP1;PRKG1;TNIK;STK3;AKT3;PXK;CAMK2D;MKNK1;NIM1K;TAF1;PIK3CD;ACVR1C;STK11;SIK3;LMTK2;STK17B;PRKAA2;MAP3K5;DCLK1;VRK2;CDK17;FAM20A;PLK2;PRKCE;CDK13;CSNK1D;SRPK2;AGK;PRKCZ;DAPK3;NEK7;NEK4;ADAM10;PRKAA1;CERK;RYK;NEK11;DGKI;EIF2AK3;FER;STAT3;DGKD;MAP3K11;ACVR1B;MAML1;STK17A;COQ8B;STK36;LIMK2;PRKACB;CDK4;MAPK3;MAPK1;SIK2;PIK3CA;TAOK1;STK24;NEK10;CSNK1G2;BRSK1;PRKAG2;CDK9;MAP3K12;AATK
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.7467495263776123,1.6454181435309034,0.0,0.22481196062919398,0.99,6/27,9.16%,HEY2;SOX9;TTN;RYR2;TGFBR3;HES1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.5893926532616492,-1.6434077630093529,0.0,0.2049928889737683,0.98,64/225,15.71%,RBM8A;LSM4;SRSF7;POLR2L;UBL5;CPSF1;SF3B5;POLR2J;PPWD1;GTF2F1;SNRPD2;SNRPB;RBM22;LSM7;DNAJC8;POLR2I;POLR2G;HNRNPA0;HSPA8;SMU1;SF3B6;ZMAT2;PRPF8;CSTF2;PRPF31;PUF60;CWC15;CSTF2T;SNRPG;SF3A2;CACTIN;MAGOH;U2AF1;BUD13;RBM15B;SLU7;SMNDC1;DDX5;CD2BP2;EIF4A3;SNIP1;PDCD7;SNRPD1;POLR2K;YBX1;SRSF9;SYF2;NOVA1;PCBP1;WBP11;SRSF10;SNRPE;POLR2E;NONO;SF3B2;BUD31;PRPF19;SNRNP35;SNRNP200;PRPF38A;RBM17;SF1;SNRPB2;HNRNPA2B1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6702404606265254,-1.6431084551668795,0.0,0.20219666943028625,0.98,16/46,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;PSMD4;PSMC4;PSMB2;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.7692233568200978,1.6403772879404694,0.044444444444444446,0.2291127111803612,1.0,5/22,4.37%,CHRM3;NEDD4L;KCNJ13;KCNJ11;AHCYL1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.948737469208248,-1.6397466244893073,0.020833333333333332,0.2071804369828382,0.98,2/7,0.81%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.7233538978594716,-1.639614638777752,0.02,0.2037253444536033,0.98,18/47,10.75%,PPIF;BAD;AIP;TSPO;TIMM8B;SLC25A6;TIMM13;TIMM23;TOMM7;TIMM44;SLC25A24;DNAJC19;SLC25A4;BCS1L;TIMM22;SLC25A5;COX18;MFF
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6787825188984848,-1.6393565240796972,0.0,0.20091905664002055,0.98,24/54,16.56%,MRPL36;ZNF658;RPS19;RPS24;RPL35A;RPS16;RPS15;LTV1;RPS28;EBNA1BP2;RPS7;RIOK2;METTL17;NOP14;NOC2L;RPL11;RPL38;RPF2;NPM1;NIP7;MRTO4;RPL5;CUL4B;LTO1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.6603960618014142,-1.6393034137771947,0.0,0.1975136489003592,0.98,18/63,16.51%,POLR2L;ELOB;POLR2J;GTF2F1;POLR2I;POLR2G;TCEA1;ELOC;CCNK;ADRM1;CTDP1;POLR2K;TCEA2;POLR2E;GTF2H2;EAF1;PAF1;CDC73
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.6569218591155986,-1.6387364752974394,0.0,0.19558710979421332,0.98,21/80,14.10%,AURKAIP1;SRSF7;SNRPB;HNRNPA0;PCBP3;ERN1;TBRG4;PRPF8;DXO;KIN;SNRPG;SF3A2;U2AF1;NUDT16L1;DDX5;RNH1;SRSF9;SNRPE;NONO;PRPF18;SF3B2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.9439039100324593,-1.6382327600282405,0.023809523809523808,0.1933879928615001,0.98,2/8,0.81%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),-0.9741377505753173,-1.6374701745860296,0.0,0.19274629043223018,0.98,1/8,0.55%,SIRT2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.9448317200293586,1.6370442335548328,0.0,0.23421045396653484,1.0,2/9,1.93%,INTU;WNT7A
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.750420281645108,-1.6366027551411457,0.0,0.19245004404250696,0.98,10/24,11.45%,OST4;DDOST;DAD1;DPM2;UBE2J1;MAGT1;OSTC;RPN1;STT3A;ALG8
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.5937076504001162,-1.636479293766026,0.0,0.1899230197363639,0.98,27/115,13.51%,MRPL40;SURF1;POLR2J;GPX4;VPS37B;EIF1B;GTF2F1;VPS28;POLR2I;POLR2G;MPC2;NME3;TMED2;DAD1;GTF2A2;EDF1;ADRM1;COX17;MPG;ADCY6;TAF6;POLR1D;POLR2K;GMPR2;DGCR8;DGUOK;POLR2E
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.9589871264887478,1.6357141121800733,0.0,0.2298801851844415,1.0,2/6,2.98%,ITGA2;ITGA8
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.6389646343104094,-1.634844142503151,0.021739130434782608,0.1903094874195809,0.98,11/43,13.89%,SOX4;COPS9;UBXN1;VPS28;DNAJA1;RPL11;UFL1;CAV1;ISG15;PRR7;PARK7
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6433739338868263,-1.633970641418975,0.0,0.18944301210434278,0.98,24/97,9.88%,UBB;SIRT2;PSMB6;ELOB;PSMD8;RPS27A;BAD;PSMB4;UBC;STOX1;ZFP36L1;MT3;PSMA7;ELOC;SFRP1;UBA52;PSMC3;PSMD10;PSME3;PSMD12;STUB1;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.9286761565957714,-1.6333675632570015,0.0,0.18829672522190424,0.98,1/8,0.48%,NOX4
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.8518214682702564,1.6325340664091386,0.0,0.2324918723277068,1.0,6/13,11.37%,PTPRC;IL5;CYLD;RORA;TRAF3IP3;CD247
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.6603558765111953,-1.6307085221362678,0.0,0.19275600595672399,0.98,11/62,8.46%,POLR2L;ELOB;POLR2J;GTF2F1;POLR2I;POLR2G;TCEA1;ELOC;CCNK;ADRM1;CTDP1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.7995061887652761,-1.63053276041916,0.0,0.19025925696652365,0.98,5/22,6.31%,UBB;RPS27A;DERL2;UBC;UBA52
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7681171965167763,-1.6294393874246669,0.0,0.19017445230551785,0.98,17/37,14.26%,MRPS7;RPS19;RPS24;RPS16;RPS15;LTV1;RPS28;NOL11;RPS7;RIOK2;MRPS11;METTL17;NOP14;TSR3;NPM1;RPS5;RPSA
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.6811785150529761,1.6237483428106672,0.03773584905660377,0.25582050692287595,1.0,8/33,9.85%,GABRA4;GABRG3;GLRA1;GLRA2;GABRB1;GABRG2;GABRA2;SLC12A1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.6895929199943345,1.6228643927681388,0.017857142857142856,0.2505513010490582,1.0,15/51,12.67%,GRIN2A;SHISA6;CNIH2;DAPK1;CACNG2;RELN;CAMK2B;BEGAIN;GRIN1;GSG1L;DLG4;NEFL;MAPK8IP2;CACNG8;SHISA9
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.7950164813836195,-1.6219537370838712,0.0,0.20509171161962345,0.98,9/20,16.72%,PTTG1IP;CXCL12;PSMD10;CD44;YJU2;CLU;TMEM161A;CDKN2D;TPT1
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8904974050389848,1.6211801503633063,0.023809523809523808,0.24877508686736893,1.0,1/6,0.17%,CHRM3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.5669219041549527,-1.620797580612375,0.0,0.20437658287833377,0.98,39/179,15.66%,GTF3C6;GMEB2;TAF9B;PTMA;POLR2L;ELOB;POLR2J;GTF2F1;ATF4;POLR2I;POLR2G;TCEA1;PARP1;PAX8;ELOC;DRAP1;GTF2A2;SMARCA5;BTF3;TAF7;CCNK;SLC25A33;CTDP1;TAF11;NAT14;COPS2;DDX5;TAF4B;TAF6;POLR2K;TCEA2;RO60;POLR2E;GTF2H2;TAF1A;TFB2M;EAF1;PRMT5;DEK
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.7227214078388471,-1.620763049149427,0.0,0.20157690366082234,0.98,10/35,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;LARP7;CTDP1;IFITM3;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.6543630084377091,-1.6203074371387547,0.0,0.19982155549939443,0.98,12/58,11.90%,EIF1;MIF4GD;EIF1B;ATF4;EIF5;POLR2G;PPP1R15B;EIF4H;EIF2B2;EIF4EBP2;NPM1;DDX1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.6292503417515236,-1.6189020287933602,0.0,0.2002975846897808,0.98,29/94,16.29%,LSM4;IMP3;YIF1A;CALR;BANF1;POP4;ATF4;LSM1;NHP2;EEF2;NOP56;BAG3;ERN1;NOP14;TUBB2A;SEC11A;PSAT1;EIF4A3;NPM1;DCP1A;ATP6V0D1;FKBP14;H2AX;IFIT1;HSPA9;HSP90B1;HSPA5;KHSRP;EIF4A2
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.8696492912276672,1.6179032283123724,0.0,0.25382980880823397,1.0,6/14,7.33%,PTPRC;ITPR1;HTR2C;RYR3;RYR2;ITPR2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.7835078075294138,1.6178311402966516,0.020833333333333332,0.2464341913616461,1.0,5/21,13.40%,KIF1C;TRAK1;RAB1A;FYCO1;FBXW11
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.6463030303243392,-1.6168936712382178,0.022222222222222223,0.20237795460933344,0.98,15/57,15.57%,POLR2L;CPSF1;SNRPB;POLR1F;CSTF2;CSTF2T;SNRPG;POLR1A;POLR2K;SNRPE;POLR2E;GTF2H2;POLR1G;TAF1A;PRMT5
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.8492474992669661,-1.6138221038994862,0.01694915254237288,0.2049362454565056,0.99,4/13,9.93%,PPIF;BAD;SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.772796614138552,1.6131142112078962,0.0,0.2621847929588554,1.0,4/19,5.51%,RASGRF1;RELN;ERBIN;MMD2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.7517723239113164,1.612344656364139,0.0,0.2591621111352696,1.0,3/19,6.48%,HOOK1;WDR91;EMP2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8687135986269678,-1.6115295570576187,0.0,0.20861049635052017,0.99,3/15,3.88%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.9110535000249863,1.6099825707894835,0.0,0.26200910870431426,1.0,2/9,2.41%,PON1;PON3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.7476843305330018,1.6081509962036546,0.0,0.2625888235786355,1.0,5/28,3.37%,EFNA5;PTPRR;EPHA7;MDGA1;TENM3
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.6322017793674013,-1.6079851286292652,0.0,0.21672850922918996,1.0,10/74,6.69%,SOX4;EIF5A;PIWIL2;TRMT10C;POLR2G;PCIF1;EEF2;RPS9;FXR2;EIF3D
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.657192945940464,-1.604500479808416,0.0196078431372549,0.22425956568027608,1.0,16/41,16.49%,ATP5MC1;ROMO1;TIMM8B;ATP5PD;ATP5F1A;MICOS13;TIMM13;ATP5F1E;ATP5PB;TIMM22;ATP5F1D;ATP5ME;HSPA9;UQCC3;ATP5MC3;MTX3
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6985306418476657,-1.6028105953482086,0.0,0.22680064311991388,1.0,23/47,17.99%,RPL23A;RPL10;RPL7A;RPL10A;RPL35A;NHP2;EBNA1BP2;RPLP0;RPL3;NOC2L;RPL11;RPL6;BRIX1;RPF1;RPF2;NPM1;RSL1D1;NIP7;MRTO4;RPL5;LTO1;SURF6;RSL24D1
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.9600668908467606,1.601109536265613,0.0,0.2855163344375347,1.0,2/6,2.41%,PON1;PON3
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.9101635959135586,-1.6010939397347026,0.022727272727272728,0.22790606268320737,1.0,2/9,1.82%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6271640475678515,1.6010526962399463,0.0,0.27869665576328173,1.0,16/73,11.00%,KCNH7;KCNQ3;KCNJ13;KCNC4;KCNJ11;HCN3;SLC24A2;KCNN3;KCNC2;KCNQ5;HCN1;KCNB2;KCND3;SLC12A1;KCNH1;NALCN
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8701222097210853,1.600109890709302,0.0,0.2763720950778461,1.0,4/10,6.17%,GLRA1;GLRA2;GRIN2A;GRIN1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.9400150763312184,-1.599991049134622,0.0,0.22861471926365817,1.0,3/8,2.84%,HSD17B10;TRMT10C;TRMT5
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.8905959457996041,1.598903271684725,0.0,0.274160927596578,1.0,3/11,4.53%,FOXO1;SOX9;GLDC
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.8416151774807172,-1.5984415951560051,0.0,0.22942840976857987,1.0,5/17,6.31%,UBB;RPS27A;DERL2;UBC;UBA52
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.8680288440953638,1.5980684818121376,0.02127659574468085,0.2706587062233464,1.0,5/10,11.93%,ADAMTS9;PKP2;TGFBR3;PROX1;TPM1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.6634289744791341,-1.5972033393201412,0.023255813953488372,0.22974106459967036,1.0,12/60,6.74%,POLR2L;POLR2J;GTF2F1;RAN;POLR2I;POLR2G;LSM1;NT5E;HNRNPA0;KPNA2;DDX54;DXO
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.55104343360125,-1.5937136723268335,0.0,0.2371907480275618,1.0,70/265,15.71%,AURKAIP1;RBM8A;LSM4;SRSF7;POLR2L;UBL5;CPSF1;SF3B5;POLR2J;PPWD1;GTF2F1;SNRPD2;SNRPB;RBM22;LSM7;DNAJC8;POLR2I;POLR2G;HNRNPA0;HSPA8;SMU1;SF3B6;ZMAT2;ERN1;TBRG4;PRPF8;CSTF2;PRPF31;KIN;PUF60;CWC15;CSTF2T;SNRPG;SF3A2;CACTIN;MAGOH;U2AF1;BUD13;RBM15B;SLU7;SMNDC1;DDX5;CD2BP2;EIF4A3;SNIP1;PDCD7;SNRPD1;POLR2K;YBX1;SRSF9;SYF2;NOVA1;PCBP1;WBP11;SRSF10;SNRPE;POLR2E;GTF2H2;NONO;PRPF18;SF3B2;BUD31;PRPF19;SNRNP35;SNRNP200;PRPF38A;RBM17;SF1;SNRPB2;HNRNPA2B1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.7844756365524556,1.5930126831497544,0.02,0.28573168302416263,1.0,7/21,11.37%,PTPRC;AHR;IL5;STAT6;RORA;TRAF3IP3;CD247
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.7587068219101535,1.5908626276781699,0.0196078431372549,0.29056723765117165,1.0,8/27,9.68%,GRIN2A;DAPK1;RELN;CAMK2B;GRIN1;DLG4;NEFL;MAPK8IP2
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.8071502435904266,-1.5908384868761336,0.021739130434782608,0.24064382618659758,1.0,3/14,7.92%,CUBN;CD320;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.8071502435904266,-1.5908384868761336,0.021739130434782608,0.24064382618659758,1.0,3/14,7.92%,CUBN;CD320;MMACHC
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7901510133962548,-1.5898208435846362,0.023255813953488372,0.24104652921870517,1.0,4/19,4.23%,NOP10;TRMT112;BUD23;NHP2
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.6517556843567859,1.5893076905797365,0.0,0.29214694400605407,1.0,8/51,8.12%,ACACB;HIF3A;CKMT2;KCNJ11;SORBS1;CECR2;RYR2;SYCP2L
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6295395353766006,1.589099319363648,0.0,0.286433386510542,1.0,16/66,11.15%,KCNH7;KCNQ3;KCNJ13;KCNC4;KCNJ11;HCN3;SLC24A2;KCNN3;KCNC2;KCNQ5;HCN1;KCNB2;KCND3;KCNH1;NALCN;KCNMB4
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.8337819405208758,-1.588816669469626,0.022727272727272728,0.24155406288139325,1.0,7/14,11.24%,ATP5MC1;ATP5PD;ATP5F1A;ATP5F1E;ATP5PB;ATP5F1D;ATP5ME
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.8327363362298105,1.5874759799275777,0.01694915254237288,0.2867860256315065,1.0,4/10,11.37%,PTPRC;TRAF3IP3;CD27;CD247
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.825185207036507,-1.5857001650817018,0.021739130434782608,0.24846460987608482,1.0,7/15,11.24%,ATP5MC1;ATP5PD;ATP5F1A;ATP5F1E;ATP5PB;ATP5F1D;ATP5ME
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.765864799972122,-1.5837566754200025,0.0,0.25021615229762784,1.0,9/26,16.31%,LSM4;LSM7;LSM1;EXOSC8;EDC3;DCPS;DCP1A;NT5C3B;LSM3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.963475620195352,1.5833569668104026,0.0,0.2995456468166163,1.0,2/8,1.69%,HEY2;SOX9
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.7757044525356078,-1.5797358875569507,0.0,0.2595275672943539,1.0,5/19,6.31%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.6943914743905661,-1.5775805597147774,0.02127659574468085,0.2611241518194995,1.0,6/45,3.88%,RRAGA;SIRT2;DAPL1;LZTS1;KIF25;MT3
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.9234566696269928,1.5765626054845097,0.018518518518518517,0.32455107359689317,1.0,1/8,1.27%,GRAMD1C
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.7334865358369762,-1.5753797126117561,0.0,0.2645195742270596,1.0,5/22,9.67%,NOP10;PPIA;NHP2;PIF1;HSP90AB1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.6043159447752426,-1.571611512074029,0.02040816326530612,0.27328434516403505,1.0,27/99,10.85%,SPCS2;ZDHHC1;VPS37B;SRP14;AIP;NACA;ICMT;TSPO;TIMM8B;ZDHHC6;SEC61G;AP4M1;SLC25A6;GOLGA7;ZDHHC4;TIMM13;TIMM23;TOMM7;TIMM44;YIF1B;CDC37;DNAJC19;RPL11;GIPC1;TIMM22;MFF;MICALL1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.7489469984812487,-1.5693323662540242,0.0,0.2774345142436404,1.0,2/25,0.81%,GTF3C6;POLR2L
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.9362358324312342,1.5686229630437816,0.0,0.36048109165237713,1.0,1/9,0.46%,VSIR
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.8011619892835372,-1.5658835796138604,0.044444444444444446,0.2850526955436553,1.0,5/18,12.47%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V0E2;ATP6V0D1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.7378003113667598,-1.5658357992091216,0.018518518518518517,0.2822768113746936,1.0,8/24,13.89%,UBXN1;TMBIM6;ALOX5;SELENOS;CREB3;CLU;RACK1;PARK7
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7776931677470317,1.5637809569915035,0.022222222222222223,0.3798613009096867,1.0,6/20,10.43%,CDH9;CDH7;PCDHB5;CDH8;CDH12;CDH20
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.788303219994503,1.5624647467839443,0.0,0.3802630404288122,1.0,3/15,3.76%,ROBO2;ZFPM2;LRP2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.5527669600165622,-1.5614847018985267,0.0,0.29317586143499097,1.0,32/136,15.01%,NR0B1;TAF9B;POLR2L;POLR2J;GTF2F1;ESRRB;POLR2I;POLR2G;POLR1F;NR2F6;GTF2A2;SMARCA5;TAF7;MED23;RRN3;TAF11;NAT14;HNF4G;NR2E1;POLR1A;TAF4B;RXRB;TAF6;POLR2K;YAP1;HDAC3;ESRRA;POLR2E;GTF2H2;POLR1G;TAF1A;TFB2M
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.592942464290584,-1.5600411299525998,0.0,0.29564668091852475,1.0,25/90,12.58%,COL9A3;BGN;MMP2;PODN;THY1;PRRX1;ATF4;FIBIN;IGFBP7;COL12A1;CHAD;SCRG1;THBS2;SFRP1;PDGFRA;CXCL12;HAS2;CHODL;FN1;ADAMTS2;SEMA5A;GAS1;AEBP1;HAPLN1;BMP2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.6625475044119127,-1.5576901606340978,0.0,0.30007692802325414,1.0,18/51,16.72%,PPIF;PTTG1IP;RTKN2;TMBIM6;PPIA;CXCL12;NOL3;SELENOS;DNAJA1;NOC2L;NDUFS3;CREB3;CLU;TMEM161A;PARK7;AKT1;CDKN2D;TPT1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.853184842182664,-1.5566004438335381,0.045454545454545456,0.300245550540601,1.0,2/11,3.51%,TRIR;EXOSC8
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.7300105771249844,-1.5563589003883218,0.0,0.2978508896131169,1.0,10/25,11.45%,OST4;DDOST;DAD1;DPM2;UBE2J1;MAGT1;OSTC;RPN1;STT3A;ALG8
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8772757779914281,1.5559592658468102,0.0,0.4099729191785875,1.0,2/10,2.48%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.8576012160849,-1.5549295494028947,0.041666666666666664,0.29911027960052466,1.0,6/11,11.34%,PPIF;GPX1;NOL3;PSMD10;CLU;PRELID1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.6143675228815917,1.5544507056878556,0.0,0.4088971167965775,1.0,19/66,14.93%,RASGRF1;TBC1D4;TBC1D10B;TIAM1;TBC1D13;NTRK3;BCR;RANGAP1;ARHGAP24;DOCK7;BCAS3;SGSM1;RAP1GAP2;TBC1D8;TBC1D22B;SIPA1L1;TBC1D1;TIAM2;TSC1
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.8161905333188145,-1.552589740847316,0.018867924528301886,0.3055625942305131,1.0,3/14,0.83%,THNSL2;HPD;HSD17B10
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6613533279548268,1.5523968914342439,0.0,0.411947924694444,1.0,9/41,11.28%,DOCK5;PTPRR;SOX9;ENPP2;MACF1;EMP2;SASH1;RHOJ;PTPRG
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.7118248929311758,-1.552336474945557,0.04,0.3034724887006168,1.0,13/23,16.60%,SQLE;TM7SF2;SC5D;MSMO1;ARV1;IDI1;PMVK;ACAT2;HMGCS1;ACLY;DHCR7;FDPS;LBR
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.5542981234248459,-1.5522078145296008,0.0,0.30132627250630695,1.0,26/145,10.72%,UBB;SIRT2;PSMB6;PSMD8;RPS27A;PSMB4;UBC;SSNA1;CDC26;ZFP36L1;TUBA1A;PSMA7;RIOK2;NPM2;UBA52;TUBG1;PSMC3;PSMD10;PSME3;TUBB4B;PSMD12;ANAPC11;PSMB9;PSMC1;PSMD2;PRKAR2B
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.7953100651863099,1.551744018765042,0.017543859649122806,0.4075589503642608,1.0,6/14,15.57%,PTPRC;TRAF3IP3;CD247;IL6R;AOAH;BCL6
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.8984738945094278,-1.5505451876154206,0.01818181818181818,0.3033530801313775,1.0,2/6,3.18%,NDUFA12;COA6
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.8324771156203967,1.549479118357823,0.017241379310344827,0.4154991461514394,1.0,2/8,3.18%,USP13;MREG
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.5238353972357339,-1.5487283116344068,0.0,0.3057154062656814,1.0,45/258,13.63%,NR0B1;GMEB2;TAF9B;POLR2L;ELOB;CPSF1;POLR2J;GTF2F1;SNRPB;PRRX1;ATF4;ESRRB;POLR2I;POLR2G;TCEA1;PARP1;NR2F6;ELOC;NABP2;DRAP1;GTF2A2;CSTF2;BTF3;CSTF2T;TAF7;MED23;SNRPG;CCNK;ADRM1;CTDP1;TAF11;HNF4G;NR2E1;COPS2;DDX5;TAF4B;RXRB;TAF6;POLR2K;YAP1;HDAC3;SNRPE;ESRRA;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7245425405970828,1.547904305245801,0.02,0.4182783255484704,1.0,11/31,13.25%,ITPR1;KCNJ11;ATP2B3;AHCYL1;RYR3;RYR2;ITPR2;ATP2B2;NOS1;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.6144011568302377,-1.5460142100551661,0.02564102564102564,0.31255560019942213,1.0,15/74,8.90%,NOX4;GPX1;GSTP1;SIRT2;PRDX5;ATF4;PRDX1;LRRC8D;STOX1;MT3;PPIA;PARP1;SELENOS;SLC25A24;CHCHD2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5952050840904334,1.5458691325511662,0.0,0.4262646829026648,1.0,27/99,17.44%,LIFR;PCLO;STMN2;SHISA6;ADGRL2;CNTN3;FAM13C;PLCXD3;LMO3;SYBU;UNC5C;ARX;CADPS2;SNAP25;PROX1;SHC2;FGF14;MAPK10;AQP4;PXK;ANK2;ABCC8;PBX1;PCP4;PPARGC1A;SPARCL1;SLC6A1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.520042946990896,1.5457471635074522,0.0,0.41997480761018996,1.0,57/210,21.36%,FHDC1;ABLIM1;INTU;RPGR;RAB17;SHTN1;FAM161A;SEPTIN6;MYLK;CFAP221;IFT172;WDR19;EMP2;CCDC57;ARHGEF6;RAB8B;VCL;RAB1A;MAK;BBS7;DNAH5;INPP5E;TTBK2;P2RY12;RABL2B;PCNT;TNIK;KIAA0586;ASAP1;DMTN;RAP1B;BBS4;CEP41;CEP131;ARHGEF4;TMEM138;ARHGEF7;DYNC2I1;TMEM216;IFT52;CEP290;EHD1;RFX3;CDC14A;TTLL3;RILPL1;CFAP43;HYLS1;STK36;DZIP1;CC2D2A;AHI1;CDC14B;CFAP70;ARL13B;CARMIL1;IFT140
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.5700795417085394,1.5453275281797647,0.0,0.41677541667607526,1.0,35/113,17.61%,CALB1;GRIN2A;OLFM3;STMN2;KCNQ3;ATP2B3;DAB1;OXTR;KCNC2;GFAP;KCNB2;GRM3;MMD2;NRGN;SNAP25;GABRG2;SATB2;PSD2;ADGRB3;KCND3;DLG4;CLVS2;CDH20;GRM1;ACTL6B;ASTN1;CALY;LRRTM1;PCP4;SEZ6L;SLC8A2;CELF3;SLC6A1;SNCB;GAD2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7613485127457984,-1.5450821080738402,0.0,0.3136964162789575,1.0,5/23,6.31%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.6543519533650833,-1.5443420240872545,0.02,0.3135483481851356,1.0,7/38,10.10%,TRMT112;RBM22;BUD23;RIOK2;ERN1;DXO;DDX5
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5680371842510685,1.5411189562314531,0.0,0.4357505323836551,1.0,33/108,17.86%,UNC5D;LIFR;PCLO;STMN2;SHISA6;RGS4;FAM13C;SULT4A1;PHYHIP;SNAP25;KCNIP1;ARNT2;ADGRB3;LSAMP;CRMP1;MAPK10;AKAP12;CLVS2;STX1A;ACTL6B;ANK2;NOVA2;KIF1B;NCS1;ERC2;ITSN1;DCLK1;ASTN1;LRRTM1;SLC8A2;CELF3;DST;UNC13A
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5728328445113761,-1.5394380835179415,0.023255813953488372,0.3279546880952847,1.0,16/94,8.90%,NOX4;GPX1;GSTP1;SIRT2;JUN;PRDX5;ATF4;ROMO1;PRDX1;MT3;PPIA;PARP1;PDGFRA;SELENOS;SLC25A24;CHCHD2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.5813036504075276,-1.5393948899205407,0.022727272727272728,0.3251919530928601,1.0,13/112,6.13%,LAGE3;POLR2L;POLR2J;GTF2F1;RNASEH2C;MRPL44;POLR2I;POLR2G;LSM1;HNRNPA0;DDX54;PCBP3;TBRG4
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.7396842820486011,-1.5391733949402169,0.0196078431372549,0.3230065150465005,1.0,1/16,0.04%,NR0B1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.7255267560381616,-1.5374215385516996,0.043478260869565216,0.3272475963308559,1.0,7/22,9.72%,UBB;RPS27A;UBC;PARP1;UBA52;COPS7B;COPS2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.59784488069359,-1.537372706731031,0.0,0.3249082168202745,1.0,10/75,6.69%,SOX4;AURKAIP1;PIWIL2;BAD;PTTG1IP;PCIF1;EEF2;VPS35;FXR2;EIF3D
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.9333481737214139,1.5372498741861464,0.0,0.4528820656153328,1.0,2/6,2.78%,CLDN12;CLDN18
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.7731534976856203,1.5368084578426142,0.0,0.4480966660910701,1.0,6/17,6.47%,GLRA1;GRIN2A;ABCA2;SLIT3;GRIN1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.8231096557145741,-1.5363846399180376,0.0,0.32622232972408066,1.0,3/13,9.11%,JUN;CTDP1;TAF11
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.5493127001396404,-1.535939204803199,0.0,0.3250398347321809,1.0,23/104,10.35%,UBB;PSMB6;APEX1;PSMD8;RPS27A;PSMB4;UBC;EXOSC8;ZFP36L1;HSPA8;PSMA7;UBA52;FXR2;PSMC3;PSMD10;SET;PCBP4;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;YWHAB
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.6089121928837704,1.5358281673283412,0.0,0.4455637721366567,1.0,9/48,7.97%,PTPRC;EFNA5;IL5;EPHA7;ENPP2;RELN;PTPRJ;EFNA1;PAK2
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.8969292523629927,1.5357431003790767,0.058823529411764705,0.43925709830447257,1.0,3/6,4.86%,PLIN5;ASXL2;LMO3
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6281728756878044,1.5347990540448042,0.03773584905660377,0.4383906175799662,1.0,8/45,9.85%,GABRA4;GABRG3;GLRA1;GLRA2;GABRB1;GABRG2;GABRA2;SLC12A1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.6250279519247786,-1.5345439707250763,0.02127659574468085,0.3270081745683183,1.0,7/55,8.27%,CNPPD1;CCND1;CDKN2C;ACTB;CCNK;CDC37;PSMD10
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.5313487775654951,1.5336742390719866,0.0,0.43826832989668313,1.0,45/170,20.51%,FHDC1;ABLIM1;INTU;RPGR;RAB17;FAM161A;SEPTIN6;CFAP221;IFT172;WDR19;CCDC57;RAB8B;RAB1A;MAK;BBS7;DNAH5;CCP110;INPP5E;TTBK2;RABL2B;PCNT;KIAA0586;ASAP1;BBS4;CEP41;CEP131;TMEM138;DYNC2I1;TMEM216;IFT52;CEP290;EHD1;RFX3;PKD2;CDC14A;TTLL3;RILPL1;CFAP43;HYLS1;STK36;DZIP1;CC2D2A;AHI1;CDC14B;CFAP70
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.8046480187268995,1.5321579744196316,0.0392156862745098,0.4408410973396671,1.0,2/10,9.16%,HEY2;HES1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5685208745777369,-1.531873296731313,0.023255813953488372,0.33431613522888665,1.0,23/77,18.79%,UBB;RPS27A;UBC;FAM50A;PHF1;PARP1;HDAC11;UBA52;COPS7B;RFWD3;CENPV;COPS2;NUP155;HDAC3;BAHD1;HMGN2;COPS6;COPS8;CUL4B;HMGN1;H3-3A;GPS1;COPS5
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.9290396504696208,-1.531832563376464,0.02,0.33184787793799614,1.0,1/6,0.23%,GTF3C6
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.7503409175984803,-1.5311413723996017,0.03636363636363636,0.33131881628710685,1.0,6/25,7.58%,UBB;CCDC88C;RPS27A;UBC;UBA52;MAPK13
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.6252027310176272,1.5304718617778366,0.041666666666666664,0.44320072238326813,1.0,8/45,9.85%,GABRA4;GABRG3;GLRA1;GLRA2;GABRB1;GABRG2;GABRA2;SLC12A1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.5634591604295863,-1.5292539678325752,0.0,0.3364507894973128,1.0,29/94,18.14%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PARP1;PSMA7;SMARCA5;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;CENPV;PSMC1;PSMD2;NPM1;MCM4;GTF2H2;PSMD4;H2AX;PSMC4;CUL4B;PSMB2;PSMD3;PSMD11;H3-3A
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.6406200862699327,-1.5289811345201145,0.01818181818181818,0.3346745276043258,1.0,15/48,17.59%,MMP2;COPS9;ATF4;PARP1;OPN3;MAPK13;SMPD1;NOC2L;NPM1;CASP9;TMEM161A;TIMP1;CUL4B;USP28;RUVBL2
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),0.8622038665591145,1.5261146270896246,0.0,0.4606373669720043,1.0,3/11,6.21%,SGO2;IHO1;FMN2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.740678600593904,-1.5241494316012796,0.0,0.350665103060986,1.0,10/18,15.32%,RPL23A;RPL10;RPLP0;RPL3;RPL11;RPL6;BRIX1;RPF2;DHX30;RPL5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5670690545253735,-1.5230306272327776,0.0,0.35272560826353344,1.0,15/71,9.88%,PSMB6;PSMD8;PSMB4;ESRRB;HES5;PSMA7;PDGFRA;PSMC3;PSMD10;PSME3;PTN;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.9514898423555523,1.522941504551694,0.01818181818181818,0.47406000393547426,1.0,1/5,0.16%,HOOK1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8697362692581729,1.5209683215191006,0.0,0.4820268363699216,1.0,7/9,11.93%,DOCK5;NR4A3;FGF9;DOCK4;DOCK7;PRKG1;TPM1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6498887752373285,-1.5191843528594955,0.025,0.3645974249299168,1.0,6/33,5.12%,PTMA;POLR2L;POLR2J;POLR2I;POLR2G;PAX8
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.7415916847558066,1.519114622723948,0.05128205128205128,0.4892500012752847,1.0,9/21,13.25%,HEY2;NEBL;TTN;CAV3;HES1;DYSF;SGCZ;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.9063980465323094,-1.5188755926332773,0.05660377358490566,0.3632894685343987,1.0,3/6,7.43%,ITM2A;ITM2B;ITM2C
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.6830692689584827,-1.518337648634064,0.041666666666666664,0.36309584948408175,1.0,13/25,16.89%,TMBIM6;HSPA8;BAG3;HSPA13;ERN1;STUB1;DNAJB12;HSPA14;HSPA9;HSPA5;DNAJC18;OPTN;BAX
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.7412972997789674,1.518180772278169,0.022222222222222223,0.49041588860733737,1.0,3/20,5.24%,EFNA5;BAIAP3;ADCY5
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.5542211876925128,1.5162109939578412,0.0,0.4979816427667272,1.0,30/134,15.31%,FSTL5;OLFM3;IGF2BP3;EFNA5;PCLO;STMN2;SHISA6;ARHGAP26;ATP2B3;FAM13C;SULT4A1;GCNT2;SNAP25;KCNIP1;TAFA5;ADGRB3;NMNAT2;LSAMP;CRMP1;MAPK10;CLVS2;TTBK2;SNX21;ACTL6B;GPR22;ANK2;KIF1B;DCLK1;ASTN1;LRRTM1
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.6939040317358354,-1.5161278747048106,0.02127659574468085,0.36973193926670667,1.0,10/25,9.39%,SQLE;TM7SF2;SC5D;MSMO1;ARV1;IDI1;PMVK;ACAT2;HMGCS1;ACLY
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.9399123289542406,1.5157540144335864,0.0,0.49557645076023343,1.0,2/8,3.00%,SPRED2;NNMT
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.8080598432304692,-1.515697904190699,0.06,0.36903082991916886,1.0,3/11,3.88%,SIRT2;ZFP36L1;MT3
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.7031703763842437,1.5152788440808107,0.0,0.49197979789867097,1.0,4/24,6.97%,MSL3;MRGBP;KAT2B;NAA50
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.8130912064670078,-1.5147313478163007,0.043478260869565216,0.37047992040413624,1.0,2/10,1.09%,SOX4;ASCL1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.8978947214694876,-1.5135957763070336,0.0,0.37259022040301565,1.0,3/8,6.29%,CHRNA4;NIPSNAP1;P2RX4
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.9598419690193187,-1.5123369118082095,0.0,0.3763259835045728,1.0,1/5,1.92%,ATF4
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.9180447930088169,1.512330716104944,0.0,0.505548525663669,1.0,4/6,6.45%,HDAC4;CAMTA2;TTN;RYR2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.864451601741963,1.5117189197823862,0.03278688524590164,0.503138942321207,1.0,3/11,2.95%,EDNRA;TPCN2;MYLK
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.7689911065011142,-1.5116722805627993,0.022222222222222223,0.3757467042211604,1.0,7/15,16.72%,TAF9B;CXCL12;CD44;CLU;TMEM161A;CDKN2D;TPT1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8189258537395832,1.5116352010550265,0.061224489795918366,0.4971686944671387,1.0,2/7,6.45%,HEY2;RYR2
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6883635215248316,1.5115457118338218,0.022727272727272728,0.49229766564081184,1.0,7/23,11.74%,HEY2;ADAMTS9;TTN;BMP7;SGCZ;GJA1;NRG1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.821207016101176,-1.5113791118516446,0.018867924528301886,0.3744337795058808,1.0,4/11,9.37%,H1-4;BANF1;NOC2L;AIFM1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.7726208690237822,1.5111817168428356,0.0,0.4890749463033225,1.0,2/13,4.06%,CHRM3;OXTR
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.8070065914421933,-1.5111462293084397,0.0,0.37313974579369863,1.0,2/11,14.45%,NIFK;POLR1G
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.7791118572493254,1.5106375532570495,0.022727272727272728,0.4868598567663291,1.0,6/16,10.06%,UNC13C;GRIK5;CDH8;GRIK3;SLC1A4;NAPB
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.9284968792988341,-1.510053070529852,0.08333333333333333,0.3747168150619877,1.0,2/5,4.23%,NOP10;NHP2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.5627819869858665,-1.5098273644097617,0.022222222222222223,0.3729307522161396,1.0,36/156,16.31%,AURKAIP1;RBM8A;LSM4;SRSF7;PIWIL2;SNRPD2;SNRPB;MRPL44;LSM1;HNRNPA0;SMU1;DDX54;SCNM1;NOL3;PRPF8;KIN;SNRPG;SF3A2;MAGOH;U2AF1;TSEN34;SLU7;YJU2;PDCD7;SNRPD1;SRSF9;PPP2R1A;NOVA1;NONO;PRPF18;SF3B2;SNRNP35;SRPK1;HNRNPA2B1;KHSRP;LSM3
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.5950914188535309,-1.5093381749717265,0.0,0.3723236663474388,1.0,12/66,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;NABP2;GTF2A2;CCNK;TAF11;TAF6;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6221958911236105,-1.5093056458369336,0.045454545454545456,0.3697916138751941,1.0,6/30,12.42%,AURKAIP1;BAD;CSTB;STUB1;CST3;CAV1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5493865034037266,-1.5088727561310424,0.0,0.36850363690867277,1.0,26/116,12.05%,G0S2;S100A10;HSD17B10;APEX1;IDH1;PCBD1;ODC1;UGDH;CRAT;UBE2L6;UROD;H2AZ1;CBR1;IDI1;ALAD;ERP29;ACAT2;CRYZ;OSTC;HMGCS1;DLD;AADAT;UROS;ACOX1;PDHB;SUCLA2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.8987845209780179,1.5082053840885312,0.041666666666666664,0.4963112133379034,1.0,1/5,0.28%,PTPRC
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.6277148542228113,-1.507468382299252,0.02127659574468085,0.370482028517943,1.0,10/54,12.17%,RBM8A;SRSF7;CPSF1;CSTF2;CSTF2T;MAGOH;U2AF1;SLU7;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7893581531540939,-1.5074185025318974,0.021739130434782608,0.3682951708848219,1.0,9/15,17.77%,MRPS7;RPS19;RPS15;RPS28;MRPS11;RPS5;RPSA;ERAL1;RPS14
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6124836421409764,1.5073161974955211,0.0,0.4964502750395952,1.0,18/70,14.08%,PTPRC;IGF1R;EPHA7;ALK;MERTK;RELN;NTRK3;CACUL1;MMD2;ZNF16;TYRO3;ROR1;EPHA4;MMD;ZNF622;LMTK2;CSF1;TAB2
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.8511488591285823,-1.5072949477029296,0.02,0.36655603224602007,1.0,2/8,6.76%,DHFR;APOD
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.5831594835979256,1.5066274877534451,0.03571428571428571,0.49557499167185143,1.0,16/79,15.07%,INPP4B;SYNJ2;PIP4K2C;PIP5K1B;PITPNM2;PLEKHA4;CDS1;PIP4P1;INPP5E;INPP4A;PIP4K2A;PLEKHA2;PGAP1;PIK3CD;PTPN13;IMPA1
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.8410029615122614,1.5059974061780503,0.05084745762711865,0.4944974549017646,1.0,2/9,6.37%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.9095830833569899,1.5059513352730296,0.0,0.4892707789951437,1.0,5/8,7.41%,DOCK5;NR4A3;FGF9;DOCK4;DOCK7
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.7283608665987479,1.5049464954293577,0.03773584905660377,0.4894818872250132,1.0,3/17,3.67%,AKT2;SORBS1;CLTCL1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.8337550479041975,-1.50224519822197,0.06521739130434782,0.38545910169221825,1.0,1/10,3.32%,ERH
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.7149300207382023,-1.5020814012688337,0.044444444444444446,0.3836281130297266,1.0,8/24,12.27%,TSR1;RPS19;RPS16;NGDN;MRPS11;NOP14;KRI1;RPS8
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.6997940869494176,-1.5018672559398498,0.04,0.38243594731838854,1.0,12/22,16.60%,SQLE;TM7SF2;MSMO1;ARV1;IDI1;PMVK;ACAT2;HMGCS1;ACLY;DHCR7;FDPS;LBR
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7641340973212671,-1.5016850012861498,0.0392156862745098,0.3807848623468354,1.0,6/14,12.02%,CPSF1;RTRAF;CSTF2;TSEN34;DDX1;C2ORF49
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.7121432296429527,-1.5009122807642097,0.044444444444444446,0.38151343440501173,1.0,2/32,0.49%,PPIF;GPX1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.7060765188485852,-1.5007087637409822,0.0,0.3798230325709751,1.0,3/21,5.19%,NR0B1;CALR;SFRP1
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.7234349539105475,-1.5005528642858752,0.045454545454545456,0.37808808944376726,1.0,2/15,2.70%,GTF3C6;NIFK
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.8197435879885803,1.5001599135197745,0.04081632653061224,0.5153596689435608,1.0,5/11,12.72%,HEY2;TMSB4X;PSEN1;SIN3A;TAF1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.8018000166166828,1.4986695937254109,0.0,0.5203823171842118,1.0,6/12,15.57%,PTPRC;TRAF3IP3;CD27;CD247;AOAH;BCL6
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.7261966672603293,1.4980704178028417,0.04081632653061224,0.518780662770314,1.0,9/19,20.65%,STAT4;STAT6;STAT5B;NMI;STAT2;FER;STAT3;PKD2;PIAS1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6958224344321823,1.4980646584333954,0.05660377358490566,0.5132617195493532,1.0,7/27,12.77%,RAB3A;NR4A3;PLEKHM1;SYTL4;PIP4P1;BORCS5;PIK3CD
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.9259557535714922,-1.4978413630234582,0.045454545454545456,0.3866156954959421,1.0,2/6,4.30%,UBB;MAP1S
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.5383611394692338,-1.4977666672219494,0.0,0.38426867389425584,1.0,32/129,17.45%,CUL7;BTG1;PSMB6;PSMD8;PSMB4;CDC26;BTG3;TRIM35;PSMA7;DUSP3;CUL9;PSMC3;PSMD10;PSME3;PSMD12;ANAPC11;PSMB9;PSMC1;PSMD2;AFAP1L2;GAS1;BRINP1;CDKN1C;SMAD3;PSMD4;HECA;UBE2S;PRMT5;PSMC4;PSMB2;BUB3;PSMD3
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.8525143192069617,-1.4972245392683394,0.018867924528301886,0.3840387176004029,1.0,3/10,4.90%,TRMT112;BUD23;RIOK2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.5962723600576669,-1.4968111256575554,0.0,0.38316356057505113,1.0,12/65,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;NABP2;GTF2A2;CCNK;TAF11;TAF6;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.8775333529610897,-1.496742735788519,0.08333333333333333,0.380946937479921,1.0,3/9,8.19%,PPIF;COX7A2;SLC25A33
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.6616854430193487,1.4964116631479225,0.02,0.5165016212167294,1.0,7/31,10.69%,CHRM3;HTR1F;ADCY5;AKAP5;AKAP12;P2RY12;ADCY3
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.8538810096232793,1.495845039952511,0.022222222222222223,0.5154995274753665,1.0,1/8,1.45%,ACSS3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.7225981565307626,-1.495572138114139,0.02631578947368421,0.3851581239337618,1.0,5/21,15.57%,TRMT112;SMYD2;PRMT6;PRMT1;PRMT5
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9342885737425182,-1.4948921232040482,0.02040816326530612,0.38607321922892746,1.0,2/6,3.05%,TRMT112;BUD23
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.7653705331618165,1.4948036998878513,0.022727272727272728,0.5163319077830525,1.0,8/18,11.93%,ZFPM2;PKP2;LRP2;RYR2;TGFBR3;PROX1;NRG1;TPM1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.702658682352265,1.4946363559578248,0.018518518518518517,0.5114621712983615,1.0,7/36,7.72%,PTPRC;AHR;EGLN3;NR4A3;SPI1;NAAA;RAB20
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.7867277808754418,1.4945714496468478,0.024390243902439025,0.5068882766228731,1.0,3/18,0.88%,AHR;SCEL;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.8331377449525407,-1.493490580080387,0.0,0.3897582958409668,1.0,4/12,9.84%,CALR;CXCL12;MOSPD2;CREB3
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6791500000595077,-1.4933308053625014,0.043478260869565216,0.38786972532986647,1.0,14/33,15.13%,MRPS7;MRPS16;MRPL47;MRPS11;SLC25A33;MRPS12;MRPS18B;GATC;MRPS14;MRPS2;MRPL51;MRPL16;TFB2M;MRPS18A
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7726423791209158,-1.4929277792370672,0.057692307692307696,0.3873154265271056,1.0,4/17,3.88%,MT1E;JUN;MT2A;MT3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.720186497188772,-1.4926856257698744,0.1111111111111111,0.38589898419813373,1.0,9/15,22.30%,POLR2L;ATF4;POLR2K;WDR43;DHX33;LYAR;UBTF;MAF1;UTP15
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6468756783214358,1.492539785045216,0.0,0.5147216455101459,1.0,10/38,9.39%,MAP3K19;DNAH7;TMCO5A;SHROOM3;NEBL;FUT2;ARFGEF3;CHST9;CDS1;DNAH5
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7769866031704694,-1.4923466655010353,0.020833333333333332,0.38511648471749005,1.0,7/15,12.02%,CPSF1;RTRAF;ERN1;CSTF2;TSEN34;DDX1;C2ORF49
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6311906734414799,-1.492336141418237,0.04081632653061224,0.3828717163228731,1.0,15/57,11.34%,PPIF;GPX1;GSTP1;RTKN2;TMBIM6;PIH1D1;NOL3;QARS1;PSMD10;NOC2L;PSME3;NDUFS3;SLC25A5;CLU;PRELID1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8680269331508782,-1.4923244340194002,0.1111111111111111,0.3805927180114274,1.0,4/8,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7088317855203187,-1.4913471896384032,0.022222222222222223,0.38130973138417684,1.0,4/17,9.43%,PSMB6;PSMB4;PSMA7;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.5887401345445169,-1.4906918063139993,0.02040816326530612,0.38256043557223557,1.0,9/62,9.14%,RPS2;UBB;PTTG1IP;CENPX;PEF1;PRICKLE1;MALT1;PSMD10;STUB1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.5924253064387107,1.4904522274573078,0.01818181818181818,0.5230773341372335,1.0,12/60,10.77%,CALCB;GNA12;HTR1F;ADGRL2;ADCY5;AKAP5;GNA14;ADGRB3;AKAP12;P2RY12;ADCY3;GRK5
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.8516551108667713,1.4886850817846629,0.0425531914893617,0.5295442857787408,1.0,5/9,8.30%,HEY2;MYLK;TTN;TGFBR3;PROX1
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.8390925075166309,-1.4880134996336334,0.06382978723404255,0.39176108272059756,1.0,5/8,11.85%,LSM1;PNRC2;EDC3;DCPS;DCP1A
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.8193977682299678,1.48790847504254,0.038461538461538464,0.5297173339941582,1.0,2/11,8.68%,GRAMD1C;RORA
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6226539877675957,-1.4871621158641681,0.043478260869565216,0.3924006576931877,1.0,13/55,8.83%,MT1E;SLC22A17;MT2A;FTL;ISCU;SLC30A10;MT3;ATP6V1G1;COX19;CYBRD1;CYB561A3;SLC31A1;ABCG2
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.8593040897053634,1.487156487644582,0.02127659574468085,0.5281953255585577,1.0,1/7,1.45%,ACSS3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.907501015066642,1.4871556617785209,0.020833333333333332,0.5231648938865715,1.0,2/5,0.22%,CHRM3;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.7819577935445559,-1.4870020994268596,0.0,0.39090193780255567,1.0,8/18,14.00%,SRSF7;TMBIM6;SAP18;PCBP4;RPS13;SRSF9;SRSF10;RPS26
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.6760837580373465,-1.4863089538695682,0.02040816326530612,0.39142139593227204,1.0,2/26,1.42%,TRMT112;SMYD2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.695827782648721,-1.4858920158633317,0.06521739130434782,0.3909986739401447,1.0,5/26,7.70%,CPSF1;SNRPB;CSTF2;CSTF2T;SNRPG
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.7003435840565533,-1.485236141610178,0.0392156862745098,0.39058075560701877,1.0,5/28,9.93%,PPIF;BAD;MICOS13;SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7358468440323426,-1.4847485062110952,0.021739130434782608,0.3910932239503304,1.0,9/24,13.80%,RPL7A;RPL10A;NIFK;NHP2;RPL35;ZNHIT3;RPF1;RPF2;RSL1D1
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.6923410897346303,-1.4846952962374238,0.04,0.3890111290159629,1.0,16/35,14.78%,AIP;TSPO;ROMO1;TIMM8B;SLC25A6;TIMM13;TIMM23;TOMM7;TIMM44;DNAJC19;AIFM1;TIMM22;MFF;GRPEL1;FIS1;TIMM21
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.7136460078263523,-1.4845085290729456,0.08,0.3875815814606439,1.0,2/26,2.96%,COPZ1;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.8268221713450455,1.4844958624990596,0.04838709677419355,0.5361184327719991,1.0,3/11,5.26%,CHRM3;SRF;KCNB2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.8048795859933237,1.4844063108952081,0.02702702702702703,0.5315647293381877,1.0,3/14,8.97%,HEY2;SOX9;NBR1
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.6210434515466231,1.4841813279363496,0.0,0.5277288818151491,1.0,9/46,8.60%,ITGA2;SCEL;FMO5;EMILIN2;SLC25A48;CDKN2A;CDKL1;ITPR2;BRCA1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.810916025883483,1.4839995449778327,0.058823529411764705,0.5236047220238785,1.0,4/14,5.01%,SYT1;NEDD4L;RNF157;CPNE5
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5703878901428306,-1.4835821358053773,0.02127659574468085,0.38850039929746455,1.0,23/72,19.66%,PSMB6;PSMD8;PSMB4;CDC26;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;ANAPC11;PSMB9;PSMC1;PSMD2;PSMD4;UBE2S;PSMC4;PSMB2;BUB3;PSMD3;PSMD11;DBF4;ANAPC2;PSMA5
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.6256033066929101,-1.4828811672228586,0.018867924528301886,0.38827755474753,1.0,10/37,13.23%,COPS9;ATF4;PARP1;OPN3;MAPK13;SMPD1;NOC2L;NPM1;CASP9;TMEM161A
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.8196153679174385,1.4827771705204957,0.02040816326530612,0.5261310746582837,1.0,2/9,2.71%,PTPRC;GPI
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5989360825560618,-1.4821439801480676,0.0,0.388901128501698,1.0,14/50,13.75%,CPSF1;TRMT10C;RTRAF;CSTF2;TRMT10A;SARS1;ADAT2;POP5;TSEN34;AARS1;PUS3;DDX1;C2ORF49;THUMPD1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.8727680242643572,-1.4812925183042298,0.04081632653061224,0.3906929878932274,1.0,3/9,5.07%,BTC;SIRT2;NPM2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.7666120298700274,1.4803526270054157,0.03773584905660377,0.5353923700060711,1.0,7/15,12.64%,TMSB4X;SPI1;CYLD;HDAC7;NMI;BMP7;NLRP12
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.7019361968056805,1.4787270077872763,0.043478260869565216,0.5395137968205268,1.0,5/25,8.94%,SHTN1;SEMA3A;CAMK2B;NSMF;PHACTR1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.7063348514612902,1.4782673893979557,0.01694915254237288,0.5369018236342468,1.0,5/25,9.49%,OTUD7B;USP13;ZRANB1;CYLD;BABAM2
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.639567954610066,-1.478172198274693,0.06382978723404255,0.4011472477227094,1.0,7/46,6.76%,GPX1;GSTP1;JUN;PRDX5;ROMO1;PDGFRA;APOD
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.9476790260040973,1.478084447078485,0.0,0.5333925274882593,1.0,2/6,0.35%,PTPRC;AHR
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.6026221926793329,-1.4774934899298977,0.08695652173913043,0.40185720025639987,1.0,9/37,12.83%,SLC22A17;FTL;ISCU;ATP6V1G1;CYBRD1;CYB561A3;ABCG2;ATP6V0D1;B2M
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.8183994950308893,1.4769071140714851,0.04,0.5361489027028188,1.0,3/14,3.43%,FABP3;SOX9;NR4A3
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5695915501108849,1.4767237368993973,0.01818181818181818,0.5323695529442458,1.0,15/75,10.05%,TPD52L1;IGF1R;WNT7A;TNFRSF19;SEMA3A;DUSP22;SH3RF1;GADD45A;TGFBR3;RIPK1;CYLD;TIRAP;MAPK8IP2;CD27;ZNF622
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.73524196383694,1.4766038604283556,0.06779661016949153,0.52865480745505,1.0,1/17,0.28%,PTPRC
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.8600037863539469,-1.4760124851840204,0.034482758620689655,0.40646839824654535,1.0,4/9,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7099725612615694,-1.4752335293066816,0.0625,0.4079089455601241,1.0,10/25,15.90%,ATP5MC1;ATP5PD;ATP5F1A;MICOS13;ATP5F1E;ATP5PB;ATP5F1D;ATP5ME;UQCC3;ATP5MC3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7271240182443082,1.4730062787400289,0.058823529411764705,0.5463742418239365,1.0,3/15,7.57%,GLRA1;GLRA2;SORT1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.5411116990237038,-1.4728025682993178,0.0,0.4181036690376467,1.0,24/112,13.63%,NR0B1;TAF9B;POLR2L;POLR2J;GTF2F1;ESRRB;POLR2I;POLR2G;NR2F6;GTF2A2;TAF7;MED23;TAF11;HNF4G;NR2E1;TAF4B;RXRB;TAF6;POLR2K;YAP1;HDAC3;ESRRA;POLR2E;GTF2H2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.7293092218204907,1.4723772610285946,0.0851063829787234,0.5453147996409277,1.0,8/17,20.65%,STAT4;STAT6;STAT5B;NMI;STAT2;STAT3;PKD2;PIAS1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.7002670079542863,-1.4714807215924823,0.043478260869565216,0.42028012151963023,1.0,4/21,9.67%,NOP10;NHP2;PIF1;HSP90AB1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.8315704702507146,-1.4712159330308363,0.017241379310344827,0.41903824156792746,1.0,3/10,1.14%,BGN;BCAN;DSEL
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.7300863795063678,1.470950825597793,0.0,0.5467220084579176,1.0,8/17,16.81%,SLC4A4;PSEN1;PRXL2C;PFKFB3;PRKAA2;PFKFB1;GAPDHS;PRKAA1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.7300863795063678,1.470950825597793,0.0,0.5467220084579176,1.0,8/17,16.81%,SLC4A4;PSEN1;PRXL2C;PFKFB3;PRKAA2;PFKFB1;GAPDHS;PRKAA1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.6583447010554042,-1.4709335252731972,0.020833333333333332,0.4182382729378741,1.0,11/31,18.65%,S100A6;GSTP1;SFRP1;PDGFRA;WNT5A;FN1;MORC3;FTH1;CDC73;BMI1;B4GALT7
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.690313023268911,-1.4706406667347458,0.07547169811320754,0.4166466245943484,1.0,4/20,3.95%,HSPG2;AGRN;GPC4;GUSB
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6891834932086514,1.4701326074427694,0.0625,0.5460863591049844,1.0,9/29,18.46%,GRIN2A;GRM3;GRIK3;GRIN1;GRM1;CPEB4;GRIK1;GRIN2B;HOMER1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.9529435382434595,-1.469816182355817,0.0,0.4185732873522365,1.0,2/5,3.92%,LAGE3;OSGEP
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.7411649866136814,1.4697909309860782,0.05263157894736842,0.543633305996577,1.0,4/24,5.05%,PTPRC;KLF6;HDAC4;PTPRJ
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.8618740906538047,-1.4697162058918316,0.018867924528301886,0.41667961480960763,1.0,2/9,10.10%,ATF4;DDX5
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8936267472255957,-1.4694382063702645,0.041666666666666664,0.4154880420705641,1.0,4/8,8.21%,HSD17B10;POP4;TRMT10C;POP5
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.8512702372840342,1.4691427789040217,0.022222222222222223,0.5428751657970754,1.0,4/6,14.21%,PCLO;RAB3A;ERC1;ERC2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.5805229434405532,1.4688591846500618,0.019230769230769232,0.5407216374785657,1.0,13/53,10.88%,HOOK1;DNAH6;PARN;TMCO5A;SORD;ACYP1;TSSK3;CCDC30;BRCA1;UBE3D;MAEL;CREM;TAF7L
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.6944322695597998,1.4683977844959246,0.034482758620689655,0.5391453162087295,1.0,6/23,8.88%,FOXO1;KAT2B;ING5;NAA50;NAA16;ESCO1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.703163559785294,1.468184621672727,0.024390243902439025,0.5364393582969812,1.0,4/22,7.97%,CLDN18;TBCD;PARD3;PAK2
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6804245545454334,-1.4681128317826462,0.05172413793103448,0.4188540066300375,1.0,4/26,8.01%,BTC;BTG1;IL20RA;WNT5A
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.7430847864150668,-1.4676258095988761,0.04081632653061224,0.41932687025538024,1.0,3/15,11.14%,FBLN5;HAS2;LTBP3
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.8139316483903573,1.4673634673427483,0.0625,0.5378992699293622,1.0,4/13,5.01%,SYT1;NEDD4L;RNF157;CPNE5
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.7166079474585778,1.4669539993365797,0.046511627906976744,0.5363814861119192,1.0,6/12,16.42%,PKP2;TTN;TGFBR3;PROX1;TPM1;ENG
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.7417353840834223,-1.46679193775097,0.10638297872340426,0.42093275334896146,1.0,2/14,3.65%,SOX4;HES5
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7443262308941887,1.4666887004860216,0.0196078431372549,0.533909609507661,1.0,6/14,13.80%,UBASH3B;CAV3;CAMK2D;NOS1;ANK2;DIAPH1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.61149561630599,-1.4655953846555667,0.08196721311475409,0.4244264467843594,1.0,5/37,3.38%,HSPG2;AGRN;RBP1;RARRES2;GPC4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5935277290559946,1.4651440325437801,0.0,0.5396083967043913,1.0,15/51,18.06%,PTPRC;PLXNA4;TBCD;RIPOR2;GCNT2;DUSP1;KNG1;PLXNA1;ADAM22;DMTN;SEMA4D;ARHGDIG;ADAM10;SPOCK1;ITGB1BP1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.764648872256186,-1.4646301888477085,0.06521739130434782,0.42604197397844223,1.0,3/11,10.01%,COL9A3;ZNF830;EIF2B2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.6397643497496709,-1.4645964426706992,0.021739130434782608,0.4240242543349321,1.0,4/31,9.16%,SIRT2;JUN;EDF1;NGF
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.8583064682704447,1.4643075983911686,0.018867924528301886,0.5395931347512967,1.0,2/6,8.60%,KAT2B;BRCA1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6292906201766867,-1.4637636541756565,0.01818181818181818,0.4253723078853466,1.0,10/52,8.83%,G0S2;FAHD1;PMEPA1;PLIN2;FERMT1;SLC30A10;CBR1;CYBRD1;GBA3;ABCG2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.9043341554699134,-1.4631370956317375,0.02,0.4267070801199934,1.0,2/6,3.88%,ATF4;MT3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7047090367469172,-1.4627217738978588,0.1,0.4269244350682128,1.0,8/22,16.51%,MMP2;COL8A1;COL12A1;ITGA4;FN1;ITGB5;PAF1;CDC73
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7585677906424299,1.4626810687205436,0.022222222222222223,0.5455309525173282,1.0,4/18,9.16%,HEY2;ADAMTS9;LRP2;HES1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.732799917268518,1.46266163845421,0.125,0.5374490124800344,1.0,2/14,3.31%,FHDC1;SORBS1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.732799917268518,1.46266163845421,0.125,0.5374490124800344,1.0,2/14,3.31%,FHDC1;SORBS1
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.8609320172218298,-1.4621783196423168,0.023255813953488372,0.4271896214940908,1.0,3/9,5.74%,SIRT2;JUN;BAG3
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.7444933332296476,1.4620506846798118,0.0625,0.537378206401689,1.0,4/15,3.60%,BCL2L11;SGO2;BRME1;TDRD9
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6805290325005581,1.460305557346256,0.0,0.5438009406270126,1.0,6/25,12.67%,SHISA6;RAB3A;CAMK2B;NSMF;DLG4;SHISA9
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5744591916303979,-1.4600983463398904,0.04,0.43456069583210816,1.0,17/74,12.24%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;TOLLIP;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.9011854877716595,-1.4597096177832323,0.04,0.43374757282435755,1.0,1/6,0.07%,PPIF
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7760603880377548,-1.4590171413830013,0.06,0.43491153038715286,1.0,4/16,3.88%,MT1E;JUN;MT2A;MT3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.8439678757800944,-1.4584676253341273,0.021739130434782608,0.43488844573597474,1.0,3/6,10.92%,ASCL1;MYT1L;POU3F2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7677451487484537,1.4582864743745352,0.041666666666666664,0.5524679561776035,1.0,5/10,14.76%,SRPX2;HDAC7;RHOJ;AKT3;JCAD
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.852121957653275,-1.4581001506957783,0.0196078431372549,0.434231666097599,1.0,3/9,7.26%,GSTP1;SELENOS;TAF7
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.864481637937119,-1.4577598487235095,0.022727272727272728,0.4336296434359683,1.0,3/6,11.92%,DCP1A;DDX1;YBX1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.8429775943660605,-1.4576441337850965,0.022222222222222223,0.4323087604114911,1.0,2/7,3.74%,UGDH;LRRC8D
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5540946034731364,-1.4574889256596564,0.0,0.4309522041627531,1.0,15/69,11.20%,CDKN2C;PSMB6;PSMD8;PSMB4;ZFP36L1;PSMA7;CDK2AP2;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;BRD7
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.5101947038972944,-1.45722239746374,0.0,0.4302303919752832,1.0,24/150,11.92%,EIF1;SOX4;MIF4GD;PIWIL2;RPL10;EIF1B;CALR;GAPDH;EIF5;PCIF1;EEF2;DHFR;RPL13A;FXR2;EIF3D;SHFL;EIF4H;NCL;EIF2B2;EIF4A3;GSPT1;NPM1;DDX1;YBX1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.7990864846850629,-1.4564702582557063,0.0425531914893617,0.43170621287586747,1.0,6/15,14.91%,RBM22;CWC15;CACTIN;DCPS;WBP11;SNRNP200
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.8459798483860269,1.4555851002473166,0.0392156862745098,0.5640340119508179,1.0,2/9,6.48%,HEY2;EMP2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7918476541152054,-1.4553964312121608,0.0784313725490196,0.4344009809589822,1.0,4/13,11.08%,PTTG1IP;PSMD10;CD44;YJU2
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.9170356317444296,1.4552504543979854,0.0,0.562029901572985,1.0,2/5,3.49%,ITGA2;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6211983528778016,-1.4551763871644754,0.0,0.4332485475476326,1.0,12/52,13.07%,UBB;PMEPA1;RPS27A;VEPH1;UBC;BAMBI;UBA52;STUB1;SPRY1;CAV1;SLC2A10;SMAD3
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.8181173584247896,-1.4551000627480912,0.04878048780487805,0.43140208856094325,1.0,5/9,11.60%,SPCS2;SEC11C;SEC11A;HM13;FURIN
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5199011489816225,1.4548801589788474,0.0,0.5597769294112678,1.0,45/135,17.61%,CALB1;OLFM3;STMN2;SHISA6;GNG4;ATP2B3;PDE1A;CACNG2;SLC24A2;NRIP3;SULT4A1;HCN1;GRM3;MMD2;GRIK3;GRIN1;PRKCA;SNAP25;GABRG2;PSD2;ATP2B2;ADGRB3;SLC22A15;HIVEP2;CNTNAP2;DLG4;CLVS2;PRKG1;PDE9A;SYT2;ACTL6B;CPLX1;ASTN1;CALY;LRRTM1;PCP4;SEZ6L;SLC8A2;CTNND2;CERK;CELF3;SLC6A1;SNCB;ABAT;GAD2
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.7838032249561063,-1.4544399401887043,0.1,0.43261180994431175,1.0,6/10,16.26%,ASAH1;GBA3;GM2A;NEU1;NEU4;NEU3
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.7681135390228955,-1.4539430900977253,0.06666666666666667,0.43339161810897675,1.0,2/11,10.04%,IDH1;AADAT
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.8484131289779022,-1.4537237155257352,0.022727272727272728,0.4322182748952695,1.0,4/8,10.36%,CALM1;SRI;CALM3;NIPSNAP2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.6153947538815016,1.4537236943475935,0.038461538461538464,0.5643014247514183,1.0,11/45,13.25%,CHRM3;PTPRC;TPCN2;PTPRJ;RYR2;P2RY12;PDPK1;ACKR4;DMTN;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7906067072687921,1.4530882451079408,0.0,0.5647298323862574,1.0,3/12,5.17%,SHTN1;SEMA3A;NSMF
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.7028986517302953,-1.4527246596752785,0.08695652173913043,0.43433050936802814,1.0,4/13,11.00%,VPS28;LEPROTL1;TMEM50B;TMEM50A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6735504007029959,1.45205531757943,0.04081632653061224,0.5685461902868747,1.0,9/25,10.80%,GABRA4;GABRG3;GLRA1;GRIN2A;GRIN1;GABRG2;GABRA2;MAPK8IP2;ARRB2
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.8705893582036082,1.4519091673080426,0.02040816326530612,0.5652318710272238,1.0,2/7,3.91%,OTUD7B;USP30
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7509362616260361,-1.4515795487836234,0.019230769230769232,0.43738812029908253,1.0,2/17,3.05%,TRMT112;BUD23
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.7787500312409636,1.4515670150412947,0.019230769230769232,0.5633019168356278,1.0,5/16,5.94%,PTPRC;KLF6;SOX9;CAMK2B;SPI1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6971794755381611,1.4514109593620572,0.02,0.5603343366525341,1.0,6/20,11.03%,CAMK2B;PSEN1;FOXO6;SHANK3;CPEB3;CAMK1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.7247499364773713,1.4506646598898487,0.02040816326530612,0.5613694669060367,1.0,4/25,4.88%,PON1;YJEFN3;RXRA;ABCA2
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.680331257927349,1.4497382291999958,0.08333333333333333,0.5625219032376243,1.0,4/22,9.06%,PON1;PON3;DDO;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.7062327483901675,-1.4493777884120898,0.047619047619047616,0.444852787352162,1.0,4/18,13.66%,CALM1;PDGFD;CALM3;RAP2C
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6821957602239919,-1.4483859637431769,0.0425531914893617,0.447290311822578,1.0,9/25,11.34%,PPIF;GPX1;BAD;NOL3;PDCD5;PSMD10;MFF;CLU;PRELID1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.48293386573141506,1.4480375065250624,0.0,0.5690023304968469,1.0,63/235,21.39%,FHDC1;ABLIM1;INTU;RPGR;RAB17;FAM161A;NPHP4;SEPTIN6;CEP135;KIF3C;DYNC2LI1;CCDC39;CFAP221;IFT172;WDR19;CCDC57;RAB8B;RAB1A;MAK;BBS7;DNAH5;CCP110;INPP5E;HAUS2;TTBK2;RABL2B;PCNT;HAUS5;KIAA0586;ASAP1;TUBA4A;BBS10;BBS4;CEP41;CEP131;TMEM138;DYNC2I1;TMEM216;CSNK1D;TNPO1;IFT27;IFT52;CEP290;EHD1;RFX3;ACTR1A;HAUS6;CDC14A;TTLL3;RILPL1;CFAP43;ALMS1;HYLS1;STK36;DZIP1;CC2D2A;AHI1;CDC14B;CFAP70;TOGARAM1;ARL13B;IFT140;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.8143685980698196,-1.4461468094397527,0.10416666666666667,0.4551435198727872,1.0,2/9,6.68%,GSTP1;DNAJA1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.7561041472370997,1.4458464180257633,0.0392156862745098,0.5785040288347557,1.0,1/15,0.24%,HEY2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.8137203542319129,-1.4446135112893537,0.0196078431372549,0.46089754843911657,1.0,4/11,7.20%,CPSF1;ERN1;CSTF2;CSTF2T
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.8150577241118915,-1.4445083061807213,0.08,0.45928028491678735,1.0,7/10,15.43%,UQCR10;UQCRQ;UQCRC1;CYC1;UQCRH;UQCRB;UQCC3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7198647200242264,-1.4441414254022673,0.06666666666666667,0.4588845014079465,1.0,4/16,8.05%,S100A10;THY1;SFRP1;LIMS1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.6432663938099232,-1.4440687270962198,0.020833333333333332,0.45724553097804943,1.0,5/40,8.17%,GSTP1;SIRT2;SELENOS;WNT5A;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6927037794163048,1.4437247645767897,0.06349206349206349,0.5896169528058008,1.0,11/22,16.11%,SOX9;CRIM1;RANBP3L;CDK6;NBR1;HDAC7;SUFU;RORB;CHRD;SEMA4D;PPARG
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.8590593474012856,-1.4426440419080186,0.022222222222222223,0.4618712397601842,1.0,1/8,0.52%,GSTP1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7160162501613702,1.4424589811804784,0.05660377358490566,0.5945794025506986,1.0,4/19,9.16%,PAK1;PRKX;RYR2;HES1
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.7531784930783779,1.4424328545761351,0.05454545454545454,0.5907819676839463,1.0,2/9,8.30%,HEY2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.9173716208041881,1.441474567076588,0.0,0.5940332872726528,1.0,5/6,7.41%,DOCK5;NR4A3;FGF9;DOCK4;DOCK7
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.8157369007732707,-1.441271104961536,0.06896551724137931,0.4666777649066207,1.0,2/10,0.93%,BGN;BCAN
prerank,PanglaoDB_Augmented_2021__Podocytes,0.5262464825011856,1.4409036482532689,0.06382978723404255,0.5939221222976951,1.0,29/141,13.35%,DOCK5;LIFR;NUAK1;CHST3;ADGRL2;KITLG;ADAMTS13;EDNRA;KIAA1217;MERTK;NEBL;ARHGEF17;HSPA12A;ETF1;ARHGAP24;FKBP9;TEAD1;CADPS2;COL4A5;PLSCR4;SULF1;PTPRG;RBFOX2;GJA1;APBB2;TPM1;MID1;MAGI2;NAV2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.6850816699320157,-1.4406874144232114,0.058823529411764705,0.46748760462913674,1.0,2/24,1.60%,RPS2;GORASP1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),-0.986938010993835,-1.4404301128123207,0.0,0.46697768125789835,1.0,1/5,0.55%,SIRT2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.6359539686753523,-1.440362898956968,0.08771929824561403,0.4654262937979264,1.0,5/31,3.38%,HSPG2;AGRN;RBP1;RARRES2;GPC4
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.5486371447989256,-1.440325016941362,0.017543859649122806,0.4636277105668581,1.0,12/72,13.63%,CCND1;GPX1;COPS9;ATF4;PARP1;MAPK13;SMPD1;NOC2L;NPM1;CASP9;TMEM161A;GTF2H2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.7676430133214356,-1.4403015306777256,0.038461538461538464,0.4620603424435721,1.0,5/13,13.28%,SRSF7;SAP18;PCBP4;SRSF9;SRSF10
prerank,PanglaoDB_Augmented_2021__Microglia,0.6449921540405346,1.4401853091377295,0.01694915254237288,0.5944972063273811,1.0,6/29,12.55%,PTPRC;MERTK;FOS;SPI1;P2RY12;IL6R
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.8288242794370355,-1.4394794566825126,0.08333333333333333,0.46343190628568615,1.0,3/7,9.25%,KIF25;RANBP1;CEP85
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5212387219650979,1.4390961713798065,0.0,0.5974776873298722,1.0,43/116,22.42%,EEF2K;IGF1R;VRK1;DAPK1;ALK;DAPK2;PAK1;PRKX;CAMK2B;TYRO3;PAK2;RIPK1;MAK;EPHA4;OXSR1;ATM;MAP3K9;GRK5;PDPK1;CDK12;TNIK;CAMK2D;MKNK1;TAF1;STK11;LMTK2;STK17B;VRK2;MAPKAPK5;DAPK3;EIF2AK3;FER;MAP3K11;ACVR1B;MAPK3;SIK2;TAOK1;STK24;ATR;MAP3K12;AATK;ERBB4;ULK2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7615999531204305,-1.438851461212053,0.04878048780487805,0.4644920715194346,1.0,5/13,9.01%,STAB2;ROMO1;RARRES2;PPP1R11;TNFRSF14
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.8278088163725776,1.4386750870430487,0.06451612903225806,0.5966092638518807,1.0,3/9,6.26%,SOX9;SRF;NFATC3
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8723498077369868,1.4385948049049126,0.03333333333333333,0.5934302678130408,1.0,4/8,9.05%,GABRA4;GABRG3;GABRG2;GABRA2
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.6679707685904561,-1.437639917839184,0.06818181818181818,0.46725009584564364,1.0,13/27,23.34%,POLR2L;POLR1F;POLR1A;POLR2K;POLR2E;GTF2H2;POLR1G;TAF1A;TBP;UBTF;GTF2H1;POLR2F;GTF2H5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.6949454986243688,1.4373909843071349,0.07547169811320754,0.5970296572583024,1.0,5/22,8.16%,AKT2;SORBS1;NR4A3;CLTCL1;C2CD5
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6517551417041981,1.4367504213562425,0.044444444444444446,0.597085121413447,1.0,7/27,9.10%,PTPRC;OTUD7B;TMSB4X;RAB1A;RIPK1;MAP2K5;TIRAP
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.548416180141938,1.436743137923138,0.0,0.59342202250907,1.0,34/106,17.61%,ROBO2;UNC5D;NKX6-2;PCSK2;EFNA5;STMN2;SHISA6;G6PC2;SULT4A1;CAMK2B;KCNB2;TGFBR3;SNAP25;KCNIP1;ADGRB3;PROX1;LSAMP;MAPK10;CLVS2;EDARADD;ACTL6B;NOVA2;DPP6;ABCC8;ASTN1;LRRTM1;PCP4;SEZ6L;SLC8A2;NPTX2;CTNND2;UNC79;CELF3;GAD2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.8997412819211186,1.4367205820849762,0.021739130434782608,0.5901611967524599,1.0,2/5,5.05%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.89089362426021,1.4366544140019322,0.018518518518518517,0.5873545690746926,1.0,2/5,5.86%,TTN;CAV3
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.7977381375819257,-1.4364265990459275,0.13725490196078433,0.4701976835138852,1.0,2/10,9.18%,VPS37B;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.714472239033429,-1.4357572084005779,0.022727272727272728,0.4713860073358004,1.0,5/20,8.05%,S100A10;THY1;SFRP1;DUSP3;LIMS1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.8438896602244981,-1.4346400094422243,0.06382978723404255,0.4734916436446214,1.0,2/7,0.49%,NOX4;GPX1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6164267881965793,-1.4346068253083524,0.05555555555555555,0.4716770077626735,1.0,9/41,13.63%,UBB;RPS27A;UBC;PARP1;UBA52;PIF1;DDX1;MCM4;GTF2H2
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.9115516134218098,1.4342276236081701,0.017241379310344827,0.600479930460063,1.0,1/6,0.28%,PTPRC
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5178152089085435,1.4340863660438938,0.022727272727272728,0.5976451262652174,1.0,33/125,15.31%,CALCB;OLFM3;NKAIN2;STMN2;SHISA6;ATP2B3;FAM13C;SULT4A1;PRKX;TLN2;PARM1;MMD2;VAMP1;CREBRF;GCNT2;SNAP25;ADGRB3;DGKZ;LSAMP;CRMP1;MAPK10;AQP4;CLVS2;SCN2A;RUFY2;ACTL6B;MAGI2;ANK2;KIF1B;ERC2;DCLK1;ASTN1;LRRTM1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.8258056534741802,1.4340645999106523,0.04081632653061224,0.5942040770978153,1.0,1/11,0.24%,HEY2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6975524390035845,-1.4340344364973814,0.02127659574468085,0.4725521665420186,1.0,5/25,6.31%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8332839090346771,1.4339021964316097,0.09259259259259259,0.591960488047286,1.0,1/7,0.83%,KIF1C
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.701987123848402,1.43348071449244,0.01818181818181818,0.5911807107901208,1.0,8/18,16.81%,SLC4A4;PSEN1;PRXL2C;PFKFB3;PRKAA2;PFKFB1;GAPDHS;PRKAA1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.7893726801696986,-1.4330866903826982,0.10869565217391304,0.47429437044976525,1.0,4/8,16.48%,H1-4;SMARCA5;H1-10;PAF1
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.8211078484546529,-1.433010888000977,0.017857142857142856,0.47262289922081363,1.0,3/11,1.14%,BGN;BCAN;DSEL
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.8243297648395047,-1.432801413767895,0.08771929824561403,0.4713778173895329,1.0,1/7,0.83%,HSD17B10
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.547466611098534,-1.432651134380982,0.02040816326530612,0.4699782356080384,1.0,12/84,12.17%,RBM8A;SRSF7;CPSF1;RAN;NUP42;MAGOH;U2AF1;RBM15B;SLU7;NUP155;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.687177456289195,1.4318872633214121,0.07407407407407407,0.5988697969773876,1.0,9/23,12.67%,SHISA6;CNIH2;CACNG2;RELN;GSG1L;SHANK3;MAPK8IP2;CACNG8;SHISA9
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.7551070149558159,1.4316392339939508,0.13333333333333333,0.5970928388096413,1.0,3/6,20.78%,RNF213;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.573702427079146,-1.4313457383967938,0.044444444444444446,0.4744881842630717,1.0,12/62,16.89%,JUN;GTF2F1;ACTB;TMBIM6;IFIT2;CAV1;ZNF304;RACK1;PARK7;IFIT1;AKT1;BAX
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6425664404295156,1.4305826464475924,0.04081632653061224,0.6000823910134883,1.0,2/21,2.87%,SCEL;SVEP1
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.910732359653276,1.4305611743100708,0.02127659574468085,0.5967459914452593,1.0,1/5,3.47%,RELN
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.8597804911426237,1.4302589441258404,0.11320754716981132,0.5952909009654532,1.0,1/6,5.07%,GUK1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8230745984267547,1.4300233486486102,0.04081632653061224,0.5940744918108913,1.0,2/10,1.46%,ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.7547109215982406,-1.4284840467202224,0.15555555555555556,0.4864689299735508,1.0,3/11,9.95%,STAB2;GUSB;CD44
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.8321419244779595,-1.4283612739569806,0.04081632653061224,0.4847416755454107,1.0,5/9,10.12%,ATP5MC1;ATP5PD;ATP5F1A;ATP5PB;ATP5F1D
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.8926972028282736,-1.427849411522011,0.08888888888888889,0.4848089731835953,1.0,2/7,6.93%,MRPL44;HENMT1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.8262481213420013,-1.4258550268625725,0.017543859649122806,0.4914874995880065,1.0,6/11,8.94%,COX6C;COX7C;COX5B;COX6B1;COX4I1;COX5A
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.7560913529851031,-1.425820084005161,0.04,0.4897207276338018,1.0,3/13,1.14%,BGN;BCAN;DSEL
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.9007793438072756,1.4255957658987257,0.06666666666666667,0.620372774676582,1.0,1/5,0.55%,GLRA1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.6771461177945455,-1.4254164858833385,0.02,0.49032779610959326,1.0,7/24,9.84%,CALR;RARRES2;CXCL12;VEGFB;MOSPD2;PTN;CREB3
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.5326623742073646,-1.4253820121243292,0.041666666666666664,0.48849959583536484,1.0,18/87,13.89%,SOX4;UBB;UBXN1;PTTG1IP;VPS28;CENPX;PRICKLE1;MALT1;DNAJA1;PSMD10;STUB1;HSP90AB1;UFL1;CAV1;HDAC3;ISG15;PRR7;PARK7
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6267164558988854,-1.4251994166973592,0.0625,0.4873603070666719,1.0,11/38,17.35%,UBB;RPS27A;UBC;CENPX;UBA52;RFWD3;RNF8;RNF168;FAN1;VCP;MUS81
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.8207556504249278,1.4249724746228534,0.031746031746031744,0.6208961501793592,1.0,3/10,4.13%,APOLD1;SOX9;PRKX
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.6169878667962768,-1.4248600428712186,0.06,0.48686241282539433,1.0,5/31,7.41%,HSPG2;AGRN;UGDH;GPC4;XYLT2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.7750586291994033,-1.424530541252152,0.06382978723404255,0.48656527474782757,1.0,6/15,16.62%,S100A1;CDH3;DHFR;SCARB1;PARK7;AKT1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.8582493466916576,-1.423646652254116,0.10256410256410256,0.4884675366467987,1.0,5/7,13.57%,GAPDH;RPS19;ROMO1;RPL30;HMGN2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.9075996633637884,1.423577247011759,0.017857142857142856,0.6259459569328275,1.0,2/5,6.37%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7893129644215336,1.4235183507270768,0.07407407407407407,0.6227942938300063,1.0,4/8,16.02%,NEDD4L;CAMK2D;PRKCE;HECW2
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.8853894860895671,1.4234678003335361,0.05555555555555555,0.6197854605191591,1.0,1/5,0.24%,HEY2
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6219500593565187,-1.423326944685943,0.047619047619047616,0.4881274557811299,1.0,4/25,8.50%,SIRT2;PARP1;TIPARP;PARP2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6341591741176518,-1.4232589122159545,0.021739130434782608,0.48642720177156595,1.0,6/41,4.85%,H1-4;POLR2L;POLR2J;POLR2I;POLR2G;MAGEF1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.681766928772487,1.4231912731081677,0.08163265306122448,0.6177226878062564,1.0,6/18,15.84%,FGF9;CCDC39;LOXL3;PROX1;FGF1;PDPN
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.7997285597342635,-1.422484325867851,0.10638297872340426,0.4872998691783084,1.0,1/11,0.07%,PPIF
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.8371354548733884,1.4224751066138814,0.06818181818181818,0.6177655349577709,1.0,2/7,6.47%,LRP2;TGFBR3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.7850618918332025,1.4222549587428202,0.05405405405405406,0.6157892834625749,1.0,2/13,0.79%,RASGRF1;CALB1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.5251400671529229,1.4221669507011734,0.0,0.6132532143414935,1.0,35/130,15.95%,TLK1;VRK1;AKT2;CAMK1D;RPS6KB2;PRKX;PNCK;PRKCA;PAK2;RIPK1;TNKS;MAPK12;SGK1;ATM;TTBK2;PDPK1;MAST4;CAMK1;TOP1;AKT3;RPS6KA2;CAMK2D;MKNK1;TAF1;LMTK2;MASTL;VRK2;CSNK1G1;PLK2;PRKCE;CSNK1D;SRPK2;CDC7;MAPKAPK5;PRKCZ
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.8428978714046456,1.4221364271191164,0.05084745762711865,0.6101138061956387,1.0,2/7,6.37%,VRK1;PRKCA
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6680020817280058,1.421472314626441,0.03571428571428571,0.611503168426166,1.0,10/25,16.84%,TMSB4X;SLC4A4;PSEN1;PRXL2C;PFKFB3;PRKAA2;PFKFB1;GAPDHS;PRKAA1;PPARGC1A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5605276133247967,-1.4210694047421972,0.043478260869565216,0.4926484367808803,1.0,25/67,18.79%,UBB;POLR2L;POLR2J;RPS27A;UBC;POLR2I;POLR2G;TCEA1;ZNF830;UBA52;COPS7B;COPS2;POLR2K;POLR2E;GTF2H2;COPS6;PRPF19;COPS8;CUL4B;POLD3;HMGN1;POLD2;GPS1;RFC5;COPS5
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.6028568860785285,-1.420953834164928,0.04081632653061224,0.49160480889503294,1.0,12/35,16.67%,GPX1;BEX3;PIH1D1;MT3;IFI6;NOL3;NGF;CD44;LAMTOR5;PARK7;AKT1;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.8003422328764627,-1.4205274107124994,0.14814814814814814,0.4916045205290952,1.0,1/7,1.04%,PIWIL2
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.8264278733749023,-1.420479757749637,0.09302325581395349,0.4901522709307199,1.0,3/8,10.89%,NOP10;NHP2;TSR3
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8918866091786757,-1.4204601177405527,0.0625,0.4883682110492542,1.0,2/5,6.25%,EYS;GNA11
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.8812212299540942,-1.4202105295415048,0.05660377358490566,0.4877730888236141,1.0,4/9,11.08%,PTTG1IP;PSMD10;CD44;YJU2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.8173536999975677,-1.41981063491497,0.1,0.4875224378518461,1.0,2/11,7.58%,PPIF;MAPK13
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5634003876926753,1.4197713253571407,0.05,0.6180249250692018,1.0,12/55,10.22%,DEPP1;ITPR1;DRAM1;TPCN2;PIP4K2C;DAPK1;USP13;DAPK2;WDR91;RPTOR;PIP4K2A;ATM
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6917284953347113,-1.4192996631399983,0.04081632653061224,0.48810187836502467,1.0,6/19,16.35%,AP4M1;HSPA8;CLU;SCARB2;NCOA4;AP3M1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.9232042685825601,1.4192939031186595,0.0196078431372549,0.6177027968150662,1.0,1/6,3.84%,KAT2B
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.6058915194093133,-1.4185160877923204,0.045454545454545456,0.4899148957716703,1.0,6/35,10.26%,RNASEH2C;ERN1;DXO;NUDT16L1;RNH1;ISG20
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.701448338405291,-1.4182223672347938,0.06666666666666667,0.489472308054957,1.0,4/23,8.53%,PPIF;MAPK13;SIGMAR1;RNF112
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.6054454771771793,1.418029863392759,0.05454545454545454,0.623094386073409,1.0,11/48,10.05%,TPD52L1;WNT7A;TNFRSF19;SEMA3A;DUSP22;SH3RF1;GADD45A;RIPK1;TIRAP;CD27;ZNF622
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.6035894409910367,-1.4178592404321824,0.08928571428571429,0.48929359784787496,1.0,5/29,11.60%,AURKAIP1;BAD;CTSC;STUB1;FURIN
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.7354805275914668,1.417855987633028,0.0196078431372549,0.6211114878571654,1.0,6/23,9.02%,CALB1;FAM107A;RELN;AKAP5;EPHA4;SHANK3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.7783455737222986,1.4176951712880514,0.08163265306122448,0.6125647282227119,1.0,2/9,14.29%,WRN;XRCC3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.7783455737222986,1.4176951712880514,0.08163265306122448,0.6125647282227119,1.0,2/9,14.29%,WRN;XRCC3
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.7783455737222986,1.4176951712880514,0.08163265306122448,0.6125647282227119,1.0,2/9,14.29%,WRN;XRCC3
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.7015128489787339,1.4171136828169588,0.041666666666666664,0.6130825173814207,1.0,4/28,10.08%,GCA;DNM1;HACE1;DYSF
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.9365252781707409,1.4169105332180185,0.03508771929824561,0.6113508929355123,1.0,4/5,6.00%,WNT7A;COL5A1;PLET1;ARHGAP24
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.9438443848812116,1.4166519343642399,0.0,0.6099345469023796,1.0,2/5,2.00%,HTR1F;HTR2C
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.6084266266695805,-1.4163255896997229,0.0851063829787234,0.49334581510995806,1.0,6/47,7.58%,PPIF;JUN;PRDX5;ROMO1;PDGFRA;MAPK13
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.6039855827379149,-1.416223406002025,0.0851063829787234,0.4919344642545593,1.0,7/37,7.41%,HSPG2;AGRN;UGDH;B3GAT2;GPC4;GUSB;XYLT2
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.8102431279216799,-1.4160559449879475,0.0625,0.4909016181828847,1.0,7/13,12.47%,ATP6V0A4;PPT1;TMEM9;ATP6V0E1;ATP6V0E2;GRN;ATP6V0D1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8392355784090012,1.4160448779422785,0.08928571428571429,0.6111982618686981,1.0,1/7,0.43%,NDST3
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7833609845409694,1.4157474734918651,0.09259259259259259,0.6097969174593496,1.0,5/15,12.11%,PTPRC;TESPA1;FOXP1;RAB29;CARD11
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6896803500673132,-1.4154176062041426,0.043478260869565216,0.49182143992990274,1.0,5/21,11.96%,CENPX;SMARCA5;CENPV;NPM1;CENPQ
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.6926768162740928,1.415193563755197,0.061224489795918366,0.610168984446845,1.0,6/20,15.84%,FGF9;CCDC39;LOXL3;PROX1;FGF1;PDPN
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.7004153237561033,-1.4150956549785247,0.06382978723404255,0.49119866709911736,1.0,5/19,11.96%,CENPX;SMARCA5;CENPV;NPM1;CENPQ
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.5321707265039131,-1.4134512641236585,0.018867924528301886,0.497431396599842,1.0,12/86,12.17%,RBM8A;SRSF7;CPSF1;NUP42;ZFP36L1;MAGOH;U2AF1;RBM15B;SLU7;NUP155;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.9035145723695402,1.4133406209322776,0.05555555555555555,0.6190960568397726,1.0,4/5,9.63%,SLC6A15;SLC6A17;SLC1A4;SLC6A7
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.748731255983331,1.412310397049083,0.05660377358490566,0.623192690689494,1.0,4/13,12.68%,SORT1;ADGRB3;KCNH1;NOS1
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5964601471220007,1.4117897108042567,0.05357142857142857,0.623878469452231,1.0,12/47,10.77%,TULP3;RGS4;SLC39A14;GRK4;GNG4;RNF157;NMT1;MRAP;CAMKMT;GNG7;RGS12;GRK5
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.7572888200567067,-1.4117606325733787,0.11320754716981132,0.5025305433222158,1.0,5/14,13.41%,EMC6;EMC10;GET3;MMGT1;EMC4
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.8545885888538645,-1.4117133568388625,0.07692307692307693,0.4992079373019844,1.0,3/6,9.44%,CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.8545885888538645,-1.4117133568388625,0.07692307692307693,0.4992079373019844,1.0,3/6,9.44%,CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.875205005778864,-1.411591439120784,0.08333333333333333,0.4980671472338358,1.0,1/5,0.52%,GSTP1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.655968799475185,1.4115832694794355,0.08,0.6220180888508517,1.0,12/40,16.84%,FOXO1;CTBP1;AKT2;NR4A3;BBS7;OSBPL11;TMEM120B;STEAP4;PRDM16;BBS4;PPARG;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.674295379215049,-1.4115704399549638,0.09523809523809523,0.4963614584771317,1.0,4/22,8.79%,UBB;GPX1;CTSC;PSME3
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.7806130843883756,1.4111164034222703,0.08,0.6218446639503601,1.0,4/10,15.74%,VSIR;CBFB;BCL6;IRF1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.5818224401289626,1.4104499721543435,0.06521739130434782,0.6227642429839956,1.0,9/47,10.72%,PTPRC;LIFR;MADD;IRAK2;RIPK1;TRIM44;CYLD;JAK1;CBFB
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7802928069918509,1.4100210231809456,0.1,0.6225416695936344,1.0,4/11,13.46%,TTLL6;TTLL4;TTLL5;CEP41
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8673835498517928,-1.408933424535567,0.12195121951219512,0.5057641391051999,1.0,1/5,10.96%,SEMA5A
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.635632611525938,1.4086729809300826,0.09615384615384616,0.627678377534311,1.0,11/34,11.56%,NEDD4L;RTN4IP1;RAB17;ALK;CAMK1D;NSMF;KIAA0319;BCL11A;ADGRB3;BMP7;TNIK
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.9270405601301157,1.4086209965226384,0.0,0.6249089698205305,1.0,1/5,3.08%,CFAP69
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.7904794996750635,1.4086090028166984,0.07272727272727272,0.622026302660155,1.0,4/11,15.39%,PTPRC;TRAF3IP3;CD247;AOAH
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.8102963389605383,-1.4085191137393953,0.058823529411764705,0.5058569319084993,1.0,4/8,12.99%,ITM2A;ITM2B;ITM2C;SLC2A10
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.7537683135428047,-1.4076563611031359,0.13953488372093023,0.5086774304255016,1.0,4/13,9.95%,STAB2;GUSB;HAS2;CD44
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.5464573594888009,1.4073812883805779,0.04,0.6261659327889584,1.0,19/76,10.75%,GRIN2A;TNS1;PLXDC2;OPALIN;FAM107A;SHISA6;ENPP2;TMEM132C;RTN1;GFAP;MMD2;KCND3;GALNT15;BAALC;SLC6A7;AQP4;CDH20;P2RY12;NDRG2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.9038314544024031,1.4070684126537192,0.019230769230769232,0.6254715049006656,1.0,3/6,6.26%,HEY2;FGF9;NFATC3
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.6626206910851316,1.4068057616694845,0.10909090909090909,0.6243705932477677,1.0,5/21,11.37%,PTPRC;ZBTB16;RORA;TRAF3IP3;CD247
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.4730365303085099,1.4063362892638924,0.017241379310344827,0.6247415679573578,1.0,21/165,6.96%,DOCK5;PTPRC;VSIR;IGF1R;FAM107A;NEDD9;SOX9;SHTN1;AKT2;MYLK;SEMA3A;ENPP2;SEMA4B;PAK1;TIAM1;NTRK3;NSMF;PLET1;PRKCA;GCNT2;WASHC1
prerank,PanglaoDB_Augmented_2021__Neurons,0.49103217371808333,1.405996072536234,0.0,0.6239270672750371,1.0,62/237,17.86%,RASGRF1;NWD2;CALB1;OLFM3;PCSK2;PCLO;STMN2;SLC6A17;NRSN2;ATP2B3;PDE1A;CACNG2;SCN8A;SULT4A1;VSNL1;NMT1;SLC30A9;RBFOX3;GRM3;MMD2;PNCK;NRGN;RYR2;RB1CC1;SNAP25;GABRG2;PSD2;ADGRB3;SGIP1;RERE;PROX1;RORA;CNTNAP2;DLG4;KMT2C;CLVS2;ARID4A;SCN2A;STX1A;ACTL6B;CPLX1;ERC2;CAMK2N1;ARHGDIG;ASTN1;DYNC2I1;CALY;LRRTM1;PCP4;CACNB4;CMIP;SLC8A2;ZCCHC7;UNC79;GNL3L;CELF3;SNCB;ABAT;GAD2;KCNK1;NEFM;UNC13A
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5787472414040099,-1.4058788023036968,0.07692307692307693,0.514444593354738,1.0,14/57,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;ZFP36L1;SFRP1;RAB14;CD44;FLRT3;ANOS1;POLR2K;DSTYK;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.7143532534956849,1.4052333836184874,0.037037037037037035,0.6256542205433245,1.0,1/16,0.28%,PTPRC
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.6751073609457585,1.4052224401973914,0.10526315789473684,0.6228611083110588,1.0,2/19,0.84%,JADE2;MSL3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.7471782183529595,-1.4052090098357077,0.1111111111111111,0.5135862481059053,1.0,5/15,7.56%,UBB;RPS27A;UBC;UBA52;IRF3
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.7471782183529595,-1.4052090098357077,0.1111111111111111,0.5135862481059053,1.0,5/15,7.56%,UBB;RPS27A;UBC;UBA52;IRF3
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6823909980056361,-1.4041187253337297,0.13043478260869565,0.5170058994667545,1.0,3/16,3.47%,SPCS2;SRP14;SEC61G
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.7004651446763337,-1.404072363975225,0.12962962962962962,0.5154215284280317,1.0,5/24,9.67%,HSBP1;BAG3;STUB1;SLU7;HSP90AB1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.8350812006580981,-1.4035838874072066,0.058823529411764705,0.515687656953205,1.0,2/7,8.06%,TXN2;ADO
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.7694942405707244,-1.403547370441152,0.075,0.5141876349355088,1.0,1/8,4.03%,WDR18
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5902529576024992,1.4019842800709754,0.05660377358490566,0.6407185714780977,1.0,12/47,11.17%,UNC13C;GABRG3;MGAT4C;CDH7;SLC24A2;HCN1;RBFOX3;SLC6A6;MCF2L2;PDE10A;CREM;SV2C
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.8909889613485391,-1.4017173202706343,0.061224489795918366,0.5208346784690513,1.0,2/5,7.95%,CALM1;CALM3
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.770165304595549,1.401392905125418,0.06976744186046512,0.6406940033416875,1.0,1/14,0.46%,VSIR
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.8638253198964125,1.4007106573155736,0.020833333333333332,0.6421802527538281,1.0,2/6,9.59%,RIPK1;RFTN1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6515650659809208,1.400525235918184,0.07547169811320754,0.6398494264061675,1.0,4/22,18.12%,SYNJ2;PIP4P1;MTMR3;MTMR7
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.873150032734382,1.4004936422036358,0.05660377358490566,0.637099308716106,1.0,1/7,1.06%,MCCC1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.8179629310062434,1.4002729380108145,0.01694915254237288,0.6351189919120728,1.0,3/10,13.23%,NEDD4L;SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.810499346844541,1.3993369135055855,0.038461538461538464,0.6377817578719525,1.0,4/12,8.30%,HEY2;ADAMTS9;MYLK;PROX1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.6675322801323795,-1.3988526682352518,0.11666666666666667,0.5315263035062532,1.0,7/28,8.60%,UBB;RPS27A;UBC;S100A1;TLR1;UBA52;CNPY3
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.6180447908235466,1.3987901323582306,0.1,0.6384225262621517,1.0,6/33,7.57%,HOOK1;ARFGEF2;EPS15;PLEKHF1;DNM1;SORT1
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8751853348034064,-1.398433698253719,0.061224489795918366,0.5317692576957661,1.0,3/7,3.88%,MT1E;MT2A;MT3
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.8871007003615441,1.398245136880565,0.06451612903225806,0.6383656288739715,1.0,1/5,0.62%,ROBO2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8012370610648998,1.3981802442602098,0.10869565217391304,0.6359409780755729,1.0,8/10,18.88%,NEDD4L;PKP2;SNTA1;CAV3;RYR2;ANK2;KCNQ1;GPD1L
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.6915268885244622,1.398178247602925,0.023255813953488372,0.633151763259452,1.0,6/16,18.34%,GRIN2A;SLC24A2;PLK2;PRKCZ;SLC8A2;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6766679009336619,1.3977729797058185,0.09433962264150944,0.6329478952288433,1.0,3/22,5.86%,STMN2;PAK1;CAV3
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5377135926177272,-1.397407591087794,0.0425531914893617,0.5349461055313982,1.0,17/95,13.20%,PPP1R14B;ZDHHC1;S100B;RARRES2;TRIM35;MALT1;IFI6;PHB2;SMPD1;LYN;SHFL;NLRP1;IFITM3;RNF187;IKBKB;B2M;ISG15
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.8404753568731425,1.3967364530154396,0.06521739130434782,0.6356781298849685,1.0,2/9,1.22%,UNC13C;SYT1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5492242316096211,-1.3963189185754548,0.024390243902439025,0.5384760699627436,1.0,14/65,12.17%,RBM8A;SRSF7;CALR;RAN;NUP42;MALT1;MAGOH;U2AF1;WASHC4;SLU7;LSG1;NUP155;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.5674619524664309,1.395618337058086,0.041666666666666664,0.6392733109704241,1.0,25/65,20.08%,GRIN2A;SHISA6;CNIH2;DAPK1;CACNG2;RELN;CAMK2B;GRIN1;GSG1L;DLG4;FGF14;NEFL;MAPK8IP2;CAMK2D;CACNG8;SHISA9;NOS1;ANK2;CACNB4;CACNG5;ANK3;GRIN2B;HOMER1;DMD;LRRC7
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.5811298126575655,-1.3948339616196752,0.02702702702702703,0.5431016153347518,1.0,4/34,2.78%,TRMT112;SNRPB;CSKMT;ICMT
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5344094269776377,-1.3939184565583893,0.05172413793103448,0.5454998944565511,1.0,24/93,14.30%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;SFRP1;UBA52;MAPK13;PSMC3;CACTIN;PSMD10;HAS2;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;TOLLIP;IKBKB;PSMD4;RC3H1;PELI1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5177840946088211,1.3938100219600216,0.044444444444444446,0.6462079932778444,1.0,16/92,7.41%,LIFR;NUAK1;CHST3;SRPX2;SOX9;KITLG;EDNRA;KIAA1217;IRF2;SRPX;ARHGEF17;TIMP3;HSPA12A;FKBP9;TEAD1;SH3PXD2B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.5918505003511888,-1.3936744725535957,0.0425531914893617,0.5447833987844124,1.0,11/36,12.69%,UQCR10;SURF1;NDUFS8;UQCRC1;ETFRF1;NDUFA5;ATP5F1D;COQ10A;SDHAF4;UQCRH;UQCRB
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.7181450206710235,1.3934191562697869,0.07142857142857142,0.6455320862403503,1.0,3/16,5.94%,PTPRC;AHR;SPI1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6891831793060599,1.3920893565261228,0.12,0.6510023051664787,1.0,2/16,5.18%,PARD3;ERBIN
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.8802475911975796,1.391848854992479,0.0,0.6496046625544407,1.0,3/5,11.28%,PTPRR;TENM3;PTPRG
prerank,PanglaoDB_Augmented_2021__Interneurons,0.47914114410458075,1.3916916431781954,0.022727272727272728,0.6475147738535039,1.0,66/235,17.86%,GABRA4;CALB1;OLFM3;PCSK2;SYT1;STMN2;SHISA6;ADGRL2;CALN1;GNG4;NRSN2;ATP2B3;PDE1A;CACNG2;RELN;NRIP3;SCN8A;SULT4A1;PARM1;KCNC2;LMO3;KCNQ5;CPNE5;GRM3;MMD2;HSPA12A;NRGN;ARX;SNAP25;GABRG2;PSD2;ADGRB3;SLC22A15;HIVEP2;RORA;ZIC4;FRYL;AQP4;CLVS2;SRGAP3;RORB;GRM1;OXR1;ACTL6B;SHISA9;NOS1;HPCAL4;FBXO11;FBXW11;GDA;CPLX1;ERC2;SV2B;CDK17;ASTN1;LRRTM1;TMEM163;SLC8A2;CTNND2;CELF3;SNCB;ABAT;GAD2;NEFM;ADCY1;UNC13A
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6326890939005841,-1.3916324393275783,0.05263157894736842,0.5522973060020272,1.0,8/25,12.47%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;MCOLN1;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.6503073492194796,1.391187592074666,0.06382978723404255,0.6474221533584823,1.0,6/30,9.10%,PTPRC;ARFGEF2;PTPRJ;PSEN1;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.8434648486171138,-1.3907506083415997,0.058823529411764705,0.5539058004506415,1.0,3/7,6.27%,CCND1;MMP2;OPN3
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.7666467852582797,-1.3905816576070793,0.17777777777777778,0.5528353697715251,1.0,2/10,3.74%,GSTP1;SLC30A10
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.49241574994078713,-1.3905379706820142,0.0,0.5511401915854142,1.0,27/123,11.92%,UBB;PSMB6;APEX1;PSMD8;RPS27A;PSMB4;UBC;EXOSC8;ZFP36L1;HSPA8;PSMA7;TBRG4;UBA52;FXR2;PSMC3;PSMD10;SET;PCBP4;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;YWHAB;NPM1;DCP1A;YBX1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.6303789356387638,-1.3904852166460693,0.10204081632653061,0.5495885441683583,1.0,5/32,7.45%,GPX1;GSTP1;GPX4;ALOX5;FADS1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5480618053431922,-1.390291978566203,0.06521739130434782,0.5485754319122617,1.0,18/56,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;YAP1;PSMD4;SETD1A;PSMC4;PSMB2;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.7277186981041346,1.3900628677339737,0.09803921568627451,0.6516425610711402,1.0,4/14,12.44%,SHTN1;RIPOR2;BCAS3;RAP1B
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.704654370789053,-1.3896400283872978,0.0851063829787234,0.5499724743510624,1.0,2/16,1.82%,SMYD2;CSKMT
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.8917782991414127,1.3886679155534318,0.0425531914893617,0.6565229041259688,1.0,1/7,0.24%,HEY2
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.7919491730663563,1.38843197082682,0.09803921568627451,0.6552128301816075,1.0,1/9,0.28%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6786792563347765,1.3883643989190464,0.08333333333333333,0.6530619141351762,1.0,2/20,1.48%,ADAMTS9;PTPRR
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.8150757968815219,1.3883333986765882,0.08771929824561403,0.6505248720614082,1.0,4/7,11.84%,USP30;NBR1;ATM;MAP1LC3B
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7022991608264566,-1.388307233369737,0.1346153846153846,0.5543472755444124,1.0,3/11,9.31%,ZDHHC1;PHB2;NLRP1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.7285275329990287,-1.388049365664429,0.05357142857142857,0.5536885479412653,1.0,6/16,6.04%,UBB;EIF5A;RPS15;RPS7;RPL23;RPL37
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.7147245894367349,1.3878292509763608,0.11627906976744186,0.6512266313449008,1.0,2/13,5.89%,ADAMTS13;CHAC2
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.761403589475449,1.3877618376988907,0.04878048780487805,0.6488781429564655,1.0,3/10,6.45%,PTPRC;PTPRJ;RYR2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7782893292349141,-1.3876495206022217,0.1111111111111111,0.550797618326636,1.0,1/7,0.77%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7782893292349141,-1.3876495206022217,0.1111111111111111,0.550797618326636,1.0,1/7,0.77%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7782893292349141,-1.3876495206022217,0.1111111111111111,0.550797618326636,1.0,1/7,0.77%,H1-4
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.6929081409774412,1.387573807622747,0.1320754716981132,0.6472669475151808,1.0,4/16,4.41%,VSIR;GRIN2A;C1RL;NLRC4
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.8722752361113382,-1.3867624075253149,0.08695652173913043,0.5525165451500859,1.0,1/5,1.59%,CALR
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.6708085641065451,-1.3867528751580684,0.10344827586206896,0.5507790717376643,1.0,5/25,6.31%,UBB;RPS27A;UBC;DYNLL2;UBA52
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8073515774292036,1.386701336179905,0.08771929824561403,0.6492051298551433,1.0,2/7,9.12%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.9652100684088785,1.3859815196188017,0.0,0.6511671910145023,1.0,1/6,0.62%,ROBO2
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.8228659473721855,-1.3856622926976185,0.09615384615384616,0.5540281192762606,1.0,1/5,1.93%,PCBD1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.8717016992573212,1.3847867306078478,0.1346153846153846,0.6559117546968876,1.0,1/5,6.37%,PRKCA
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6061865455302653,1.3847660546071536,0.08,0.6532775709430848,1.0,16/34,18.46%,SYT1;CACNG2;RELN;GRM3;GRIK3;DGKZ;SHANK3;MAPK8IP2;TPRG1L;GRM1;CACNG8;CACNG5;DGKI;GRIK1;UNC13A;HOMER1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.7126203709313371,-1.384748157707487,0.06451612903225806,0.5558808383892802,1.0,1/19,1.12%,PPT1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.65635701035918,-1.384715828441461,0.07272727272727272,0.554308626475551,1.0,10/21,16.89%,TMBIM6;HSPA8;BAG3;HSPA13;ERN1;HSPA14;HSPA9;HSPA5;OPTN;BAX
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.7787363714439847,-1.3846824979996486,0.17307692307692307,0.5510982979516007,1.0,2/6,8.83%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.7787363714439847,-1.3846824979996486,0.17307692307692307,0.5510982979516007,1.0,2/6,8.83%,BLVRB;ABCG2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.6711228161883975,-1.384644162361079,0.06382978723404255,0.5495237990420767,1.0,5/30,10.17%,NR0B1;CALR;RNF6;DDX5;UFL1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.8327623098797302,-1.3843753478349565,0.12,0.5489987597348971,1.0,3/7,6.11%,PPIF;DNAJC30;PHB2
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.9125757050276513,1.3840791920432112,0.03636363636363636,0.6544960384230797,1.0,2/5,2.00%,FABP3;HTR2C
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.5578544410972391,1.384032176861757,0.08,0.6520831943072671,1.0,16/47,22.54%,PAK1;BAIAP2;CAV3;CRACD;CDC42EP4;CDC42EP3;VASP;PRKCE;FER;NAV3;TOGARAM1;FCHSD2;CARMIL1;CLASP1;MAPT;NCK2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.82778674649906,1.3839240370067891,0.06666666666666667,0.6501937363745995,1.0,2/7,5.94%,PTPRC;SPI1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.901565609073997,1.383531448532831,0.07142857142857142,0.6497100432894235,1.0,2/5,5.30%,ENPP2;PLA2G15
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.8639139605704719,-1.383487027704197,0.057692307692307696,0.5512411572573556,1.0,1/7,0.33%,ATP6V0A4
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.8888170824710012,1.3832978516895247,0.14814814814814814,0.648460518411939,1.0,1/5,0.46%,VSIR
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.8462384063648385,1.3828840549314159,0.06382978723404255,0.6484473892521866,1.0,1/7,0.24%,HEY2
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6033037675721331,1.382793371562095,0.02,0.6462962054297499,1.0,20/56,19.81%,CALCB;CALB1;EDNRA;TRPC4;ATP2B3;ADCY5;CAV3;RYR2;ATP2B2;DLG4;KNG1;ACKR4;SLC8A1;SLC8A2;FPR3;SPPL3;ATP2B1;LPAR1;FZD9;ABL2
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.8358180474236911,-1.3826742889624712,0.14,0.5538769410843063,1.0,3/7,6.77%,TRMT10C;TBRG4;TRMT10A
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.780008636822552,1.3825745342457472,0.08928571428571429,0.6449224186075524,1.0,2/10,5.46%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.664141409168397,-1.3819861913882894,0.08771929824561403,0.5554039527581177,1.0,3/27,0.44%,AURKAIP1;BTC;CUL7
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.6793001951929667,-1.3819824180956615,0.07692307692307693,0.5537469199619423,1.0,3/22,3.88%,SOX4;BAD;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.8843823877068557,-1.3818605805282398,0.041666666666666664,0.5525653917349764,1.0,5/5,11.60%,LAPTM4B;CDH3;HSP90AB1;FN1;FURIN
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.7183162666007009,-1.3817170108402361,0.05454545454545454,0.5515456878902952,1.0,5/14,13.28%,SRSF7;SAP18;PCBP4;SRSF9;SRSF10
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.7327908472634118,-1.3816400615233095,0.043478260869565216,0.5504087513842392,1.0,1/14,0.33%,ATP6V0A4
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.7177290854958964,1.3813590538116691,0.06896551724137931,0.6498482576124983,1.0,6/12,21.06%,FAM161A;DIP2B;CAMK1;PRKAA2;PRKAA1;TAOK1
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7654893429152638,1.380948106254943,0.061224489795918366,0.6500941470200597,1.0,1/8,1.93%,WNT7A
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.7183336987363579,1.3808244453994494,0.08333333333333333,0.6486840101432679,1.0,4/12,10.92%,LRIF1;BRCA1;RBM15;CDYL
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.8002671691643486,1.3806219369546524,0.12,0.6472846789130416,1.0,2/7,4.45%,SOX9;PLIN5
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.729488834669257,1.380486332024955,0.10204081632653061,0.6456721876218819,1.0,8/14,22.62%,SLCO1A2;RXRA;NCOA1;SLC51A;NCOA2;AKR1C1;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.9053328693391662,1.3804460295337284,0.125,0.6432914905820332,1.0,1/5,0.24%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6501850898670231,1.37986932544074,0.06521739130434782,0.6438537541735315,1.0,6/31,9.10%,PTPRC;ARFGEF2;PTPRJ;PSEN1;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.5919658772400473,-1.3797162810294596,0.1276595744680851,0.5556361398878465,1.0,5/30,3.19%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.5919658772400473,-1.3797162810294596,0.1276595744680851,0.5556361398878465,1.0,5/30,3.19%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8981033353269354,1.3788586563958452,0.02127659574468085,0.6451125826750783,1.0,2/7,5.35%,SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8981033353269354,1.3788586563958452,0.02127659574468085,0.6451125826750783,1.0,2/7,5.35%,SEMA3A;SLIT3
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8721339872331428,-1.3778040746758338,0.07317073170731707,0.5620473841972652,1.0,2/6,6.09%,NR0B1;ASAH1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.5443635108515839,-1.3769109971798097,0.06,0.5644889752568593,1.0,25/78,18.46%,RBM8A;SRSF7;SAP18;SMU1;JMJD6;LARP7;FXR2;C9ORF78;PUF60;MAGOH;PCBP4;RBM15B;NCL;DDX5;SRSF9;RBM23;NOVA1;SRSF10;SRPK1;SF1;SRSF3;RBM39;RBM3;CWC22;CIRBP
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.8632171128232453,1.3763387065292922,0.05660377358490566,0.657998726648613,1.0,1/6,5.55%,WRN
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7778478729186395,-1.376198713419809,0.11538461538461539,0.5659133302480198,1.0,6/11,18.46%,MT2A;COX19;SLC31A1;PRNP;ATP7B;COMMD1
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.7928028109470504,-1.3760868803487851,0.058823529411764705,0.5647540682291785,1.0,3/10,7.20%,CPSF1;CSTF2;CSTF2T
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5190032008542621,-1.3758141166151614,0.047619047619047616,0.5639339221838436,1.0,29/92,18.79%,UBB;POLR2L;POLR2J;RPS27A;UBC;POLR2I;POLR2G;TCEA1;ZNF830;PARP1;UBA52;COPS7B;COPS2;POLR2K;RAD23A;POLR2E;GTF2H2;COPS6;PRPF19;FAN1;COPS8;CUL4B;POLD3;HMGN1;POLD2;GPS1;COMMD1;RFC5;COPS5
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7700474279400826,1.375613982020427,0.14,0.6590812687427263,1.0,3/10,9.36%,TRAK1;SYBU;NEFL
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.5143700412991569,1.3752499203619533,0.041666666666666664,0.6587023148999561,1.0,30/99,18.34%,GRIN2A;OLFM3;STMN2;MEIS2;ATP2B3;NTRK3;KCNC2;TMEM132B;GRM3;MMD2;GRIN1;SNAP25;GABRG2;PSD2;LSAMP;GABRA2;CLVS2;SCN2A;GRM1;ACTL6B;MAGI2;ASTN1;SLC8A2;UNC79;CNTNAP5;CELF3;SLC6A1;GAD2;UNC13A;GRIN2B
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.7026058326259588,1.3751248820437145,0.07017543859649122,0.6567694991521478,1.0,5/12,11.84%,USP30;RB1CC1;NBR1;ATM;MAP1LC3B
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.6768895683775942,-1.3748373317651243,0.08888888888888889,0.5664617125053225,1.0,4/16,4.51%,ACTG1;ACTB;PRDX1;CDH3
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.8243690297087806,-1.3747167776448557,0.15254237288135594,0.5652810113104777,1.0,1/6,1.28%,CD151
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.6211312115671023,-1.374302535750894,0.0851063829787234,0.565304894662556,1.0,9/29,14.61%,POLR2L;POLR1F;RRN3;POLR1A;POLR2K;POLR2E;GTF2H2;POLR1G;TAF1A
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.49951820802949864,1.3730211188565555,0.02127659574468085,0.6662123736213449,1.0,36/139,15.95%,TLK1;VRK1;AKT2;CAMK1D;RPS6KB2;PRKX;PNCK;PRKCA;PAK2;TNKS;MAPK12;SGK1;ATM;TTBK2;PDPK1;MAST4;CAMK1;TOP1;AKT3;RPS6KA2;CAMK2D;MKNK1;TAF1;LMTK2;MASTL;GALNT16;GALNT13;VRK2;CSNK1G1;PLK2;PRKCE;CSNK1D;SRPK2;CDC7;MAPKAPK5;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.8440273735339276,1.3724738199685114,0.1206896551724138,0.6670691216687544,1.0,1/6,3.98%,PAK1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.7976484435281606,1.3723840460985128,0.08771929824561403,0.6651985055788813,1.0,2/7,14.29%,WRN;XRCC3
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),-0.8933705826685651,-1.3721566118408,0.0,0.5713355957446027,1.0,1/6,0.55%,SIRT2
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),-0.8933705826685651,-1.3721566118408,0.0,0.5713355957446027,1.0,1/6,0.55%,SIRT2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.5602835496558274,-1.3720555585287315,0.024390243902439025,0.5703028647979385,1.0,13/54,15.29%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;PPIA;KPNA2;CTDP1;POLR2K;RAD23A;POLR2E;IFIT1;SRPK1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.6126736417537045,1.371933597091729,0.09803921568627451,0.6648754874971307,1.0,12/36,14.85%,ITPR1;HTR2C;KCNJ11;G6PC2;KCNC2;PRKCA;SNAP25;ITPR2;STX1A;ABCC8;CLOCK;ENSA
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.7741870793510529,-1.3711846652456559,0.16666666666666666,0.5724428589473829,1.0,3/7,15.65%,GAS1;PRNP;SNX12
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.7290135504597772,1.3711502011988472,0.10869565217391304,0.667433833469566,1.0,6/19,11.72%,GRIN2A;IGF1R;PSEN1;GRIN1;EPHA4;GJA1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7524184458745605,-1.371110696334767,0.13043478260869565,0.5711177838235603,1.0,2/12,5.44%,RARRES2;PDGFRA
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.8745899548933866,1.3710729335785112,0.038461538461538464,0.6654405702934082,1.0,3/5,10.32%,UBASH3B;FOXP1;PRXL2A
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.8082249359537259,1.370979542462778,0.09523809523809523,0.6636734194810674,1.0,2/9,13.23%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7451141346644801,-1.370972633865489,0.10638297872340426,0.5700357301157701,1.0,5/11,12.33%,RPS19;ROMO1;RARRES2;TNFRSF14;RPL30
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.7779206536647812,1.3708434384453199,0.08620689655172414,0.6622002606334438,1.0,1/8,17.04%,RYK
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.7606290530644287,1.3706682979431288,0.05454545454545454,0.6609478649260361,1.0,6/11,20.94%,TTN;CAV3;RYR2;SLC8A1;DMD;PIK3CA
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.8395760174993836,-1.370460795481734,0.047619047619047616,0.5707790466143855,1.0,2/8,5.12%,NR0B1;PAX8
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.5800967476709185,1.3704235993178595,0.044444444444444446,0.6598440496604076,1.0,9/39,14.12%,ARFGEF2;GRK4;DNM1;ARRB2;RAB31;SNCA;LMTK2;SNX25;AP2M1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.7563277512574983,1.370175934004782,0.12,0.6590611508651305,1.0,6/13,22.95%,PLA2G15;GPAM;AGMO;MOGAT1;GPAT4;PNPLA2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.7598811251734124,1.3697043828126403,0.16666666666666666,0.6589770267471842,1.0,1/9,1.48%,BAIAP3
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.8027961993639912,1.369607017013761,0.06666666666666667,0.657235642773534,1.0,2/7,10.29%,ROBO2;BMP7
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.8968576933311508,1.3694805974984046,0.06521739130434782,0.6555753561030139,1.0,3/6,8.59%,ITPK1;RIPK1;CYLD
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6726209479283548,1.3694089003861776,0.041666666666666664,0.6536523505159128,1.0,3/23,6.49%,BCL9;TGFBR3;PCSK6
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5309998790696612,1.3692464880382895,0.0,0.6522212612720489,1.0,16/58,18.34%,GRIN2A;SYT1;BAIAP3;CACNG2;SLC24A2;RELN;AKAP5;SHANK3;DLG4;CACNG8;PLK2;PRKCZ;SLC8A2;CACNG5;ADCY1;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.5500269930486528,-1.3691584166372193,0.05263157894736842,0.5743561035707109,1.0,10/56,9.57%,BTC;SIRT2;RANBP1;SVIL;WIZ;NPM2;MAP10;RCC2;GIPC1;CENPV
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.7053431073732159,-1.3690174601574372,0.09302325581395349,0.5732157236969472,1.0,7/24,11.34%,PPIF;GPX1;NOL3;PSMD10;SLC25A5;CLU;PRELID1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5562656194568025,1.3685387458306497,0.057692307692307696,0.6530819810673267,1.0,14/63,10.05%,IGF1R;EPHA7;ALK;MERTK;NLRC5;TSPYL2;NTRK3;TTN;ZNF16;EMP2;TYRO3;ROR1;EPHA4;ZNF622
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.770056964358136,-1.3684259214565102,0.07692307692307693,0.574176402012195,1.0,2/11,5.32%,LSM4;EDC3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.6237096155453996,-1.368012143234814,0.08888888888888889,0.5740002879578334,1.0,4/24,9.67%,NOP10;NHP2;PIF1;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.7831252642738382,1.3679196398418803,0.06896551724137931,0.6547512597310402,1.0,3/9,13.10%,RNF152;ATM;STK11
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6388796674665281,-1.3664824819632448,0.14893617021276595,0.5785402721158734,1.0,5/26,8.82%,H1-4;PPP4C;USP51;KPNA2;FIGNL1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7724823676698384,1.3660436004993015,0.07272727272727272,0.6631394782693857,1.0,2/10,9.12%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.8427169613229026,1.365676406156957,0.12727272727272726,0.6633469560934283,1.0,2/6,9.16%,HEY2;HES1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.7108485446342463,-1.365673911279258,0.12244897959183673,0.5807181910444809,1.0,5/12,13.18%,DERL2;UBE2J1;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.767554449716243,-1.3656480006858547,0.1568627450980392,0.5791444891753473,1.0,2/10,3.29%,GPX1;NT5E
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.75632784399288,1.3654546989740253,0.14285714285714285,0.662343799738096,1.0,5/11,11.12%,NR4A3;AZIN2;C2CD5;CA2;ACSL1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6980722972406929,-1.3651024186305445,0.15555555555555556,0.5795874786252327,1.0,6/13,16.89%,BAD;IFI6;MFF;CLU;FIS1;BAX
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.7256998403628615,-1.3649212997005464,0.15384615384615385,0.5788838410037277,1.0,4/10,20.19%,CRAT;ACOX1;CROT;ACOT8
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.588643523298865,-1.3647925682597364,0.08163265306122448,0.577756261412853,1.0,5/38,6.65%,GPX4;NDUFA6;FTL;PRDX1;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6255465705155047,1.3637761634300463,0.1,0.6697495098673188,1.0,9/27,16.81%,RNF152;ATM;UBR1;TNFAIP8L1;STK11;PRKAA2;TSC1;MAPKAPK5;PRKAA1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.757078083334061,1.3635850297709942,0.1206896551724138,0.6686312697567791,1.0,4/10,13.23%,PKP2;RYR2;GJA1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.9255560421256934,-1.3632846001297805,0.019230769230769232,0.582380815288936,1.0,4/7,4.53%,UBB;EIF5A;PTTG1IP;RPS7
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6812523974986753,1.3622402120250052,0.07407407407407407,0.6731725197899912,1.0,5/19,7.42%,ROBO2;FAM107A;DUSP22;PHLDB2;BCAS3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8257450157579987,-1.3622095421310934,0.09302325581395349,0.585504711064721,1.0,2/5,12.06%,PLEKHG5;CORO1B
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.7157167304499348,-1.3619486776514955,0.16,0.5849622289541143,1.0,2/13,3.29%,GPX1;NT5E
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7695978144578057,-1.3618727913065398,0.15384615384615385,0.5835764412780193,1.0,2/10,5.72%,KIF25;SYNE2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7606011652732665,-1.3616684036998206,0.125,0.5829578403365296,1.0,4/10,13.41%,EMC6;EMC10;MMGT1;EMC4
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5052376238739241,1.3615131791728547,0.0,0.6754630257018053,1.0,32/114,17.86%,ROBO2;OLFM3;PCLO;STMN2;EPHA7;ATP2B3;SULT4A1;NTRK3;RBFOX3;GRM3;MMD2;GRIK3;SNAP25;NPAS3;ADGRB3;PROX1;HIVEP2;LSAMP;CLVS2;ACTL6B;ANK2;NOVA2;KIF1B;ERC2;DCLK1;ASTN1;SLC8A2;CTNND2;UNC79;CELF3;GAD2;UNC13A
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.746705734406134,1.3612631634215755,0.11764705882352941,0.6744028601542345,1.0,4/13,13.23%,GRIN2A;GRIN1;RYR2;SLC8A1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.8142004104328546,-1.361195750743798,0.1,0.5832403966882165,1.0,5/7,11.23%,GSTP1;ALOX5;MID1IP1;SLC25A33;SPHK2
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.5195115614627402,-1.3607645095470935,0.0392156862745098,0.5838011948854255,1.0,11/82,12.17%,RBM8A;SRSF7;CPSF1;NUP42;MAGOH;U2AF1;RBM15B;SLU7;NUP155;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.7988228228182872,-1.3607123775154952,0.06382978723404255,0.5824057723917736,1.0,3/6,11.85%,LSM1;DCPS;DCP1A
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5916932271905799,-1.3606097499240417,0.08771929824561403,0.5812127194217697,1.0,10/37,6.31%,UBB;NCSTN;HSPG2;RPS27A;UBC;SNCAIP;UBE2L6;ITM2B;APH1A;UBA52
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7711920313911023,1.3604573811500087,0.061224489795918366,0.6765421570274252,1.0,3/9,4.15%,BCL2L11;FAM107A;KLF9
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.6543579235931504,1.3602790580889534,0.1346153846153846,0.6752230845510049,1.0,6/18,17.00%,RAB17;CBFB;RAP1B;TJP1;PDLIM5;MYO1C
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6525524887427672,-1.360101551430978,0.06896551724137931,0.5819132089381035,1.0,3/22,7.56%,EIF5A;IFI6;IRF3
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.7970166586020402,-1.359110512732724,0.15789473684210525,0.5853498474809131,1.0,1/7,2.58%,PCGF2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.8927385932749823,-1.3585245530719714,0.06521739130434782,0.5868910565126597,1.0,1/6,2.24%,CALM1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.8545139655213894,-1.3581612871650928,0.125,0.5871852501013856,1.0,2/5,11.41%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.6040046636199742,1.3575855725312578,0.11320754716981132,0.6879370218817448,1.0,7/28,11.51%,OTUD7B;NEDD4L;RIPOR2;CAV3;SPI1;TTBK2;SIN3A
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.8041318338427061,1.3575351997997402,0.12962962962962962,0.6859371314675973,1.0,1/8,0.61%,AKR1C2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.8266972360014743,-1.3572995894498248,0.06382978723404255,0.5897016013334225,1.0,3/8,9.84%,CXCL12;MOSPD2;CREB3
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.7884804880158223,1.3567594534142773,0.09259259259259259,0.6874251617159335,1.0,2/9,3.49%,GLRA1;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.6764402869533052,-1.3566379962915964,0.16,0.5909723909900468,1.0,4/18,9.67%,CCND1;STOX1;PSMD10;HSP90AB1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.769514159377992,-1.3563852678205932,0.18,0.5904887486478282,1.0,5/6,21.54%,B3GALT2;B4GAT1;B3GALT5;GAL3ST3;B3GNT7
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.6107962203937582,1.356233911406009,0.06,0.6887738747696339,1.0,5/37,10.69%,CALCB;ADGRL2;ADCY5;ADGRB3;ADCY3
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8988715543630104,-1.3561739867299398,0.10638297872340426,0.5880080759961018,1.0,4/5,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8988715543630104,-1.3561739867299398,0.10638297872340426,0.5880080759961018,1.0,4/5,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.8507891164169195,-1.3559699621955283,0.14285714285714285,0.5873735719214015,1.0,2/5,13.90%,ULK3;VPS11
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.8196741577149982,-1.3552478325864217,0.1836734693877551,0.5887418146978005,1.0,1/5,1.93%,PCBD1
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.756938083783,1.3552195492563943,0.09090909090909091,0.6921782521481727,1.0,2/10,10.85%,PEX5L;PEX16
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8715060959388408,-1.3547269346263937,0.06382978723404255,0.5891057877116695,1.0,2/5,7.54%,XYLB;DCXR
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.5891570645272418,-1.3539587354296538,0.04,0.590623564019711,1.0,9/32,14.31%,HSD17B10;SQLE;TM7SF2;SC5D;MSMO1;PMVK;PSAT1;PARK7;DHCR7
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7721210600917267,1.3529555400555497,0.0847457627118644,0.7001057864441015,1.0,4/8,16.73%,CACNG2;DLG4;CACNG8;CACNG5
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7721210600917267,1.3529555400555497,0.0847457627118644,0.7001057864441015,1.0,4/8,16.73%,CACNG2;DLG4;CACNG8;CACNG5
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8420443069690667,1.352891841499615,0.125,0.6982331127299732,1.0,3/6,7.84%,NR4A3;NPAS2;SGIP1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.6956520494103754,-1.352743902108329,0.09302325581395349,0.5939026366452121,1.0,4/15,10.16%,S100A6;PDGFRA;WNT5A;FN1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.8038597477352194,1.3527074462342907,0.13636363636363635,0.6968183784634668,1.0,3/8,12.98%,IGF1R;CALCOCO2;FYCO1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6783778927177028,-1.352116636921057,0.19148936170212766,0.5939561104448235,1.0,4/17,11.96%,CENPX;SMARCA5;NPM1;CENPQ
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6783778927177028,-1.352116636921057,0.19148936170212766,0.5939561104448235,1.0,4/17,11.96%,CENPX;SMARCA5;NPM1;CENPQ
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5219613797404872,-1.3519767151554725,0.07692307692307693,0.5930251172872484,1.0,26/88,15.29%,RBM8A;LSM4;SRSF7;SNRPD2;SNRPB;LSM1;SMU1;SCNM1;NOL3;PRPF8;SNRPG;MAGOH;U2AF1;SLU7;SMNDC1;YJU2;PDCD7;SNRPD1;PPP2R1A;NOVA1;SRSF10;NONO;PRPF18;SF3B2;SNRNP35;SRPK1
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.8251461200303494,-1.3519503868684073,0.1111111111111111,0.5917275430594267,1.0,3/6,12.06%,SYAP1;HAS2;CORO1B
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.527667375176152,-1.3517441316810817,0.10204081632653061,0.5910981838674366,1.0,16/64,18.46%,SOX4;PIWIL2;PCIF1;EEF2;FXR2;EIF3D;EIF4A3;CLU;SPHK2;NPM1;RACK1;RPL5;SMPD3;RBM3;CHRNA7;CIRBP
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7653655169455309,1.35151467817492,0.14,0.7003000473185239,1.0,3/6,20.78%,RNF213;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),-0.883930718329979,-1.351176507288355,0.09523809523809523,0.5924514817105442,1.0,2/5,8.37%,CXCL12;LYN
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.8427505714138951,1.3507847825262844,0.11904761904761904,0.7020193952784161,1.0,3/7,6.37%,SLC39A14;MRAP;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.6625515419901825,-1.350775897529896,0.08888888888888889,0.5925869027278344,1.0,10/32,13.07%,AURKAIP1;BTG1;ZFP36L1;BTG3;TRIM35;NABP2;GAS1;BRINP1;CDKN1C;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.7016523365830678,1.3497961870601356,0.13725490196078433,0.7053987634216449,1.0,5/13,16.02%,NEDD4L;CAV3;CAMK2D;PRKCE;HECW2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.9670707267245479,1.349740298655412,0.0,0.7034763196928909,1.0,1/5,0.46%,VSIR
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.829334796823897,1.3495180853395208,0.08695652173913043,0.7024747203439823,1.0,3/8,9.10%,FOXP1;MAP2K5;TIRAP
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.6139499554472803,-1.349157243905522,0.125,0.5983931040690189,1.0,7/26,15.47%,NOL3;PUF60;SF3A2;SLU7;SRSF9;SRSF10;SF1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.9199924469561571,-1.3490826500634483,0.0,0.5971507733450085,1.0,1/6,0.49%,GPX1
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.7914266990376373,1.3488086563157937,0.08771929824561403,0.7039777786448006,1.0,2/9,8.88%,KAT2B;ESCO1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.7782072165356473,1.3487627067476065,0.125,0.7018603262678532,1.0,2/9,9.55%,PTPRC;HDAC7
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6599488548646963,1.34855223103131,0.09090909090909091,0.700563096635654,1.0,7/21,11.03%,RELN;CAMK2B;PSEN1;FOXO6;SHANK3;CPEB3;CAMK1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.8347188316288977,1.3480734241163126,0.0967741935483871,0.7011299823310319,1.0,2/5,2.32%,SLC6A15;SLC6A17
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.7451073182450122,1.3479960734701883,0.14583333333333334,0.6993498942574062,1.0,1/11,0.46%,VSIR
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.6545412164273898,-1.3478193954612718,0.10714285714285714,0.6013483368232171,1.0,4/22,4.33%,GPX1;HSPA8;MAP1S;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.7266744404596482,-1.346602252048339,0.1702127659574468,0.6050034107765264,1.0,3/13,7.95%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.5096756044897939,-1.3464942800000064,0.09090909090909091,0.6038837133000967,1.0,27/137,10.75%,HSD17B10;AIP;TSPO;TIMM8B;COX7A2;PTCD2;PARP1;SLC25A6;ATCAY;CHCHD10;TIMM13;PHB2;IFIT2;TIMM23;TOMM7;TIMM44;SLC25A33;DNAJC19;SLC25A4;BCS1L;CHCHD2;AIFM1;HAX1;TIMM22;ATP5F1D;NIPSNAP2;MFF
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.599082674093825,1.346124951367454,0.07142857142857142,0.7076320696753219,1.0,9/43,12.95%,NEDD9;PAK1;CDC42BPB;MKLN1;PHACTR1;TNIK;THSD7B;DMTN;SIPA1L1
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.7949633385079404,1.3457709383350729,0.13725490196078433,0.707252238686528,1.0,4/10,14.34%,PON1;RXRA;SGK1;KMT2A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.826804954903985,-1.3453808744665718,0.13636363636363635,0.6077471820406579,1.0,2/5,6.11%,TMBIM6;NOL3
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.9463397968614833,1.3450113260784375,0.01818181818181818,0.7098071115626644,1.0,2/5,3.54%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.6221753043658849,1.3448411307737647,0.05454545454545454,0.7089965720290062,1.0,7/27,22.01%,THAP9;WRN;RPA1;XRCC3;RAD54B;RECQL5;HDAC10
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6745261064097907,-1.344730469877921,0.1320754716981132,0.6091862515907872,1.0,10/20,23.96%,ATF4;PIH1D1;NOL11;NCL;WDR43;DHX33;LYAR;UBTF;UTP15;SMARCB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.6793291464031885,-1.3445156982242605,0.07142857142857142,0.6086577379843661,1.0,2/17,9.23%,BTC;ANAPC11
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.8676293451494592,-1.3442212260731603,0.06976744186046512,0.6084148998005423,1.0,3/6,8.91%,PIH1D1;PRPF31;ZNHIT3
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.7982593395998285,-1.3437136378575754,0.16393442622950818,0.60881489306228,1.0,2/6,10.04%,HPD;AADAT
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.9091333622882255,1.343535637542372,0.046511627906976744,0.7140496556684486,1.0,1/5,3.77%,GCLC
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.4981153900556656,1.3434955251906375,0.02127659574468085,0.7120205440361159,1.0,37/118,17.81%,OLFM3;PCSK2;STMN2;ATP2B3;SLC24A2;NTRK3;HCN1;MMD2;HSPA12A;PRKCA;RNF152;SNAP25;GABRG2;LIN7A;ADGRB3;SGIP1;PROX1;VWC2L;LSAMP;CNTNAP2;FAM135B;CLVS2;NAPB;SCN2A;CDH20;GRM1;ACTL6B;MAGI2;KIF1B;SV2B;ASTN1;SEZ6L;UNC79;CNTNAP5;CELF3;GAD2;NEFM
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.8291586491462071,1.3432561164347439,0.11475409836065574,0.7109693338899913,1.0,3/5,16.94%,ODAD4;CCDC39;RFX3
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6153045628757898,-1.342442559801403,0.09090909090909091,0.61287374456459,1.0,8/36,17.43%,GABARAPL2;HSPA8;RPL23;MAP1LC3A;CAV1;MAP1LC3B2;VCP;LIX1L
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.5623255143808792,-1.3422826921516078,0.06521739130434782,0.6121114780806223,1.0,6/39,7.22%,PPIF;BAD;ZDHHC6;CHCHD10;VPS35;PDCD5
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.6532702215080167,1.3420317991011081,0.14583333333333334,0.7153381248916895,1.0,7/22,14.87%,ABLIM1;ARHGEF6;VCL;P2RY12;DMTN;ARHGEF4;ARHGEF7
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.876579725090123,1.3418372039603472,0.09259259259259259,0.7142831872591742,1.0,1/5,5.07%,RHCE
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8497853293002593,1.3418093364760832,0.05263157894736842,0.7123379648656192,1.0,1/5,1.29%,CTBP1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.5986814402194115,-1.3416356085188421,0.1111111111111111,0.6138238890249224,1.0,14/40,15.47%,SNRPD2;NOL3;PUF60;SNRPG;SF3A2;SNRPD1;DDX1;SRSF9;SRSF10;SNRPE;PRPF19;SNRNP200;SRPK1;SF1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4900840533592108,-1.341567898580463,0.05660377358490566,0.6126310806566567,1.0,16/103,9.88%,UBB;PSMB6;PSMD8;RPS27A;PSMB4;UBC;PSMA7;UBA52;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;GINS3;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.6376625985567445,-1.3414653656297657,0.16216216216216217,0.6114695242179776,1.0,6/21,9.79%,RAN;CHAMP1;KIF25;SMC1A;TUBG1;KIF18B
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.535977155397349,-1.3410800672187195,0.047619047619047616,0.6118054806658367,1.0,9/43,13.89%,SOX4;UBXN1;VPS28;DNAJA1;UFL1;CAV1;ISG15;PRR7;PARK7
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.8044647140833142,1.3409455316753787,0.08333333333333333,0.7150236192122058,1.0,2/7,9.82%,PLEKHM1;PIP4K2A
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.8486578060317028,1.3408342027127285,0.05660377358490566,0.7133553570328501,1.0,3/5,11.03%,CAMK2B;SHANK3;CAMK1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.7177268988428909,-1.3405838285805902,0.07317073170731707,0.6123163366871427,1.0,4/12,13.89%,MT3;PARP2;UFL1;PARK7
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5998310568937352,-1.3401774667405084,0.109375,0.6127743621490496,1.0,2/23,0.35%,NR0B1;COL9A3
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6896771076100602,1.3398934891630687,0.1320754716981132,0.7162882271272463,1.0,5/14,13.41%,LIFR;IRAK2;MAP2K5;CBFB;PARP9
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.837335076586414,1.3395401357148602,0.11320754716981132,0.7158369548945609,1.0,1/7,0.35%,AHR
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.783031035624727,-1.3394198287837744,0.13043478260869565,0.6153133127649798,1.0,2/9,8.95%,DHFR;PTN
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.7309471530930843,-1.3393703647989972,0.12195121951219512,0.614009175820644,1.0,2/11,9.39%,IDH1;ACLY
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.6326589236225633,-1.33933107175023,0.038461538461538464,0.6126614485062002,1.0,9/28,13.32%,SNRPD2;SNRPB;MALT1;SNRPG;RBM15B;LSG1;SNRPD1;NPM1;SNRPE
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.7658970764620835,-1.3391987058603316,0.1568627450980392,0.6118185842354497,1.0,2/10,4.78%,STOX1;ALOX5
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6158346646072936,-1.338978437166439,0.14893617021276595,0.6112532139441225,1.0,4/25,9.37%,H1-4;BANF1;SET;AIFM1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.561391628655478,1.3384721586248451,0.09803921568627451,0.7195395911180593,1.0,14/51,13.25%,CALCB;HTR2C;TPCN2;ATP2B3;SLC24A2;VAPB;GRIN1;RYR2;TMTC2;ATP2B2;ATP13A4;SNCA;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.539943965769971,1.3381997817182625,0.045454545454545456,0.7190812653732856,1.0,14/65,9.16%,PTPRC;EFNA5;CRLF1;NEDD9;IL5;ENPP2;RELN;PTPRJ;EFNA1;SRCIN1;PAK2;EPHA4;DLG4;HES1
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7104164410462085,1.3379964421052022,0.15555555555555556,0.718186712548952,1.0,7/17,21.68%,GNA12;DMTN;ARHGEF7;PRKCE;APPL2;ITGB1BP1;MACIR
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.8507835457224553,1.3378861907101829,0.2,0.7164805327982463,1.0,2/5,12.68%,CYP2E1;NOS1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.7800722565582447,-1.3375593218607627,0.20454545454545456,0.6164181302174027,1.0,2/9,8.26%,ODC1;SRM
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.8380254082350014,-1.3374638702933972,0.13636363636363635,0.6152754832348252,1.0,1/6,0.55%,SIRT2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.5374879367989578,1.3367539851732009,0.08333333333333333,0.7206898955263525,1.0,12/61,7.38%,THBS3;ITGA2;ADAMTS9;ADAMTS13;ITGA8;SORBS1;ITGBL1;TIAM1;BCR;MKLN1;EMP2;VCL
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5144622391448895,-1.3366945296832555,0.07894736842105263,0.6168279279172074,1.0,11/65,8.01%,UBB;CCDC88C;RPS27A;UBC;GPC4;SFRP1;WNT3;VPS35;UBA52;PORCN;WNT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6341472717639869,1.3363987435743663,0.06976744186046512,0.7201465837262622,1.0,10/21,22.84%,ST18;SPI1;JAK1;IL6ST;IL6R;FER;STAT3;SMAD4;PTPRT;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6937679048052764,1.3363875661464928,0.10204081632653061,0.7181027278549196,1.0,5/15,18.38%,CAMK1D;RELN;ADCY1;CRTC1;CRTC3
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.696061312698059,-1.3361243245756558,0.14893617021276595,0.6178067460752072,1.0,7/14,19.61%,SCNM1;PUF60;SLU7;DDX5;SRSF9;RBM17;RSRC1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.7243219050648121,1.3357615657827657,0.06382978723404255,0.7195020733026686,1.0,3/10,8.91%,KAT2B;BRCA1;CENATAC
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.5229812782786665,1.3357251440696813,0.02040816326530612,0.7177883673899893,1.0,20/81,14.45%,EFNA5;NUAK1;EPHA7;PLXNA4;PRKX;FUT2;RIPOR2;PTPRJ;EFNA1;PRKCA;EPHA4;DUSP1;ATM;KNG1;PLXNA1;CHRD;TPM1;ADAM22;SEMA4D;ARHGDIG
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.9195834823699414,-1.3355525460558622,0.03773584905660377,0.6183879617358947,1.0,1/5,0.55%,SIRT2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5816225702772887,-1.3354534761579056,0.13157894736842105,0.6173740266444514,1.0,2/26,2.19%,RNASEH2C;ADPRM
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.761104215776006,1.3352588092168467,0.07547169811320754,0.7179765382940266,1.0,1/10,0.28%,PTPRC
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7396765606060308,1.3349901879284862,0.05660377358490566,0.7173062023736984,1.0,4/13,10.80%,GRIN2A;GRIN1;MAPK8IP2;ARRB2
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.867624713675754,-1.334554577623366,0.046511627906976744,0.6195420701599806,1.0,1/7,1.76%,CHAMP1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.8008772261535647,1.3341923369457778,0.05555555555555555,0.7178809637634713,1.0,2/9,5.46%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.8008772261535647,1.3341923369457778,0.05555555555555555,0.7178809637634713,1.0,2/9,5.46%,SYNJ2;INPP5A
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.8971352772786789,1.3341684803315816,0.06,0.7139291114628035,1.0,1/5,0.24%,HEY2
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.8971352772786789,1.3341684803315816,0.06,0.7139291114628035,1.0,1/5,0.24%,HEY2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.8146330705904189,1.3339960885474047,0.09259259259259259,0.7130547514556341,1.0,3/8,14.47%,GALNTL6;GALNT16;GALNT13
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.8372454110246801,-1.333757244374195,0.12962962962962962,0.6212121628579856,1.0,3/7,6.77%,HSD17B10;TRMT10C;TRMT10A
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8822232687688276,1.3335950309130205,0.13636363636363635,0.7130842149492725,1.0,2/5,5.86%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8784110243368265,1.3334208473476294,0.07692307692307693,0.7118251889063902,1.0,3/5,6.17%,GRIN2A;SHISA6;GRIN1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.7486695141431662,1.3331004741412185,0.15873015873015872,0.7117183623149079,1.0,3/9,13.96%,NNMT;PARP9;NUDT12
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.7559400646551027,1.3330072948479268,0.0851063829787234,0.710108385487978,1.0,2/11,3.49%,GLRA1;UBASH3B
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.46905119687795027,1.3328747616958982,0.0,0.7086186293597334,1.0,25/145,7.47%,SEC14L5;MYRF;NKX6-2;OPALIN;KIF6;PEX5L;FAM107A;SHISA6;ST18;ZDHHC9;MOBP;ENPP2;SORBS1;ASPA;PHYHIP;GFAP;ADCY5;GRM3;MMD2;SRCIN1;PSD2;ITPR2;ATP2B2;MPPED1;TYRO3
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.5626623820248284,-1.33214137910356,0.10810810810810811,0.625766158082079,1.0,5/51,3.19%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.5626623820248284,-1.33214137910356,0.10810810810810811,0.625766158082079,1.0,5/51,3.19%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),0.804141608508581,1.3315996080305916,0.22641509433962265,0.7129798219289464,1.0,2/6,12.68%,CYP2E1;NOS1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.7955570801182746,1.3315920227346512,0.1,0.7109933660282174,1.0,3/7,18.48%,FOXP1;NLRP12;TMED10
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5992239824046685,-1.3314422045318537,0.07547169811320754,0.6270949824996352,1.0,4/39,3.91%,SOX4;BAD;NLGN2;PPIA
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5522520706126924,-1.331253647310439,0.07692307692307693,0.6263646760487163,1.0,13/60,5.86%,BGN;MMP2;PODN;THY1;PRRX1;FBLN2;KRT10;FIBIN;COL12A1;THBS2;PDGFRA;CXCL12;DYNLT1
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.8527032902795912,1.331187161693124,0.16363636363636364,0.7112207905710606,1.0,1/6,7.97%,PAK2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.8605601122810742,-1.3310943930210182,0.17307692307692307,0.6254691448288247,1.0,2/5,2.73%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.5193842084001645,1.330421720236137,0.038461538461538464,0.7133139639895529,1.0,20/96,15.07%,INPP4B;SYNJ2;PIP4K2C;PIP5K1B;PITPNM2;PLEKHA4;SOCS4;CDS1;INPP5E;INPP4A;PIP4K2A;ITPKB;PLEKHA2;ITPKC;PIK3CD;PIGH;PTPN13;EFR3A;MPPE1;IMPA1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7918106962173679,-1.3298477848966304,0.11764705882352941,0.6290729129261071,1.0,2/11,2.01%,TAF9B;PTTG1IP
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.668068083985415,1.3298315718558393,0.10909090909090909,0.7148204442950916,1.0,7/19,14.01%,PCLO;WNT7A;RAB3A;SNAP25;STX1A;SNCA;CPLX1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.8492369316869814,-1.3298013097773234,0.11627906976744186,0.62771958248385,1.0,1/5,6.69%,EIF3D
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.7634722196388319,1.3297609292088506,0.21153846153846154,0.7133151910855383,1.0,2/8,5.86%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.5466846148223876,-1.3296700572389444,0.10714285714285714,0.6271142700513929,1.0,12/57,13.83%,RRAGA;DAPL1;ATF4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;LAMTOR4;ATP6V0E2;ATP6V0D1;TFEB;LAMTOR5
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6877653987550737,1.3296585976888302,0.07142857142857142,0.7119000041869366,1.0,4/20,7.63%,INTU;KAT2B;SMOC1;RSPO2
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.8510164724655394,1.3295464039471643,0.08333333333333333,0.7106827378585934,1.0,2/6,3.46%,INTU;COL5A1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.5859140398633234,-1.32916225171023,0.08888888888888889,0.6283736273731271,1.0,7/47,8.61%,RRAGA;SIRT2;DAPL1;KIF25;MT3;ATRAID;TIMP4
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5960903389376883,-1.3290835454572294,0.09615384615384616,0.6274600229949998,1.0,5/29,6.77%,HSD17B10;TRMT112;TRMT10C;TRMT5;TRMT10A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7422857067886998,1.3289287108919388,0.09433962264150944,0.7120444346171918,1.0,4/8,16.02%,NEDD4L;CAMK2D;PRKCE;HECW2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.5079593855454385,1.3285527780281918,0.058823529411764705,0.7117245340169257,1.0,33/86,21.71%,LIFR;ADAMTS9;CHST3;ADGRL2;EDNRA;TENM3;SLIT3;TYRO3;PDE10A;AKAP12;PTPRG;GJA1;APBB2;TPM1;ANK2;NOVA2;PRKAA2;ALDH7A1;ITSN1;TACC2;ZNF532;FIGN;TJP1;FARP1;MPDZ;RNF150;PAPPA;DIXDC1;DZIP1;ZBTB8A;LIMCH1;MYH10;ABI2
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.8208788498561947,-1.328447378438638,0.18181818181818182,0.6287364932987047,1.0,2/5,6.99%,SNCAIP;COMT
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7998661072149758,-1.3282699187664568,0.13043478260869565,0.6279922071672113,1.0,3/10,3.88%,MT1E;MT2A;MT3
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.7019890376313132,-1.3282666657491315,0.08888888888888889,0.6265655280809509,1.0,7/18,12.69%,UQCR10;SURF1;NDUFS8;UQCRC1;ATP5F1D;UQCRH;UQCRB
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.7869248922282377,-1.3281902505032765,0.16666666666666666,0.6253813720046837,1.0,4/6,20.19%,PEX11A;MFF;FIS1;ACOT8
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.6743738595290851,1.3278199572875369,0.1346153846153846,0.7135066873580528,1.0,2/24,0.65%,GLRA1;GLRA2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7816466131220875,1.327658506211568,0.1590909090909091,0.7123789421323324,1.0,2/6,12.05%,ATP10A;ASAP1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.4851956955484388,-1.3276476729425966,0.047619047619047616,0.6262271522832838,1.0,23/117,13.91%,CCND1;PSMB6;PSMD8;PSMB4;SSNA1;STOX1;TUBA1A;PSMA7;TUBG1;PSMC3;RCC2;PSMD10;PSME3;TUBB4B;PSMD12;PSMB9;PSMC1;PSMD2;PRKAR2B;ODF2;PPP2R1A;HAUS8;PSMD4
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.8135392850089948,-1.3276156715676246,0.1956521739130435,0.6250022309829737,1.0,3/6,6.79%,PRDX1;MT3;ADPRS
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6634413126762253,1.3274346419258234,0.1,0.7114180519446298,1.0,5/18,11.45%,HEY2;NEBL;RORA;MRTFA;SGCZ
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5540521740617047,1.3273271459908507,0.10416666666666667,0.7100885271049703,1.0,14/45,11.72%,CDH9;CLDN12;CDH7;PKP2;TBCD;CDH8;TLN2;CNTNAP1;PRKCA;VCL;PAK2;CDH12;CDH20;GJA1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.7355918328180931,1.3273244530465182,0.16666666666666666,0.7081536809820683,1.0,3/8,8.68%,OTUD7B;TMSB4X;MAP2K5
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.5932179539467434,1.3271963879501607,0.1,0.7068402523941529,1.0,5/25,12.44%,AHR;HCN3;HCN1;DMTN;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6953339283079982,1.3268750103972693,0.10714285714285714,0.7065670128223308,1.0,2/10,3.31%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.6514606333729664,1.3268200450621812,0.1935483870967742,0.7050536330473042,1.0,2/18,0.35%,PTPRC;AHR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.5451754080141871,-1.326761157303233,0.09090909090909091,0.6276493387611876,1.0,10/46,16.31%,LSM4;LSM7;LSM1;EXOSC8;EDC3;DCPS;DCP1A;RC3H1;NT5C3B;LSM3
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7854455308782908,-1.3264899389941458,0.17307692307692307,0.6275489733314537,1.0,2/5,5.92%,UBE2D4;RNF6
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.9035025032755976,1.3263144706632508,0.07142857142857142,0.7056561061165277,1.0,1/5,0.46%,VSIR
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5047798650106232,-1.3259600787258912,0.047619047619047616,0.6281955007057877,1.0,16/89,11.27%,SOX4;ASCL1;PPT1;OLIG1;OLIG2;UGDH;MYT1L;IER2;WNT3;TENM4;ITM2C;WNT5A;RNF112;USH2A;POU3F2;ANOS1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5896542966796865,-1.3256993560623838,0.14814814814814814,0.6280943502054057,1.0,11/31,19.16%,GPX1;BEX3;MT3;IFI6;NGF;CD44;LAMTOR5;AKT1;CDKN2D;YWHAE;RAF1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.8287224022892226,1.3256606824026513,0.1896551724137931,0.7064918183026845,1.0,1/5,1.93%,WNT7A
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.7672792969580796,-1.3256313454008055,0.17647058823529413,0.6270416251597318,1.0,1/5,0.44%,CUL7
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.790561505748242,-1.3254983499302406,0.1282051282051282,0.6259704957866256,1.0,4/10,8.26%,ODC1;SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.7720765511648815,1.3253447893458377,0.16981132075471697,0.7063010577967904,1.0,2/9,2.25%,HDAC4;SAE1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.681698118319502,-1.3247797159258772,0.1282051282051282,0.6276549457225574,1.0,2/13,1.28%,RHOC;CD151
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.8241277094437223,1.324708621613924,0.125,0.7075748688764005,1.0,1/5,2.02%,PARN
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.7414671314701813,-1.3246575712424518,0.14545454545454545,0.6266795136229854,1.0,3/9,11.74%,PODXL2;ITGA4;MADCAM1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.758146434700893,1.324332240028277,0.10909090909090909,0.7076428891735639,1.0,3/10,4.45%,AKT2;NR4A3;PLIN5
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5270013133511654,-1.3242140110812306,0.14634146341463414,0.6270661499961543,1.0,12/58,7.30%,BGN;MMP2;PODN;THY1;PRRX1;FBLN2;FIBIN;IGFBP7;THBS2;PDGFRA;CXCL12;CYBRD1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.6361074628600879,-1.3240731971083406,0.1875,0.626096412201348,1.0,7/24,13.57%,BAD;IFI6;VPS35;IFIT2;MFF;CLU;FIS1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.6665148972215313,1.323766006428593,0.09803921568627451,0.7083084518112452,1.0,2/21,4.87%,PON1;RXRA
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5136655225829013,1.3237211357961456,0.043478260869565216,0.7067666989680346,1.0,17/85,13.25%,CALCB;CALB1;HTR2C;TPCN2;TRPC4;ATP2B3;SLC24A2;VAPB;PSEN1;CAV3;RYR2;ATP2B2;PACS2;CAMK2D;ATP13A4;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.8631670012212536,-1.3230938457155543,0.08888888888888889,0.6287963959417135,1.0,1/5,1.43%,IDH1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.8482624858589649,-1.3230641874345936,0.15217391304347827,0.6275985501144955,1.0,1/5,0.13%,SOX4
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7683002202357445,-1.322812978025877,0.0425531914893617,0.6275463698384512,1.0,6/9,18.94%,VBP1;LDLR;CLU;PFDN1;PFDN2;PFDN4
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7968295229989006,-1.3227914940625847,0.11764705882352941,0.6261973341846612,1.0,5/8,17.82%,MT2A;COX19;SLC31A1;PRNP;ATP7B
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.6069179264605367,-1.3226898705255878,0.1956521739130435,0.6253083901664289,1.0,4/25,6.68%,ACTG1;ACTB;ARL6IP5;DNAJA1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.620798039272826,1.3224454614951782,0.10204081632653061,0.7110512184703907,1.0,8/25,19.11%,PARN;DND1;THRAP3;TENT5A;MEIOC;TAF15;LARP1;NAF1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.9411369692180724,-1.3222887685345872,0.0,0.6254655199924295,1.0,1/5,1.92%,ATF4
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.5531982564778479,-1.322242874675294,0.06976744186046512,0.6243334587804836,1.0,13/51,16.89%,GTF2F1;ACTB;TMBIM6;IFIT2;ITGA4;PTPRF;CAV1;B2M;RACK1;PARK7;IFIT1;AKT1;BAX
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6379589455917938,1.3221576327320466,0.14285714285714285,0.7107224975357724,1.0,12/27,24.70%,TULP3;NPHP4;ODAD4;WDR19;RAB29;BBS4;CSNK1D;EHD1;TUB;IFT140;IFT122;TCTN1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.7278203083656312,-1.322087214401534,0.13725490196078433,0.6235447159929225,1.0,1/10,1.56%,THY1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.7294811955831221,1.322086980275171,0.1111111111111111,0.7073251816167417,1.0,2/10,11.09%,RPTOR;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.7294811955831221,1.322086980275171,0.1111111111111111,0.7073251816167417,1.0,2/10,11.09%,RPTOR;UBR1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.8541924415895884,1.3212365517129012,0.11538461538461539,0.7096443109594885,1.0,1/5,4.44%,PLEKHM1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.8104458385073218,1.3211494487838287,0.12962962962962962,0.7082763472973119,1.0,1/7,2.09%,ITPK1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.7916222115585235,1.320805121817653,0.08620689655172414,0.7080354955685757,1.0,2/7,10.66%,SHTN1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.7158064092454843,-1.32072241791214,0.11764705882352941,0.6273956457894581,1.0,3/13,9.18%,VPS37B;KPNA2;CHMP2A
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.873013638993494,1.319934011315817,0.1702127659574468,0.7106647545942856,1.0,2/5,10.72%,VSIR;CBFB
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.8832223631127128,1.3196570141702981,0.1702127659574468,0.7103429961218911,1.0,1/5,4.05%,FOXP1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6205967612390245,1.3193885120086222,0.11627906976744186,0.7100481574169791,1.0,5/24,7.97%,CLDN12;CLDN18;TBCD;PARD3;PAK2
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.585760785716322,-1.3187728401311647,0.16,0.634508334164083,1.0,16/47,15.66%,H1-4;POLR2L;ACTB;POLR1F;WBP2;SMARCA5;POLR1A;SPHK2;POLR2K;MYBBP1A;POLR2E;POLR1G;H1-10;TAF1A;SMARCD1;DEK
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.5500995960853634,-1.31851658754096,0.03773584905660377,0.6342850959415259,1.0,18/65,18.15%,RBM22;TMBIM6;FAM50A;JMJD6;LARP7;ERN1;C9ORF78;RPS13;RBM23;SRSF10;RPS26;AKAP17A;AFF2;SRPK1;SF1;SRSF3;RBM39;CWC22
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7883572096680521,-1.318152990591834,0.13725490196078433,0.6344652843721155,1.0,2/5,17.39%,CNBP;PKM
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.6235506311056654,-1.3176855602364752,0.10526315789473684,0.6348008557283129,1.0,8/30,13.92%,EMC6;SEC61G;EMC10;SEC61B;GET3;MMGT1;EMC4;PRNP
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.879984598200644,1.317292946123196,0.07407407407407407,0.7187735164356973,1.0,1/5,1.96%,EGLN3
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6789914505892741,1.3171995660755842,0.13333333333333333,0.7174283111528721,1.0,7/15,17.89%,ST18;SPI1;JAK1;IL6ST;IL6R;FER;STAT3
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.7135483697656329,1.3165015874808104,0.14893617021276595,0.7189220836843289,1.0,4/7,21.03%,ERC1;KIF1B;ERC2;FCHSD2
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.6286471261124531,-1.3162269236560362,0.125,0.6394091229933064,1.0,17/41,16.03%,AIP;TSPO;ROMO1;TIMM8B;SLC25A6;TIMM13;TIMM23;TOMM7;TIMM44;DNAJC19;AIFM1;TIMM22;MFF;GRPEL1;FIS1;TIMM21;HSPA4
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5479450795555085,-1.316203050695766,0.12,0.6381553959952705,1.0,10/49,13.51%,POLR2L;POLR2J;GTF2F1;POLR2I;POLR2G;RAB14;FLRT3;ANOS1;POLR2K;POLR2E
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7037541625461387,-1.3162029650211218,0.0851063829787234,0.6367741072593499,1.0,4/10,17.33%,CHAMP1;RCC2;SPDL1;BUB3
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.8030367371177831,-1.3161688217676655,0.22,0.635509370125058,1.0,5/6,16.26%,GBA3;GM2A;NEU1;NEU4;NEU3
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7298435656061422,-1.3158581572408603,0.19148936170212766,0.6353094116318401,1.0,4/10,13.39%,CFL1;KIF25;ZBED3;TLE6
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.6021828572325751,1.3158269426925748,0.09803921568627451,0.7209081864366391,1.0,5/20,12.44%,AHR;HCN3;HCN1;DMTN;RAP1B
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.6769320145993366,1.315751509338064,0.07692307692307693,0.7193683522795303,1.0,3/13,9.91%,SCEL;BRCA1;RAI2
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7180448457791333,1.3145577274828837,0.20833333333333334,0.7236811172062902,1.0,5/11,19.32%,SHISA6;RAB3A;SHISA9;SLC8A2;SYP
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.500913881818154,-1.314432092292441,0.0851063829787234,0.6409681267432724,1.0,28/109,16.77%,BICD2;SCG3;CALR;GABARAPL2;SEC61G;VPS35;DNAJA1;LAMP5;ARL1;WASHC2A;RPL11;SEC61B;AUP1;MICALL1;TOLLIP;DCP1A;DDX1;YBX1;IFT20;ISG15;LAMP1;PRNP;CEP68;RAB33B;WDR35;OPTN;PAF1;OBSCN
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.4882563508716979,1.314244056474448,0.02040816326530612,0.7232584308302275,1.0,28/149,11.00%,SLC6A15;SLC6A11;KCNH7;KCNQ3;SLC6A17;KCNC4;TRPC4;SLC39A14;KCNJ11;HCN3;SLC24A2;SCN8A;KCNN3;KCNC2;SLC4A4;KCNQ5;HCN1;RHCE;KCNB2;RYR3;SLC6A6;KCND3;SLC39A11;SLC6A7;SLC12A1;KCNH1;SCN2A;NALCN
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.7978052255882087,-1.3141016008419026,0.14893617021276595,0.6409550837558833,1.0,2/7,2.21%,CFL1;PPIB
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.8055621532726317,-1.3137514333798528,0.08163265306122448,0.6412490822361712,1.0,3/10,9.73%,PIH1D1;NOL11;NCL
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.7215503333196807,1.313708943655551,0.15789473684210525,0.723877191445879,1.0,4/11,8.80%,PTPRC;IL5;SPI1;TRAF3IP3
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5026303945084704,1.3134486715146718,0.058823529411764705,0.7230365352120093,1.0,23/67,22.93%,STMN2;ALK;CAMK1D;TENM3;RELN;CAMK2B;NTRK3;ROR1;BMP7;CAMK1;MAGI2;ARHGAP35;PTK7;ABL2;PLPPR5;EPHA3;LRRC7;CAPRIN2;CBFA2T2;COBL;DAB2IP;APOE;PACSIN1
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.5098414966052885,-1.313379427917193,0.09090909090909091,0.6414761822433607,1.0,33/117,14.54%,PPIF;BTG1;PPT1;E2F5;CLTB;EIF5;TMBIM6;CNP;ATP6V1F;BTG3;SELENOW;WIZ;UROD;HSPA13;DNAJA1;PDLIM3;PSMC3;SIGMAR1;LYN;GRINA;PARP2;SLC25A4;RPN1;FURIN;RXRB;GRPEL1;CDKN1C;BMP2;NPTXR;PPAT;H2AX;AP2S1;FKBP4
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6561966652015357,-1.3132434448133619,0.14583333333333334,0.6406979481576481,1.0,1/19,0.26%,CCND1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.8319944319812711,1.3129698378315893,0.08771929824561403,0.7237512205296011,1.0,3/6,12.42%,RAC3;P2RY12;PIEZO1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.5060437398541481,1.3128504699974852,0.1111111111111111,0.7224239276675082,1.0,8/61,10.61%,RASGRF1;MADD;BCR;ERBIN;MMD2;ARHGAP17;SYNGAP1;DENND4B
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.7528921974653959,-1.311624656408416,0.10416666666666667,0.6462196364594371,1.0,4/11,16.62%,S100A1;DHFR;SCARB1;AKT1
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5644873858222582,1.3115301448192398,0.11538461538461539,0.7280115338322314,1.0,15/54,11.93%,DOCK5;FABP3;EDNRA;ARHGAP26;CKMT2;MEF2D;SYNPO2;LAMA2;TTN;CAV3;WASHC1;NBR1;SULF1;PRKG1;TPM1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.4715149241982015,1.311168635737536,0.05660377358490566,0.7283907524385885,1.0,21/117,13.94%,PON1;HEY2;PCTP;PTPRR;SOX9;SPRED2;SRF;EFNA1;SPI1;DOCK7;RAB11FIP5;PROCR;ACOT11;PTPRG;GJA1;USF3;NLRP12;ACVR1C;STK11;NOVA2;OVOL2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.7069013416035649,-1.3110649864212567,0.09523809523809523,0.6472826483468747,1.0,5/14,14.99%,SLITRK2;GPC4;PTPRF;LRRC4;SLITRK1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.656227657076123,1.3108566098659964,0.1346153846153846,0.7283780773632846,1.0,9/21,20.35%,SRF;MMP21;CCDC39;MICAL2;BBS7;BBS4;ENG;PKD2;AHI1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6547166401774291,1.310813100229694,0.13725490196078433,0.7268093366999641,1.0,10/23,20.35%,SRF;CCDC39;RYR2;MICAL2;BBS7;HES1;BBS4;ENG;PKD2;AHI1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.8872109949771324,-1.3108033917307864,0.09615384615384616,0.6471045261150059,1.0,2/5,2.73%,HSD17B10;TRMT10C
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.8442092297086718,1.3106516007887057,0.1346153846153846,0.7256607023481341,1.0,1/5,0.86%,BCL2L11
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.7920078766647063,1.3105329824362681,0.1346153846153846,0.7244693660224477,1.0,2/7,19.85%,ADSS2;HPRT1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8263511183717753,1.3105116134051542,0.11764705882352941,0.7227529559809418,1.0,3/5,15.42%,LMO3;CLOCK;PER1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.676557003580227,-1.3103307322946565,0.16326530612244897,0.6479230291136243,1.0,9/16,14.96%,SURF1;COA6;COX19;SMIM20;BCS1L;COX17;COX18;TIMM21;COA5
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.8531854698491277,-1.310074342336529,0.15217391304347827,0.6475066665288358,1.0,3/6,11.48%,COX11;SLC7A8;UNC80
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5226397919602584,1.3097557557807278,0.020833333333333332,0.7246803198649998,1.0,28/86,18.46%,IQSEC2;SYT1;BAIAP3;GRIK5;RELN;BCR;GRM3;GRIK3;SYN3;BEGAIN;DGKZ;DLG4;MAPK8IP2;TPRG1L;KCNMB4;NRG3;GRM1;PXK;CPLX1;BTBD9;SLC8A2;NPTX2;CACNG5;SLC4A8;DGKI;GRIK1;UNC13A;HOMER1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7002632708508338,-1.309327405600124,0.08,0.6489029490003662,1.0,2/18,3.88%,ATF4;MT3
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.8020849401597386,-1.3089382741274873,0.1346153846153846,0.6493898209609007,1.0,2/7,6.26%,FGFBP3;PDE3A
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.5146605891196374,-1.308668784582132,0.08888888888888889,0.648994469819977,1.0,12/87,12.17%,RBM8A;SRSF7;CPSF1;NUP42;MAGOH;U2AF1;RBM15B;SLU7;ENY2;NUP155;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7542948940657737,1.3086612734970995,0.16666666666666666,0.7281352242619946,1.0,1/12,0.07%,FHDC1
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7651266848400843,-1.3086069190652,0.1590909090909091,0.6477867013469543,1.0,2/8,6.74%,EXOSC8;DXO
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6329807909358631,1.3083561943611703,0.07142857142857142,0.7279077804515591,1.0,7/19,15.23%,HS3ST4;CHST9;CHST12;SULF1;CHST8;CHST11;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.7704446786327337,1.3083074152380865,0.1956521739130435,0.7264148352593792,1.0,2/7,9.16%,PTPRC;HES1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.5284609077342843,-1.3081716753885277,0.075,0.6484438800596879,1.0,10/63,12.17%,RBM8A;SRSF7;CPSF1;CSTF2;CSTF2T;MAGOH;U2AF1;SLU7;EIF4A3;SRSF9
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.7096455749255544,-1.3079572755564184,0.16,0.647988969556003,1.0,2/11,2.21%,CFL1;PPIB
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.8589767258741469,-1.307740739028213,0.08,0.6474295039731603,1.0,1/5,4.78%,ALOX5
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.48575585387900305,1.3075084269652186,0.07547169811320754,0.72812374353519,1.0,9/100,4.35%,CDH9;ROBO2;UNC5D;CLDN12;CLDN18;CDH7;PCDHB5;TENM3;CDH8
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.6398232281539716,1.3074202425641426,0.16363636363636364,0.7267564482034845,1.0,5/22,14.87%,ATP10A;PLSCR4;ATP8B2;ATP8A1;ATP10B
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8442656682500738,-1.3069712410536989,0.21052631578947367,0.6492943070464195,1.0,1/5,3.29%,SYAP1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.7649943814057895,-1.306843764860014,0.16,0.6485224438766427,1.0,3/9,9.44%,CDH3;OPN3;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.7191628099336148,-1.3068436991929797,0.1276595744680851,0.6471825214719389,1.0,4/14,13.89%,TMBIM6;SELENOS;CREB3;PARK7
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.810154686775148,1.3067868406643517,0.15217391304347827,0.7285274047067632,1.0,1/5,0.62%,ROBO2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.7654581985376574,1.3066850648081882,0.16981132075471697,0.7273314216292651,1.0,3/9,16.14%,SOCS4;CHMP6;CBLB
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.5719582254001792,1.306327339213609,0.05454545454545454,0.7273217033336432,1.0,9/35,14.78%,ROBO2;SHTN1;TIAM1;PLXNA4;MACF1;LIMK1;PLXNA1;SEMA4D;TIAM2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.6522604478897014,1.3062972789168785,0.14814814814814814,0.7256397794682911,1.0,3/18,6.68%,SHTN1;MACF1;LIMK1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6924888514696396,-1.3062413254284884,0.10526315789473684,0.6479594982970382,1.0,5/18,6.31%,UBB;RPS27A;UBC;TLR1;UBA52
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.6589302798203267,1.3057411190942982,0.18,0.7262215801763302,1.0,2/14,2.71%,PTPRC;GPI
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5233467608921577,-1.3053788512569449,0.1276595744680851,0.6501239170814699,1.0,8/46,5.50%,BGN;MMP2;FBLN5;FIBIN;IGFBP7;COL12A1;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8526932705340513,1.305242197713708,0.16071428571428573,0.7273162679974206,1.0,2/5,6.48%,MYLK;EMP2
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.7752921973608919,1.3051172129795918,0.14893617021276595,0.7263479426944065,1.0,2/10,3.00%,CTBP1;NNMT
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8160813331777496,1.3050367646297287,0.08,0.7250343194308756,1.0,2/6,9.12%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.863361072642046,1.3050355743277884,0.08163265306122448,0.7233080472417546,1.0,3/6,9.36%,PKP2;GFAP;NEFL
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.6317503120425164,1.3049480967906588,0.125,0.721961450761687,1.0,7/25,14.87%,ABLIM1;ARHGEF6;VCL;P2RY12;DMTN;ARHGEF4;ARHGEF7
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.6095651644411596,1.3047279456180445,0.09259259259259259,0.7210613173652831,1.0,4/24,11.37%,PTPRC;TRAF3IP3;CD27;CD247
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.7135496865499736,-1.3046641616856234,0.13333333333333333,0.6519850686852052,1.0,5/11,16.72%,CXCL12;CLU;TMEM161A;CDKN2D;TPT1
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.8057689985248677,-1.30454801404933,0.09090909090909091,0.6512575679741229,1.0,5/7,16.13%,COPRS;PRMT6;PRMT1;PRMT5;PRDM4
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.6042936061727799,-1.3044065465404826,0.1,0.6504073965565448,1.0,12/23,21.99%,ST13;HSPA8;HSPA13;DNAJB12;HSPA14;HSPA9;HSPA5;DNAJC18;BAG1;ENTPD5;SDF2;UGGT1
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.6879963568690384,1.3043298473167237,0.16666666666666666,0.7194121057583324,1.0,5/13,13.30%,RAB17;MREG;BBS7;RAB27A;BBS4
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.6879963568690384,1.3043298473167237,0.16666666666666666,0.7194121057583324,1.0,5/13,13.30%,RAB17;MREG;BBS7;RAB27A;BBS4
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5121029496657581,-1.3043221535211633,0.05405405405405406,0.6493308140203016,1.0,9/67,8.27%,CCND1;DIPK2A;CALM1;SYAP1;PDGFD;PIH1D1;CALM3;WNT5A;PSMD10
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.8543715147470574,1.3037805794631394,0.14814814814814814,0.7206861993121659,1.0,2/5,5.23%,VSIR;SH3RF1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.7309617289257948,-1.303756402689374,0.1320754716981132,0.6503859010815136,1.0,7/11,22.82%,SEC61G;SEC61B;GET3;SEC62;HSPA5;SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.7402422478807632,1.3034019083426884,0.11627906976744186,0.7209906347061812,1.0,1/10,0.24%,HEY2
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.6202695415766023,-1.302924699437142,0.14754098360655737,0.6528103795487488,1.0,6/28,11.01%,BGN;BCAN;TXN2;ADO;GALNS;NCAN
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5644305016122128,1.3025722582136268,0.078125,0.7228502283625585,1.0,7/44,11.37%,CALCB;PRKAR1B;ADCY5;PRKAR2A;GPR176;ADCY3;CD247
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.6143472459901586,-1.3024179881286813,0.14545454545454545,0.6534594770903596,1.0,4/28,4.53%,UBB;EIF5A;BAD;RPS7
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.8421538886815121,-1.302345740061684,0.15,0.652509807968104,1.0,1/7,1.30%,APEX1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.48066119571423416,-1.301942696351994,0.10869565217391304,0.6528465821445644,1.0,17/95,9.88%,PSMB6;VANGL1;CCDC88C;PSMD8;CALM1;PSMB4;PRICKLE1;PSMA7;SFRP1;PSMC3;WNT5A;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7779031399439507,-1.3016679775335325,0.24,0.6529548979755938,1.0,2/7,11.41%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.8147764783189998,-1.3016516064861778,0.14583333333333334,0.6504354020280658,1.0,2/7,9.95%,TAF9B;CD44
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.8147764783189998,-1.3016516064861778,0.14583333333333334,0.6504354020280658,1.0,2/7,9.95%,TAF9B;CD44
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6679655662127256,-1.30090559943964,0.22641509433962265,0.6519433517351314,1.0,7/12,27.21%,PPP1R15B;UFL1;RACK1;HSPA5;DDRGK1;PTPN1;WFS1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.44327054755983747,-1.3007871134045697,0.06382978723404255,0.6511309928468507,1.0,61/270,17.45%,UBB;SIRT2;PSMB6;PSMD8;RPS27A;UBXN1;DERL2;PSMB4;UBC;GID8;CDC26;PSMA7;TNFAIP1;KBTBD6;FOXRED2;UBA52;UBE2J1;SELENOS;FBXO45;HECTD3;SPSB3;PSMC3;PSMD10;FAM8A1;UBXN4;PSME3;FBXO44;PSMD12;STUB1;ANAPC11;PSMB9;PSMC1;RNF126;DNAJB12;PSMD2;SEC61B;AUP1;OS9;YOD1;TMUB2;RNF187;UCHL1;RAD23A;UBQLN2;DMAC2;PSMD4;PELI1;RHBDD2;UBE2S;PSMC4;HSP90B1;KCTD5;HSPA5;DNAJC18;CUL4B;VCP;PSMB2;FBXL14;KBTBD7;BUB3;PSMD3
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.7111453004750086,1.3004719389997141,0.12962962962962962,0.7313011583978107,1.0,2/15,2.48%,PTPRC;LMBR1L
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.8185251781560565,1.2998737952992838,0.16326530612244897,0.7306957001441295,1.0,3/6,13.80%,GABRB1;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8185251781560565,1.2998737952992838,0.16326530612244897,0.7306957001441295,1.0,3/6,13.80%,GABRB1;GABRG2;DIAPH1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.7310710462872152,1.2998251565550372,0.10204081632653061,0.7291590999848527,1.0,1/11,1.28%,IGF1R
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.5133556969114597,-1.299739554217592,0.06382978723404255,0.6542871295756721,1.0,11/58,12.17%,RBM8A;SRSF7;RTRAF;ZFP36L1;MAGOH;U2AF1;SLU7;NUP155;EIF4A3;YBX1;SRSF9
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8778179511876634,-1.2994626286570055,0.14,0.6515100414133264,1.0,2/5,3.88%,SNX17;MT3
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8778179511876634,-1.2994626286570055,0.14,0.6515100414133264,1.0,2/5,3.88%,SNX17;MT3
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8778179511876634,-1.2994626286570055,0.14,0.6515100414133264,1.0,2/5,3.88%,SNX17;MT3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6613378324651684,1.2993325741762591,0.16326530612244897,0.7292813118961535,1.0,1/15,0.28%,PTPRC
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6950153837123557,-1.2986952482433005,0.20408163265306123,0.6539509917436505,1.0,2/12,4.30%,UBB;MAP1S
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.8522432882972328,1.2982159246352987,0.08,0.7333985127906298,1.0,2/5,10.44%,XRCC4;LIG3
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.48392571861363104,1.2980340572620965,0.07692307692307693,0.7325644804033052,1.0,22/100,15.14%,ROBO2;OLFM3;UNC5D;PCSK2;STMN2;FAM13C;GNRHR;FMN2;ADGRB3;RSPO2;SGIP1;LSAMP;FGF14;MAPK10;CLVS2;SULF1;RAB27A;PRKG1;MAGI2;PTPRN;ASTN1;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7023549134104391,1.2976368094845783,0.14814814814814814,0.7327903708185183,1.0,2/9,3.31%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.736726204915379,-1.2974433216282617,0.20408163265306123,0.6580215295986225,1.0,3/13,3.15%,GPX1;PRDX5;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.7502961251888828,1.2974083262964649,0.10714285714285714,0.7322305801825623,1.0,2/9,9.82%,PIP4K2C;PIP4K2A
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.7669683978004399,1.297319593187674,0.1568627450980392,0.7310247049292556,1.0,2/7,11.92%,SOX9;CHRD
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.664181274619296,1.297296300082471,0.1,0.7277165614741582,1.0,2/16,4.01%,BAZ2A;FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.664181274619296,1.297296300082471,0.1,0.7277165614741582,1.0,2/16,4.01%,BAZ2A;FOS
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.6937106476496833,1.297290106786306,0.2,0.7260848748186963,1.0,1/12,9.28%,STN1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5615165059615219,1.296959192850543,0.08928571428571429,0.725790442942284,1.0,14/52,15.26%,FMO5;MAP3K19;TMCO5A;ALDH1L1;DDO;L3MBTL4;CCPG1;SGK1;SLC8A1;PRKAA2;FAM20A;CFLAR;CPEB4;CHL1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.7530480847610975,-1.2969050873854602,0.15,0.6587434127387536,1.0,2/7,4.99%,CALM1;DHFR
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.6781396284727831,1.296857588779078,0.14583333333333334,0.7245243228501163,1.0,2/18,4.87%,PON1;RXRA
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.7286330434074029,-1.2966286565324971,0.25,0.6587770885914052,1.0,3/6,16.89%,ARL6IP5;PRELID1;BAX
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.6213163571277902,1.2965930967841635,0.1836734693877551,0.7241906145619202,1.0,1/20,0.57%,OTUD7B
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.8382808771742536,-1.2965109716240306,0.14893617021276595,0.6579053132093897,1.0,3/6,8.26%,SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7986190019817319,1.2964984164134767,0.1702127659574468,0.7231539458194667,1.0,1/7,1.28%,IGF1R
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.8495170429579606,1.2963976338259895,0.15384615384615385,0.7221439012805091,1.0,2/5,12.05%,IL5;ASAP1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.6538539562493053,1.2962690044735572,0.14285714285714285,0.7211383860892601,1.0,5/18,16.73%,HTR2C;BEGAIN;SLC8A2;NPTX2;CACNG5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.8070850513881915,-1.2960295068859609,0.17391304347826086,0.657173971433841,1.0,1/6,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.8070850513881915,-1.2960295068859609,0.17391304347826086,0.657173971433841,1.0,1/6,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.7132399000802596,-1.2959708748142915,0.1590909090909091,0.6561504326548958,1.0,3/10,7.41%,DSEL;B3GAT2;XYLT2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.5523960413892266,1.2957294651680318,0.1016949152542373,0.7217117751742582,1.0,11/45,16.02%,VSIR;FOXO1;NEDD4L;ATG7;HACE1;STX5;WWP1;BARD1;PLK2;WWP2;HECW2
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.7957123272037356,1.2956218678379927,0.125,0.7205808058715439,1.0,1/6,1.69%,SOX9
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.8624887041151198,-1.2951075699037824,0.1568627450980392,0.6583446585757682,1.0,2/5,7.45%,ALOX5;FADS1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.5521565358545799,-1.2950889599604434,0.09836065573770492,0.6571235998790242,1.0,8/44,10.17%,UBB;GPX1;GABARAPL2;ALAD;PSMC3;PSME3;HSP90AB1;UFL1
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.5394990628640464,-1.2946621936636262,0.1111111111111111,0.6577167099855629,1.0,12/58,13.83%,RRAGA;DAPL1;ATF4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;LAMTOR4;ATP6V0E2;ATP6V0D1;TFEB;LAMTOR5
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5778810146021596,1.2941998886021446,0.10869565217391304,0.7249189783046539,1.0,10/40,14.59%,ABLIM1;RPGR;PITPNA;EYA4;WHRN;RABGGTB;CRYBG3;ADGRV1;COL18A1;RDH12
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.766402271315668,1.2940261569983456,0.16363636363636364,0.7238293503388659,1.0,2/8,4.32%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.618832218491679,1.2937490744540119,0.23404255319148937,0.7234597568459582,1.0,3/24,2.00%,AHR;SOX9;HTR2C
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.7663962305663855,-1.293726864396295,0.2127659574468085,0.6605301922146392,1.0,4/5,21.54%,B3GALT2;B4GAT1;B3GALT5;B3GNT7
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.5666576417368845,1.292554326074338,0.11764705882352941,0.7270491466250607,1.0,12/44,18.72%,JADE2;MSL3;ING5;EP400;KANSL3;ACTL6B;MORF4L2;KMT2A;PER1;OGT;MCRS1;DMAP1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6882111923777697,-1.2924621779690957,0.12244897959183673,0.6643429420243359,1.0,4/12,6.67%,CIAO2B;ISCA1;MAGEF1;GLRX5
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6050548263284851,1.2924589181589912,0.14035087719298245,0.726026763725033,1.0,10/30,17.95%,BCAS3;RAB29;B3GAT3;PCNT;PGAP1;STK11;CEP131;CEP290;EHD1;STX18
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.7285412117574299,1.2924030999645415,0.19642857142857142,0.7215503641018238,1.0,4/10,9.10%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.7285412117574299,1.2924030999645415,0.19642857142857142,0.7215503641018238,1.0,4/10,9.10%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.7285412117574299,1.2924030999645415,0.19642857142857142,0.7215503641018238,1.0,4/10,9.10%,CAMK1D;DAPK2;RIPOR2;TIRAP
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.6882267957956658,1.2923621876197107,0.19148936170212766,0.7185702216048,1.0,5/12,13.30%,RAB17;MREG;BBS7;RAB27A;BBS4
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.6882267957956658,1.2923621876197107,0.19148936170212766,0.7185702216048,1.0,5/12,13.30%,RAB17;MREG;BBS7;RAB27A;BBS4
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.8700712444538957,1.2920666930322522,0.10909090909090909,0.7183037078699767,1.0,2/5,6.83%,SOX9;CRACD
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.8254286431202624,-1.291923275946705,0.13043478260869565,0.6653931278743686,1.0,1/7,8.37%,LYN
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7428811778613689,1.2917310211725404,0.15254237288135594,0.7184208307063373,1.0,3/9,13.23%,RYR3;RYR2;SLC8A1
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.8060607752301644,-1.2917108448715653,0.1509433962264151,0.665196241221248,1.0,1/5,3.93%,SH3GL2
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.7033314047667996,1.2916138771917278,0.1276595744680851,0.7173288929554741,1.0,2/12,1.93%,ROBO2;WNT7A
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.6495265848343325,1.2914154822343364,0.1346153846153846,0.7165590339309402,1.0,2/18,4.01%,BAZ2A;FOS
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.766294151620306,1.290899269195044,0.17777777777777778,0.7170591656241151,1.0,3/5,20.78%,RNF213;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.8734322339223705,1.2899338723781237,0.13793103448275862,0.7202114057300893,1.0,1/5,1.06%,MCCC1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7587473238762519,1.2899031329774195,0.19230769230769232,0.7188517465729011,1.0,2/8,7.31%,SOX9;ZBTB16
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8456854100940474,1.2893415285899876,0.21052631578947367,0.7202037208587427,1.0,2/5,9.08%,FOXO1;MLIP
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5850074024644211,-1.2892890075303294,0.10638297872340426,0.6733694756648541,1.0,18/42,17.20%,SNX17;SQLE;TM7SF2;MT3;MSMO1;ARV1;SOAT1;IDI1;PMVK;ACAT2;HMGCS1;ACLY;LCAT;DHCR7;FDPS;LBR;FDX1;STARD3
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.778590975830217,1.2890659320261617,0.14583333333333334,0.7197289721772735,1.0,2/6,12.72%,SASH1;TAF1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6354529403883479,-1.2889174955749922,0.15789473684210525,0.6734332026488662,1.0,9/25,13.43%,ATP6V0A4;TMEM9;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;ATP6V0D1;CLCN3
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.47781725489602855,1.2887839520963786,0.06818181818181818,0.7195277643660687,1.0,18/99,13.89%,HOOK1;BAIAP3;EPS15;TBC1D10B;CLTCL1;WDR91;RBSN;EMP2;WASHC1;SORT1;VTI1A;RAB6B;VPS52;RAB29;STX5;ERC1;LMTK2;VPS54
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.6827848270824662,1.2885844848280998,0.10416666666666667,0.7189939584450322,1.0,6/15,23.85%,KIF1C;NEFL;FBXW11;DST;ACTR10;KIF5A
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.730495888854071,-1.288504721717692,0.25,0.673692857169653,1.0,1/5,10.64%,NUP155
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.48314612688134345,-1.2884199961788483,0.10204081632653061,0.6727963187359234,1.0,18/85,17.38%,TSR1;HDGF;TBRG4;PRPF8;EIF3D;NOP14;RCC2;NOL6;CEP85;RFWD3;ITGA4;LSG1;YBX1;GANAB;SNRNP200;NEU3;ELAC2;POLG
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7967895084902924,-1.2879960108874289,0.2641509433962264,0.6734665858407118,1.0,1/6,10.52%,MPG
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.8352978989586681,-1.2877024910809902,0.15217391304347827,0.6732175611615331,1.0,1/5,0.52%,GSTP1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.7002558801953205,1.2874841335809968,0.13725490196078433,0.7228089272551588,1.0,3/12,9.14%,RASGRF1;ARHGAP24;ARHGAP17
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.5120874927239606,-1.2874069524482077,0.06666666666666667,0.6733004391767233,1.0,21/58,17.46%,ACTG1;SQLE;TM7SF2;GUSB;LDLR;SC5D;FABP5;ANXA5;IDI1;PMVK;ACAT2;HMGCS1;CLU;PCYT2;PNRC1;DHCR7;FDPS;TRIB3;CD9;ECH1;GNAI1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.760805080716794,1.287260528326195,0.14035087719298245,0.7221874116030601,1.0,3/8,13.98%,LMBR1L;DOCK8;CADM1
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.8418291654936981,-1.2871227274205141,0.14,0.6732858474194039,1.0,1/5,0.52%,GSTP1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.742639365868744,-1.2870787485613764,0.21428571428571427,0.6721658388116617,1.0,6/10,18.79%,COPS7B;COPS2;COPS6;COPS8;GPS1;COPS5
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5457609036078573,1.2869491177450747,0.10638297872340426,0.7220241174739754,1.0,9/33,17.13%,TMSB4X;SRPX2;PRKCA;HDAC7;RHOJ;PDPK1;AKT3;JCAD;MAP2K3
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.8192896857144363,1.286640593248414,0.1836734693877551,0.7221921500201371,1.0,1/5,2.02%,PARN
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.5815835915564918,1.286093728626078,0.037037037037037035,0.7230812144067774,1.0,9/31,11.51%,SHTN1;SEMA3A;DIP2B;MACF1;KIAA0319;LIMK1;NRCAM;TRIM46;SIN3A
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5491785433361379,1.2860606855883847,0.07407407407407407,0.7216618269350876,1.0,12/42,21.55%,KCNJ13;SLC39A14;KCNJ11;SLC24A2;SLC12A1;SLC8A1;SLC9A9;SLC8A2;SLC6A1;SLC39A8;SLC12A5;SLC9A5
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.8167470868265486,-1.2858913653094948,0.10638297872340426,0.675831388300099,1.0,3/9,9.25%,TSR1;NOP14;KRI1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.7876066395757534,1.2858694414389815,0.08163265306122448,0.7211519222996589,1.0,2/8,7.41%,WNT7A;DOCK7
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.8369354826467801,-1.2855975721888067,0.13953488372093023,0.6756768563285028,1.0,2/7,8.01%,JUN;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.6846519256283154,-1.2855415428012593,0.14583333333333334,0.6745008185841597,1.0,6/15,18.65%,GSTP1;SFRP1;MORC3;FTH1;CDC73;B4GALT7
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.58655946937536,1.2854927528727915,0.15555555555555556,0.7214638145868801,1.0,11/28,22.54%,SPIRE1;BAIAP2;CRACD;CDC42EP4;CDC42EP3;VASP;PRKCE;FER;FCHSD2;CARMIL1;NCK2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7213779835217025,1.2854345597707577,0.16981132075471697,0.7203634481576537,1.0,3/10,17.95%,VAPB;MOSPD3;STX18
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.672183107458225,1.2851583107642728,0.2909090909090909,0.7200226949987393,1.0,4/12,15.63%,SAE1;ATG7;UBA5;DESI2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.4898249488040025,-1.2851281559433088,0.06666666666666667,0.6751962993899752,1.0,16/87,9.88%,JUN;PSMB6;PSMD8;CALM1;PSMB4;LAT2;MALT1;PSMA7;PSMC3;PSMD10;LYN;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.7330705314593151,-1.2835643308148825,0.14814814814814814,0.6804424886871363,1.0,8/12,24.36%,TSPO;DHCR7;FDX1;STARD3;HSD17B14;STARD3NL;HSD17B7;AKR1B1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7407952623454581,-1.2833988219261483,0.25,0.6797818945325284,1.0,3/6,21.65%,MID1IP1;ABCD2;NR1H2
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7608904447565703,-1.283277170358696,0.23809523809523808,0.6790472079237958,1.0,2/6,7.84%,ESRRB;CDK2AP2
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7062419616541096,1.283190235313712,0.12962962962962962,0.7266680086098539,1.0,3/13,5.35%,BCL2L11;FAM107A;SLIT3
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.6885051293101345,1.2831397437677703,0.13953488372093023,0.725360474975963,1.0,4/16,13.23%,YWHAH;SCN8A;SCN2A;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.5808007771307215,1.2829817953075402,0.1276595744680851,0.7245450605556983,1.0,5/30,6.81%,EFNA5;TBCD;PLET1;GCNT2;CDKN2A
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4786728517743503,-1.2825998766623883,0.05555555555555555,0.6801493216949079,1.0,21/147,12.97%,COPZ1;YIF1A;GORASP1;RANGRF;RAB1B;TMED2;PEF1;TMEM115;DYNLL2;KDELR1;CTSC;TRAPPC2L;YIF1B;LMAN2;TMED9;TRAPPC6A;TRAPPC2;KLHL12;ANK1;SAR1B;TMED1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.6810783263444669,-1.2824204575142597,0.17857142857142858,0.6796073791722455,1.0,2/10,15.73%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.5377938134480542,1.2822975408166102,0.09803921568627451,0.7261209793263219,1.0,12/62,15.42%,JADE2;MSL3;MRGBP;KAT2B;ING5;SPI1;NAA50;EP400;TADA2A;ACTL6B;MORF4L2;PER1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.7875901601974089,-1.2822169381653554,0.14583333333333334,0.6792577889046197,1.0,1/6,3.99%,HSPA8
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.7866004841214981,1.2820578816441928,0.14,0.7256506799612107,1.0,4/8,16.99%,SNTA1;CAV3;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5863989162752654,-1.281912155431405,0.11320754716981132,0.6795364445618144,1.0,2/26,0.35%,NR0B1;COL9A3
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.8224030782376596,1.2818031516123336,0.14285714285714285,0.7255249289691604,1.0,1/6,0.77%,FOXO1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.8103543764520234,-1.281787569278727,0.2222222222222222,0.6789227947306986,1.0,2/5,6.65%,LDLR;SELENOS
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7309256335753845,1.2815609964851649,0.2391304347826087,0.7253393594642943,1.0,2/7,15.00%,SLC24A2;PLK2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.48455755398570977,1.2814784116109992,0.08695652173913043,0.7242312996468026,1.0,22/96,15.31%,ROBO2;UNC5D;STMN2;SHISA6;SULT4A1;NTRK3;TMEM132B;FMN2;SNAP25;KCNIP1;ADGRB3;LSAMP;CRMP1;NEFL;CLVS2;ACTL6B;MAGI2;ANK2;NOVA2;DCLK1;ASTN1;LRRTM1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.759925928303573,-1.2814292716349274,0.2826086956521739,0.6789739009037198,1.0,4/7,22.52%,RHOG;MADCAM1;ZP3;CD81
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.5790798389691663,-1.2803345640268278,0.10344827586206896,0.6822366776790484,1.0,13/37,16.89%,TMBIM6;HSPA8;BAG3;HSPA13;ERN1;DNAJA1;HSP90AB1;HSPA14;HSPA9;HSPA5;HSPA4;OPTN;BAX
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.5462749435209161,-1.2801386204598344,0.11627906976744186,0.681659162363603,1.0,15/57,14.63%,IPO13;RAN;SNRPD2;SNRPB;PTTG1IP;PRICKLE1;PHB2;SNRPG;PPP1R10;NUP155;SNRPD1;SNRPE;FAM53C;RANBP17;RANBP6
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.7578885757750361,-1.280131620542143,0.1875,0.6804437600902009,1.0,3/7,8.95%,SIRT2;WNT5A;PTN
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.8613337705773306,1.2801196621406052,0.10526315789473684,0.7293569791831318,1.0,2/6,3.54%,SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.8144164623485293,1.2800914748538836,0.11666666666666667,0.728045349159521,1.0,1/7,4.74%,SLC4A4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.720928619547477,1.2800453167879546,0.18518518518518517,0.726759020550437,1.0,1/7,3.84%,KAT2B
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.550554811296654,-1.2790383978299673,0.11363636363636363,0.6832913045560653,1.0,9/33,13.20%,STAB2;RPS19;ROMO1;RARRES2;PPP1R11;TNFRSF14;NLRP1;RPL30;ISG15
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.7643045906465888,1.278802292207154,0.1836734693877551,0.731231111115873,1.0,3/7,13.67%,PRKCA;RIPK1;CSF1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.847456899801868,-1.2782368881462902,0.17073170731707318,0.6854719977627585,1.0,4/5,11.85%,PNRC2;ZFP36L1;EDC3;DCP1A
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6388287490727814,-1.2781471521592709,0.17777777777777778,0.6834187494271186,1.0,3/16,7.60%,GSTP1;GSTM4;AKR1A1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6388287490727814,-1.2781471521592709,0.17777777777777778,0.6834187494271186,1.0,3/16,7.60%,GSTP1;GSTM4;AKR1A1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.470359242115777,-1.2780448455060853,0.03571428571428571,0.6825469543577232,1.0,26/137,13.89%,SOX4;TAF9B;CALR;GAPDH;PPIB;MT3;RABL3;WIZ;RPS7;RPL23;CCT5;GOLGA7;BAG3;PHB2;CCT3;CDC37;GBA3;RPL11;ZBED3;HSP90AB1;CLU;GRN;PFN1;MORC3;LAMP1;PARK7
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.8074064507211813,1.277918686170936,0.26,0.7340758170067797,1.0,1/5,1.49%,NUAK1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5474785582667555,1.2775724734989355,0.14545454545454545,0.7340143228162994,1.0,10/58,8.01%,CALCB;NEDD4L;HTR2C;TPCN2;ATP2B3;SLC24A2;VAPB;RYR2;ATP2B2;LETM2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.6905547203182331,-1.2775306695961408,0.08888888888888889,0.6831119522465195,1.0,4/14,10.97%,PPT1;PPCS;ACLY;SLC25A1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.5615269123906712,-1.2772654728224686,0.11320754716981132,0.6830244352635312,1.0,5/42,8.37%,GSTP1;SELENOS;WNT5A;CACTIN;LYN
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5732083469478121,-1.2772562050956335,0.16326530612244897,0.6818056231757649,1.0,10/42,20.31%,HSD17B10;CRAT;ACAT2;ACOX1;CROT;ABCD2;ACADS;MECR;ACOT8;ACAA2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.4374623833275671,-1.2771995111001293,0.02040816326530612,0.6808689811900278,1.0,30/134,17.68%,CCND1;CDKN2C;MT2A;MARCKS;ODC1;SQLE;HSPA8;E2F4;KPNA2;H2AZ1;SMC1A;CBX1;NCL;SNRPD1;GSPT1;ODF2;SAP30;SMAD3;SRSF10;HMGN2;DR1;H2AX;HIRA;UBE2S;PRMT5;STMN1;LBR;BUB3;NUMA1;SLC7A1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.480242314170918,1.2768997686080272,0.057692307692307696,0.7353974776188393,1.0,16/78,13.67%,LIFR;IGF1R;NEDD9;EPHA7;ALK;MERTK;NTRK3;TYRO3;ROR1;EPHA4;SHC2;PTPRU;PTPRG;IL6ST;LMTK2;CSF1
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.7729566185451555,1.2767305112683176,0.125,0.7346029476791633,1.0,2/9,10.44%,XRCC4;LIG3
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.675074960419717,1.276707140870072,0.15517241379310345,0.7332007194223169,1.0,6/16,19.10%,MYLK;DOCK8;SPI1;SERPINB1;AOAH;IGSF6
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.7603337455715173,1.2766751054061232,0.14814814814814814,0.7317648002004243,1.0,3/8,13.67%,PRKCA;RIPK1;CSF1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.7279839696023724,1.276326483316546,0.13953488372093023,0.7317870735200689,1.0,7/11,23.03%,TGFBR3;PRKCSH;PROX1;PKD2;COBL;NIPBL;NF1
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.7917612436751587,1.2761700628974848,0.10526315789473684,0.7311040880477508,1.0,3/6,18.86%,CCDC39;PROX1;SRP54
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.6779875805813275,1.2757837635383533,0.12,0.7310689470999971,1.0,1/15,0.71%,FMO5
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.5214947206239056,1.2756657508846672,0.09090909090909091,0.7301560033452734,1.0,15/58,16.81%,HDAC4;SLC4A4;POM121;PSEN1;SLC2A6;POM121C;PRXL2C;PFKFB3;NUP93;PRKAA2;PFKFB1;GAPDHS;NCOR1;OGT;PRKAA1
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.7776595550655111,-1.2756322479768056,0.21621621621621623,0.6848547088667148,1.0,3/7,7.95%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.7776595550655111,-1.2756322479768056,0.21621621621621623,0.6848547088667148,1.0,3/7,7.95%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.6038426101649477,-1.2755716600685545,0.05,0.6839360542965943,1.0,8/25,22.53%,AP4M1;LAMTOR4;LAMTOR5;SCARB2;NCOA4;AP3M1;CD81;M6PR
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.755476047894289,1.275343404937611,0.19607843137254902,0.7302786588739433,1.0,3/7,16.42%,MYLK;PROX1;ENG
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6390951908205222,-1.2752293040365206,0.13333333333333333,0.6843811508172414,1.0,6/25,17.43%,CALM1;GABARAPL2;MAP1LC3A;MAP1LC3B2;VCP;LIX1L
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.7353939269457604,1.2751375348273153,0.20930232558139536,0.729623535806409,1.0,7/12,23.03%,CCDC39;TGFBR3;PRKCSH;PROX1;PKD2;COBL;NF1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.6356807619223636,1.275127066711661,0.16666666666666666,0.7282340512099926,1.0,4/21,6.58%,FAM107A;NEDD9;BAIAP2;RFLNA
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.7908771575236568,-1.274761561229784,0.20833333333333334,0.6848246520098575,1.0,4/5,16.26%,GM2A;NEU1;NEU4;NEU3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.6958309261666035,-1.2746253912569214,0.13333333333333333,0.6840941685465916,1.0,3/12,7.67%,THNSL2;SEPHS2;SARS1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.7339200011140165,-1.2745798922375977,0.23404255319148937,0.6830920038773967,1.0,2/7,7.56%,PHB2;IRF3
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.737350844823558,1.2740771861462843,0.2549019607843137,0.7318437402798496,1.0,2/11,3.00%,AKT2;NNMT
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.7349613749483588,-1.2738775508047764,0.1568627450980392,0.684448101833265,1.0,4/8,14.46%,SMPD1;SHFL;ISG15;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.6287504129882543,1.273563344769052,0.1509433962264151,0.7323677490406112,1.0,2/18,2.71%,PTPRC;GPI
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7682927091500592,-1.2732763334704675,0.14583333333333334,0.6852709668396871,1.0,5/9,13.65%,CFL1;TENM4;ZBED3;TLE6;RACK1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.8132461738360515,1.2732656285944675,0.17647058823529413,0.732234206042142,1.0,2/6,6.79%,UNC13C;SNAP25
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.4868703326556778,-1.2732437285354434,0.09523809523809523,0.6842356749415074,1.0,21/107,10.96%,SOX4;PSMB6;PSMD8;TMEM9;PSMB4;GID8;CDH3;PSMA7;SFRP1;BAMBI;GSKIP;PSMC3;PSMD10;PSME3;PSMD12;ZBED3;PSMB9;PSMC1;PSMD2;LRRK1;SEMA5A
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.4697688916411431,1.2731973492248765,0.09090909090909091,0.7311198972944295,1.0,40/134,25.08%,INPP4B;SYNJ2;PCTP;PIP4K2C;PIP5K1B;PITPNM2;PLEKHA4;DGKG;GPAM;CDS1;DGKZ;INPP5E;INPP4A;PIP4K2A;PLEKHA2;ABHD3;PIK3CD;PTPN13;IMPA1;AGK;MTMR3;LIPH;MTMR7;SLC44A3;DGKD;GPD1L;ABHD8;PIK3CA;STARD7;GPAT4;PLA2G12A;PIP4K2B;PIK3R1;SLC44A1;CDS2;SACM1L;MTMR9;LPCAT3;PI4K2B;TAMM41
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.8259152469105959,1.2727656572986348,0.1590909090909091,0.7315846300581194,1.0,3/5,16.81%,SNCA;FGF1;PRKAA1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.7943070272416726,1.2725487755293543,0.14814814814814814,0.7308976070379319,1.0,4/7,13.80%,UBASH3B;RYR2;ANK2;DIAPH1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.52166586773061,-1.2721184889866655,0.09523809523809523,0.6869442556035853,1.0,9/44,8.05%,S100A10;SLITRK2;THY1;CLSTN2;NLGN2;SFRP1;SYNDIG1;EPHB3;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.7406203776943708,1.2718681905403908,0.22413793103448276,0.7330633522635268,1.0,2/7,4.45%,ALK;PLIN5
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.6245438621641782,-1.2716527660534913,0.21153846153846154,0.6873777256225116,1.0,8/23,10.60%,RANGRF;DERL2;SURF4;SELENOS;TMED9;SEC61B;AUP1;OS9
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.6932720444724236,-1.2713577882896823,0.2608695652173913,0.6875201893780089,1.0,1/9,4.65%,PARP1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5215690180567409,1.2712631028901447,0.0784313725490196,0.7337506544482907,1.0,19/62,13.39%,GLRA1;EDNRA;TPCN2;CKMT2;MYLK;SORBS1;OXTR;SNTA1;TTN;CAV3;VCL;TMOD3;MYOM1;DYSF;TPM1;SLC6A8;NOS1;SLC8A1;SGCA
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.709429507111986,-1.271091292021121,0.15555555555555556,0.687355126333875,1.0,3/12,16.82%,CHMP2A;SMPD3;SNF8
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5781383137893248,1.270997002228563,0.20408163265306123,0.7331777476914472,1.0,12/33,20.51%,MAP3K19;FAM161A;ECT2L;CCDC39;SAXO2;CCDC181;CFAP77;APPL2;VWA3B;CFAP43;CCDC60;CFAP70
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.656239855173683,1.2708480775874742,0.15789473684210525,0.7323028076357326,1.0,4/18,15.26%,NEDD4L;CAV3;ANK2;WWP2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.42201551096146295,-1.2708095683743432,0.022727272727272728,0.6869743030296899,1.0,53/274,10.98%,GSTP1;ILF2;NCSTN;ARPC5;IDH1;CKAP4;PGRMC1;C6ORF120;AGA;SRP14;FTL;CSTB;YPEL5;SURF4;EEF1A1;CAP1;PPIA;GUSB;HSPA8;CD63;RHOG;EEF2;DDOST;ALOX5;LPCAT1;CYB5R3;FABP5;GOLGA7;DYNLT1;MOSPD2;ASAH1;CTSC;PA2G4;MAGT1;ALAD;APEH;PSMC3;OSTF1;HLA-B;PRCP;TUBB4B;PSMD12;RAB14;GALNS;ACLY;RAB5B;HSP90AB1;PSMD2;CD44;GM2A;NEU1;DBNL;CST3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7374905830127523,1.27080223776595,0.1896551724137931,0.7310137168082765,1.0,5/7,18.88%,PKP2;AHCYL1;NOS1;ANK3;GPD1L
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.7034712532275967,1.2698086856612303,0.16666666666666666,0.7335939332058304,1.0,4/10,19.10%,MERTK;SPI1;AOAH;IGSF6
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.6939536970755307,-1.2697163908378655,0.21568627450980393,0.6897622500283234,1.0,2/12,4.33%,BICD2;CAMSAP3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.4316880074227063,-1.2696121512775467,0.044444444444444446,0.6888395839845248,1.0,24/224,9.16%,SOX4;CDKN2C;NOX4;GSTP1;SIRT2;BTG1;PODN;FABP7;SMYD2;IGFBP7;TMEM115;BTG3;TNS2;PTPN14;SFRP1;APOD;PDCD5;SPEG;ATRAID;ZBTB49;WNT5A;LYN;FUZ;NGF
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.8006927494349427,-1.2691101473082826,0.14285714285714285,0.6896417882777963,1.0,2/5,12.83%,PTPRF;B2M
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.7787501307716915,-1.2690694947173644,0.11363636363636363,0.6886151446412345,1.0,1/5,3.88%,NLGN2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.558430070479102,1.2690398293746636,0.2,0.7356347984258631,1.0,8/34,12.68%,CHRM3;TPCN2;INPP5A;RYR2;P2RY12;PDPK1;ACKR4;NOS1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8555822157115405,-1.2687073189441334,0.18181818181818182,0.6888073218751647,1.0,2/6,8.21%,POP4;POP5
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5968602917709356,-1.2685874383332272,0.1694915254237288,0.6882495492959262,1.0,2/23,0.35%,NR0B1;COL9A3
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.6417743825928607,1.2684251668335158,0.18604651162790697,0.7376111751716631,1.0,2/14,2.84%,BCL2L11;USP13
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.6461297429988642,1.267941397076236,0.13793103448275862,0.7383746107420776,1.0,8/15,20.94%,TTN;RYR2;TPM1;CAMK2D;SLC8A1;KCNQ1;DMD;PIK3CA
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5638259365143546,1.267911982596892,0.1836734693877551,0.7371050354609711,1.0,9/36,15.50%,FECH;RRH;UBE4B;DDB2;MAPK10;ZRANB3;PRIMPOL;CLOCK;MSH6
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.6609363662946512,1.2677116821835654,0.1702127659574468,0.7366845746496338,1.0,4/25,9.99%,HOOK1;TPCN2;CLVS1;CLVS2
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.8048163850314026,-1.2677003308992607,0.13333333333333333,0.6904897264685854,1.0,3/6,9.93%,SLC25A24;SLC25A4;SLC25A5
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.5001372317744267,-1.2675967653699893,0.10416666666666667,0.6896465207912599,1.0,17/108,7.63%,EIF1;CCND1;G0S2;JUN;BTG1;PANX1;PMEPA1;MARCKS;BTG3;LDLR;SAT1;IER2;TIPARP;IFIT2;TRIP10;PHLDA1;TUBB2A
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.7367519654930089,1.2673257733257939,0.23404255319148937,0.7369585485992994,1.0,1/8,0.95%,MYRF
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7271826977367059,1.2672071910213654,0.20833333333333334,0.7359606116565823,1.0,2/7,12.18%,NEDD9;DMTN
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.7790003798013088,-1.2669002475038726,0.23076923076923078,0.6913263472305559,1.0,3/6,15.65%,GAS1;PRNP;SNX12
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.49362002262816757,-1.2665706715379892,0.11904761904761904,0.6912109901104398,1.0,13/74,5.50%,BGN;MMP2;PODN;HSPG2;PRRX1;FBLN2;FIBIN;RARRES2;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4950464155495857,1.2665300065913647,0.13043478260869565,0.7375966268834707,1.0,24/92,17.61%,UNC5D;PCSK2;BAIAP3;STMN2;SHISA6;SORBS1;FAM13C;KCNB2;SNAP25;GABRG2;KCNIP1;PROX1;SHC2;MAPK10;ACTL6B;ABCC8;ASTN1;LRRTM1;NPTX2;PPARGC1A;SPARCL1;CELF3;SLC6A1;GAD2
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.7834875403953139,-1.266321226330452,0.18181818181818182,0.6909722298375174,1.0,3/5,14.98%,CXCL12;VEGFB;SCG2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.7697171128124725,-1.266300914715051,0.15384615384615385,0.6898515202192902,1.0,4/8,20.06%,PPP1R3F;KHK;AKT1;PPP1R3B
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.776197887873741,1.2659214561728036,0.17777777777777778,0.7384630729934866,1.0,2/6,13.53%,DUSP22;DOCK3
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.5859013282076458,-1.265709964545608,0.15789473684210525,0.6903737995187335,1.0,13/31,16.89%,UBB;BAD;TUSC2;STOX1;ARL6IP5;SLC25A33;PRELID1;PYCR1;PARK7;PRDX3;VCP;AKT1;BAX
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.7900732937435962,1.2655408297826298,0.21568627450980393,0.738973155756419,1.0,4/5,18.10%,JAK1;DMTN;PDPN;ANK3
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.42020478843406006,-1.2654769969093471,0.022222222222222223,0.6900145449703734,1.0,53/277,10.98%,GSTP1;ILF2;NCSTN;ARPC5;IDH1;CKAP4;PGRMC1;C6ORF120;AGA;SRP14;FTL;CSTB;YPEL5;SURF4;EEF1A1;CAP1;PPIA;GUSB;HSPA8;CD63;RHOG;EEF2;DDOST;ALOX5;LPCAT1;CYB5R3;FABP5;GOLGA7;DYNLT1;MOSPD2;ASAH1;CTSC;PA2G4;MAGT1;ALAD;APEH;PSMC3;OSTF1;HLA-B;PRCP;TUBB4B;PSMD12;RAB14;GALNS;ACLY;RAB5B;HSP90AB1;PSMD2;CD44;GM2A;NEU1;DBNL;CST3
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.6401723795048795,1.2652495260896868,0.20689655172413793,0.7387394102681955,1.0,8/17,24.84%,PLA2G15;ABHD12B;ABHD12;SERINC1;MBOAT2;PLAAT3;PLA2G12A;LPCAT3
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.7713696891879651,1.2652203115008152,0.18181818181818182,0.7375068922518494,1.0,4/7,18.60%,PMS2;POLQ;MSH6;SAMHD1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.6750729295793478,-1.2652010742496829,0.2702702702702703,0.6898672980770634,1.0,3/13,3.88%,SIRT2;PPT1;MT3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.6901841109716689,1.2651754664722836,0.16326530612244897,0.7362975112281377,1.0,4/12,16.59%,SOX9;BRCA1;NCOR1;APPL2
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.8131136237431095,-1.2647632807097284,0.10526315789473684,0.6891016916157692,1.0,1/5,2.76%,VPS28
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.8131136237431095,-1.2647632807097284,0.10526315789473684,0.6891016916157692,1.0,1/5,2.76%,VPS28
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.6648308490917447,1.2647384892228961,0.20754716981132076,0.7368631572550818,1.0,2/14,4.88%,GRAMD1C;ABCA2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7872159977776312,1.2646089452288616,0.14285714285714285,0.7361013259314533,1.0,1/6,0.39%,JADE2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5814760809835527,-1.264201028418945,0.18181818181818182,0.6899702877896753,1.0,5/25,12.42%,CALM1;S100A1;DHFR;SCARB1;CAV1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.6983262646584902,-1.26376710763396,0.19607843137254902,0.6902427975443187,1.0,1/8,3.57%,MYH3
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.5468514669458946,1.2635961349187852,0.06382978723404255,0.7394211634130363,1.0,9/39,10.43%,CDH9;CDH7;TBCD;CDH8;VCL;PVR;PAK2;CDH12;CDH20
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.6262145074462183,-1.2635817576724813,0.15,0.6898700164082856,1.0,4/21,3.88%,SOX4;ZNF488;HES5;MT3
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.46391181889100624,1.2635812075322255,0.07017543859649122,0.7380888972513092,1.0,20/115,14.11%,PTPRC;PTPRB;PTPRR;UBASH3B;EYA4;DUSP22;PTPRJ;DUSP4;PPP2R2C;EYA1;SSH2;DUSP1;PTPRU;PTPRG;TAB1;DUSP8;EYA2;STK11;FBXW11;PTPN13
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7294914732737132,1.2633949168878058,0.1509433962264151,0.7376402215759558,1.0,2/9,1.35%,BCL2L11;FAM107A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6776506669725229,1.263235908837613,0.1590909090909091,0.7371566832561331,1.0,9/19,18.88%,NEDD4L;PKP2;SNTA1;CAV3;RYR2;GJA1;ANK2;KCNQ1;GPD1L
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.8266823425483266,1.2629705185865094,0.11764705882352941,0.7368573080097212,1.0,1/5,0.28%,PTPRC
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6980891904320979,-1.2628235719191792,0.21052631578947367,0.6917064818596229,1.0,1/8,1.59%,CALR
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5450049759615525,-1.262742682699203,0.14285714285714285,0.6909680031961511,1.0,7/35,8.83%,SLC22A17;FTL;ISCU;ATP6V1G1;CYBRD1;CYB561A3;ABCG2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7523559389362732,1.2626650515621616,0.14893617021276595,0.7368138746878611,1.0,2/8,10.29%,ROBO2;BMP7
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.8203041832684946,-1.262246232560998,0.16,0.6919647076781481,1.0,3/8,3.15%,GPX1;PRDX5;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.7686334716091829,1.2620882322686435,0.16071428571428573,0.7378788563919576,1.0,2/7,4.32%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5867908354358224,-1.2620510274375554,0.2,0.6915915367015918,1.0,3/23,9.23%,UBE2D4;CDC26;ANAPC11
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.4664987954961982,1.2616225785162614,0.11363636363636363,0.7383233173394372,1.0,32/110,17.61%,OLFM3;STMN2;SHISA6;ATP2B3;SULT4A1;KCNC2;GFAP;GRM3;MMD2;NRGN;GABRB1;SNAP25;GABRG2;PSD2;KCNIP1;ADGRB3;PDE10A;LSAMP;ATXN1;AQP4;CLVS2;SCN2A;ACTL6B;ARHGDIG;ASTN1;LRRTM1;SLC8A2;SPOCK1;CELF3;SLC6A1;SNCB;GAD2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.6094099655125278,-1.2616034920983694,0.1282051282051282,0.6922384600726301,1.0,10/19,20.88%,ST13;HSPA8;HSPA13;DNAJB12;HSPA14;HSPA9;HSPA5;DNAJC18;BAG1;SDF2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5885050621058792,1.261387622154448,0.14545454545454545,0.7379334952440403,1.0,7/28,11.33%,PTPRC;DOCK8;BCL11A;SPI1;PRKCA;TRAF3IP3;ETV6
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.6503035199690319,-1.2613150448475725,0.1320754716981132,0.6921591533341853,1.0,7/19,12.47%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;ATP6V0D1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.48618193296185824,-1.260660932093111,0.14814814814814814,0.6909451232366458,1.0,13/72,9.88%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;PSMC3;PSMD10;LYN;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.48618193296185824,-1.260660932093111,0.14814814814814814,0.6909451232366458,1.0,13/72,9.88%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;PSMC3;PSMD10;LYN;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.48618193296185824,-1.260660932093111,0.14814814814814814,0.6909451232366458,1.0,13/72,9.88%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;PSMC3;PSMD10;LYN;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5589168841899846,1.2606369667369406,0.0784313725490196,0.7398577342896001,1.0,6/41,2.43%,IL1RAPL2;ROBO2;SRPX2;RAB17;WNT7A;MDGA1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6281461649729279,1.2606278371547628,0.22448979591836735,0.7385467851473915,1.0,4/15,15.08%,SOX9;ZBTB16;TRPS1;MBOAT2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.7477772419915649,-1.260475155351758,0.21153846153846154,0.6905945254592822,1.0,1/9,6.03%,SMDT1
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6472754871622626,1.2604666481735538,0.11666666666666667,0.7380507004369913,1.0,8/21,21.51%,BRCA1;BABAM2;ATM;DONSON;CDC14B;NOP53;TAOK1;BRSK1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.777512256553365,1.2604522598075414,0.23076923076923078,0.7367299250063012,1.0,2/6,5.29%,DNAH7;CCDC39
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.8013540702545517,-1.260408848987831,0.18181818181818182,0.6897322353798505,1.0,2/5,15.22%,LYN;TGFBR2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.8149096198146293,1.2603241632302722,0.2,0.7358264954682545,1.0,2/7,7.08%,LRRC19;OCIAD2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.8052813880504522,-1.2602114185142461,0.225,0.6891288236710947,1.0,2/5,7.95%,CALM1;CALM3
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.6494886268078376,1.2599222875724025,0.1875,0.7361616057488227,1.0,6/17,15.84%,FGF9;CCDC39;LOXL3;PROX1;FGF1;PDPN
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7757258676518707,1.2599080114383956,0.2,0.7349230042729107,1.0,3/6,20.23%,SLIT3;PADI2;ROBO1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.6301236488497248,1.2597916086404843,0.2,0.7340278178176151,1.0,6/26,7.42%,FAM107A;DUSP22;PLET1;PHLDB2;CDKN2A;BCAS3
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6395477084273586,1.259668614473455,0.22916666666666666,0.7333495413254535,1.0,2/23,1.93%,INTU;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.44660166789525085,-1.2583662425335767,0.13043478260869565,0.6945931403917469,1.0,42/217,12.24%,PPIF;UBB;GSTP1;TAF9B;PTMA;PRDX5;ASCL1;PPT1;RPL10;GPX4;CFL1;RPS27A;UBC;TMBIM6;MT3;ZNF830;MALT1;API5;SFRP1;IFI6;BAG3;PHB2;NOL3;OPN3;UBA52;ANXA5;PA2G4;DNAJA1;WNT5A;PSMD10;FIGNL1;NGF;HAX1;RPS3A;CD44;DCPS;SOX8;PRELID1;NPM1;WDR73;DSTYK;IKBKB
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.4217504976815724,-1.2581663370533918,0.025,0.6943578839992164,1.0,53/275,10.98%,GSTP1;ILF2;NCSTN;ARPC5;IDH1;CKAP4;PGRMC1;C6ORF120;AGA;SRP14;FTL;CSTB;YPEL5;SURF4;EEF1A1;CAP1;PPIA;GUSB;HSPA8;CD63;RHOG;EEF2;DDOST;ALOX5;LPCAT1;CYB5R3;FABP5;GOLGA7;DYNLT1;MOSPD2;ASAH1;CTSC;PA2G4;MAGT1;ALAD;APEH;PSMC3;OSTF1;HLA-B;PRCP;TUBB4B;PSMD12;RAB14;GALNS;ACLY;RAB5B;HSP90AB1;PSMD2;CD44;GM2A;NEU1;DBNL;CST3
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.7005073730241173,-1.2580112682024207,0.14285714285714285,0.6936988571960288,1.0,2/11,3.65%,ESRRB;HES5
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.7244431813411057,1.257785019622687,0.14285714285714285,0.7404755060534385,1.0,3/7,21.73%,ACSL1;SLC27A4;ACSL3
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6991781526370164,-1.2575458243967617,0.24528301886792453,0.6942626942610379,1.0,2/9,8.78%,COPS9;RPL11
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.6289990452698617,1.2574538988536246,0.18604651162790697,0.7405685252416131,1.0,4/17,13.59%,RNF138;BRCA1;ATM;BARD1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.6960429331507557,-1.2572718766217568,0.25925925925925924,0.6939275952873661,1.0,3/11,12.38%,RANGRF;HSP90AB1;TMEM35A
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.5817697430605395,1.2567889684396654,0.1320754716981132,0.7422902795822158,1.0,3/28,11.75%,PTPRC;NMI;IL6ST
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.5084483862771019,1.2567770381976577,0.06557377049180328,0.7410186836558164,1.0,10/56,14.90%,ITGA2;TNS1;MMP19;SLC39A14;FAM20C;CA2;DYSF;CEBPD;SEMA4D;SPP1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.8299022856245675,-1.2567438137464026,0.2037037037037037,0.6949623368847834,1.0,1/5,4.78%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.6293592029097457,-1.2561585254694632,0.1836734693877551,0.6958587081597517,1.0,2/15,1.82%,PPIF;BAD
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.7079961522712694,1.2558907809797666,0.19230769230769232,0.7434744317182236,1.0,3/9,24.84%,NLRC4;ENO1;LPCAT3
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5770123162398105,1.255783051884762,0.22641509433962265,0.742610351107763,1.0,4/25,5.10%,AKT2;SORBS1;CLTCL1;GRB10
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5651547643899832,1.2557103089261281,0.21428571428571427,0.7416087393761768,1.0,6/24,14.25%,SYT1;RAB3A;SYT12;RAB27A;SYT2;SYT6
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.6314902125447935,1.2557007060053746,0.20408163265306123,0.740329950435129,1.0,8/19,20.35%,SRF;CCDC39;MICAL2;BBS7;BBS4;ENG;PKD2;AHI1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.4978673570736055,1.2556699874392445,0.13953488372093023,0.7391608463978572,1.0,28/91,17.61%,UNC13C;PCSK2;ST18;MOBP;CACNG2;SLC24A2;ASPA;KCNC2;HCN1;RBFOX3;MCF2L2;GNG7;ATP2B2;CNDP1;SGSM1;PROX1;FAM135B;NAPB;ACTL6B;DPP6;SV2B;KCNT1;SEZ6L;CACNB4;KCNQ1;CNTNAP5;CELF3;GAD2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.6208261837640087,-1.255410673870879,0.17391304347826086,0.6972405596635474,1.0,2/22,3.38%,ACTB;GPC4
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6217488308785324,-1.2553390198410341,0.18604651162790697,0.6963983303877388,1.0,7/19,16.62%,P2RX4;HSP90AB1;CLU;CAV1;SMAD3;KHSRP;AKT1
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.8161792931604845,-1.255046486597325,0.1568627450980392,0.6964989430402464,1.0,3/7,4.99%,FBLN5;ALOX5;DHFR
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6357455859177548,-1.2550117446813158,0.2,0.6954763279775212,1.0,1/15,0.30%,BTC
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.6681140282949668,-1.254863277317488,0.17647058823529413,0.6948586298064959,1.0,3/15,7.95%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.5800226460562024,-1.2540549210061167,0.2,0.6964814164866067,1.0,5/25,4.57%,BGN;BCAN;DSEL;UGDH;CHST7
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.6802597072999788,-1.2539476848787132,0.2549019607843137,0.6957807044617551,1.0,3/8,17.33%,CHAMP1;SPDL1;BUB3
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7701674902053641,-1.2536979403628705,0.21951219512195122,0.6954985379563522,1.0,1/6,0.92%,FBLN5
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.6766966987105919,1.2536733612922433,0.16981132075471697,0.7461092292173686,1.0,3/12,21.25%,XRCC4;ATM;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.4541678585656802,1.2536690521088236,0.06896551724137931,0.7448292543423599,1.0,35/153,15.56%,CARD14;IGF1R;EFNA5;SOX9;EPHA7;BRAT1;ALK;MERTK;AKT2;PAK1;NTRK3;FGF9;SLC4A4;PSEN1;EFNA1;ZNF16;RB1CC1;TYRO3;PRXL2C;RIPK1;PFKFB3;ROR1;EPHA4;WDFY2;ZNF622;TNIK;LMTK2;PRKAA2;SEMA4D;PFKFB1;FAM20A;FGF1;GAPDHS;ARRB1;CSNK1D
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.4948813949350792,1.2535961614842601,0.07407407407407407,0.743745498208045,1.0,22/90,14.07%,NEDD4L;KCNJ13;SLC6A17;KCNC4;PANX2;LRP2;SCN8A;SLC4A4;KCNB2;TMEM63C;SLC6A6;GRIN1;KCND3;SLC9B2;KCNH1;SLC22A4;SGK1;SCN2A;KCNMB4;PIEZO1;SLC8A1;ABCC8
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.7382575519785706,-1.2534420490516105,0.2,0.6952837821397101,1.0,1/7,1.12%,PPT1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6496354962013022,-1.2527378033107244,0.1896551724137931,0.6965136351993476,1.0,4/18,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.770400029624085,1.2526642207065266,0.3191489361702128,0.7464397126940854,1.0,1/6,0.72%,ARFGEF2
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.7429853325306287,-1.2522415807716136,0.19642857142857142,0.697507530353565,1.0,1/10,4.28%,CNTN6
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.7357955666538336,-1.2521300163356273,0.13043478260869565,0.6967281052950706,1.0,4/9,11.49%,VPS35;WASHC2A;MICALL1;TOLLIP
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.44324605589434796,1.2515889465653185,0.03636363636363636,0.7504611792538064,1.0,41/131,21.71%,RTN4IP1;STMN2;RAB17;CAMK1D;BAG5;SEMA3A;TENM3;RELN;PAK1;CAMK2B;NTRK3;PSEN1;SRCIN1;PAK2;ROR1;EPHA4;SHANK3;RAB29;CRMP1;CAMK1;MAGI2;SIPA1L1;NCS1;ARHGAP35;GAK;PDLIM5;SPOCK1;PTK7;CAMSAP2;MAG;LPAR1;ABL2;PLPPR5;EPHA3;LRRC7;STX1B;TANC2;CBFA2T2;BRSK1;EFNB2;ABI2
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6647947937916445,1.2514449606325766,0.22033898305084745,0.7497198131991158,1.0,2/12,5.68%,HEY2;TTN
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.6662880177492364,-1.2514255529086415,0.22916666666666666,0.6981809073822822,1.0,1/9,0.77%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.793464660436033,1.250929592104739,0.16279069767441862,0.7505899604323847,1.0,2/7,6.58%,SOX9;RFLNA
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.7474369590228864,1.2505799410576757,0.22,0.7506281057542284,1.0,1/6,0.35%,AHR
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7448610697505871,1.250553539523839,0.1896551724137931,0.7493904409563447,1.0,2/11,13.23%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5547478004655603,-1.2499001072991025,0.16,0.7026796426689611,1.0,6/32,15.85%,PMEPA1;RPL13A;CLU;CDC42;PARK7;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.8017091078901449,-1.2496971566440522,0.24489795918367346,0.7021920007190778,1.0,1/5,1.34%,PMEPA1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7261393655260854,1.249679427451333,0.15217391304347827,0.7517881295168094,1.0,2/10,6.47%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7727509860116039,1.2490903947992194,0.17543859649122806,0.7531466944193286,1.0,3/5,17.98%,KCNJ11;ABCC8;PKD2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.7482468623524169,-1.248975997831027,0.16666666666666666,0.7038755895487633,1.0,1/8,0.52%,GSTP1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.735479267380532,1.2486624273754114,0.375,0.7535916416331471,1.0,1/7,2.74%,TESPA1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.7066343234948324,1.2486460342489567,0.24444444444444444,0.7510592348414665,1.0,3/9,10.69%,AHR;ADCY5;ADCY3
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.7066343234948324,1.2486460342489567,0.24444444444444444,0.7510592348414665,1.0,3/9,10.69%,AHR;ADCY5;ADCY3
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.6256492240386886,1.2485880531883156,0.15384615384615385,0.7499190692147072,1.0,7/27,17.32%,HOOK1;TPCN2;CLVS1;CLVS2;ATP10B;MYO7A;TMEM165
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.639615752847988,-1.24800661595685,0.18181818181818182,0.706489181748446,1.0,1/15,1.80%,RBM22
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.6322051115211587,-1.247571551909339,0.21153846153846154,0.7071446834528374,1.0,1/15,0.83%,HSD17B10
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6784754592582,-1.2475213014830484,0.14,0.7062440725837918,1.0,6/13,19.13%,PRPF8;PRPF31;CD2BP2;SRSF10;PRPF19;PRPF6
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.47713302385906275,1.2470894185918349,0.125,0.7554921561335267,1.0,15/82,9.91%,DEPP1;PCSK2;STMN2;CNTN3;RGS4;FAM13C;KCNB2;ARX;SNAP25;KCNIP1;PROX1;SHC2;FGF14;MAPK10;RAI2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.7602270907196381,1.2469681855320198,0.17647058823529413,0.7546712281386062,1.0,1/6,2.76%,AKT2
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.6559262669135733,-1.246582632540552,0.1568627450980392,0.7088087180765098,1.0,9/14,17.36%,SURF1;COX19;SMIM20;BCS1L;COX17;COX18;TIMM21;COA5;COA3
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.8140348384085281,-1.2462514661519322,0.2619047619047619,0.7089845211135155,1.0,2/5,3.88%,PRDX1;MT3
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.772035057587892,-1.2462423880682933,0.24489795918367346,0.7079550401211231,1.0,4/6,17.53%,SAPCD2;EPB41;GNAI1;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6589445467778448,-1.2462329585989231,0.16666666666666666,0.7069125730956647,1.0,3/11,14.24%,TNFRSF14;PRNP;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5062047244179256,1.2461614865226078,0.2033898305084746,0.7567719049078755,1.0,16/67,13.88%,TPD52L1;WNT7A;TNFRSF19;SEMA3A;DUSP22;SH3RF1;GADD45A;SPI1;SASH1;RIPK1;TIRAP;CD27;ZNF622;MID1;RELL1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.5168867770344001,1.2449630912664453,0.16363636363636364,0.7601696873841045,1.0,19/52,23.46%,TBC1D10B;DYNC2LI1;TBC1D13;CDKL1;ATG5;CYLD;CCP110;TBC1D8;TBC1D22B;BBS4;TBC1D1;ARHGAP35;RABGAP1;TAPT1;LIMK2;IFT140;KCTD17;ATG3;TBC1D2B
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.8465623840751663,1.2443668576267712,0.12962962962962962,0.7615602403321139,1.0,1/5,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5415036332797091,1.243812273050969,0.125,0.7627096479107145,1.0,4/30,7.53%,HOOK1;ARFGEF2;PLEKHF1;DNM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.7494706992086144,1.2436596754287181,0.18518518518518517,0.7621361399921041,1.0,4/8,16.81%,KLF15;DIP2B;PRKAA2;PRKAA1
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.5118616737544718,1.2436060184683202,0.2033898305084746,0.7610767258028965,1.0,5/48,5.18%,ITGA2;NEDD9;ADAMTS13;ITGBL1;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.7170333101726392,-1.2435403734541557,0.19230769230769232,0.7150262657572573,1.0,4/9,15.11%,RPS19;GRN;RC3H1;ENPP3
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.7916783056278041,1.243280391158031,0.23529411764705882,0.7595891332885572,1.0,2/5,7.58%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.7916783056278041,1.243280391158031,0.23529411764705882,0.7595891332885572,1.0,2/5,7.58%,DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.6386841421040143,1.2432735904972154,0.14545454545454545,0.7583219410502919,1.0,9/22,18.88%,MMP21;ODAD4;CCDC39;BBS7;DNAH5;DNAH11;RFX3;PKD2;ENKUR
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.44862699498636754,1.2432286431303448,0.05454545454545454,0.7572261654191804,1.0,49/163,22.54%,BCL2L11;SEPTIN9;TLK1;NEDD9;RAPGEF5;RACGAP1;KIF3C;TIAM1;TBCD;BCR;SSH2;VCL;DOCK4;KLC1;RANBP9;PCNT;MID1;TUBA4A;SOS1;CDC42EP4;CEP131;KIF1B;ITSN1;CDC27;ARHGEF7;TSC1;TUBD1;CSNK1D;RASAL2;FARP1;PDLIM5;RABGAP1;DST;PKD2;PPP4R2;AKAP13;MAP3K11;RFC1;ALMS1;ANLN;ARFGEF1;PREX1;MYH10;CLASP1;SORBS2;NIN;RICTOR;HOOK3;NCK2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.76275346753652,1.242890568921183,0.2,0.7574184834701787,1.0,2/6,10.44%,XRCC4;LIG3
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.8335851750336731,1.2426131433148513,0.19230769230769232,0.7574269797155876,1.0,2/6,2.40%,YWHAH;HSD11B1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7417863942344431,1.2426015574148295,0.1956521739130435,0.7561720849646115,1.0,2/9,6.47%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5286953248324581,-1.2423660063351585,0.1590909090909091,0.7186261095494193,1.0,5/41,9.23%,CCND1;STOX1;PHB2;RCC2;ANAPC11
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.7338577669328122,1.241910708257395,0.20408163265306123,0.7574272906944469,1.0,2/8,2.41%,PON1;PON3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.7590677366035622,1.2417378288503,0.14893617021276595,0.7568061890540044,1.0,1/10,1.29%,CTBP1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.7013302822015467,1.2413352035588106,0.19298245614035087,0.7570637458840105,1.0,3/13,9.02%,RELN;AKAP5;SHANK3
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.49275032515088524,1.2413169624443825,0.11538461538461539,0.7559004980556521,1.0,22/72,21.97%,ITPR1;KCNJ11;G6PC2;KCNC2;TTN;SYTL4;PRKCA;SNAP25;ITPR2;MYOM1;STX1A;GOLPH3L;ABCC8;CLOCK;ENSA;RFX3;TMED10;PPID;MYH10;CACNA1D;UNC13B;GOLPH3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4356296067192282,1.241245409438649,0.07692307692307693,0.7548730376812961,1.0,23/146,12.77%,ROBO2;UNC5D;EFNA5;EPHA7;SEMA3A;RELN;LAMA2;SEMA4B;DAB1;PLXNA4;GRB10;SLIT3;EFNA1;UNC5C;SPTBN5;PRKCA;RANBP9;EPHA4;SHANK3;SPTBN4;PLXNA1;SOS1;PIK3CD
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.6542552535652527,1.2411781344564772,0.20833333333333334,0.7538819473185401,1.0,1/12,1.44%,TLK1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.7708878264910589,-1.2408136924462785,0.1509433962264151,0.7229749074723695,1.0,4/7,15.32%,RPS7;RPL23;RPL11;RPL5
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7057176558927537,1.2407752939415027,0.20833333333333334,0.7543891016451477,1.0,1/9,1.28%,IGF1R
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6649357432256099,1.2407586136596749,0.2,0.7531397481743854,1.0,2/13,2.25%,HDAC4;SAE1
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.7041922692870414,1.2407558519287039,0.22916666666666666,0.7518945801423862,1.0,3/10,8.77%,LRIF1;BRCA1;RBM15
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.46772843356873495,1.240022406306912,0.13157894736842105,0.7532361190690088,1.0,30/95,17.61%,OLFM3;NKAIN2;STMN2;ATP2B3;SULT4A1;CAMK2B;PARM1;PHYHIP;KCNC2;GFAP;MMD2;SNAP25;GABRG2;PSD2;KCNIP1;ADGRB3;AQP4;CLVS2;SPTBN4;ACTL6B;ANK2;ABCC8;HS6ST3;ASTN1;SLC8A2;CTNND2;CELF3;SLC6A1;SNCB;GAD2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.7479307592445575,-1.2399414737468575,0.22807017543859648,0.7249518420403548,1.0,3/7,13.33%,PPT1;CAV1;CDC42
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5821878831891436,-1.239799711447887,0.16981132075471697,0.7244552352224299,1.0,3/29,4.30%,UBB;BICD2;MAP1S
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.6476056020915282,1.23972952128987,0.19230769230769232,0.7533003811051834,1.0,2/14,6.48%,SRF;EMP2
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7939115001735145,1.239105468938321,0.19607843137254902,0.7548305938951959,1.0,1/7,0.51%,DPYD
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.7661328403450041,-1.239091057336785,0.2222222222222222,0.725731287403633,1.0,1/6,10.46%,CAND2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.5077062191484258,-1.2387514772421464,0.09615384615384616,0.7258298136979237,1.0,12/69,11.03%,BGN;BCAN;HSPG2;DSEL;AGRN;UGDH;GPC4;CHST7;XYLT2;HAS2;NCAN;CHST15
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.7460458995425363,-1.2386236687633858,0.25,0.725205762595147,1.0,2/7,15.73%,PSMC3;PSMC4
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.7338886643951804,-1.238562772605372,0.2692307692307692,0.7242150829437431,1.0,3/6,21.44%,PSAT1;PSPH;PHGDH
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.5468758899661286,1.2383964077238059,0.19642857142857142,0.7567460412411485,1.0,4/35,5.51%,RASGRF1;GPR18;ERBIN;MMD2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6351012794862856,-1.2383334156412147,0.2391304347826087,0.7239315103598808,1.0,3/15,3.88%,SIRT2;SLC30A10;MT3
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.5107776435536082,1.2380767868961344,0.11904761904761904,0.7569665185969705,1.0,11/40,15.91%,SYT1;RAB3A;RAB10;SYTL4;CADPS2;RAB8B;SEPTIN4;RAB27A;SNCA;CPLX1;CHMP6
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4112495933922868,-1.238014669091771,0.08888888888888889,0.7239843037109844,1.0,63/256,18.46%,CUL7;PSMB6;ELOB;SCG3;CKAP4;PSMD8;NUCB1;PSMB4;ICMT;BTBD6;IGFBP7;RAB1B;ASB18;PSMA7;ELOC;VWA1;RCN1;KBTBD6;CHGB;SPSB3;CUL9;ASB1;PSMC3;PSMD10;PSME3;FBXO44;COPS7B;PSMD12;MFGE8;PSMB9;PSMC1;COPS2;WSB1;PSMD2;STT3A;FN1;CST3;DSCC1;KLHL9;PSMD4;KTN1;TIMP1;COPS6;SUMF2;SCG2;DCAF8;RAB11B;ASB13;PSMC4;HSP90B1;COPS8;CUL4B;RAB2A;PSMB2;FBXL14;GOLM1;KBTBD7;PSMD3;PSMD11;RAB8A;PDIA6;GPS1;COMMD1
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6279935155078736,-1.2377093217451596,0.17647058823529413,0.7239412301405914,1.0,4/17,17.89%,UGDH;MPI;GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.7849324911501332,1.2371573808717573,0.2037037037037037,0.7596987640643474,1.0,2/5,18.00%,NTRK3;ANGPT2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.6462303228611214,1.237071015878916,0.18604651162790697,0.7587484585416346,1.0,2/17,7.33%,TMSB4X;SSH2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5439034678733671,1.2370659358932088,0.18867924528301888,0.7574943288580948,1.0,7/34,8.33%,PTPRC;PTPRR;SPRED2;TIMP3;LMO3;DUSP4;RANBP9
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7746762972790511,-1.2367812258628486,0.20833333333333334,0.7259049165422258,1.0,4/6,22.19%,GUSB;GBA3;FUCA1;ABHD10
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6948749763067953,1.2366022491538529,0.21153846153846154,0.7579540575324353,1.0,5/13,12.62%,CAMK1D;DAPK2;RIPOR2;TIRAP;MPP1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.5592846190107698,-1.2365986022465105,0.17857142857142858,0.7252706620868963,1.0,5/23,10.95%,GPX1;CYB5R3;CXCL12;MEOX2;ADCY6
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.7578640660819371,1.2363704750649733,0.21666666666666667,0.7576071286929531,1.0,1/6,1.63%,STMN2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.7061963122465982,-1.2357871940474465,0.35714285714285715,0.7273532081750144,1.0,1/5,6.40%,REC8
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.65792609814793,-1.235726615769846,0.13725490196078433,0.7264333458041767,1.0,3/13,8.24%,CCND1;STOX1;RCC2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.643368952190826,1.2356744473762593,0.3103448275862069,0.7593673455606391,1.0,4/10,18.68%,WNT7A;TMEM79;SIPA1L3;RILPL1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.760496332393312,1.2355556065725595,0.19607843137254902,0.7586500860298951,1.0,1/6,0.24%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.7303353642225555,1.2354331727366838,0.15517241379310345,0.7580313201343749,1.0,4/8,19.41%,HMBOX1;PARP9;DTX3L;MED25
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5484656796513089,1.2351641146350671,0.15384615384615385,0.7577505258039586,1.0,9/26,25.15%,SRF;MAPK12;CAMK1;PTBP1;CDK9;CTNNA1;ABL1;MAPK11;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.6930921118002843,1.2351635341861738,0.26666666666666666,0.7565123713500307,1.0,3/10,12.68%,NEDD4L;CAV3;NOS1
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.8185939008689065,-1.2350383688064395,0.20408163265306123,0.727621337188099,1.0,2/5,10.27%,GPX1;MST1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6884822169968244,-1.2349129480090537,0.14583333333333334,0.7268777300436648,1.0,3/14,9.73%,PIH1D1;NOL11;NCL
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6785605584583915,1.2348218227745522,0.23076923076923078,0.7565698211173839,1.0,3/12,7.78%,KAT2B;NAA50;NAA16
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6499352433387546,-1.2345176103659607,0.25,0.7273513490181146,1.0,3/15,4.90%,TRMT112;BUD23;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.7067031766798512,-1.2338067739688636,0.2,0.728658477825369,1.0,5/12,12.58%,CALM1;PPP1R15B;CALM3;HSP90AB1;BMP2
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.7518006207077317,1.2333997436996353,0.25,0.7614506231989525,1.0,4/9,22.61%,GPAM;AGMO;MOGAT1;GPAT4
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6095044718247569,1.233321723415654,0.18518518518518517,0.7604508929109257,1.0,4/18,11.59%,FAR2;ACSBG2;ACSL1;ELOVL2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.7454114273452348,1.2332769860553494,0.2,0.7593909381558417,1.0,2/8,9.90%,BAIAP2;GAS2L1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.4449963221408758,-1.2332767165832903,0.11904761904761904,0.72934812490074,1.0,37/174,17.45%,SIRT2;PSMB6;PSMD8;UBXN1;PSMB4;GID8;PSMA7;TNFAIP1;KBTBD6;FBXO45;HECTD3;SPSB3;PSMC3;PSMD10;PSME3;FBXO44;PSMD12;STUB1;PSMB9;PSMC1;RNF126;DNAJB12;PSMD2;RNF187;UCHL1;RAD23A;ERLEC1;PSMD4;PELI1;PRPF19;PSMC4;KCTD5;CUL4B;VCP;PSMB2;KBTBD7;PSMD3
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4928717287078894,1.2330704169730415,0.18867924528301888,0.7589522521191899,1.0,7/50,8.89%,HEY2;SOX9;KIAA0319;BCL11A;SPI1;SUZ12;CDK6
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.5732455401666984,-1.232869761853957,0.16666666666666666,0.7299728334095211,1.0,5/20,12.34%,CXCL12;BRK1;HAX1;DBNL;PFN1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7491873522458629,-1.232707705090824,0.1702127659574468,0.729544953364367,1.0,5/5,25.12%,TIMP2;TIMP1;LRP1;DDRGK1;SVBP
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.47445853582761205,-1.2325332109320288,0.13333333333333333,0.7288365424773079,1.0,4/39,5.00%,MAP7D3;GPX4;MSRB2;MID1IP1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.6806980874852795,-1.2325271664500816,0.32558139534883723,0.727739448767902,1.0,2/10,7.84%,PPIB;CCNK
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.7978337277378332,1.232383039180518,0.1836734693877551,0.7593739682979518,1.0,3/5,17.89%,JAK1;STAT5B;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.7978337277378332,1.232383039180518,0.1836734693877551,0.7593739682979518,1.0,3/5,17.89%,JAK1;STAT5B;STAT3
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7533237341634604,-1.2323453728401836,0.2222222222222222,0.7272701000281254,1.0,1/7,8.11%,PIF1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.6303215897749026,1.231915545135133,0.17647058823529413,0.7598991103988625,1.0,2/11,2.08%,RMI1;EME2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5591824408922582,-1.2314910800014527,0.2682926829268293,0.7294674279079723,1.0,8/25,11.03%,BGN;BCAN;UGDH;B3GAT2;CHST7;XYLT2;NCAN;CHST15
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7757946531071589,1.2314384337650028,0.21818181818181817,0.7605012603599219,1.0,3/5,20.23%,SLIT3;PADI2;ROBO1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6877407074864754,-1.2314315998859988,0.24324324324324326,0.728452190140481,1.0,1/8,2.24%,CALM1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5061658400156115,-1.2312875346785954,0.1276595744680851,0.7278285070709356,1.0,21/54,19.69%,UBB;RPS27A;UBC;PNRC2;PARP1;EDC3;UBA52;DXO;ISG20;DCP1A;DDX1;GTF2H2;FAN1;CUL4B;MUS81;POLD3;POLD2;RNASE1;RFC5;EXD2;RFC3
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.5975443600874468,-1.231188971310055,0.19230769230769232,0.727005013773398,1.0,4/15,10.67%,DHFR;P2RX4;APOD;FLRT3
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.5451783663625726,-1.2308533718473462,0.1724137931034483,0.7273304146286779,1.0,3/33,5.19%,S100A10;RHOC;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.5707606796297193,-1.2308317542709069,0.18181818181818182,0.7263400078689899,1.0,6/24,6.35%,SLITRK2;CLSTN2;AGRN;NLGN2;SYNDIG1;EPHB3
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.5793851437844763,-1.2308117572170147,0.2558139534883721,0.7253062531833139,1.0,4/28,11.71%,NOX4;OAT;AADAT;PYCR1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4887090604470269,-1.2307898687253944,0.17073170731707318,0.7242601902846181,1.0,13/66,5.50%,BGN;MMP2;PODN;FBLN5;THY1;PRRX1;FBLN2;FIBIN;IGFBP7;THBS2;PDGFRA;TLR1;CXCL12
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7563916613578766,1.2305125707848912,0.23636363636363636,0.7634115089728954,1.0,1/8,1.96%,EGLN3
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.8173035488136919,-1.2304987931444147,0.2558139534883721,0.7240950016811631,1.0,2/6,2.33%,PPT1;TMEM9
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.4538419170525714,-1.2301452613409762,0.1,0.72426857277616,1.0,19/119,5.50%,BGN;NOX4;MMP2;PODN;FBLN5;CKAP4;THY1;PRRX1;COL8A1;FBLN2;FIBIN;RARRES2;IGFBP7;NT5E;COL12A1;THBS2;NR2F6;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5342437191664202,1.2299176707446025,0.12698412698412698,0.7644140097547344,1.0,7/43,11.37%,CALCB;PRKAR1B;ADCY5;PRKAR2A;GPR176;ADCY3;CD247
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.45665914977512656,-1.2298230452369332,0.1,0.7242266874669283,1.0,23/116,11.66%,BGN;MMP2;DAPL1;SLITRK2;THY1;PRRX1;FIBIN;DBI;TCEAL7;THBS2;PDGFRA;ITM2B;CXCL12;S100A16;EDNRB;DOK5;PTN;CD44;FNDC4;KCNJ10;SEMA5A;CLU;BRINP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.6806066408471643,1.2296350425538531,0.2,0.7644734480593077,1.0,4/15,12.44%,SHTN1;RIPOR2;BCAS3;RAP1B
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.787779136773741,-1.2295099168303296,0.20454545454545456,0.7243075642432506,1.0,2/5,13.20%,UBE2L6;ISG15
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6514446798691531,1.229263834985144,0.19230769230769232,0.764845478019573,1.0,6/16,23.03%,ROBO2;HES1;ENG;PKD2;ROBO1;NF1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7467662125895986,-1.2292634771921014,0.3181818181818182,0.7242504391975989,1.0,4/6,12.42%,CALM1;SRI;CALM3;CAV1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.4678335857415801,-1.2292218347051578,0.1111111111111111,0.7232917389936198,1.0,16/87,9.88%,JUN;PSMB6;PSMD8;CALM1;PSMB4;LAT2;MALT1;PSMA7;PSMC3;PSMD10;LYN;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7666778435940385,-1.2289042472066023,0.22641509433962265,0.7235262580148137,1.0,1/8,0.13%,SOX4
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.39523316167345557,-1.2288665795597107,0.06,0.7225562503982965,1.0,76/461,12.59%,PPIF;SOX4;UBB;GSTP1;JUN;TAF9B;PTMA;UTP11;NCSTN;PRDX5;ASCL1;PPT1;RPL10;APEX1;CFL1;RPS27A;CALR;BAD;ATF4;FGD3;UBC;TMBIM6;SAP18;PLEKHG5;PNMA1;MT3;PPIA;TRIM35;ZNF830;MALT1;ARL6IP5;PAX8;API5;SFRP1;IFI6;APH1A;BAG3;PHB2;NOL3;OPN3;UBA52;ANXA5;PA2G4;IFIT2;DNAJA1;MCF2;PDCD5;PHLDA1;IRF3;SMPD1;WNT5A;PSMD10;SIGMAR1;FIGNL1;NGF;AIFM1;PHLDA3;STPG1;HAX1;RPS3A;CD44;CLU;SPHK2;SOX8;PRELID1;GAS1;CLIP3;NPM1;SPTLC1;WDR73;DSTYK;MTCH1;IKBKB;CASP9;BMP2;HS1BP3
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5979440959591397,-1.2287490833739292,0.225,0.7219543021024744,1.0,1/19,1.86%,RPS23
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6961079528710821,-1.2286361958034058,0.28205128205128205,0.7212022088043184,1.0,4/9,24.11%,ARFIP2;CORO1B;WHAMM;ARF1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.7104526643351248,1.228546415145332,0.2545454545454545,0.7663093071092918,1.0,5/12,11.57%,PRKAR1B;AKAP5;PRKAR2A;AKAP12;ADGRV1
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.7159877292590574,-1.2280429448570342,0.28888888888888886,0.7222576467087611,1.0,2/8,11.34%,ZFP36L1;PRELID1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.6071685966786167,-1.2277838278937527,0.2127659574468085,0.722249590126576,1.0,3/19,8.06%,NOX4;TXN2;ADO
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.5768843189102201,1.2271210868008284,0.15217391304347827,0.7711825033191594,1.0,7/33,4.74%,PON1;CYP2E1;HSD11B1;SORD;LRP2;SLC13A3;SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6647335674465641,-1.226561495191395,0.21621621621621623,0.7253725967883637,1.0,4/15,7.11%,NOP10;NHP2;CCT5;CCT3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.6566485791502309,-1.2263311331290379,0.25,0.7252240382854362,1.0,3/11,17.33%,CHAMP1;SPDL1;BUB3
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.6625933636597012,-1.2260411324108453,0.20833333333333334,0.724970348673953,1.0,5/13,11.25%,SOX4;ASCL1;EDNRB;FN1;SOX8
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6436540628372361,1.225727072387055,0.2127659574468085,0.7761491304829699,1.0,6/10,31.50%,AKR1C3;AKR1C1;BCO1;RDH11;CYP1B1;ALDH8A1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5858483169791024,-1.2255788646298578,0.2222222222222222,0.7254251811677583,1.0,1/19,0.83%,HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.6965041718263587,1.2254717644531152,0.21739130434782608,0.7758631070916152,1.0,2/9,16.99%,RYR2;KCNQ1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7005094505707827,-1.2242747839956403,0.23529411764705882,0.7293371763382098,1.0,5/10,11.77%,RAN;RPS15;LTV1;LSG1;NPM1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.6067108916148213,1.2239246969507827,0.12727272727272726,0.7807910226821386,1.0,3/21,4.33%,FAM107A;NEDD9;BAIAP2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6124728426405303,-1.2237006657206664,0.18,0.7308503300450887,1.0,7/17,20.58%,EIF5;EIF3D;EIF4H;DHX29;EIF4A2;EIF4B;DENR
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.6370420172626362,-1.2236944811788364,0.1509433962264151,0.7297802709967065,1.0,4/20,12.58%,ATF4;MT3;CREB3;BMP2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.5622036792632176,1.223630917525415,0.2,0.7806844340791097,1.0,4/24,2.44%,SYNJ2;SYT1;WNT7A;RAB3A
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.710002413737589,-1.2232465493796076,0.2,0.7301954696046479,1.0,4/10,15.71%,MRPL44;SMAD3;DGCR8;HNRNPA2B1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.6047929168455958,-1.2229049203525597,0.2653061224489796,0.7302506765267343,1.0,3/17,9.99%,USP51;ATXN7L3;ENY2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7477556783667403,-1.2226150164248755,0.28,0.7302758677936063,1.0,6/8,18.79%,ERN1;FICD;RACK1;HSPA5;BAX;COPS5
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.8248643319484699,1.2225024356466858,0.2222222222222222,0.7840116070566684,1.0,3/5,14.90%,PLEKHM1;PRKCA;SPP1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.4630593277474191,1.2223815270974525,0.12727272727272726,0.7833289340448095,1.0,18/74,12.72%,AHR;GLRA1;GLRA2;SOX9;HCN3;HCN1;NSMF;RYR3;SLC38A9;GABRB1;GABRG2;RPTOR;BRCA1;CPEB3;P2RY12;DMTN;RAP1B;TAF1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.6704437431420969,-1.2223757675441402,0.24444444444444444,0.7299432507779039,1.0,1/10,0.13%,SOX4
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7303569573049009,1.222289686087433,0.26,0.7812311836914401,1.0,3/8,16.47%,SLC24A2;SLC8A1;SLC8A2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7303569573049009,1.222289686087433,0.26,0.7812311836914401,1.0,3/8,16.47%,SLC24A2;SLC8A1;SLC8A2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.7182895399431672,-1.2222535988064434,0.2982456140350877,0.7292543856901618,1.0,1/5,3.87%,CAP1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6076603128013474,1.222047480283701,0.2222222222222222,0.7808634746792944,1.0,7/18,18.06%,SRPX2;MAP2K5;HDAC7;RHOJ;AKT3;JCAD;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.5132323078423128,1.221976392592751,0.2,0.7798984854917353,1.0,9/63,8.30%,DOCK5;SOX9;GPI;ENPP2;FOXP1;PRKCA;SASH1;BCAS3;PROX1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6298309172542768,-1.221596257776069,0.2608695652173913,0.7305739381791923,1.0,6/16,15.46%,GORASP1;RPS7;RPL23;RPL11;RPL5;UBE2S
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7737591189077198,-1.221440532688265,0.2033898305084746,0.7300048822875453,1.0,2/6,16.62%,NPM1;AKT1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.7273836495663748,1.2213658077498648,0.32075471698113206,0.7808668952780011,1.0,1/8,1.80%,HDAC4
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.773770700651961,1.2208477056105695,0.2857142857142857,0.7818475705001016,1.0,2/5,19.35%,NOS1;SLC39A8
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.7343875535013948,1.220681846528702,0.23214285714285715,0.7812521082897954,1.0,3/8,21.79%,SMC5;XRCC3;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.6239376620526834,1.2205539079722956,0.17647058823529413,0.7805060167405069,1.0,7/19,18.90%,DND1;THRAP3;TENT5A;MEIOC;NBAS;TAF15;LARP1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.46106608819977135,-1.2204921157445883,0.1282051282051282,0.7323865217826669,1.0,16/96,5.50%,SSPN;BGN;NOX4;MMP2;PODN;FBLN5;THY1;PRRX1;FBLN2;FIBIN;PDGFD;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.5997667271878414,1.2204003785650777,0.2222222222222222,0.7798688242793719,1.0,5/20,9.63%,SLC6A15;SLC6A17;SLC6A6;SLC1A4;SLC6A7
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.8279388269109503,-1.2201809821596692,0.16326530612244897,0.7326599728400339,1.0,1/5,4.39%,MSRB2
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6859648838363493,1.22000205248617,0.24489795918367346,0.7807689446099575,1.0,2/9,8.32%,KIAA0319;NUP93
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5116672781457262,1.2199627397733186,0.14545454545454545,0.779662814310091,1.0,21/61,21.19%,CALB1;ALDH1L1;MACC1;NEBL;MAP7;TMEM213;PDZD2;KLHL3;RSPH3;ACOT11;SLC8A1;LPP;GDA;ATP10B;CPEB4;PPARGC1A;TRHDE;TSC22D2;SLC16A7;COBL;CACNA1D
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.5665020919056794,-1.219519556219254,0.16666666666666666,0.733701016342337,1.0,5/26,9.31%,GSTP1;PANX1;MALT1;WNT5A;NLRP1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5891221945326062,1.2191868999951216,0.20930232558139536,0.7815454833521686,1.0,5/24,6.06%,EPHA7;SEMA3A;SEMA4B;SLIT3;UNC5C
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.729647970867991,-1.219058123268328,0.275,0.7343406672177686,1.0,1/5,10.73%,ACHE
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6437450373052119,-1.218571537384925,0.17307692307692307,0.7350816157017819,1.0,4/20,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.7627434131998571,-1.218522736780194,0.2978723404255319,0.7341578798535725,1.0,1/5,8.17%,CACTIN
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7686878343361403,1.2180652658214246,0.25,0.7847538254161494,1.0,3/6,21.76%,UHRF2;UHRF1;ZNF445
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.8276255310488398,1.2179569007944548,0.21052631578947367,0.7840394551934621,1.0,2/5,12.77%,CDKN2A;PIK3CD
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.6913011148477521,-1.2178698062857845,0.28888888888888886,0.7355580940723584,1.0,6/10,18.01%,ADRM1;PSMD10;PSMD4;POMP;PSMG1;PSMD11
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8011239627432416,-1.2176471807656641,0.16363636363636364,0.735311175534869,1.0,1/7,0.83%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.6654744232537819,-1.2175759099142345,0.21153846153846154,0.7345522228607548,1.0,5/15,14.84%,THY1;DUSP3;PRELID1;FGL1;PRKCQ
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.765391927076559,-1.217559783969679,0.32075471698113206,0.7335174913464058,1.0,3/5,22.75%,GALE;GALK1;PGM2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6910477572858498,1.217444938271129,0.2,0.7850317820038764,1.0,3/11,3.66%,PTPRC;WNT7A;TCOF1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.7276306543920508,-1.2173615887967608,0.1794871794871795,0.7333329722520038,1.0,5/8,13.18%,DERL2;UBE2J1;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.5355912868796607,-1.2172891276133548,0.11320754716981132,0.7324633839066269,1.0,11/45,15.29%,BANF1;PPIA;TRIM35;LARP7;SHFL;IFITM3;ISG20;ISG15;IFIT5;IFIT1;SRPK1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5431279297238267,-1.216286486282669,0.16981132075471697,0.7352087309171115,1.0,12/32,18.15%,ZFP36L1;JMJD6;PTCD2;LARP7;C9ORF78;RBM23;SRSF10;SRPK1;SF1;SRSF3;RBM39;CWC22
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6734253623215627,1.216091257167707,0.22807017543859648,0.7891536888221684,1.0,1/12,3.77%,RAB10
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.6291532030161457,1.216030409601257,0.24528301886792453,0.7880448693493586,1.0,3/10,12.68%,ADGRB3;KCNH1;NOS1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.6412125977248521,1.2159149965418843,0.24489795918367346,0.7872547606805936,1.0,4/19,10.96%,FMO5;PON3;TG;KNG1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7768231573255793,-1.2158912899159287,0.2608695652173913,0.735837154202587,1.0,3/5,21.93%,MST1;PGP;CLK2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6698012490857865,-1.2155757530308848,0.2222222222222222,0.7357520670985914,1.0,3/10,11.74%,PODXL2;ITGA4;MADCAM1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.4514037821351362,-1.2154009390732274,0.1111111111111111,0.735377131436351,1.0,20/109,9.88%,PSMB6;PSMD8;ODC1;PSMB4;SQLE;TM7SF2;LDLR;PSMA7;SC5D;IDI1;PMVK;EDF1;PSMC3;PSMD10;PSME3;PSMD12;HMGCS1;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.7510937592119943,-1.2152261738193961,0.3392857142857143,0.7347280610892615,1.0,4/6,19.60%,TSPO;FDX1;STARD3;STARD3NL
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7507891934286621,1.2151951785224675,0.19607843137254902,0.7889106839257605,1.0,2/7,4.45%,AKT2;PLIN5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.48858382066684514,-1.2151331427252843,0.17307692307692307,0.7340518972606201,1.0,15/74,13.07%,UBB;PMEPA1;RPS27A;VEPH1;UBC;BAMBI;UBA52;STUB1;GIPC1;HSP90AB1;SPRY1;CDKN1C;CAV1;SLC2A10;SMAD3
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.43981497683088755,-1.2149998437576215,0.06818181818181818,0.7334642994468676,1.0,16/102,6.26%,BGN;MMP2;PODN;HSPG2;THY1;PRRX1;CSTB;FIBIN;AMOTL2;COL12A1;TNS2;THBS2;PDGFRA;CXCL12;SMARCA5;PDE3A
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.703541508478848,-1.2145585784837603,0.2,0.7339023731198692,1.0,5/9,13.18%,DERL2;UBE2J1;OS9;YOD1;ERLEC1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5294196182440286,-1.213936139839249,0.19047619047619047,0.7348721062539998,1.0,8/44,13.95%,CUL7;YIF1A;HDGF;ERN1;TLN1;ATP6V0D1;FKBP14;EXTL1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.5100234653220717,-1.2136471148123171,0.17073170731707318,0.73484674008953,1.0,2/48,0.47%,CCND1;CDKN2C
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.47564650639596295,-1.2134908331317085,0.13043478260869565,0.7343762206081164,1.0,15/68,9.88%,PSMB6;VANGL1;PSMD8;PSMB4;PRICKLE1;PSMA7;SAPCD2;PSMC3;WNT5A;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.6547160336780515,1.2133487570159374,0.25,0.7948425275564837,1.0,5/11,21.67%,PROX1;NRG1;PIEZO1;MAML1;EFNB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.503391418461629,-1.2133398215893099,0.15384615384615385,0.733792283390612,1.0,11/49,9.95%,GPX1;BAD;BEX3;MT3;MALT1;ARL6IP5;IFI6;DELE1;PDCD5;NGF;CD44
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7401314816841204,1.2130817535969423,0.22033898305084745,0.794523908988737,1.0,5/11,19.61%,TAFA5;PRKG1;TPM1;PPARG;PDCD4
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.653732654569069,-1.212907723751999,0.2127659574468085,0.7343557320468853,1.0,4/13,12.42%,CSTB;CST3;FURIN;CAV1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.73039305779609,-1.2127408392530017,0.25,0.7338735678778606,1.0,3/5,16.89%,ARL6IP5;PRELID1;BAX
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6628166578914807,1.212635560570772,0.2631578947368421,0.7950867084184172,1.0,5/8,28.60%,CAMK2D;NOS1;SESTD1;CACNB2;BIN1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.6535143079116407,1.2125585940256662,0.2127659574468085,0.7942173871565434,1.0,1/10,0.28%,PTPRC
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.7641505113290177,-1.2124717783899728,0.2553191489361702,0.732556717136751,1.0,3/5,20.52%,KMT5B;BEND3;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.7641505113290177,-1.2124717783899728,0.2553191489361702,0.732556717136751,1.0,3/5,20.52%,KMT5B;BEND3;SMYD5
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.5838066708776941,1.2122122775778181,0.14035087719298245,0.7942731092628819,1.0,2/25,1.79%,GLRA1;RACGAP1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7200963967710294,-1.2119384086189815,0.23076923076923078,0.7331187496200462,1.0,2/7,14.46%,DYNLT1;IFIT1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.45351902457043347,-1.2115416541949826,0.11428571428571428,0.7337361106954238,1.0,16/94,6.74%,BGN;MMP2;PODN;FBLN5;MT2A;FIBIN;TSPO;RARRES2;IGFBP7;SYAP1;TNS2;THBS2;PDGFRA;CXCL12;EPSTI1;TRIP10
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.49956282646417394,-1.2114982102369363,0.25,0.7328888788550659,1.0,6/60,5.67%,POLR2L;POLR2J;NUP42;POLR2I;POLR2G;WTIP
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7473274200146588,1.211232747076174,0.2037037037037037,0.7972550500177641,1.0,3/7,17.89%,NR4A3;SGIP1;STAT3
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4841664395260351,-1.2106178901675078,0.22727272727272727,0.7352068142885989,1.0,17/69,14.12%,ZDHHC1;VPS37B;SRP14;NACA;ICMT;ZDHHC6;GOLGA7;ZDHHC4;SSR2;YIF1B;ATAD1;MICALL1;GET3;ACBD5;ZDHHC22;FIS1;SEC62
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5260084473255483,1.2104858566857817,0.22448979591836735,0.799100692146101,1.0,7/36,6.68%,SYT1;NEDD4L;SHTN1;RNF157;MACF1;CPNE5;LIMK1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7704976091206239,1.2103626144209871,0.24528301886792453,0.79827498694564,1.0,4/5,22.95%,PLA2G15;GPAM;MOGAT1;PNPLA2
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.6333126932552091,1.2102795552676062,0.2727272727272727,0.7973186940186484,1.0,2/13,6.47%,HEY2;TGFBR3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.5643032516917839,1.209423064592441,0.16666666666666666,0.799362586135816,1.0,4/29,5.24%,AHR;AKR1C2;KLF9;ADCY5
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5718541376349313,-1.2094140113297047,0.2127659574468085,0.7382548362997094,1.0,5/25,12.83%,CALR;CANX;HLA-B;SAR1B;B2M
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.6884348222310582,1.2091754540670123,0.32608695652173914,0.7990709605917071,1.0,2/8,10.29%,HES1;BMP7
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5792365633167642,1.2091061391817512,0.2978723404255319,0.7982355537636637,1.0,4/19,5.86%,TTLL6;TTLL4;AGBL4;TTLL5
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.5740054662289792,-1.2090445780460057,0.2558139534883721,0.7386212466860526,1.0,5/23,11.74%,THY1;AGRN;PTN;ITGA4;MADCAM1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4866033416212739,-1.2088293515498014,0.23529411764705882,0.7383086768848615,1.0,8/36,18.44%,STOX1;WDR18;KPNA2;PIF1;SMG5;SUB1;KPNA1;UBE2N
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.45778689097367053,1.2087559060999749,0.1320754716981132,0.7983433567554541,1.0,16/101,9.28%,ROBO2;SYNJ2;GRIN2A;ADGRL2;EPHA7;SLC6A17;MDGA1;MEIS2;RELN;B3GNT5;GRIN1;ARNT2;PROX1;SHANK3;CNTNAP2;ATXN1
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.6075623060210492,-1.2086294281652716,0.24489795918367346,0.7379546534351209,1.0,3/15,5.69%,S100B;H2AZ1;ASPM
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.6563055311286775,-1.2085732158249303,0.20454545454545456,0.7370381836775969,1.0,3/12,15.01%,RPL23;SET;SMARCD1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.7138131404255281,1.208555810772738,0.26785714285714285,0.7980105462365711,1.0,3/10,12.11%,TESPA1;RAB29;CARD11
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.7217986821912271,1.2084638984466904,0.2786885245901639,0.7970485977851419,1.0,3/5,15.66%,ABHD12B;ABHD12;ABHD6
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5866059638959207,1.208062424540984,0.24528301886792453,0.7974357088238619,1.0,3/21,9.16%,PTPRC;OCIAD2;HES1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.6874130574612757,-1.2078231913855915,0.28888888888888886,0.7377974098371334,1.0,1/10,2.73%,BLOC1S4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.6874130574612757,-1.2078231913855915,0.28888888888888886,0.7377974098371334,1.0,1/10,2.73%,BLOC1S4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7156709158914802,-1.2077877128832344,0.2826086956521739,0.735946913440585,1.0,4/8,20.22%,SLC25A33;BCS1L;UQCC3;UQCRFS1
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7156709158914802,-1.2077877128832344,0.2826086956521739,0.735946913440585,1.0,4/8,20.22%,SLC25A33;BCS1L;UQCC3;UQCRFS1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.7632272506362774,1.2076211246888462,0.17391304347826086,0.7955893242871805,1.0,1/5,15.70%,MAN1A1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.7632272506362774,1.2076211246888462,0.17391304347826086,0.7955893242871805,1.0,1/5,15.70%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.7632272506362774,1.2076211246888462,0.17391304347826086,0.7955893242871805,1.0,1/5,15.70%,MAN1A1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.5761545688731982,-1.2072915451913382,0.16363636363636364,0.7365363009373539,1.0,4/20,9.31%,PANX1;MALT1;WNT5A;NLRP1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.638538983549702,1.207257627065749,0.24528301886792453,0.7958017591837774,1.0,10/15,30.49%,SYNGR2;SNAP25;STX1A;SYP;STX1B;SNAP47;SNAP23;AP3D1;STX3;STX4
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.7580310236901671,-1.2069130583450274,0.24489795918367346,0.7367049740282742,1.0,1/7,3.29%,NT5E
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7180796851992246,-1.2067121956574096,0.3111111111111111,0.736398847552517,1.0,2/5,21.05%,CTDP1;RPRD1B
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.48971168205294024,-1.2066858390552282,0.21568627450980393,0.7355084019130328,1.0,5/45,9.26%,SOX4;CCND1;E2F4;PCBP4;RFWD3
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.7533284189046641,-1.2066684254432438,0.29310344827586204,0.7345647229040012,1.0,2/5,14.24%,PRNP;RC3H1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7247296044875013,-1.2064239509365335,0.23404255319148937,0.7344711623343477,1.0,4/8,18.78%,WNT5A;TNFRSF14;SPHK2;TRIL
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.6203030345988977,-1.2063099746392592,0.19607843137254902,0.7339338374164731,1.0,3/16,7.95%,THY1;CALM1;CALM3
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6145154405567997,-1.2059072170849927,0.2826086956521739,0.7344510822196891,1.0,5/19,9.59%,CIAO2B;ISCA1;ISCU;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.802884971541183,-1.2058461867656536,0.30612244897959184,0.733638475509411,1.0,4/6,16.45%,ISCU;PRELID1;PARK7;VCP
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5418546744044344,1.2052832859634042,0.2222222222222222,0.8024911216878019,1.0,11/52,16.48%,FHDC1;SORBS1;CDC42BPB;TTN;TMOD3;PHACTR1;CIT;TPM1;ARRB1;MYOM2;TJP1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.5033942885674357,1.205006424059856,0.13793103448275862,0.8023446351290664,1.0,9/55,9.66%,EFHC1;DNAH6;MAP3K19;DNAH7;NME9;GFAP;CFAP221;SAXO2;AQP4
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7735260322069353,1.2048135966291964,0.2542372881355932,0.8019813729807826,1.0,3/5,13.40%,THRAP3;RORA;FBXW11
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.6435682714123556,-1.2046893427994685,0.25925925925925924,0.736559295484507,1.0,4/18,6.31%,UBB;RPS27A;UBC;UBA52
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.7523163343795636,-1.204658093926363,0.28846153846153844,0.7356494325214533,1.0,6/7,22.82%,SEC61G;SEC61B;SEC62;HSPA5;SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6421482507262751,1.2042532228119363,0.26785714285714285,0.803267536711747,1.0,7/10,30.49%,SNAP25;STX1A;STX1B;SNAP47;SNAP23;STX3;STX4
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.48354189272636855,1.2040926901688649,0.16326530612244897,0.8027884815917457,1.0,10/60,11.04%,PON1;AHR;CYP2E1;HSD11B1;PON3;ZHX2;SLBP;PROX1;KNG1;TMEM97
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.5549255730345869,1.203706555289439,0.2127659574468085,0.803276749666414,1.0,7/22,9.16%,HEY2;ROBO2;ZFPM2;SLIT3;TGFBR3;PROX1;HES1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.48903261674296084,-1.2027932565340278,0.16666666666666666,0.7412472096328157,1.0,8/56,6.23%,TUBB2B;SALL2;RND2;IGFBPL1;SEMA5B;FBN3;CXCL12;LINGO1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.7213443323469964,-1.2026343528595176,0.26,0.7407739286884505,1.0,1/6,0.13%,SOX4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.715951786539181,-1.2025665714019476,0.26666666666666666,0.7400270145971856,1.0,4/8,9.58%,ROMO1;TIMM8B;TIMM13;TIMM22
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4392915246332339,-1.202476571441924,0.1568627450980392,0.7393781902752206,1.0,31/163,11.42%,SSPN;CDKN2C;UQCR10;GPX4;CD151;PLIN2;IDH1;NDUFB7;ARL4A;MRPL15;UBC;UQCRQ;CRAT;JAGN1;CHCHD10;UQCRC1;VEGFB;GBE1;PPP1R15B;DHRS7;NDUFS3;AIFM1;ACLY;NDUFA5;DLD;SCARB1;NDUFAB1;ADCY6;SLC25A1;ACOX1;CYC1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.5297020644015311,-1.2024180202731498,0.18181818181818182,0.7386214360283725,1.0,12/35,17.20%,SQLE;TM7SF2;SC5D;MSMO1;ARV1;SOAT1;PMVK;LCAT;DHCR7;LBR;FDX1;STARD3
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5728183368234969,-1.2024093491554533,0.21739130434782608,0.7376750443872241,1.0,6/24,18.14%,CENPX;SMARCA5;NPM1;CENPQ;HIRA;H3-3A
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7776198476842343,-1.202383326373967,0.3541666666666667,0.7357898322380564,1.0,2/5,13.45%,GINS3;MCM4
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7776198476842343,-1.202383326373967,0.3541666666666667,0.7357898322380564,1.0,2/5,13.45%,GINS3;MCM4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5265290594736601,-1.2023455988889444,0.14634146341463414,0.7348782623070899,1.0,13/40,21.16%,HSD17B10;ALOX5;ACSM5;ACLY;OXSM;NDUFAB1;PARK7;GAMT;ALDH1A2;ACOT8;OSBPL2;GATM;ACMSD
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6653732981555952,-1.2023156866195082,0.22641509433962265,0.7340780546665404,1.0,4/16,3.88%,MT1E;MT2A;SLC30A10;MT3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5871673298026202,-1.202234697597247,0.24444444444444444,0.7334431622571709,1.0,3/15,8.37%,ARL6IP5;SEMA4C;LYN
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6871216684379013,1.2020520497229759,0.21153846153846154,0.8088307377775836,1.0,7/13,26.86%,PLIN5;FTO;NFKB1;FBXW7;NFKBIA;ITGAV;MEST
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.7294222083899957,-1.2017544785564644,0.30434782608695654,0.7343582013410297,1.0,3/6,8.26%,SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7289262473500365,1.2013342491435637,0.34,0.8103436240710237,1.0,1/6,4.31%,SPIRE1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7438417321729361,-1.2011578689600058,0.3469387755102041,0.7354607002941104,1.0,3/7,12.92%,SCARB1;CLU;LCAT
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.7399704607830229,-1.201004112117698,0.3137254901960784,0.7349619502918375,1.0,1/5,3.88%,NLGN2
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7191947383923665,1.2005955418767995,0.3269230769230769,0.8119381855859589,1.0,2/7,15.96%,AGO1;AGO4
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7495834856703758,-1.2004001609528216,0.2765957446808511,0.736060738879189,1.0,3/8,20.68%,DUSP3;FRMD5;PIN1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.46586109549725985,1.2003547137294364,0.21818181818181817,0.8115072570920707,1.0,15/76,10.77%,FOXO1;TBC1D4;SLC39A14;AKT2;SORBS1;NR4A3;RAB10;KAT2B;PRKAR1B;ADCY5;RAB8B;PRKAR2A;C2CD5;ADCY3;PDPK1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.7543732010541904,1.2000330085286917,0.27419354838709675,0.8103062176149134,1.0,1/6,7.53%,DNM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.7543732010541904,1.2000330085286917,0.27419354838709675,0.8103062176149134,1.0,1/6,7.53%,DNM1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.7284780087341668,-1.2000059468705033,0.23529411764705882,0.736400099109158,1.0,2/7,15.85%,PPP1R15B;HSPA5
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.40940405726803225,-1.1999793813868638,0.057692307692307696,0.7354973332527326,1.0,44/234,12.06%,UBB;COL9A3;MAP7D3;FBLN5;NCSTN;RHOC;HSPG2;CD151;CCDC88C;RPS27A;MARCKS;COL8A1;RND2;MARCKSL1;PPIB;UBC;COL12A1;SNCAIP;RHOG;CAMSAP3;UBE2L6;ITM2B;APH1A;MYO1D;MAP10;UBA52;COL9A2;TUBGCP4;FIGNL1;COL4A4;ZBED3;MFGE8;HSP90AB1;KIF18B;CGNL1;ADAMTS2;CST3;LTBP3;FURIN;CLIP3;RHOBTB1;ADAMTS3;WDR73;CORO1B
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7271715207063241,1.1999462185782652,0.3076923076923077,0.809380135246534,1.0,3/10,9.13%,CAMK2B;SHANK3;DLG4
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6836234988294387,1.1998219797721985,0.19298245614035087,0.8086562310526858,1.0,5/12,15.59%,CD160;PVR;ARRB2;CADM1;KLRD1
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),0.7876308755157179,1.1997599988948615,0.23529411764705882,0.8078632957715501,1.0,1/5,2.40%,HSD11B1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6892732669866022,-1.1997569633093967,0.2033898305084746,0.7341295174469318,1.0,1/7,1.92%,ATF4
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6892732669866022,-1.1997569633093967,0.2033898305084746,0.7341295174469318,1.0,1/7,1.92%,ATF4
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6158779569471652,1.1997254030936395,0.2631578947368421,0.8068453531378402,1.0,1/10,0.86%,BCL2L11
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.4397300429133842,1.1997134507473906,0.12,0.8056885012944919,1.0,32/139,16.68%,AHR;FOXO1;BCL2L11;EFNA5;EGLN3;TNFRSF19;DAPK1;BRAT1;DAPK2;AHCYL1;GADD45A;HIP1;RNF152;ARHGEF6;ZBTB16;RIPK1;SEPTIN4;YARS1;CIT;SCN2A;TRAF7;BCL2L13;STK3;STK11;CFLAR;PRKCE;MAGEH1;IRF1;DAPK3;OGT;C19ORF12;FEM1B
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.5568303770887058,1.1991627038659114,0.28888888888888886,0.8065748843292406,1.0,6/22,22.80%,ADAMTS9;GADD45A;PPARG;ANGPT2;DAB2IP;APOE
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.7697806695440729,1.1986709571654024,0.2653061224489796,0.8074021204778056,1.0,1/5,2.61%,SLCO1A2
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.7426171111663461,-1.197976810854307,0.30952380952380953,0.7391193633921297,1.0,1/5,1.09%,ASCL1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.6169956903085779,1.1979038877924657,0.125,0.8093145833231294,1.0,4/23,5.97%,CARD14;RPS6KB2;SYNGR2;TMEM79
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.7063032158092815,1.1978681316299333,0.29411764705882354,0.8083583090269381,1.0,2/8,10.35%,VRK1;STX5
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.5194870234439485,-1.197821235992747,0.21739130434782608,0.7386069730544721,1.0,10/49,13.65%,UBB;RPS27A;UBC;S100A1;TLR1;UBA52;CNPY3;IKBKB;CTSL;CTSK
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.6804477683571333,-1.197755534900465,0.2765957446808511,0.7378412603178127,1.0,4/7,16.19%,STUB1;DNAJB12;CLU;DNAJC18
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.7719895091419722,1.1973150987966281,0.3225806451612903,0.8097145989558321,1.0,2/6,9.16%,RYR2;HES1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.653778152318388,-1.1972040021932717,0.24,0.7386169203254216,1.0,2/15,3.84%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6439674406544462,1.1968195199055627,0.26666666666666666,0.8107716433101285,1.0,2/17,6.47%,BCL9;TGFBR3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6607429998487995,1.1967871904046832,0.2127659574468085,0.8097893099575578,1.0,2/12,6.47%,ZFPM2;TGFBR3
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.7109481544212055,1.1966181763917059,0.19642857142857142,0.8094268327338562,1.0,3/7,15.66%,ABHD12B;ABHD12;ABHD6
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5184223663204681,1.1965370068630397,0.22807017543859648,0.8086452895535964,1.0,9/37,18.82%,IL5;PIP4K2C;CCP110;PIP4K2A;ASAP1;BBS4;ARHGAP35;STX18;TAPT1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.6293961491169194,1.1961908583155358,0.18181818181818182,0.8076614046430565,1.0,5/14,12.18%,FAM107A;DUSP22;PHLDB2;BCAS3;DMTN
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.6293961491169194,1.1961908583155358,0.18181818181818182,0.8076614046430565,1.0,5/14,12.18%,FAM107A;DUSP22;PHLDB2;BCAS3;DMTN
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.5871190101597313,-1.1954666825589844,0.16666666666666666,0.7433074842301649,1.0,3/24,2.15%,CALR;RAN;NUP42
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),0.7021231297170198,1.1953901040130652,0.22916666666666666,0.8098835892343531,1.0,2/7,12.72%,TMSB4X;TAF1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6625590446966915,1.1952275257156815,0.2978723404255319,0.8094400172932964,1.0,1/9,0.75%,ITPR1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.45544652399048025,-1.1949833877833707,0.1590909090909091,0.7440739948975814,1.0,8/85,6.69%,SOX4;PIWIL2;PCIF1;BRPF3;EEF2;NPM2;FXR2;EIF3D
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.7337741408153965,1.1949043986475134,0.3137254901960784,0.809790228892666,1.0,3/6,17.59%,SOX9;SULF1;EIF2AK3
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6948555817952963,1.194898403223528,0.2549019607843137,0.8086677269569401,1.0,1/8,1.31%,NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5603679203054446,1.1945591092410932,0.23076923076923078,0.8090457693836562,1.0,7/24,24.92%,PAK1;CAV3;NAV3;TOGARAM1;CLASP1;MAPT;ANKRD53
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.721853776833786,1.1944351975277505,0.21568627450980393,0.8084812940572984,1.0,3/8,16.99%,RYR2;TPM1;KCNQ1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.7998745538567172,1.1943939303898823,0.2833333333333333,0.8064735625224144,1.0,2/5,9.08%,SHANK3;CNTNAP2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.7998745538567172,1.1943939303898823,0.2833333333333333,0.8064735625224144,1.0,2/5,9.08%,SHANK3;CNTNAP2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5824517756093707,-1.1943600632568478,0.18518518518518517,0.745198515167484,1.0,3/19,5.46%,LOC400499;SFRP1;H2AZ1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.6872307069368961,1.1941060726037487,0.2765957446808511,0.8064251939047467,1.0,2/11,4.79%,ASPA;DDO
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.6872384722692066,1.193838127568508,0.20689655172413793,0.8065421632224102,1.0,2/10,6.26%,INPP5A;NFATC3
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.541562475222283,-1.1938068531793984,0.19298245614035087,0.7460138380572591,1.0,4/27,7.67%,S100A10;BTC;S100A16;PDLIM3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6486054694009937,1.1935808293419796,0.18,0.8064663392888404,1.0,1/10,1.69%,SOX9
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.5171012939867102,-1.1935679607362242,0.16666666666666666,0.7458429236818432,1.0,8/38,8.19%,SIRT2;ROMO1;MT3;ALOX5;DHRS4;CBR1;DCXR;SLC25A33
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.60670663320927,1.1935560542457389,0.23529411764705882,0.805429758800367,1.0,4/21,5.05%,PTPRC;MERTK;CAMK1D;PTPRJ
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.7086873353411578,-1.1933878597079692,0.30434782608695654,0.7445606466489966,1.0,2/8,8.30%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.7086873353411578,-1.1933878597079692,0.30434782608695654,0.7445606466489966,1.0,2/8,8.30%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5938693941892439,1.1931268963242734,0.2,0.8060000251986604,1.0,6/16,28.81%,SLC4A4;KCND3;KCNQ1;KCNA5;ATP1B1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6561026207493577,1.1928587177658856,0.25,0.8057473132817624,1.0,3/10,20.78%,DENND10;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4990877336635717,1.1924408156056197,0.21153846153846154,0.806069470753408,1.0,11/47,15.20%,SYNPO2;BAIAP2;NTRK3;LIMK1;CRACD;BCAS3;PROX1;CDC42EP4;CDC42EP3;VASP;PRKCE
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.551304584323077,1.1924340634372173,0.25862068965517243,0.8049982811745392,1.0,7/32,9.63%,SLC6A15;SLC6A11;SLC6A17;SLC13A3;SLC6A6;SLC1A4;SLC6A7
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.579061522910056,1.1924229747535682,0.25,0.8039709767816818,1.0,7/21,24.27%,NRCAM;STAT5B;SIN3A;NIPBL;APOE;ABL1;INSR
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.5047886000326087,-1.1924073114521747,0.14893617021276595,0.7471742085038384,1.0,7/67,4.56%,COPZ1;BICD2;SURF4;RAB1B;TMED2;TMEM115;KDELR1
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.653361348290632,-1.1923011589918069,0.2727272727272727,0.7466454632382556,1.0,3/11,7.72%,NCSTN;APH1A;APEH
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.8012369609658573,-1.1922442628537044,0.28,0.7448926683801853,1.0,2/5,16.51%,PAF1;CDC73
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.8012369609658573,-1.1922442628537044,0.28,0.7448926683801853,1.0,2/5,16.51%,PAF1;CDC73
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.7062492335370569,1.1921742735092735,0.2549019607843137,0.8038722462852068,1.0,6/11,24.82%,SNTA1;CAV3;ANK2;KCNQ1;CACNA1D;KCNA5
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.7098368170391104,-1.1920307025923162,0.32653061224489793,0.744896065056145,1.0,1/6,4.33%,CAMSAP3
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.4120958209202048,-1.191861286897457,0.14285714285714285,0.7445835610882143,1.0,28/202,9.42%,SOX4;UBB;JUN;UTP11;NCSTN;RPS27A;BAD;ATF4;FGD3;UBC;SAP18;PLEKHG5;PNMA1;TRIM35;ARL6IP5;SFRP1;APH1A;UBA52;IFIT2;DNAJA1;MCF2;PDCD5;PHLDA1;SMPD1;NGF;AIFM1;PHLDA3;STPG1
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.6661214421107311,-1.1916890783298324,0.2608695652173913,0.7441272615066187,1.0,2/11,4.65%,PPIF;PARP1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.5716181362781507,-1.191674307230399,0.3333333333333333,0.7431863806108621,1.0,3/16,3.65%,ASCL1;CALR;HES5
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.6334440912396014,-1.1916704399246199,0.2978723404255319,0.7422347975370965,1.0,2/15,8.27%,CCND1;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6600437029690323,1.191634285783213,0.25,0.8047525931769002,1.0,9/15,27.30%,PAK1;SASH1;MAP3K5;MAP3K11;TRAF6;TRAF2;DAB2IP;DVL2;MAP3K10
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7520608850051023,1.1915206667382174,0.32653061224489793,0.8041643296999357,1.0,4/6,19.44%,CPEB3;CPEB4;CPEB1;CPEB2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.5786129550870902,1.1913502473046154,0.2127659574468085,0.80379460638398,1.0,4/25,9.13%,IGF1R;WNT7A;SHANK3;DLG4
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5586107016968981,1.1911935496050594,0.2549019607843137,0.8031957613013038,1.0,3/23,12.11%,PTPRC;HDAC7;CARD11
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.5249613839504988,1.19099926725522,0.17777777777777778,0.8027472847579697,1.0,6/32,11.72%,GRIN2A;IGF1R;PSEN1;GRIN1;EPHA4;GJA1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7047118724422344,1.1909477272937732,0.2,0.8018410267625341,1.0,2/9,9.59%,VSIR;RFTN1
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.731002554220464,1.190543988476227,0.36363636363636365,0.8021776106409021,1.0,4/5,22.80%,ABCA2;DTX3L;ITCH;APOE
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.4791731739854322,1.1904619954245088,0.22641509433962265,0.8013688777440943,1.0,8/51,10.43%,CDH9;CDH7;PKP2;CDH8;TLN2;PVR;CDH12;CDH20
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.41084667490577437,-1.1902836465136193,0.1276595744680851,0.7456331341835475,1.0,50/277,12.61%,PPIF;UBB;GPX1;GSTP1;TAF9B;PTMA;PRDX5;ASCL1;PPT1;RPL10;CFL1;RPS27A;UBC;BEX3;TMBIM6;SLC30A10;MT3;ZNF830;MALT1;API5;SFRP1;IFI6;BAG3;PHB2;NOL3;OPN3;UBA52;ANXA5;PA2G4;DNAJA1;PTPRZ1;QARS1;WNT5A;PSMD10;SET;FIGNL1;NGF;HAX1;RPS3A;CD44;SOX8;PRELID1;NPM1;WDR73;DSTYK;GRN;IKBKB;CAV1;ZNF304;YAP1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.6083250272910945,1.1901225550395482,0.2641509433962264,0.8014228424845999,1.0,4/16,7.06%,PTPRC;DUSP22;SOCS4;SRCIN1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.6850298064804696,1.1900488119896082,0.3191489361702128,0.8004293982841632,1.0,3/6,22.80%,ABCA2;AGT;APOE
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.6335575107861412,1.190041460187592,0.2608695652173913,0.7993716395748742,1.0,2/15,3.13%,GPI;G6PC2
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.617236590893087,1.1898149160985674,0.28,0.7990398190892067,1.0,2/18,1.69%,AHR;SOX9
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.5372600323799671,-1.1895177995488724,0.15217391304347827,0.7472310889920077,1.0,10/33,16.40%,SIRT2;VBP1;LDLR;EDNRB;HSP90AB1;CLU;PFDN1;PRNP;SNX12;PFDN2
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.7207670002304899,1.1894587886617198,0.3584905660377358,0.7991902738860582,1.0,2/5,9.97%,SHTN1;RHOJ
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.7278101090326174,-1.1888437945062913,0.2558139534883721,0.7484723087167167,1.0,2/8,5.19%,ZFP36L1;SFRP1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.4476073333741549,-1.188733902982207,0.08333333333333333,0.7480406325433935,1.0,13/105,6.96%,S100A6;TUBB2B;FABP7;DLL3;ASCL1;SOX21;INAFM2;RND2;S100B;HES5;SEMA5B;LINGO1;PTPRZ1
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.7329574242746207,1.1887271527584984,0.28888888888888886,0.8008625653775564,1.0,4/6,26.25%,SHANK3;APOE;NLGN1;GPHN
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.509746513129444,1.188622126234262,0.21153846153846154,0.8001033542744094,1.0,13/48,15.96%,MEIS2;NR4A3;KAT2B;SPI1;ZBTB16;RBM15;CDK6;AGO1;KMT2C;CBFB;SIN3A;KMT2A;AGO4
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.7183461062392036,-1.1885209274190638,0.27906976744186046,0.7480139288887174,1.0,1/7,2.85%,NOMO3
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.604042824279797,1.1884918715357708,0.2857142857142857,0.7983916514838385,1.0,3/17,2.43%,IL1RAPL2;WNT7A;MDGA1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.604042824279797,1.1884918715357708,0.2857142857142857,0.7983916514838385,1.0,3/17,2.43%,IL1RAPL2;WNT7A;MDGA1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.7638827626754322,1.1882806617519799,0.3333333333333333,0.7981568309200472,1.0,2/5,16.59%,RAB31;APPL2
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5998673877780523,-1.1877453898176367,0.2,0.7498089230759887,1.0,4/18,13.89%,SIRT2;EDF1;NGF;PARK7
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.6211919294218702,1.1876047113435224,0.1702127659574468,0.7995539301782915,1.0,4/19,14.87%,ATP10A;ATP8B2;ATP8A1;ATP10B
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7331988999041436,1.1875561933195145,0.2982456140350877,0.7987089245754415,1.0,4/7,26.22%,PIK3CD;MYO1C;PRKD2;HSPB1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.6862577913548265,-1.1874285780897984,0.2553191489361702,0.749896999347867,1.0,2/9,6.74%,EXOSC8;DXO
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5494901323565254,1.1874154235885626,0.21951219512195122,0.7981704169047091,1.0,7/26,9.16%,HEY2;ROBO2;ZFPM2;SLIT3;TGFBR3;PROX1;HES1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.4919364259513207,-1.186896955800884,0.17307692307692307,0.7508933585660162,1.0,7/45,10.20%,AURKAIP1;KIF25;PCGF2;CBX5;PPP1R10;CHMP2A;RING1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.7893982958214036,-1.1866150784051637,0.26,0.7509539146940126,1.0,2/6,5.44%,LDLR;PDGFRA
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.6500263202907979,-1.1864427971547027,0.32558139534883723,0.7506129965368433,1.0,4/10,17.17%,PMEPA1;DDX5;RNF14;AR
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6769941866498024,1.186243070377357,0.2777777777777778,0.8009223293015163,1.0,2/10,4.45%,AKT2;PLIN5
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.7026040040292579,1.1861876899125783,0.22,0.8000393254779818,1.0,1/7,5.55%,WRN
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.46551020675684296,1.1861687825720562,0.1956521739130435,0.7990269708147422,1.0,23/71,18.41%,SHISA6;TNFRSF19;NEBL;PRIMA1;AHCYL2;PARM1;TMEM132C;ADCY5;SH3BGRL2;CDS1;SHC2;RAI2;BMP7;NDRG2;PDE9A;ITGA9;PBX1;B4GALNT3;ARHGAP32;SPARCL1;KCNQ1;ANK3;SLC44A3
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5237379708262865,-1.1861442636807735,0.2,0.7505444587527295,1.0,8/38,11.23%,SYT11;TLR1;SELENOS;MAPK13;WNT5A;HLA-B;AFAP1L2;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.6061927835806045,-1.1852202262444351,0.21428571428571427,0.7524776388905805,1.0,2/23,6.11%,CCND1;PHB2
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.5296159130815686,-1.1848729663236948,0.20408163265306123,0.7526003792871484,1.0,10/36,9.13%,SIRT2;CALM1;ACTB;S100A1;CNP;COX6B1;YWHAQ;CALM3;NDUFS3;ATP5PB
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.7194051422080202,1.1847539837308536,0.24561403508771928,0.802687494279999,1.0,3/8,9.82%,PIP4K2C;WASHC1;PIP4K2A
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7707855346901232,-1.1843926460433,0.2608695652173913,0.7534956533795575,1.0,3/6,8.26%,SAT1;SAT2;SRM
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.670368967847073,-1.1841026409580502,0.2641509433962264,0.75347529668283,1.0,3/8,11.23%,KDSR;SGPP1;SPHK2
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.6495825907485759,1.1839999981919245,0.30612244897959184,0.8043018374053229,1.0,4/10,22.99%,FOXP1;DMTN;ABCB10;ALAS1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.4078811624496157,-1.1839948348397986,0.06818181818181818,0.7528511169760904,1.0,41/259,11.77%,COPZ1;IPO13;CALR;RANGRF;RAN;ARL4A;PTTG1IP;NUP42;SNX17;VPS28;SURF4;RAB1B;TMED2;AP4M1;RABL3;CAMSAP3;PRICKLE1;ARFIP2;SYNDIG1;BAG3;VPS35;PHB2;ERP29;SCG5;ARL1;CDC37;TMED9;BCS1L;RPL11;PPP1R10;RAB14;GIPC1;RAB5B;SLU7;STX6;COX18;NUP155;VPS26B;CLIP3;TBC1D25;NPM1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.49655767319922595,1.1839078764451494,0.25,0.8034846385113784,1.0,11/60,16.59%,AHR;CD160;FOXP1;PVR;TIRAP;CD247;BCL6;KLRD1;IRF1;TRAF3;APPL2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6766706673142405,1.183406613449947,0.3137254901960784,0.8042157204487294,1.0,5/10,23.65%,IGF1R;GIGYF2;EIF2AK3;IRS1;PIK3R1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.7838876742769597,-1.1831792777854357,0.2549019607843137,0.7545383127911234,1.0,1/5,3.74%,SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.5542781854711987,-1.1831598838186035,0.17543859649122806,0.7536580405774703,1.0,4/22,9.31%,PANX1;MALT1;WNT5A;NLRP1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6493219678018664,-1.183006199524012,0.21739130434782608,0.7531767753534887,1.0,4/14,11.56%,NIFK;RPL35;ZNHIT3;RPF2
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.7489141055482871,-1.182419535978897,0.33962264150943394,0.7541157605702988,1.0,3/6,17.59%,PIH1D1;ZNHIT3;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.7419215078805809,-1.1819459240007255,0.24489795918367346,0.7546438191280563,1.0,1/9,2.79%,TCTA
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.5530162674103718,-1.1819257724342256,0.19230769230769232,0.7538315623522611,1.0,5/33,4.51%,CCND1;ATP6V0A4;AMOTL2;FERMT1;CDH3
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7215394421051916,1.1818144644823505,0.3392857142857143,0.8090142542216289,1.0,2/6,8.72%,AHCYL1;CA2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.7396736396424654,1.1817835849285334,0.2857142857142857,0.8079980214825012,1.0,2/5,17.92%,KDM7A;KDM6A
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6463893533157182,1.1817058551570645,0.1724137931034483,0.8072194019085983,1.0,2/10,9.82%,PIP4K2C;PIP4K2A
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5464034471576772,-1.1815902602473205,0.25,0.7540529843099039,1.0,7/33,10.39%,HSD17B10;SQLE;TM7SF2;SC5D;MSMO1;PMVK;DHRS11
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4967292501482145,-1.1815789716543013,0.16363636363636364,0.7531798760239068,1.0,7/61,6.31%,UBB;JUN;RPS27A;UBC;DUSP15;BAMBI;UBA52
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6856103407303922,-1.1812576120787965,0.2558139534883721,0.7532745079247859,1.0,2/9,8.37%,GSTP1;LYN
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.7165723201674239,-1.1812173512654855,0.3181818181818182,0.7514860078765793,1.0,3/7,12.37%,LIN7B;LIN7C;ANK1
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.7165723201674239,-1.1812173512654855,0.3181818181818182,0.7514860078765793,1.0,3/7,12.37%,LIN7B;LIN7C;ANK1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6128805775481687,1.1811806193995473,0.25806451612903225,0.8082674194934483,1.0,5/10,23.89%,AKT2;PRKCE;PPARG;IRS1;PPM1K
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.449691025780381,-1.1808948690486896,0.16,0.7514937780132183,1.0,14/69,9.88%,PSMB6;VANGL1;PSMD8;PSMB4;PRICKLE1;PSMA7;PSMC3;WNT5A;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.7168989078638937,-1.1808899887289945,0.2916666666666667,0.7505660079169056,1.0,1/5,5.19%,SFRP1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.671630053772623,-1.1808799057509634,0.28846153846153844,0.7496784055501144,1.0,4/15,3.88%,MT1E;MT2A;SLC30A10;MT3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.5833573870912063,1.1806238927223631,0.2641509433962264,0.8098202398141076,1.0,3/23,2.56%,SOX9;WNT7A;SLC39A14
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.5877967258989142,-1.1804880423449071,0.25,0.7499784269634711,1.0,5/19,11.00%,LAPTM4B;LEPROTL1;TMEM50B;CHMP2A;TMEM50A
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.5912172761184246,1.1804112275276104,0.2830188679245283,0.8093152595153078,1.0,6/17,24.28%,DUSP4;DUSP1;DUSP8;PPM1F;DUSP6;PPM1D
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.6321942342352148,1.1802735223479195,0.32,0.8088116204656417,1.0,1/15,0.43%,NDST3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7407505369248607,1.179392373620408,0.2631578947368421,0.8109149685848575,1.0,1/5,2.31%,ST18
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4428680598993274,-1.1793630340359254,0.1590909090909091,0.7527716245082308,1.0,22/116,13.07%,SOX4;PIWIL2;PCIF1;BRPF3;LDLR;EEF2;CDH3;MID1IP1;NPM2;OPN3;P2RX4;FXR2;EIF3D;GIPC1;HSP90AB1;SCARB1;EIF4A3;CLU;NPM1;PRMT1;DYRK2;SMAD3
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7192322053066106,1.1790768293507061,0.3076923076923077,0.8108766105412575,1.0,2/6,15.96%,AGO1;AGO4
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.49058421360492993,-1.1786673002612897,0.24489795918367346,0.7539854525847524,1.0,8/46,10.10%,RBM8A;SAP18;SMU1;FXR2;PUF60;MAGOH;RBM15B;DDX5
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.7438481050137027,1.1785477207359796,0.2608695652173913,0.8107485502215319,1.0,3/6,15.69%,HDAC4;PFKFB1;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.7438481050137027,1.1785477207359796,0.2608695652173913,0.8107485502215319,1.0,3/6,15.69%,HDAC4;PFKFB1;NCOR1
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.7152765199155103,1.1784973595817927,0.34146341463414637,0.8098594915312549,1.0,3/6,24.82%,KCND3;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6735770966494694,1.177894879023863,0.2391304347826087,0.8107885793236768,1.0,1/8,0.28%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.5840582774693177,1.1778469203690136,0.24561403508771928,0.809888946495515,1.0,4/20,9.16%,MEIS2;PRKCA;CCDC57;HES1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6893231325544076,-1.1777268695086194,0.22727272727272727,0.7564150697864793,1.0,3/8,23.73%,LAMP1;IL18;HLA-F
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.6451460408393159,-1.1775770109252874,0.3111111111111111,0.7558394686701487,1.0,3/14,3.88%,NOX4;PRDX1;MT3
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.4081065724295158,-1.1774645694718224,0.16326530612244897,0.7553154120501441,1.0,30/221,9.42%,SOX4;UBB;SIRT2;JUN;BTG1;UTP11;NCSTN;RPS27A;BAD;ATF4;FGD3;UBC;SAP18;PLEKHG5;PNMA1;TRIM35;ARL6IP5;SFRP1;APH1A;UBA52;IFIT2;DNAJA1;MCF2;PDCD5;PHLDA1;SMPD1;NGF;AIFM1;PHLDA3;STPG1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.636875927452456,-1.1774549301639707,0.3448275862068966,0.754442117721557,1.0,4/8,19.63%,RTRAF;YBX1;HNRNPA2B1;RBFOX1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.6327684142581502,1.177168116895607,0.3333333333333333,0.8114063868381461,1.0,2/9,4.32%,RELN;CAMK2B
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5623859805600826,-1.1770442703715323,0.25,0.7550338363822028,1.0,6/26,19.05%,CCDC88C;SERF2;RAD23A;PRNP;CDC73;MUL1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.4841505228451766,-1.1765383196030619,0.2222222222222222,0.7556490878334727,1.0,14/51,15.38%,TUBB2B;DLL3;PCGF2;IGFBPL1;SEZ6L2;EFNA2;LINGO1;C1QL1;AADAT;POU3F2;MSI1;CKB;FAM171A2;CSPG5
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.6360775514271964,-1.176508544339873,0.3137254901960784,0.7548783605082157,1.0,1/10,2.30%,LGALS3BP
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.41278853138307964,-1.1764901457064154,0.16,0.7540347627179365,1.0,18/152,8.83%,H4C3;ISCA1;GDE1;TMEM9B;YPEL5;ERMAP;CROCCP2;SLC30A10;TCEA1;HDGF;BLVRB;UROD;LRP10;GLRX5;ALAD;MARCHF2;ABCG2;HEBP1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5356845672970131,-1.176476859706971,0.2857142857142857,0.7531434450544066,1.0,5/31,6.31%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6359381276109144,-1.1762535435647243,0.3125,0.752999933706792,1.0,4/11,7.69%,PPT1;SMPDL3A;ASAH1;SMPD1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.45228992802927387,1.1762149307532088,0.18867924528301888,0.8137023121369921,1.0,14/77,15.76%,RFC4;RMI1;ING5;WRN;TOP1MT;RAD9A;BRCA1;HELB;RPA1;ATM;TOP1;BARD1;DONSON;CDC7
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6457954530966566,-1.1761832590753034,0.3191489361702128,0.7523478652042933,1.0,4/11,9.98%,ACTG1;ACTB;FUZ;LAMA5
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.3913021992567876,1.1761160409633946,0.09259259259259259,0.8131610925351141,1.0,44/251,12.77%,VSIR;TMSB4X;IGF1R;FAM107A;GNA12;NEDD9;ZMYND8;AKT2;MYLK;SEMA3A;ENPP2;SEMA4B;PAK1;TIAM1;PLXNA4;PRKX;CAMK2B;NTRK3;FGF9;DUSP22;MACF1;PTPRJ;PLET1;PRKCA;GCNT2;WASHC1;TCAF1;SRCIN1;SASH1;VCL;HACE1;EPHA4;PHACTR1;SGK1;ATM;TTBK2;SULF1;SRGAP3;PTPRU;PLXNA1;CHRD;TPM1;MAGI2;PIK3CD
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4721030531840099,-1.1758385366840352,0.23404255319148937,0.7524784049275107,1.0,11/53,11.60%,SPCS2;GPX1;GSTP1;GSTM4;SEC11C;APEH;MMACHC;SEC11A;HM13;AEBP1;FURIN
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.703720951968372,1.1756600764558545,0.26,0.8136575843441544,1.0,3/7,11.33%,YJEFN3;ARIH2;ETV6
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7276675619878592,-1.175629425512848,0.34,0.7521876307266584,1.0,2/5,8.01%,WNT3;WNT5A
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.7329025325774343,1.1755184012292728,0.28846153846153844,0.8131178381631871,1.0,4/6,22.61%,OXTR;SLC22A4;ERBB4;GPAT4
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.7483588692529396,1.1754513395375341,0.32653061224489793,0.8123242941113912,1.0,1/5,1.69%,SOX9
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5868507226376606,-1.1753438746157692,0.2222222222222222,0.7520459670357083,1.0,4/22,3.91%,PPIF;PPWD1;PPIB;PPIA
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7660592464186599,1.174601716155568,0.3508771929824561,0.8142090004285377,1.0,1/5,8.30%,PROX1
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.48809707037832184,-1.174600910169242,0.2127659574468085,0.7538069190276475,1.0,20/69,16.45%,DERL2;FOXRED2;UBE2J1;SELENOS;FAM8A1;UBXN4;FBXO44;STUB1;DNAJB12;SEC61B;AUP1;OS9;YOD1;TMUB2;UBQLN2;RHBDD2;HSP90B1;HSPA5;DNAJC18;VCP
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.5213157082992355,1.1743531544778607,0.24193548387096775,0.8139506414220716,1.0,8/33,8.32%,SLC6A15;SLC6A17;SLC38A9;SLC6A6;SLC25A48;SLC16A10;SLC1A4;SLC7A11
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7366642099271061,-1.1742345997305033,0.26,0.7538487089286585,1.0,3/6,3.85%,RAN;RPS15;LTV1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.7727131881133639,-1.1738221884228786,0.25,0.754124529532089,1.0,1/5,8.64%,NUDT16L1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5473410221526495,-1.1736698991326464,0.26666666666666666,0.7536242901611884,1.0,4/19,4.57%,BGN;BCAN;UGDH;CHST7
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.6346283335323486,-1.1736117570648323,0.2857142857142857,0.7529162689305786,1.0,4/11,17.64%,GMPR2;DGUOK;POLD3;POLD2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.7469819121467175,-1.1735613132387586,0.26,0.7521608321018818,1.0,1/8,1.92%,ATF4
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.67996020712169,-1.1732458959382812,0.2608695652173913,0.7525231984946873,1.0,4/11,12.58%,SFRP1;ATRAID;SOX8;BMP2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.5981305567656415,1.1731718276632845,0.2,0.81716294164363,1.0,3/21,10.68%,SORBS1;GRIN1;RAB27A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6241347028701602,-1.1731004263729654,0.23529411764705882,0.7522967460502017,1.0,3/11,8.50%,PARP1;TIPARP;PARP2
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.4979791108653309,1.1730427944360218,0.21428571428571427,0.8164571249999152,1.0,12/53,14.47%,GALNTL6;CDC42BPB;PRKCA;OXSR1;TNKS;CIT;PDPK1;CAMK2D;TAF1;LMTK2;GALNT16;GALNT13
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.7300312004291829,-1.1729427082769737,0.3275862068965517,0.7518750848838832,1.0,3/5,26.79%,PHB2;OAS3;TRIM25
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7814739360807316,1.172811440964742,0.2857142857142857,0.816425052306968,1.0,2/5,14.09%,PKP2;DSC2
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4445280000875725,-1.172474464723756,0.14814814814814814,0.7524931100680791,1.0,21/98,12.75%,CCND1;BGN;GPX1;MMP2;JUN;PPT1;GPX4;TSPO;BTG3;SAT1;SC5D;DNAJA1;VDAC2;CD44;IFITM3;ISG20;CLU;CASP9;CAV1;BMP2;TIMP2
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.6479253258244205,-1.172446991100323,0.30434782608695654,0.7516328328075084,1.0,1/12,8.83%,ABCG2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.6084399758811585,-1.1722535726530154,0.25,0.7513597559870696,1.0,3/18,9.18%,VPS37B;TRIM35;CHMP2A
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.46930055206326504,-1.1716634263158878,0.1509433962264151,0.7522440651609278,1.0,22/94,16.62%,RRAGA;GAPDH;LZTS1;ATP6V0E1;ATP6V1G1;ERN1;VPS35;ATP6V1B2;SCOC;LAMTOR4;ATP6V0E2;VPS26B;TBC1D25;CAPN1;UCHL1;ATP6V0D1;UBQLN2;LAMTOR5;SNX5;VPS26A;EXOC7;AKT1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6721495087261828,1.1716086043271356,0.3,0.819912871504018,1.0,3/7,15.20%,AKT2;SNCA;PRKCE
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.5866252520112359,1.1714239604865246,0.2,0.8195982255527571,1.0,5/20,8.30%,RAB17;PKP2;GPRC5C;EFNA1;PROX1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.5745707624253206,1.1713985141393255,0.27586206896551724,0.8187034831811396,1.0,3/25,2.48%,PTPRC;WNT7A;LMBR1L
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.40660829052597763,1.171210564654192,0.09302325581395349,0.8184290462356048,1.0,27/182,9.02%,ROBO2;UNC5D;EFNA5;WNT7A;SHTN1;EPHA7;RAB3A;SEMA3A;RELN;LAMA2;SEMA4B;RAB10;DAB1;BAIAP2;PARD3;GRB10;SLIT3;EFNA1;UNC5C;SPTBN5;PRKCA;USP9X;DOCK7;NRCAM;RANBP9;EPHA4;SHANK3
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6047349791722085,-1.1710517782921857,0.3023255813953488,0.7532722144006408,1.0,5/20,9.59%,CIAO2B;ISCA1;ISCU;GLRX5;NUBP2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.7683589335965971,1.1709512110241622,0.30434782608695654,0.8182057002774082,1.0,4/5,22.80%,PROCR;KNG1;HS3ST5;APOE
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.6126718257198029,-1.1708102564977476,0.28,0.7530589011186961,1.0,2/13,6.93%,MRPL44;HENMT1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.5555852777787735,-1.1707966596412749,0.23076923076923078,0.7522273157075154,1.0,5/16,18.45%,PCGF2;RING1;RNF168;CUL4B;BMI1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.7099050608979831,1.170670448400383,0.34545454545454546,0.8182974219108299,1.0,1/6,4.45%,PLIN5
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6410918432153921,1.1706432121609391,0.23076923076923078,0.817358697586571,1.0,5/11,23.57%,DYNC2LI1;WDR19;DYNC2I1;IFT140;IFT122
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.6063677821343046,1.1701785072000903,0.2830188679245283,0.8181413786273352,1.0,1/12,2.23%,SRF
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.5030038916724091,1.1700354533192567,0.1951219512195122,0.8176814516731068,1.0,17/66,17.34%,FABP3;PCTP;PITPNA;SLCO1A2;RXRA;ABCA2;NCOA1;PITPNC1;ACSL1;ABCA8;SLC51A;ABCA10;ATP8A1;PITPNB;NCOA2;SLC27A4;AKR1C1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.7670890502227208,1.1688220787690773,0.23809523809523808,0.8207019501319394,1.0,2/6,2.75%,TPCN2;EPS15
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.6645249654002341,1.1684413178006237,0.23809523809523808,0.8210148801250198,1.0,4/10,11.58%,ANGPTL4;PCSK6;SORT1;LMF1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5965813288731221,1.1682724099668889,0.3269230769230769,0.8203907624293408,1.0,5/18,21.55%,SLC4A4;CA2;SLC9A9;SLC4A8;SLC9A5
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5497676612482502,1.1682676671265535,0.29411764705882354,0.8193942151970117,1.0,3/28,2.78%,SCEL;CRLF1;CLDN18
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5263046763216441,-1.16782345448414,0.2857142857142857,0.760583548740941,1.0,5/33,6.31%,UBB;RPS27A;UBC;PARP1;UBA52
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.720177581036701,1.1677254495076506,0.3333333333333333,0.8201558694391444,1.0,2/7,15.96%,AGO1;AGO4
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.7604334957168037,-1.1676897731547198,0.3611111111111111,0.7602776201703324,1.0,2/5,9.93%,SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.48954333795083516,-1.1676449215842972,0.2,0.7594162776299299,1.0,10/64,14.69%,SOX4;UBB;MT3;VPS35;SLC25A24;CHMP2A;CLU;PRR7;PARK7;LRP1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.680051820820897,1.1675864100968505,0.2909090909090909,0.819746633074225,1.0,3/7,13.30%,SOX9;RORB;BBS4
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.715343110141907,1.1669883179127043,0.32653061224489793,0.8209157594446624,1.0,2/5,20.23%,SLIT3;ROBO1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6552904636058398,1.166881124750094,0.30612244897959184,0.8203081317771936,1.0,1/10,1.69%,SOX9
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.7107578790419656,1.166648260925844,0.3064516129032258,0.8202347447654672,1.0,3/7,21.84%,KDM7A;KDM2B;KDM4C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.7288386445358144,-1.1665871332999775,0.30612244897959184,0.7618294714201158,1.0,3/5,23.80%,WNT5A;HSPD1;CD226
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.47368173458286367,1.1662838190319242,0.24074074074074073,0.8206193334469615,1.0,12/62,10.29%,PTPRC;FOXO1;PTPRR;SPRED2;TIMP3;LMO3;PTPRJ;DUSP4;CAV3;RANBP9;DUSP1;BMP7
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.4568293983960071,1.1661987315516946,0.2558139534883721,0.8198661003586964,1.0,29/105,18.10%,RAB40A;RAB3A;PKP2;RAB10;PLEKHF1;MAP7;TSPAN5;KCNB2;RAB40C;CAV3;RAB40B;MRAP;EMP2;RAB8B;PACS1;C2CD5;SPTBN4;TNIK;PACS2;ANK2;DPP6;SEC16A;EFR3A;DPP10;GAK;EHD1;ASB3;ITGB1BP1;ANK3
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.46611926104820706,-1.1660478198731155,0.1388888888888889,0.762403641493363,1.0,10/66,5.50%,BGN;MMP2;PODN;THY1;PRRX1;FIBIN;COL12A1;THBS2;PDGFRA;CXCL12
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.5533353148446657,1.1659554138872474,0.19230769230769232,0.819793549448553,1.0,6/31,9.12%,HEY2;RTN1;UNC5C;NRCAM;CDK6;CRMP1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.682438516267234,1.165667901619758,0.30612244897959184,0.819856766338661,1.0,2/10,4.45%,AKT2;PLIN5
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.44921371631979773,1.1655160527704083,0.171875,0.8193658573824621,1.0,27/100,16.80%,LIFR;NUAK1;CHST3;SOX9;TNFRSF19;ARHGEF17;PHYHIP;GFAP;CDC42BPB;CMTM4;HSPA12A;TEAD1;SH3PXD2B;TYRO3;ARNT2;CEP170B;PTPRU;RBFOX2;NAV2;SLC13A4;NCS1;CAMK2N1;SLC19A1;ZNRF3;TJP1;FARP1;SEMA3B
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.42328478143804865,1.1654249834310533,0.17647058823529413,0.8186056959612996,1.0,16/97,11.67%,PTPRC;IGF1R;EPHA7;PAK1;NTRK3;PTPRJ;CAV3;TGFBR3;PAK2;ROR1;NBR1;DUSP1;ZNF622;TRAF7;TNIK;STK3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.760321257548636,1.1652504823385985,0.3404255319148936,0.818424578104423,1.0,1/5,4.15%,KLF9
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.46100880985637854,-1.1648518738973386,0.15384615384615385,0.7655666194082461,1.0,9/63,11.65%,COL9A3;CD151;COL8A1;PPIB;COL12A1;COL9A2;COL4A4;ADAMTS2;ADAMTS3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4577318609133099,-1.1648243356620014,0.11904761904761904,0.7647993751915279,1.0,19/60,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;YAP1;PSMD4;SETD1A;PSMC4;PDCD2;PSMB2;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.7348625409283146,1.1648134674301227,0.27450980392156865,0.8178432282451392,1.0,1/7,0.78%,RFC4
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.7348625409283146,1.1648134674301227,0.27450980392156865,0.8178432282451392,1.0,1/7,0.78%,RFC4
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.43687616788983097,-1.1647671499804582,0.2,0.7641421027515484,1.0,21/122,10.96%,SOX4;PSMB6;PSMD8;TMEM9;PSMB4;GID8;CDH3;PSMA7;SFRP1;BAMBI;GSKIP;PSMC3;PSMD10;PSME3;PSMD12;ZBED3;PSMB9;PSMC1;PSMD2;LRRK1;SEMA5A
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.4762137361146229,1.164700244509993,0.22641509433962265,0.8172233447195976,1.0,18/57,17.34%,SLC6A15;SLCO1A2;SLC13A3;RXRA;NCOA1;SLC6A6;SLC25A48;SLC16A10;SLC1A4;SLC7A11;ACSL1;SLC51A;SLC19A1;PDPN;NCOA2;SLC38A4;SLC27A4;AKR1C1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6066516253764895,-1.1642176321056485,0.2653061224489796,0.7649749765414866,1.0,5/14,14.19%,SELENOS;ZBED3;EIF2B2;KHK;EIF2B1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.6159732766219637,-1.1641246844972286,0.28,0.7643550102279467,1.0,4/15,11.77%,CCND1;STOX1;RCC2;NPM1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.6147692335822158,1.1639142504947007,0.27586206896551724,0.8190974913359328,1.0,3/14,12.77%,PTPRC;RFTN1;PIK3CD
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.642360289758737,-1.1637700522029502,0.30434782608695654,0.7647066148158801,1.0,6/10,20.86%,LDLR;ARV1;CAV1;LCAT;STARD3;OSBPL2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6748678323985198,-1.1632642551911834,0.23529411764705882,0.7653564680734808,1.0,2/12,3.91%,PPIB;PPIA
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.7372651100883121,-1.1630782680944378,0.2909090909090909,0.7649174595775085,1.0,2/7,6.76%,GSTP1;APOD
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.6639033552974605,1.162956854900518,0.30952380952380953,0.8213574476464428,1.0,2/12,20.37%,AGMO;PLAAT3
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.5416136803706795,1.1628417065907464,0.21818181818181817,0.8207476886399117,1.0,5/30,10.58%,SOX9;WNT7A;SLC39A14;ZBTB16;SULF1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.653803589824498,-1.1627563204182554,0.2708333333333333,0.7651716998698181,1.0,2/6,16.65%,VPS11;MSN
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.4518382829415224,-1.1625912833550611,0.17777777777777778,0.7647220075815049,1.0,7/85,5.19%,MT1E;CDKN2C;BTG1;PPT1;MT2A;MT3;SFRP1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4427605204050085,1.162411153725982,0.16981132075471697,0.8213079982421141,1.0,27/97,16.80%,LIFR;NUAK1;CHST3;ADGRL2;EDNRA;TENM3;FAM13C;GULP1;HSPA12A;TEAD1;ARNT2;PTPRG;RBFOX2;GJA1;ANK2;NAV2;ASAP3;ALDH7A1;PBX1;ITSN1;DCLK1;LRRTM1;FIGN;PCDH7;TJP1;FARP1;SEMA3B
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.7507982813868381,1.162409508772179,0.3333333333333333,0.8202864708811165,1.0,1/5,5.94%,SPI1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.48608294666596624,1.1623486782588508,0.17777777777777778,0.8195467509926048,1.0,17/48,17.10%,ITPR1;KCNJ11;ATP2B3;AHCYL1;RYR3;CAV3;RYR2;ITPR2;ATP2B2;TPM1;CAMK2D;NOS1;SLC8A1;ANK2;SLC8A2;KCNQ1;ASB3
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6639058712973044,1.1620987589644198,0.29310344827586204,0.8194516023107076,1.0,1/10,0.51%,DPYD
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.43430612737580887,-1.1619720035987877,0.2,0.7658689213420068,1.0,13/80,5.50%,BGN;MMP2;PODN;THY1;PRRX1;FBLN2;FIBIN;RARRES2;NT5E;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.6376048402553877,-1.1616964319653165,0.2222222222222222,0.7658238372985992,1.0,2/11,7.47%,CUL7;CUL9
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.6481226555377003,1.161630923417856,0.28888888888888886,0.8202529819368716,1.0,3/8,15.20%,TIRAP;NMI;PRKCE
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.7017468271686159,1.1614722210994466,0.3275862068965517,0.8199031562400387,1.0,4/6,24.47%,SLC25A48;SLC22A4;SLC25A29;SLC25A45
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.7470168499429438,-1.1613753637488191,0.3333333333333333,0.7659451714077635,1.0,3/5,15.47%,SF3A2;SLU7;SF1
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.46775928384834226,-1.161337413413045,0.12962962962962962,0.7651762912881305,1.0,13/77,8.05%,UBB;JUN;RPS27A;UBC;ZFP36L1;DUSP15;SFRP1;BAMBI;PDE3A;UBA52;PDCD5;WNT5A;LIMS1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.7212038168504744,1.160879054813423,0.32727272727272727,0.821004049480034,1.0,3/5,22.80%,PRKAA2;PRKAA1;APOE
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.6783337275159889,-1.1602598909387576,0.32558139534883723,0.766804700705177,1.0,2/15,12.26%,SVIL;TWF1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.6783337275159889,-1.1602598909387576,0.32558139534883723,0.766804700705177,1.0,2/15,12.26%,SVIL;TWF1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.721661297389671,1.159551494972064,0.2619047619047619,0.8235472085859356,1.0,2/5,21.39%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.721661297389671,1.159551494972064,0.2619047619047619,0.8235472085859356,1.0,2/5,21.39%,PHLDB2;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5096352482007088,1.1594476773543112,0.25,0.8229663371351523,1.0,9/31,20.23%,ROBO2;KAT2B;TSPAN5;IL6ST;TP63;STAT3;ITGB1BP1;MAML1;ROBO1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.475253749569199,1.1592206744211935,0.2553191489361702,0.8228918469043897,1.0,15/54,17.27%,EFHC1;DNAH7;ALDH1L1;TMEM213;AGBL4;CFAP221;PDZD2;CCDC30;RSPH3;PACRG;TMEM150C;TACC2;RGS22;SLC4A8;VWA3B
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.5227089908619296,1.1587528561681428,0.25925925925925924,0.8236580929087866,1.0,1/32,0.46%,VSIR
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.6911660797744241,1.1581768720560486,0.3269230769230769,0.8245783697572475,1.0,3/7,21.05%,IRAK2;IRAK4;TRAF6
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6066166574089117,1.158034422201824,0.2857142857142857,0.8239631466219292,1.0,4/12,17.00%,NPHP4;CBFB;TJP1;MYO1C
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.4879881318431597,-1.1579629427675546,0.23809523809523808,0.7728603252693242,1.0,8/52,9.79%,RAN;KIF25;SMC1A;TUBG1;CTDP1;MZT1;CHMP2A;KIF18B
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.4583388501946859,1.1578559920051121,0.22,0.8233853209719024,1.0,10/85,10.63%,PTPRC;VSIR;OTUD7B;TMSB4X;NLRC5;UFD1;CYLD;MAP2K5;HDAC7;RARA
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.765701855920185,1.1577533949721366,0.3137254901960784,0.8226774670670112,1.0,2/6,16.84%,NNMT;PPARGC1A
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5054230453779257,1.1577308784855835,0.2608695652173913,0.8217565190382308,1.0,2/46,0.34%,HOOK1;KATNAL2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.420846739859902,-1.1576844503116488,0.14285714285714285,0.7727602452040795,1.0,15/128,5.50%,BGN;MMP2;JUN;FBLN5;PMEPA1;THY1;PRRX1;PPIB;FBLN2;NT5E;COL12A1;SAT1;THBS2;SFRP1;CXCL12
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6504610133426579,-1.1570250104133546,0.2777777777777778,0.7741822632534117,1.0,6/13,14.78%,ROMO1;TIMM23;TIMM44;DNAJC19;GRPEL1;TIMM21
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6148814669020602,1.1570234890112734,0.3269230769230769,0.823317185612854,1.0,2/14,12.24%,ASPA;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.7347744351482436,-1.1566213452347767,0.32558139534883723,0.7744697592469579,1.0,1/5,2.21%,PPIB
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.729186945737681,1.1565993437552418,0.3392857142857143,0.8237906478725017,1.0,3/5,21.73%,ACSL1;SLC27A4;ACSL3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.608499271241469,1.1564974059427184,0.3225806451612903,0.8231808737161331,1.0,1/11,0.17%,CHRM3
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.7778433633968563,1.1563849787398908,0.2909090909090909,0.8205429226506501,1.0,3/5,13.23%,RYR3;RYR2;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.7778433633968563,1.1563849787398908,0.2909090909090909,0.8205429226506501,1.0,3/5,13.23%,RYR3;RYR2;SLC8A1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.7778433633968563,1.1563849787398908,0.2909090909090909,0.8205429226506501,1.0,3/5,13.23%,RYR3;RYR2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.7013081155803651,-1.1556747381233616,0.36363636363636365,0.7766986941746736,1.0,4/7,23.37%,SLC30A10;PARK7;ABCD2;PPARA
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6232629720358294,-1.1552319389377057,0.32075471698113206,0.7771589927162548,1.0,1/9,2.21%,PPIB
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.49776155543346656,1.1549725304404568,0.17647058823529413,0.8249100839804776,1.0,5/36,5.97%,SCEL;COL5A1;BCR;ALOX12;TMEM79
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7466906326569265,1.1549335489110053,0.3389830508474576,0.8240189833923967,1.0,1/5,8.68%,MAP2K5
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.540563499417434,-1.154773433679209,0.2682926829268293,0.7776886953631289,1.0,4/28,8.05%,S100A10;THY1;SFRP1;LIMS1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.6795846507181779,1.1547543820698831,0.29411764705882354,0.8238265226018463,1.0,4/9,15.72%,SLC2A9;SLC2A6;SORT1;SLC2A3
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6589787888957943,1.1544629030203837,0.28,0.8239292919058098,1.0,1/9,0.25%,CARD14
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.42423187701465315,1.154453482688814,0.16071428571428573,0.8229601588627204,1.0,27/124,14.93%,RASGRF1;TBC1D4;TBC1D10B;RGS7;TIAM1;DOCK11;TBC1D13;NTRK3;BCR;DOCK8;RANGAP1;ARHGAP24;DOCK7;BCAS3;SGSM1;RAP1GDS1;RAP1GAP2;TBC1D8;TBC1D22B;SIPA1L1;ASAP3;TBC1D1;SEMA4D;TIAM2;ZC3H15;ARHGEF7;TSC1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.46577918064380197,1.1544360084433043,0.17391304347826086,0.8220286450317836,1.0,15/60,17.44%,SLC6A17;LRP2;SLC13A3;SLC4A4;ABCA2;SLC6A6;SLC1A4;SLC29A2;ATP8A1;SLC19A1;SLC2A3;SLC8A2;SLC4A8;SLC27A4;SLC6A1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6330169799875957,1.1540767720414549,0.3023255813953488,0.8224504038340291,1.0,2/13,4.67%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5912707075886903,-1.1537243502792585,0.28846153846153844,0.7804341269527472,1.0,3/12,8.62%,PARP1;SLC25A33;SLC25A4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5270329636784419,-1.1534833459497609,0.2391304347826087,0.7802441677331066,1.0,9/31,14.61%,POLR2L;POLR1F;RRN3;POLR1A;POLR2K;POLR2E;GTF2H2;POLR1G;TAF1A
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.7953421993822061,-1.1534490411504033,0.2982456140350877,0.7794811935882471,1.0,1/5,4.96%,RPL23
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6448107789977089,1.1528203874778964,0.2909090909090909,0.8255347710270012,1.0,4/17,7.67%,PEX5L;RNF157;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.7324425229967048,1.152724587232639,0.37735849056603776,0.8248965194935456,1.0,1/6,10.22%,ATM
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.7297465338327425,-1.152363463488873,0.3584905660377358,0.7820164521631693,1.0,2/6,13.07%,CDH3;SMAD3
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6622933600296291,1.1522756077325023,0.3076923076923077,0.8257347410978049,1.0,3/10,12.85%,IHO1;RAD18;SMC5
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7542363403237398,-1.151839475646884,0.35294117647058826,0.7827010650799968,1.0,3/5,22.75%,GALE;GALK1;PGM2
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.7805010049060082,1.1518180945889265,0.28846153846153844,0.8263020435587178,1.0,1/5,5.86%,CAV3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.7096395427967576,1.1514792430240053,0.4117647058823529,0.825344730420347,1.0,3/7,17.89%,JAK1;STAT5B;STAT3
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.7096395427967576,1.1514792430240053,0.4117647058823529,0.825344730420347,1.0,3/7,17.89%,JAK1;STAT5B;STAT3
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5098725173698754,-1.1514713823765168,0.2894736842105263,0.782882607123315,1.0,8/25,19.25%,SMARCA5;TAF7;NAT14;TAF6;TCEA2;PRMT5;PRIM1;TBP
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.6218874678712559,1.151451719313621,0.3148148148148148,0.8244425567625108,1.0,3/13,6.25%,IGF1R;ETF1;CLEC16A
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.738809088159189,1.1513605227817885,0.32608695652173914,0.8238101644236567,1.0,1/5,2.44%,RAB3A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7599876451657825,-1.1513542898726987,0.28,0.7823530990916732,1.0,1/5,3.85%,ZFP36L1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.5103960121702478,1.1510371908046424,0.2,0.8239812211532512,1.0,9/48,10.63%,PTPRC;VSIR;ARFGEF2;FOXP1;PTPRJ;PSEN1;RIPK1;TIRAP;RARA
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.503767884664556,-1.1509297490492492,0.24,0.78268589908785,1.0,3/31,9.18%,S100A10;NLGN2;CHMP2A
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5315194095170944,1.1508542307426641,0.2549019607843137,0.8234669647419448,1.0,7/32,15.07%,INPP4B;ITPK1;INPP5A;INPP4A;ITPKB;ITPKC;IMPA1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.6753521941966287,-1.1505334766923376,0.3333333333333333,0.7830411902595553,1.0,2/9,8.30%,PPT1;ABHD17A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6688628377547973,1.150322272736606,0.3389830508474576,0.824240953388391,1.0,1/9,0.51%,DPYD
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5911057132059163,1.149956869699113,0.28846153846153844,0.8246077700742066,1.0,2/15,12.96%,PSEN1;SNCA
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.6821718785488051,-1.1494002474009897,0.2978723404255319,0.7857641488147217,1.0,1/10,0.84%,BICD2
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5107614496315557,1.1493303666905093,0.2641509433962264,0.8257834349039119,1.0,4/29,8.86%,RAB3A;RAB10;RAB8B;TANGO2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5608848745177473,-1.1492811433475674,0.37254901960784315,0.7854193283204505,1.0,9/25,12.47%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;RAB14;ATP6V0E2;MCOLN1;ATP6V0D1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.4985129343883429,1.148986716223517,0.23076923076923078,0.8258471648583696,1.0,9/42,16.42%,FAM117A;WRN;BCL11A;NMI;RAB27A;PIEZO1;MPP1;VASP;ENG
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6588674567946355,1.1488451929936314,0.375,0.8254029815719471,1.0,2/7,13.23%,TTN;SLC8A1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.42228541723770086,-1.1484395071216205,0.14,0.7871835567781957,1.0,25/124,12.44%,MT1E;BGN;JUN;BTG1;BCAN;PRDX5;PLIN2;MT2A;GAPDH;GPC4;JMJD6;TIPARP;GBE1;TPI1;WSB1;TPST2;ISG20;SCARB1;SLC25A1;NCAN;TMEM45A;CDKN1C;SAP30;CAV1;PNRC1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7231362068553024,1.1484248006998536,0.44680851063829785,0.825939594485517,1.0,1/5,2.22%,SPRED2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7247245854466471,-1.1483086023926945,0.42857142857142855,0.7840297632068517,1.0,1/5,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7247245854466471,-1.1483086023926945,0.42857142857142855,0.7840297632068517,1.0,1/5,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7247245854466471,-1.1483086023926945,0.42857142857142855,0.7840297632068517,1.0,1/5,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7247245854466471,-1.1483086023926945,0.42857142857142855,0.7840297632068517,1.0,1/5,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6527982820139766,-1.1481161414570262,0.2682926829268293,0.7838274458198593,1.0,4/11,9.93%,LRRC8D;SLC25A24;SLC25A4;SLC25A5
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.4649321966172008,-1.1480437818520157,0.19607843137254902,0.7833034206529943,1.0,8/77,4.57%,BGN;GSTP1;BCAN;DSEL;UGDH;CNDP2;GSTM4;CHST7
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.6384786441947665,-1.1478813678034445,0.3469387755102041,0.7828035575242511,1.0,1/7,4.49%,JMJD6
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.48765393168945537,1.1474358664137647,0.2653061224489796,0.8284666711157268,1.0,10/38,15.96%,NR4A3;KAT2B;ZNF16;RBM15;AGO1;KMT2C;CBFB;SIN3A;KMT2A;AGO4
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.5776411690406085,-1.1473282504170168,0.3111111111111111,0.7838775755974265,1.0,3/11,10.69%,NOP10;NHP2;PUS3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.418778510811503,1.147087610755102,0.19047619047619047,0.8287109337444242,1.0,26/166,10.58%,PTPRC;TPD52L1;WNT7A;SLC39A14;SORBS1;RELN;KAT2B;NTRK3;TSPAN5;ING5;ASXL2;LMO3;MACF1;GRB10;GRIN1;PRKCA;EMP2;SASH1;RSPO2;LOXL3;ZRANB1;TRIM44;SHANK3;DLG4;TRAF7;SULF1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7049762807426098,1.1470840262348223,0.3269230769230769,0.8277600970022354,1.0,3/7,16.64%,RAB40B;RAB29;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7271731274777941,1.1469670074322698,0.3090909090909091,0.8271671347890139,1.0,1/7,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.5018727273468133,1.1467976750789615,0.2962962962962963,0.8267932817818561,1.0,4/44,5.30%,PON1;PCTP;ENPP2;PLA2G15
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7640476008770607,-1.1463805236037765,0.2978723404255319,0.7858894943590706,1.0,3/6,20.06%,PPP1R3F;AKT1;PPP1R3B
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.6707621981382095,1.1462755173474304,0.3559322033898305,0.8278052064182407,1.0,5/8,29.33%,MBOAT2;PLAAT3;PLA2G12A;LPCAT3;LPCAT4
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.708404170273094,-1.1462172134903525,0.3103448275862069,0.7855831393774861,1.0,4/6,27.83%,HLA-B;B2M;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5658699288109859,-1.1460937017767943,0.2727272727272727,0.7850600800567404,1.0,3/18,8.37%,TUBB2B;RPS19;LYN
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.5078932560807808,-1.1460785894463281,0.26,0.7842067544379638,1.0,3/30,6.35%,NR0B1;PAX8;EPHB3
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.6506999146193195,1.145985399940916,0.35185185185185186,0.8277287158604709,1.0,2/11,8.89%,RELN;CDK6
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.7077636472364441,-1.145966463980847,0.2727272727272727,0.7836064837056972,1.0,2/6,3.88%,HES5;MT3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.6394523641391019,1.1452806500669932,0.3125,0.8291825138688312,1.0,5/10,17.89%,RORB;MYO7A;CEP290;AGTPBP1;STAT3
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.44631129101519007,-1.1452083586969386,0.16326530612244897,0.7852425965519261,1.0,12/58,9.88%,PSMB6;PSMD8;PSMB4;MALT1;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.362313269027298,-1.1451674554322784,0.10204081632653061,0.7844716497986403,1.0,58/430,10.17%,SOX4;BTC;CDKN2C;NOX4;SIRT2;JUN;BTG1;COPS9;PODN;FABP7;SMYD2;CLEC11A;CALR;DERL2;S100B;RTKN2;TSPO;SQLE;ROMO1;GID8;IGFBP7;PDGFD;HES5;STOX1;ZFP36L1;TMEM115;BTG3;RHOG;DUSP15;TNS2;PTPN14;RPL23;SFRP1;BAMBI;PDGFRA;RPS9;TBRG4;SAPCD2;PDCD5;CADM4;SPEG;RPS15A;ZBTB49;LIMS1;SLC25A33;NACC1;LYN;HAS2;FUZ;COX17;CNBP;PTN;NGF;IL12RB2;RNF126;SLC25A5;FN1;UFL1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6818526083111227,1.1450852336223734,0.3269230769230769,0.8289221081938288,1.0,3/7,21.48%,UBA5;AGTPBP1;MYCBP2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7000375101308804,1.14503672772372,0.34,0.8281610565470704,1.0,5/7,29.81%,DOCK11;NOTCH2;LFNG;PTK2B;DOCK10
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5318678158157968,1.1447173846398264,0.3018867924528302,0.8283689791893857,1.0,8/20,20.97%,AKT2;TCAF1;C2CD5;DMTN;MYO1C;ITGB1BP1;ANK3;PDZK1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.6675636232143289,-1.1446858373520394,0.25,0.78514741701335,1.0,4/12,9.84%,CXCL12;MOSPD2;LYN;CREB3
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.5734453010478233,1.1438072443824514,0.3148148148148148,0.8308609078804837,1.0,3/20,11.37%,PTPRC;TRAF3IP3;CD247
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.71011812733221,-1.143775278049493,0.29545454545454547,0.787333273151654,1.0,3/5,22.36%,CSNK2A2;NUMA1;TPR
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.6907484893475221,1.1436187363382542,0.3333333333333333,0.8304067715045337,1.0,1/6,3.06%,TTLL4
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.5557218449054625,-1.1434340646963574,0.22727272727272727,0.7875275547831339,1.0,5/23,6.78%,THY1;MT3;RNF6;LINGO1;MCF2
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.62970520296658,1.143339892690247,0.3333333333333333,0.8302938662943342,1.0,1/12,1.96%,EGLN3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5560589586684737,-1.1432050408450327,0.2962962962962963,0.7873812013672642,1.0,6/20,9.67%,GABARAPL2;RPS7;RPL23;ALAD;RPL11;HSP90AB1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5213730711676747,1.1430358783201247,0.25,0.8301698966314692,1.0,6/34,10.69%,DCAKD;ADCY5;ADSS2;PAPSS2;PANK4;ADCY3
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.6830422258937845,1.1424483757547403,0.3333333333333333,0.8317092251176069,1.0,3/6,21.51%,ADCY3;SLC6A1;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5894539440552968,1.1421028604836876,0.2807017543859649,0.8318438040572061,1.0,6/18,18.82%,SEPTIN9;CEP135;CCP110;BBS4;ARHGAP35;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.565738900700774,-1.1420909067883291,0.2553191489361702,0.7901123856308307,1.0,2/15,5.19%,G0S2;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.5883509570323637,1.1420295871628146,0.3157894736842105,0.8310976960021121,1.0,4/11,16.83%,RAB3A;RAB27A;STX1A;SLC4A8
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.6828950362109101,-1.1419253238115796,0.30612244897959184,0.7898164032197901,1.0,3/9,16.45%,COX7A2;SLC25A33;VCP
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5757241525014082,-1.1419220525826124,0.2545454545454545,0.7889559437932963,1.0,8/19,13.24%,PGRMC1;TSPO;UROD;ALAD;ABCG2;UROS;SUCLA2;NFE2L1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.6585566738335944,-1.1418714428114443,0.3125,0.788255443791591,1.0,1/9,3.41%,ZDHHC6
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7700279355499119,1.1418047361265977,0.328125,0.8309733711477173,1.0,3/5,19.61%,NFATC3;ENG;PDCD4
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.4113893993952545,1.1415710180888177,0.1276595744680851,0.8307479849477823,1.0,26/129,10.43%,GRIN2A;OPALIN;FAM107A;STMN2;SLC6A11;SOX9;SHISA6;ALDH1L1;SORBS1;TMEM132C;PHYHIP;SLC4A4;GFAP;ADCY5;MMD2;NFATC3;TEAD1;SNAP25;PSD2;KCNIP1;ATP2B2;ADGRB3;DAAM2;BAALC;AQP4;CDH20
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.7151918393230513,-1.141549174641227,0.3333333333333333,0.7885150922914297,1.0,1/5,0.48%,NOX4
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7709201907709633,-1.141253542719703,0.34146341463414637,0.7884587409498379,1.0,2/5,11.19%,HSP90AB1;CLU
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.7300246883559005,1.1410707292916704,0.26,0.8315804209354867,1.0,1/5,1.48%,BAIAP3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4898468674778111,-1.1408954473095456,0.3018867924528302,0.7886163190546152,1.0,3/37,2.67%,PPIF;BAD;RTKN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6583383693657149,1.1405649032040492,0.3448275862068966,0.8313542488559851,1.0,4/11,15.59%,CD160;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6583383693657149,1.1405649032040492,0.3448275862068966,0.8313542488559851,1.0,4/11,15.59%,CD160;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.61126917024802,-1.1402943943597403,0.2826086956521739,0.7897852028644098,1.0,6/19,13.26%,MMP2;COL8A1;COL12A1;ITGA4;FN1;ITGB5
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.44574197843098073,1.140066504944896,0.23076923076923078,0.832474565219802,1.0,21/78,19.49%,FOXO1;NEDD4L;WNT7A;ABCA2;PSEN1;ATG7;RAB1A;HACE1;RANBP9;MAP2K5;STX5;WWP1;BARD1;CSF1;PLK2;WWP2;HECW2;UHRF1;ITCH;ABCB10;AGT
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.690398208817286,1.139919906653629,0.3333333333333333,0.8318680736504733,1.0,2/7,11.37%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.7167459932158539,1.1398653460830994,0.3469387755102041,0.8311399507531807,1.0,3/7,15.20%,DMTN;ARHGEF7;PRKCE
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7038625664794671,1.139422599098518,0.3488372093023256,0.8316199364472535,1.0,4/5,28.81%,CAV3;SNCA;NFKB1;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4282669701843124,-1.1391508776483963,0.1836734693877551,0.7919508374670166,1.0,21/103,10.28%,EIF5A;PSMB6;PSMD8;TXNDC17;PSMB4;ZFP36L1;PSMA7;SFRP1;ASAH1;PSMC3;LIMS1;CACTIN;PSMD10;HAS2;PSME3;TNFRSF14;PSMD12;PSMB9;PSMC1;PSMD2;TRAF5
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5996204135663668,-1.138835675333152,0.2653061224489796,0.7920592091291899,1.0,4/10,18.52%,CAMSAP3;CDC42;MSN;RAP2A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.4565383516950514,-1.1387574973669405,0.225,0.7914727155419712,1.0,11/65,5.50%,BGN;MMP2;PODN;THY1;PRRX1;FIBIN;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7006554147182843,1.1387401962474626,0.37037037037037035,0.8331142068879676,1.0,5/6,29.81%,DOCK11;NOTCH2;LFNG;PTK2B;DOCK10
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.5728331740736169,-1.1382363042431196,0.288135593220339,0.7921857103415095,1.0,7/18,21.28%,PPP1R35;TIPRL;BMP2;GPATCH2;HSP90B1;PPP1R26;PPP1R2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.41648491058364717,-1.1382084738197376,0.23076923076923078,0.7914103125163896,1.0,22/119,11.93%,COL9A3;BGN;MMP2;FBLN5;BCAN;HSPG2;AGRN;COL8A1;ADAMTS6;COL9A2;COL4A4;ITGA4;CD44;LAMA5;FN1;VWF;ADAMTS2;NCAN;FURIN;ADAMTS3;MADCAM1;HAPLN1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.6742670496560197,1.13819563004474,0.34782608695652173,0.8330199355254382,1.0,8/9,31.35%,JAK1;STAT5B;STAT3;IRS1;IL7;SMARCA4;BRWD1;IRS2
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.6742670496560197,1.13819563004474,0.34782608695652173,0.8330199355254382,1.0,8/9,31.35%,JAK1;STAT5B;STAT3;IRS1;IL7;SMARCA4;BRWD1;IRS2
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.6666683650208151,-1.1379181258388222,0.37254901960784315,0.7915523019830899,1.0,3/8,23.11%,ISG20;MUS81;SETMAR
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.5707428306331077,-1.137907728924802,0.2830188679245283,0.7907346640193456,1.0,4/15,7.95%,SIRT2;CALM1;CADM4;CALM3
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5577277984840808,-1.137712391093997,0.3023255813953488,0.7906096543151742,1.0,6/20,13.09%,RAN;RBM22;BAG3;PDCD5;SMAD3;HDAC3
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6394295941162921,1.1374748800703367,0.34782608695652173,0.8344852734558655,1.0,3/10,11.10%,SEMA3A;PLXNA4;PLXNA1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4787044407250782,-1.1372542413076634,0.32608695652173914,0.7911082306296218,1.0,5/47,8.16%,CCND1;JUN;MED10;MED23;MED30
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.6617831274302024,-1.1371673750402678,0.35,0.790504990145527,1.0,1/6,6.69%,EIF3D
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.5588194263879769,1.1371469613641991,0.3333333333333333,0.8346699403874217,1.0,3/22,9.85%,KCNJ13;KCNJ11;SLC12A1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.5072562254699637,-1.1371192494342852,0.24324324324324326,0.7898253129382794,1.0,8/28,12.53%,ZDHHC1;ZDHHC6;SELENOK;GOLGA7;ZDHHC4;PORCN;CLIP3;ZDHHC22
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.43919961300975635,1.1368844356008532,0.25,0.834765430476265,1.0,15/81,14.45%,CALCB;IL5;CAMK1D;GPRC5C;NRIP2;PTPRJ;TG;RYR2;ZBTB16;SGK1;CPEB3;TENM2;NOS1;BARD1;ARHGDIG
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7539309927012265,-1.1365639500148066,0.30612244897959184,0.79066704598051,1.0,2/5,4.00%,DBI;RABL3
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.7367492223483791,-1.1365118651319988,0.2857142857142857,0.7899443348417835,1.0,2/5,8.60%,WNT5A;DNAJC19
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.43597066369622706,-1.1364481751875832,0.22916666666666666,0.7892674681068877,1.0,22/113,11.66%,GPR17;CHRNA4;ASCL1;OLIG1;TCEAL6;OLIG2;TCEAL7;CNP;GPR37L1;LGI3;SYNDIG1;PDGFRA;LINGO1;HPCA;SHC3;PTN;C1QL1;TMEM179;NCAN;NEU4;CLIP3;BRINP1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5815140417468102,-1.1362162466741366,0.2608695652173913,0.7891339293541474,1.0,2/18,6.11%,SMDT1;PHB2
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.5799068209980112,1.1357590734337126,0.26666666666666666,0.8375314958370963,1.0,3/15,8.74%,ABCA2;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.6871166348522563,-1.13557969682934,0.42,0.7900832417702504,1.0,2/8,5.20%,PIH1D1;NABP2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.6135891243599397,1.13535898730473,0.3191489361702128,0.8380109639801321,1.0,5/15,8.76%,PPA2;SULT4A1;BPNT1;DDO;TPST1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.38336815933857976,-1.1352200669181978,0.1320754716981132,0.7902911861545273,1.0,47/270,13.89%,SOX4;POLR2L;PIWIL2;RBM22;ATF4;GAPDH;ACTG1;ACTB;POLR1F;PCIF1;STOX1;MT3;EEF2;CDH3;RPS7;RPL23;WNT3;WBP2;ERN1;VPS35;SMARCA5;FXR2;EIF3D;ERP29;PDCD5;MED23;WNT5A;LIMS1;RPL11;NGF;POLR1A;DDX5;FN1;EIF4A3;CLU;SPHK2;NPM1;POLR2K;MYBBP1A;BMP2;YAP1;LRP3;SLC2A10;SMAD3;POLR2E;LAMTOR5;PARK7
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.6110525307677463,-1.1350298257382656,0.3125,0.7899916349754832,1.0,6/13,22.36%,RBM22;BAG3;RAPGEF3;YWHAE;ANP32B;TPR
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.6731238573415665,1.1348626640103272,0.29411764705882354,0.8388431729851368,1.0,4/6,14.21%,RAB3A;CBLN2;ERC1;ERC2
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.4737508146425244,1.1347808469250493,0.26785714285714285,0.8382156197490567,1.0,9/57,9.10%,PTPRC;KITLG;YJEFN3;ARIH2;PRKX;TGFBR3;ZNF160;ZBTB16;TIRAP
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.4144466862052411,-1.134276668569349,0.21818181818181817,0.7912893125176687,1.0,22/120,11.93%,COL9A3;BGN;MMP2;FBLN5;BCAN;HSPG2;AGRN;COL8A1;ADAMTS6;COL9A2;COL4A4;ITGA4;CD44;LAMA5;FN1;VWF;ADAMTS2;NCAN;FURIN;ADAMTS3;MADCAM1;HAPLN1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.531386961894174,1.134189863249496,0.23076923076923078,0.8393877140265411,1.0,1/25,1.00%,BCL9
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.6026064126196786,1.1340388624001798,0.38,0.8379484981795267,1.0,1/15,0.39%,JADE2
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.6026064126196786,1.1340388624001798,0.38,0.8379484981795267,1.0,1/15,0.39%,JADE2
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.6937324052994096,1.1339165440434171,0.3695652173913043,0.8374347235918809,1.0,2/5,25.90%,GAD2;PAH
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.6774302120753491,-1.13380280039081,0.3684210526315789,0.7917702688960498,1.0,3/9,15.85%,CALR;HSP90B1;HSPA5
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.44295724127123143,1.1337802324397122,0.2,0.8369770160992122,1.0,18/92,13.69%,SOX9;ADGRL2;HTR2C;KIAA1217;SHROOM3;SLC2A12;ARHGEF17;ADCY5;CDC42BPB;CMTM4;TEAD1;CADPS2;SHC2;CEP170B;PTPRU;CHRD;CDC42EP4;SLC13A4
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4684589296648137,-1.1337448631310676,0.225,0.7911185013657923,1.0,13/57,12.65%,ZDHHC1;VPS37B;GORASP1;NACA;ICMT;ZDHHC6;GOLGA7;ZDHHC4;YIF1B;COX18;MICALL1;ZDHHC22;GORASP2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.6139560269671847,-1.1337185492167845,0.3469387755102041,0.7903583757507505,1.0,7/12,18.94%,VBP1;LDLR;CLU;PFDN1;PFDN2;CHRNA7;PFDN4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.7357092282539194,1.1336517215631106,0.39622641509433965,0.8365861571064428,1.0,1/6,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.6388303085051166,-1.1334599611596525,0.30952380952380953,0.7902467403470582,1.0,1/8,3.88%,MT3
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4349508176245036,1.1333585701213378,0.26666666666666666,0.8368207739018161,1.0,26/108,14.39%,RAB40A;RAB3A;PKP2;RAB10;PLEKHF1;MAP7;TSPAN5;KCNB2;RAB40C;WDR19;CAV3;RAB40B;MRAP;EMP2;RAB8B;PACS1;LIN7A;C2CD5;RAB29;SPTBN4;TNIK;PACS2;ANK2;DPP6;SEC16A;EFR3A
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6607988867954274,1.1329046681298571,0.3389830508474576,0.8374598529480628,1.0,5/13,16.11%,FABP3;ADIPOR2;PRKAA2;NCOR1;PPARG
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.5638708321650167,-1.132853508055161,0.2653061224489796,0.791044363536492,1.0,5/15,7.45%,GSTP1;GPX4;GSTM4;ALOX5;FADS1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.4589246303669502,1.1328468139941243,0.2692307692307692,0.8367964312185581,1.0,16/62,16.39%,FOXO1;TBC1D4;SLC39A14;AKT2;SORBS1;RAB10;KAT2B;RAB8B;SORT1;C2CD5;PDPK1;RAB31;TSC1;CPEB1;PPARG;OGT
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.41781980011061587,1.1328102616033848,0.18518518518518517,0.8359706746816751,1.0,24/99,14.08%,PTPRC;NEDD9;RELN;PAK1;CACUL1;MMD2;EFNA1;EMP2;SRCIN1;RPTOR;PAK2;EPHA4;MMD;DLG4;CAMK1;TNIK;STK3;MTCP1;IL6R;SNCA;STK11;BORA;CSF1;TAB2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.7047110379410291,1.132212444807817,0.3333333333333333,0.836198935328539,1.0,4/7,22.58%,ATG7;RB1CC1;ULK2;ATG2B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.7047110379410291,1.132212444807817,0.3333333333333333,0.836198935328539,1.0,4/7,22.58%,ATG7;RB1CC1;ULK2;ATG2B
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.4457229798042487,1.1322025468702714,0.2692307692307692,0.8353004101212829,1.0,22/62,22.80%,STMN2;SYNPO2;PAK1;BAIAP2;PSEN1;CAV3;LIMK1;CRACD;PROX1;CDC42EP4;CDC42EP3;VASP;PRKCE;FER;NAV3;TOGARAM1;FCHSD2;CARMIL1;CLASP1;MAPT;NCK2;APOE
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7640860278882439,-1.1321558445563702,0.3076923076923077,0.7923654189575612,1.0,1/6,6.65%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.566988960199307,-1.1317102279617584,0.32558139534883723,0.7929295764648874,1.0,6/30,9.67%,UBXN1;GABARAPL2;ALAD;RPL11;GIPC1;HSP90AB1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.43736246138379153,-1.1316249302791095,0.18181818181818182,0.792411746302871,1.0,13/77,5.50%,BGN;MMP2;PODN;THY1;PRRX1;RBP1;FIBIN;IGFBP7;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5707776729776123,-1.1315463700278974,0.3333333333333333,0.7918623029053644,1.0,3/23,6.68%,GSTP1;DUSP3;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.6602863909867743,-1.1311828324388566,0.40425531914893614,0.7922617882863964,1.0,3/9,13.89%,SLC25A4;SLC25A5;PARK7
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.43578517272077033,-1.131180827890853,0.23636363636363636,0.7914307344867471,1.0,17/86,15.31%,UBB;JUN;RPS27A;UBC;DUSP15;BAMBI;UBA52;STUB1;DDX5;FURIN;FNTA;BMP2;SMAD3;ITGB5;RGMB;TGFBR2;BMP8B
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.7188827353562239,-1.1311558420702763,0.37735849056603776,0.7906449277771882,1.0,4/5,27.83%,TGFBR2;IL18;CD81;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.41625989890914805,-1.1310214661194817,0.20967741935483872,0.79022999821416,1.0,19/117,9.25%,GSTP1;SIRT2;PMEPA1;THY1;CALM1;RTRAF;PPIA;SH3GL2;SFRP1;GSKIP;QARS1;CADM4;TAF7;PPP1R15B;CALM3;CACTIN;LYN;ZBED3;CEP85
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5785110368901113,-1.1307017189218491,0.2857142857142857,0.7902173100529694,1.0,2/12,5.07%,BRPF3;NPM2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.5066676719369151,1.1304231798871855,0.24074074074074073,0.840024998315624,1.0,5/35,5.05%,PTPRC;KLF6;HDAC4;LMBR1L;PTPRJ
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.39292012831726575,-1.1301505539973529,0.22448979591836735,0.7910173600796689,1.0,23/208,9.99%,UBB;TAF9B;PSMB6;MBD6;PSMD8;RPS27A;ACTB;PSMB4;UBC;USP51;PSMA7;UBA52;JOSD2;ADRM1;PSMC3;PSMD10;ATXN7L3;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;ENY2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6636198480423868,1.1300751412469832,0.425531914893617,0.8402645691748845,1.0,2/8,18.43%,PARD3;DGKD
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.646139660725177,1.1295341583968315,0.36538461538461536,0.8411436654608496,1.0,6/11,28.40%,SLC8A1;SLC9A9;SLC6A1;SLC9A5;HCN2;SLC9C1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.6745307763554637,1.1285428856720485,0.3333333333333333,0.8433645261683351,1.0,1/7,0.95%,MYRF
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.590016099380922,1.1280739323459814,0.33962264150943394,0.844032578846425,1.0,6/14,22.66%,ATG7;RB1CC1;ATG5;ULK2;ATG2B;ATG3
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6212880622505907,-1.127904630382609,0.38636363636363635,0.7969790988625988,1.0,1/7,0.55%,SIRT2
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.49976489220883946,1.127853894405329,0.2826086956521739,0.8440179706961756,1.0,12/42,12.64%,TMSB4X;LRRC19;SPI1;SASH1;TRIM44;CYLD;PTP4A3;HDAC7;CD27;NMI;BMP7;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6878384638576052,1.1277887495739758,0.4074074074074074,0.8432581618104708,1.0,4/8,21.36%,TMSB4X;NOS1;PPARGC1A;ENO1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.584417861381283,-1.127605246557553,0.28,0.7970133904035385,1.0,9/17,25.83%,HSP90AB1;MKKS;CLU;TMEM35A;HSPA4;PSMG1;HSPD1;HSP90AA1;HSPA1A
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7255505268778447,-1.127298107051521,0.34782608695652173,0.7970908170374993,1.0,2/6,12.58%,CDH3;BMP2
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.572974346735037,1.1270868731173773,0.28888888888888886,0.8443880277649067,1.0,6/19,18.60%,FOXP1;TIRAP;IRF1;TRAF3;APPL2;SAMHD1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.6118919530269596,1.1270026377894444,0.2631578947368421,0.8438342429024087,1.0,5/12,18.82%,SOX9;ZBTB16;TRPS1;MBOAT2;TAPT1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.5864240480810365,1.126954944818442,0.3275862068965517,0.8430448523594775,1.0,4/15,13.96%,NNMT;NMNAT2;PARP9;NUDT12
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.45062312565575685,-1.126887940205119,0.17777777777777778,0.7973730995621288,1.0,14/59,16.68%,IPO13;RAN;PTTG1IP;PRICKLE1;RPL23;KPNA2;PHB2;PPP1R10;NUP155;FAM53C;RANBP17;RANBP6;AKT1;KPNA4
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.48862183723071767,-1.126858869749589,0.24444444444444444,0.7966199924073597,1.0,6/46,7.45%,GPX1;GSTP1;GPX4;GSTM4;ALOX5;FADS1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.5022845982051773,-1.1268579830898895,0.2653061224489796,0.7957823268002017,1.0,5/32,12.41%,SMYD2;USP51;FXR2;RFWD3;CASP9
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.7021710129174263,1.1267797756076772,0.34545454545454546,0.8428271050880976,1.0,2/5,4.37%,CHRM3;AHCYL1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.690883531511601,1.1264118075755765,0.3191489361702128,0.8430394817918563,1.0,3/6,18.10%,RYR3;SNCA;ANK3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.6352236178971171,-1.1262218298789808,0.3695652173913043,0.7965383790796497,1.0,4/7,18.52%,CAMSAP3;CDC42;MSN;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.5398917083407336,1.125884029477604,0.3170731707317073,0.8440560931025358,1.0,4/22,12.96%,STMN2;TBCD;SSH2;SNCA
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.6208985576016901,-1.125630531574094,0.3392857142857143,0.7976689262111617,1.0,3/11,15.85%,ATF4;QRICH1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.6022654818292358,-1.1255378161107727,0.2608695652173913,0.7970796754968716,1.0,1/14,0.07%,PPIF
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.7460996945841689,1.1254709963154828,0.3333333333333333,0.8444810080957623,1.0,3/7,16.11%,DND1;NCOR1;PPARG
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.49656997120309043,1.1254612117767133,0.3333333333333333,0.8435988796447083,1.0,4/30,8.74%,RTN1;ABCA2;EFNA1;EPHA4
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.6607392622564925,1.1251120395946843,0.3137254901960784,0.8438094825176445,1.0,4/8,22.52%,BBS4;CCDC120;NIN;HOOK3
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.6693809444260084,1.1248217799177445,0.3137254901960784,0.8437846113651116,1.0,4/8,24.13%,NRCAM;SIN3A;APOE;ABL1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5516792642490984,1.124459696154129,0.32,0.8438344899656366,1.0,2/20,0.83%,HOOK1;KIF1C
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.6922959369052772,-1.1243287619741895,0.41304347826086957,0.8000730351303544,1.0,3/5,23.35%,UFL1;HSPA5;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.7223572816823037,-1.1242273921256392,0.43137254901960786,0.7995789056062917,1.0,3/5,17.53%,EPB41;GNAI1;NUMA1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.5688830291743141,1.123816085107459,0.3877551020408163,0.8449075373966949,1.0,5/12,23.18%,UFD1;SEC14L1;ZCCHC3;NOP53;ANKRD17
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.650986220289132,-1.1238060957010612,0.3469387755102041,0.7998776290680863,1.0,4/9,16.89%,VPS35;MFF;FIS1;BAX
prerank,PanglaoDB_Augmented_2021__T Cells,0.5388929841061614,1.1222248798022123,0.2916666666666667,0.8488850228816482,1.0,9/31,16.99%,PTPRC;CD160;RORA;TRAF3IP3;CREM;CD247;MAFF;PXDC1;CERK
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.6626459929838079,1.1220900500820232,0.40350877192982454,0.8484931149715939,1.0,2/9,16.99%,KCND3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5843022147818248,1.121523237016096,0.31343283582089554,0.8496000971472002,1.0,1/13,0.28%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.6410992735212315,1.121309634868021,0.3584905660377358,0.849462972228736,1.0,2/10,5.05%,PTPRC;PTPRJ
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.5999230357936304,-1.121258392486182,0.32653061224489793,0.8063967881376585,1.0,7/17,24.32%,HIPK1;PHLDA3;DYRK2;USP28;AEN;PML;RPS27L
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6791702981935288,1.1206957244962725,0.2916666666666667,0.8507361226337622,1.0,3/9,9.08%,FOXO1;CAV3;MLIP
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.7125720823985358,1.120334272902608,0.37037037037037035,0.8509051697449888,1.0,2/6,4.91%,MYRF;PARD3
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.43317109284279953,1.1201045865609565,0.2727272727272727,0.8507882344026061,1.0,23/101,14.24%,LIFR;NUAK1;CHST3;ADGRL2;EDNRA;KCNJ11;TENM3;FAM13C;ARHGEF17;TLN2;ADCY5;HSPA12A;TEAD1;ARNT2;CRMP1;SHC2;RBFOX2;GJA1;IL6ST;NOS1;ANK2;ABCC8;DCLK1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5573150386911406,-1.1197851299745898,0.3269230769230769,0.81012608208688,1.0,2/18,3.29%,GPX1;NT5E
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.3953414824130158,1.119540298399866,0.21153846153846154,0.8517599482245269,1.0,15/125,6.96%,VSIR;IGF1R;FAM107A;NEDD9;AKT2;MYLK;SEMA3A;SEMA4B;PAK1;TIAM1;NTRK3;PLET1;PRKCA;GCNT2;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.7121918181179877,1.1190860980441695,0.4126984126984127,0.8516515200984943,1.0,3/6,18.58%,CAMTA1;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7121918181179877,1.1190860980441695,0.4126984126984127,0.8516515200984943,1.0,3/6,18.58%,CAMTA1;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5623462681825739,-1.1184955496617182,0.25,0.8133142648603504,1.0,10/25,16.62%,UBXN1;GAPDH;CSTB;TIMP4;CST3;TIMP2;PARK7;TIMP1;LRP1;AKT1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5463291821692464,1.1183767951512678,0.3877551020408163,0.8527455558705105,1.0,7/16,30.91%,RAP1B;SLC4A8;RAB3GAP1;NLGN1;RAB5A;DTNBP1;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6009579706315581,-1.1183368359631998,0.2765957446808511,0.8128515506007582,1.0,4/12,12.58%,TENM4;PTPRZ1;PTN;BMP2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.68088718513081,-1.118275297309312,0.4318181818181818,0.8121236818277647,1.0,1/5,2.44%,RBP1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.46618910334398794,-1.118167104606274,0.2727272727272727,0.8115568288177958,1.0,18/56,16.45%,UBB;RPS27A;UBC;MALT1;CTSC;UBA52;ZYG11B;CTSF;FBXO44;STUB1;HM13;CTSL;ISG15;CTSK;NGLY1;PRPF19;CUL4B;VCP
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.6289578507999362,-1.11813422767296,0.3076923076923077,0.8107999454917727,1.0,5/9,20.58%,EIF5;EIF4H;DHX29;EIF4B;DENR
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6256552211501831,1.1179727138836397,0.33962264150943394,0.8531112558476593,1.0,3/10,14.09%,PKP2;RYR2;DSC2
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.48997016796678133,-1.1176920845738516,0.28,0.8112967958227375,1.0,5/35,6.31%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.5925201710051159,1.1172766771979303,0.3488372093023256,0.8546427952558924,1.0,4/14,18.10%,SCN8A;SCN2A;KCNMB4;ANK3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5360524116792351,1.1172652325107655,0.3333333333333333,0.8537668070035052,1.0,4/34,5.94%,JADE2;KAT2B;ING5;SPI1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5976597961877794,1.1172572131195884,0.3125,0.8528926985542346,1.0,4/14,27.97%,SLC12A1;SLC12A5;KCNMA1;ATP1B1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.6693232501212534,1.1167971542875559,0.3673469387755102,0.8536338215195481,1.0,4/6,24.13%,MAPK12;ATM;MAPK3;ABL1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.42880937485028514,-1.116746974065237,0.22,0.812873876905893,1.0,12/82,8.18%,PPIF;MT1E;JUN;MT2A;ZNF658;MT3;SYT11;P2RX4;HPCA;SMPD1;WNT5A;SLC25A24
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.4818477790992948,1.116403068441591,0.25925925925925924,0.8541012640718294,1.0,4/37,7.84%,ACACB;ABCA2;MKLN1;CNDP1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.648161650636321,-1.1163360978668866,0.38095238095238093,0.8131663521328365,1.0,1/9,0.37%,TUBB2B
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.565948203369619,-1.1162613858470802,0.3,0.8125484565409073,1.0,6/16,23.73%,MALT1;HLA-B;B2M;ZP3;HSPD1;HLA-F
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.7795261974941505,-1.1162334655474602,0.3333333333333333,0.8118155908769482,1.0,1/5,0.28%,EYS
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.5269777898294985,-1.1161500195740912,0.3181818181818182,0.8112425893094578,1.0,1/19,0.30%,BTC
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.5587736817467487,-1.1160685378764184,0.32,0.8107551359455376,1.0,3/14,9.67%,NT5E;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.6132211736503778,1.1159941185263158,0.28,0.8545467988687669,1.0,2/9,12.71%,KLF15;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.6160706776061633,1.1158284705751127,0.3584905660377358,0.8542708305124125,1.0,1/8,2.22%,SPRED2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5433047830342775,1.1157748800389748,0.3125,0.8535260280562982,1.0,4/17,8.74%,ABCA2;EFNA1;RANBP9;EPHA4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.511758467499983,-1.1156395838173871,0.2926829268292683,0.8113116651181981,1.0,1/23,0.15%,RPS2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6739120989420124,1.1155029190605406,0.3673469387755102,0.8534080439255167,1.0,3/9,18.57%,GALNT16;GALNT13;POGLUT2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6146990995077581,-1.1152786454605355,0.3148148148148148,0.8116249909988505,1.0,4/12,12.54%,SARS1;POP5;AARS1;DTD1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4924889083322734,1.1151021219198054,0.32,0.8537587344022425,1.0,8/40,12.56%,SPRED2;EYA4;EYA1;NPAS2;BRCA1;BABAM2;ATM;EYA2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4647567767601262,1.1149074752021226,0.23636363636363636,0.8535367704110435,1.0,11/52,13.91%,RAB17;TBC1D10B;DYNC2LI1;TBC1D13;CDKL1;ATG5;CYLD;TBC1D8;DMTN;TBC1D22B;TBC1D1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4654045840289968,1.1148795083602603,0.32,0.8527024284993376,1.0,18/49,21.97%,BAIAP3;RAB3A;TTN;SYTL4;CADPS2;MYOM1;RAB27A;STX1A;GOLPH3L;SNCA;TMED10;PPID;STX1B;RAB9A;MYH10;CLASP1;UNC13B;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.7063480677701899,1.1146997733970068,0.4117647058823529,0.8524094233217153,1.0,2/6,11.37%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5858398155575429,-1.1145497030459952,0.34146341463414637,0.8129995384325834,1.0,4/15,17.81%,ARFIP2;BRK1;CORO1B;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.5635300240380309,1.1144956018989618,0.3269230769230769,0.8523243446252935,1.0,5/18,9.13%,WNT7A;RELN;GRIN1;SHANK3;DLG4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5389279413498441,1.1144235960284055,0.3125,0.8516388983857409,1.0,7/31,15.07%,INPP4B;ITPK1;INPP5A;INPP4A;ITPKB;ITPKC;IMPA1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.746206522338136,-1.1142466863947478,0.37037037037037035,0.8131004358194875,1.0,2/5,14.24%,MALT1;RC3H1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5076356021254012,1.113935638540891,0.23404255319148937,0.8522167873071625,1.0,10/31,17.70%,IQSEC2;GRIK5;RELN;BCR;GRIK3;NRG3;PXK;BTBD9;SLC4A8;GRIK1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.6898960808714572,-1.1137168256454253,0.3695652173913043,0.813820152685282,1.0,1/6,1.67%,UBXN1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.44528632547949315,1.1135371244261467,0.29411764705882354,0.8526384687508832,1.0,22/54,22.29%,RNF157;SH3RF1;RAD18;BRCA1;UBE3D;DDB2;TRIM52;UHRF2;WWP2;UBE2D3;RNF213;UHRF1;RNF115;OBI1;DTX3L;SH3RF3;ITCH;NFX1;TRAF6;RNF10;TRAF2;RNF11
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.4034381517884842,1.1134477623600867,0.2727272727272727,0.8520167910572841,1.0,14/82,14.11%,LIFR;HDAC4;SRF;TIMP3;IRAK2;CALCOCO2;PRKCA;RIPK1;IL6ST;IL6R;NLRP12;SNCA;YTHDC2;PTPN13
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.5889728524662352,-1.1133572330822494,0.32608695652173914,0.8139200035941652,1.0,4/21,12.40%,JUN;CTDP1;TAF11;SAP30
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.6419545598341889,1.1132294979008421,0.38,0.8509833605674286,1.0,2/9,9.90%,KLF9;GAS2L1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.6419545598341889,1.1132294979008421,0.38,0.8509833605674286,1.0,2/9,9.90%,KLF9;GAS2L1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.45801464854723317,1.1131210005963519,0.30612244897959184,0.8504682770548533,1.0,14/64,18.44%,GRIN2A;TRPC4;ATP2B3;SLC24A2;RYR3;GRIN1;NALCN;PMPCB;SLC8A1;SLC8A2;TMEM165;PKD2;GRIN2B;ATP2B1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.6116411652124755,1.1129783063453609,0.3076923076923077,0.8500467793095363,1.0,5/14,23.85%,LRP2;PROX1;FZD9;NAP1L1;DISC1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5201654727283802,1.1127682133648877,0.28846153846153844,0.8497904432497488,1.0,2/22,4.31%,FAM107A;SPIRE1
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.5227987296173235,-1.1123795529907874,0.2978723404255319,0.8157158735975751,1.0,1/14,0.55%,SIRT2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5106073786583585,1.112358497091543,0.32075471698113206,0.8501295214504313,1.0,10/24,19.30%,YWHAH;NEDD4L;CAV3;FGF14;CAMK2D;PRKCE;HECW2;ANK3;GPD1L;DMD
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.4942697794646638,1.112310543684957,0.3269230769230769,0.849351103465451,1.0,8/46,12.56%,EYA4;WRN;USP9X;EYA1;NPAS2;BRCA1;BABAM2;EYA2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.4426655837772571,1.1121883325998685,0.32,0.8488711309202864,1.0,16/75,13.31%,CARD14;PAK1;NTRK3;PRKAR1B;ADCY5;EMP2;PRKAR2A;PAK2;TIRAP;ADCY3;PDPK1;TNIK;STK3;NRG1;STK11;BORA
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.42475746005548987,-1.1121630937411826,0.2608695652173913,0.8155207092035056,1.0,16/75,10.28%,EIF5A;PSMB6;PSMD8;TXNDC17;PSMB4;PSMA7;PSMC3;LIMS1;PSMD10;PSME3;TNFRSF14;PSMD12;PSMB9;PSMC1;PSMD2;TRAF5
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.6304060745277524,-1.1120961104603813,0.4090909090909091,0.8148139349632953,1.0,3/10,8.62%,LRRC8D;SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.37640272559194643,1.1120337296421932,0.1896551724137931,0.848494405525539,1.0,39/221,15.56%,CARD14;PTPRC;EFNA5;SOX9;IL5;BRAT1;AKT2;ENPP2;RELN;PAK1;NTRK3;FGF9;PTPRJ;CACUL1;MMD2;EFNA1;RB1CC1;RPTOR;DOCK7;PAK2;RIPK1;MMD;WDFY2;BMP8A;BMP7;CAMK1;TNIK;MTCP1;IL6R;NOS1;SNCA;GDF11;CSF1;TAB2;SEMA4D;FAM20A;FGF1;ARRB1;CSNK1D
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.5402629094205288,1.1120218884303312,0.36,0.8476282137393488,1.0,7/27,14.39%,PIP4K2C;SOCS4;PIP4K2A;ITPKB;ITPKC;PIK3CD;EFR3A
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.7276394794233777,-1.1119676335625062,0.40816326530612246,0.8144008794869393,1.0,1/6,1.12%,PPT1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5165964167466518,1.1119565310829769,0.32142857142857145,0.8469576864749943,1.0,12/27,22.95%,DGKG;CAV3;DGKZ;LMF1;ABHD12;ABHD6;DGKI;DGKD;LYPLA2;PLAAT3;APOE;PNPLA2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4818530789194237,1.1118073903397911,0.28846153846153844,0.8465433655519321,1.0,5/37,7.00%,CHRM3;MAP7;EFNA1;SH3BGRL2;CDS1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.622696089688154,1.1118000185314847,0.4074074074074074,0.8456920946494951,1.0,4/11,9.60%,RIPOR2;DOCK8;OXSR1;DUSP1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5107328739368803,-1.111657328927297,0.26,0.814687332177238,1.0,10/33,19.97%,BANF1;SHFL;IFITM3;ISG20;ISG15;IFIT5;IFIT1;SRPK1;MORC2;OAS3
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.7681286779877298,-1.1114412245568395,0.3170731707317073,0.814556511807477,1.0,2/5,8.01%,CCNK;PSMC3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.44402156858486524,-1.1109555708888945,0.2857142857142857,0.8153105242427343,1.0,20/67,16.96%,TUBB2B;DLL3;RND2;IGFBPL1;EFNA2;LINGO1;ACLY;OGDHL;TMEM179;ACHE;POU3F2;NCAN;GDAP1L1;ZDHHC22;MSI1;SCG2;FAM171A2;CSPG5;STMN1;TMEM59L
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6588854704056606,1.1109142704431096,0.4,0.847792216184464,1.0,4/7,28.44%,GRIN1;CPEB4;GRIN3A;PTK2B
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.6497206040983486,1.1107000032140728,0.5,0.8476221726280958,1.0,1/6,0.28%,PTPRC
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6331676053863912,-1.1105675112496862,0.40816326530612246,0.8156263693042235,1.0,3/9,16.65%,NT5E;ITGA4;MSN
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.5681622909889517,-1.1105144229260506,0.24,0.8149653310037762,1.0,7/23,14.78%,ROMO1;TIMM23;TIMM44;DNAJC19;AIFM1;GRPEL1;TIMM21
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.7451617256893535,-1.1104048955264105,0.38235294117647056,0.8145027579212758,1.0,3/6,23.70%,DACH1;MAD2L2;BHLHE41
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5695536107761461,-1.1104022343275075,0.2962962962962963,0.8136887269545704,1.0,2/14,5.27%,PPIA;KPNA2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.49523491577721906,1.1102388708520265,0.3090909090909091,0.8481122310828566,1.0,7/38,12.56%,EYA4;UBR5;EYA1;NPAS2;BRCA1;BABAM2;EYA2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.5914048964176304,-1.1100932554053493,0.4318181818181818,0.8137460829833305,1.0,3/9,22.52%,LDLR;CD9;CD81
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6654379087311445,1.110002643875042,0.3829787234042553,0.8480638817890035,1.0,2/7,10.98%,SYT1;STX1A
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6061449346412962,1.1100026267053238,0.35714285714285715,0.8471850591135744,1.0,2/12,7.31%,SOX9;ZBTB16
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.442404180488529,-1.1095847938044325,0.2692307692307692,0.8143618774767682,1.0,13/79,13.07%,UBB;PMEPA1;RPS27A;VEPH1;UBC;BAMBI;UBA52;STUB1;SPRY1;CAV1;BMP2;SLC2A10;SMAD3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.5887418249600785,-1.109523511165917,0.3508771929824561,0.8136951171990386,1.0,3/12,11.71%,ALOX5;DHRS11;PYCR1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6136380791871466,1.1092061389455892,0.391304347826087,0.8487769603663385,1.0,4/9,21.33%,DUSP1;XRCC3;PCID2;LCMT1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.7466314362086169,1.1090278984328987,0.3508771929824561,0.8486067776927005,1.0,2/5,24.54%,SHMT1;GMPS
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5464415697302578,1.1089399981991679,0.3392857142857143,0.8481744102107005,1.0,3/18,4.88%,FMO5;SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.6498121256399466,1.1086279819829323,0.36,0.8484389473900541,1.0,4/11,14.87%,STMN2;TBCD;SNCA;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.631933670693913,-1.108533195109209,0.3584905660377358,0.8162194293314288,1.0,3/9,16.14%,PRNP;RC3H1;IL18
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7091747733951637,-1.1083632910748924,0.38636363636363635,0.8159336982509897,1.0,4/6,21.61%,GSTM4;CRYZ;GSTM3;GSTO1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.4781570874330309,1.1079509780072352,0.2807017543859649,0.8498617636712503,1.0,11/36,21.93%,STMN2;PAK1;TBCD;CAV3;SNCA;PRUNE1;CAMSAP2;NAV3;TOGARAM1;CLASP1;MAPT
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.38521059225704596,-1.107914739735516,0.2857142857142857,0.8162872645113765,1.0,45/218,18.79%,UBB;TAF9B;PSMB6;MBD6;PSMD8;RPS27A;ACTB;PSMB4;UBC;USP51;PSMA7;UBA52;JOSD2;ADRM1;PSMC3;PSMD10;PSME3;COPS7B;PSMD12;PSMB9;PSMC1;COPS2;PSMD2;YOD1;UCHL1;RAD23A;SMAD3;PSMD4;OTUB1;COPS6;ACTL6A;PSMC4;COPS8;CFTR;VCP;ACTR8;PSMB2;AR;USP18;PSMD3;USP28;PSMD11;GPS1;OTUD5;COPS5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5555846784876799,-1.107580411588696,0.36,0.816506329013839,1.0,4/21,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.496604981012839,-1.1074911155887412,0.2727272727272727,0.8160052634699597,1.0,1/21,0.30%,BTC
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5264630016445428,-1.1074379568196966,0.3076923076923077,0.8153203255092214,1.0,4/23,5.97%,GPX1;GPX4;ALOX5;CBR1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.46438745163062367,1.107049041422558,0.32786885245901637,0.8520265597821881,1.0,9/49,12.95%,SAE1;POM121;RANGAP1;BCL11A;POM121C;EYA1;NUP93;STX1A;PIAS4
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.707895595357237,1.1069621960051197,0.4117647058823529,0.8514114452760766,1.0,4/7,24.02%,RAB29;SNCA;NSF;VAMP3
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6294690879305099,1.1060328394033303,0.3,0.8537208839586854,1.0,4/10,18.46%,GRM3;GRIK3;GRM1;HOMER1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.5157412627719824,-1.1059341843548878,0.3333333333333333,0.8186999911068358,1.0,7/23,11.15%,ACTG1;ACTB;PPIA;PDGFRA;FN1;GNAS;TLN1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6859612892431467,1.1057558904290332,0.46296296296296297,0.8536873433981017,1.0,1/5,1.69%,SOX9
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7299391378933061,1.1056308273941728,0.3584905660377358,0.8531526186606763,1.0,1/7,0.28%,PTPRC
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5188251752364574,-1.105630358487557,0.3488372093023256,0.8187312558942819,1.0,5/19,14.72%,SNRPB;CSKMT;GSPT1;PRMT1;VCPKMT
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.3860720776186513,1.1053391933114147,0.2807017543859649,0.853159788221714,1.0,31/141,18.46%,INTU;LIFR;YJEFN3;TULP3;RGS4;GRK4;GNG4;UBASH3B;TSPYL2;IRAK2;CAV3;GNG7;FBXL17;RORA;MAPK8IP2;RGS12;SULF1;CBFB;GRK5;TSPAN12;NLRP12;OVOL2;RGS5;AKR1C3;OGT;SLC8A2;GIT2;HHIP;ANKRD54;ITGB1BP1;HOMER1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6801169213126528,1.105190563417304,0.3673469387755102,0.8527167389216364,1.0,3/5,27.65%,CARMIL1;SNX33;MAPKAPK2
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.7072006555145234,1.105182421966509,0.3829787234042553,0.8518748233391118,1.0,1/6,7.65%,TMOD3
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.6027635753795437,1.105176412246579,0.35294117647058826,0.8510645800041637,1.0,2/11,11.03%,FAM161A;CAMK1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6506784079604528,1.1049732495840394,0.42857142857142855,0.8509042944613321,1.0,3/9,7.93%,DGKG;PLA2G15;DGKZ
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6252096116306675,-1.1046409971351276,0.26666666666666666,0.8206671284360129,1.0,5/15,20.05%,ESRRB;PTN;WDR43;CNOT3;CNOT1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6137947115773932,-1.1046293759505554,0.32608695652173914,0.8198575110877416,1.0,2/8,10.01%,ZNF830;EIF2B2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7430672400093156,1.1046145169670027,0.3389830508474576,0.8510930667457838,1.0,1/5,2.76%,AKT2
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.6897642030191271,-1.1046140430466056,0.41509433962264153,0.8191414872524888,1.0,1/7,3.91%,PPIA
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7098788252570066,-1.104344356094209,0.38596491228070173,0.8190292537002283,1.0,2/6,11.34%,DBI;PRELID1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4368594224331501,1.1041491210980532,0.29411764705882354,0.8518289024460473,1.0,21/59,23.46%,TBC1D10B;DYNC2LI1;TBC1D13;CDKL1;ATG5;CYLD;TRAPPC12;TBC1D8;TBC1D22B;TBC1D1;PLK2;MTMR3;RABGAP1;STX18;ALMS1;ATXN2;IFT140;ATG3;TBC1D12;C10ORF90;TBC1D2B
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.6612010462700936,-1.1038739705512188,0.42857142857142855,0.8197535916798935,1.0,3/6,11.90%,KDELR1;OS9;GPAA1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5512963232782926,-1.1036478077599823,0.3125,0.8195594586849916,1.0,3/13,5.83%,MMP2;JUN;ERN1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6313569418940235,-1.1035577018059313,0.3333333333333333,0.8182062963003581,1.0,5/11,16.62%,P2RX4;HSP90AB1;CLU;SMAD3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6313569418940235,-1.1035577018059313,0.3333333333333333,0.8182062963003581,1.0,5/11,16.62%,P2RX4;HSP90AB1;CLU;SMAD3;AKT1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.4593808731640523,-1.1034824379505992,0.2857142857142857,0.8176688737802629,1.0,14/46,17.89%,RAN;RBM22;CCT5;LARP7;BAG3;CCT3;YAP1;SMAD3;HDAC3;LAMTOR5;PARK7;CCT7;AKT1;TRIM28
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.5173772231680677,-1.1032571494839565,0.3333333333333333,0.8175689159243373,1.0,3/21,8.64%,TRIR;EXOSC8;NUDT16L1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6263960842334078,-1.1032150906196605,0.37254901960784315,0.8169115233761418,1.0,1/10,1.16%,ARPC5
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6361043307530644,1.103117701642532,0.35555555555555557,0.8544127268337721,1.0,3/8,29.21%,CSGALNACT1;GFPT1;UGP2
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5946972972223444,-1.1030501556138415,0.32608695652173914,0.816549164959275,1.0,1/15,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5974940274415411,-1.1028557840747808,0.4117647058823529,0.8164202536388628,1.0,4/17,3.91%,PPIF;PPWD1;PPIB;PPIA
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.7159656112508069,1.1025285778083012,0.41818181818181815,0.855441694302975,1.0,3/6,21.52%,SPI1;PLAAT3;KLF7
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6431473645083702,1.1022316167429234,0.33962264150943394,0.8556846331960007,1.0,3/7,29.32%,RAB20;SYT7;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5515101543724756,1.1020671327413707,0.3404255319148936,0.8553025465705189,1.0,6/18,25.69%,CPEB3;CPEB1;CPSF6;ZC3H14;CDK9;NELFE
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6540206431523574,1.1019647296420159,0.30357142857142855,0.8547429770453165,1.0,5/8,27.98%,MACF1;SEMA4D;MYO9A;NTNG1;MOV10
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.5196820977172302,1.1017926089640717,0.35294117647058826,0.8543922964204564,1.0,5/26,9.13%,WNT7A;RELN;GRIN1;SHANK3;DLG4
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4545272081694671,-1.1016602991302953,0.32653061224489793,0.8189299803418807,1.0,3/46,1.71%,SIRT2;BANF1;RAN
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.585073929784189,-1.101371406827966,0.2962962962962963,0.8189605558186298,1.0,4/13,13.33%,CAMSAP3;BAG3;CLIP3;CDC42
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.5132396382480321,-1.1007633696222536,0.2830188679245283,0.8199495099324324,1.0,6/23,13.89%,ATF4;PPIA;GPR37L1;NOL3;PYCR1;PARK7
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.5293331837734472,-1.1007129078535047,0.29508196721311475,0.8192533409177164,1.0,3/24,8.01%,CCND1;APH1A;WNT5A
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.48971637056657785,-1.1006918423002583,0.3877551020408163,0.8184981270270227,1.0,5/36,6.31%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.400735328661831,-1.1006114637568707,0.20930232558139536,0.8178651060455421,1.0,30/116,18.01%,PSMB6;CCDC88C;PSMD8;PSMB4;PRICKLE1;PSMA7;SFRP1;PSMC3;WNT5A;PSMD10;FUZ;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;KLHL12;CAV1;TLE4;BMP2;TLE6;PSMD4;PTPRO;PSMC4;PSMB2;AMER2;PSMD3;RUVBL2;AMFR;PSMD11
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.624623692731442,1.1004290272936443,0.37777777777777777,0.8580351166266041,1.0,2/9,6.47%,WNT7A;TGFBR3
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.6323301600818384,1.1001466656698073,0.3137254901960784,0.8582544626075791,1.0,3/8,19.58%,TMCO5A;SYCP3;SYCP2
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.48616212974692763,-1.099322871073741,0.28846153846153844,0.8206601140752221,1.0,10/34,15.51%,ATP6V0A4;ATP6V0E1;ATP6V1F;ATP6V1G1;ATP6V1B2;ATP6V0E2;MCOLN1;ATP6V0D1;RAB11B;FTH1
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5446788356603259,1.099095969607601,0.32653061224489793,0.8608503975674735,1.0,10/19,27.00%,NLRC5;RIPK1;TRIM44;PARP9;CSF1;PARP14;IL7;UBE2K;PRKN;C1QTNF4
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.6856971257104025,-1.099003055153794,0.39215686274509803,0.820889600992888,1.0,1/8,0.07%,PPIF
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7546167240501013,1.0989770244892245,0.33962264150943394,0.8603668819346055,1.0,2/5,15.07%,ITPK1;IMPA1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.5264572181186544,1.0987757602234518,0.3617021276595745,0.8601697969062894,1.0,2/24,8.68%,FMO5;RORA
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.6870476846660336,1.0987527362652771,0.44680851063829785,0.8593831024069539,1.0,1/6,2.22%,SPRED2
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.6847180408053376,1.0987142302342991,0.47368421052631576,0.858686401160519,1.0,2/7,15.50%,XRCC4;MSH6
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.559360599455442,1.0984136672708706,0.39655172413793105,0.8586780570601195,1.0,11/20,23.22%,PTPRC;CSF2RA;IL6R;CFLAR;IRF1;FPR3;IGSF6;PTPRE;TRAF6;NFKB1;CIITA
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.6854737409834297,1.098290954804134,0.37037037037037035,0.8581599297786943,1.0,2/5,18.09%,PMPCB;MIPEP
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),-0.6349702915898539,-1.0976303115672708,0.3269230769230769,0.8231407589990992,1.0,3/9,27.06%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),-0.6349702915898539,-1.0976303115672708,0.3269230769230769,0.8231407589990992,1.0,3/9,27.06%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.6640987135058849,1.0976277430776624,0.35135135135135137,0.8593470005021668,1.0,4/5,33.09%,IL7;PTK2B;RAB3D;ZNF675
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.6569383832688931,1.0975694230512774,0.375,0.8586237723364907,1.0,2/5,19.27%,WRN;POLH
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.5568864175446803,1.0973639111693831,0.37209302325581395,0.8584102611468294,1.0,6/18,19.37%,MRAP;DMTN;AP2M1;PPFIA1;ITGB1BP1;PICALM
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.6378062992065145,-1.097361536203996,0.3469387755102041,0.8231369195722339,1.0,1/8,1.37%,CCDC88C
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6121612800006644,1.0973143135771883,0.34545454545454546,0.8576601197908178,1.0,4/11,21.79%,SMC5;XRCC3;RAD54B;NSMCE2
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.6002313273733835,1.0971191852351299,0.3148148148148148,0.8574967711164049,1.0,2/13,8.03%,RFC4;GINS1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.5082778844662588,1.0969702285642855,0.3469387755102041,0.8570413922378284,1.0,11/30,25.78%,TRAK1;MYO1H;RAB1A;FBXW11;MYO7A;MYO1C;MYO6;TANC2;SYT4;ACTN4;CCDC186
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5412664077895917,-1.0968794321935906,0.39215686274509803,0.823943100523285,1.0,7/24,12.92%,LDLR;LIMA1;SOAT1;SCARB1;CLU;CAV1;LCAT
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.6996094629434232,-1.0968744232046175,0.5,0.8231892056096841,1.0,2/5,13.89%,NONO;PARK7
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4672902818261915,1.0967691842623821,0.2982456140350877,0.8567621593284075,1.0,11/29,19.37%,SYNJ2;SYT1;DNM1;STX1A;SYT2;SNCA;ITSN1;GAK;SNCB;DNAJC6;PICALM
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.4788061726254162,-1.0967360134779685,0.3181818181818182,0.8228759295593882,1.0,3/37,8.74%,SOX4;E2F4;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6303594436885678,1.0966602061403838,0.4117647058823529,0.8561917079848511,1.0,3/10,29.18%,CD27;IL7;ZMIZ1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.5692018592753243,-1.0964656516726232,0.34615384615384615,0.8229920143203951,1.0,7/17,13.24%,PGRMC1;TSPO;UROD;ALAD;ABCG2;UROS;NFE2L1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5494060343045316,-1.0963745467582227,0.375,0.8224205471321248,1.0,2/13,5.06%,FTL;NR2F6
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.7022548161299604,1.0963438683550337,0.3076923076923077,0.8563608170946452,1.0,1/5,9.06%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.6557253571120778,1.0959907416066317,0.4489795918367347,0.8568110784793493,1.0,5/8,21.73%,SGK1;NRG1;KCNQ1;MYO6;ACSL3
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5763572268843935,1.095860215731081,0.39622641509433965,0.8564168198244386,1.0,5/12,19.80%,TTN;NRG1;SLC8A1;AKAP13;CBY1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3802018284441415,-1.0958270418799352,0.23255813953488372,0.8230642818855293,1.0,33/133,18.01%,PSMB6;CCDC88C;PSMD8;PSMB4;PRICKLE1;PSMA7;SFRP1;PSMC3;WNT5A;PSMD10;FUZ;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;HMGXB4;KLHL12;CAV1;TLE4;BMP2;TLE6;RACK1;PSMD4;LRP1;PTPRO;PSMC4;PSMB2;AMER2;PSMD3;RUVBL2;AMFR;PSMD11
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.46085696447335983,1.0957777459510711,0.2978723404255319,0.855810223200996,1.0,16/49,15.42%,YWHAH;SYT1;NEDD4L;NKAIN2;KCNJ13;KCNJ11;CA2;SYT12;SPTBN4;PXK;SYT2;NOS1;SNCA;SYT6;WWP2;PER1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5501127404897546,-1.095576502652628,0.34545454545454546,0.8229511818393639,1.0,4/20,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.518511198057642,-1.0953665571100668,0.36363636363636365,0.8227985721412356,1.0,7/24,14.84%,PLEKHG5;RHOG;PDGFRA;CXCL12;SEMA5A;CORO1B;PRKCQ
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.6799030893600004,1.0952108716987852,0.37254901960784315,0.856675831547864,1.0,2/5,20.82%,BNIP3L;AFG1L
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.419625548568694,1.094835881386333,0.2222222222222222,0.8571046637276881,1.0,20/101,15.57%,HEY2;YWHAH;SRF;ALK;TCFL5;TIAM1;PHLDB2;SLC6A6;SUZ12;EMP2;SMOC1;CDK6;CBFB;CAMK1;TRPS1;CEBPD;CSF1;ZFHX2;MBOAT2;BCL6
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.40875677896396856,1.0947850154410046,0.26,0.8564605515051189,1.0,22/84,18.11%,MCCC1;CKMT2;ALOX12;GPAM;NAAA;ACSBG2;ACOT11;SLC6A8;SLC16A3;PDHA1;ME2;ACSF2;AOAH;CPT1A;PPARG;ME3;SLC27A4;HLCS;AKR1C1;CPT1C;ABAT;LDHA
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.3898857391864131,-1.094706137264105,0.20454545454545456,0.8239659691039452,1.0,32/174,13.65%,COL9A3;BGN;MMP2;FBLN5;BCAN;HSPG2;CD151;AGRN;COL8A1;PPIB;COL12A1;ADAMTS6;COL9A2;HAS2;COL4A4;ITGA4;CD44;LAMA5;FN1;VWF;ADAMTS2;NCAN;FURIN;ADAMTS3;MADCAM1;HAPLN1;CAPN1;TIMP2;CTSL;ITGB5;COLQ;CTSK
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.5896630279292079,-1.0945978447527265,0.28,0.82343597726168,1.0,3/13,5.97%,CUBN;RBP1;CBR1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5430293830576243,1.0944971297302788,0.35714285714285715,0.8564641937151173,1.0,4/18,10.30%,CAV3;RPTOR;RAP1GAP2;PRR16
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7496963072058215,-1.0943716276969695,0.4166666666666667,0.82338237594057,1.0,3/5,17.54%,NOP14;KRI1;RPS21
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.6835136178525147,1.09428169941275,0.38181818181818183,0.8562750391343497,1.0,2/6,9.04%,WDR19;RAB29
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3504454207435511,-1.0935054730749583,0.2553191489361702,0.8254758495313556,1.0,45/405,10.83%,RRAGA;UBB;CUL7;PSMB6;ELOB;UBE2D4;PSMD8;RPS27A;PSMB4;UBC;RNF167;TRIM35;RNF141;UBE2Q2;PSMA7;MAGEF1;UBE2L6;ELOC;TNFAIP1;RNF6;UBA52;UBE2J1;SELENOS;MARCHF2;FBXO45;CUL9;ASB1;PSMC3;PSMD10;RNF112;PSME3;FBXO44;PSMD12;STUB1;ANAPC11;RFWD3;PSMB9;UBE2Q1;PSMC1;RNF126;WSB1;PSMD2;CAND2;OS9;KLHL12
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.45649447201803695,-1.0930878866899791,0.26,0.8257762184725667,1.0,7/44,8.31%,HSPG2;AMOTL2;FERMT1;COL12A1;CDH3;S100A16;LRIG3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.5191267958501936,-1.0926751146366163,0.4,0.8263031284040343,1.0,1/23,0.13%,SOX4
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.6548577463924853,1.0926525157772995,0.4230769230769231,0.8604101197831054,1.0,3/7,20.94%,DAPK2;STK11;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.4385660023245521,1.0926045454443836,0.26666666666666666,0.8597268080138348,1.0,11/66,15.00%,FOXO1;DAPK1;TPCN1;PLEKHF1;RNF152;MID2;SVIP;STK11;BNIP3L;PRKAA2;PLK2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5337677691486726,1.092504918678378,0.3392857142857143,0.8591601725674635,1.0,8/26,21.19%,MYLK;PKP2;AHCYL1;ANK2;ANK3;ATP2B1;GPD1L;CACNA1D
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.47032905890430987,-1.0924947172643005,0.2916666666666667,0.8260200699628507,1.0,8/46,13.07%,G0S2;BAD;BAG3;DELE1;HIPK1;NGF;CASP9;SMAD3
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5786929746940879,1.0923931560681723,0.3508771929824561,0.8585178375202337,1.0,2/15,4.38%,SPIRE1;GULP1
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.5921548475297473,-1.0923802810134249,0.38,0.8256094311561891,1.0,3/8,14.24%,SFRP1;LYN;RC3H1
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5931750292488024,-1.092171082044908,0.3409090909090909,0.8254063545579495,1.0,1/12,0.97%,DNAAF2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.5262938117650874,1.0919905814707094,0.39473684210526316,0.858922310986071,1.0,3/19,2.86%,NEDD4L;KCNJ13;KCNJ11
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.7473013402755109,-1.0917123299972264,0.5,0.8260594742308222,1.0,1/5,3.93%,SH3GL2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.5231078629986363,-1.0914318716473028,0.3673469387755102,0.8261806600923376,1.0,3/22,6.57%,KIF25;DYNLT1;SAPCD2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.47769747952839237,-1.0911161048354787,0.30952380952380953,0.8263703394993872,1.0,6/26,12.24%,RHOC;RND2;RHOG;EPB41L3;RHOBTB1;IKBKB
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.39122165214771687,-1.0904504056247375,0.23529411764705882,0.8275895569686144,1.0,26/161,10.00%,IDH1;CALR;ATP5MC1;GAPDH;SQLE;TM7SF2;PRDX1;PPIA;TCEA1;LDLR;DHFR;SC5D;CTSC;IDI1;GBE1;CANX;FADS1;TUBG1;PSME3;PSMD12;HMGCS1;SEC11A;ACLY;TPI1;RPN1;PSAT1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.5930313871002064,-1.0897932400259958,0.37037037037037035,0.8286398546265321,1.0,3/12,11.77%,BANF1;RBM15B;NPM1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4915375645725913,-1.0895979354516558,0.2653061224489796,0.8284056762574223,1.0,4/23,5.83%,MMP2;JUN;HES5;ERN1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.4978470539647526,-1.0895553605802346,0.38461538461538464,0.8277318236094185,1.0,8/22,24.12%,CCNK;TCEA2;WDR43;EAF1;HMGN1;SUPT5H;KAT7;LDB1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5193389866664603,1.0895463995114636,0.3389830508474576,0.8657752006379279,1.0,4/19,10.58%,NDST3;HS3ST4;B3GAT3;SULF1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.6150504530414123,-1.0894273507149321,0.37254901960784315,0.8272058241556349,1.0,5/8,25.01%,LIMA1;SEMA5A;PLEKHH2;CFL2;MTPN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4593194065285167,-1.089325264504611,0.3541666666666667,0.8258349972707152,1.0,3/43,1.71%,SIRT2;BANF1;RAN
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4593194065285167,-1.089325264504611,0.3541666666666667,0.8258349972707152,1.0,3/43,1.71%,SIRT2;BANF1;RAN
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.6773309299268191,1.0893160850523702,0.4727272727272727,0.8657601178529374,1.0,1/6,7.18%,SASH1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.6342184653097245,-1.0892096950401453,0.4,0.8253610203086368,1.0,2/8,22.63%,BMP2;GREM1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4907199181556784,-1.0890206303116752,0.2727272727272727,0.8251020923350434,1.0,5/34,8.82%,PPP4C;PARP1;USP51;MAGEF1;FIGNL1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5606232234546428,-1.0888206140041565,0.35555555555555557,0.824931178911588,1.0,3/13,15.38%,MFF;FIS1;CSPG5
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6121621800029907,-1.0884873401984774,0.375,0.825168641830768,1.0,1/11,2.11%,MRPL44
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.6447101079050512,-1.088473426476427,0.41304347826086957,0.8244253167212278,1.0,2/6,12.58%,PAX8;BMP2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.5993745211186418,1.0879723120184077,0.38461538461538464,0.8687864243850656,1.0,3/15,10.44%,RFC4;GINS1;LIG3
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.5550937818231525,-1.0878155885129706,0.3404255319148936,0.8253319104838616,1.0,1/9,0.55%,SIRT2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.5928832525463047,-1.087430258614724,0.40425531914893614,0.8255005046612771,1.0,1/9,3.88%,NLGN2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6951668096540076,-1.0873931149601594,0.43137254901960786,0.8248460827444081,1.0,3/6,22.75%,GALE;GALK1;PGM2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.7216549748981759,1.0868936516444216,0.4716981132075472,0.8712239791768369,1.0,1/5,2.53%,STAT4
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.3614791242868528,1.0866019672890324,0.20754716981132076,0.8714136170924074,1.0,56/305,13.65%,IL1RAPL2;CHRM3;ROBO2;INTU;IGF2BP3;EFNA5;RAPGEF5;HDAC4;ARHGAP26;CRIM1;PCDHB12;IGF2BP2;MERTK;MOBP;PCDHB5;NRSN2;APBA2;RELN;SCN8A;BPNT1;TRAK1;B3GNT5;RBFOX3;NRGN;LIMK1;TEAD1;ZBTB16;TYRO3;ARNT2;NPAS2;NRCAM;PROX1;FBXL17;LSAMP;SHANK3;RAB29;CRMP1;DLG4;HES1;ATXN1;ZIC4;SCN2A;WWP1;CHST8;RBFOX2;ADGRV1;NRG1;ADAM22;ACTL6B;ATXN10;HPCAL4;ACVR1C;GDF11;NAV2;GDA;IGSF8
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.3862812156159746,1.086098952499912,0.22,0.8719271100797604,1.0,27/120,17.30%,INPP4B;SYNJ2;IGF1R;ADGRL2;RGS4;SCN8A;RXRA;PRKCA;TGFBR3;MAP2K5;ATXN1;DUSP1;GRK5;GJA1;APBB2;AKT3;MAGI2;PIK3CD;SIPA1L1;BHLHE40;PRKCE;CDK13;PPARG;NEK7;TJP1;PDLIM5;COL5A2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7090061431803452,1.085981689510808,0.32608695652173914,0.8715059817933158,1.0,1/7,11.98%,CD59
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.4227616171733231,-1.0856833141563647,0.35294117647058826,0.8284378745388287,1.0,15/80,14.63%,IPO13;CALR;RAN;PTTG1IP;PRICKLE1;CHCHD10;PHB2;RPL11;PPP1R10;NUP155;RPF2;MORC3;FAM53C;RANBP17;RANBP6
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.6949615651598193,1.085422736700354,0.43548387096774194,0.8718452003862845,1.0,3/5,18.85%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.6949615651598193,1.085422736700354,0.43548387096774194,0.8718452003862845,1.0,3/5,18.85%,CCDC39;DNAH11;CFAP43
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.6312684459150083,1.0852755189928371,0.38636363636363635,0.8714348784434974,1.0,4/8,18.90%,CLEC16A;RPTOR;CARD11;LARP1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.4912622881203293,1.0850476001267773,0.3392857142857143,0.8714049428761658,1.0,4/27,6.26%,AEBP2;PHF19;SPI1;SUZ12
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.5429354380392667,-1.0850287744099767,0.34782608695652173,0.8293179406991029,1.0,1/11,4.37%,LDLR
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.4085948928876639,1.0848942324522381,0.32142857142857145,0.8710148049950056,1.0,22/105,15.91%,RASGRF1;RACGAP1;ARHGAP26;RAC3;RELN;TIAM1;ARHGEF17;BCR;ARHGAP24;ARHGEF6;ARHGAP17;RHOJ;SRGAP3;SOS1;ARHGEF4;ITSN1;ARHGDIG;TIAM2;ARHGEF7;ARHGAP31;ARHGAP32;ARHGAP35
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.65985705190621,-1.084759512875322,0.375,0.8294435367066876,1.0,3/8,17.59%,PIH1D1;ZNHIT3;RUVBL2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.5899416363542326,-1.0847119194393016,0.38181818181818183,0.8288167938332003,1.0,2/14,4.80%,DBI;LPCAT1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.6224914313926546,-1.084709651022349,0.3617021276595745,0.8280370978841568,1.0,4/8,12.42%,CALM1;SRI;CALM3;CAV1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.6801721847534036,1.0845523372304848,0.41509433962264153,0.8713357744356236,1.0,2/6,19.37%,DNM1;PICALM
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5652824591841253,1.0841915670277409,0.39622641509433965,0.8715804249958465,1.0,7/18,19.40%,DGKG;PLA2G15;GPAM;DGKZ;DGKI;DGKD;MOGAT1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5848070949492254,-1.0841214682248324,0.37777777777777777,0.8288949837684731,1.0,3/11,15.46%,CTDP1;CHMP2A;UBE2S
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.6975228198922528,1.0837364983024544,0.4807692307692308,0.8721365523357765,1.0,4/6,16.48%,DENND6A;PTPRU;ADAM19;TJP1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6290737874037358,-1.0836927590152532,0.37254901960784315,0.8293858818980535,1.0,2/13,3.91%,PPIB;PPIA
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.636382253228687,1.083448811292625,0.4375,0.8720494200588016,1.0,2/11,3.66%,HEY2;TCOF1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.40912074844477553,1.0833268744285072,0.34615384615384615,0.8715190212859046,1.0,4/86,2.46%,RASGRF1;ITPR1;BCL2L11;TTC23L
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.509882435765978,1.0831089280917112,0.3333333333333333,0.8713383957253189,1.0,8/28,14.11%,PTPRB;UBASH3B;DUSP22;PTPRJ;DUSP4;DUSP1;DUSP8;PTPN13
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.6072103751139194,-1.0825328591398498,0.3076923076923077,0.8316337856553555,1.0,2/6,8.99%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6018502103095237,1.0819766091390444,0.39622641509433965,0.8743974293434308,1.0,4/8,12.96%,CTBP1;KLF15;BRCA1;SNCA
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.4539584804364399,1.0816936576149487,0.2807017543859649,0.8744119394301512,1.0,12/42,11.92%,PON1;ACSS3;PON3;SORBS1;EYA4;ARX;PCSK6;PROX1;ACSL1;ELOVL2;ABCA8;CHRD
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4195794892706379,1.081581074354372,0.26,0.8739470984526543,1.0,19/101,15.16%,FOXO1;DAPK1;TPCN1;AKT2;PLEKHF1;PLIN5;SLC4A4;PSEN1;RNF152;MID2;PRXL2C;PFKFB3;SVIP;SNCA;STK11;PRKAA2;PFKFB1;PLK2;GAPDHS
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.6784633953964442,1.0813988112588317,0.37254901960784315,0.8736427714464918,1.0,2/7,6.48%,SCEL;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5624108491246406,-1.0812969651738704,0.34782608695652173,0.8342421677439702,1.0,3/14,6.24%,PTTG1IP;VPS35;CTSC
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.39244465360470543,-1.0812299808694998,0.27450980392156865,0.8336432172999333,1.0,20/110,10.72%,PPIF;CCND1;ASCL1;UGDH;COX6C;BTG3;SLC16A1;BLVRB;FABP5;CXCL12;GALE;OPN3;SCUBE2;DCXR;MAPK13;PDLIM3;CD44;ISG20;SCARB1;PRKAR2B
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.5445999737233344,-1.0808596998786164,0.40384615384615385,0.8338787776752784,1.0,5/21,10.66%,CHRNA4;NIPSNAP1;P2RX4;USH2A;GNAS
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.6248925799886099,-1.0807393652656576,0.3125,0.8335588235047311,1.0,5/10,19.65%,PDGFRA;FUZ;EIF4A3;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6507126019747487,-1.0806659766667528,0.4,0.8329908727656622,1.0,1/8,3.82%,STOX1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.6983468741794405,1.0806017542168178,0.4067796610169492,0.8751119343677767,1.0,3/6,22.17%,MTHFD1;MTHFD2;SHMT1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.4863202587066085,1.080319817013819,0.3541666666666667,0.8752100469015406,1.0,7/31,11.09%,GLRA1;GLRA2;NSMF;SLC38A9;RPTOR;CPEB3;UBR1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3478226810565209,-1.0802198836487336,0.1794871794871795,0.8334747446117498,1.0,62/463,13.09%,NR0B1;HSBP1;CCND1;UBB;ZBTB32;SIRT2;JUN;TAF9B;ASCL1;RPL10;SMYD2;RPS27A;CALR;ATF4;PCGF2;ZNF491;UBC;MYT1L;HES5;ZNF688;PARP1;HDGF;RPL23;NR2F6;LARP7;EID1;BAG3;ZFP90;DRAP1;ZNF582;UBA52;ZNF558;EDNRB;DPF2;TAF7;SARS1;CBX5;PSMD10;CHD3;NOC2L;CNBP;ZNF124;DACH1;ZBTB21;NR2E1;DDX5;ZNF614;PHF6;MZF1;SOX8;ZNF337;ZNF77;AEBP1;SAP30;CAV1;BEND3;BMP2;YAP1;ZNF596;MOSPD1;SMAD3;HDAC3
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6589637585955352,1.0801397443852812,0.43137254901960786,0.874905384677533,1.0,2/7,12.96%,VAMP1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6896465230009264,-1.0798749956538434,0.4262295081967213,0.8328761103402614,1.0,1/5,0.24%,AURKAIP1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6896465230009264,-1.0798749956538434,0.4262295081967213,0.8328761103402614,1.0,1/5,0.24%,AURKAIP1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.7111764901816923,1.0798420229248094,0.425531914893617,0.8749941535668487,1.0,4/5,24.82%,GJA1;ANK2;KCNQ1;KCNA5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4460741438772818,-1.0796021676350038,0.25,0.8328634004937272,1.0,2/47,0.47%,CCND1;CDKN2C
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6000474481726074,-1.0795321954433015,0.37777777777777777,0.8322606677151049,1.0,5/11,27.63%,IFITM3;RO60;TPR;IFNAR1;EIF2AK2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.38551690875790173,-1.0792227047807739,0.2826086956521739,0.8323246172602605,1.0,36/167,18.37%,UBB;UBE2D4;RPS27A;PCYOX1;UBC;CDC26;RNF167;UBE2L6;ELOC;RNF6;UBA52;PPP1R11;FBXO45;ADRM1;STUB1;ANAPC11;PCYOX1L;RNF126;OS9;TOLLIP;UBQLN2;ISG15;RNF8;RC3H1;RNF168;UBQLN4;UBL7;UBE2S;RNF14;FBXL14;RNF146;BUB3;PSMD3;AMFR;PSMD11;UBE2I
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4650122241133335,1.0789742117330519,0.3333333333333333,0.8766900208791139,1.0,12/48,10.63%,AKR1C2;ROBO2;NR4A3;ARID5A;KLF9;NCOA1;NSMF;SLIT3;BCAS3;STAT5B;GAS2L1;RARA
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6308668947688306,-1.0788025299302813,0.3076923076923077,0.8324169458307955,1.0,2/13,3.91%,PPIB;PPIA
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6724049471782949,1.0787113451057664,0.37735849056603776,0.8766742234477427,1.0,2/5,11.57%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.49958571317752076,1.078701182641168,0.34615384615384615,0.8758656824895029,1.0,8/38,12.56%,EYA4;SPIRE1;FMN2;EYA1;NPAS2;BRCA1;BABAM2;EYA2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.40486817599217756,1.0786277165545153,0.2708333333333333,0.8753102652441603,1.0,20/102,13.18%,FKBP5;CLDN12;CHST3;ADGRL2;ZDHHC9;KIAA1217;SLC39A14;ARHGEF17;PLIN5;KCTD3;FKBP9;TEAD1;TSPAN9;RORA;CEP170B;PTPRU;RBFOX2;TSPAN12;CDC42EP4;PMPCB
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.4367580167979172,-1.0784527441475005,0.32608695652173914,0.8326799308179711,1.0,9/51,13.16%,ZDHHC1;PIGO;ZDHHC6;SELENOK;DPM2;PORCN;PIGF;ZDHHC22;WDR45B
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.6664245386969907,1.0784389258407978,0.39622641509433965,0.8752213551302771,1.0,4/6,16.64%,FOXP1;DYSF;CSF1;ADAM10
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5729457309465046,1.0778268287205706,0.39215686274509803,0.8762021287684145,1.0,1/13,0.17%,CHRM3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.7100679099597115,1.0773524727403097,0.3877551020408163,0.8761066633661678,1.0,2/7,20.31%,SLC12A1;SLC12A5
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.7100679099597115,1.0773524727403097,0.3877551020408163,0.8761066633661678,1.0,2/7,20.31%,SLC12A1;SLC12A5
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.7397353395485091,-1.0770376189896458,0.4634146341463415,0.8359386245829468,1.0,2/5,16.14%,TMBIM1;IL18
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.42237174998584814,-1.0770209990750763,0.3333333333333333,0.835193741940825,1.0,11/82,5.50%,BGN;MMP2;THY1;PRRX1;FIBIN;AMOTL2;TCEAL7;TNS2;SFRP1;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.6511416935896639,-1.0768233216182292,0.41509433962264153,0.8349896902098142,1.0,1/5,6.08%,VPS35
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.5622628143107185,1.0765528331972223,0.4074074074074074,0.8779648027657654,1.0,3/14,6.58%,WNT7A;CAV3;RFLNA
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.5720967842067025,-1.076244193081483,0.36363636363636365,0.8359868469563206,1.0,2/13,1.12%,S100A10;PPT1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.6869136070300731,-1.0756736571088075,0.45652173913043476,0.8368876974835859,1.0,2/7,7.68%,SFRP1;ATRAID
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.6141495943323874,-1.0756630830770928,0.425531914893617,0.836163562107179,1.0,1/10,8.01%,WNT5A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5485654460061361,1.075410258598514,0.32727272727272727,0.8805513439983457,1.0,7/19,27.75%,PARN;CNOT11;SAMD4B;SAMD4A;CNOT7;CNOT4;CNOT2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5894225089864982,1.0753706513373225,0.375,0.8798470738458771,1.0,3/14,11.51%,OTUD7B;SUFU;SIN3A
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),0.6666566359796584,1.075336563380092,0.47619047619047616,0.8791163942715472,1.0,3/5,26.87%,RDH12;RDH11;CYP1B1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.5995563840610986,1.075311151696447,0.4883720930232558,0.8783686187548798,1.0,3/8,11.96%,HTR2C;KCNC2;PDE9A
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.33345489191103794,-1.074991966991073,0.13157894736842105,0.837260605086507,1.0,90/640,13.09%,NR0B1;HSBP1;CCND1;UBB;ZBTB32;SIRT2;JUN;TAF9B;PRDX5;ASCL1;RPL10;SMYD2;RPS27A;CALR;ATF4;ZNF658;PCGF2;ZNF491;UBC;ZNF12;TCEAL7;SAP18;MYT1L;HES5;ZNF688;MT3;HSPA8;PRICKLE1;PARP1;HDGF;RPL23;NR2F6;SFRP1;LARP7;EID1;ZFP90;DRAP1;ZNF582;PHB2;UBA52;ZNF558;PA2G4;QARS1;EDNRB;DPF2;YWHAQ;TAF7;SCML1;LBH;SARS1;CBX5;ZBTB33;WNT5A;LIMS1;CREBZF;PSMD10;NACC1;SET;CHD3;NOC2L;CNBP;ZNF124;RBM15B;DACH1;ZBTB21;NR2E1;DDX5;RING1;ZNF614;PHF6;MZF1;BRD7;SOX8;ZNF337;ZNF77;AEBP1;MYBBP1A;ZBTB14;CDKN1C;PRMT6;SAP30;CAV1;BEND3;BMP2;YAP1;HIC2;ZNF596;MOSPD1;SMAD3;HDAC3
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.3867878531027375,1.0746155499268397,0.3181818181818182,0.8797451257286047,1.0,30/127,17.81%,OLFM3;STMN2;GALNTL6;ATP2B3;SULT4A1;CPNE5;CHRNB3;MMD2;PRKCA;SNAP25;PSD2;ADGRB3;CDK14;CRMP1;NEFL;CLVS2;MTUS2;ACTL6B;ERC2;ASTN1;CALY;DPP10;LRRTM1;NELL1;KLHDC8A;TMEM163;SLC8A2;CELF3;SNCB;NEFM
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7368189028925771,1.0745604614431468,0.5294117647058824,0.8790442737826265,1.0,3/5,25.21%,RXRA;PPARG;ACTN4
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3599833627179842,-1.0741971515763835,0.3409090909090909,0.8389397051115215,1.0,15/134,9.79%,CDKN2C;RAN;SNRPB;RANBP1;EXOSC8;KPNA2;H2AZ1;NOP56;TBRG4;SMC1A;PA2G4;TUBG1;CBX5;GINS3;KIF18B
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.4251387851274618,-1.0739288312155462,0.3389830508474576,0.8388839263145902,1.0,12/66,13.92%,DBI;PPIA;SH3GL2;CADM4;PPP1R15B;CACTIN;LYN;ZBED3;YWHAB;BEX4;PARK7;PRNP
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.42848617851242715,1.0739260557061368,0.41304347826086957,0.8800859002101447,1.0,15/61,17.44%,SLC6A17;LRP2;SLC13A3;SLC4A4;ABCA2;SLC6A6;SLC1A4;SLC29A2;ATP8A1;SLC19A1;SLC2A3;SLC8A2;SLC4A8;SLC27A4;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.48064631737729013,1.0739212665753228,0.2857142857142857,0.8792571940894195,1.0,5/29,12.96%,RAB3A;SYTL4;CADPS2;RAB27A;SNCA
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4186506878886085,1.0738438977506448,0.3333333333333333,0.8786047547989739,1.0,7/75,7.22%,PTPRC;SYT1;RAB17;RAB3A;RAB10;HIP1;RAB8B
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.4686609856031071,-1.0735558687450115,0.3392857142857143,0.839176171008754,1.0,5/45,5.19%,SIRT2;BAD;ZFP36L1;MT3;SFRP1
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.6333567612533251,1.073426208224848,0.39622641509433965,0.8792396515127556,1.0,3/8,21.76%,MACROH2A1;MAPK3;CDK9
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.6164718586084008,1.0734234523830888,0.3409090909090909,0.8784232522466131,1.0,6/15,18.55%,TTN;CAV3;PIEZO1;PIEZO2;PKD2;LHFPL5
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.5993994965072116,1.0732932966278277,0.42592592592592593,0.8779934936816969,1.0,5/10,18.75%,TDRD9;HSF2BP;MEIOC;SYCP3;MYBL1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6150237198670341,-1.072988716994904,0.44,0.840003374226908,1.0,4/12,5.78%,SFR1;LOC400499;SFRP1;WBP2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5024081997302664,1.0729011778152904,0.3404255319148936,0.8783706794723225,1.0,7/30,21.82%,KAT2B;CAV3;BRCA1;CCP110;SCFD1;LIMK2;SMAD4
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.5859053256315085,-1.0726676287732566,0.35555555555555557,0.840275285041206,1.0,1/10,3.88%,NLGN2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6886673480855466,1.0726166821475038,0.46296296296296297,0.8784085315595753,1.0,2/5,24.13%,TTBK2;ABL1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6059186809484165,-1.072512518232149,0.4583333333333333,0.8398902771569874,1.0,3/11,13.65%,SYT11;FER1L5;RACK1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.39863363390503687,1.0724994206680105,0.3076923076923077,0.8779525622342936,1.0,20/131,14.24%,RASGRF1;STMN2;WNT7A;SHTN1;PAK1;CNTNAP1;WHRN;DOCK7;EPHA4;SHANK3;CNTNAP2;DLG4;FRYL;SGK1;BMP7;TNIK;ADGRV1;ATXN10;MAP4;DCLK1
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.6294652869538628,-1.0722988421489879,0.4716981132075472,0.839637137795366,1.0,2/8,14.84%,NOC2L;MTA2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.67250596690166,1.072219470669001,0.4230769230769231,0.8780638142071822,1.0,2/6,4.67%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3887966238818472,-1.072207253304659,0.3695652173913043,0.8391410935393163,1.0,20/76,18.01%,PSMB6;PSMD8;PSMB4;PSMA7;PSMC3;PSMD10;PSME3;FBXO44;PSMD12;PSMB9;PSMC1;PSMD2;DMAC2;PSMD4;PSMC4;CUL4B;PSMB2;FBXL14;PSMD3;PSMD11
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.5312675030261871,-1.0719939185477974,0.36363636363636365,0.838982618187289,1.0,5/19,13.09%,RAN;RBM22;BAG3;SMAD3;HDAC3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5954402228044383,-1.0719002257175383,0.38636363636363635,0.8384787330966625,1.0,2/11,13.57%,MFF;FIS1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.49416003642075046,-1.0718759795810289,0.32653061224489793,0.8377517339336444,1.0,3/20,5.74%,RBM22;PTPN14;BAG3
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.6904865215405549,-1.0717245605181946,0.40350877192982454,0.8373711282337726,1.0,1/5,0.29%,S100A10
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.6671527456617168,-1.0717087292715395,0.4444444444444444,0.8366464599198801,1.0,1/5,5.74%,BAG3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.6380669158135338,1.0714469894504262,0.3508771929824561,0.8796715970107629,1.0,5/6,33.99%,CD247;KLRC4-KLRK1;PYHIN1;GPR171;CD96
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.540294867208434,1.0711929137217566,0.375,0.8796625046099172,1.0,7/23,15.42%,GADD45A;SPI1;SASH1;CYLD;DUSP1;RELL1;PER1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.6760292026197283,-1.0709632146825154,0.4222222222222222,0.8368845142817961,1.0,1/5,6.43%,DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.6760292026197283,-1.0709632146825154,0.4222222222222222,0.8368845142817961,1.0,1/5,6.43%,DUSP3
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.6124238686532872,-1.0709166711055282,0.4406779661016949,0.8362737684476593,1.0,3/9,13.58%,CHRNA4;ACHE;COLQ
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.6041351651038349,1.0707142979138031,0.44,0.8804641696443987,1.0,1/10,3.00%,NNMT
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.46007551312854594,1.0706974093213915,0.3888888888888889,0.8796625725275433,1.0,15/53,17.86%,SLC6A15;SYT1;RAB3A;SYN3;SNAP25;LIN7A;NAAA;GABRA2;STX1A;SLC29A2;STXBP3;CPLX1;PPFIA1;GAD2;UNC13A
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.676856252079996,1.0706398202568443,0.47058823529411764,0.8790079466882386,1.0,3/6,26.02%,AKAP5;EHD1;ZDHHC2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5536785249804796,1.0705881922737077,0.43103448275862066,0.8783636216711918,1.0,7/16,22.30%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;PRKACB;ADCY2
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.577839254393215,-1.0704323755905387,0.40384615384615385,0.836917459124755,1.0,4/13,14.01%,FGFBP3;SPRY1;DSTYK;GPC1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4477431916054423,1.070326534014801,0.2830188679245283,0.8784737688871194,1.0,17/57,16.11%,SOX9;CRIM1;SMOC1;RANBP3L;CDK6;NBR1;HDAC7;ZHX3;BMP7;SUFU;RORB;IL6ST;CHRD;IL6R;SEMA4D;NELL1;PPARG
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.6467891980036099,1.0697647619387889,0.5238095238095238,0.8793181543074121,1.0,4/8,22.80%,KCNC2;NOS1;AGT;APOE
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5328390840778603,-1.069719244998869,0.34146341463414637,0.8381072387736046,1.0,1/18,1.03%,PRDX5
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.6499378905594725,-1.0692314367044933,0.4489795918367347,0.8387759064975502,1.0,2/6,8.24%,SIRT2;RCC2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5093822452720103,1.0691508526476357,0.41304347826086957,0.8803512091657465,1.0,9/27,21.76%,CTBP1;BRCA1;TADA2A;NOS1;ARRB1;PPARGC1A;MAPK3;NIPBL;CDK9
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.708028907366197,-1.0688756829944945,0.42105263157894735,0.8389989456946987,1.0,2/5,14.15%,NLGN2;LRRC4
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.5138654433096373,-1.0680738298502788,0.38095238095238093,0.8405998874946086,1.0,2/27,3.84%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.5133723469453187,1.06788184146929,0.3333333333333333,0.8836178000044322,1.0,11/24,25.62%,BBS10;BBS4;TMEM216;CSNK1D;CEP290;TOGARAM1;ARL13B;C2CD3;IFT122;DISC1;CEP250
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.4864002597411784,1.0674835769597142,0.36,0.8840662762578202,1.0,7/26,9.13%,PTPRC;NEDD9;RELN;EFNA1;SRCIN1;EPHA4;DLG4
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5373759188601547,1.0672529887762494,0.36363636363636365,0.883854465481007,1.0,3/16,8.68%,FMO5;ABCA2;RORA
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.6873417521011287,1.0672116573773054,0.48,0.880698020639253,1.0,1/6,11.59%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.6873417521011287,1.0672116573773054,0.48,0.880698020639253,1.0,1/6,11.59%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.6873417521011287,1.0672116573773054,0.48,0.880698020639253,1.0,1/6,11.59%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.6873417521011287,1.0672116573773054,0.48,0.880698020639253,1.0,1/6,11.59%,ELOVL2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5081411572427014,1.0671863955574716,0.32608695652173914,0.8800047084122811,1.0,10/25,17.24%,SOX9;GADD45A;HABP4;TMEM150C;PIEZO1;CASP8AP2;IRF1;PIEZO2;MAP2K4;MAP3K14
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5262731987109672,-1.067059468727177,0.40350877192982454,0.8426415566695995,1.0,5/23,7.54%,GSTP1;ROMO1;DHRS4;CBR1;DCXR
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.7305848521417186,-1.0669657729056765,0.3888888888888889,0.8420756431100647,1.0,2/5,22.89%,CBLL1;GRB2
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.6673674707888758,-1.0669530139302088,0.45454545454545453,0.8413446925202802,1.0,2/5,8.99%,CXCL12;BRK1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.7028035052734428,-1.0667488796017202,0.4318181818181818,0.8410298258440151,1.0,2/6,7.72%,TRMT112;APEH
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.40827439871946375,-1.066656997314028,0.29545454545454547,0.8405221411049865,1.0,20/87,17.75%,GTF2F1;RAN;ACTB;TMBIM6;BAMBI;IFIT2;RPL11;CAV1;BMP2;B2M;RACK1;EPB41;PARK7;IFIT1;LRP1;TRIB3;FLOT1;AKT1;BAX;AMFR
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.4964704648132411,1.0660317730108682,0.4074074074074074,0.8825558419233839,1.0,6/29,19.54%,OTUD7B;SIN3A;PARP9;EIF2AK3;DTX3L;LIMK2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5592945174221331,-1.0659779062289036,0.43137254901960786,0.8414782490499594,1.0,5/16,16.67%,CDKN2C;CDKN1C;ANKLE2;DYNLL1;CDKN2D
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5592681845204188,-1.0657502277400375,0.3695652173913043,0.8413755320938715,1.0,3/14,13.12%,SFRP1;ULK3;EVC
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.5408635617718603,1.0655629141898089,0.4166666666666667,0.8831904864435686,1.0,3/18,3.13%,FOXO1;PCSK2;G6PC2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6357691552360719,1.0652120586901979,0.45901639344262296,0.8835101085357535,1.0,4/9,14.59%,SPI1;SERTAD2;PADI2;ARID1B
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.4046439703312133,1.0651776871983658,0.26666666666666666,0.882852597310885,1.0,18/118,10.80%,PTPRC;PTPRR;HTR2C;EPHA7;SPRED2;NTRK3;TIMP3;LMO3;DUSP4;PRKCA;TGFBR3;GCNT2;PRXL2C;RANBP9;ROR1;TIRAP;TRAF7;ARRB2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.6159594552268952,-1.06480782171108,0.4090909090909091,0.8431649039037936,1.0,3/11,22.52%,LAMTOR4;LAMTOR5;CD81
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.583449738521178,-1.0647304420392687,0.36363636363636365,0.8426112468052793,1.0,4/10,21.44%,SEPHS2;PSAT1;PSPH;PHGDH
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.6383785394869944,1.0647244593751237,0.4716981132075472,0.8833688642496877,1.0,3/6,13.07%,CHAC2;ABHD12B;ABHD12
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.46057556624064616,1.0647169315554192,0.36363636363636365,0.8825964295452353,1.0,6/40,12.63%,ARFGEF2;RAB10;MACF1;CCDC93;GOLPH3L;RAB31
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.6267769172994432,1.064532171716771,0.40384615384615385,0.8823614819099412,1.0,1/7,5.83%,EFNA1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6136564208637246,-1.0639151268623566,0.4489795918367347,0.8443046328618479,1.0,1/7,5.12%,PAX8
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5924650639534461,-1.063879393700369,0.359375,0.8436501938261763,1.0,1/11,0.30%,BTC
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.644975401327024,1.0638763844707944,0.3488372093023256,0.8835016325286918,1.0,1/7,0.69%,PTPRB
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.6632089148642228,1.0635729195990622,0.41509433962264153,0.8835070812302587,1.0,4/7,30.16%,DNM1;PICALM;DNM3;AP3D1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.5377385293241932,1.0633918421963304,0.38095238095238093,0.8832630358357576,1.0,6/14,24.67%,FUT2;DUSP4;OVOL2;LIPH;GOLPH3;QSOX1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5386160710525812,-1.0633584372852258,0.42857142857142855,0.844287239897914,1.0,1/17,0.49%,GPX1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.45158506696693096,-1.0630941205106976,0.31666666666666665,0.8441825651836907,1.0,6/51,7.58%,UBB;RPS27A;UBC;ZFP36L1;UBA52;MAPK13
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.6130473376264032,-1.0626997233553601,0.37254901960784315,0.8445165498491448,1.0,3/12,7.45%,GSTP1;ALOX5;FADS1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.6560768523727643,-1.0624349503717965,0.4791666666666667,0.8444666175737594,1.0,1/6,5.97%,CBR1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3884545847515609,1.062367718558633,0.3,0.8854051800166414,1.0,25/137,12.77%,PTPRC;PTPRB;INPP4B;ITPK1;EPHA7;ALK;GPI;G6PC2;PPA2;PAK1;ACYP1;PLA2G15;INPP5A;DUSP4;PIP4P1;PAK2;PFKFB3;INPP4A;PIP4K2A;TOP1;ITPKB;ITPKC;DUSP8;GPD2;PIK3CD
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5098404412786011,1.0618357852130447,0.3673469387755102,0.8863427448045094,1.0,4/20,15.50%,PMS2;PMS1;RPA1;MSH6
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6848390573689327,1.0613963778215985,0.42857142857142855,0.8860643428708276,1.0,2/5,4.67%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6848390573689327,1.0613963778215985,0.42857142857142855,0.8860643428708276,1.0,2/5,4.67%,FOXO1;KCNC2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3956746565557318,1.061296130502155,0.3469387755102041,0.8855529925518318,1.0,25/113,14.25%,GTPBP2;TMSB4X;SYT1;PCLO;RAB3A;RAB10;SYNGR2;TIMP3;TTN;SYTL4;TMEM79;SNAP25;VCL;RAB11FIP5;HABP4;ARHGAP17;SYT12;KNG1;STX1A;SYT2;TUBA4A;RAB31;SNCA;CPLX1;SYT6
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.6692182824059804,1.0612374663581632,0.49056603773584906,0.8848919208714887,1.0,1/5,31.44%,JAM3
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5046318229807645,1.0611060579994114,0.42,0.8845330709916609,1.0,6/19,14.25%,SYT1;SYT12;STX1A;SYT2;STXBP3;SYT6
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),0.6931362572018924,1.0610599473128322,0.4406779661016949,0.8838652731862952,1.0,2/5,6.48%,CAV3;EMP2
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.6317244628203993,-1.061025510590603,0.425,0.8477359365269926,1.0,5/9,19.71%,CRAT;OXSM;CROT;GLYATL2;ABHD2
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.441114428169847,-1.060896056518847,0.3333333333333333,0.8474463567824305,1.0,12/57,14.63%,IPO13;RAN;PTTG1IP;PRICKLE1;PHB2;LAMP5;PPP1R10;NUP155;LAMP1;FAM53C;RANBP17;RANBP6
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.612181841845304,1.0608255903556818,0.4426229508196721,0.8837554544759324,1.0,3/10,7.42%,BAIAP2;NTRK3;BCAS3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3755297754479039,1.060811674796023,0.3018867924528302,0.8830277580080831,1.0,36/127,23.53%,PTPRC;TPD52L1;IGF1R;HTR2C;NTRK3;PTPRJ;PRKCA;GCNT2;PRXL2C;ROR1;TIRAP;ZNF622;TRAF7;ARRB2;MID1;DENND2B;FGF1;JCAD;ARRB1;PRKCZ;RYK;PDE8A;LPAR1;BCAR3;ROBO1;MAPK3;GPR37;TAOK1;NEK10;MAP3K12;ERBB4;DAB2IP;APOE;FBXW7;IL34;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.674415236790212,1.0606132871767804,0.4482758620689655,0.8828042114301013,1.0,2/5,21.76%,MAPK3;CDK9
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6473132442326661,-1.060347905627845,0.5094339622641509,0.8481585522105782,1.0,1/6,6.08%,VPS35
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5243930731954827,-1.0603312228014816,0.40384615384615385,0.8474416801848724,1.0,4/21,5.78%,SFR1;LOC400499;SFRP1;WBP2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.40296023319937707,-1.0602900111667977,0.2909090909090909,0.8467805976187496,1.0,18/90,14.07%,SOX4;BCAN;DLL3;PPIB;RPL13;PRDX1;HES5;WNT5A;COL9A2;CD44;TRAPPC2;GNAS;NCAN;HAPLN1;BMP2;EVC;EXTL1;RAB33B
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6605165476696534,1.0602006365502188,0.45454545454545453,0.8824023556118152,1.0,4/7,28.46%,NFATC3;PPP3CA;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6605165476696534,1.0602006365502188,0.45454545454545453,0.8824023556118152,1.0,4/7,28.46%,NFATC3;PPP3CA;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.5119670765806956,1.0601321145693776,0.35185185185185186,0.8817224863717693,1.0,7/22,23.18%,PRKCA;SASH1;NMI;ZCCHC3;POLR3G;POLR3B;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.5771107073939896,1.0600077745370553,0.3541666666666667,0.8813514884410394,1.0,5/9,22.93%,ALK;BMP7;COBL;DAB2IP;PACSIN1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.6884640843133268,-1.0598761997176194,0.4888888888888889,0.846350817297318,1.0,2/5,16.10%,CAV1;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.6884640843133268,-1.0598761997176194,0.4888888888888889,0.846350817297318,1.0,2/5,16.10%,CAV1;KHSRP
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.5005650289648733,1.0597985955201736,0.40384615384615385,0.881244618981097,1.0,2/26,5.12%,PTPRC;DOCK8
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7014484794203931,1.0597554666514863,0.4444444444444444,0.8805676198885832,1.0,2/5,22.54%,MAPK8IP2;NCK2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.4001728543021798,1.0597257476029587,0.31666666666666665,0.8798743025288438,1.0,18/108,13.33%,AKR1C2;IGF1R;KITLG;AKT2;LRP2;NTRK3;FGF9;PTPRJ;HIP1;GCNT2;NRG4;P2RY12;PDPK1;ARRB2;NRG1;MAGI2;PIK3CD;NRG2
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5894170204372324,-1.0595674524190875,0.46,0.8465986642818422,1.0,6/18,11.08%,SMYD2;PTTG1IP;PSMD10;CD44;DDX5;YJU2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.36129695285031793,-1.059433284672621,0.3125,0.8461489089402515,1.0,46/298,10.28%,CCND1;UBB;EIF5A;MMP2;PSMB6;PSMD8;CFL1;MT2A;RPS27A;TXNDC17;AIP;PSMB4;UBC;IL20RA;MT3;PPIA;HSPA8;JAGN1;ALOX5;PSMA7;IFI6;CXCL12;RPLP0;UBA52;IFIT2;PTPRZ1;CANX;IRF3;PSMC3;LIMS1;PSMD10;NDN;HLA-B;PSME3;TNFRSF14;PSMD12;IL12RB2;PSMB9;PSMC1;PSMD2;CD44;LAMA5;FN1;IFITM3;ISG20;TRAF5
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.42529485260675887,-1.0593811922442669,0.29411764705882354,0.8455280726951014,1.0,18/72,15.66%,GPX1;POLR2L;ACTB;POLR1F;PHF1;WBP2;SMARCA5;CREBZF;POLR1A;SPHK2;POLR2K;MYBBP1A;TDG;POLR2E;POLR1G;TAF1A;PPHLN1;DEK
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3548759109468553,-1.0593166741698754,0.3488372093023256,0.844917370461696,1.0,44/348,13.14%,SOX4;CDKN2C;NOX4;SIRT2;BTG1;PODN;FABP7;PIWIL2;PPT1;SMYD2;TMBIM6;IGFBP7;MT3;RNF167;TMEM115;BTG3;SYT11;TNS2;ALOX5;PTPN14;SFRP1;VPS35;PDCD5;SPEG;PLXNA3;ZBTB49;LYN;FUZ;NDUFS3;NGF;CHMP2A;SEMA5A;FER1L5;CLU;BRD7;SPHK2;BRINP1;TAF6;NPM1;BMP2;PPP2R1A;PIWIL4;SMAD3;EI24
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6118906080294413,-1.0592617380711469,0.45,0.8444251369417657,1.0,1/9,5.67%,WTIP
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.562853532110399,1.0589368337610658,0.42105263157894735,0.881161637954703,1.0,1/13,0.62%,ROBO2
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.625177507065932,-1.0585773373605918,0.4878048780487805,0.8457562491099083,1.0,3/7,26.68%,BMP2;EDA;LRP6
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.504569968219344,-1.0584763097509768,0.391304347826087,0.8453182291157617,1.0,2/22,1.12%,SIRT2;PPT1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5515941395003109,-1.0582128036497689,0.40350877192982454,0.8453853323913684,1.0,8/17,16.45%,DERL2;SELENOS;SEC61B;HM13;AUP1;OS9;HSP90B1;VCP
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.6476581499646205,1.058170542308515,0.43333333333333335,0.8825691769545463,1.0,2/7,21.93%,SHANK3;MAPT
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.6880890001089706,1.0579494099955704,0.4909090909090909,0.8824267251390607,1.0,2/5,21.81%,NEK11;MAP3K12
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5190626618583655,1.0576226137867517,0.32653061224489793,0.8827649513597923,1.0,7/21,21.19%,PKP2;KCND3;SLC8A1;ANK2;KCNQ1;DMD;CACNA1D
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.6892960593711961,-1.0573847744864242,0.5,0.8469730449019743,1.0,2/5,12.47%,ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.6376724328673791,-1.0573340222190832,0.3958333333333333,0.8456577966596134,1.0,1/8,0.55%,SIRT2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.6376724328673791,-1.0573340222190832,0.3958333333333333,0.8456577966596134,1.0,1/8,0.55%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.7260749283274361,-1.0570130028705407,0.5098039215686274,0.8457423165390645,1.0,1/5,10.98%,CST3
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.4949887079527462,1.0565555477796313,0.3958333333333333,0.8853280025632215,1.0,8/31,15.19%,GRK4;CAV3;DNM1;ARRB2;RAB31;SNCA;AP2M1;ARRB1
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.45370259813936137,1.056321733073828,0.38181818181818183,0.8853752974537092,1.0,6/47,3.20%,ITGA2;SCEL;SRPX2;MYLK;NNMT;TMEM14A
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6859563999693788,1.0562185459430524,0.45652173913043476,0.8849172343157753,1.0,2/5,24.73%,MTMR3;MTMR9
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4395298585972426,1.0560704005778991,0.3829787234042553,0.8845383216888949,1.0,12/68,10.43%,CDH9;CDH7;PCDHB5;PKP2;CDH8;TLN2;FBLIM1;NRCAM;CDH12;SHANK3;RAB29;CDH20
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6170060025540123,1.0559850202856107,0.48333333333333334,0.8839426804129781,1.0,3/11,5.29%,EFHC1;DNAH7;CCDC39
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.6655307116404243,1.0559288299327825,0.48936170212765956,0.8832612142053667,1.0,1/5,9.16%,HES1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6251500312906243,1.0558523011471392,0.36538461538461536,0.8827632524621448,1.0,2/6,8.94%,SEMA3A;PHACTR1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.6756653500082747,-1.0558042115719304,0.475,0.8484270800060919,1.0,2/6,18.99%,TPI1;PGP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.5232152171506882,1.0556777571281608,0.43137254901960786,0.8826217660333777,1.0,7/17,20.97%,AKT2;TCAF1;C2CD5;MYO1C;ITGB1BP1;ANK3;PDZK1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.5822084525999147,1.0556693557142574,0.43478260869565216,0.8818739610389186,1.0,6/16,19.49%,EDNRA;GCLC;KCNMB4;NOS1;ITGB1BP1;AGT
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.651354345682246,1.0551259694221817,0.44,0.8825126971439476,1.0,2/5,28.18%,DOCK3;NTRK2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5940196398386376,1.0549007015246759,0.44680851063829785,0.882337208310155,1.0,4/11,16.42%,TGFBR3;BMP7;NRG1;ENG
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.5488978717447532,-1.0548713009528556,0.4489795918367347,0.8502739566237194,1.0,1/10,2.19%,ADPRM
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.6357784168819627,-1.0543815623111155,0.42857142857142855,0.8493080238900793,1.0,2/6,8.32%,TMED2;TMED9
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.6357784168819627,-1.0543815623111155,0.42857142857142855,0.8493080238900793,1.0,2/6,8.32%,TMED2;TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.6357784168819627,-1.0543815623111155,0.42857142857142855,0.8493080238900793,1.0,2/6,8.32%,TMED2;TMED9
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.441783875294076,-1.0542591072056269,0.4,0.8488175413573597,1.0,13/53,18.03%,RANGRF;VPS28;SYT11;HSP90AB1;CENPQ;TMEM35A;YAP1;LAMTOR5;PARK7;ENTR1;AKT1;NUMA1;MEAK7
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.49907888079722257,-1.0542072728194862,0.37209302325581395,0.8482387132992923,1.0,6/25,13.09%,RAN;RBM22;BAG3;APOD;SMAD3;HDAC3
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.6776731790668422,1.0540519396401051,0.48,0.8840028381516548,1.0,2/6,8.74%,FAM107A;EPHA4
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.673044940937827,-1.0539415009341229,0.425531914893617,0.8482491005606348,1.0,2/5,21.51%,WLS;DDIT3
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.6138849620967198,1.0535473284306471,0.4339622641509434,0.8846984434669913,1.0,4/8,21.76%,CDK7;CDK12;CDK13;CDK9
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.5626207730993811,1.053222824211607,0.3584905660377358,0.8847630471717353,1.0,2/15,9.12%,DPYD;CRMP1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.6754462327590908,-1.052957957620354,0.4883720930232558,0.850360929256899,1.0,3/5,31.98%,RACK1;MTRES1;ZNF598
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.44526764750539743,1.0525480781957834,0.3,0.8859739210625562,1.0,3/33,7.36%,SYNJ2;PLPP4;PIP4P1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.3919818493668443,1.052384160239992,0.32075471698113206,0.8855550243823029,1.0,18/104,9.90%,CORO6;NEDD9;SHROOM3;RAC3;NEBL;SPIRE1;BAIAP2;MYO1H;TTN;HIP1;EMP2;RFLNA;MPRIP;TMOD3;PROX1;RHOBTB2;ARHGAP17;GAS2L1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.6531805620679672,1.0523516256473264,0.46938775510204084,0.8848615290533646,1.0,4/7,30.91%,RAP1B;STXBP3;SYT4;RAP1A
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.6802715067472804,-1.0518757935941407,0.4,0.8525669526826057,1.0,1/6,3.88%,NLGN2
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.511836187205173,1.0518237425321364,0.3695652173913043,0.8856478837497925,1.0,6/23,21.55%,SLC4A4;CA2;SLC9A9;SLC4A8;TMEM165;SLC9A5
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.4594807797054858,1.0518044046528894,0.4,0.8849297582205711,1.0,6/28,7.21%,GLRA1;GLRA2;NSMF;SLC38A9;GRIN1;RPTOR
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.45059231552398,1.0517655837247257,0.3090909090909091,0.8842643832176741,1.0,11/30,23.51%,PIP4K2C;SORBS1;GRB10;PIP4K2A;PRKCZ;OGT;SLC27A4;PTPRE;SIK2;IRS1;PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6152679174995721,1.0514188566069305,0.4074074074074074,0.8844833041413575,1.0,3/11,15.35%,BRD4;CDK12;CDK13
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.48726075282759673,-1.0510555297234503,0.3829787234042553,0.8542180263327296,1.0,5/29,7.95%,SIRT2;CALM1;STOX1;CADM4;CALM3
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.4995004702397791,-1.0508659804253144,0.39215686274509803,0.8540722092315756,1.0,5/23,9.57%,SIRT2;SVIL;MAP10;GIPC1;CENPV
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.35253084191080153,1.0506801651259403,0.36065573770491804,0.8857812265769408,1.0,65/324,16.81%,RFC4;TMSB4X;PEX5L;GNA12;NUAK1;RMI1;RACGAP1;ARHGAP26;PIP4K2C;DAPK2;RAC3;PIP5K1B;PAK1;TIAM1;ARHGEF17;NTRK3;ING5;BCR;PRKAR1B;WRN;ARHGAP24;AKAP5;ARHGEF6;PIP4P1;PRKAR2A;PAK2;RAD9A;TAF3;CYLD;BRCA1;ARHGAP17;AKAP12;PIP4K2A;RHOJ;RPA1;SGK1;ATM;SRGAP3;PDPK1;TNIK;STK3;SOS1;NLRP12;TAF1;STK11;BARD1;PRKAA2;ARHGEF4;PTPN13;ITSN1;ARHGDIG;VRK2;BANP;FGF1;TIAM2;ARHGEF7;ARHGAP31;ARHGAP32;TAF15;MAPKAPK5;ARHGAP35;TRAF3;PPP1R13B;ARAP2;PRKAA1
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6737615613087373,-1.0505363363571685,0.4634146341463415,0.8542904634559648,1.0,4/6,17.56%,KRT10;FN1;F13A1;FLG
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.5888195444860499,1.050248984362714,0.4642857142857143,0.8853430059698145,1.0,4/10,21.88%,ALOX12;TMEM79;TP63;FA2H
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.5888195444860499,1.050248984362714,0.4642857142857143,0.8853430059698145,1.0,4/10,21.88%,ALOX12;TMEM79;TP63;FA2H
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.40474465106899404,1.0495951162028394,0.35714285714285715,0.8866965818689998,1.0,25/91,20.68%,ROBO2;STMN2;CAMK1D;TENM3;RELN;TIAM1;PLXNA4;CAMK2B;NTRK3;ROR1;DLG4;CAMK1;PLXNA1;MAGI2;TIAM2;ARHGAP35;PTK7;FBXW8;ABL2;PLPPR5;EPHA3;LRRC7;ROBO1;CAPRIN2;CBFA2T2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.45135200372381806,1.049593769204606,0.3673469387755102,0.8859221743739177,1.0,9/38,14.59%,ABLIM1;RPGR;PITPNA;EYA4;RABGGTB;CRYBG3;ADGRV1;COL18A1;RDH12
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.6003800916308926,1.049466208625275,0.43478260869565216,0.8856011645819284,1.0,1/10,1.69%,SOX9
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.43615361879854214,1.0494365564696795,0.3898305084745763,0.8849313232848649,1.0,18/53,17.89%,FOXO1;SOX9;FOXP1;RXRA;ABCA2;ERBIN;STAT5B;TIRAP;PAQR7;RARA;NOS1;SNCA;TAB2;SPP1;ALPL;PPARG;FER;STAT3
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.6831835421531319,1.0492801966654597,0.4782608695652174,0.884611735854089,1.0,3/6,16.44%,MADD;DENND4B;DENND1A
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4062825732711339,1.0490579504817208,0.35714285714285715,0.8845308980324038,1.0,10/65,11.72%,ACACB;IGF1R;CAMK1D;STAT6;OXTR;GRB10;ADIPOR2;ACSL1;PRDM16;GJA1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.6558906677760353,-1.0485288820690526,0.5,0.8595087309444489,1.0,4/5,24.02%,PLAT;DDR1;PARVA;AAMP
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.44880754076951135,1.048524348684962,0.39215686274509803,0.8852916519930278,1.0,7/38,10.58%,PTPRR;KIAA1217;ARNT2;PROX1;BRCA1;BMP7;SULF1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5301993997274044,-1.0484349541913047,0.37254901960784315,0.8589689515446511,1.0,8/17,21.94%,SIRT2;CACTIN;MUL1;LYAR;NFKBIL1;TRAFD1;PCBP2;C1QBP
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.6204451514879427,-1.0483358916617433,0.3877551020408163,0.8585628644534501,1.0,2/10,1.82%,BTG1;BAD
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5466113151703256,1.0481029494185135,0.42592592592592593,0.8858217967435444,1.0,5/18,10.69%,PRKAR1B;ADCY5;PRKAR2A;AQP4;ADCY3
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5653817153908309,1.0480047716834022,0.42857142857142855,0.8853243662413944,1.0,6/11,19.24%,CEP135;PTP4A3;KIAA0586;CEP290;SCFD1;GAPVD1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.3724879388321717,-1.0478643194940014,0.28888888888888886,0.8592451644094045,1.0,38/270,11.77%,COPZ1;ATP6V0A4;PPT1;ARL4A;SNX17;RAB26;RAB1B;ATP6V0E1;TMED2;ATP6V1F;AP4M1;RABL3;SCAMP3;ARFIP2;ATP6V1G1;ARL6IP5;SYNDIG1;GOLGA7;VPS35;ERP29;CANX;SCG5;ARL1;TMED9;ATP6V1B2;CHMP2A;RAB14;RAB5B;SLU7;STX6;UNC119B;ATP6V0E2;CLU;VPS26B;SCAMP4;TBC1D25;MCOLN1;NPM1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.6085992729811583,1.0477945523973367,0.4166666666666667,0.8850990751315002,1.0,2/11,8.43%,EME2;RAD9A
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.4508694190134902,1.0477520669102858,0.36363636363636365,0.8844422021287182,1.0,3/41,1.80%,MSL3;BAZ2A;HDAC4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.5681220930784618,1.0477048191978235,0.46808510638297873,0.8838118547062114,1.0,2/8,9.06%,PARN;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.46992622927015093,1.0475207789308638,0.4186046511627907,0.8835884566628093,1.0,9/26,20.78%,PARN;PARM1;TNKS;HMBOX1;MAPKAPK5;NEK7;NAF1;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.7019895612088386,-1.0472187722336956,0.509090909090909,0.8603503834467029,1.0,1/5,11.52%,AEBP1
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.4971282037922872,1.04715876487799,0.41509433962264153,0.8838300894015876,1.0,4/18,16.65%,PTPRR;ARNT2;ADAM10;MBNL1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.41885483359347114,1.0468561479050327,0.3469387755102041,0.8837927587925117,1.0,6/60,9.32%,PTPRC;IRF2;NLRC5;AGBL4;ATG7;TRIM52
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.5816630994628995,-1.046573547930133,0.4444444444444444,0.8611447265041302,1.0,1/12,2.73%,TRMT10C
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4532753070564809,-1.046229679418306,0.43902439024390244,0.8613202925733868,1.0,3/24,5.83%,MMP2;JUN;ERN1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.6774611085011114,-1.0462290440178923,0.5098039215686274,0.8605878656114617,1.0,2/6,8.85%,GPR37L1;PRCP
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.41221895394891933,1.0460164350025092,0.3620689655172414,0.8851723215545475,1.0,18/82,16.42%,AKR1C2;IGF1R;KITLG;AKT2;LRP2;FGF9;PTPRJ;HIP1;GCNT2;NRG4;P2RY12;PDPK1;NRG1;PIK3CD;NRG2;FGF1;AKR1C3;ENG
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5737187842296451,1.0458389253662868,0.40816326530612246,0.884822127501889,1.0,4/12,22.06%,KAT2B;PBX1;MAML1;MAML3
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.5104550436420422,1.0455184102029398,0.3877551020408163,0.8850366082156832,1.0,2/20,4.28%,MAP3K19;FUT2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.35303140793853066,-1.0451004979949399,0.2708333333333333,0.8628679928517293,1.0,56/292,17.45%,SIRT2;PSMB6;VPS37B;UBE2D4;PSMD8;UBXN1;PSMB4;VPS28;GID8;CDC26;RNF167;PSMA7;UBE2L6;ELOC;TNFAIP1;KBTBD6;RNF6;PPP1R11;FBXO45;HECTD3;SPSB3;ADRM1;PSMC3;PSMD10;PSME3;PSMD12;STUB1;ANAPC11;PSMB9;PSMC1;RNF126;PSMD2;OS9;TOLLIP;RNF187;UCHL1;RAD23A;UBQLN2;PSMD4;RNF8;RC3H1;PELI1;RNF168;UBQLN4;UBL7;UBE2S;PSMC4;KCTD5;VCP;RNF14;PSMB2;FBXL14;KBTBD7;RNF146;BUB3;PSMD3
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6091566088344618,1.0450175878078891,0.5166666666666667,0.8856208359980566,1.0,3/10,16.73%,BEGAIN;NPTX2;CACNG5
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.6772399664855291,1.0446514640506546,0.5,0.886027564597238,1.0,2/5,21.25%,ATM;NIPBL
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6902677178175005,-1.0445534100451312,0.52,0.8636222537503074,1.0,2/5,12.92%,SCARB1;LCAT
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.5844343585298355,1.0445249419880187,0.5,0.8856106609815223,1.0,2/11,6.45%,KCNJ11;RYR2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.45031426009876147,-1.0444752571069316,0.36,0.8630567438812764,1.0,10/46,13.07%,BTG1;RNF167;BTG3;TRIM35;GAS1;BRINP1;TAF6;CDKN1C;BMP2;SMAD3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.6076846003420348,-1.044235319156174,0.45652173913043476,0.863159658878273,1.0,1/8,3.88%,NLGN2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6638457895429064,1.043918062807641,0.4745762711864407,0.8866040050594818,1.0,1/5,7.78%,NAA16
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),-0.6685192425684711,-1.0436313261282277,0.5116279069767442,0.8641837489101738,1.0,1/5,1.14%,DSEL
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.48801883360114606,1.0435301219157045,0.42857142857142855,0.8868160378477814,1.0,5/25,7.21%,GLRA1;GLRA2;NSMF;SLC38A9;RPTOR
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5081270326946439,-1.0434871007525441,0.38,0.8638383923843435,1.0,9/32,16.95%,UBXN1;RPS7;RPL23;RPL11;GIPC1;HSP90AB1;PARK7;RPL5;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3983225761335981,1.043429363471858,0.35,0.8863995303225514,1.0,20/111,13.36%,BCL2L11;SOX9;DAPK1;ALK;DAPK2;MADD;NLRC4;WRN;FANK1;HIP1;ANP32E;RABGGTB;RIPK1;SEPTIN4;TOMM70;SGK1;ATM;MOAP1;FBXO11;BNIP3L
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.5175127968214698,1.0431999538384151,0.375,0.8862515286820106,1.0,7/26,10.56%,TPD52L1;DAPK2;MADD;ING5;CYLD;MAPK8IP2;TRAF7
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6947250618076537,1.0430929558041337,0.4791666666666667,0.8858863848202888,1.0,3/5,20.15%,TTN;MYOM1;PRKACB
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.4692572869507559,1.0430850593828658,0.3409090909090909,0.8851459254026147,1.0,7/28,14.81%,VRK1;RB1CC1;KLC1;STX5;MRRF;MCTS1;UBA5
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.5427540769900436,-1.0430689356757137,0.4222222222222222,0.8642031675105099,1.0,3/16,11.22%,MRPL44;HENMT1;SNIP1
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.5459279790979327,1.0429734824975565,0.4375,0.8846654901899204,1.0,5/13,23.31%,KAT2B;BRCA1;PLK2;ALMS1;C10ORF90
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5493285125103393,-1.0428643137928426,0.3584905660377358,0.8640859439143197,1.0,5/19,17.53%,ZFP36L1;SGPP1;CTSL;CTSK;NUMA1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6356469771258888,1.0427657804332138,0.4576271186440678,0.8845278131908177,1.0,2/7,9.39%,ODAD4;DNAH5
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.4695493586313414,-1.0427561917141865,0.3829787234042553,0.863601638856901,1.0,7/27,11.15%,ACTG1;ACTB;PPIA;PDGFRA;FN1;GNAS;TLN1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6425077810305023,-1.0426851613053607,0.4358974358974359,0.8631006855780505,1.0,4/9,16.73%,SPHK2;SAMD8;RACK1;SMPD3
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.567088444413352,1.0426168091117651,0.5384615384615384,0.884173716834645,1.0,2/15,1.93%,PCLO;WNT7A
prerank,MSigDB_Hallmark_2020__Coagulation,-0.43163521416909495,-1.0421956164195574,0.44,0.8636481734283832,1.0,16/66,15.21%,MMP2;SIRT2;S100A1;ISCU;PEF1;MSRB2;FN1;VWF;MST1;CLU;FURIN;CASP9;CTSK;TIMP1;LRP1;RAPGEF3
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6000414509676,1.0421341522436225,0.4166666666666667,0.8839914082598308,1.0,3/9,18.06%,EFNA5;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6000414509676,1.0421341522436225,0.4166666666666667,0.8839914082598308,1.0,3/9,18.06%,EFNA5;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.4392849900321994,1.0419663570139048,0.39285714285714285,0.8836137365590891,1.0,7/43,7.53%,MDGA1;SEMA3A;RELN;SH3RF1;KIAA0319;USP9X;NRCAM
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.5402294957761467,-1.0418350275371289,0.3829787234042553,0.8637149935354403,1.0,7/16,20.71%,CUBN;CD320;ABCG2;SLC2A10;TCN2;SLC5A6;SLC2A8
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5074888600489675,-1.0417931170556232,0.43137254901960786,0.8631367875245133,1.0,4/23,11.19%,MAGEF1;CTSC;PSMC3;CLU
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.5779599301706644,1.0416776956826397,0.4583333333333333,0.8836768467582248,1.0,4/13,9.60%,RIPOR2;DOCK8;OXSR1;DUSP1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5047224713585077,1.041620338021741,0.4489795918367347,0.883125836186868,1.0,6/27,6.69%,SOX9;SRF;FOS;SPI1;NFATC3;TEAD1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.5981292280049046,-1.041244424805128,0.46296296296296297,0.8637960471019857,1.0,1/11,5.19%,SFRP1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5421352834958043,1.0412274743382546,0.4074074074074074,0.8833716429148692,1.0,11/22,29.20%,ZNF16;STAT5B;ANKRD54;STAT3;ACVR1B;ABCB10;FOXO3;FAM210B;MAPK11;HMGB2;ACVR2A
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.511114975969414,-1.0409436782245627,0.4,0.8638886719282056,1.0,5/24,16.41%,BICD2;ARL1;IFT20;RAB33B;OPTN
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.6387561341858663,1.040805354844232,0.5087719298245614,0.8838241184677134,1.0,2/8,22.10%,DCUN1D2;DCUN1D4
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.524875206832425,-1.0407863467057026,0.32653061224489793,0.8635986546376376,1.0,3/16,7.95%,CALM1;STOX1;CALM3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.5457561173947866,1.0404657807636433,0.4166666666666667,0.8841434052989326,1.0,8/17,23.57%,TENM3;COL5A1;AGTPBP1;COL5A2;STAT3;NIPBL;NF1;IFT122
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.5341035609245373,1.0401387703268345,0.39285714285714285,0.8842306086279135,1.0,5/16,24.35%,PRKCSH;MAN2A1;MAN1A1;MAN1C1;ST8SIA1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.541092445227342,1.040125324570874,0.35185185185185186,0.8834914233569438,1.0,4/15,19.35%,SLC4A4;CA2;SLC4A8;SLC39A8
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.4749574064442053,1.040030067447707,0.37254901960784315,0.8830671931765431,1.0,12/40,23.20%,TPD52L1;PAK1;SASH1;MAP3K5;FGF1;MAP3K11;ROBO1;TRAF6;NEK10;TRAF2;DAB2IP;IL34
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.41776687858741607,1.0398026819913444,0.42592592592592593,0.8829323753318725,1.0,9/70,7.21%,SYT1;NEDD4L;SHTN1;BRAT1;RNF157;MACF1;CPNE5;LIMK1;RPTOR
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.6414502417537319,-1.0392573827656746,0.4716981132075472,0.8667312023888532,1.0,3/8,15.85%,ATF4;QRICH1;HSPA5
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.6165483919579429,-1.0392318685825281,0.4782608695652174,0.8660227187329721,1.0,1/6,1.09%,ASCL1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6006136055424653,1.039108567759968,0.5098039215686274,0.8839351134732595,1.0,1/11,1.80%,HDAC4
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.553975031585676,1.0382887152877516,0.4166666666666667,0.8853643596545797,1.0,7/14,22.30%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;PRKACB;ADCY2
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.5888263602457378,1.0382832891980593,0.44,0.8846191034595843,1.0,3/11,11.75%,CRLF1;JAK1;IL6ST
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.6401940412836846,-1.0382474165095585,0.42857142857142855,0.8681421013306685,1.0,2/6,14.01%,DDX5;GPC1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.6152984495042193,1.0381649488175013,0.48148148148148145,0.8841299430909856,1.0,1/9,1.49%,NUAK1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.6497259129839132,1.0380186835677696,0.5384615384615384,0.8837812395988084,1.0,2/8,11.24%,TOP1MT;TOP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6112855094088425,-1.0375572406243376,0.4727272727272727,0.8692356142350175,1.0,3/10,11.74%,THY1;PTN;MADCAM1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.6049194855958859,1.037544215515103,0.4782608695652174,0.8844343650248732,1.0,1/6,11.19%,AK3
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.5470088658393542,1.036598809389334,0.46296296296296297,0.8863327988199938,1.0,2/13,8.16%,NR4A3;C2CD5
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.5359059117829653,1.0361373571144223,0.46808510638297873,0.8868352137637883,1.0,5/17,14.25%,SYT1;ARHGAP17;SYT12;SYT2;SYT6
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.455886127994736,-1.0359530449767125,0.41379310344827586,0.8729327636414316,1.0,3/37,5.19%,S100A10;RHOC;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5648643079967309,1.0355207567133349,0.43137254901960786,0.8878197783904066,1.0,5/17,15.59%,CD160;SPI1;PVR;CADM1;KLRD1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.5680395124789815,1.0353566986790825,0.4222222222222222,0.887502163947974,1.0,6/11,25.32%,ABCA2;RANBP9;TMED10;PICALM;APOE;FLOT2
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.5989770344212343,1.0353566866892658,0.37777777777777777,0.8867601052824656,1.0,1/9,0.28%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.7070303064108157,1.035083657640573,0.49122807017543857,0.8867705378114835,1.0,3/6,19.61%,CDKN2A;PPARG;PDCD4
prerank,MSigDB_Hallmark_2020__Myogenesis,0.40319082068288475,1.0350119897044439,0.4444444444444444,0.8862750974561525,1.0,25/112,14.02%,ABLIM1;TPD52L1;FABP3;CKMT2;MEF2D;AKT2;DAPK2;MYLK;SORBS1;LAMA2;SYNGR2;CAMK2B;CAV3;MYOM1;PTP4A3;MAPK12;KCNH1;ACSL1;SLC6A8;DENND2B;NOS1;LARGE1;NAV2;SGCA;BHLHE40
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.6423098396432368,1.0347255625091827,0.47368421052631576,0.8863511343282353,1.0,1/6,0.61%,AKR1C2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.4248454093939925,-1.034260201182749,0.37209302325581395,0.8765890727183874,1.0,10/54,5.50%,BGN;MMP2;PODN;FIBIN;RARRES2;COL12A1;TNS2;THBS2;PDGFRA;CXCL12
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.42151733669105745,-1.0333282107573225,0.4772727272727273,0.8784590643621425,1.0,17/69,16.62%,IPO13;RAN;PTTG1IP;PRICKLE1;PHB2;ATAD1;PPP1R10;NUP155;CLU;ACBD5;FIS1;FAM53C;RANBP17;RANBP6;HSPA4;PEX13;AKT1
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4299163027005376,1.0330835730232586,0.3409090909090909,0.8905811785273027,1.0,10/49,15.85%,PON1;PLA2G15;SMPD4;PIGX;ABHD3;ABHD12;PIGH;SERINC1;ABHD6;AGK
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.4839463349255282,-1.033028681987107,0.3488372093023256,0.8784781834713208,1.0,3/25,9.18%,VPS37B;VPS28;CHMP2A
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6052924247834967,1.0328756959658747,0.42592592592592593,0.8902872673202823,1.0,4/10,33.90%,MAGI2;ACVR1B;ACVR2A;ACVR1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.6316299377954552,1.0325946903584482,0.5576923076923077,0.8902540630023474,1.0,1/6,5.94%,SPI1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.5806753587700287,-1.0325117501090408,0.4888888888888889,0.8791184091386847,1.0,4/11,17.81%,ARFIP2;LIMA1;CORO1B;CYFIP1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.46969800584868404,-1.0324218770165408,0.4186046511627907,0.878576662788213,1.0,5/38,6.31%,UBB;RPS27A;UBC;UBE2L6;UBA52
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.5843244476481638,1.032385534957698,0.4117647058823529,0.8902209138869364,1.0,2/12,2.56%,TRPC4;SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.6081284386373196,-1.0322475563267604,0.62,0.8774959015814737,1.0,3/6,24.05%,DYRK2;PRNP;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.6081284386373196,-1.0322475563267604,0.62,0.8774959015814737,1.0,3/6,24.05%,DYRK2;PRNP;CHP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.5375696847356018,1.0314574786168402,0.45652173913043476,0.8920144373123627,1.0,3/16,14.13%,MSL3;EP400;MORF4L2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.7100801705185772,1.031435597799522,0.49019607843137253,0.8913552919956789,1.0,3/5,22.58%,ATG7;ULK2;ATG2B
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4225698614062041,-1.0314020992740516,0.40476190476190477,0.87896020534254,1.0,3/59,4.99%,CCND1;CDKN2C;DHFR
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.4691730273096461,1.0311317166078446,0.425531914893617,0.8915077234598547,1.0,10/26,16.84%,CTBP1;SPI1;BRCA1;TADA2A;CAMK1;NOS1;SNCA;KMT2A;ARRB1;PPARGC1A
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.4584737275427522,1.0310978243734734,0.38461538461538464,0.8908419920382952,1.0,8/37,15.80%,PCTP;PITPNA;ATP10A;ATP8B2;PITPNC1;ATP8A1;ATP10B;PITPNB
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.42028455337000364,1.0310808400967588,0.46938775510204084,0.890153088566761,1.0,9/56,8.35%,ITGA8;RELN;TBCD;EFNA1;SPI1;SRCIN1;TYRO3;PROX1;RADIL
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.5464848539104099,1.0308332986673008,0.46153846153846156,0.8902333736383802,1.0,3/15,9.13%,WNT7A;SHANK3;DLG4
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.6459296290078949,-1.0307563995762612,0.48,0.8800698318527703,1.0,2/5,31.81%,ANAPC2;CPLX2
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.6260864752675952,1.0307012300610496,0.4489795918367347,0.8897722970687687,1.0,3/6,33.29%,SPSB4;PRKN;XIAP
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.4870008881954268,-1.0306648375555876,0.4666666666666667,0.8795896432967273,1.0,5/24,14.08%,CENPX;SMARCA5;NPM1;CENPQ;RNF8
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.3551800623956207,-1.030532606816557,0.375,0.8792045989350672,1.0,24/177,13.39%,G0S2;CFL1;BAD;GAPDH;RPS19;PPIB;ESRRB;PAX8;FABP5;BAMBI;WNT5A;PTN;ZBED3;GLIPR2;MST1;KMT5B;GNAS;ACHE;SOX8;CAV1;BMP2;SMAD3;HDAC3;TLE6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.5675275941702006,1.0302849832964076,0.45098039215686275,0.8900949051903297,1.0,1/10,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.6024031634686978,-1.030108976608288,0.4528301886792453,0.8798313615199046,1.0,2/8,13.49%,GMPR2;DGUOK
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.6237676706664522,1.0300203260946998,0.49019607843137253,0.8900701982637976,1.0,4/9,21.04%,BRCA1;RIF1;ZNF274;ATRX
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.6140562094988403,1.0289474468227278,0.43636363636363634,0.8923581967825933,1.0,2/6,21.46%,HES1;RNF10
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.6608521725995693,1.0288511256586865,0.5769230769230769,0.891929094855006,1.0,4/6,31.64%,SHMT1;GMPS;CTPS2;CTPS1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6255972926624723,1.0285987489511508,0.627906976744186,0.8919351185156331,1.0,2/8,10.22%,SPRED2;ATM
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3728389972966161,1.0285902978932053,0.3728813559322034,0.8912096574256292,1.0,13/106,12.40%,BAZ2A;SOX9;HDAC4;PHF19;KAT2B;PAK1;SPI1;SATB2;TADA2A;TOP1;PRDM16;PADI2;ACTL6B
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.42390325624054326,-1.0278528013441046,0.41025641025641024,0.8846781464653946,1.0,21/81,16.45%,DERL2;FOXRED2;UBE2J1;SELENOS;FAM8A1;UBXN4;FBXO44;STUB1;DNAJB12;SEC61B;AUP1;OS9;YOD1;TMUB2;UBQLN2;ERLEC1;RHBDD2;HSP90B1;HSPA5;DNAJC18;VCP
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.480562966224651,1.0278161082779256,0.45,0.8926057257135055,1.0,5/29,7.97%,CLDN18;TBCD;PARD3;VCL;PAK2
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.48935572179087955,-1.027501347936027,0.4444444444444444,0.8841927563099502,1.0,6/21,15.82%,DBI;ACSM5;ACLY;OXSM;CROT;ACOT13
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.48935572179087955,-1.027501347936027,0.4444444444444444,0.8841927563099502,1.0,6/21,15.82%,DBI;ACSM5;ACLY;OXSM;CROT;ACOT13
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.6532758078222617,1.027290976898806,0.4418604651162791,0.8933976276492568,1.0,3/6,22.69%,UBA5;CDKN2B;ZFPM1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4162387084903856,-1.027268200364646,0.3333333333333333,0.8841641831301799,1.0,4/58,5.19%,S100A10;RHOC;ACTG1;SFRP1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5104607771758164,-1.0271598775557933,0.375,0.8837089841216905,1.0,3/23,7.70%,SNRPB;LSM1;SNRPG
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5112785311455756,-1.0271189942639518,0.42857142857142855,0.8830328576900447,1.0,3/17,14.43%,BLOC1S4;TRAPPC6A;AP1M1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5476924076058927,1.0270143874751168,0.41509433962264153,0.8934906292724288,1.0,2/17,1.11%,ACACB;FABP3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.494204464901579,-1.0264231726803406,0.3333333333333333,0.8833353416056239,1.0,4/20,5.80%,ZDHHC1;ZDHHC6;GOLGA7;ZDHHC4
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.494204464901579,-1.0264231726803406,0.3333333333333333,0.8833353416056239,1.0,4/20,5.80%,ZDHHC1;ZDHHC6;GOLGA7;ZDHHC4
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4265906288044918,-1.0261368770781667,0.391304347826087,0.8832905889864603,1.0,10/48,14.42%,SIRT2;CALM1;ESRRB;CDK2AP2;CALM3;KIF18B;KLHL9;TLE6;RACK1;ENTR1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4270086017811853,1.0260459229533272,0.3125,0.8956104715215637,1.0,8/54,5.10%,FOXO1;IGF1R;SLC39A14;AKT2;SORBS1;ATP6V1E2;BAIAP2;GRB10
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.34433788771216206,-1.0259238023034196,0.3953488372093023,0.8831949222829311,1.0,30/266,10.28%,UBB;PSMB6;UBE2D4;PSMD8;RPS27A;PSMB4;UBC;CDC26;RNF167;UBE2Q2;PSMA7;UBE2L6;KBTBD6;RNF6;UBA52;UBE2J1;PSMC3;PSMD10;PSME3;FBXO44;PSMD12;STUB1;ANAPC11;PSMB9;UBE2Q1;PSMC1;RNF126;WSB1;PSMD2;TRAF5
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.5801736305848343,-1.0251524474853906,0.48936170212765956,0.8844919405174657,1.0,3/10,13.30%,CFL1;TWF1;DSTN
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.5495840482983606,-1.0248748890811128,0.5,0.8844208889509088,1.0,4/16,13.65%,ZFP36L1;SGPP1;CTSL;CTSK
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5484862093497379,1.0248100533263524,0.49122807017543857,0.8982391786618004,1.0,7/15,22.30%,PRKAR1B;ADCY5;PRKAR2A;ADCY3;ADCY1;PRKACB;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.4529018984411342,-1.0247482767999199,0.3829787234042553,0.8839854459125187,1.0,5/34,6.35%,SLITRK2;CLSTN2;NLGN2;SYNDIG1;EPHB3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6629728132387704,1.024738104212989,0.5192307692307693,0.8976720951231962,1.0,5/5,33.73%,AGO1;AGO4;MOV10;AGO2;AGO3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.4639267634055077,-1.0246250299309287,0.4117647058823529,0.8836269527098813,1.0,8/31,14.19%,SOX4;ERN1;SELENOS;ZBED3;EIF2B2;KHK;RACK1;EIF2B1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.6263235330545567,1.02431387997594,0.5,0.8978971645208881,1.0,1/8,1.06%,MCCC1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5485272662645139,1.024221200813007,0.42857142857142855,0.8974271147878952,1.0,4/12,8.76%,SULT4A1;BPNT1;PAPSS2;TPST1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.5209228824791026,-1.0242048100580072,0.4423076923076923,0.8838953099492461,1.0,3/17,7.95%,CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.5314039638991979,1.0241000302629426,0.45098039215686275,0.8970296446443744,1.0,5/16,19.81%,ABCA2;PSEN1;DLG4;PICALM;ATXN2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.4878667222049727,1.0240082322865962,0.38461538461538464,0.8965849871777396,1.0,9/28,16.78%,SLC39A14;LRP2;SLC6A6;SNAP25;SLC22A4;SLC29A2;NEURL1B;SLC19A1;LRRC8A
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.5852980923764518,1.0236252970301094,0.41304347826086957,0.8968898700726301,1.0,2/11,7.10%,STMN2;KIF19
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.43074061028204413,-1.0234689114140114,0.4222222222222222,0.8851356589387456,1.0,3/51,8.74%,SOX4;E2F4;PCBP4
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.5661635758384149,1.0233707325621029,0.43902439024390244,0.896971386606142,1.0,6/15,12.68%,YWHAH;NEDD4L;SNTA1;CAV3;CAMK2D;NOS1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.4847814918064276,-1.0233111298695554,0.42857142857142855,0.8848024510125364,1.0,3/21,7.02%,RARRES2;EPHB3;EDNRB
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6224366172757957,1.023099973675661,0.5510204081632653,0.8969891452083,1.0,5/8,20.77%,SLC1A4;SLC6A8;SLC19A1;PDPN;MGST1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5831791782899906,-1.0223861183864957,0.5178571428571429,0.8864874337944757,1.0,2/9,6.26%,SH3GL2;PDE3A
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6223048277816834,1.0219816728245041,0.52,0.899430616468507,1.0,3/6,13.25%,CAV3;DYSF;ANK2
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.5879758944541226,1.0218934482840218,0.45,0.8988825915653069,1.0,1/11,2.67%,FMNL3
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.605315956864958,-1.0213801440250383,0.475,0.887463921190661,1.0,3/7,16.73%,SPHK2;RACK1;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.605315956864958,-1.0213801440250383,0.475,0.887463921190661,1.0,3/7,16.73%,SPHK2;RACK1;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.4224428685747747,-1.0213434369755112,0.4318181818181818,0.8868604166849506,1.0,5/48,8.27%,CCND1;CALR;DUSP3;RPS15A;PSMD10
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.44364593794610074,-1.0212023025301953,0.4098360655737705,0.8864430178415026,1.0,11/35,15.85%,ROMO1;SEC61G;TIMM23;TIMM44;DNAJC19;AIFM1;SEC61B;GRPEL1;SEC62;TIMM21;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.6426494553738019,1.021079684106048,0.5272727272727272,0.9005093156160151,1.0,2/7,12.29%,NEDD4L;CAMK2D
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6370376310379432,1.0209400392784127,0.4807692307692308,0.8993824984018685,1.0,7/8,33.73%,AGO1;AGO4;TNRC6C;TNRC6A;RBM4;AGO2;AGO3
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.6370376310379432,1.0209400392784127,0.4807692307692308,0.8993824984018685,1.0,7/8,33.73%,AGO1;AGO4;TNRC6C;TNRC6A;RBM4;AGO2;AGO3
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.4648826513788957,-1.0209107189035473,0.41379310344827586,0.8864971164655489,1.0,4/41,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),0.609272960202779,1.0206501654742537,0.5,0.8993111586824171,1.0,1/10,2.23%,SRF
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.6105029780121543,1.0205752462061952,0.4791666666666667,0.8988366204134723,1.0,3/7,16.85%,SORT1;SLC2A3;SLC27A4
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.6545263586901784,1.0202206776965486,0.4727272727272727,0.8991688252728728,1.0,2/5,13.30%,RORB;BBS4
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.6773261305035515,1.0199764981624315,0.5094339622641509,0.8991136217072412,1.0,1/5,5.92%,HIP1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.548319725430376,1.0198709225931675,0.42592592592592593,0.8986956146596666,1.0,2/10,18.09%,PMPCB;MIPEP
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.627488710514401,1.019728373910205,0.5471698113207547,0.8976095813735578,1.0,1/7,3.14%,EEFSEC
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.627488710514401,1.019728373910205,0.5471698113207547,0.8976095813735578,1.0,1/7,3.14%,EEFSEC
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.4149243872709603,-1.0196469735948992,0.36,0.8890040611479674,1.0,8/65,6.23%,CHRNA4;SLC22A17;PCSK1N;ENHO;SEMA5B;CAMSAP3;EFNA2;LINGO1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5082105797248868,1.0195684510240786,0.4230769230769231,0.8972882339542657,1.0,3/23,4.45%,FABP3;SORBS1;PLIN5
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5351873784667235,1.019522518120962,0.42592592592592593,0.8966607238680997,1.0,5/14,23.81%,ACSBG2;ACSL1;ELOVL2;ACSL3;ACSBG1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5112159855611164,-1.0193776954642126,0.37209302325581395,0.8890223975656035,1.0,4/18,7.11%,NOP10;NHP2;CCT5;CCT3
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.40175411062361244,1.0193197611707359,0.4074074074074074,0.8964978010579399,1.0,14/85,12.24%,SOX9;SRF;MEF2D;ZFPM2;PKP2;KAT2B;MMP21;NTRK3;TGFBR3;MICAL2;SH3PXD2B;BMP7;SGCZ;MTHFD1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.4198441616391529,-1.0192663118096328,0.3488372093023256,0.888579435352822,1.0,13/57,11.45%,MPDU1;OST4;ALG2;DDOST;DAD1;DPM2;UBE2J1;MAGT1;ALG10;OSTC;RPN1;STT3A;ALG8
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3770174713391245,-1.0190057634179428,0.43902439024390244,0.8885478102124068,1.0,7/90,8.27%,NR0B1;COMMD6;HES6;TCEAL7;PHB2;CACTIN;PSMD10
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.6629022841898096,-1.0189278969572046,0.5348837209302325,0.8880222305700376,1.0,1/6,15.91%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.4988053027982202,1.0188665897604883,0.4909090909090909,0.8970417254943627,1.0,5/26,12.28%,PTPRC;TIRAP;CD27;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5661665630388077,1.0184834450031273,0.46153846153846156,0.8973415927284831,1.0,4/9,22.30%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.36101243419632145,-1.0183918815989423,0.3953488372093023,0.8886353055864281,1.0,32/189,13.96%,SOX4;PSMB6;CCDC88C;PSMD8;TMEM9;PSMB4;GID8;CDH3;PRICKLE1;PSMA7;SFRP1;BAMBI;GSKIP;PSMC3;WNT5A;PSMD10;FUZ;PSME3;PSMD12;ZBED3;PSMB9;PSMC1;PSMD2;LRRK1;KLHL12;SEMA5A;CAV1;TLE4;BMP2;TLE6;PSMD4;WLS
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.37149597898454234,1.0183006023589811,0.421875,0.8970452637734686,1.0,25/133,15.56%,CARD14;EFNA5;SOX9;FAM161A;BRAT1;AKT2;NNMT;PAK1;NTRK3;FGF9;NSMF;EFNA1;ATG7;RB1CC1;RIPK1;WDFY2;SVIP;CAMK1;TNIK;CAMTA1;SEMA4D;FAM20A;FGF1;ARRB1;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.5474319922416812,1.0182436551753398,0.45098039215686275,0.8964674549044793,1.0,5/14,12.29%,NR4A3;PRKCA;IL6ST;PDE9A;CAMK2D
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6735865649210702,1.0179096109160577,0.4444444444444444,0.8964775068025443,1.0,2/6,28.12%,PPARG;THOC5
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.423016606279527,1.01780720505845,0.38461538461538464,0.896002730737259,1.0,1/55,0.14%,PON1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.537541342150519,-1.0177947736067152,0.4423076923076923,0.8894229253122986,1.0,1/8,0.55%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4901979911926019,1.0177232493863637,0.43859649122807015,0.8954974605231705,1.0,9/21,23.51%,PIP4K2C;GRB10;PIP4K2A;PRKCZ;APPL2;SLC27A4;PTPRE;IRS1;PIP4K2B
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.33832932468299864,-1.01722372910799,0.3958333333333333,0.8902259651737164,1.0,46/302,14.17%,SOX4;ZNF488;BTG1;SOX21;ZNF114;CALR;ATF4;ZNF460;ESRRB;HES6;ZNF22;ZNF92;PHF1;SPIN2B;ZNF257;WTIP;RNF6;SLC2A4RG;DRAP1;ZNF117;MED23;EDF1;FADS1;MLF2;ZNF676;CHD3;CNBP;RPL6;ZNHIT3;COPS2;TRAPPC2;MZF1;ASCC2;ZSCAN21;YBX1;MYBBP1A;SAP30;BMP2;PPP2R1A;TFEB;ZFPL1;SRSF10;ESRRA;NONO;ZNF212;AKAP17A
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.35133917360734074,-1.0171256958099766,0.3333333333333333,0.8897257682958601,1.0,50/328,10.17%,SOX4;CCND1;BTC;SIRT2;TAF9B;COPS9;CLEC11A;CALR;DERL2;RPS19;S100B;RTKN2;ROMO1;GID8;PDGFD;HES5;STOX1;ZFP36L1;MT3;RHOG;CDH3;RPL23;SFRP1;BAMBI;PDGFRA;CXCL12;RPS9;TENM4;TBRG4;P2RX4;PA2G4;SAPCD2;FXR2;RPS15A;WNT5A;SLC25A33;LMAN2;PSMD10;NACC1;LYN;HAS2;COX17;CNBP;PTN;IL12RB2;ACLY;HSP90AB1;SLC25A5;FN1;UFL1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.49564431023067096,-1.0171081039510563,0.35714285714285715,0.8890345914904612,1.0,8/24,21.60%,CSKMT;KMT5B;BEND3;VCPKMT;SETD1A;ANTKMT;SMYD5;ZNF335
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.40808494039899784,1.0167899731215315,0.423728813559322,0.897405377497034,1.0,10/63,11.37%,CALCB;PRKAR1B;ADCY5;SPI1;TYRO3;PRKAR2A;GPR176;NMI;ADCY3;CD247
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.4379466240565695,-1.0165336068165876,0.391304347826087,0.8897110054543939,1.0,8/52,8.97%,TRMT112;TRMT10C;TRMT5;BUD23;PCIF1;TRMT10A;HENMT1;RBM15B
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.42754543953480123,1.016316390194006,0.38461538461538464,0.897867096584184,1.0,6/43,3.57%,BRAT1;SLC39A14;GPI;KCNJ11;G6PC2;SORD
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.5577866132787543,1.0163146436299662,0.4791666666666667,0.8971510941148185,1.0,6/10,16.45%,CTBP1;SPI1;BRCA1;SIN3A;SNCA;ZNF451
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.49653812370895617,-1.0160665025143183,0.4634146341463415,0.8903530182157301,1.0,13/32,21.28%,CALM1;PPIA;TIPRL;SMPD1;CALM3;YWHAB;PPP1R16A;ANKLE2;HSP90B1;PPP1R7;PPP2R5A;PIN1;PPP1R2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.5247364354667213,1.016057868395704,0.4375,0.8970203621516295,1.0,5/18,10.80%,GLRA1;GRIN2A;GRIN1;MAPK8IP2;ARRB2
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.5113934637830136,1.0159947125819915,0.4,0.8965707684910059,1.0,5/24,21.45%,XRCC4;TNKS;RPA1;ATRX;ATR
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.532169947285488,-1.0157108343421344,0.42857142857142855,0.8908941650312335,1.0,7/15,16.45%,DERL2;SELENOS;SEC61B;AUP1;OS9;HSP90B1;VCP
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.6306470592355584,1.0157089053038528,0.4883720930232558,0.8965573462220195,1.0,2/6,4.88%,NECAB1;ABCA2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.5618273530411171,-1.0148014238719945,0.5,0.8926313355090244,1.0,2/12,7.53%,HPCA;SRI
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.4880529807246316,-1.0147653644334447,0.44,0.8920319608997281,1.0,4/18,17.53%,DYNLT1;SAPCD2;SPDL1;NUMA1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.40206845006669995,1.0143716042651703,0.49019607843137253,0.8995819447600556,1.0,27/95,17.86%,OLFM3;STMN2;SULT4A1;KCNB2;GRIK3;CADPS2;SNAP25;GABRG2;SRCIN1;MAPK8IP2;CLVS2;SCN2A;ACTL6B;NOVA2;ABCC8;ERC2;HS6ST3;ASTN1;CALY;LRRTM1;SLC8A2;CTNND2;CELF3;SNCB;GAD2;ADCY1;UNC13A
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6219854864731751,-1.013773441894475,0.45652173913043476,0.8941554162361487,1.0,2/7,11.71%,ALOX5;PYCR1
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5854015776688803,1.013768513156183,0.46153846153846156,0.9005676627090253,1.0,4/13,6.55%,PYGB;PHKG1;PYGL;RB1CC1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.42780186350820254,-1.013695385437481,0.38636363636363635,0.8935972363495842,1.0,11/46,17.17%,GPX1;GSTP1;IFI6;NOL3;PSME3;PARK7;TMBIM1;SCG2;AKT1;PEA15;AR
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.5739696321307438,1.013573353591882,0.43478260869565216,0.9003183756626294,1.0,5/12,12.29%,NR4A3;PRKCA;IL6ST;PDE9A;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.37886110828220065,1.0135394216099218,0.40350877192982454,0.8997206739341598,1.0,23/119,12.41%,FOXO1;SOX9;CRIM1;SPRED2;MEIS2;ZFPM2;COL5A1;PKP2;EFNA1;SUZ12;ZBTB16;RANBP3L;RORA;CDK6;NBR1;HES1;HDAC7;BMP7;SUFU;RORB;ADGRV1;CHRD;USF3
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.5244854848935722,1.0134230246133684,0.5208333333333334,0.8993020588650295,1.0,8/17,22.62%,SLCO1A2;RXRA;NCOA1;SLC51A;NCOA2;AKR1C1;SLCO2B1;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.6163725595316176,1.0133372433339676,0.5283018867924528,0.8987912379631899,1.0,2/7,14.95%,DMTN;ENPP4
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.3791811504451648,-1.0131259316495609,0.35294117647058826,0.8945229605924031,1.0,22/112,14.84%,PSMB6;PSMD8;THY1;PSMB4;ERMAP;LAT2;MALT1;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;EIF2B2;BTN3A3;IKBKB;PSMD4;EIF2B1;RC3H1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3417076423529601,-1.012594871879963,0.41304347826086957,0.8949918858025702,1.0,49/334,14.17%,SOX4;ZNF488;BTG1;RPL10;SOX21;ZNF114;CALR;ATF4;ZNF460;ESRRB;HES6;ZNF22;PCIF1;RABL3;ZNF92;PHF1;SPIN2B;ZNF257;WTIP;RNF6;SLC2A4RG;DRAP1;ZNF117;MED23;EDF1;FADS1;MLF2;ZNF676;CHD3;CNBP;RPL6;ZNHIT3;TRAPPC2;MZF1;ASCC2;ZSCAN21;YBX1;MYBBP1A;SAP30;DSCC1;BMP2;PPP2R1A;TFEB;ZFPL1;SRSF10;ESRRA;NONO;ZNF212;AKAP17A
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.47806247024346077,-1.0125139270616486,0.37037037037037035,0.8944591974818721,1.0,4/33,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.5478779502849563,-1.012408259356102,0.5121951219512195,0.8939934879175687,1.0,4/11,19.55%,ZNF304;PPHLN1;TRIM28;MORC2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.41324692015096054,-1.0122242817854408,0.45454545454545453,0.8936854352182985,1.0,9/49,8.24%,S100A10;THY1;ACTG1;CAMSAP3;SFRP1;DUSP3;APOD;LIMS1;RCC2
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.6286365027437595,1.0121617875170839,0.42,0.9008395683765325,1.0,3/6,13.09%,WASHC1;CDC42EP4;CDC42EP3
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.6286365027437595,1.0121617875170839,0.42,0.9008395683765325,1.0,3/6,13.09%,WASHC1;CDC42EP4;CDC42EP3
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.5162454083744661,-1.0121468570502055,0.4807692307692308,0.8931220811959731,1.0,3/18,9.25%,EXOSC8;NOP14;KRI1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.6832753542077633,1.0120374060075519,0.5217391304347826,0.9003905092580741,1.0,1/5,22.80%,APOE
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.686289906974914,1.011802194768071,0.5925925925925926,0.9003278903699068,1.0,1/5,2.32%,SLC6A17
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.6112391492383291,-1.011658631633423,0.49019607843137253,0.8936974302144811,1.0,1/5,3.88%,MT3
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.6559837501057241,1.0115034225362103,0.5192307692307693,0.9004118325748958,1.0,1/5,4.05%,FOXP1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.4214698302133799,-1.011133342487836,0.44,0.8942141856386591,1.0,12/34,22.10%,H1-4;SMARCA5;NOC2L;NPM1;BAHD1;H2AX;H1-10;PAF1;H3-3A;KAT6B;ANP32B;ASF1A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.47601174254360346,1.01081285799737,0.47619047619047616,0.9014584510993839,1.0,1/25,0.28%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5083914835827295,-1.010785032191756,0.475,0.8944255395073248,1.0,4/21,15.58%,H1-4;DACH1;H1-10;SUB1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.6001754227327754,1.0107775707298354,0.4827586206896552,0.9008333017392891,1.0,3/8,16.11%,RXRA;RARA;PPARG
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.6912837226190885,1.0107238760688095,0.5106382978723404,0.9002552781834002,1.0,1/5,4.05%,FOXP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.45807714230861923,1.0105679672975982,0.42,0.900047010000555,1.0,5/34,11.69%,BCL2L11;BCL2L2;BRCA1;ATM;MOAP1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.4846379527039079,1.0105189706353948,0.4807692307692308,0.8994474774420248,1.0,11/33,14.01%,SYT1;PCLO;RAB3A;SYN3;SNAP25;LIN7A;NAAA;STX1A;STXBP3;SNCA;CPLX1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.6676460345849848,1.010476458593274,0.5192307692307693,0.8988412138254461,1.0,2/5,15.62%,PRIMPOL;SRPK2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.5180389611923553,1.01038411931153,0.44680851063829785,0.8983278958748151,1.0,7/19,12.29%,NR4A3;CAV3;PRKCA;MLIP;IL6ST;PDE9A;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.547851937430299,-1.0099732924048999,0.44680851063829785,0.8960677091368944,1.0,4/12,17.74%,SFRP1;H2AZ1;RUVBL2;SSTR1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.6631914435277719,-1.009859759793194,0.52,0.8956855092703917,1.0,2/5,20.31%,STPG1;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.6431857093384867,-1.0094770652913991,0.5283018867924528,0.8960594115521219,1.0,3/7,14.69%,DBI;PRELID1;LRP1
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.46886302654440987,1.0093187376403006,0.4489795918367347,0.9004887971856437,1.0,5/19,12.96%,SYNJ2;SYT1;STX1A;SYT2;SNCA
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.46327015940965266,-1.0090644700172766,0.4166666666666667,0.8965475882528158,1.0,5/25,6.34%,LOC400499;DHFR;ARL6IP5;SFRP1;TIPARP
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.48401263635726866,-1.0087856378196027,0.46938775510204084,0.8965348632039463,1.0,2/21,2.76%,VPS37B;VPS28
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.5607787578653395,1.008628749601164,0.5185185185185185,0.9017813878154809,1.0,5/10,23.03%,AKAP5;NOS1;MAPK3;CACNA1D;NF1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5862958574646776,1.0080293171852166,0.49122807017543857,0.9025595244570509,1.0,4/14,16.14%,SOCS4;CHMP6;PPARG;CBLB
prerank,MSigDB_Hallmark_2020__Apical Junction,0.3622673562179647,1.0079340205393235,0.3584905660377358,0.9022206763436365,1.0,12/129,7.38%,THBS3;PTPRC;ITGA2;YWHAH;AKT2;CLDN18;SKAP2;BAIAP2;CDH8;PPP2R2C;ARHGEF6;VCL
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.3815558592308809,-1.0077547116787635,0.36,0.8985292304271794,1.0,11/78,11.70%,PPT1;CUBN;CD320;SCAMP3;ARL6IP5;SLC50A1;ABCG2;CHMP2A;GM2A;ABCA6;SCAMP4
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.661571127131072,-1.0076992024858693,0.5084745762711864,0.8972411030069252,1.0,3/5,27.83%,HLA-B;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.661571127131072,-1.0076992024858693,0.5084745762711864,0.8972411030069252,1.0,3/5,27.83%,HLA-B;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.661919300582806,-1.0076990327210331,0.5490196078431373,0.8965250287028494,1.0,1/6,1.56%,THY1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.4554765660124074,-1.0076623955530746,0.37037037037037035,0.89588359045456,1.0,3/19,4.00%,SOX4;ZFP36L1;RABL3
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.5833121454650741,-1.007230337578609,0.4727272727272727,0.8961162400930093,1.0,1/8,8.01%,WNT5A
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4583830161846666,-1.0069497641391372,0.47368421052631576,0.896030552431205,1.0,5/35,11.92%,RAN;NUP42;NOL6;NUP155;YBX1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.4621853861171461,-1.0069413717331168,0.4166666666666667,0.8953421593811001,1.0,3/25,8.80%,MAP7D3;TUBG1;TUBGCP4
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.524621626321847,1.0066361035504778,0.4883720930232558,0.9048834140841789,1.0,3/14,10.66%,RAC3;EFNA1;P2RY12
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.40591726118702054,-1.0064247634889645,0.41304347826086957,0.895965406235247,1.0,8/66,6.35%,MMP2;NCSTN;ARPC5;ACTG1;ACTB;EFNA2;APH1A;EPHB3
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4961351601716144,1.0063064362524623,0.49019607843137253,0.9051079241704846,1.0,3/25,2.81%,PTPRC;MERTK;CAMK1D
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5253923423995287,-1.006294435093375,0.41509433962264153,0.8955140319730478,1.0,5/14,16.65%,PTTG1IP;VPS35;ATRAID;VPS11;MSN
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.391430380869658,-1.0061942316661365,0.34615384615384615,0.8950715012912779,1.0,18/82,14.56%,PPT1;KDSR;ARV1;SGPP1;ASAH1;SMPD1;GBA3;GM2A;NEU1;NEU4;SPHK2;SPTLC1;PPP2R1A;SAMD8;ST6GALNAC3;CERS2;SUMF2;TECR
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.5030576748179465,1.0060686766138986,0.43548387096774194,0.9049508658685577,1.0,2/20,3.24%,CMTR1;PUS7
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.4085420312975801,-1.0059135124451233,0.4146341463414634,0.8951331539211522,1.0,7/37,11.21%,UBB;ERMAP;UROD;ALAD;ITGA4;CD44;UROS
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.44770636971670663,1.0057683475900976,0.40350877192982454,0.9050378418416664,1.0,4/37,5.05%,PTPRC;KLF6;HDAC4;PTPRJ
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.36436497025431597,1.0056739510136086,0.49019607843137253,0.9045994207479261,1.0,33/144,18.03%,OLFM3;SYT1;STMN2;KCNH7;EPHA7;RELN;LINGO2;SULT4A1;RIPOR2;SNAP25;ADGRB3;RNF138;TRIM44;CNTNAP2;CRMP1;NEFL;CLVS2;SRGAP3;ELAVL2;NRG1;ACTL6B;ANK2;KIF1B;ERC2;DCLK1;GALNT13;ASTN1;TMEM163;GNL3L;CELF3;SNCB;NEFM;SLC25A36
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.5793252225589466,1.005609317129041,0.49056603773584906,0.9040019442049252,1.0,7/12,31.56%,TOP1MT;TOP1;ABL1;MTERF1;HMGB2;TOP3A;KAT6A
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.6465800408508171,-1.0056034746658364,0.5217391304347826,0.8953326508161771,1.0,2/7,5.65%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.44810158364143443,1.0055691470716397,0.4098360655737705,0.9034053968633907,1.0,12/44,13.23%,GPR18;EDNRA;HTR2C;ADCY5;CAV3;GRIN1;RYR2;DLG4;KNG1;ACKR4;GRM1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6421468437822794,1.0053785500313808,0.4666666666666667,0.9032122978881634,1.0,4/6,27.29%,AP2M1;PICALM;ALS2;RAB5A
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.4849531461358548,1.0053340161854953,0.49056603773584906,0.9026855895517822,1.0,11/32,14.01%,SYT1;PCLO;RAB3A;SYN3;SNAP25;LIN7A;NAAA;STX1A;STXBP3;SNCA;CPLX1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.5443334020947597,-1.0053330916967487,0.4782608695652174,0.8953696756208464,1.0,1/17,2.73%,TRMT10C
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.4287433866115048,-1.0049277464391368,0.45,0.8957306976272946,1.0,8/27,8.95%,SIRT2;ASCL1;HES6;HES5;WNT3;TENM4;PTPRZ1;PTN
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.6080112344266385,-1.0048733859926902,0.5106382978723404,0.8951602249555574,1.0,2/7,5.92%,UBE2D4;RNF6
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.43716044764043044,-1.0048057198331026,0.41304347826086957,0.8946149192931352,1.0,4/39,8.79%,G0S2;GSTP1;NOL3;PSME3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.4463689361401606,-1.0048043728006568,0.45454545454545453,0.8939088301697783,1.0,5/46,8.27%,TAF9B;DERL2;SFRP1;SLC25A33;PSMD10
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.5516884947651133,-1.004170898454695,0.5111111111111111,0.8947624915210444,1.0,1/10,0.61%,BTG1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4589560325710009,-1.0041311886127993,0.4473684210526316,0.8934340479345265,1.0,4/33,10.64%,RAN;NUP42;NOL6;NUP155
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4589560325710009,-1.0041311886127993,0.4473684210526316,0.8934340479345265,1.0,4/33,10.64%,RAN;NUP42;NOL6;NUP155
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.543391426891283,-1.0038110388023767,0.47058823529411764,0.8936012419048194,1.0,4/10,15.85%,KDELR1;OS9;GPAA1;HSPA5
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.619759163919553,1.0036250603945718,0.54,0.9066336437665765,1.0,1/6,12.24%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.41686290558465694,-1.0035680401884033,0.41509433962264153,0.8934864075052095,1.0,15/68,16.67%,CDKN2C;PPIA;SH3GL2;CADM4;PPP1R15B;CACTIN;LYN;ZBED3;CDKN1C;ANKLE2;PARK7;PRNP;PRDX3;DYNLL1;CDKN2D
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.37456661590941964,-1.0035391328540644,0.45,0.8928810622941271,1.0,10/85,9.19%,PPT1;CUBN;CD320;SLC7A10;LRRC8D;SCAMP3;ARL6IP5;ABCG2;CHMP2A;SLC7A8
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6414873641457939,1.003523537132913,0.5555555555555556,0.906218756024658,1.0,3/5,34.52%,CAMK2D;PDE4D;PLN
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.42697848840761127,1.0034252422837109,0.5094339622641509,0.9058650807072557,1.0,9/51,10.68%,PON1;NEDD4L;MERTK;AKT2;CAMK1D;RXRA;C2CD5;SGK1;RAB27A
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6272579399619207,1.0033124903865351,0.5084745762711864,0.9054514300694728,1.0,3/5,28.87%,GOLPH3;VPS13C;VPS13D
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.48271581559151966,-1.0031079315708986,0.4666666666666667,0.8932492417229292,1.0,3/16,5.45%,G0S2;NR2F6;TLR1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.6366508705129098,1.0030487238372683,0.5294117647058824,0.905446632244606,1.0,1/5,8.14%,SLC1A4
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.5212755502795887,-1.0029912258814149,0.4375,0.8927976305900562,1.0,5/16,6.29%,MT1E;MT2A;ZNF658;MT3;P2RX4
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.581699903724711,1.002917338287735,0.49056603773584906,0.9049735150574966,1.0,2/9,10.66%,PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.531977112753457,1.002859751659603,0.46153846153846156,0.904448293779946,1.0,4/14,13.32%,GADD45A;SPI1;SASH1;RELL1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.6775712968257518,1.0027603323728767,0.5,0.9040068450381469,1.0,1/5,2.24%,DAPK1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.6661144107145406,1.0025343634702044,0.5409836065573771,0.9039353501266905,1.0,2/5,16.59%,ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4092267144139743,-1.0019613067727158,0.3333333333333333,0.8948265159560462,1.0,9/55,9.64%,CUBN;CD320;ALDH1L2;FLAD1;CYB5R3;DHFR;MMACHC;DHFR2;PCCB
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.39298035277869625,1.0018522688076912,0.3389830508474576,0.9052344945131654,1.0,14/85,12.95%,HDAC4;SAE1;KAT2B;POM121;RANGAP1;BCL11A;POM121C;EYA1;LOXL3;NUP93;ESCO1;STX1A;ATPSCKMT;PIAS4
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.539754569060665,1.0017547367408173,0.42857142857142855,0.9041350590521932,1.0,4/13,12.56%,EYA4;EYA1;MAP2K5;EYA2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.539754569060665,1.0017547367408173,0.42857142857142855,0.9041350590521932,1.0,4/13,12.56%,EYA4;EYA1;MAP2K5;EYA2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5951934097917995,1.0016753247760657,0.52,0.9022559374219215,1.0,2/10,8.51%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.5951934097917995,1.0016753247760657,0.52,0.9022559374219215,1.0,2/10,8.51%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5951934097917995,1.0016753247760657,0.52,0.9022559374219215,1.0,2/10,8.51%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.3978712920645884,1.0013529067309386,0.42857142857142855,0.9025009897197991,1.0,9/73,7.41%,HEY2;SOX9;SRF;ZFPM2;PKP2;KAT2B;NTRK3;MICAL2;SH3PXD2B
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.4119244805439795,-1.0004473922817532,0.45098039215686275,0.8982074214827632,1.0,7/39,5.80%,HSD17B10;CYP3A43;CUBN;TSPO;MSMO1;DHRS4;ARV1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.4161979489354874,-1.00037661191607,0.5208333333333334,0.8976808770073949,1.0,3/43,4.78%,SOX4;BAD;ALOX5
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.514710329916217,-1.0002924582291726,0.47058823529411764,0.8971631622832126,1.0,3/17,16.62%,CALM1;CAV1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.6147913269306571,-1.0000936849017508,0.5531914893617021,0.8970302625939038,1.0,2/7,12.78%,CAV1;UBQLN2
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6315584406042486,-0.9998520416571096,0.631578947368421,0.8969215520441952,1.0,3/6,5.35%,LIN7B;AP4M1;LIN7C
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.4165832850844283,0.9997839882302518,0.4107142857142857,0.9057191913085009,1.0,8/51,10.31%,EFHC1;SEPTIN9;RACGAP1;SEPTIN6;SPIRE1;CECR2;SEPTIN4;CIT
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5464417673296934,0.9993513935912766,0.42592592592592593,0.9061408385797457,1.0,3/11,15.69%,HDAC4;PFKFB1;NCOR1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5857024712336205,0.9993276387415911,0.5102040816326531,0.9055821537723207,1.0,6/8,30.52%,WDR91;WDR81;PIK3R1;RBL2;EEF1A2;RBL1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.3580607840167012,0.9993245414686792,0.43548387096774194,0.9048972854843226,1.0,21/123,12.28%,SOX9;SRF;ALK;ENPP2;RELN;SPIRE1;CAMK2B;PHLDB2;PSEN1;TMEM79;SLC6A6;FOXO6;ZBTB16;SHANK3;DLG4;BMP7;CPEB3;CAMK1;GJA1;TP53BP1;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.6665043685994331,-0.9990610846043622,0.5652173913043478,0.8980271333581373,1.0,2/5,20.92%,GRN;HAVCR2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5152636272449729,0.9989815080460591,0.47540983606557374,0.9052737917055945,1.0,4/12,9.66%,CABYR;ODAD4;CCDC39;AQP4
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.6224602310250693,0.9989433944875598,0.5333333333333333,0.904687202599706,1.0,4/8,28.25%,SRP54;COBL;NIPBL;PKD1
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.5097167761727035,-0.9987202668808223,0.5116279069767442,0.8982450535378207,1.0,8/21,18.55%,CALM1;PPIA;SMPD1;CALM3;BMP2;ANKLE2;PPP1R7;PPP2R5A
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.40202217032263005,-0.9986793926589655,0.4444444444444444,0.8976491634000294,1.0,17/56,25.60%,POLR2L;GAPDH;IRF3;POLR2K;ISG15;POLR2E;DHX33;FLOT1;POLR3D;OAS3;CRCP;HSPD1;POLR2F;RIPK2;HSP90AA1;RELA;XRCC5
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.6347440098478816,0.9981922675623215,0.5510204081632653,0.9059803467600739,1.0,4/8,25.34%,SPIRE1;COBL;CARMIL1;PLS3
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5857452593876897,0.9981099357433552,0.5416666666666666,0.905520763740589,1.0,4/8,30.20%,ST3GAL1;NPL;ST6GAL1;GNPDA2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.599686940121879,-0.9979669195220588,0.4444444444444444,0.8988631633319735,1.0,1/8,4.78%,ALOX5
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.5267668630310471,-0.9978954035763125,0.5192307692307693,0.8976811571698758,1.0,3/19,2.98%,HSD17B10;ACAD8;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.5267668630310471,-0.9978954035763125,0.5192307692307693,0.8976811571698758,1.0,3/19,2.98%,HSD17B10;ACAD8;SLC25A44
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.3947227668301152,0.9978470785445682,0.5319148936170213,0.9054862087874228,1.0,23/89,17.86%,OLFM3;UNC5D;PCSK2;STMN2;ENPP2;SULT4A1;KCNB2;ARX;SNAP25;KCNIP1;CLVS2;ACTL6B;PTPRN;ABCC8;ASTN1;CALY;LRRTM1;SLC8A2;CTNND2;UNC79;CELF3;GAD2;UNC13A
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.5201404711257382,0.997389524875585,0.5,0.9060319239175378,1.0,2/12,10.11%,WRN;RPA1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.578589173150406,-0.9970798841867724,0.5,0.8991626194792995,1.0,3/9,10.59%,ACTG1;ACTB;CGNL1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5132692020803562,-0.997002014031688,0.45,0.89871927005389,1.0,6/24,9.67%,CALM1;PPIA;PPP1R15B;SMPD1;CALM3;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.48057854974330017,0.996990962725856,0.45098039215686275,0.9064355815125912,1.0,6/16,22.97%,GADD45A;DMTN;GPD1L;DMD;NCK2;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5638606396103253,0.9962493668549387,0.48,0.9077224839558504,1.0,5/13,26.81%,SORBS1;PPARG;APOE;CREBL2;EEF1A2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.37208450060372805,-0.9959262146859885,0.5102040816326531,0.9005945363193755,1.0,27/102,18.44%,PSMB6;PSMD8;THY1;PSMB4;ERMAP;MALT1;PSMA7;PSMC3;PSMD10;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;EIF2B2;BTN3A3;IKBKB;PSMD4;EIF2B1;RC3H1;PRKCQ;PSMC4;PSMB2;PSMD3;PSMD11;BTN2A1;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.42970994810606766,-0.9954054614621888,0.4166666666666667,0.9011501917714899,1.0,2/32,3.84%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.5654482507837417,-0.9953711074958352,0.45652173913043476,0.8998830163821012,1.0,3/10,7.11%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.5654482507837417,-0.9953711074958352,0.45652173913043476,0.8998830163821012,1.0,3/10,7.11%,CCT5;LARP7;CCT3
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.5827076692764679,0.9953442093630465,0.5,0.909482423537794,1.0,2/9,11.92%,SOX9;CHRD
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.44132162316397633,0.9952685636915445,0.45652173913043476,0.9090074433674725,1.0,9/37,22.74%,CRIM1;LRP2;VWC2L;CHRD;UBE2D3;PPARG;SMAD5;SMAD4;TRIM33
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.4427233129932304,0.9951464699366572,0.4807692307692308,0.9086962141356646,1.0,5/38,13.98%,ROBO2;TENM3;PVR;IGSF11;CADM1
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.5654160485308086,-0.994862708444316,0.4807692307692308,0.9004616741850892,1.0,3/8,11.21%,UGDH;FADS1;UROS
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.36507406503360423,-0.9944285907103803,0.4339622641509434,0.9007626771508712,1.0,20/117,13.83%,RRAGA;DAPL1;ATF4;GABARAPL2;ATP6V0E1;ATP6V1F;HSPA8;ATP6V1G1;SFRP1;MAP1LC3A;FADS1;RRP8;ATP6V1B2;LAMTOR4;ATP6V0E2;MYBBP1A;ATP6V0D1;TFEB;WDR45B;LAMTOR5
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.5014947927783961,-0.9943497125304236,0.44642857142857145,0.9002730795861158,1.0,2/16,6.26%,BAD;PDE3A
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.5745633730371484,0.9940838226586829,0.5660377358490566,0.9109327329605464,1.0,2/11,11.26%,TMSB4X;SUFU
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5401314039343482,-0.9940371232188974,0.46511627906976744,0.9005027063940869,1.0,4/20,6.31%,UBB;RPS27A;UBC;UBA52
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.5631664046388627,-0.99369567429895,0.5365853658536586,0.9009607657660498,1.0,3/12,11.23%,CALM1;SGPP1;SPHK2
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.4102194199589363,-0.9935271090994471,0.4444444444444444,0.9007322891227892,1.0,10/48,10.97%,SLC35B4;LRRC8D;ARL6IP5;SLC1A6;SLC25A30;PRAF2;SLC25A4;SLC7A8;SLC25A5;SLC25A1
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.5107527877524625,0.9934277712825196,0.5416666666666666,0.9117822025637055,1.0,3/20,8.71%,GUK1;REXO2;NMNAT2
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.602707974033267,-0.993122338348781,0.5686274509803921,0.9011185737510439,1.0,1/5,3.74%,LRRC8D
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4748936063883324,-0.9928590627029018,0.425,0.9010477469168767,1.0,6/16,24.53%,SVIL;CAV1;ZBTB18;MYL6;LEMD2;RYR1
prerank,MSigDB_Hallmark_2020__Androgen Response,0.371830249923866,0.9928143768833878,0.5319148936170213,0.9126599617228984,1.0,12/87,10.20%,FKBP5;INPP4B;LIFR;SRF;MERTK;SORD;MAP7;MAK;CDK6;AKAP12;STEAP4;SGK1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.5161784242916844,-0.9924960125688924,0.5652173913043478,0.901299491764079,1.0,2/20,1.92%,SIRT2;ATF4
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.4138329783301535,-0.9924236214083524,0.4523809523809524,0.8994472512150893,1.0,10/54,12.58%,GORASP1;RAB1B;TMED2;PEF1;CTSC;TRAPPC2L;TRAPPC6A;TRAPPC2;KLHL12;SAR1B
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.4138329783301535,-0.9924236214083524,0.4523809523809524,0.8994472512150893,1.0,10/54,12.58%,GORASP1;RAB1B;TMED2;PEF1;CTSC;TRAPPC2L;TRAPPC6A;TRAPPC2;KLHL12;SAR1B
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4138329783301535,-0.9924236214083524,0.4523809523809524,0.8994472512150893,1.0,10/54,12.58%,GORASP1;RAB1B;TMED2;PEF1;CTSC;TRAPPC2L;TRAPPC6A;TRAPPC2;KLHL12;SAR1B
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.5757901283172305,0.992313100708155,0.5636363636363636,0.9133590799810949,1.0,4/11,12.72%,KCNJ11;RYR3;P2RY12;TAF1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5535675316881081,0.9921539836209583,0.5111111111111111,0.9131047993702174,1.0,1/12,0.28%,PTPRC
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5551381927815944,0.992111625314361,0.509090909090909,0.9125484484237304,1.0,4/12,19.61%,CD160;PIAS4;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5208844674602994,0.9917877344753113,0.42857142857142855,0.9126563596780489,1.0,4/17,12.56%,EYA4;EYA1;MAP2K5;EYA2
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.45791798119924493,0.9916768197406229,0.5333333333333333,0.9122779646737513,1.0,4/37,3.29%,DOCK5;EFNA5;NEDD9;RAC3
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.3900026745942253,-0.9916079638475155,0.4,0.9007344440011004,1.0,18/82,12.61%,TUBB2B;RPL23A;PCGF2;NKX2-2;CAMSAP3;DUSP15;SEZ6L2;SOWAHA;VWA1;EFNA2;LINGO1;LRIG3;HNF4G;C1QL1;FLRT3;PTPRF;MAGI1;YAP1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.42015847224836733,-0.9912943234484213,0.45652173913043476,0.9008836123081846,1.0,6/45,10.24%,SIRT2;ALOX5;VPS35;SELENOS;CACTIN;FNDC4
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.41847299051447345,-0.9912348059979775,0.45652173913043476,0.9003905851354805,1.0,11/35,22.36%,RAN;RBM22;BAG3;SMAD3;HDAC3;RAPGEF3;TRIM28;YWHAE;ECT2;ANP32B;TPR
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.4404104206887427,-0.9911523213382173,0.40425531914893614,0.8999139570307508,1.0,8/37,19.05%,STOX1;VPS35;HAX1;MFF;PRMT6;FIS1;CSNK2A2;MUL1
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4403786272517457,-0.9910878185815507,0.42592592592592593,0.8993677043388923,1.0,11/38,16.62%,AMOTL2;SEMA5B;SEMA4F;SEMA4C;CENPV;ITGA4;SEMA5A;SOX8;AMOT;SOX10;AKT1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.40429902695503245,-0.9908088315686856,0.4166666666666667,0.8993690518778006,1.0,17/61,21.94%,SIRT2;ALOX5;VPS35;DUSP3;SELENOS;CACTIN;FNDC4;CERS2;ENPP3;TNFAIP6;MUL1;LYAR;TEK;NFKBIL1;TRAFD1;PCBP2;C1QBP
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6002908786717317,0.9907359584722231,0.5098039215686274,0.9140493371744929,1.0,1/7,1.93%,WNT7A
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.6014712928881073,-0.9907045659464263,0.5769230769230769,0.8988474622187058,1.0,2/6,21.00%,CHMP2A;FNBP1L
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.42944343652510364,0.9904180556321933,0.4444444444444444,0.9142661964149279,1.0,11/41,15.10%,WNT7A;SRF;RAB3A;PAK1;MACF1;SYTL4;DYSF;NRG1;TPM1;FGF1;CFLAR
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4107047757469428,-0.9904031779591875,0.4230769230769231,0.8989817879106393,1.0,8/64,9.16%,PPT1;ATF4;SLC30A10;MT3;VPS35;PTPRZ1;SET;NGF
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.4723606453060011,-0.9903709528721782,0.49056603773584906,0.8984067350122523,1.0,4/25,10.16%,CD151;THY1;RCC2;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3456559366212548,-0.9903011745603321,0.3953488372093023,0.8979260030717318,1.0,46/243,12.85%,SOX4;BTC;S100A6;COPS9;CLEC11A;CALR;BAD;DERL2;S100B;RTKN2;ROMO1;GID8;PDGFD;HES5;STOX1;RHOG;RPL23;SFRP1;BAMBI;PDGFRA;RPS9;TBRG4;SAPCD2;RPS15A;WNT5A;SLC25A33;NACC1;LYN;HAS2;COX17;CNBP;PTN;IL12RB2;SLC25A5;FN1;UFL1;POU3F2;SOX8;RNF187;NPM1;CAPN1;GRN;ZNF304;BMP2;YAP1;PRMT1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.38437810001930767,-0.9900790788046361,0.4897959183673469,0.8976716588102068,1.0,8/67,9.79%,RAN;KIF25;SMC1A;REC8;TUBG1;SET;CHMP2A;KIF18B
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5870513799594287,0.9897518868797928,0.5833333333333334,0.9151735541442183,1.0,3/8,20.69%,ST3GAL1;CSGALNACT1;GFPT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.543720327073369,-0.9892794129822958,0.4583333333333333,0.8989649995061584,1.0,3/16,10.97%,PPT1;ACLY;SLC25A1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.3774655838056824,0.9889812539743403,0.5217391304347826,0.9165348563775908,1.0,18/101,13.83%,RFC4;IGF1R;PARN;EPHA7;ALK;MERTK;NTRK3;PARM1;ZNF16;TYRO3;ROR1;EPHA4;TNKS;ZNF622;HMBOX1;DCUN1D2;LMTK2;SERINC1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5897698560611657,0.9887731574015596,0.5254237288135594,0.9164631728352278,1.0,2/8,13.69%,RACGAP1;SLC13A4
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.45717064051983436,0.9887114780798405,0.41818181818181815,0.9159296393931066,1.0,7/24,19.32%,ALOX12;SPI1;PROX1;TSPAN9;AOAH;PPARG;SYP
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.6158726451269702,0.9887082716355922,0.5555555555555556,0.9152430354655255,1.0,3/7,28.88%,ENG;NF1;PGM5
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.5306820939555429,-0.9886614589601073,0.5106382978723404,0.8997202841203749,1.0,1/10,1.59%,CALR
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.5470337619465789,-0.9877286692823198,0.4523809523809524,0.9015846155227065,1.0,3/12,14.33%,LARP7;RNF8;RNF168
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.41539802769122347,0.9876585833429199,0.5227272727272727,0.9175080942610916,1.0,14/46,21.45%,RFC4;PARN;PARM1;CCT8;TNKS;ATM;CCT6A;HMBOX1;MAPKAPK5;NEK7;NAF1;MAPK3;MAPK1;ATR
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.526544142466627,-0.9873934938689607,0.5434782608695652,0.901770459174161,1.0,5/15,24.05%,PPP1R35;YWHAB;GPATCH2;PPP1R26;CHP1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.3399254485579275,-0.9873584147696547,0.42,0.9011963424597447,1.0,38/207,19.23%,UBB;CHRNA4;APEX1;RPS27A;RAN;UBC;NT5E;PARP1;NABP2;KPNA2;SMC1A;UBA52;ADPRS;PARP2;CNBP;KMT5B;MPG;RAD17;NPM1;TDG;MCM4;PARK7;FAN1;VCP;ENDOV;LTO1;MUS81;POLG;POLD3;POLD2;TRIM28;PARP4;UBE2N;DBF4;RFC5;PRIM1;SUMO1;EXD2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6047657499668342,0.9871334779238745,0.5,0.9181748323028904,1.0,1/7,0.28%,PTPRC
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.43816754613838843,0.9870377084104438,0.49019607843137253,0.9177658970930092,1.0,3/40,1.80%,MSL3;BAZ2A;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.6230500119287082,-0.987020154103857,0.5581395348837209,0.9013512148059755,1.0,2/7,16.41%,TOMM7;OPTN
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.4581476339482507,0.986998130867686,0.4528301886792453,0.9171676364799726,1.0,4/30,13.85%,KIF1C;TRAK1;NEFL;KIF1B
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.48149743660809957,0.9869951235848158,0.45454545454545453,0.9164899716529307,1.0,4/19,21.45%,WRN;ATM;PRKAA1;ATR
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3884794440008321,-0.9869655736655285,0.37209302325581395,0.9007860229899821,1.0,10/70,8.18%,PPIF;CALM1;PEF1;SYT11;ALG2;HPCA;SMPD1;CALM3;WNT5A;SLC25A24
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.6255639243296558,-0.9868674529735062,0.5384615384615384,0.9003841044389264,1.0,2/6,13.33%,PARP1;CDC42
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.5314378505021221,0.9868254100662,0.5531914893617021,0.9163020399194708,1.0,1/11,1.86%,KLF15
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5444200964467603,0.9867599491357573,0.5283018867924528,0.915742653880906,1.0,5/13,17.98%,MMP21;BBS7;DNAH5;DNAH11;PKD2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5966432249536235,-0.9860269072513531,0.5238095238095238,0.9018376145014936,1.0,1/6,2.13%,ODC1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6383007715093809,0.9859844651629578,0.5106382978723404,0.916953987669681,1.0,2/5,20.77%,HS6ST3;HS3ST5
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.5980487644583915,0.9859641914237868,0.5660377358490566,0.9162930564050072,1.0,5/6,34.88%,ZCCHC3;ANKRD17;PUM2;PUM1;USP15
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.568249844491654,-0.9859479349185643,0.5405405405405406,0.901327392757497,1.0,1/9,1.60%,GORASP1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.47350575956306906,-0.9859210771177449,0.40816326530612246,0.9007021883467642,1.0,2/15,12.42%,SYT11;CAV1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.4769994196069354,0.9857456008938702,0.46551724137931033,0.9162076475176586,1.0,8/20,23.51%,PIP4K2C;GRB10;PIP4K2A;PRKCZ;SLC27A4;PTPRE;IRS1;PIP4K2B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3900080793159163,-0.9856149898978033,0.42,0.9009646865962072,1.0,14/61,16.76%,SIRT2;ELOB;PRICKLE1;ZYG11B;PSMD10;STUB1;CLU;RAD23A;CAV1;UBQLN2;RACK1;TRIB3;VCP;RNF14
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.43059717023891836,0.9854375205248492,0.48,0.9163258482539217,1.0,10/40,16.59%,TMSB4X;BRD4;FOXP1;LRRC19;CYLD;TIRAP;BCL6;IRF1;TRAF3;APPL2
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.36966663618435847,0.9851488588593131,0.4090909090909091,0.9163349457973656,1.0,29/119,13.85%,GRIN2A;OPALIN;FAM107A;SHISA6;ALDH1L1;NTRK3;SLC4A4;GFAP;GRM3;MMD2;PSD2;KCNIP1;ATP2B2;NPAS3;ADGRB3;KCND3;BAALC;LSAMP;MAPK10;SEPTIN4;AQP4;CLVS2;SCN2A;CDH20;GJA1;MAGI2;CDC42EP4;DPP6;KIF1B
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3290706574672773,0.9851377002889748,0.5294117647058824,0.9156764367798564,1.0,64/312,20.51%,FHDC1;ABLIM1;INTU;RPGR;RAB17;VPS37C;FAM161A;SEPTIN6;CFAP221;IFT172;WDR19;ATG7;RB1CC1;CCDC57;CDS1;RAB8B;SH3PXD2B;TMOD3;RAB1A;ATG5;MAK;BBS7;DNAH5;INPP5E;HAUS2;TNKS;TTBK2;RABL2B;PCNT;HAUS5;PACS2;MAP1LC3B;KIAA0586;ASAP1;BBS4;CEP41;CEP131;TMEM138;DYNC2I1;TMEM216;CSNK1D;NCOR1;CHMP6;NEK7;STX12;IFT52;CEP290;EHD1;RFX3;HAUS6;CDC14A;TTLL3;VPS37A;RILPL1;CFAP43;HYLS1;STK36;ATXN2;DZIP1;CC2D2A;ANLN;AHI1;CDC14B;CFAP70
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.4134452851281991,-0.98502830148547,0.3888888888888889,0.9018277925982342,1.0,6/65,5.45%,NOX4;PRDX5;HSPG2;TUSC2;HNRNPA0;TLR1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.3919283472199503,-0.984946171533323,0.47368421052631576,0.9013730083343837,1.0,21/93,12.58%,S100A10;BGN;PODN;STAB2;HSPG2;IGFBP7;TNS2;VWA1;CD82;PDGFRA;CXCL12;EDNRB;PCDH12;ABCG2;MEOX2;VWF;MCAM;MADCAM1;CDKN1C;CAV1;BMP2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.4095914958024365,0.9846720202713252,0.4406779661016949,0.9161065642450328,1.0,5/40,11.26%,INTU;TULP3;FBXL17;RORA;SUFU
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.616785618768272,0.9846042457051483,0.5740740740740741,0.915579623199994,1.0,2/7,27.97%,ANK2;ATP1B1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.5505377921817755,-0.9845232525701981,0.5263157894736842,0.9017421211328083,1.0,2/6,8.83%,SLC16A9;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.6418706868620689,0.9843505916049402,0.5208333333333334,0.9155385643015,1.0,1/6,4.45%,PLIN5
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.5931426591683412,0.984313395827776,0.5423728813559322,0.9149766489534853,1.0,3/7,8.14%,SLC6A17;SLC6A6;SLC1A4
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.40695347607004057,-0.9841454021058786,0.4897959183673469,0.9021568065673451,1.0,7/47,13.16%,EMC6;GABARAPL2;RAB1B;MAP1LC3A;ULK3;UBQLN2;WDR45B
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.40467051150591055,-0.9839287988936596,0.4358974358974359,0.9021099472608047,1.0,16/64,16.65%,SURF4;STOX1;SYT11;CAMSAP3;VPS35;TMED9;CENPV;MFF;TBC1D25;PRMT6;SAR1B;FIS1;VPS11;RAB33B;SCARB2;MSN
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.37559137697727685,0.9836899314815838,0.5084745762711864,0.9158831757238693,1.0,3/91,2.19%,RASGRF1;STMN2;FAM161A
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.42276505077051163,0.9834032929624386,0.4186046511627907,0.915899777644842,1.0,9/47,13.27%,CDC42BPB;PRKCA;OXSR1;TNKS;CIT;PDPK1;CAMK2D;TAF1;LMTK2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.5845426940231284,-0.9833822831028006,0.48,0.9028921968768954,1.0,2/7,9.50%,DNAJA1;HAX1
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6385230922809316,-0.9829846166701304,0.5957446808510638,0.9033587826917076,1.0,1/6,7.26%,TAF7
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.5815010679364861,0.9829752894584337,0.46938775510204084,0.9162412069545488,1.0,1/6,6.58%,RFLNA
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.6059330682453297,-0.9827700343254914,0.5918367346938775,0.9031578330748874,1.0,2/7,5.65%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4785801958901027,-0.9826141256369242,0.5098039215686274,0.9029801612349431,1.0,1/17,0.43%,ZDHHC1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.515522715171724,-0.9826070677998191,0.5531914893617021,0.902305288169745,1.0,2/16,8.16%,JUN;MED30
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.4740618663030779,0.9825636782964771,0.5,0.9165244234796163,1.0,5/22,18.44%,ATP2B3;RYR2;SLC8A1;SLC8A2;ATP2B1
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.5564521901930317,-0.982377374990072,0.425531914893617,0.9020979279334745,1.0,4/7,21.94%,TSPAN6;MUL1;PCBP2;C1QBP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.5060850111379471,-0.9821057087601129,0.4727272727272727,0.9020742830912842,1.0,4/11,21.89%,ERH;ENPP3;SLC19A3;DCTD
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6053703935518595,0.9819319710252881,0.5,0.9175136341107987,1.0,2/6,20.73%,MTHFD1;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4651308251209466,-0.9817106159420231,0.46296296296296297,0.9023713944966518,1.0,2/26,0.48%,BTC;NOX4
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.384931883579502,-0.9816669125468748,0.5116279069767442,0.9018515970762587,1.0,14/85,6.29%,BGN;MMP2;PODN;HSPG2;THY1;PRRX1;FIBIN;IGFBP7;COL12A1;TNS2;THBS2;PDGFRA;CXCL12;P2RX4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.6476720838419048,0.9816440383984664,0.5818181818181818,0.9176586390746633,1.0,2/6,14.87%,ENPP2;ARHGEF7
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.404061660893373,-0.9815706814346171,0.5454545454545454,0.9014621960540192,1.0,10/76,8.84%,PRDX5;IDH1;TSPO;PRDX1;CRAT;IDI1;FADS1;PEX11A;SLC25A4;CNBP
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.38033095396765987,-0.981567860945464,0.45614035087719296,0.9008143227596705,1.0,13/102,12.60%,HSBP1;ATF4;NUP42;HSPA8;USP51;ALOX5;BAG3;CHCHD2;HSP90AB1;NUP155;NPM1;CASP9;VASH1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),-0.5783697040578757,-0.9812202029747442,0.46,0.901088646823968,1.0,3/7,21.44%,PSAT1;PSPH;PHGDH
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.4797516108765924,-0.9812068784269584,0.43137254901960786,0.9004800529574805,1.0,5/22,14.98%,ALOX5;ATP5F1A;CAV1;VASH1;SCG2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.4100176536650232,0.9811886948656146,0.543859649122807,0.9181633138791863,1.0,7/47,9.14%,FAM107A;EFNA5;RAC3;PAK1;BAIAP2;RHOBTB2;ARHGAP17
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5062766682839763,0.980740699675037,0.5111111111111111,0.9186960154553606,1.0,2/14,9.10%,FOXP1;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.6038842781360616,0.9805739040116878,0.5178571428571429,0.9184732899171305,1.0,1/7,1.46%,ADAMTS9
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),-0.5429634561540095,-0.9804606646533907,0.543859649122807,0.9015296422251571,1.0,5/10,22.88%,SMPDL3A;ENPP3;ENPP1;ITPA;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3989204786309599,0.9803792250306248,0.46808510638297873,0.9182293462685877,1.0,11/49,12.64%,TMSB4X;NLRC5;ERBIN;IRAK2;SPI1;CDKN2A;CYLD;MAP2K5;BMP7;ARRB2;NLRP12
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),-0.6912176579319116,-0.9803008271172748,0.5789473684210527,0.9011951003273073,1.0,1/5,5.44%,PDGFRA
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5649497382864196,0.9801864450268873,0.574468085106383,0.9180072904221808,1.0,3/9,12.98%,CALCOCO2;CLEC16A;FYCO1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.5724014614492123,-0.9797162535674928,0.4666666666666667,0.9019541481472965,1.0,1/8,0.55%,SIRT2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.4655948368089644,0.9796302819557154,0.5,0.918768023601744,1.0,6/25,9.85%,PTPRC;GPR18;GNG7;TRAF3IP3;CD27;SLC12A1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.6071346556800505,0.9795727136474248,0.49056603773584906,0.9182090961131308,1.0,3/8,12.41%,TMSB4X;XRCC4;ATPSCKMT
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.4597165272450818,0.9791412183288415,0.48,0.9185890467104199,1.0,7/34,10.29%,HEY2;SOX9;TGFBR3;LOXL3;RANBP3L;FBXL17;BMP7
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.38280584694827935,-0.9785869754042257,0.4067796610169492,0.9039408909899711,1.0,19/110,7.25%,SLC22A17;OLIG1;THY1;TCEAL6;S100B;TCEAL7;CNP;MT3;CMTM5;TNS2;GPR37L1;LGI3;CD82;SYNDIG1;BAG3;BCHE;APOD;EDNRB;CADM4
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.5175629876395027,-0.9783148187934699,0.5272727272727272,0.9039539729755303,1.0,1/10,3.43%,HNRNPA0
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.5537163612770857,-0.9778681503489701,0.5192307692307693,0.9044896474687553,1.0,4/10,11.79%,DHFR;ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.36833086297207773,0.9777480174578765,0.4745762711864407,0.9216159814475436,1.0,10/82,12.40%,BAZ2A;SOX9;HDAC4;KAT2B;PAK1;CECR2;SATB2;TADA2A;TOP1;ACTL6B
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.5744943527847963,-0.9776557814884509,0.5849056603773585,0.9043585032799152,1.0,3/8,13.89%,GPR37L1;PYCR1;PARK7
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.6458802866270528,-0.9775691633337625,0.5510204081632653,0.9031596884637796,1.0,1/5,6.45%,SOAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.6458802866270528,-0.9775691633337625,0.5510204081632653,0.9031596884637796,1.0,1/5,6.45%,SOAT1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5003843110415818,-0.9774835288598482,0.4523809523809524,0.9026824350581362,1.0,3/17,10.49%,NCSTN;APH1A;HM13
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.6472833265326932,0.977401668556826,0.5555555555555556,0.9218784794364477,1.0,3/6,16.93%,RIPOR2;CFLAR;EHD1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.3730230507583055,0.9773512487242694,0.5,0.9213260575671259,1.0,18/92,14.90%,AHR;HCN3;NR4A3;HCN1;ADCY5;RYR3;GABRB1;GABRG2;BRCA1;RORA;P2RY12;ADCY3;DMTN;RAP1B;TAF1;DIAPH1;LCOR;SPP1
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.5898226025031619,0.9773439297114341,0.5740740740740741,0.9207030443997986,1.0,3/9,8.30%,NEBL;TTN;PROX1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3363444902040089,-0.9772920285862668,0.45652173913043476,0.9025379168556873,1.0,40/245,13.99%,COPZ1;RRAGA;BICD2;FBLN5;ARL4A;SNX17;SEPTIN3;RAB1B;TMED2;AP4M1;RABL3;CD63;ARFIP2;SYNDIG1;VPS35;ARMCX3;ERP29;SCG5;ARL1;WNT5A;ABHD17A;TMED9;RAB14;RAB5B;SLU7;STX6;COX18;EPB41L3;VPS26B;TBC1D25;NPM1;CORO1B;SAR1B;UNC50;AMOT;TMED1;WDR45B;MESD;WLS;CEP68
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.41649662979897206,0.9768166658315798,0.5102040816326531,0.9213794420684027,1.0,11/38,22.68%,TGFBR3;USP9X;BMP8A;BMP7;CHRD;ENG;PDCD4;SMAD5;MAPK3;SMAD4;RUNX2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.39902361852609114,0.976738119390218,0.47058823529411764,0.9209141460195229,1.0,5/38,8.35%,ITGA8;EFNA1;SRCIN1;TYRO3;RADIL
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.4260756791658889,0.9766482398201903,0.5,0.9204495282447669,1.0,7/41,9.12%,YWHAH;STMN2;BAG5;SEMA3A;EPHA4;RAB29;CRMP1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4336734417430184,-0.9763625681470499,0.4897959183673469,0.9041958198237369,1.0,8/31,17.17%,PMEPA1;DDX54;WBP2;DDX5;YAP1;NCOA4;RNF14;AR
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3398222436066148,0.976348063320949,0.5,0.920526633812278,1.0,23/181,9.29%,IL1RAPL2;ROBO2;SYNJ2;GRIN2A;MYRF;SOX9;ADGRL2;EPHA7;SLC6A17;MDGA1;MEIS2;RELN;B3GNT5;GRIN1;ZBTB16;ARNT2;NPAS2;NRCAM;LOXL3;PROX1;CNTNAP2;ATXN1;ZIC4
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.385556308202165,-0.9763161458816724,0.43478260869565216,0.9036661120318842,1.0,11/74,8.43%,BGN;HSPG2;FIBIN;AMOTL2;RARRES2;COL12A1;TNS2;CXCL12;S100A16;LRIG3;HAS2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.585531452321537,0.9761073145162104,0.5531914893617021,0.9205538301784567,1.0,2/8,4.41%,GRIN2A;NLRC4
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.49704687940479486,0.9757603588959679,0.4,0.9207160518796269,1.0,6/22,11.72%,GRIN2A;IGF1R;PSEN1;GRIN1;EPHA4;GJA1
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.5256469972630415,0.9756535293491344,0.5370370370370371,0.9202955497761384,1.0,3/12,5.74%,SLC2A12;SLC2A9;SLC2A6
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.614802975770584,0.9755966880558996,0.6122448979591837,0.9198046748865194,1.0,3/10,19.85%,PUDP;UCK1;HPRT1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.6324083072023903,0.9754490346871285,0.5423728813559322,0.9195131221128384,1.0,3/5,18.10%,CNTNAP1;CNTNAP2;ANK3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3130620706900932,-0.9754108967472265,0.5208333333333334,0.9052830996946436,1.0,27/311,10.64%,RRAGA;UBB;CUL7;ELOB;UBE2D4;RPS27A;NUP42;UBC;TRIM35;UBE2Q2;MAGEF1;ELOC;TNFAIP1;RNF6;UBA52;SELENOS;MARCHF2;FBXO45;CUL9;ASB1;STUB1;ANAPC11;RFWD3;UFL1;CAND2;OS9;NUP155
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.4431309042501498,0.9753406489399268,0.4909090909090909,0.9191581996567137,1.0,6/31,9.90%,FAM107A;EFNA5;STMN2;PHLDB2;CYLD;GAS2L1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.4245482026396102,-0.9753161481884567,0.48214285714285715,0.9048511834180936,1.0,9/53,11.99%,UBB;RPS27A;UBC;DYNLL2;PHB2;UBA52;UFL1;AUP1;ACBD5
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.6227937860385174,0.9749258620556261,0.5689655172413793,0.9195262496775001,1.0,1/8,2.56%,SLC39A14
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.6439278328622808,0.9747837678895043,0.5333333333333333,0.9192709208349447,1.0,2/5,23.87%,SEC16A;GBF1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.48161525519997067,0.9747806035808572,0.4583333333333333,0.9186128191795436,1.0,5/15,22.52%,BBS4;CEP131;CSNK1D;HOOK3;C2CD3
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.45162688131979517,-0.9746281825364048,0.40816326530612246,0.9056604497386562,1.0,3/26,5.35%,LIN7B;CAMSAP3;LIN7C
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.39845336395207076,0.9744818201271208,0.5423728813559322,0.9185493441194146,1.0,12/56,9.97%,GRIN2A;CNTN3;MYLK;ENPP2;FAM13C;SLC4A4;SGIP1;PROX1;LSAMP;GABRA2;FGF14;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5970120503672455,0.9744155627373372,0.5319148936170213,0.9180339638812411,1.0,1/5,6.25%,CLEC16A
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.3629451410302773,0.9743620631396703,0.603448275862069,0.9174981558172655,1.0,26/123,14.02%,ABLIM1;FKBP5;TPD52L1;IGF1R;RAB17;SEC14L2;ITPK1;MREG;FOS;TIAM1;SYBU;PAPSS2;SLC1A4;MPPED2;HES1;SYT12;RARA;MAST4;ELOVL2;GJA1;IL6ST;RPS6KA2;RAB31;NAV2;OVOL2;BHLHE40
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5418570099044665,0.9743203961489854,0.5217391304347826,0.9169349118830479,1.0,1/9,8.32%,NUP93
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.5712259368550653,0.9743165769539976,0.509090909090909,0.9163020083649516,1.0,4/9,16.51%,ACACB;PRKAA2;CPT1A;ACACA
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.46946296544624766,0.9740917408654065,0.46511627906976744,0.9162545110081775,1.0,1/28,0.24%,HEY2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4794513127041609,-0.97405412390272,0.4782608695652174,0.9062206009414022,1.0,5/29,10.41%,BTC;SH3GL2;DUSP3;RNF126;SPRY1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5552312819263794,-0.9738860500810146,0.5,0.9059991559305733,1.0,3/7,26.48%,RO60;TPR;IFNAR1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.5686509621712781,0.9738614808980001,0.543859649122807,0.9162493042152181,1.0,3/9,5.74%,SLC2A12;SLC2A9;SLC2A6
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.3999230357693581,-0.9737227196333476,0.45098039215686275,0.9057330236766108,1.0,7/89,6.24%,SSPN;PPT1;TMED2;SH3GL2;SCAMP3;CD63;CTSC
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.6764230614527249,-0.9736031583553755,0.6458333333333334,0.9053473377326373,1.0,1/5,7.50%,TOMM7
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.5566953744002479,0.9733991965933126,0.5576923076923077,0.9165113196310916,1.0,5/11,15.84%,ALOX12;PRKCA;PRKG1;DMTN;PDPN
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3772627311501823,0.973379743676835,0.46938775510204084,0.9159227020977181,1.0,21/99,16.98%,NEDD4L;EFNA5;PAK1;NSMF;PHLDB2;EMP2;SRCIN1;ADGRB3;PAK2;ZRANB1;EPHA4;SHANK3;TNIK;TSPAN12;SIPA1L1;STAT2;SEMA4D;BCL6;ARHGAP35;HECW2;PDLIM5
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.39624677234123196,0.9727736568184229,0.48148148148148145,0.9170131554975314,1.0,9/48,9.12%,STMN2;BAG5;SEMA3A;KIAA0319;BCL11A;EFNA1;EPHA4;RAB29;CRMP1
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.4917459660469373,-0.9719495957312149,0.5238095238095238,0.9087151945413556,1.0,6/16,27.06%,PIH1D1;PPHLN1;RUVBL2;LEMD2;LRWD1;CHMP7
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.30184258193643365,-0.9713348595123256,0.5111111111111111,0.9095180868786971,1.0,98/755,13.17%,FIZ1;SOX4;UBB;EIF5A;SIRT2;JUN;SALL2;LAGE3;ILF2;H1-4;SFR1;ASCL1;APEX1;E2F5;GTF2F1;RPS27A;AGRN;ATF4;UBC;ESRRB;RTRAF;HES5;MT3;TCEA1;RHOG;BEX1;JMJD6;PARP1;IER2;ZNF300;PAX8;E2F4;SFRP1;BAMBI;H2AZ1;GABPB2;MED19;CHCHD10;ZFP90;WBP2;RNF6;DRAP1;HNRNPAB;SMARCA5;UBA52;CKAP2;GALR1;DPF2;TAF7;MED10;EDF1;IRF3;LBH;CCNK;ZBTB49;PSMC3;WNT5A;MED30;ATXN7L3;CNBP;CHCHD2;ZBED3;NAT14;HNF4G;HAX1;MEOX2;CREB3;ENY2;RFX5;CAND2;ATMIN;POU3F2;JUND;MZF1;AFAP1L2;BRD7;SOX8;LITAF;USF2;RXRB;TAF6;RNF187;NPM1;ZSCAN21;YBX1;CDKN1C;IKBKB;RBM23;ZNF304;BMP2;YAP1;TFEB;MOSPD1;SMAD3;HDAC3;QRICH1;PCBP1;ZNF711
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.41940004589912216,-0.971302742710764,0.475,0.9088986003118745,1.0,3/29,2.03%,CUL7;GORASP1;LZTS1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.3367082770209617,-0.9711791755845303,0.5,0.908601424675155,1.0,30/204,12.75%,ELOB;GORASP1;BAD;TSPAN4;NIFK;ST13;RAB1B;HES5;TMED2;PEF1;CXCL12;CHCHD10;NOL3;CTSC;WDCP;TRAPPC2L;TUBGCP4;TRAPPC6A;DNAJB12;FN1;CAND2;TRAPPC2;DBNL;KLHL12;GPAA1;MAGI1;TLE4;SAR1B;YAP1;PPP2R1A
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.6369237823921772,0.970770482784313,0.5925925925925926,0.9206548325922836,1.0,2/5,30.20%,NPL;GNPDA2
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.6369237823921772,0.970770482784313,0.5925925925925926,0.9206548325922836,1.0,2/5,30.20%,NPL;GNPDA2
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.5380991980944376,0.9707354496525226,0.5,0.9200859528771071,1.0,3/15,19.08%,HDAC4;PIEZO1;MAML1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.5200969022382247,-0.9704466333003507,0.5483870967741935,0.909858259408308,1.0,3/15,8.24%,TMED2;FICD;RCC2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.4475051547404276,-0.970286616888511,0.4,0.9096055995653755,1.0,3/26,9.18%,VPS37B;VPS28;CHMP2A
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.38354248246910555,-0.9702107969102706,0.5094339622641509,0.9091444770573484,1.0,4/72,5.74%,HSBP1;NUP42;HSPA8;BAG3
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.4261193982052665,0.9701284662060006,0.5192307692307693,0.9208202123529086,1.0,10/35,17.89%,STAT4;STAT6;TGFBR3;SORT1;STAT5B;EIF2B4;STAT2;TSC1;OGT;STAT3
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6029147270994415,0.9696888158534728,0.5869565217391305,0.921371505630576,1.0,1/7,0.28%,PTPRC
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4304587987834645,-0.9694739140422035,0.4878048780487805,0.9104056251865964,1.0,5/37,11.77%,RAN;NUP42;NOL6;NUP155;NPM1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.32070045825131543,-0.9694416762216967,0.58,0.9098105385248958,1.0,34/262,11.27%,ATP6V0A4;MMP2;SIRT2;POLR2L;NCSTN;ARPC5;POLR2J;GTF2F1;ACTG1;ACTB;RARRES2;POLR2I;POLR2G;PDGFD;ATP6V0E1;ATP6V1F;CLNK;ATP6V1G1;PDGFRA;EFNA2;APH1A;VEGFB;EPHB3;SHC3;LYN;ATP6V1B2;BRK1;NGF;RAB14;ATP6V0E2;MST1;FLRT3;MPZL1;ANOS1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.3971915600994768,0.9693954379027151,0.5084745762711864,0.921481531476185,1.0,17/47,21.97%,TTN;SYTL4;BCAS3;RAB29;MYOM1;B3GAT3;PCNT;GOLPH3L;CEP131;CEP290;CNST;TMED10;PPID;MYH10;UNC13B;ACSL3;GOLPH3
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.33555366516691826,-0.9693682735950014,0.5238095238095238,0.9093130625390214,1.0,47/231,18.93%,UBB;CHRNA4;APEX1;RPS27A;UBXN1;UBC;CENPX;PARP1;NABP2;KPNA2;SMC1A;SMARCA5;UBA52;ADPRS;ALKBH2;PARP2;RFWD3;KMT5B;MPG;RAD17;ASCC2;NPM1;DDX1;PRMT6;RAD23A;TDP2;TDG;GTF2H2;PARK7;RNF8;RNF168;H2AX;FAN1;CUL4B;VCP;ENDOV;ACTR8;CDKN2D;MUS81;POLD3;POLD2;TRIM28;PARP4;UBE2N;COMMD1;RFC5;SUMO1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.5810046602174996,0.969351438193021,0.4883720930232558,0.9208787537300023,1.0,4/6,39.16%,PRKN;EIPR1;LRRK2;ATP9A
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.570887395335743,0.9690352423029757,0.5111111111111111,0.9210378465268293,1.0,2/8,8.73%,STAT6;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6149196502243187,-0.9690273893964707,0.48936170212765956,0.9094707276423408,1.0,1/5,5.92%,LIMA1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6314406422480006,-0.9686813795428477,0.6046511627906976,0.9097767874670841,1.0,1/5,7.25%,CADM4
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.5441789471559115,-0.968664576068237,0.5106382978723404,0.909139328221966,1.0,2/8,11.41%,ZNF830;RAD17
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.5020142945914208,-0.9683789199114142,0.4772727272727273,0.9090815846421911,1.0,6/16,11.08%,CALM1;C12ORF57;P2RX4;SRI;CALM3;GRK2
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6461109509223029,0.9682596520341366,0.6170212765957447,0.9220967135424597,1.0,3/6,25.66%,NCOR1;STAT3;NCOR2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4942320440850041,-0.9678225656879674,0.4634146341463415,0.909542977111881,1.0,3/18,10.49%,NCSTN;APH1A;HM13
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.504987835514037,0.9676024716642453,0.5,0.9232168160528168,1.0,4/11,19.80%,SORT1;NRG1;AKAP13;CBY1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.40062096103639294,-0.9674479882417328,0.5,0.909870327819172,1.0,7/60,9.14%,UBB;PTTG1IP;CENPX;PRICKLE1;MALT1;PSMD10;STUB1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5206791398793046,-0.9673566921919261,0.5853658536585366,0.9094345610488713,1.0,4/12,19.55%,ZNF304;PPHLN1;TRIM28;MORC2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.5654621651213408,0.9670821894007008,0.5333333333333333,0.9231409011343715,1.0,4/8,26.42%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.5654621651213408,0.9670821894007008,0.5333333333333333,0.9231409011343715,1.0,4/8,26.42%,SORBS1;PRKCZ;IRS1;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.42451919921297887,-0.9669776652610423,0.48148148148148145,0.9097319211950226,1.0,9/45,13.89%,PPT1;SLC30A10;MT3;PTPRZ1;SET;NGF;GRN;NONO;PARK7
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.45652442778425606,0.9667545778963724,0.4716981132075472,0.9233047745872,1.0,12/28,20.47%,SLC6A11;SLCO1A2;RXRA;NCOA1;SLC6A8;SLC51A;SLC16A3;NCOA2;SLC27A4;AKR1C1;SLC16A7;SLCO2B1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.5952808413620454,0.9667527654164288,0.5925925925925926,0.922661989446058,1.0,5/6,37.00%,STAT3;PIK3R1;JAK2;PTK2;GHR
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.3636752079105091,0.9666258302509597,0.5087719298245614,0.9222702101050814,1.0,19/96,10.58%,HEY2;SRPX2;EDNRA;SVEP1;NNMT;SRPX;ITGBL1;COL5A1;TIMP3;PTPRJ;FKBP9;SMOC1;MICAL2;TMTC2;CHST12;APH1B;PLSCR4;PROCR;SULF1
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.6495460567965965,-0.9663447782516355,0.5952380952380952,0.9105537989149469,1.0,3/6,18.68%,CXCL12;FN1;CX3CL1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.5945212440111138,0.9662325112988908,0.5111111111111111,0.9218698625621922,1.0,1/6,10.85%,PEX16
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.5945212440111138,0.9662325112988908,0.5111111111111111,0.9218698625621922,1.0,1/6,10.85%,PEX16
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.5304925554417672,0.9661065940518423,0.5652173913043478,0.921673580803407,1.0,2/14,10.22%,WRN;ATM
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.5978113552330155,-0.9660412534167364,0.5,0.9106799918872621,1.0,2/9,8.60%,PHB2;DNAJC19
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.589052442338776,-0.966003559192092,0.5283018867924528,0.9101267707535512,1.0,2/8,10.15%,MT3;MKKS
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.6244577412215805,0.9660006427156889,0.5454545454545454,0.92126975798962,1.0,2/5,14.91%,ATPSCKMT;ZFHX2
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.6190157359381827,0.9659618126042921,0.631578947368421,0.9207211366993032,1.0,2/6,6.48%,CAV3;EMP2
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5669803672675807,0.9659508938338874,0.5957446808510638,0.9201110344075311,1.0,2/10,10.29%,FTO;BMP7
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.5392694500577497,0.965597615740908,0.5957446808510638,0.9200962796749351,1.0,4/15,16.51%,ACACB;PRKAA2;CPT1A;ACACA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.5111498887410297,0.9655765305857325,0.5660377358490566,0.9195012967667313,1.0,4/15,19.37%,MRAP;AP2M1;PPFIA1;PICALM
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.5115858679761335,-0.9655559938511095,0.4897959183673469,0.9104375305217081,1.0,3/14,12.08%,SHFL;IFITM3;XAF1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.46183222419408126,-0.9655170970483757,0.47058823529411764,0.909870535866039,1.0,4/26,4.33%,GPX1;GSTP1;CNDP2;GSTM4
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.3980982563747352,0.9654284839080493,0.5,0.9192591994887741,1.0,6/33,13.11%,SOX9;HDAC4;IRAK2;PRKCA;SNCA;YTHDC2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.4678523917532772,-0.9652781775263616,0.5476190476190477,0.9098495167770813,1.0,4/22,6.43%,RARRES2;PDGFRA;P2RX4;DUSP3
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.5523798505169217,-0.9652453896083444,0.574468085106383,0.9092616748997059,1.0,1/8,5.97%,CBR1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.41132998240341617,-0.9650271846267666,0.5454545454545454,0.9091160639510244,1.0,6/41,10.04%,IDH1;ALDH1L2;DHFR;DHFR2;ACLY;AADAT
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.5852280638175213,0.9650240780164392,0.6363636363636364,0.918893212228961,1.0,1/7,3.77%,GCLC
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.5852280638175213,0.9650240780164392,0.6363636363636364,0.918893212228961,1.0,1/7,3.77%,GCLC
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.5685556642613094,-0.9648963853884929,0.5957446808510638,0.9088089365916722,1.0,1/5,6.45%,SOAT1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3737218604288868,-0.9645687353914546,0.5652173913043478,0.9089650405896764,1.0,10/69,12.85%,UGDH;LRRC8D;JMJD6;NOL3;ALAD;WDCP;RNF112;CHMP2A;BEND3;PRMT1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.4570470438079065,0.9641084907461075,0.5625,0.9202845716206017,1.0,11/27,23.51%,EME2;MMS22L;WRN;ZRANB3;PRIMPOL;ZGRF1;SAMHD1;ATRX;ATR;CDK9;FANCM
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6544246776740419,-0.9635946127473484,0.6226415094339622,0.9107431974725836,1.0,2/5,17.35%,SMC1A;MUS81
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.5238885302425582,0.9631607649640935,0.5272727272727272,0.9218254062296896,1.0,6/13,23.97%,SLC22A4;SLC25A19;SEC14L1;PDZK1;SLC25A29;SLC44A1
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.47589370052719765,0.9629630126792209,0.5319148936170213,0.9216650679762056,1.0,5/25,5.34%,YWHAH;NKAIN2;PKP2;AHCYL1;SNTA1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.487135714156363,0.962912521909037,0.4807692307692308,0.9211269005086651,1.0,4/22,11.51%,HEY2;HABP4;TNKS;SIN3A
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.6224109293740253,0.9627387948310808,0.6097560975609756,0.9209054584495526,1.0,2/5,26.30%,GRIPAP1;ARHGAP44
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.4042867815625182,0.9625995304721152,0.4583333333333333,0.9206019585865555,1.0,13/48,22.54%,BAIAP2;CRACD;SSH2;CDC42EP4;CDC42EP3;VASP;PRKCE;FER;ARFGEF1;FCHSD2;CARMIL1;ABITRAM;NCK2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.4391687455605437,-0.9625842044781174,0.509090909090909,0.9126141665351815,1.0,6/32,12.15%,GSTP1;DNAJA1;SMPD1;LYN;SPRY1;UCHL1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.45655654847628524,0.9624088680403046,0.5869565217391305,0.9203606179497784,1.0,3/26,3.00%,SCEL;NEDD9;NNMT
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.33059600571188014,-0.962277456100076,0.46153846153846156,0.9127305609011029,1.0,27/213,10.35%,UBB;BTC;PSMB6;PSMD8;RPS27A;CALM1;PSMB4;UBC;ICMT;ZFP36L1;MT3;PSMA7;PDGFRA;GOLGA7;PEBP1;UBA52;SHC3;MAPK13;PSMC3;PSMD10;ABHD17A;PSME3;PSMD12;PSMB9;PSMC1;PSMD2;YWHAB
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.6181368177249345,-0.9622083393037014,0.6041666666666666,0.9121948756680286,1.0,2/8,6.99%,SNCAIP;COMT
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5119785209905308,0.9621010502050477,0.5769230769230769,0.9203183945923338,1.0,1/19,0.35%,UNC13C
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.46793575796566755,-0.9618762819277418,0.5185185185185185,0.9123772800178552,1.0,2/19,3.09%,ACTG1;FERMT1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.4546393001516174,-0.961441725968507,0.5652173913043478,0.9128812574785562,1.0,6/26,8.95%,THY1;GORASP1;DYNLT1;LINGO1;MCF2;PTN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.4091813984477714,0.9613691479064853,0.5094339622641509,0.921214630784587,1.0,8/36,10.56%,BCL2L11;TPD52L1;ING5;PAK2;RIPK1;CYLD;SEPTIN4;TRAF7
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.4977973004540629,-0.9613675684486926,0.5714285714285714,0.9117396890527394,1.0,1/22,0.91%,CPSF1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.4977973004540629,-0.9613675684486926,0.5714285714285714,0.9117396890527394,1.0,1/22,0.91%,CPSF1
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5556193177682431,-0.9612746454945126,0.5689655172413793,0.9113963869495592,1.0,1/8,4.87%,CYB5R3
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5025638981500545,-0.9611757009193862,0.5227272727272727,0.9109733446848586,1.0,5/15,19.05%,NPM1;CAV1;IFIT1;FLOT1;MUL1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.5224008332953755,-0.9609206518528188,0.5102040816326531,0.9109882069422337,1.0,1/16,1.82%,BAD
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.5795568551123095,-0.9608084628567987,0.5,0.9106825877711321,1.0,1/7,0.26%,CCND1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.4644808716306461,-0.9602394210372547,0.5116279069767442,0.9114691048195115,1.0,7/26,13.34%,PIWIL2;RAN;NIFK;HENMT1;DTD1;PIWIL4;DGCR8
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.35325641912227795,0.9600775653437931,0.5,0.9238002874923246,1.0,30/152,13.71%,RAB40A;RAB3A;PKP2;RAB10;PLEKHF1;MAP7;TSPAN5;KCNB2;RAB40C;WDR19;CAV3;RAB40B;MRAP;EMP2;RAB8B;PACS1;SH3PXD2B;LIN7A;C2CD5;SHANK3;RAB29;DLG4;RFTN1;SPTBN4;TNIK;PACS2;MAGI2;ANK2;DPP6;SEC16A
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5629601043937096,0.9597526159771484,0.5319148936170213,0.9239335870602623,1.0,4/9,25.69%,BARD1;ZC3H14;CDK9;NELFE
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6047897807175251,0.9595850748161063,0.5882352941176471,0.9237181015332708,1.0,1/6,0.28%,PTPRC
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.28721824725559164,-0.9593007480745694,0.7391304347826086,0.9131054272765754,1.0,172/1384,13.39%,NR0B1;FIZ1;HSBP1;SOX4;CCND1;UBB;EIF5A;GMEB2;ZBTB32;SIRT2;JUN;TAF9B;SALL2;LAGE3;DACH2;ASCL1;RPL10;OLIG1;SOX21;APEX1;E2F5;GTF2F1;SMYD2;RPS27A;CALR;AGRN;ZNF426;PRRX1;ATF4;ZNF658;OLIG2;PCGF2;ZNF491;UBC;ESRRB;RTRAF;HES6;ZNF12;SAP18;ZNF22;NKX2-2;ZNF821;MYT1L;HES5;ZNF333;ZNF688;TCEA1;WIZ;BEX1;JMJD6;PARP1;HDGF;ZNF761;IER2;ZNF300;RPL23;NR2F6;PAX8;E2F4;ELOC;ZNF699;H2AZ1;LARP7;EID1;GABPB2;MED19;ZFP90;WBP2;SLC2A4RG;DRAP1;ZNF582;ZNF584;SMARCA5;UBA52;CKAP2;ZNF558;GALR1;ZNF525;EDNRB;ZNF317;MED29;DPF2;TAF7;ZNF726;MED10;MED23;IRF3;SARS1;ZNF649;CBX5;CCNK;ZBTB49;ZBTB33;PSMC3;WNT5A;CREBZF;MED30;PSMD10;NACC1;CHD3;CTDP1;NOC2L;ATXN7L3;CNBP;ZNF124;CHCHD2;DACH1;ZBED3;ZNF446;HNF4G;ZBTB21;HAX1;NR2E1;ZXDB;MEOX2;CREB3;ENY2;DDX5;ZNF260;RFX5;ZNF614;ATMIN;ZNF677;ZNF701;PHF6;POU3F2;JUND;MZF1;BRD7;SOX8;MYNN;LITAF;HES4;ZNF337;ZNF77;AEBP1;USF2;RXRB;TAF6;NPM1;ZSCAN21;ZNF48;YBX1;ZNF32;ZBTB14;ZNF454;IKBKB;ZNF791;ZNF320;CCNL1;SAP30;CAV1;BEND3;ZNF740;ZNF304;BMP2;YAP1;HIC2;ZNF596;TFEB;ZNF302;MOSPD1;ZNF384;BRD3;SMAD3;HDAC3;PCBP1;ZNF808;NFE2L1;ZNF665;ESRRA;TLE6
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.4159176570533525,0.9592603143015664,0.4807692307692308,0.9239468991094648,1.0,9/32,16.77%,KIF3C;DYNC2LI1;IFT172;WDR19;CEP131;DYNC2I1;TNPO1;IFT27;IFT52
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6292832558248913,0.9590897669783902,0.6086956521739131,0.9237248795223714,1.0,2/5,19.30%,SNTA1;DMD
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.5643577524907408,-0.9586246036995238,0.5869565217391305,0.9143033661893519,1.0,2/5,16.39%,CAV1;EXOC7
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4008921359364025,-0.9583511075912661,0.46,0.9143158140263077,1.0,6/57,11.19%,SOX4;MT3;VPS35;CHMP2A;DCPS;CLU
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.5727400745377557,-0.9579999399710359,0.6052631578947368,0.9145314508520562,1.0,1/10,4.95%,PTPN14
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.526411516487028,-0.9573189760093871,0.5813953488372093,0.915530024158347,1.0,1/8,1.76%,CHAMP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.3950135866753038,0.9573152537507195,0.5116279069767442,0.9275821027932915,1.0,8/38,18.00%,TMSB4X;GADD45A;PRKCA;PDPK1;AKT3;PPARG;MAP2K3;ANGPT2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.55065535537451,-0.9570338482235243,0.5217391304347826,0.9155125890138833,1.0,5/10,6.29%,MT1E;MT2A;ZNF658;MT3;P2RX4
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.47033698500068655,0.956775493016124,0.5,0.9283053098675204,1.0,3/17,12.71%,SORT1;SOS1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.47509536149563336,-0.9565538991233403,0.5348837209302325,0.9160890210697291,1.0,2/13,7.95%,CALM1;CALM3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.4520671633629174,0.9563663979426534,0.5769230769230769,0.9286460676970699,1.0,3/25,3.57%,BRAT1;KCNJ11;SORD
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.5643773111677417,0.9561966165908405,0.5849056603773585,0.9284690411052805,1.0,4/9,18.43%,DGKG;DGKZ;DGKI;DGKD
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.4403257934739958,0.9561793699988326,0.5333333333333333,0.9278569347199284,1.0,12/38,24.27%,IGF1R;RELN;EPHA4;FER;ABL2;EPHA3;MAPK3;ABI2;AATK;ERBB4;ABL1;INSR
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.5578170292249203,0.9559263987897072,0.5555555555555556,0.9278506341454769,1.0,4/8,22.80%,KNG1;DMTN;ENPP4;APOE
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.38369923740654954,0.9556573141480487,0.5961538461538461,0.927749247079126,1.0,9/63,10.34%,PTPRC;TNS1;PLXDC2;KITLG;ARID3A;SPI1;BAALC;DYSF;PROCR
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5633835934544303,0.9552978658876777,0.5319148936170213,0.9278516348504543,1.0,2/8,10.58%,TMEM63C;SULF1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.47227018795699627,-0.9552769230503119,0.6052631578947368,0.9182929328213983,1.0,4/29,8.48%,SALL2;ASCL1;PAX8;HIPK1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.3724035409858053,0.955222669509147,0.5869565217391305,0.9273298362109154,1.0,11/75,11.62%,BAIAP3;TBC1D10B;CLTCL1;RBSN;WASHC1;VTI1A;RAB6B;VPS52;RAB29;STX5;ERC1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.6006579652043917,-0.9551394267614361,0.6363636363636364,0.9166462246951715,1.0,3/5,7.60%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.6006579652043917,-0.9551394267614361,0.6363636363636364,0.9166462246951715,1.0,3/5,7.60%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.6006579652043917,-0.9551394267614361,0.6363636363636364,0.9166462246951715,1.0,3/5,7.60%,XYLB;DCXR;AKR1A1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.4589411770552822,0.9547817915800528,0.5813953488372093,0.9277916273026873,1.0,1/24,0.66%,ZNF385B
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.5697336774287913,0.9543501554097608,0.5625,0.9283814784403098,1.0,3/8,14.48%,ST6GALNAC5;ST3GAL1;B4GALT5
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.3710729475785439,-0.954145680953628,0.4411764705882353,0.9185909549463419,1.0,19/108,14.46%,SSPN;BTG1;MT2A;ARL4A;LGALS3BP;UBE2L6;EPSTI1;IFIT2;SRI;HLA-B;PSMB9;IFITM3;ISG20;SLC25A28;XAF1;B2M;ISG15;PELI1;IFIT1
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5515659296508595,-0.9540772980191119,0.5660377358490566,0.9181099216997447,1.0,4/11,16.62%,DNAJA1;COX18;ISG15;AKT1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4891191758761312,-0.9538959532395258,0.42,0.9178673736322018,1.0,3/18,5.83%,TRIR;NHP2;ERN1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.3774874548401511,-0.9537837570119478,0.38596491228070173,0.9174667394283531,1.0,15/77,12.83%,EIF5A;THY1;RPS19;TLR1;RPS9;EIF3D;LYN;AARS1;EIF3J;RPS3A;ACHE;RPL9;NPM1;IKBKB;B2M
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.45114286850000523,-0.953777884881581,0.5,0.9168291943991107,1.0,3/26,11.22%,RAN;WTIP;SNIP1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.5246974536506748,-0.9536632581399443,0.5818181818181818,0.9164442341933474,1.0,2/11,8.65%,UBXN1;TMEM259
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6077055741477241,0.9535191543382595,0.5818181818181818,0.9298030993600912,1.0,3/6,25.08%,GPAM;CDS2;TAMM41
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.40895467684254044,0.9535144393108358,0.4727272727272727,0.9291664013211366,1.0,9/42,16.99%,NEDD4L;KCNN3;CAV3;KCNIP1;KCNMB4;DPP6;DPP10;WWP2;KCNQ1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5221087713422734,0.9534897927167383,0.5283018867924528,0.9285711417292796,1.0,2/11,8.73%,STAT6;STAT5B
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.5688855510459891,0.952864086022836,0.5961538461538461,0.9294560420280211,1.0,3/8,7.67%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),-0.603876884318657,-0.9524148212578639,0.5714285714285714,0.9188192686836746,1.0,1/5,12.58%,BMP2
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.6004493967186711,0.9522780736814183,0.5538461538461539,0.9303127188924529,1.0,2/6,13.23%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.580870825189659,0.9522780426677154,0.5660377358490566,0.9296706811292421,1.0,2/6,8.94%,LRP2;PHACTR1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5129557384307053,0.9517965563642352,0.5777777777777777,0.9301485329972626,1.0,4/11,18.55%,WHRN;ADGRV1;PIEZO2;LHFPL5
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4497080422545623,-0.9517618082229308,0.5333333333333333,0.919783488320562,1.0,2/25,8.01%,CALM1;WNT5A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5012072464432533,0.9509879016712642,0.5094339622641509,0.9314138782943328,1.0,5/14,16.73%,CACNG2;RELN;SHANK3;CACNG8;CACNG5
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.43214380032378924,-0.9509458438316872,0.6222222222222222,0.921047748881778,1.0,7/26,12.16%,VEPH1;IGFBPL1;IGFBP7;SCG5;SRI;GRK2;MTCH1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.35965925850171643,0.9504994582563084,0.46153846153846156,0.9320043103698619,1.0,11/86,9.85%,HEY2;DRAM1;TNS1;EDNRA;LAMA2;ARID5A;TIMP3;NRGN;SASH1;PLSCR4;SLC12A1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.40576623723065397,-0.9503106290593778,0.5192307692307693,0.9218584668809781,1.0,3/39,1.59%,S100A10;CUL7;CALR
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.45393870964264654,0.9502864586414274,0.5961538461538461,0.9318943144319582,1.0,5/24,11.72%,PTPRC;SH3PXD2B;RANBP3L;SULF1;GJA1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.46748498900630564,0.9502490980178367,0.5217391304347826,0.9314080129506634,1.0,5/17,22.52%,BBS4;CEP131;CSNK1D;HOOK3;C2CD3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.34478255418166326,0.9499142100437126,0.5652173913043478,0.9316546226773984,1.0,21/94,14.26%,KIF1C;TNS1;MRO;SOX9;KITLG;ANGPTL4;FAM20C;ARHGEF17;GPRC5C;TIMP3;FKBP9;PFKFB3;TSPAN9;SHC2;PLSCR4;CHRD;PADI2;CDC42EP4;SLC16A3;ANKRD7;COL18A1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5373008646468342,0.9498778266397239,0.5208333333333334,0.9310751688827282,1.0,4/13,16.48%,DENND6A;PTPRU;ADAM19;TJP1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.37015261602511546,0.9498603826138238,0.4791666666666667,0.9304696760868952,1.0,13/96,8.16%,FOXO1;IGF1R;TBC1D4;SLC39A14;AKT2;SORBS1;ATP6V1E2;RAB10;KAT2B;BAIAP2;GRB10;RAB8B;C2CD5
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.5838652960424298,0.9494622203730421,0.6346153846153846,0.9308639099804629,1.0,2/8,6.46%,FOXO1;ATG7
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.3500747283252474,-0.9493483425781744,0.5416666666666666,0.9234921360963388,1.0,23/114,16.05%,DNAAF2;GPX4;VBP1;CLTB;COX7A2;MID1IP1;NSG2;ADRM1;CHMP2A;AIFM1;EIF4H;HSP90AB1;DNAJB12;RPL38;MKKS;CLU;TMEM35A;SMAD3;PSMD4;AP2S1;POMP;HSPA4;PSMG1
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.39522139321471567,-0.9492050211226134,0.6,0.9231685802856002,1.0,4/49,6.90%,EMC6;GABARAPL2;RAB1B;MAP1LC3A
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.558584363539045,-0.9491770775419028,0.5957446808510638,0.9225878625253365,1.0,2/7,14.11%,WARS2;TARS2
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.5535417009642563,0.9489598585044253,0.5079365079365079,0.9315121808780775,1.0,1/8,6.81%,CDKN2A
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.48316681844175535,0.948870992312929,0.46938775510204084,0.9310816981687062,1.0,2/20,0.75%,SCEL;MLANA
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.43686693629191065,-0.9487280311658479,0.5,0.9228875228809554,1.0,4/21,12.42%,ACTG1;ALOX5;CADM4;CAV1
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5179195992366307,0.9487144345721589,0.6140350877192983,0.9308391313329845,1.0,2/10,9.03%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5423369371959507,0.9486936153030852,0.5098039215686274,0.9302692990480156,1.0,4/10,22.30%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.5312426010193934,-0.9485734175812214,0.6122448979591837,0.9225722123203663,1.0,2/11,4.51%,ZFP36L1;CDH3
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.4942094490828361,-0.948297739005987,0.5476190476190477,0.9226929411969631,1.0,6/18,16.45%,STUB1;RNF126;DNAJB12;AUP1;DNAJC18;VCP
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.5890424877166331,-0.9479835999960871,0.5319148936170213,0.9229490858476084,1.0,2/7,13.65%,IFI6;RACK1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.3013865827231826,0.9479266395569665,0.6851851851851852,0.9313437936256543,1.0,137/754,17.16%,CHRM3;PTPRC;PTPRB;FBXO31;CTBP1;TLK1;PTPRR;NUAK1;NEK3;EGLN3;HIF3A;VRK1;DAPK1;RAB3A;MERTK;AKT2;GRK4;DAPK2;EVA1A;FBXL4;PAK1;FAM20C;FUT2;CAMK2B;BCR;NEURL2;B3GNT5;PTPRJ;PRKAR1B;CDC42BPB;DUSP4;TSSK3;PRKCA;CDK19;ATG7;GCNT2;LIMK1;CDKL1;ZBTB16;SSH2;FBXL13;RAB1A;RABGGTB;PAK2;ATG5;PRKCSH;CDK14;PSMD6;JAK1;MAK;DDB2;OXSR1;CDK6;ST3GAL1;MAN2A1;MAPK10;FBXO6;DUSP1;TNKS;SGK1;ATM;KLHL3;MAP3K9;RARA;GRK5;PDPK1;PTPRU;PHEX;KNG1;ENGASE;CAMK1;CDK7;CDK12;PTPRG;FBXL5;PRKG1;CD247;TNIK;STK3;TAB1;PGAP1;AKT3;PXK;CAMK2D;DUSP8;ASB16;MKNK1;NIM1K;TAF1;PIK3CD;SPSB4;ACVR1C;LARGE1;STK11;SIK3;PIGH;LMTK2;FBXO11;STK17B;FBXW11;PARP9;PRKAA2;CSF1;MAP3K5;MGAT1;PTPN13;ANO8;UBXN7;DCLK1;B4GALT5;VRK2;CDK17;FAM20A;SPP1;PLK2;PRKCE;WWP2;CDK13;CSNK1D;SRPK2;FBXL18;PRKCZ;UBE2D3;PSMB5;DAPK3;NEK7;NEK4;ADAM10;FEM1B;PRKAA1;FEM1C;SPARCL1;MTMR3;RYK;NEK11;ASB3;HLCS
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.4057409232642204,0.9473579672627476,0.5652173913043478,0.932076317523124,1.0,11/41,22.68%,SOX9;TGFBR3;USP9X;BMP8A;BMP7;ENG;PDCD4;SMAD5;MAPK3;SMAD4;RUNX2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.511624120011765,-0.9473425703275211,0.5531914893617021,0.9238537977176098,1.0,3/11,11.99%,LDHD;ACOX1;ACBD5
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.40715849357671174,0.9469603964152616,0.5,0.9324608990537141,1.0,9/42,9.66%,RAB17;KIAA1217;SLC2A9;GPRC5C;EFNA1;CDS1;PHACTR1;HES1;AQP4
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5177949379715,0.9467205129570625,0.5517241379310345,0.9323849041552805,1.0,1/10,0.28%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.6187230168868384,-0.9464419051139855,0.6363636363636364,0.925427101014895,1.0,1/6,3.88%,MT3
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.35842426196615945,0.946232782097771,0.58,0.9327620881516073,1.0,15/101,11.47%,FHDC1;VRK1;BAG5;SPTBN5;BCAS3;VTI1A;RAB1A;HACE1;TANGO2;RAB29;TRAPPC12;STX5;ATP8B2;GOLPH3L;FAM174B
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.5493192422264255,0.9462142598587959,0.5294117647058824,0.9321599832995655,1.0,3/7,22.99%,DMTN;ABCB10;ALAS1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.37095552023002737,0.9459731627363441,0.5208333333333334,0.9320510794393179,1.0,14/80,12.31%,LIFR;CHST3;SOX9;ADGRL2;TENM3;PRTG;EYA4;HSPA12A;TEAD1;EYA1;PTPRU;PTPRG;RBFOX2;MID1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.3682058840375646,0.9459233712762585,0.5882352941176471,0.9315699643925084,1.0,5/66,4.89%,PTPRC;IGF2BP3;IGF2BP2;FOXP1;LRRC19
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.4588189644846823,-0.9458765920528865,0.4897959183673469,0.9261009556880719,1.0,5/25,15.71%,MRPL44;SNIP1;SMAD3;DGCR8;HNRNPA2B1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.4601436305991072,0.9456364421635228,0.5609756097560976,0.9315812152718275,1.0,3/23,3.70%,ROBO2;SEMA3A;SEMA4B
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.45592404068279513,0.9455209888088982,0.6111111111111112,0.9312073169528674,1.0,1/21,0.24%,HEY2
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4011229529598498,0.9455169507759853,0.5849056603773585,0.9305817684913045,1.0,10/45,15.70%,ADAMTS9;ADAMTS13;PCSK6;PRKCSH;MAN2A1;FBXO6;ENGASE;LARGE1;B4GALT5;MAN1A1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.37587200784934177,-0.9454284743931524,0.5208333333333334,0.9264394140014718,1.0,13/61,16.76%,SIRT2;ELOB;PRICKLE1;MAGEF1;ZYG11B;PSMD10;STUB1;CLU;RAD23A;RACK1;TRIB3;VCP;RNF14
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.5635684598301188,-0.9452657387210356,0.5681818181818182,0.9261942818512771,1.0,3/7,18.90%,GBA3;B3GALT2;B4GALT3
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.5498224673721251,-0.9451692516041992,0.6086956521739131,0.9258144704302899,1.0,2/10,12.83%,MALT1;B2M
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5426003779492068,0.9448853593795709,0.5526315789473685,0.9314490955642473,1.0,4/6,31.44%,PDE3B;CYP1B1;WNK1;JAM3
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.364658561363736,0.9448388438988131,0.5769230769230769,0.9309567660719917,1.0,9/75,10.80%,PTPRC;HTR2C;NTRK3;PRKCA;GCNT2;PRXL2C;ROR1;TIRAP;ARRB2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.5486985873482194,0.9448051615732922,0.5740740740740741,0.9303591477788224,1.0,3/9,22.07%,KDM7A;KDM4C;KDM3A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.3544701928735556,0.944581733408016,0.5454545454545454,0.9302719063191268,1.0,21/149,11.47%,HOOK1;ARFGEF2;BAG5;PLEKHF1;SYNGR2;VAPB;CAV3;SPTBN5;BCAS3;DNM1;RAB1A;HACE1;NUP93;TANGO2;RAB29;TRAPPC12;SMPD4;DYSF;ATP8B2;GOLPH3L;FAM174B
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.3599904721358982,0.9444744437029916,0.5818181818181818,0.9299334781383404,1.0,7/64,5.25%,EFNA5;CHST3;ADGRL2;EDNRA;SRPX;TENM3;FBLIM1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.46357929108140195,-0.9441081098322702,0.5121951219512195,0.926738283108776,1.0,4/17,12.99%,GIPC1;HSP90AB1;CDKN1C;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.46357929108140195,-0.9441081098322702,0.5121951219512195,0.926738283108776,1.0,4/17,12.99%,GIPC1;HSP90AB1;CDKN1C;SLC2A10
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.49337717633357836,-0.9438402227963537,0.6,0.9267701925162928,1.0,1/14,0.43%,ZDHHC1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.3728079591979692,0.9436325721423505,0.5689655172413793,0.9313468428041615,1.0,20/84,16.31%,TMSB4X;AKT2;ENPP2;PLXNA4;PRKX;FGF9;MACF1;SRCIN1;NRG4;HACE1;CDK6;SGK1;TTBK2;PLXNA1;NRG1;NRG2;DIAPH1;FGF1;DAPK3;CCDC25
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.5989378989147064,-0.9435852275886231,0.5434782608695652,0.9268020577585395,1.0,2/8,6.65%,SYT11;SELENOS
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.5384081936333194,0.9434391339196514,0.5686274509803921,0.9305445080278476,1.0,3/8,11.57%,GRM3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.5384081936333194,0.9434391339196514,0.5686274509803921,0.9305445080278476,1.0,3/8,11.57%,GRM3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.5986100697469869,-0.9432064847035828,0.54,0.9271525561932177,1.0,2/6,4.37%,LAPTM4B;LDLR
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5187746260328698,-0.9431297311773696,0.6,0.9267311964773342,1.0,1/18,0.13%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4444610413571106,-0.942925744560702,0.48148148148148145,0.9266427997254045,1.0,4/26,11.23%,TLR1;MAPK13;WNT5A;SPHK2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.35874344495068194,-0.9427771236394398,0.4418604651162791,0.9263919827172468,1.0,19/92,16.20%,STAB2;HSPG2;PPT1;CALR;CUBN;CLTB;LDLR;CANX;SCARB1;MICALL1;GRK2;CAV1;LRP3;CTSL;AP2S1;LRP1;SCARB2;HSP90B1;CD9
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.46384928997535185,-0.9421997217226463,0.5714285714285714,0.9271725901264808,1.0,5/25,8.30%,CFL1;LZTS3;VPS35;WNT5A;ABHD17A
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5293956425882547,0.9419163310429672,0.5925925925925926,0.9337089847536925,1.0,3/12,12.96%,RNF157;MRAP;SNCA
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.5714732062563863,0.941449166790437,0.6122448979591837,0.9341471163603826,1.0,2/5,8.06%,VAPB;MOSPD3
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.3765521628024002,-0.9413856014557146,0.6304347826086957,0.9285590505938791,1.0,11/61,13.54%,GORASP1;RAB1B;TMED2;PEF1;CTSC;TRAPPC2L;TRAPPC6A;TRAPPC2;KLHL12;SAR1B;SEC23B
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.47670578463790997,-0.9412311112588971,0.46808510638297873,0.9282298550796436,1.0,4/18,11.99%,SIRT2;MT3;ACOX1;ACBD5
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5437959271060004,0.9405562259387413,0.6065573770491803,0.935691197086134,1.0,2/10,2.67%,IGF2BP3;IGF2BP2
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.5979071526991266,-0.940545555872116,0.5510204081632653,0.9292119662927916,1.0,1/5,8.54%,FUZ
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6028012830340689,0.9405417561006723,0.5957446808510638,0.9350940125529812,1.0,3/5,37.09%,ITCH;OTUD4;TANK
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.5854334092579185,0.9404821746012952,0.5892857142857143,0.9346620737774578,1.0,2/7,22.55%,ADGRB3;ANKS1A
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.39681968318198774,-0.9404043436700251,0.5294117647058824,0.9289250310620693,1.0,5/29,9.19%,SLC7A10;SLC16A1;SLC25A30;SLC38A10;SLC7A8
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.5928530432632793,0.9403729443057798,0.5660377358490566,0.9342635822399337,1.0,2/5,30.20%,CTBS;GNPDA2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.49696745392755326,-0.9401942172871245,0.5833333333333334,0.9288988930098144,1.0,1/13,3.57%,MYH3
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.5845534677875248,0.9401196668091952,0.5686274509803921,0.9341546552442052,1.0,3/7,18.44%,ATP2B3;SLC8A2;ATP2B1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.535875785760567,0.9396786238826977,0.5263157894736842,0.9345119489348573,1.0,1/12,0.86%,BCL2L11
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.46832249228542333,-0.9395703824472641,0.56,0.9298574219015208,1.0,4/17,13.40%,PARP1;PARP2;MPG;TDG
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.5786177930348184,-0.9394515941529228,0.6153846153846154,0.9295917192298464,1.0,1/5,3.88%,MT3
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.5296493937377912,0.9390100702022474,0.5961538461538461,0.935426364923254,1.0,1/8,1.69%,SOX9
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.5835574626948918,0.9388374263643978,0.6470588235294118,0.9352382097594865,1.0,2/8,11.22%,NEIL2;NEIL1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.5805657136761642,0.9387459192569945,0.6037735849056604,0.9348603211850444,1.0,2/7,12.96%,PDPK1;SNCA
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.3804459436342618,0.9387424522053558,0.5208333333333334,0.9342341588801649,1.0,2/37,1.81%,HEY2;KITLG
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6109032640536778,0.9382729913792587,0.5652173913043478,0.9347930198085055,1.0,4/5,26.54%,ALDH7A1;CHDH;SLC44A1;DMGDH
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.39771052461667966,-0.9374182847593939,0.48936170212765956,0.9334631820617612,1.0,13/44,23.92%,HSD17B10;ACAT2;ACOX1;CROT;PEX13;ABCD2;ACADS;MECR;ACAA2;ADIPOR1;ECHDC1;CYP4V2;MTLN
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.43410206451743427,0.9373443097133868,0.5476190476190477,0.9364822213384499,1.0,4/28,9.16%,HEY2;TGFBR3;PROX1;HES1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.3581095270153048,-0.937318716673138,0.5681818181818182,0.933069037110777,1.0,7/81,7.17%,JUN;CCDC88C;NUCB1;RUNDC3A;ARFIP2;RASSF1;SHC3
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.5526892296977786,0.9372946080061776,0.6545454545454545,0.9359542362279714,1.0,5/10,17.41%,TIAM1;DAAM2;CSNK1D;ZNRF3;RNF213
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5918724743996804,0.9365915217980486,0.6101694915254238,0.9370592933605987,1.0,3/5,21.59%,NAPB;STX1B;UNC13B
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.5777327759658987,0.9365896645486952,0.5882352941176471,0.9364337531113595,1.0,1/6,3.24%,PUS7
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.49280937301216543,-0.9365784144531197,0.6037735849056604,0.9342395117474437,1.0,2/13,6.80%,MT3;GBE1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.30268846573036784,-0.9360981086724801,0.6578947368421053,0.9347215011648872,1.0,74/576,13.15%,FIZ1;SOX4;UBB;EIF5A;SIRT2;JUN;SALL2;LAGE3;ASCL1;APEX1;E2F5;GTF2F1;RPS27A;AGRN;ATF4;UBC;ESRRB;RTRAF;TCEA1;BEX1;JMJD6;PARP1;IER2;ZNF300;PAX8;E2F4;H2AZ1;LARP7;GABPB2;MED19;WBP2;DRAP1;SMARCA5;UBA52;CKAP2;GALR1;DPF2;TAF7;MED10;IRF3;CCNK;ZBTB49;PSMC3;WNT5A;MED30;CNBP;CHCHD2;ZBED3;HNF4G;HAX1;MEOX2;CREB3;RFX5;ATMIN;POU3F2;JUND;MZF1;SOX8;LITAF;USF2;RXRB;TAF6;NPM1;ZSCAN21;YBX1;IKBKB;ZNF304;BMP2;YAP1;TFEB;MOSPD1;SMAD3;HDAC3;PCBP1
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.35009645070695294,0.9356663868071102,0.6181818181818182,0.9380912700037415,1.0,13/117,9.19%,PTPRC;AHR;IGF2BP3;IGF2BP2;FOXP1;MKLN1;PSEN1;SORT1;PROX1;ZUP1;TRIM44;CDK6;TOB2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5523252665830007,0.9355016902274773,0.5111111111111111,0.9378242717030029,1.0,6/10,37.88%,RAB27A;KIF5A;KIF5C;SYNJ1;SPG11;DNM2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.38238447663724556,0.9354258876713597,0.5306122448979592,0.9373297110032784,1.0,10/59,7.35%,CALCB;HTR2C;TPCN2;SLC39A14;ATP2B3;SLC24A2;VAPB;SLC30A9;RYR2;ATP2B2
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.5630823218502108,-0.9354165973433654,0.5625,0.9358612274673588,1.0,2/8,8.33%,DHFR;DHFR2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.3787162655255205,0.9354002785486522,0.55,0.936790255556486,1.0,25/82,18.14%,FAM107A;STMN2;SHISA6;SORBS1;PRIMA1;TMEM132C;PHYHIP;GFAP;ADCY5;GRIK3;KCNIP1;DAAM2;SHC2;AQP4;NDRG2;SORCS1;ANK2;CCDC3;DCLK1;ASTN1;CHL1;SPARCL1;INTS6;SLC6A1;LGI4
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.41901304305264064,0.9349032081504521,0.5357142857142857,0.9373960956062738,1.0,5/33,4.76%,FOXO1;ZDHHC9;ZDHHC14;KAT2B;ING5
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.5227600302673319,-0.9347479768900134,0.5625,0.9368734060027075,1.0,3/14,3.07%,ODC1;TMEM9;RARRES2
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.5544912595330028,0.9346388542138742,0.5263157894736842,0.937312240452865,1.0,1/7,6.81%,CDKN2A
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.5546435198296553,-0.9345621498686436,0.5319148936170213,0.9360347598903738,1.0,1/6,0.55%,SIRT2
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.5546435198296553,-0.9345621498686436,0.5319148936170213,0.9360347598903738,1.0,1/6,0.55%,SIRT2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.5580399546272053,0.9341081999995345,0.5849056603773585,0.9382221766417446,1.0,2/7,16.99%,KCND3;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.5521886321206345,0.9340660055526282,0.5652173913043478,0.9376835614048783,1.0,1/7,8.03%,RAP1GDS1
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.38682694358484376,-0.9339977162229761,0.5531914893617021,0.936891076454378,1.0,6/46,8.18%,PPIF;SYT11;HPCA;SMPD1;WNT5A;SLC25A24
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.524205900565754,0.933936015351319,0.5714285714285714,0.9373726717074629,1.0,3/12,15.60%,BMP7;TRERF1;AKR1C3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.43316345904422415,-0.9339323261880347,0.5,0.9364618425130277,1.0,10/43,13.70%,MT2A;CALM1;MT3;PEF1;ALG2;CALM3;ATP5F1D;KHK;CAV1;SLC30A4
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6327131108739555,-0.9339031794635083,0.6122448979591837,0.935872754840822,1.0,2/5,23.66%,CHMP5;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.48703251509899,-0.9337271743647694,0.509090909090909,0.9355981569590077,1.0,4/15,14.84%,THY1;HAS2;CD44;PRKCQ
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5140772846893975,0.9335775615652766,0.5777777777777777,0.9374899878204387,1.0,2/10,7.18%,PRKCA;SASH1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.5983337572116224,-0.9335611809577345,0.6153846153846154,0.9353448309712157,1.0,1/6,16.45%,VCP
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.4635169717625262,-0.9330026273475427,0.5,0.9359480968790043,1.0,5/19,19.00%,MT3;TIMP1;IFIT1;TMBIM1;PHPT1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.4350886858058387,0.9328449012682288,0.5333333333333333,0.9385658072218559,1.0,11/37,15.84%,PTPRC;SEPTIN6;NR4A3;SPI1;NAAA;ETV6;ADAM19;CAMK2D;CADM1;AOAH;PDPN
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.396823339073825,0.9317957035830079,0.5833333333333334,0.9406305912729649,1.0,9/54,7.98%,CHST3;EDNRA;SVEP1;SRPX;COL5A1;TIMP3;FKBP9;TEAD1;NRG4
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.4551464456331366,-0.9316637307965815,0.6190476190476191,0.9387001425275998,1.0,6/19,23.80%,IL12RB2;ISG15;IL18;ZP3;HSPD1;CD226
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.3964855104958263,-0.9316199201310246,0.4772727272727273,0.9382227654754957,1.0,8/45,10.89%,NOP10;JMJD6;HENMT1;ADAT2;RBM15B;AARS1;PUS3;TSR3
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.5216631558092945,-0.931127030751503,0.5454545454545454,0.9386213825000382,1.0,3/10,7.65%,LRRC8D;SLC1A6;SLC25A30
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.554907953832654,-0.9306789337396301,0.5652173913043478,0.9391305387591667,1.0,1/6,13.60%,LAMP1
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.48908943061127613,-0.9304008758138042,0.6078431372549019,0.9392088627641364,1.0,2/10,10.25%,PPIA;IFITM3
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.6027490437651715,-0.9302451988473145,0.6428571428571429,0.9389750919994716,1.0,1/5,16.65%,MSN
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.5228367556862955,0.9301337945269276,0.5370370370370371,0.9440899140237414,1.0,4/11,19.41%,HMBOX1;PARP9;DTX3L;MED25
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3937631405757041,0.9301239664656193,0.5849056603773585,0.9434655159324559,1.0,6/49,10.72%,HEY2;SOX9;SRF;CDKN2A;AGO1;CBFB
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.6258225373327777,-0.9297131886985257,0.6428571428571429,0.9395869013465363,1.0,3/5,18.68%,RPS19;PTPRO;CX3CL1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.5170960599922286,-0.929354854854195,0.5714285714285714,0.9398032320599082,1.0,5/13,23.62%,LARP7;RNF8;RNF168;SUPT5H;HEXIM1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3343299357558446,0.9290659490426779,0.58,0.9453808409033123,1.0,19/181,7.21%,DEPP1;ITPR1;FOXO1;DRAM1;TPCN2;PIP4K2C;DAPK1;TPCN1;USP13;DAPK2;ATP6V1E2;PLEKHF1;GFAP;SLC38A9;RNF152;RB1CC1;MID2;WASHC1;RPTOR
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.534071319053707,-0.9289068027902352,0.5581395348837209,0.9402475983891693,1.0,1/7,1.76%,CHAMP1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.5614323428423049,-0.9286115386238301,0.6888888888888889,0.9404217047032377,1.0,2/7,12.77%,SYT11;PNKD
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.3571765615097854,-0.9282169291713294,0.6226415094339622,0.9407752280352548,1.0,9/103,6.23%,TUBB2B;DLL3;ASCL1;RND2;IGFBPL1;PHF1;SEMA5B;EFNA2;LINGO1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.528400435476522,0.9282028172649378,0.6,0.9467577850321466,1.0,3/13,6.09%,PYGB;PHKG1;PYGL
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3626389692458406,-0.9281686822160896,0.6956521739130435,0.9402375254401064,1.0,7/54,10.69%,TRMT112;TRMT5;OSGEP;TRMT10A;ADAT2;AARS1;PUS3
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.44961552682954625,-0.9281099390200568,0.5833333333333334,0.9397833520626049,1.0,3/21,12.43%,PIGO;DPM2;PIGF
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.41131402719689153,0.9280364196343838,0.6037735849056604,0.9465070651199858,1.0,5/26,14.49%,SOX9;ZBTB16;SH3PXD2B;SULF1;SLC39A13
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.5804134989776167,0.9277504164195808,0.5925925925925926,0.9465339191272644,1.0,1/6,12.24%,MTHFD1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.37359607681855883,-0.9276954400148996,0.5576923076923077,0.9400883209454161,1.0,7/65,6.35%,S100A6;SLITRK2;S100B;ACTB;MAP1S;DHFR;EPHB3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4640995793273818,0.9276938122171305,0.54,0.9460001736716706,1.0,3/22,8.65%,ZER1;UFD1;FBXL17
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5684689289943015,-0.9274916807038278,0.6222222222222222,0.9398484830985738,1.0,1/6,7.25%,CADM4
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.34832415710530873,0.9273199810610719,0.6037735849056604,0.9461239115257848,1.0,28/99,22.51%,TPD52L1;CEP135;CCDC57;CDK14;FBXL17;CCP110;HAUS2;PCNT;CDK7;HAUS5;TUBA4A;BORA;FBXW11;CEP41;CEP131;MASTL;ENSA;CSNK1D;CEP290;ACTR1A;HAUS6;ALMS1;LCMT1;CLASP1;BRSK1;CDKN2B;PPP1R12B;TAF2
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.43221268866719054,0.9270908570502933,0.5283018867924528,0.9460673125782584,1.0,8/27,18.90%,DND1;THRAP3;TIRAP;TENT5A;SYNCRIP;MEIOC;TAF15;LARP1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4690981259868592,-0.9270835281918488,0.5531914893617021,0.9401667709167121,1.0,6/19,17.16%,LAPTM4B;RAB1B;IFT20;UBQLN2;SCARB2;NPRL3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.373814195437598,0.9269620556665509,0.5652173913043478,0.9457792883724065,1.0,11/59,17.95%,SHTN1;RAB10;VAPB;MOSPD3;SMPD4;STX5;STX1A;SEC16A;GAK;EIF2AK3;STX18
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.38978702231402335,0.9266794648643144,0.5283018867924528,0.9458900747509092,1.0,11/55,16.04%,XRCC4;BRCA1;BABAM2;ATM;LIG3;TP53BP1;SMC5;PIAS4;POLQ;BARD1;RIF1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6030339940973798,0.9266268509382297,0.6078431372549019,0.9454163046365063,1.0,3/5,37.07%,FER;AFDN;PLEKHA7
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.4645937985908159,0.9259920801842079,0.5454545454545454,0.9464513587583964,1.0,9/25,24.33%,ZNF16;STAT5B;ANKRD54;STAT3;ACVR1B;ABCB10;FOXO3;FAM210B;MAPK11
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.6107523861076918,-0.9258245055605415,0.625,0.9426799346507183,1.0,2/5,12.55%,PIH1D1;ZNF304
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.5665802801825022,0.9252788447522102,0.5283018867924528,0.9474337451815922,1.0,2/7,10.58%,TMEM63C;SULF1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.4624784202064992,-0.9249250572653777,0.5454545454545454,0.9441994047829537,1.0,3/23,6.45%,IDH1;SQLE;SOAT1
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5560624292119222,0.9249108844220417,0.5882352941176471,0.947658526440719,1.0,1/9,1.29%,CTBP1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.5219649738542735,0.9247545386017915,0.5471698113207547,0.9467309757973591,1.0,1/8,1.69%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5219649738542735,0.9247545386017915,0.5471698113207547,0.9467309757973591,1.0,1/8,1.69%,SOX9
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.4941815754080386,0.9245636497745839,0.5555555555555556,0.9465399784413044,1.0,2/12,10.66%,EDNRA;P2RY12
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.37241465475833946,-0.924539280602651,0.4782608695652174,0.9446034753738941,1.0,8/44,10.81%,GPX4;GSTM4;ALOX5;ACSM5;FADS1;ACLY;OXSM;NDUFAB1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.39643149361476204,0.9242461277742707,0.5714285714285714,0.9466880438370264,1.0,6/42,11.15%,SYT1;RAB3A;RAB10;RAB8B;SEPTIN4;KCNMB4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.46393307740533685,0.9242012793579473,0.5882352941176471,0.9461778982934755,1.0,8/22,16.85%,ACACB;FABP3;ACSL1;PRKAA2;CPT1A;PPARG;ACACA;SLC27A4
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.5626940328915176,0.9240471317341801,0.5714285714285714,0.9459876364498782,1.0,1/9,1.69%,SOX9
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.6048355807626352,0.9240023882671184,0.6349206349206349,0.9454722338994104,1.0,2/5,13.23%,EDNRA;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.5437313757598496,0.9239635468914917,0.5918367346938775,0.944944751726607,1.0,2/9,5.86%,NEDD4L;CAV3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.38835574115017985,-0.9236679753414491,0.6304347826086957,0.945499215545767,1.0,7/51,10.02%,ARPC5;ACTG1;ACTB;LYN;BRK1;HSP90AB1;MYO10
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.38835574115017985,-0.9236679753414491,0.6304347826086957,0.945499215545767,1.0,7/51,10.02%,ARPC5;ACTG1;ACTB;LYN;BRK1;HSP90AB1;MYO10
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.553162168623352,-0.9230642316227082,0.6170212765957447,0.9462651190950035,1.0,2/11,5.65%,NCSTN;APH1A
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.510227130757931,0.9230361278875826,0.673469387755102,0.9465652740578563,1.0,4/12,21.19%,PKP2;CAMK2D;PIK3CA;CACNA1D
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.5962263062644289,0.9230193418178787,0.7021276595744681,0.9453518578801848,1.0,2/9,18.43%,PUDP;UCK1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.5962263062644289,0.9230193418178787,0.7021276595744681,0.9453518578801848,1.0,2/9,18.43%,PUDP;UCK1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.36140958045751587,0.9230130584150459,0.5471698113207547,0.9447495137085918,1.0,17/83,14.41%,PTPRC;CAMK2N2;RELN;UBASH3B;TSPYL2;CACUL1;MMD2;TTN;CAV3;PAK2;MMD;PDPK1;TAB1;SNCA;CSF1;TAB2;CAMK2N1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.5862977755842074,-0.9229974078591392,0.5909090909090909,0.9458716388938528,1.0,2/6,14.93%,SARAF;STIM1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.5220718158863054,0.9223804414867954,0.5555555555555556,0.9456732219591987,1.0,6/9,22.61%,ALK;CCDC3;NCOR1;PRKAA1;PDE3B;ASXL3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.5133015239725365,0.9217664254133358,0.5957446808510638,0.9465258670647241,1.0,1/8,5.61%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),0.5018764817500526,0.9217425994908569,0.5964912280701754,0.9459874042918575,1.0,3/12,21.82%,BRCA1;KMT2A;SMAD4
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.588033643744302,0.9217224280793566,0.6304347826086957,0.945398897042014,1.0,2/5,29.44%,HIBADH;HIBCH
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.5841067055328018,-0.921636482601114,0.62,0.9479787917284257,1.0,1/6,3.84%,PIH1D1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.41997910538733924,-0.9216236760672271,0.5555555555555556,0.9473861862372295,1.0,9/32,14.69%,PPT1;CD151;VPS28;SMPD1;CLU;CLIP3;B2M;CDC42;LRP1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.4805390904275514,-0.9215459913141463,0.574468085106383,0.9469448625048469,1.0,2/17,5.83%,SOX4;ERN1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.4893982557208285,-0.9214920899662877,0.54,0.9464357690924247,1.0,4/13,10.86%,GDE1;SMPDL3A;SMPD1;ENPP6
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.351717811143134,0.9214818500866497,0.6557377049180327,0.9453245960783169,1.0,15/122,9.60%,CDH9;TNS1;ADAMTS9;EDNRA;HSD11B1;MEIS2;SYNPO2;ENPP2;LAMA2;SLC4A4;PAPSS2;ROR1;LSAMP;PLSCR4;DUSP1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.45478548053696266,0.9209472027970523,0.5932203389830508,0.9461435832966772,1.0,7/20,18.10%,TMSB4X;RELN;SHANK3;ATPSCKMT;ANK2;PKD2;ANK3
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.5175146390435813,-0.9209062326613952,0.6296296296296297,0.9464231545972416,1.0,2/9,16.62%,CYB5R3;AKT1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5175146390435813,-0.9209062326613952,0.6296296296296297,0.9464231545972416,1.0,2/9,16.62%,CYB5R3;AKT1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.5062700764021024,0.9206757514278424,0.5614035087719298,0.9461195409989384,1.0,1/14,0.54%,CMTR1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.38446210905944506,0.920437560974552,0.6170212765957447,0.9460955298239149,1.0,16/44,21.45%,PARN;CCT8;STN1;TNKS;ATM;CCT6A;HMBOX1;MAPKAPK5;NEK7;GNL3L;TENT4B;NAF1;EXOSC10;MAPK3;MAPK1;ATR
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6142544369235842,0.9203696017582834,0.5964912280701754,0.9456542711971935,1.0,2/5,26.97%,JCAD;FGF2
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3744499530125152,0.9201756079323492,0.58,0.9455421354127066,1.0,10/70,10.72%,TIAM1;MACF1;GRB10;PSEN1;RSPO2;DAAM2;ZRANB1;CDK14;SULF1;CBFB
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.5248568148528807,-0.919966201461995,0.6031746031746031,0.9479279832494415,1.0,2/10,6.86%,ALOX5;CPA1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.5094656652000222,-0.9198495763887832,0.5813953488372093,0.946905062246166,1.0,4/11,27.74%,SET;SMARCD1;SMARCB1;HMGA1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.5094656652000222,-0.9198495763887832,0.5813953488372093,0.946905062246166,1.0,4/11,27.74%,SET;SMARCD1;SMARCB1;HMGA1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.34733063581915097,0.9197634336819065,0.6666666666666666,0.9459921112657347,1.0,28/100,22.51%,TPD52L1;CEP135;CCDC57;CDK14;FBXL17;CCP110;HAUS2;PCNT;CDK7;HAUS5;TUBA4A;BORA;FBXW11;CEP41;CEP131;MASTL;ENSA;CSNK1D;CEP290;ACTR1A;HAUS6;ALMS1;LCMT1;CLASP1;BRSK1;CDKN2B;PPP1R12B;TAF2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.5613908539072072,0.919444535155352,0.6363636363636364,0.9461764795392398,1.0,2/9,6.08%,BAIAP3;SYN3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3655126643142852,-0.9193966721703573,0.6170212765957447,0.947276338091759,1.0,6/64,4.30%,S100A6;SLITRK2;CDHR1;S100B;ACTB;MAP1S
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.5123405577982308,-0.9193662841100667,0.5357142857142857,0.9467285677367462,1.0,7/12,26.66%,RC3H1;KHSRP;CNOT1;GTPBP1;ZC3HAV1;NUDT21;UPF1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.36215140057205897,0.9191571166655771,0.5476190476190477,0.9462660186304162,1.0,16/68,16.78%,GLRA1;SLC25A18;SLC24A2;PANX2;KCNN3;TMEM63C;GRIN1;GABRB1;SLC12A1;LASP1;PIEZO1;SLC8A1;SLC9A9;SLC8A2;PIEZO2;LRRC8A
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.4211142411032625,0.9188637739785716,0.5510204081632653,0.9463869523619354,1.0,5/39,14.77%,GADD45A;WRN;RAD9A;ATM;CLOCK
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.4264671909916357,0.9184131872490697,0.6666666666666666,0.94669037107515,1.0,6/22,16.99%,PKP2;KCND3;CAMK2D;ANK2;DSC2;KCNQ1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.46877680445346,0.9184093191030949,0.7037037037037037,0.9460807829418112,1.0,2/16,4.78%,SCEL;BCR
prerank,PanglaoDB_Augmented_2021__Platelets,0.3613360905655746,0.9181721219106795,0.5901639344262295,0.9459374285430338,1.0,14/52,16.64%,ITGA2;ALOX12;SPI1;NRGN;SH3BGRL2;MAP3K7CL;CA2;P2RY12;RAP1B;ATP8A1;SMOX;AOAH;SLC2A3;ADAM10
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.6109676178716846,-0.9181720879826129,0.673469387755102,0.9487381657480651,1.0,2/5,5.65%,NCSTN;APH1A
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.34744897379869216,0.9179930448336249,0.5918367346938775,0.9458256875681482,1.0,17/105,15.02%,LIFR;STMN2;ADGRL2;EDNRA;FAM13C;ADCY5;CRMP1;SHC2;MAPK10;PAMR1;PRKG1;GJA1;ANK2;CCDC3;PBX1;DCLK1;ASTN1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.3778789186764382,0.9178641374252885,0.5777777777777777,0.9455570459860511,1.0,9/52,16.42%,CRIM1;LRP2;PCSK6;VWC2L;SULF1;CHRD;UBE2D3;PPARG;ENG
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.353403899437079,0.9178176413905478,0.6428571428571429,0.9450941397013003,1.0,16/108,14.48%,RASGRF1;STMN2;SRF;ALK;TENM3;TBCD;DOCK7;CNTNAP2;FRYL;TENM2;THOC2;ACTL6B;ATXN10;MAP4;PBX1;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.42814196512208513,0.917419707634827,0.5925925925925926,0.9454474093547898,1.0,6/18,18.16%,RANGAP1;SUFU;DMTN;BARD1;ITGB1BP1;BAG4
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.35986270755093613,-0.9174151043919907,0.6071428571428571,0.9500112297313817,1.0,14/67,16.76%,SIRT2;ELOB;PRICKLE1;ZYG11B;PSMC3;PSMD10;TMEM259;STUB1;CLU;RAD23A;RACK1;TRIB3;VCP;RNF14
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.4513377995759935,-0.9173629719404249,0.5555555555555556,0.9495645939000242,1.0,7/21,9.22%,SF3B5;RHOG;BLVRB;RASSF1;YIF1B;CNPY3;TRAPPC6A
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.4982458148081124,-0.917356513809029,0.6153846153846154,0.948948898559887,1.0,5/13,22.36%,ZNF304;PPHLN1;TRIM28;MORC2;TPR
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.5708178054855398,0.9171707389755019,0.6153846153846154,0.945336269395355,1.0,2/8,9.02%,WNT7A;SHANK3
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.5688345567379416,0.9170400944620835,0.6122448979591837,0.9451187556652244,1.0,1/6,4.22%,DOCK11
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.36240278103545304,0.9168751949027708,0.6326530612244898,0.9449265672135971,1.0,10/80,6.69%,LIFR;NUAK1;CHST3;ADGRL2;KITLG;EDNRA;SRPX;TENM3;FKBP9;TEAD1
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.6140882655111543,0.9167559431187405,0.6666666666666666,0.9445781838516832,1.0,1/5,3.24%,PUS7
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.37345439000301,-0.9163678320540822,0.5576923076923077,0.9505719350873716,1.0,15/74,11.48%,SCG3;CALM1;LGALS3BP;RARRES2;BRPF3;CD63;VEGFB;ANXA5;LYN;PCYOX1L;FN1;VWF;TLN1;CLU;CHID1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.5723610170893122,-0.9161659541991344,0.5918367346938775,0.9504714458514987,1.0,2/5,19.97%,MUL1;OAS3
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.36231252153629756,0.9158902196184415,0.66,0.9459499961783192,1.0,10/62,10.66%,TMSB4X;GRK4;BRD4;FOXP1;NMT1;LRRC19;CAMKMT;CYLD;TIRAP;P2RY12
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.5461975286165502,-0.9157514345415299,0.5952380952380952,0.9501016629283341,1.0,1/8,3.51%,EXOSC8
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.5461975286165502,-0.9157514345415299,0.5952380952380952,0.9501016629283341,1.0,1/8,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.5367248036950121,-0.9157117313195802,0.48936170212765956,0.9496026282061306,1.0,1/8,1.04%,PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.298895123062833,0.9156175013791588,0.7884615384615384,0.9459826318413928,1.0,53/326,17.13%,HEY2;AHR;KLF6;FOXO1;MYRF;YWHAH;SOX9;HDAC4;WNT7A;SEC14L2;BRD4;FOS;ING5;RXRA;NCOA1;THRAP3;FANK1;PSEN1;TEAD1;ZBTB16;NPAS3;ARNT2;NPAS2;NAA16;TRIM44;BRCA1;RORA;HES1;YAF2;BMP7;FUBP3;RARA;RORB;PRDM16;TP53BP1;NOS1;FBXW11;PARP9;MAP3K5;KMT2A;ARID1B;CLOCK;SPP1;TRERF1;TAF15;IRF1;TASP1;PPARG;NEK4;CEP290;PPARGC1A;RFX3;MAP2K3
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.40609989153991605,0.9154323175336834,0.5111111111111111,0.9457903826086986,1.0,3/25,5.44%,PON1;PON3;ALOX12
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.502414110769824,-0.9153732263318671,0.5306122448979592,0.9497666522466051,1.0,3/9,7.79%,ARL6IP5;SLC1A6;PRAF2
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.5827662183607485,0.9153038899106722,0.6326530612244898,0.945417370885207,1.0,2/5,4.86%,PAK1;LMO3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.5952142137842977,-0.9147048101790931,0.5869565217391305,0.950754536323706,1.0,1/5,5.75%,CHCHD10
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.5794617999028833,0.9146976220756367,0.65,0.9463360334878861,1.0,1/5,18.57%,TENT4B
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.5737727435543254,-0.9146784775956953,0.5740740740740741,0.9501750548493431,1.0,1/5,12.58%,BMP2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.4790135390840753,0.9145850114494825,0.5652173913043478,0.9460317201931873,1.0,3/9,12.29%,NEDD4L;CAV3;CAMK2D
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),0.5603042786451771,0.9145775016897876,0.6470588235294118,0.9454474573372406,1.0,1/7,4.41%,NLRC4
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.5519071746395661,-0.9144785474913982,0.5581395348837209,0.950061798801386,1.0,1/5,10.12%,DHODH
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.5500234759908503,-0.9140124896497214,0.6326530612244898,0.950528450926115,1.0,2/6,11.77%,RAN;NPM1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.5346661696252181,0.9137911235203989,0.6,0.9466320527729043,1.0,2/9,9.13%,PCLO;DLG4
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5362980918042426,-0.9137164016324233,0.5555555555555556,0.9505835351323884,1.0,1/9,0.26%,CCND1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.3697307168829736,0.9137090188476057,0.6363636363636364,0.9462285835211499,1.0,11/53,15.23%,FUT2;B3GNT5;CHST9;GCNT2;CHST12;CHST8;CHST11;LARGE1;MGAT1;B4GALT5;CSGALNACT1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5347848092248679,-0.9136398122420543,0.5555555555555556,0.9500999453125418,1.0,2/8,7.19%,CCDC88C;EPDR1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5639353043513824,0.9135278989031851,0.6610169491525424,0.946080558731487,1.0,6/8,29.18%,SERTAD2;PADI2;ARID1B;ARID1A;ZMIZ2;ZMIZ1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.5170143337700941,-0.9129020820643652,0.6170212765957447,0.9511509969524785,1.0,2/7,12.58%,PAX8;BMP2
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5806050118350077,0.912713390947604,0.6296296296296297,0.9470885038088008,1.0,4/5,41.10%,PRKN;ADAM9;LRRK2;D2HGDH
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5018557189096614,-0.9126940439178711,0.6097560975609756,0.9510240245634206,1.0,1/14,0.32%,GPR17
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5672833950456121,-0.9126664148159759,0.6046511627906976,0.9504940627883989,1.0,2/5,21.89%,ENPP3;DCTD
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.5546224594017335,0.9126223730455421,0.6415094339622641,0.9467041433600526,1.0,4/6,27.49%,RAB11FIP5;PTPRN;RAB11FIP2;PTPRN2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.494978385005258,0.9125499689305029,0.5957446808510638,0.9462582110955515,1.0,5/14,9.19%,PARN;IHO1;FMN2;USP9X;TOB2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3626509141155902,0.9124346224252662,0.6727272727272727,0.945936885763757,1.0,11/70,14.11%,ROBO2;LRP2;NCOA1;SLIT3;ZNF16;MAP2K5;STAT5B;NLRP12;NOS1;ACVR1C;PTPN13
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.37746037491985895,0.9120122533758068,0.6481481481481481,0.9463597421815908,1.0,10/54,13.40%,EFNA5;TBC1D10B;PLXNA4;WRN;EPHA4;PLXNA1;PRKG1;NOS1;SIPA1L1;FBXW11
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5535970297713086,0.9115293453880908,0.64,0.9470298302914384,1.0,3/8,16.93%,RIPOR2;CAMK1;EHD1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.5164459055486678,0.9108004888622766,0.5217391304347826,0.9480457246557173,1.0,1/11,7.16%,ENTPD3
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.4922324806823676,0.9107253015922199,0.6052631578947368,0.9476003544671826,1.0,4/13,22.30%,ADCY5;ADCY3;ADCY1;ADCY2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.34777945114568126,0.9106688854363189,0.671875,0.9470937233106965,1.0,17/114,9.57%,ITGA2;PTPRR;SOX9;WNT7A;HSD11B1;AKT2;ITGBL1;RELN;ANGPTL4;MAP7;FGF9;SNAP25;CA2;MMD;TSPAN13;AKAP12;CSF2RA
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.5037949882995003,-0.9105844175584912,0.5510204081632653,0.9549337930840157,1.0,1/9,1.69%,RANGRF
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.5070557601025991,0.9105674341078599,0.5272727272727272,0.9467916241097417,1.0,1/11,0.38%,SCEL
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4631170496444079,-0.9105410200805732,0.6274509803921569,0.954455647467291,1.0,1/15,0.13%,SOX4
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.3715240506126425,-0.9104641474135773,0.625,0.9540451887656923,1.0,4/44,8.37%,BTC;RPS19;CADM4;LYN
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.555818026647313,-0.9104313449582585,0.5957446808510638,0.9534610237055701,1.0,2/8,11.73%,SELENOS;TMCO1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.46377164184152186,-0.9104114619724537,0.5882352941176471,0.9528709254651363,1.0,5/17,16.62%,CYB5R3;ASAH1;SPHK2;SPTLC1;AKT1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.5207428520058048,-0.910130242952212,0.6341463414634146,0.953031205284783,1.0,2/11,5.55%,KRT10;FARSA
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4606676558639034,-0.9100838499503606,0.6,0.9524756013807202,1.0,6/17,10.34%,BAD;ROMO1;TIMM8B;TIMM13;TIMM22;COX18
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6227819455917998,-0.9098561252837362,0.6521739130434783,0.9524019837237805,1.0,4/5,36.10%,CRCP;BRF1;BDP1;POLR3H
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.41228109962229825,0.9096052808465003,0.6363636363636364,0.9484225645484413,1.0,6/26,12.14%,NDST3;CHST9;CHST12;B3GAT3;CHST8;CHST11
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.42378106883966216,-0.9092425626808158,0.5306122448979592,0.9532101982436739,1.0,8/41,12.10%,CCDC88C;PPIB;MT3;RABL3;CADM4;LYN;FN1;PPP1R16A
prerank,MSigDB_Hallmark_2020__Glycolysis,0.3345515726590284,0.9091015191394521,0.6078431372549019,0.9488666659527485,1.0,15/138,9.26%,NDST3;SOX9;EGLN3;MERTK;COL5A1;PKP2;PYGB;GCLC;ANGPTL4;BPNT1;PYGL;SDHC;CHST12;TPST1;B3GAT3
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.5808919959344272,-0.9090752208437242,0.6666666666666666,0.9529025564275915,1.0,2/6,7.02%,P2RX4;EDNRB
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.34963110959654786,-0.9090514713417961,0.5535714285714286,0.9523351419299394,1.0,19/82,16.76%,SIRT2;ELOB;UBXN1;PRICKLE1;ZYG11B;PSMD10;RPL11;STUB1;GIPC1;HSP90AB1;UFL1;CLU;RAD23A;RACK1;PARK7;UBQLN4;TRIB3;VCP;RNF14
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.4426538238570669,-0.9090363996410877,0.5416666666666666,0.9517351323899128,1.0,4/21,17.53%,DYNLT1;SAPCD2;SPDL1;NUMA1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.3661585541600273,-0.9089321189813023,0.6458333333333334,0.9513091269177509,1.0,4/53,4.78%,SOX4;BAD;LRRC8D;ALOX5
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.3892356306527683,0.9088811579413278,0.5952380952380952,0.9487860260234093,1.0,9/56,9.97%,ADAMTS9;GPI;FOXP1;PRKCA;EMP2;SASH1;BCAS3;PROX1;RHOJ
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.44333109954978867,0.9086583322066695,0.5555555555555556,0.9486869989444144,1.0,6/25,16.79%,BCAS3;RAB29;B3GAT3;PCNT;CEP131;CEP290
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.4553899690439264,0.9079104542252303,0.6530612244897959,0.9497336823917795,1.0,8/20,29.41%,MAPK12;CAMK1;NRG1;CTNNA1;ABL1;MAPK11;RBM4;MEF2A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.3106482801679691,-0.9078570818468652,0.6530612244897959,0.9529010807071814,1.0,27/156,17.01%,NR0B1;CALR;TMBIM6;TNS2;SFRP1;APOD;QARS1;CADM4;SMPD1;CACTIN;LYN;ULK3;YWHAB;SPRY1;HMGXB4;BMP2;SLC2A10;RACK1;GPC1;LRP1;PRKCQ;TMBIM1;VCP;AKT1;MOSMO;CSNK2A2;HIF1AN
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.47519717954332075,0.9076546500458911,0.5882352941176471,0.9496588040093041,1.0,2/12,10.58%,PCSK6;SULF1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.5374562676920532,-0.9075007857451078,0.6491228070175439,0.9531801716100493,1.0,5/9,19.25%,GTF2A2;TAF7;TAF11;DR1;TBP
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.6194078109860292,0.90719380405475,0.6530612244897959,0.9501806970331447,1.0,2/5,11.97%,CKMT2;SLC6A8
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.5495047250363524,0.9065159369517742,0.5892857142857143,0.9510400429078331,1.0,1/7,12.77%,PIK3CD
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.49767206344853865,-0.9065053220084098,0.5714285714285714,0.9549151310031752,1.0,6/16,22.52%,PHB2;CLU;ZP3;C5;C1QBP;CD81
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3988902488023817,-0.906491773732314,0.5686274509803921,0.9543220391928329,1.0,3/22,6.51%,SIRT2;ZFP36L1;PIK3C2G
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.4764098399673198,-0.9063362275894092,0.5555555555555556,0.9539820682454258,1.0,2/9,16.65%,VPS11;MSN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5938018466888583,0.9062953110428218,0.5964912280701754,0.9510382075621153,1.0,2/6,19.61%,PPARG;PDCD4
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.42798127161645494,0.9061701227125001,0.5434782608695652,0.9507293885588283,1.0,5/31,10.29%,HEY2;SOX9;TGFBR3;LOXL3;BMP7
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5397303097284548,0.906125703785359,0.7021276595744681,0.95018165853749,1.0,1/8,5.48%,ZC3H12B
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.5415382998908342,-0.9060308136680036,0.5625,0.9539478182516488,1.0,3/7,15.91%,SQLE;AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.331530043762646,-0.905515548638947,0.6739130434782609,0.9545967322928992,1.0,13/186,4.37%,UBB;BTC;PPT1;ARPC5;RPS27A;CLTB;ACTG1;ACTB;UBC;STON2;SH3GL2;HSPA8;LDLR
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.37607670479801497,-0.905395969607302,0.5769230769230769,0.9541511966947988,1.0,10/59,16.51%,GSTP1;HNRNPA0;SELENOS;WNT5A;CACTIN;SCARB1;PELI1;PRDX3;PAF1;CDC73
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.34651271007185935,-0.9051177783009161,0.5918367346938775,0.9541036564655102,1.0,11/95,12.24%,CDKN2C;SIRT2;CCDC88C;NUP42;CADM4;LYN;FN1;NUP155;RAD17;CDKN1C;IKBKB
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.5346340236184758,-0.9044473766398653,0.5714285714285714,0.9549166955811453,1.0,2/5,11.23%,PIH1D1;SPHK2
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4400694550097874,-0.9040004396217737,0.6,0.95525901270828,1.0,4/23,13.92%,SEC61G;SEC61B;COX18;PRNP
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.3318305244365457,0.9036457924143284,0.7058823529411765,0.9549449413764938,1.0,22/143,13.88%,FSTL5;GRAMD1C;EFNA5;PCLO;KCNC4;NRSN2;CARNS1;ARFGEF3;SYBU;HSPA12A;SRCIN1;MAPK8IP2;CEP170B;PTPRU;SPTBN4;PACRG;NRG1;DUSP8;ABHD3;CERS5;MORN4;NCS1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.45631084022516566,0.9035977604190097,0.6428571428571429,0.9544258960401578,1.0,5/22,18.09%,FBXL17;BHLHE40;CLOCK;PER1;CRTC1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.36881057946144497,0.9035515870863792,0.6444444444444445,0.9539442471255625,1.0,10/59,12.77%,TMSB4X;GPI;FOXP1;PRKCA;SASH1;BCAS3;PROX1;PDPK1;AKT3;PIK3CD
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.5640117377152513,0.903289576182624,0.7222222222222222,0.9538365516957197,1.0,2/7,4.62%,MYRF;CNTNAP1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.36230179031473586,0.9028217738474975,0.5833333333333334,0.954389591035908,1.0,10/63,9.03%,ITPR1;EFNA5;KCNJ11;G6PC2;KCNC2;ADCY5;PRKCA;SNAP25;ITPR2;BMP8A
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.4827432956880896,0.9026403302375038,0.6346153846153846,0.9541778334952119,1.0,7/15,18.10%,GRIN1;TMTC2;CNNM2;SNCA;SLC8A1;FAM20A;ANK3
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5885261365884297,-0.9024268616527473,0.6862745098039216,0.9579278970898601,1.0,3/6,11.77%,RAN;LSG1;NPM1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.4727899501491347,-0.9020807659558804,0.5961538461538461,0.9581819445702999,1.0,3/12,16.14%,MALT1;B2M;IL18
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.5342276143821374,-0.9019620803998158,0.65,0.9578348554219468,1.0,1/8,2.41%,CDHR1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.5350815655118151,-0.9019335901661851,0.625,0.957283674218817,1.0,2/8,12.47%,ATP6V1G1;ATP6V0D1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5026970104261222,-0.9018609122553365,0.575,0.9568123283770548,1.0,3/14,16.47%,TLR1;CAV1;FLOT1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.454190258648336,0.9017400480682418,0.5370370370370371,0.9555607950461213,1.0,1/17,0.43%,NDST3
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.6030040386408441,-0.9014628909711828,0.6296296296296297,0.9571257457700679,1.0,2/5,19.81%,WNT5A;NOXA1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.5091208706171925,-0.9012054849562543,0.5769230769230769,0.9572148593878108,1.0,2/10,13.21%,CRAT;CROT
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.5788425355916028,-0.9011980934533427,0.6530612244897959,0.9566194259874646,1.0,2/8,9.42%,VDAC2;STPG1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.31502443212095554,-0.9010113656066376,0.7666666666666667,0.9563733307348853,1.0,23/153,13.67%,CUL7;MMP2;NCSTN;CNDP2;MALT1;APH1A;CTSC;CPA1;APEH;RNPEP;CTSF;PRCP;NLRP1;HM13;AEBP1;FURIN;ADAMTS3;CAPN1;VASH1;PM20D2;CTSL;CTSK;XPNPEP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.49672434832458595,0.9009873400213929,0.5686274509803921,0.9568382404912807,1.0,1/9,7.21%,RPTOR
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.3590944007078015,-0.9002231326004726,0.6909090909090909,0.9575998212726717,1.0,9/58,13.33%,AGRN;ACTG1;ACTB;NLGN2;RAB39B;LIMS1;SDK1;SMAD3;CDC42
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.5877009988514553,-0.9000630489783851,0.7560975609756098,0.9572417497707917,1.0,2/7,6.35%,PDGFRA;EPHB3
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.35953487950010327,-0.8997568816463085,0.6818181818181818,0.9572911181648242,1.0,23/68,22.38%,CUL7;CALM1;USP51;SFRP1;CUL9;CALM3;CEP85;TXLNG;KLHL9;CDC42;ENTR1;PRMT5;ZFYVE26;CSNK2A2;NUMA1;DBF4;PIN1;RPRD1B;DBF4B;MAP9;ECT2;NUDT16;KLHL13
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.5741269709285806,-0.8994408426300692,0.5833333333333334,0.9576028233787607,1.0,1/7,1.10%,RHOC
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.5697533167594722,-0.8992053932098957,0.7209302325581395,0.9575404487649343,1.0,2/7,5.94%,KRT10;SGPP1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.534789202631164,0.898881968855049,0.6078431372549019,0.9610061518444831,1.0,2/6,27.07%,SENP1;SENP6
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.41751706410962086,0.8987110604293729,0.5957446808510638,0.9607846975079561,1.0,8/23,16.03%,SOX9;RAB17;GPRC5C;EFNA1;AQP4;OVOL2;SPP1;ALPL
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5070938573732803,0.8986573357180248,0.5925925925925926,0.960277111347454,1.0,1/9,4.28%,TSPYL2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.4405421123346322,0.8985327507241335,0.5471698113207547,0.9599284974188291,1.0,2/18,4.45%,STMN2;NTRK3
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.387743232332872,-0.898524088569761,0.5714285714285714,0.9586377885258611,1.0,9/48,11.97%,ALOX5;LPCAT1;ACSM5;FADS1;ACLY;DHRS11;OXSM;NDUFAB1;PCYT2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5070287696853086,0.8983622567466018,0.6363636363636364,0.9596472658013101,1.0,2/9,13.77%,RAB1A;PTPRN
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.5750695987726386,0.8983405409731896,0.64,0.9585083823224761,1.0,1/5,7.56%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.5750695987726386,0.8983405409731896,0.64,0.9585083823224761,1.0,1/5,7.56%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.5426965755913596,-0.8979675008771181,0.6078431372549019,0.9593998066863016,1.0,2/6,13.89%,NONO;PARK7
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.5824648788456676,-0.8979419425274663,0.717948717948718,0.9588522040163195,1.0,2/5,15.54%,SULT1C4;ALDH2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),0.5401756322817317,0.8975349322472167,0.5869565217391305,0.9582342101857104,1.0,2/5,23.00%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),0.5401756322817317,0.8975349322472167,0.5869565217391305,0.9582342101857104,1.0,2/5,23.00%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),0.5401756322817317,0.8975349322472167,0.5869565217391305,0.9582342101857104,1.0,2/5,23.00%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.5885150739965025,-0.897442629194604,0.6285714285714286,0.9592992373319318,1.0,1/5,3.88%,NLGN2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5371593142961392,-0.8974271347698671,0.631578947368421,0.9587001186901328,1.0,4/7,32.23%,KDM5D;KDM5C;KDM1B;RIOX2
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.6109855334694465,0.8973874160478197,0.6078431372549019,0.9579126315740489,1.0,2/5,16.93%,RIPOR2;EHD1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.4803784748332307,0.8973467145837333,0.703125,0.9574035983635204,1.0,5/17,19.61%,TAFA5;PRKG1;TPM1;PPARG;PDCD4
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.469076618503822,0.8970912406404443,0.6444444444444445,0.9573615102662976,1.0,1/13,8.32%,NUP93
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.38922223663533556,0.8969868920676762,0.6545454545454545,0.9570350171052143,1.0,7/48,9.05%,WNT7A;PCDHB5;GABRG2;NRCAM;SHANK3;RAB29;GABRA2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.4805686443483503,-0.8966223121817875,0.6170212765957447,0.9597866889794103,1.0,1/13,1.16%,ARPC5
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6108925417765726,-0.8964144682721285,0.723404255319149,0.9595600369189842,1.0,2/5,5.74%,DIPK2A;BAG3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.4926625762232335,0.8960166847310481,0.6896551724137931,0.9586565563916131,1.0,1/13,0.51%,DPYD
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.4455735353340613,-0.8957684912002333,0.6458333333333334,0.9605142273897034,1.0,4/24,11.71%,OAT;ALDH4A1;AADAT;PYCR1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4111379462706797,-0.8957020520829205,0.5434782608695652,0.9600722986855901,1.0,2/27,2.83%,ASCL1;BTBD6
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.4965819605960013,-0.8956503769756203,0.6363636363636364,0.9595397348529641,1.0,1/10,5.80%,ARV1
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.42208981548039987,0.8956272119035688,0.5714285714285714,0.9589039216609108,1.0,3/22,6.65%,SEMA3A;SLIT3;USP9X
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.40973367252489856,0.8954485715843787,0.6326530612244898,0.9586254090515304,1.0,4/32,6.17%,GRIN2A;DAPK1;NLRC4;GRIN1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.5099239833977509,0.895322639551822,0.6046511627906976,0.9583653524794762,1.0,2/12,8.68%,ANGPTL4;RORA
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.47156688150201886,0.8952204928789127,0.5882352941176471,0.9579728777503763,1.0,2/16,4.56%,BRAT1;TRAK1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.37260884368354347,0.8950572765274346,0.5740740740740741,0.9577436939789387,1.0,11/60,16.81%,BRAT1;GADD45A;EYA1;RAD9A;XRCC4;BRCA1;BABAM2;ATM;STK11;CLOCK;PRKAA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5170465184983397,0.8947304101259277,0.675,0.9578582839760463,1.0,1/10,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.5749587915802604,0.8945849109529586,0.6730769230769231,0.9569856112658619,1.0,2/6,27.23%,CDC27;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.5749587915802604,0.8945849109529586,0.6730769230769231,0.9569856112658619,1.0,2/6,27.23%,CDC27;TACC3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.5755490453093726,0.8943945543285752,0.6851851851851852,0.9567997044378496,1.0,3/5,37.72%,CEP250;MARK4;GSK3B
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.5072160948817286,-0.8943322693093886,0.6,0.9613131754030666,1.0,3/9,22.75%,GBE1;GYG1;PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.5072160948817286,-0.8943322693093886,0.6,0.9613131754030666,1.0,3/9,22.75%,GBE1;GYG1;PGM2
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.3439659344203763,0.8941996172715861,0.6851851851851852,0.9566861623149455,1.0,6/67,6.56%,PTPRC;IRF2;NLRC5;AGBL4;ATG7;ZDHHC11
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.5348869347778714,-0.8939960304809659,0.5957446808510638,0.9615415359287296,1.0,2/8,19.48%,TUBB4B;TUBB
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.33254037649963014,-0.8936769641478202,0.6739130434782609,0.9615876748300829,1.0,23/124,13.54%,IDH1;MT2A;PGRMC1;UGDH;HES6;TMBIM6;CNDP2;SLC46A3;GSTM4;BLVRB;CBR1;COMT;DHRS7;DCXR;SSR3;CSAD;ACOX1;PYCR1;SAR1B;LCAT;GSS;CROT;ACP2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.44599668637611417,-0.8936586075377982,0.5434782608695652,0.9610233713835928,1.0,5/23,16.12%,PPT1;ACLY;SLC25A1;TECR;HSD17B12
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3806212871686823,-0.8936168996771637,0.6153846153846154,0.9604922298008386,1.0,6/42,13.07%,PMEPA1;FURIN;CDKN1C;FNTA;BMP2;SMAD3
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5490479163575984,-0.893082430472252,0.7,0.9611485562855803,1.0,2/11,11.19%,ALOX5;CLU
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.36965794585996364,-0.8930177771532792,0.6206896551724138,0.960630970034406,1.0,10/47,15.29%,BANF1;PPIA;SHFL;IFITM3;ISG20;RAD23A;ISG15;IFIT5;IFIT1;SRPK1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.41163777372856236,-0.8929401865772434,0.5306122448979592,0.9601529006392728,1.0,3/35,7.17%,BTC;SLC30A10;SHC3
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.533790768098218,0.8929010300444837,0.6481481481481481,0.9588616712579505,1.0,1/9,1.52%,CHST3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.5276731163351578,-0.8928433657875916,0.6190476190476191,0.959759583617973,1.0,1/10,1.56%,THY1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.40999152913973425,0.8927993611352066,0.5862068965517241,0.9585308598026605,1.0,11/31,21.19%,MYLK;CAMK2B;CAV3;PLPP4;NOS1;ANK2;PKD2;ATP2B1;HOMER1;BCL2;CACNA1D
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.47136232498753144,0.8927332184447068,0.6346153846153846,0.9580984499807079,1.0,5/15,21.96%,USP30;CHCHD3;GDAP1;MIGA2;MFN1
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.519433872483271,-0.8924913947018944,0.6981132075471698,0.9599036766710939,1.0,5/11,19.25%,GTF2A2;TAF7;TAF11;DR1;TBP
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.5535397360006075,0.8923287297643661,0.6078431372549019,0.9584821062429744,1.0,1/6,12.55%,IL6R
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.508061033125429,-0.8922446030417048,0.6964285714285714,0.9599182928034854,1.0,1/11,1.56%,THY1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.6092633501632951,0.8922054682616041,0.6545454545454545,0.9581341572647956,1.0,2/6,22.14%,SHANK3;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.4372551366019329,0.892187388162829,0.5777777777777777,0.9575949791442698,1.0,5/20,9.50%,VSIR;EFNA1;GRIN1;EPHA4;APH1B
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.3099068103936663,-0.8920433796793442,0.7142857142857143,0.9598165984229677,1.0,28/198,12.58%,CCND1;CDKN2C;SIRT2;JUN;GADD45GIP1;CALR;CDC26;RNF167;USP51;RPL23;SFRP1;ERN1;TBRG4;RASSF1;RPS15A;ZBTB49;RRP8;RNF112;FIGNL1;HSP90AB1;JUND;AFAP1L2;BRINP1;TAF6;MYBBP1A;TXLNG;RAD23A;BMP2
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.5317553779947104,0.8919497530812026,0.6326530612244898,0.9575772058206844,1.0,4/7,29.94%,PFKL;GFPT1;HK1;PFKP
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.5004441449666048,0.8919103828687016,0.6229508196721312,0.9570868837419284,1.0,2/11,4.91%,MYRF;PARD3
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.564284724965487,0.8919055284760771,0.7045454545454546,0.956507487747634,1.0,1/5,21.93%,MAPT
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.307972993951115,-0.8917824166295811,0.6811594202898551,0.9598377076252205,1.0,27/221,10.16%,CCND1;UBB;MMP2;MT2A;RPS27A;GAPDH;UBC;IL20RA;ZFP36L1;HSPA8;ALOX5;PTPN14;SFRP1;CXCL12;ASAH1;UBA52;RPL13A;PTPRZ1;MAPK13;WNT5A;CACTIN;NDN;HAS2;IL12RB2;HAX1;LAMA5;FN1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.3665814960528057,0.890760908358906,0.6739130434782609,0.9583246115903773,1.0,7/60,6.49%,VSIR;MYRF;PCSK2;ADAMTS13;C1RL;PSEN1;PCSK6
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4154682984444926,-0.8904094551413827,0.6,0.9623623713040822,1.0,4/37,9.95%,JUN;HAX1;ITGA4;CD44
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.43867388550759806,0.8902862483476859,0.6428571428571429,0.9588677045890318,1.0,2/17,6.47%,HEY2;TGFBR3
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.5777477639556295,0.8902416585369405,0.7,0.9584255304065598,1.0,1/5,5.78%,TG
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.569626354911481,0.8902409017070665,0.6206896551724138,0.9578407680329133,1.0,3/5,19.77%,ABHD12;ABHD6;LYPLA2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.45330390807028514,-0.8902408370654381,0.6363636363636364,0.9621239121789144,1.0,5/11,30.68%,CAV1;CSNK1A1;DVL1;LRP6;PPP1CA
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.5611052626797333,0.8896880425160935,0.6862745098039216,0.9583950826356551,1.0,1/5,6.32%,ZNF16
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.5653721092170024,-0.889561604584025,0.7209302325581395,0.9627428593299193,1.0,1/5,3.84%,PIH1D1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.5337469500367518,-0.8894686954817381,0.673469387755102,0.962266167755705,1.0,1/8,15.91%,PLA2G4C
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.3796991921451081,-0.8894082238233295,0.5882352941176471,0.9617965117226375,1.0,10/49,13.21%,RAN;BAD;DBI;SULT1C4;ACSM5;ACLY;TPST2;OXSM;GMPR2;CROT
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.5158653932666271,0.8893666696469031,0.5957446808510638,0.9585198617049993,1.0,3/8,7.97%,TBCD;VCL;PAK2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5738170348768122,0.889197590981593,0.6981132075471698,0.958328992472947,1.0,2/5,11.01%,SRF;ADIPOR2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.578358823665029,-0.8889177589365784,0.7115384615384616,0.9622343948033804,1.0,2/5,16.89%,CASP9;BAX
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.3432189882191694,0.8887230834836766,0.6481481481481481,0.9588582012323948,1.0,17/78,19.69%,AHR;KLF6;SLC4A4;IRAK2;PSEN1;PVR;NMI;CSF1;KIF1B;SEMA4D;IRF1;PDPN;PCDH7;ATP2B1;ACVR1B;LPAR1;PTPRE
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.36008535438080524,-0.8887024262011389,0.7222222222222222,0.9619967644742744,1.0,12/63,9.71%,PCGF2;GPC4;SH3GL2;CAMSAP3;DUSP15;SEZ6L2;SOWAHA;VWA1;LINGO1;SCG5;SLC7A8;OGDHL
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3311792489328305,-0.8885658374947143,0.6981132075471698,0.9617337355312365,1.0,15/106,14.39%,RHOC;GAPDH;S100B;TMEM9B;PLEKHG5;MALT1;TRAF5;LITAF;DDX1;IKBKB;TSPAN6;LAMTOR5;WLS;PELI1;IFIT5
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.38813556694601076,-0.8879119443910756,0.6666666666666666,0.9626074055702663,1.0,5/32,13.65%,GSTP1;HIPK1;CLIP3;IKBKB;RACK1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5193837356792729,0.8878170224795052,0.6666666666666666,0.960272648501597,1.0,4/13,29.54%,INTS10;INTS6;INTS3;INTS12
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.43513299780022757,0.8871434644823505,0.6037735849056604,0.9611149532362465,1.0,7/26,7.98%,CHRM3;YWHAH;NEDD4L;AHCYL1;CAV3;TCAF1;RIPK1
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5894396469513408,0.8868617436705671,0.6792452830188679,0.9610714286045392,1.0,2/5,38.28%,NLGN4X;LRRK2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.4730989695240002,-0.8868213556147643,0.6086956521739131,0.9637487235287387,1.0,5/15,22.52%,PHB2;CLU;C5;C1QBP;CD81
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.4730989695240002,-0.8868213556147643,0.6086956521739131,0.9637487235287387,1.0,5/15,22.52%,PHB2;CLU;C5;C1QBP;CD81
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.36400116140242766,0.886795435564047,0.64,0.9606540714080478,1.0,10/52,19.08%,YJEFN3;KAT2B;TSPAN5;IL6ST;ARRB1;WWP2;TP63;STAT3;ITGB1BP1;MAML1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.313881288053133,-0.8866211069219258,0.6444444444444445,0.9636518675456166,1.0,32/135,17.69%,S100A10;JUN;BTG1;RPL18;ISCU;ZFP36L1;SAT1;PTPN14;DNTTIP2;CD82;DCXR;CCNK;RRP8;CTSF;PHLDA3;RPL36;GM2A;BMP2;HDAC3;EI24;TRAF4;RACK1;ANKRA2;TGFA;TRIB3;BAX;CGRRF1;RPS12;FUCA1;HINT1;TCN2;IP6K2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5449969536182028,0.8866061399126856,0.6363636363636364,0.9604032911778043,1.0,3/7,8.76%,SULT4A1;BPNT1;TPST1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3557321752543496,-0.8863511736206827,0.6388888888888888,0.9636640024817228,1.0,6/47,9.16%,SIRT2;ZFP36L1;PDGFRA;PIK3C2G;PLCL2;NGF
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.5163090791303016,-0.8859731201471124,0.7307692307692307,0.9639769270318921,1.0,2/10,13.07%,FN1;SMAD3
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.30952958114977,0.8858778327778125,0.8421052631578947,0.9614805731478806,1.0,26/175,12.72%,AHR;GLRA1;GLRA2;FOXO1;SOX9;DAPK1;HCN3;NR4A3;FOS;KCNC2;HCN1;NSMF;RYR3;SLC38A9;RPTOR;RORA;TIRAP;ATM;CPEB3;P2RY12;RORB;TPM1;DMTN;ERCC6L2;RAP1B;TAF1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5333118908210799,0.8857085168935902,0.6666666666666666,0.9611940525905436,1.0,1/9,3.43%,NR4A3
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.4044522997326602,-0.8855374331568525,0.6153846153846154,0.9643342334000592,1.0,10/28,27.13%,DNAJC30;GAS1;LAMP1;RAB11B;NUMA1;ANTKMT;CAPN10;NUP214;RINT1;PTPN1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.5307159582597029,-0.885486531831519,0.6470588235294118,0.9638217665124378,1.0,3/7,24.72%,AKT1;MSN;STK10
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5014748068035861,-0.8853820261360635,0.7045454545454546,0.9634696421102724,1.0,2/8,13.26%,CAMSAP3;ITGB5
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),0.5715513707249926,0.8852514214946227,0.6304347826086957,0.9615354320614459,1.0,1/7,7.16%,ENTPD3
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.5686789720479526,0.885199041584441,0.6290322580645161,0.9610243895461847,1.0,1/8,1.69%,SOX9
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3628137599807145,-0.8850765053445151,0.7021276595744681,0.9635839990886592,1.0,7/73,4.76%,BGN;MMP2;HSPG2;PRRX1;AMOTL2;COL12A1;TNS2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.45475426232634514,-0.885023807995546,0.725,0.9631239988287672,1.0,2/21,5.19%,GPX1;SFRP1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.45550776905061086,0.8849512953314268,0.56,0.9609751908691303,1.0,8/17,20.78%,RBSN;ARMH3;STX5;STX18;CAMSAP2;PDE4DIP;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5137683879516814,0.8848861983979323,0.7291666666666666,0.9605655677543692,1.0,1/12,1.69%,SOX9
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.5357298135161433,0.8846921255952882,0.6341463414634146,0.9603867737247995,1.0,4/8,16.99%,SGK1;KLHL3;AKR1C3;KCNQ1
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.5697960560877771,-0.8846566117785775,0.6739130434782609,0.9633021905253912,1.0,1/5,11.71%,PYCR1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.35391363368181333,0.8840597346211323,0.676923076923077,0.9610876585090062,1.0,10/65,14.33%,IGF1R;SOX9;PIP4K2C;PIP5K1B;NTRK3;ROR1;PIP4K2A;PIK3CD;PTPN13;SEMA4D
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.47917991309898417,0.8840097927509125,0.7254901960784313,0.9605961249167029,1.0,4/13,16.51%,ACACB;MVK;ACSS1;ACACA
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.37900658759524464,0.8839866862505195,0.64,0.9600580217240486,1.0,5/39,9.16%,HEY2;WNT7A;LRP2;DOCK7;HES1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5155721558427917,-0.8839779810496112,0.58,0.9640536605481431,1.0,4/10,13.89%,ATF4;RACK1;NONO;PARK7
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.47535658983622997,-0.8835906310358639,0.5909090909090909,0.9642437889863842,1.0,3/12,11.65%,CD63;CADM4;ADAMTS3
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.39579021194000413,-0.8834745467605148,0.6170212765957447,0.9638672581657436,1.0,2/23,6.68%,HSPA8;DNAJA1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.48227972469441305,0.8833184892503225,0.6808510638297872,0.9605810843898244,1.0,2/11,11.19%,NMNAT2;AK3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.5221085328428821,0.8832620317778009,0.6481481481481481,0.9601437381906137,1.0,3/9,15.84%,ENPP2;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.5563407772168028,0.882943084866268,0.5714285714285714,0.9602365386914472,1.0,2/5,8.74%,EFNA1;EPHA4
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.4143607054000803,0.8821964513101208,0.5652173913043478,0.9611172985367392,1.0,5/29,7.93%,CYP2E1;DGKG;ALOX12;PLPP4;DGKZ
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5168162560693206,0.882136319432393,0.6607142857142857,0.9607098068112537,1.0,3/11,4.88%,MYRF;CNTNAP1;ABCA2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.4211414842246393,-0.8819519022636503,0.631578947368421,0.9658615643218746,1.0,10/33,14.46%,IFI6;IFIT2;IRF3;HLA-B;IFITM3;ISG20;XAF1;ISG15;IFIT5;IFIT1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.4211414842246393,-0.8819519022636503,0.631578947368421,0.9658615643218746,1.0,10/33,14.46%,IFI6;IFIT2;IRF3;HLA-B;IFITM3;ISG20;XAF1;ISG15;IFIT5;IFIT1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.36561948960662877,0.8819255821406007,0.5686274509803921,0.9605083969012309,1.0,9/57,7.35%,ITPR1;TRPC4;NIPAL2;LRP2;SLC30A9;RYR3;PSEN1;RYR2;ATP2B2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.39581462114522126,-0.881417040456836,0.5769230769230769,0.966685345281281,1.0,4/27,12.34%,CAMSAP3;HAX1;DBNL;PFN1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.4166721842328112,-0.8812211639248054,0.6296296296296297,0.9664923416079839,1.0,3/32,14.06%,CHAMP1;CHMP2A;SPDL1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.5554165989346793,-0.8809504177196644,0.6041666666666666,0.9664264688291572,1.0,1/7,1.12%,PPT1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.4651964106221636,0.8807465471881264,0.6458333333333334,0.9622268923569639,1.0,4/15,17.44%,SLC6A6;SLC22A4;SFXN3;SLC6A1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.3841820022782555,-0.8805336748371924,0.7457627118644068,0.9666777105310613,1.0,5/29,10.96%,SH3GL2;SEMA5B;HSP90AB1;FLRT3;SEMA5A
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.4645203828445641,-0.8804990799948885,0.6739130434782609,0.9661428862226662,1.0,5/14,9.44%,LRRC8D;ARL6IP5;SLC1A6;PRAF2;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5612837961790917,0.8801506352657327,0.6739130434782609,0.9628579285635874,1.0,1/5,22.42%,ULK2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.3787030736001614,0.8801408538437023,0.72,0.9623096467620221,1.0,4/39,8.86%,RAB3A;RAB10;RAB8B;TANGO2
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.2660891235881102,-0.8799453889113286,1.0,0.9667486302232247,1.0,197/1410,14.17%,NR0B1;SOX4;GMEB2;ZNF488;ZBTB32;SIRT2;JUN;SALL2;BTG1;ILF2;POLR2L;DACH2;SFR1;ASCL1;OLIG1;SOX21;E2F5;ZNF114;CALR;ZNF426;PRRX1;ATF4;ZNF658;OLIG2;ZNF460;ZNF491;ESRRB;HES6;ZNF12;TCEAL7;SAP18;ZNF22;NKX2-2;ZNF821;MYT1L;HES5;ZNF333;ZNF688;MT3;HSPA8;ZNF92;RHOG;PHF1;WIZ;SPIN2B;JMJD6;PRICKLE1;HDGF;ZNF761;ZNF300;DHFR;NR2F6;PAX8;E2F4;ELOC;SFRP1;ZNF699;BAMBI;EID1;ZNF257;WTIP;ZFP90;WBP2;RNF6;SLC2A4RG;DRAP1;ZNF582;PHB2;HNRNPAB;ZNF584;SMARCA5;ZNF558;PA2G4;ZNF117;ZNF525;QARS1;ZNF317;MED29;DPF2;YWHAQ;TAF7;ZNF726;MED23;EDF1;FADS1;IRF3;SCML1;LBH;ZNF649;CBX5;MLF2;CCNK;ZBTB49;ZNF676;ZBTB33;WNT5A;RRP8;LIMS1;CREBZF;MED30;NACC1;SET;CHD3;ATXN7L3;CNBP;ZNF124;RPL6;ZNHIT3;RBM15B;DACH1;ZNF446;NAT14;HNF4G;ZBTB21;NR2E1;ZXDB;MEOX2;CREB3;ENY2;DDX5;RING1;ZNF260;RFX5;CAND2;ZNF614;ATMIN;TRAPPC2;ZNF677;ZNF701;PHF6;POU3F2;JUND;MZF1;AFAP1L2;BRD7;SOX8;MYNN;LITAF;HES4;ZNF337;ZNF77;ASCC2;USF2;RXRB;RNF187;NPM1;ZSCAN21;ZNF48;POLR2K;YBX1;ZNF32;MYBBP1A;ZBTB14;ZNF454;CDKN1C;IKBKB;ZNF791;ZNF320;CCNL1;PRMT6;SAP30;RBM23;ZNF740;ZNF304;BMP2;YAP1;HIC2;ZNF596;TCEA2;PPP2R1A;TFEB;ZNF302;ZFPL1;ZNF384;BRD3;SMAD3;HDAC3;QRICH1;ZNF711;ZNF808;NFE2L1;ZNF665;SRSF10;ESRRA;BAHD1;ZNF746;GTF2H2;ZNF480;NONO;ZNF667;KMT2B;ZNF567;ZNF239;ZNF212;SNX5;RGMB;AKAP17A
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.4525508328854322,-0.8799385178021993,0.6037735849056604,0.9661701208648972,1.0,3/19,7.18%,PPP1R35;TIPRL;PPP1R11
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5570289326259157,0.8799211109671801,0.65,0.9621956602906995,1.0,2/5,34.52%,SLC8B1;PLN
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.43232083912860353,-0.8796952981054494,0.5818181818181818,0.9661615754795142,1.0,2/23,6.68%,GSTP1;DNAJA1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.4935092458621098,-0.8793891034289665,0.6410256410256411,0.9661214352031983,1.0,1/10,2.40%,ACTG1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.5034991974717858,0.8791008810292673,0.6851851851851852,0.9631008345906579,1.0,2/10,7.78%,NAA50;NAA16
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.4324435636250845,0.8789338768687377,0.625,0.9628928636019584,1.0,10/25,20.31%,GRIN1;TMTC2;LETM2;CNNM2;SLC12A1;SNCA;SLC8A1;FAM20A;ANK3;SLC12A5
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.407810493388497,0.8788848679903368,0.6341463414634146,0.9624570129317597,1.0,12/28,21.45%,PARN;CCT8;TNKS;ATM;CCT6A;HMBOX1;MAPKAPK5;NEK7;NAF1;MAPK3;MAPK1;ATR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.5772592569625775,-0.8788435341548969,0.717391304347826,0.966769918016053,1.0,2/5,11.23%,WNT5A;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5059944579657789,-0.8780889044280198,0.6458333333333334,0.9676953861546157,1.0,3/11,20.62%,CAV1;PPP2R1A;ADIPOR1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.5157376551145811,-0.8780408549494254,0.68,0.9672442637631331,1.0,4/8,16.90%,AGA;PARK7;NGLY1;MAN2B1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.42385617038963064,-0.8778607749099054,0.6122448979591837,0.9670900563329535,1.0,5/20,20.19%,PEX11A;MFF;FIS1;ABCD2;ACOT8
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.5498757514284203,0.877688456786815,0.6888888888888889,0.964465291881746,1.0,2/6,12.13%,TLK1;PADI2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.6387724432119208,-0.8769223069888891,0.75,0.9683223992009155,1.0,2/5,8.37%,TLR1;LYN
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.4934475220941694,-0.8768902168821545,0.6610169491525424,0.9678024481274815,1.0,1/12,1.50%,GDE1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3769087498249985,0.8768724069048329,0.6296296296296297,0.9656415409130482,1.0,13/38,24.49%,NEDD4L;SLC4A4;AQP4;KLHL3;PPARG;SLC4A8;TENT4B;ABHD8;TLCD3B;PNPLA2;FBXW7;THADA;ADCK1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3905328972597432,-0.876823274098174,0.6976744186046512,0.9673083117764893,1.0,7/31,19.51%,RPS19;LYN;SLC25A5;UFL1;HSPA9;RPS14;LYAR
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.42713347286902115,-0.8765912877588067,0.6410256410256411,0.9672299242084135,1.0,3/32,6.57%,CHRNA4;C12ORF57;MAGT1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.4647266956065006,0.8763141726806771,0.7037037037037037,0.966320072316463,1.0,4/16,9.39%,DNAH7;ODAD4;CCDC39;DNAH5
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5194030096822633,0.8762912146686903,0.6727272727272727,0.9657781777051845,1.0,1/11,1.52%,CHST3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4260574645618045,0.8762613171370106,0.7073170731707317,0.9652485937474645,1.0,4/20,8.30%,HEY2;PKP2;TGFBR3;PROX1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.39470471442857835,-0.8762592459887257,0.7045454545454546,0.967421937976276,1.0,11/49,16.62%,BTC;SH3GL2;IFI6;DUSP3;RNF126;SPRY1;AFAP1L2;CDC42;TGFA;NEU3;AKT1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.41854904476009436,0.8757176785313755,0.6170212765957447,0.965827060744649,1.0,3/22,9.03%,KCNJ11;RAB11FIP5;BMP8A
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.4116936277234475,0.8754966286864871,0.6170212765957447,0.9657116573786485,1.0,6/21,28.23%,SNX25;AP2M1;ZNRF3;CLTC;NEDD4;KIF16B
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.5099867681392111,-0.8745219151158755,0.6727272727272727,0.970604094979166,1.0,1/7,4.31%,ZNF830
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.44291292845773383,0.8745210914601635,0.6610169491525424,0.9673370439441021,1.0,5/21,22.07%,KDM7A;KDM6A;KDM2B;KDM4C;KDM3A
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.4181207606722304,-0.8740864682130141,0.6909090909090909,0.9709758797607444,1.0,5/18,13.37%,SIRT2;RRP8;CENPV;BEND3;BAHD1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.474702607896529,0.8739296063983806,0.6346153846153846,0.9680645058273896,1.0,3/6,19.80%,NRG1;AKAP13;CBY1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5015541726723327,0.8738425587985046,0.603448275862069,0.9676863179740766,1.0,4/13,29.54%,INTS10;INTS6;INTS3;INTS12
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.2819609586134194,-0.873623863009798,0.8378378378378378,0.9714036804098379,1.0,46/321,13.72%,NR0B1;SIRT2;JUN;ASCL1;CALR;ZNF658;ZNF12;TCEAL7;SAP18;MT3;HSPA8;PRICKLE1;SFRP1;EID1;PHB2;PA2G4;QARS1;DPF2;YWHAQ;TAF7;SCML1;LBH;CBX5;ZBTB33;WNT5A;LIMS1;CREBZF;NACC1;SET;RBM15B;DACH1;ZBTB21;COPS2;RING1;BRD7;SOX8;MYBBP1A;ZBTB14;CDKN1C;PRMT6;BMP2;HIC2;HDAC3;BAHD1;ZNF746;NONO
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.5688743132390804,-0.8726253075382697,0.7222222222222222,0.9729346121393952,1.0,4/6,38.51%,CMPK1;AK8;AK5;AK9
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.480384466275225,-0.8725689424867533,0.6956521739130435,0.9724457187218556,1.0,5/15,19.71%,WBP2;CAV1;YAP1;CATSPERD;ABHD2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.46695086508715783,-0.8724442059650972,0.673469387755102,0.9721390531382684,1.0,5/14,13.89%,SLC30A10;ALOX5;SLC25A33;SPHK2;PARK7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.4858979833325521,-0.8720901152592456,0.7,0.9722458741543467,1.0,1/11,2.58%,ACTB
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5647712558178175,-0.8720217134009076,0.6590909090909091,0.9717958300924188,1.0,3/5,7.01%,GSTP1;PPIA;QARS1
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.33681831836733206,0.8716984340278818,0.7692307692307693,0.9716495438422975,1.0,12/98,7.41%,AHR;MLANA;CHST3;SRPX2;SOX9;SRPX;TIMP3;PRKCA;FKBP9;TEAD1;SASH1;SH3PXD2B
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.42261181687359084,0.8716825836265967,0.660377358490566,0.9711012506881157,1.0,2/24,4.78%,SCEL;BCR
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.5548912543977025,0.871469305307381,0.660377358490566,0.9709773222610593,1.0,1/5,3.20%,TMEM14A
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4296820679188194,-0.8710811917072561,0.6304347826086957,0.9732968427379736,1.0,4/25,7.01%,GSTP1;PPIA;DUSP3;QARS1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.38798199828451824,-0.8710015307481284,0.6545454545454545,0.9728467066196335,1.0,7/32,13.09%,ODC1;TMEM9;LDLR;VPS35;HSP90AB1;FURIN;PM20D2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.5611817703096338,0.8708830160351683,0.6909090909090909,0.97143942682926,1.0,2/6,16.54%,ME2;ME3
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.4814753632995981,0.8707188962691922,0.5686274509803921,0.9712574707331671,1.0,3/10,11.57%,GRM3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.39003116798622944,0.8704122291861212,0.6666666666666666,0.9713074892873561,1.0,5/34,9.68%,WNT7A;PHACTR1;SHANK3;DLG4;MAPK8IP2
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.4136166132550022,-0.8703332277569644,0.6666666666666666,0.973814507837617,1.0,4/24,12.43%,PIGO;DPM2;GPAA1;PIGF
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3633402245942848,-0.8701949612235544,0.7446808510638298,0.9735206097921277,1.0,3/38,4.39%,CFL1;SVIL;MSRB2
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.4565500727915721,-0.869821638035277,0.673469387755102,0.973757163412588,1.0,5/10,22.14%,SMPDL3A;ENPP3;ENTPD5;ENPP1;ITPA
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.327293706842676,0.8698027136822829,0.7017543859649122,0.9720117797016732,1.0,18/93,18.74%,MSL3;BAZ2A;HDAC4;MRGBP;EYA4;EYA1;NAA50;SIN3A;PADI2;EYA2;MORF4L2;TRERF1;NEK11;HLCS;UHRF1;USP36;NSD3;ATXN7
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.36588457863274476,0.8697865278172514,0.6530612244897959,0.9714536456102054,1.0,9/56,11.51%,YWHAH;ALK;TIAM1;MMD2;NRCAM;MMD;HES1;BMP7;SIN3A
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.41446177697396663,-0.8693981913399734,0.5769230769230769,0.9739747312779112,1.0,2/26,3.62%,RPL10;PCIF1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.3556037543039041,0.8688543519820114,0.7017543859649122,0.9728626260230374,1.0,14/73,12.68%,MLANA;LIFR;EDNRA;KIAA1217;SVEP1;LAMA2;TIMP3;FKBP9;SASH1;PLSCR4;PAMR1;GJA1;ABCA8;NOS1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.3601848584126115,-0.8688406992498766,0.6346153846153846,0.9744598732705926,1.0,10/52,16.16%,CALM1;SVIL;MAP10;CALM3;GIPC1;CENPV;KLHL9;CDC42;ENTR1;ZFYVE26
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.31996886824530246,0.8687519378363835,0.7735849056603774,0.9725300793423467,1.0,17/118,14.87%,RASGRF1;EFNA5;TBC1D10B;RGS7;PLXNA4;DOCK11;DOCK8;BCAS3;RAP1GDS1;EPHA4;PLXNA1;PRKG1;SIPA1L1;ASAP3;SEMA4D;ZC3H15;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.324805695669371,-0.8687180579569721,0.6818181818181818,0.9741413974594395,1.0,8/76,8.01%,SIRT2;ODC1;TMEM9;VPS28;RAB26;EEF1A1;TIPARP;WNT5A
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.42521069437059184,-0.8686697495855991,0.6875,0.9736739988317784,1.0,2/16,5.88%,HES5;C12ORF57
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.38685456132441026,-0.868535020054601,0.6818181818181818,0.9733501694463961,1.0,2/31,4.65%,APEX1;PARP1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.504743915442555,-0.8684320557025883,0.574468085106383,0.9729956646026938,1.0,1/7,1.09%,ASCL1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5584564614201836,0.8682769175226367,0.6470588235294118,0.973012461832075,1.0,4/5,35.09%,PDPN;CLASP1;DDR2;CLASP2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.6124752009256482,0.8681784450862585,0.7391304347826086,0.9726802194972509,1.0,2/6,12.13%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.4599829835793859,0.8681317594448936,0.6346153846153846,0.9722271987622985,1.0,2/14,9.48%,ADAMTS9;FBXO6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.41742028575327467,-0.8680687192146058,0.6041666666666666,0.9731570133208185,1.0,5/32,10.41%,BTC;SH3GL2;DUSP3;RNF126;SPRY1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36539605481786686,0.8674891365721654,0.6363636363636364,0.9730087707816989,1.0,19/66,22.34%,DOCK11;PLEKHM1;RIPOR2;WASHC1;BCAS3;CCP110;P2RY12;TENM2;CDC42EP4;CDC42EP3;BBS4;ARHGAP35;TAPT1;PLPPR5;ANLN;PIK3CA;ABI2;KCTD17;PALM
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.4937460446948683,-0.8674558577160077,0.6976744186046512,0.9738767208001825,1.0,1/7,5.35%,LIN7C
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.4415570704366887,0.8673015211440757,0.54,0.972821198992173,1.0,3/16,10.66%,PLEKHM1;ARHGAP24;P2RY12
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4944903514960401,0.8669090801265883,0.7346938775510204,0.9731407133863905,1.0,3/14,6.09%,PYGB;PHKG1;PYGL
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.5126175150541625,-0.8668581425341769,0.6481481481481481,0.9745459372332166,1.0,3/8,16.62%,DUSP3;FGL1;AKT1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.47508570997959626,-0.8668413603287229,0.5849056603773585,0.9739870116138758,1.0,3/7,12.48%,SIRT2;RRP8;BEND3
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.5629793338636296,0.8665990573572195,0.6595744680851063,0.9731605166213196,1.0,1/5,15.86%,MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.43528693364567506,-0.8665657688645186,0.6086956521739131,0.9739243539174357,1.0,1/18,0.44%,CUL7
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.39259134862750733,0.8663557579561508,0.75,0.9730652355314185,1.0,14/38,24.13%,GADD45A;RAD9A;FBXO6;CDC5L;ATM;TP53BP1;CLOCK;DONSON;MYO6;ATRX;ATR;USP10;HINFP;ABL1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.5546591710798843,0.8662562776199407,0.6825396825396826,0.972740079876427,1.0,2/7,27.97%,KCNMA1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.3840280449222101,-0.866208489134721,0.6470588235294118,0.9740351241981743,1.0,9/32,23.11%,GABARAPL2;DYNLL2;PFN1;DNAJC24;DYNLL1;CHTOP;MSH3;RGN;SETMAR
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.4559523286013563,0.8661866742537273,0.6666666666666666,0.972300380805735,1.0,2/18,3.08%,GLRA1;CFAP69
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.3713456631464136,0.8659049142141024,0.6833333333333333,0.9724010319740558,1.0,10/45,15.91%,ROBO2;PAK1;TIAM1;PLXNA4;PAK2;EPHA4;PLXNA1;SIPA1L1;TIAM2;ARHGAP35
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.39063968700306717,-0.8656492115718936,0.723404255319149,0.9747830638018934,1.0,10/33,16.65%,CFL1;AIP;PPIA;RPLP0;IL12RB2;CDC42;TALDO1;HSPA9;HNRNPA2B1;MSN
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.4960849278713505,-0.8656019216260318,0.6595744680851063,0.9742995491304428,1.0,3/9,11.88%,PPCS;ACLY;PDHB
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.34596325923165894,-0.8655865400913105,0.7083333333333334,0.9737300988825968,1.0,2/36,4.65%,APEX1;PARP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.42154665654107526,0.865480363494246,0.7291666666666666,0.9727081883028073,1.0,4/18,13.94%,SPRED2;EFNA1;USF3;OVOL2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.4275519957626608,0.8651501979765087,0.6909090909090909,0.9727912735033778,1.0,8/19,20.94%,TTN;RYR2;TPM1;NOS1;SLC8A1;KCNQ1;DMD;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5046211911636586,0.8650969015808954,0.7254901960784313,0.97235257595917,1.0,2/12,14.41%,CDKN2A;CAMK2N1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.361937070463506,-0.8648138304017831,0.8035714285714286,0.9748597943977299,1.0,6/47,8.43%,ZFP36L1;SFRP1;ASAH1;SMPD1;CACTIN;HAS2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.41530979759211284,-0.8647129301987486,0.7446808510638298,0.9745314201023068,1.0,2/16,4.33%,FERMT1;CAMSAP3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.46437037717612806,-0.8645010875076933,0.7083333333333334,0.9743576607580899,1.0,2/14,10.04%,OAT;AADAT
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.5772667532223309,0.8642152868965822,0.6744186046511628,0.9736962500914675,1.0,4/6,41.26%,MYO7A;NRXN1;CDH23;SHANK1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5361353077158292,-0.8641452930925746,0.6666666666666666,0.9745786744054089,1.0,3/6,13.33%,SIRT2;RCC2;CDC42
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4939115932494388,-0.8640368612653763,0.6666666666666666,0.9742510619889744,1.0,4/11,7.43%,ITM2A;ITM2B;SOAT1;ITM2C
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.5208775457778734,0.8639907573671587,0.7333333333333333,0.9735953756109268,1.0,2/9,8.68%,ANGPTL4;RORA
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.5286866607947679,0.8638848353714254,0.6666666666666666,0.973225650658859,1.0,2/5,17.89%,AGTPBP1;STAT3
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.35872920151291215,-0.8637081455266318,0.6326530612244898,0.9742933022447102,1.0,15/61,16.58%,E2F5;PARP1;PIF1;RCC2;SET;RFWD3;NCL;PHF6;NPM1;BEND3;MCM4;PPAT;KNTC1;ERCC6L;DNMT3B
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.47291965794123136,-0.8633388385680097,0.6590909090909091,0.9744401087789129,1.0,2/8,7.41%,B3GAT2;XYLT2
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.5269075784688587,0.8633192126528374,0.717391304347826,0.9737714603710613,1.0,2/8,8.74%,SEMA3A;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4135298010672542,0.8630390431751824,0.6551724137931034,0.9737507434789147,1.0,3/22,10.66%,EDNRA;NTRK3;P2RY12
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.4465982873764528,-0.8629396742464124,0.58,0.9746666921921217,1.0,3/13,12.41%,SMC1A;REC8;DSCC1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4211935738534165,-0.8628882764406476,0.6122448979591837,0.974210735845755,1.0,5/27,12.83%,PPT1;CD63;ATAD1;CLU;B2M
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.5018717283486881,-0.8622022366581159,0.6792452830188679,0.9750023289681542,1.0,4/11,20.15%,AEBP1;SLC2A10;LRP1;DDR1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5144716682876695,-0.8620138528933708,0.6595744680851063,0.9748413990553045,1.0,2/7,18.05%,CADM4;EPN2
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.3633051329642983,0.8619735029905813,0.6666666666666666,0.9753353200564866,1.0,7/36,10.58%,ROBO2;ITGA8;PRKX;ZBTB16;PROX1;BMP7;SULF1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.31709636752448395,-0.861819737776574,0.78,0.974643848940494,1.0,21/141,14.39%,GSTP1;RHOC;GAPDH;S100B;TMEM9B;PLEKHG5;MALT1;WNT5A;CACTIN;UFL1;TRAF5;SPHK2;LITAF;DDX1;IKBKB;TSPAN6;TRAF4;LAMTOR5;WLS;PELI1;IFIT5
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3623385595403574,-0.8617761564347577,0.6739130434782609,0.9741828665497088,1.0,8/47,14.86%,NUP42;COX7A2;SLC25A33;NUP155;SPHK2;BEND3;FIS1;PGAM1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.486108688584473,-0.8615273891812923,0.6792452830188679,0.9740962539354555,1.0,1/13,1.04%,PIWIL2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.38554494107044623,-0.8613849522870148,0.7058823529411765,0.9732133220655725,1.0,5/25,13.20%,ALOX5;ATRAID;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.38554494107044623,-0.8613849522870148,0.7058823529411765,0.9732133220655725,1.0,5/25,13.20%,ALOX5;ATRAID;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4756282186065982,0.861021466874289,0.6346153846153846,0.976723927079407,1.0,1/10,6.47%,TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.5492468048694112,-0.86090895053953,0.72,0.9735801153239263,1.0,1/5,3.91%,PPIA
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4216076398351959,-0.8608421162213176,0.6304347826086957,0.9731517117150233,1.0,2/26,3.43%,SIRT2;HNRNPA0
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.39649159611514556,0.8606454878677583,0.6458333333333334,0.9769069400614683,1.0,12/34,24.49%,FABP3;ABCA2;PRKAA2;PPARG;PRKAA1;ABHD8;TLCD3B;APOE;PNPLA2;FBXW7;THADA;ADCK1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3853773879280395,0.8605655728964955,0.6956521739130435,0.9765251718883505,1.0,1/29,0.66%,ZNF385B
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.41381714467676,-0.860515919677839,0.6862745098039216,0.9732431593272516,1.0,4/28,7.95%,THY1;CALM1;SRI;CALM3
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.4413945500011459,-0.860451653818276,0.6545454545454545,0.9727849363678013,1.0,2/15,4.32%,CHRNA4;SYT11
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.4161375998255058,-0.8602798507132472,0.6136363636363636,0.9725713635624492,1.0,3/20,6.96%,SOX4;HES5;PTPRZ1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.5317366222345314,-0.8602334659323776,0.6444444444444445,0.9720896906866306,1.0,1/6,5.20%,NABP2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.38624485306041245,-0.8602290026552556,0.7358490566037735,0.9715232565407652,1.0,6/38,11.92%,THY1;SLC30A10;ALOX5;LYN;CLU;YBX1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.5131716211631877,0.8601785591356155,0.6666666666666666,0.9768277742719944,1.0,3/7,13.67%,P2RY12;MTUS1;CSF1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.454797171088264,0.8599685223719765,0.6206896551724138,0.9766572512770564,1.0,2/9,4.88%,CNTNAP1;ABCA2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3864606319567506,0.8597206075378002,0.7333333333333333,0.9765381615632059,1.0,6/29,9.02%,RELN;CAMK2B;EFNA1;SRCIN1;EPHA4;SHANK3
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.45653573473618786,-0.8594340295289473,0.6363636363636364,0.9725108821132143,1.0,1/8,5.44%,PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.37037915936524646,-0.8593735083183643,0.6724137931034483,0.9720605447392742,1.0,14/59,18.30%,BTG1;S100A1;VEGFB;WNT5A;EMC10;HIPK1;SEMA5A;GRN;ZNF304;STIM1;RAPGEF3;BMPER;PKM;CHRNA7
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.48543203370624854,-0.8591227809798576,0.6530612244897959,0.9720366554175616,1.0,4/15,18.85%,GAPDH;NLRP1;ATN1;ERBB3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5130771963352906,-0.8591100254254339,0.6153846153846154,0.9714776790713808,1.0,3/7,22.63%,BMP2;SOX6;GREM1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.4148163002470162,0.8589480516104789,0.72,0.9776083004239959,1.0,4/22,12.09%,NUAK1;CDKN2A;CDK6;AKT3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.41472441866026977,0.8587982670933297,0.7692307692307693,0.977380759809584,1.0,6/33,13.68%,PTPRC;NLRC5;SLIT3;PADI2;CCDC3;STAT2
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.42042395214059625,-0.8585809300164386,0.62,0.971940343856272,1.0,2/20,3.85%,BTG1;ZFP36L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.4212420665727299,-0.8581919403559078,0.6458333333333334,0.9721655877162455,1.0,4/21,7.95%,CALM1;P2RX4;SRI;CALM3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.4059605522682479,-0.8581913206673495,0.6521739130434783,0.9715893188438589,1.0,6/26,9.67%,CALM1;TIPRL;PPP1R11;PPP1R15B;CALM3;HSP90AB1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.466285393304685,0.858131491099526,0.6428571428571429,0.9781650239439148,1.0,2/12,11.22%,NEIL2;NEIL1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.45005372276743727,-0.8578942811166619,0.7083333333333334,0.9715961116824462,1.0,3/14,12.42%,THY1;P2RX4;CAV1
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.4322414324408982,0.857604690982814,0.6590909090909091,0.9787552734049877,1.0,3/16,5.83%,HEY2;SLIT3;EFNA1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2747361248713663,-0.8575895862915783,0.975,0.9716999021642462,1.0,93/661,14.24%,SOX4;GPX1;ZNF488;BTG1;ASCL1;SOX21;ZNF114;CALR;ATXN7L3B;ATF4;ACTG1;ZNF460;ESRRB;HES6;ERMAP;ZNF22;FAM50A;STOX1;ZFP36L1;MT3;SH3GL2;ZNF92;PHF1;SPIN2B;CDH3;RPS7;RPL23;SFRP1;ZNF257;PCBP3;WNT3;WTIP;RNF6;SLC2A4RG;DRAP1;VPS35;HNRNPAB;TIPARP;ZNF117;ERP29;PDCD5;MED23;EDF1;FADS1;ATRAID;MLF2;ZNF676;WNT5A;LIMS1;CACTIN;LYN;CHD3;PCBP4;RPL11;CNBP;RPL6;ZNHIT3;NGF;FN1;TRAPPC2;BTN3A3;MZF1;CLU;ANXA7;ASCC2;RNF187;ZSCAN21;YBX1;MYBBP1A;SAP30;BMP2;YAP1;LRP3;PPP2R1A;NOVA1;TFEB;ZFPL1;RO60;SLC2A10;SMAD3;PCBP1;ZNF711;SRSF10;ESRRA;TDG;RACK1;NONO;LAMTOR5;PARK7;ZNF212;AKAP17A;ANKRA2;RC3H1
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.5229198356315783,-0.857294936631511,0.66,0.9716763251903603,1.0,2/8,13.45%,ZNF830;MCM4
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.30236598161223066,0.8572137897401785,0.9411764705882353,0.9791404937780975,1.0,32/172,17.84%,CARD14;EFNA5;SOX9;EPHA7;BRAT1;AKT2;PAK1;BRD4;TSPYL2;NTRK3;FGF9;TTN;EFNA1;RB1CC1;RIPK1;WDFY2;BMP7;SPTBN4;TNIK;STAT2;PTPN13;SEMA4D;FAM20A;FGF1;ARRB1;CSNK1D;ENG;EIF2AK3;PPP2R5C;ANKRD54;PDE8A;FER
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5326058554237708,-0.8568963802041186,0.6896551724137931,0.9718283909578256,1.0,1/6,11.77%,NPM1
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5531276754956506,-0.8564263027464374,0.7115384615384616,0.9722526217342774,1.0,1/5,4.80%,LPCAT1
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.46055046215585416,0.8562681661224532,0.7142857142857143,0.9805974479931352,1.0,2/12,9.03%,KCNJ11;BMP8A
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.3238881954878591,-0.8561871402644092,0.7959183673469388,0.9721743232872689,1.0,19/111,17.02%,GSTP1;KDSR;GSTM4;LPCAT1;SGPP1;SLC25A15;AKR1A1;ACHE;SPHK2;FURIN;SPTLC1;GAL3ST4;LCAT;SAMD8;CERS2;PLA2G4C;GSTA4;CSNK2A2;GSTM3
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.5354565323697992,0.8557639993462434,0.6363636363636364,0.9811115542973905,1.0,4/6,32.54%,MVK;PHYH;PDSS1;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3496470443663784,-0.8557632888276785,0.7045454545454546,0.9724104552200419,1.0,11/45,17.75%,RAN;BAMBI;RPL11;CAV1;BMP2;B2M;EPB41;LRP1;TRIB3;FLOT1;AMFR
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5122155459541877,0.8555673191836981,0.6086956521739131,0.9809507703129284,1.0,1/7,5.63%,PSEN1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.44792051911274966,-0.8555516156944807,0.6744186046511628,0.9722415351336007,1.0,4/14,23.66%,IRF3;HAVCR2;HSPD1;RIPK2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.5305230650169956,0.855342328789289,0.660377358490566,0.9808524662425729,1.0,2/7,11.57%,WHRN;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.5610499886973606,-0.8551916532005283,0.7083333333333334,0.9724169706607859,1.0,2/5,27.83%,NKAP;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.43708939323406726,0.8549350321840526,0.6888888888888889,0.9811900787643395,1.0,3/26,3.29%,DOCK5;NEDD9;RAC3
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.31951686883314345,0.8546072842766159,0.875,0.981295384005465,1.0,17/92,12.93%,PTPRR;ZMYND8;DUSP22;PTPRJ;PHLDB2;TCAF1;VCL;EPHA4;SULF1;SRGAP3;PTPRU;PTPRG;GJA1;CHRD;TPM1;MAGI2;ACVR1C
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.5144685969678909,-0.8544332605708808,0.6727272727272727,0.9735094090618935,1.0,1/7,0.13%,SOX4
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.39112439113486275,0.8543928513365426,0.7045454545454546,0.9811179059822621,1.0,12/30,21.45%,PARN;CCT8;TNKS;ATM;CCT6A;HMBOX1;MAPKAPK5;NEK7;NAF1;MAPK3;MAPK1;ATR
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.5063297679151223,-0.8543434671139162,0.6666666666666666,0.9731773107719032,1.0,2/5,16.17%,CAV1;WNT7B
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.4478956387580278,-0.8542648834153891,0.7142857142857143,0.9727612230276158,1.0,5/13,19.71%,GDE1;ENPP6;PLA2G4C;GPCPD1;ABHD2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.4736242303759786,0.8542195299942478,0.6923076923076923,0.9809123833294014,1.0,2/10,11.23%,SNAP25;SLC29A2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.42493761959662957,-0.8541868084498941,0.6666666666666666,0.9724058610501832,1.0,3/25,7.02%,SIRT2;MT3;EDNRB
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5141867865021384,0.8537442361196331,0.6851851851851852,0.9813959952114614,1.0,3/10,6.93%,GRK4;NMT1;CAMKMT
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.46706788624133716,-0.8534988392036456,0.7222222222222222,0.9731706525164983,1.0,5/15,9.43%,BEX3;MT3;DELE1;NGF;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.30841212771220494,0.8534049989705939,0.82,0.9814727211784728,1.0,31/141,17.63%,OTUD7B;ITPR1;TMSB4X;RNF157;PTPRJ;DGKG;CAV3;SPI1;BCL2L2;RIPK1;PDE10A;CYLD;RORA;HDAC7;DUSP1;NMI;BMP7;CIT;ARRB2;UBR1;NLRP12;MAGI2;TNFAIP8L1;PRKAA2;TSC1;PER1;MAPKAPK5;TLE1;PRKAA1;MAP2K3;PPP2R5C
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.3648570678178399,0.8533838668098906,0.5892857142857143,0.9810022610751986,1.0,2/32,2.23%,YJEFN3;SRF
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.2815664216191906,-0.8532132257117987,0.8787878787878788,0.9730922287200426,1.0,57/383,13.72%,NR0B1;SIRT2;JUN;ASCL1;CALR;GAPDH;ZNF658;DBI;ZNF12;TCEAL7;SAP18;PCIF1;MT3;HSPA8;PRICKLE1;DHFR;SFRP1;EID1;PHB2;PA2G4;RPL13A;FXR2;SELENOS;QARS1;DPF2;YWHAQ;TAF7;SCML1;LBH;CBX5;ZBTB33;WNT5A;LIMS1;CREBZF;NACC1;SET;RBM15B;DACH1;ZBTB21;NCL;RING1;EIF4A3;BRD7;SOX8;RAD17;YBX1;MYBBP1A;ZBTB14;CDKN1C;PRMT6;BMP2;HIC2;HDAC3;BAHD1;ZNF746;RACK1;NONO
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.5433868563479495,0.8531953624575653,0.6730769230769231,0.9808311007833204,1.0,1/5,21.93%,MAPT
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.4456023894147715,-0.8531780019987252,0.6136363636363636,0.9725869730314114,1.0,4/12,19.05%,CAV1;IFIT1;FLOT1;MUL1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3210012080366002,-0.8530886692994999,0.6530612244897959,0.9722686044077373,1.0,6/88,5.92%,CDKN2C;BTG1;PPT1;MT3;SFRP1;RNF6
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5537914231070349,0.8528346406433575,0.7291666666666666,0.9810488616456042,1.0,2/5,5.94%,CTBP1;SPI1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.4619761103132768,-0.8527455578678207,0.6595744680851063,0.9724010562817064,1.0,5/17,12.83%,MALT1;WNT5A;TNFRSF14;SPHK2;B2M
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),0.5603246987561071,0.8521415208437711,0.7083333333333334,0.9820490019290411,1.0,2/5,22.63%,CDKN2B;PDK2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5206794723818265,0.85210501396201,0.6818181818181818,0.9815230215200412,1.0,3/10,13.40%,SHANK3;BBS4;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.3529521926370387,-0.8520647125719893,0.7288135593220338,0.9733016652112192,1.0,11/57,12.61%,VBP1;HSPA8;CAMSAP3;LDLR;MID1IP1;LIMA1;CLU;CLIP3;TWF1;PFN1;PFDN1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.33708559749892986,0.8517737107273333,0.7407407407407407,0.9816106574318345,1.0,7/61,9.14%,FAM107A;EFNA5;RAC3;PAK1;BAIAP2;RHOBTB2;ARHGAP17
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.39647573022449745,0.8514693577881906,0.6610169491525424,0.9816925718342002,1.0,7/25,15.32%,RAD9A;FBXO6;CDC5L;ATM;TP53BP1;CLOCK;DONSON
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.45076334355410486,0.8514411606751637,0.6170212765957447,0.9811957905842092,1.0,1/13,2.84%,USP13
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.4725233291424558,0.8512252082572476,0.6666666666666666,0.9810308215764236,1.0,3/13,12.77%,SOX9;GJA1;PIK3CD
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.49597144103677804,-0.8509862503735566,0.6808510638297872,0.9749570833364049,1.0,1/12,1.71%,RAN
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3512959579403397,-0.8509163103042555,0.7083333333333334,0.9745121690131081,1.0,7/52,10.02%,ARPC5;ACTG1;ACTB;LYN;BRK1;HSP90AB1;MYO10
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.4363866383997798,-0.8508762361860106,0.6875,0.9740318239418579,1.0,3/16,7.95%,CALM1;SRI;CALM3
prerank,MSigDB_Hallmark_2020__Apical Surface,0.39424628543832674,0.8503378545129608,0.6862745098039216,0.9822239138436996,1.0,5/31,3.83%,EFNA5;MDGA1;CRYBG1;SRPX;CD160
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3594875442772949,0.8497901241619198,0.7413793103448276,0.9827595219722365,1.0,4/42,8.38%,IGF1R;SOX9;NTRK3;ROR1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5292520837324173,0.8497807492957564,0.6666666666666666,0.982196013072023,1.0,3/8,19.61%,CD160;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.4587160095276404,0.8495830337414193,0.6851851851851852,0.9819916392631183,1.0,6/15,18.83%,ASPA;DDO;AASS;ALDH7A1;SLC25A21;CRYM
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.38432528268806876,-0.8493581144073854,0.5869565217391305,0.9765462403316418,1.0,6/20,21.05%,PEX11A;MFF;FIS1;MUL1;ACOT8;MTFR1L
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.542269907244884,-0.8492358888625684,0.7307692307692307,0.9762867091955365,1.0,2/5,11.88%,DLD;PDHB
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.39025938711735025,-0.8491164986064806,0.6888888888888889,0.9759856114254108,1.0,10/35,16.65%,CFL1;AIP;PPIA;RPLP0;IL12RB2;CDC42;TALDO1;HSPA9;HNRNPA2B1;MSN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5789860895759933,0.8489546977888228,0.7674418604651163,0.9820927368956235,1.0,2/5,17.69%,XRCC3;PCID2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5789860895759933,0.8489546977888228,0.7674418604651163,0.9820927368956235,1.0,2/5,17.69%,XRCC3;PCID2
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.32570950181718983,-0.8486515740391826,0.7962962962962963,0.9762946121975024,1.0,20/118,12.58%,GPX4;PLIN2;CKAP4;ARL4A;ODC1;S100A1;NT5E;SMPDL3A;SYT11;P2RX4;PHLDA1;PRAF2;CD44;GLIPR2;RNH1;DCPS;IFITM3;FURIN;CDKN1C;BMP2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.4427027307685471,0.8486058898590124,0.6212121212121212,0.982213096219277,1.0,5/14,26.08%,PPARG;PNPLA2;NFKBIA;TTC39B;ITGAV
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.5243120588326939,0.8484889520693928,0.6956521739130435,0.9818750540389536,1.0,2/7,8.74%,EFNA1;EPHA4
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.4439439463110768,0.8484669740217031,0.7090909090909091,0.9813474949214598,1.0,1/15,1.79%,RACGAP1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.3784645267515766,-0.8484393317813924,0.6851851851851852,0.976179068301267,1.0,6/40,7.69%,GPX4;GDE1;LPCAT1;FADS1;PLPPR2;SMPD1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.40748874936958995,-0.8480918624443788,0.7142857142857143,0.9762607001838862,1.0,2/14,12.42%,SVIL;CAV1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.34196392048171415,-0.847937604084142,0.7358490566037735,0.9760259614994674,1.0,16/106,12.89%,BTG1;HSPG2;ALOX5;THBS2;SFRP1;VEGFB;SARS1;WNT5A;EMC10;HIPK1;RNH1;SEMA5A;GRN;ZNF304;VASH1;AMOT
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2793369995242672,0.8477859120424767,0.9375,0.982132355501214,1.0,49/316,15.10%,PTPRC;AKR1C2;BCL2L11;IGF1R;SOX9;KITLG;TNFRSF19;AKT2;RELN;LRP2;BRD4;NTRK3;FGF9;LRRC19;PTPRJ;HIP1;SLC38A9;GCNT2;MID2;SASH1;RPTOR;RIPK1;NRG4;TRIM44;ROR1;TIRAP;PTP4A3;TRIM52;SEPTIN4;CD27;ZNF622;NMI;TRAF7;P2RY12;PDPK1;ADGRV1;GJA1;NRG1;CARD11;NLRP12;PIK3CD;NRG2;TAB2;SEMA4D;ZCCHC3;FGF1;JCAD;PLK2;CFLAR
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.37598033497548095,-0.847652979205704,0.7555555555555555,0.975994271745234,1.0,5/38,9.56%,FARSA;WARS2;QARS1;SARS1;AARS1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.44404158726667353,0.8469435345130649,0.6938775510204082,0.9831841128082746,1.0,5/15,29.13%,CECR2;ACVR1C;ACIN1;HMGB2;H1-0
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.37062208207100683,-0.8469307083016026,0.6666666666666666,0.9768447749341572,1.0,13/47,16.51%,GPX1;BAD;ZFP36L1;SFRP1;LIMS1;CDKN1C;GRN;ZNF304;YAP1;B2M;RAB33B;TGFA;CDC73
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.36703440850912206,-0.8468479925750377,0.7258064516129032,0.9764016095148502,1.0,7/37,15.82%,GSTP1;ATF4;PLCL2;NOVA1;FIS1;TFE3;ACOT13
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.5673872566505237,-0.8465582172739219,0.7169811320754716,0.9758202800104343,1.0,3/5,28.71%,DPH2;DPH7;DPH5
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.5673872566505237,-0.8465582172739219,0.7169811320754716,0.9758202800104343,1.0,3/5,28.71%,DPH2;DPH7;DPH5
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.39151676563323945,-0.8464867787305493,0.6595744680851063,0.9753725349328028,1.0,3/30,5.52%,GORASP1;RAB26;GOLGA7
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4902434909107148,0.8463706530589853,0.7,0.9838053311187187,1.0,1/11,6.81%,CDKN2A
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.4768167857214888,-0.8460490633153677,0.7692307692307693,0.9755671770138087,1.0,1/9,0.97%,DNAAF2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.3992705961398947,0.8460394921100373,0.7115384615384616,0.9838351398840492,1.0,6/20,14.09%,PKP2;CAV3;RYR2;CAMK2D;ANK2;DSC2
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.4888681079073549,0.8456910503952589,0.6938775510204082,0.9838983315444761,1.0,2/9,9.05%,GABRG2;GABRA2
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.4806803759467887,-0.8456440012188094,0.6851851851851852,0.9757912921400117,1.0,2/12,8.37%,RARRES2;LYN
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.3073659873973029,-0.8455394731187578,0.8837209302325582,0.9754155784692792,1.0,13/115,8.53%,TUBB2B;ASCL1;OLIG1;OLIG2;HES6;MYT1L;HES5;IER2;WNT3;ITM2C;TUBB2A;WNT5A;RNF112
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3322959912646251,0.8453664852829379,0.7391304347826086,0.9839280533975309,1.0,15/90,16.11%,TMSB4X;BRD4;FOXP1;LRRC19;TYRO3;RIPK1;CYLD;RORA;NMI;MVK;NLRP12;SNCA;AOAH;BCL6;PPARG
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.3669449402631842,-0.8453022617375111,0.723404255319149,0.975265749859014,1.0,2/27,4.73%,SOX4;DDOST
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.3669010183729064,0.8451556539263412,0.7142857142857143,0.9837630315959552,1.0,2/41,1.93%,BCL9;WNT7A
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5203042134146589,0.8447134886311232,0.6304347826086957,0.9841541948630296,1.0,1/6,6.13%,UBR5
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.41847618405273407,-0.8446286998314982,0.66,0.9759580768811499,1.0,1/14,3.88%,NLGN2
prerank,PanglaoDB_Augmented_2021__Basophils,-0.37341816671943506,-0.8443957236446773,0.65,0.9758318118183815,1.0,7/39,9.98%,IGFBP7;GPC4;PLEKHG5;SNCAIP;FADS1;CD44;LAMA5
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.3934100399281546,-0.8443178189768998,0.7272727272727273,0.9754450987314381,1.0,4/20,9.19%,ARL6IP5;SLC1A6;PRAF2;SLC7A8
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.4324431076513185,0.8441781147204651,0.7017543859649122,0.9846727200596634,1.0,5/14,12.50%,BAG5;NLRC5;EMP2;ATM;HMBOX1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.36634765770428124,-0.8440035423109136,0.6923076923076923,0.9754139828671314,1.0,2/37,3.85%,POLR2G;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.5247783182535024,0.843996460570735,0.7647058823529411,0.9844298052670374,1.0,4/5,40.74%,F8;F3;KLKB1;A2M
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.44070647814944264,0.8438490492316583,0.6666666666666666,0.9841316613425979,1.0,3/11,17.69%,NUP93;THOC2;PCID2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.5024140054295827,0.8434378493845203,0.7692307692307693,0.9844939906436285,1.0,1/7,7.38%,VCL
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.3941338336496587,0.8433661393579336,0.6744186046511628,0.9840797202347789,1.0,7/27,19.71%,ITGA8;PROX1;SULF1;IFT27;CEP290;AGT;PYGO2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.3698695385993491,0.8432044266134648,0.7058823529411765,0.9838321513752164,1.0,8/40,11.93%,RAC3;PTPRJ;PRKCA;EPHA4;ATM;P2RY12;CHRD;TPM1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.4573370014572158,-0.8431410525169898,0.6470588235294118,0.9765187269060523,1.0,3/15,16.82%,CHMP2A;SMPD3;SNF8
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.42616134014960944,0.8430827524205001,0.673469387755102,0.9835848630469397,1.0,3/17,10.69%,EDNRA;ADCY5;ADCY3
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.4187610042326305,0.842694134260277,0.7083333333333334,0.9838636594969108,1.0,4/26,14.77%,RRH;GADD45A;RAD9A;CLOCK
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.3620774804199754,0.8425425981616222,0.6875,0.9835668483451464,1.0,3/36,5.30%,ADAMTS13;ENPP2;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4152134788066995,0.842405086688423,0.7407407407407407,0.9833146011565439,1.0,5/21,13.41%,CRLF1;HES1;IL6ST;IL6R;PARP9
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.5420104130108412,-0.8423652000149036,0.7142857142857143,0.9775926335880677,1.0,1/6,1.43%,PLIN2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.44007844201408053,-0.842186375760021,0.7073170731707317,0.9774776074717737,1.0,5/12,19.69%,PPIA;CDKN2D;POLD3;POLD2;RFC3
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.4917176906711682,0.8421721665208965,0.7142857142857143,0.9831510455583938,1.0,2/9,12.07%,ITPKB;ITPKC
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.5371190228390642,0.8420513614184625,0.7142857142857143,0.9828109618545544,1.0,3/5,22.62%,CA2;PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.4130095201495198,-0.8420373549058996,0.6964285714285714,0.977285942333345,1.0,6/25,16.62%,GAPDH;MT3;TIMP4;TIMP2;TIMP1;AKT1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.30347826693147256,0.8417399147385439,0.8461538461538461,0.9828741609184048,1.0,31/151,18.38%,CARD14;HDAC4;SRF;ALK;CAMK1D;RELN;NLRC4;IRAK2;FANK1;MID2;RIPK1;ROR1;TIRAP;TRIM52;ERC1;STK3;TAB1;CARD11;TP53BP1;TAF1;TAB2;CLOCK;CFLAR;PRKCZ;PPARG;PPARGC1A;ADCY1;FER;STAT3;CRTC1;CRTC3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.5141467687859456,0.841726641463711,0.6521739130434783,0.9823801680306288,1.0,2/6,32.66%,NTNG1;PXDN
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4693923671760013,-0.8413282627435239,0.6595744680851063,0.9780565422493015,1.0,3/19,12.77%,SYT11;ERP29;PNKD
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4532382514667941,-0.8410074536976808,0.6666666666666666,0.9781302064439602,1.0,3/10,14.01%,FUZ;SPRY1;GPC1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.4133435360838415,0.840934028953997,0.6949152542372882,0.9833531729897886,1.0,4/25,5.29%,CABYR;DNAH7;ODAD4;CCDC39
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.44241148934706853,0.8405579999401545,0.6744186046511628,0.9835812543443934,1.0,5/11,27.07%,SLC39A11;SLC9B2;C3P1;PAH;PHYHIPL
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.43021961551017973,0.8404061535496186,0.7058823529411765,0.983274926588812,1.0,5/16,17.50%,CDYL;YTHDC2;BBS4;MEIOC;SYCP3
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.42188588922789116,0.8402222803770286,0.68,0.9830735126191862,1.0,3/15,7.58%,ALG6;DPAGT1;DHDDS
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.4416360540568016,0.8399034820762281,0.7068965517241379,0.9830593431922434,1.0,1/12,2.86%,KCNJ11
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.4017669449648321,-0.839878714204825,0.6904761904761905,0.9797837303429477,1.0,3/28,10.49%,NCSTN;APH1A;HM13
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.35307964590020524,-0.839643989865737,0.8,0.9797090179053314,1.0,14/50,22.10%,H1-4;SMARCA5;SET;NPM1;RNF8;H2AX;H1-10;SMARCD1;PAF1;H3-3A;ZNHIT1;KAT6B;ANP32B;ASF1A
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.48802371214905166,0.839384535779827,0.74,0.9835124713749039,1.0,3/12,7.67%,PKIG;PRKAR1B;PRKAR2A
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.40705788080751504,-0.8393326992861441,0.7169811320754716,0.9797050538165777,1.0,3/23,11.44%,ERN1;VEGFB;GAS1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.3798181329740825,0.8390347906345044,0.6545454545454545,0.9835255428391654,1.0,3/34,2.79%,EFHC1;RACGAP1;SEPTIN6
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.33403604617223687,0.8389537001252134,0.803921568627451,0.9831047905081882,1.0,17/90,12.18%,PCLO;NEDD9;FMNL3;RAC3;CNTNAP1;CDC42BPB;CECR2;MICAL2;ZRANB1;RANBP9;SPRYD3;RHOBTB2;BRWD3;MAST4;TNIK;TPM1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.38493889013077576,-0.8387965633562362,0.6981132075471698,0.9802307578782024,1.0,4/27,5.65%,NCSTN;MT3;MID1IP1;APH1A
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.5152285739278206,-0.8386571247259723,0.6530612244897959,0.9799500554412761,1.0,2/5,23.37%,AKT1;PPARA
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.499452618971224,0.8385127515204512,0.6607142857142857,0.9833924847638477,1.0,1/7,7.89%,RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.303567485972051,0.8383962208421994,0.86,0.9830381004236604,1.0,32/129,23.23%,HEY2;FOXP1;PSEN1;SPI1;AGO1;DLG4;TAF1;PARP9;CCDC3;PRKAA2;ZNF148;OVOL2;WWP2;AGO4;ENG;ADAM10;PRKAA1;PICALM;ATXN2;SFMBT2;ROBO1;TNRC6C;TNRC6A;MAPT;SLC24A3;PARP14;APOE;CNOT7;NFKB1;FBXW7;PC;SETDB1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.4622057272561216,-0.8383411861414968,0.717391304347826,0.9799577165995738,1.0,1/11,1.43%,PLIN2
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.3213528992993453,-0.8378096295121453,0.7,0.9804353707027936,1.0,11/82,11.66%,TUBB2B;BCAN;GNG3;NLGN2;LINGO1;HPCA;CADM4;TMEM179;NCAN;CLIP3;BRINP1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.5944939969829015,0.8377730963209803,0.7924528301886793,0.983725696482878,1.0,2/5,19.61%,PPARG;PDCD4
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.5055438257752642,-0.8377670319991075,0.5777777777777777,0.9793703454229993,1.0,3/5,17.17%,NCOA4;MSN;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.5055438257752642,-0.8377670319991075,0.5777777777777777,0.9793703454229993,1.0,3/5,17.17%,NCOA4;MSN;AR
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5157225333674045,-0.8368217365487401,0.7105263157894737,0.9806568751720022,1.0,2/9,10.15%,UGDH;MKKS
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.3864936116070046,0.8364507169713132,0.717391304347826,0.9857822572705655,1.0,4/24,12.96%,SYT1;RAB29;DLG4;SNCA
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.4562862166870326,0.8362675755516461,0.6666666666666666,0.9856625922595432,1.0,3/13,13.40%,TMEM201;DOCK7;FBXW11
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.4725490865044598,-0.8362519143459574,0.75,0.9811447585543561,1.0,2/10,3.29%,GPX1;NT5E
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.5723605597208484,0.8360878565182981,0.7169811320754716,0.9845007976284451,1.0,3/5,21.79%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.5723605597208484,0.8360878565182981,0.7169811320754716,0.9845007976284451,1.0,3/5,21.79%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.5723605597208484,0.8360878565182981,0.7169811320754716,0.9845007976284451,1.0,3/5,21.79%,SMC5;MACROH2A1;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.33070926607801104,0.8358650643440221,0.6976744186046512,0.9843329438091772,1.0,12/74,13.23%,PTPRC;PTPRB;CAMK2N2;UBASH3B;GADD45A;CAV3;SRCIN1;PAK2;PDPK1;TAB1;SNCA;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.37464014731789785,-0.8356619094345814,0.6976744186046512,0.9817668227021644,1.0,4/33,5.19%,RARRES2;SYAP1;ZFP36L1;SFRP1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.39471549229107505,0.8356378131331904,0.72,0.9842035015760182,1.0,6/35,12.18%,RAB17;DOCK11;RIPOR2;BCAS3;TENM2;DMTN
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.40321823518544614,0.8355879221334749,0.7407407407407407,0.9837794973655509,1.0,5/23,14.81%,PAK1;GPAM;BRCA1;CBFB;UBA5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.499371582321378,-0.8355118646858302,0.7045454545454546,0.981492380824122,1.0,2/6,17.95%,WNK2;WNK3
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4184000285406303,-0.8354466723598692,0.72,0.981007597816002,1.0,4/21,6.43%,SYAP1;EEF1A1;ZFP36L1;DUSP3
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.44131255454862983,0.8352564706629012,0.75,0.9839232325790722,1.0,4/14,24.95%,RAB1A;SEC31A;SEC24A;SEC23A
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.44895852603695274,0.8352363962136105,0.5769230769230769,0.9834344403488438,1.0,4/11,16.81%,FAM107A;RPTOR;PRKAA2;PRKAA1
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.500778454767954,-0.8351624436433969,0.7391304347826086,0.9809678301934138,1.0,2/7,5.21%,FABP7;FABP5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.33387417323356205,0.8349347770648494,0.7560975609756098,0.9834746880251544,1.0,5/50,6.59%,SPRED2;TIAM1;PHLDB2;EFNA1;GCNT2
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4197136821002858,-0.8349232828274065,0.7142857142857143,0.9808579698661726,1.0,2/16,4.99%,ESRRB;DHFR
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3901705898798936,0.834759768034351,0.6792452830188679,0.9832752947262731,1.0,5/27,17.98%,KCNJ11;SFXN3;SLC25A19;ABCC8;PKD2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.4430511386068824,0.834575877258532,0.746031746031746,0.9831142198116312,1.0,6/16,23.10%,ADAMTS9;FBXO6;AOAH;SAMHD1;OGA;FBXO17
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4156792993881832,0.8341877503855487,0.7307692307692307,0.9832742432281014,1.0,2/19,9.45%,ARHGAP24;CCP110
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.44474442707636497,0.8338610949150554,0.6862745098039216,0.9833362355866694,1.0,4/15,11.54%,CEP135;CCT8;PTP4A3;CCT6A
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.3337696836044329,-0.8338098661926151,0.75,0.9823838570057086,1.0,11/63,12.52%,CIAO2B;NCSTN;ISCA1;MAGEF1;APH1A;STUB1;NDUFAB1;AEBP1;FURIN;ADAMTS3;NAA40
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.4855943367090068,-0.8336616528163722,0.7727272727272727,0.9821215220265943,1.0,1/7,19.86%,SLC25A46
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.44048880012014835,-0.8336231772880953,0.72,0.9811137316219584,1.0,4/16,8.17%,GSTP1;SYT11;SELENOS;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.44048880012014835,-0.8336231772880953,0.72,0.9811137316219584,1.0,4/16,8.17%,GSTP1;SYT11;SELENOS;CACTIN
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.37488373226233296,-0.8335279307317729,0.7333333333333333,0.980730175078345,1.0,6/43,14.49%,MALT1;CTSC;CTSF;CTSL;CTSK;AP2S1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.45535739348768894,-0.8332561721574039,0.6222222222222222,0.9806615991406338,1.0,3/10,21.91%,BRK1;CYFIP1;WHAMM
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3414836539794948,0.833219279949684,0.7358490566037735,0.9838599860476853,1.0,8/51,18.58%,IGF2BP3;IGF2BP2;HNRNPH2;NOVA2;MBNL2;MBNL1;USP36;PTBP1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.38567958600375035,-0.8330766862707416,0.6909090909090909,0.9805290637719359,1.0,6/20,23.35%,PHB2;PSME3;PAF1;CDC73;EZH2;DDRGK1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.350833731259953,0.832916135915259,0.7446808510638298,0.9839107236319877,1.0,13/50,16.81%,FOXO1;FAM107A;WRN;CLEC16A;ATG7;RPTOR;GAS2L1;MAP1LC3B;PRKAA2;TSC1;AKR1C3;SREBF1;PRKAA1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.36311747328224386,-0.8326978283527545,0.7659574468085106,0.9807166840996255,1.0,14/56,20.31%,HSD17B10;ACAT2;PCCB;ACOX1;ACBD5;CROT;GLYATL2;PEX13;ABCD2;ACADS;ABHD2;MECR;ACOT8;ACAA2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.28508542278542176,0.8322788481067372,0.8846153846153846,0.9845366907722809,1.0,37/205,18.10%,HEY2;VSIR;SOX9;NTRK3;FGF9;PSEN1;TTN;UBR5;BRCA1;MAP2K5;AGO1;RAB29;MYOM1;ATM;BMP7;FUBP3;RAB27A;ARRB2;ADAM19;GJA1;MAGI2;PIK3CD;SNCA;ANK2;CSF1;OVOL2;CAMK2N1;FGF1;ARRB1;SRPK2;AGO4;TLE1;PRKAA1;PPARGC1A;EIF2AK3;STAT3;ANK3
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4116764039510506,-0.8321747243281444,0.6470588235294118,0.9812704344765946,1.0,5/26,13.89%,UBXN1;RPL11;GIPC1;HSP90AB1;PARK7
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.44001077594917726,0.8321069846202057,0.72,0.9843212100433957,1.0,4/16,9.13%,PCLO;PAK2;JAK1;DLG4
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.48994711771616795,0.8316183552439824,0.7,0.9846535100697028,1.0,3/9,11.75%,STAT4;JAK1;IL6ST
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.4885850423089821,0.8313439393220687,0.717391304347826,0.9846170040822243,1.0,2/9,13.98%,EMP2;CADM1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.2940910759403595,0.8308975262756845,0.9310344827586207,0.9849866784228828,1.0,18/174,9.97%,FAM107A;PCLO;NEDD9;SOX9;WNT7A;SKAP2;RAC3;PKP2;BAIAP2;PARD3;FBLIM1;WDR19;TEAD1;LIN7A;RANBP9;DLG4;HES1;RHOJ
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3464115645138232,0.8307685717094764,0.78,0.9846631817880441,1.0,4/55,4.11%,ROBO2;LRP2;TIAM1;PLXNA4
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4522614799841215,0.8307621876202622,0.6904761904761905,0.984123675009562,1.0,4/12,35.26%,OVOL2;TMC4;TSPAN8;SLC9A8
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.3188973253987629,-0.8307598343124836,0.8085106382978723,0.983462447290275,1.0,20/100,17.49%,VPS37B;VPS28;GABARAPL2;DYNLL2;MAP1LC3A;TOMM7;CHMP2A;ULK3;YOD1;ACBD5;EI24;MTMR14;MAP1LC3B2;DYNLL1;VCP;MTERF3;SNF8;CSNK2A2;LIX1L;FUNDC1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.508540642619892,0.8307212618698522,0.8043478260869565,0.9836550457993752,1.0,1/9,2.02%,PARN
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.4196375682383045,0.8305006502799682,0.7037037037037037,0.9835165313905931,1.0,4/20,14.48%,ALG6;B3GNT5;LARGE1;B4GALT5
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.496063392198744,-0.8304774043983104,0.7272727272727273,0.9834273662954878,1.0,1/9,8.37%,LYN
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.3845220358769698,0.830333368379246,0.72,0.9833673695578751,1.0,4/25,12.55%,TMSB4X;NTRK3;P2RY12;IL6R
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.5325381385892185,-0.8302900722398628,0.7755102040816326,0.9831485116746795,1.0,4/8,19.65%,PDGFRA;EIF4A3;TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.380476249600257,0.8302635552739337,0.7540983606557377,0.9829593041007867,1.0,5/31,8.59%,FAM107A;EFNA5;MACF1;PHLDB2;CYLD
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.32471596906026895,0.830185016011946,0.7666666666666667,0.9825409004895992,1.0,10/60,16.02%,FOXO1;NEDD4L;ATG7;HACE1;STX5;WWP1;BARD1;PLK2;WWP2;HECW2
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.5396212346914613,-0.8299031451171376,0.7222222222222222,0.9833921343132039,1.0,2/6,29.66%,CMPK1;AK8
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3537551271341224,0.8299022178522628,0.7857142857142857,0.9825003496760847,1.0,10/36,20.78%,PARN;PARM1;TNKS;ATM;HMBOX1;MAPKAPK5;NEK7;NAF1;MAPK3;MAPK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.3911088533626895,-0.8297168483325931,0.6862745098039216,0.9831600034997316,1.0,3/20,7.95%,RANGRF;CALM1;CALM3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.34380654450089687,0.8295149274148234,0.6888888888888889,0.9827346484701993,1.0,16/64,21.43%,GALNTL6;TRAK1;B3GNT5;TMTC2;TMTC4;GALNT15;ST3GAL1;LARGE1;GALNT16;GALNT13;B4GALT5;OGT;POGLUT2;GALNT18;PLOD2;OGA
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.5251457907584454,-0.8293045597281584,0.7608695652173914,0.983385958212081,1.0,4/8,21.93%,MST1;PGP;ACMSD;CLK2
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.5430704437315617,-0.8293039841471348,0.7708333333333334,0.9828297444348116,1.0,3/5,35.30%,SNRPC;PSIP1;SRSF12
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.4321507575090542,-0.8291818153428403,0.7083333333333334,0.9825230724487588,1.0,3/15,8.33%,ALDH1L2;DHFR;DHFR2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.49631569456996016,-0.829038906484295,0.6666666666666666,0.9823498112473109,1.0,1/9,3.51%,EXOSC8
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.4712407510476443,0.8289001859005117,0.7346938775510204,0.9834210595399956,1.0,7/12,33.51%,ITPKB;ITPKC;FGF2;PPIP5K2;CYP27A1;IPPK;CYP2R1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.3656044350371886,-0.8285309282927651,0.7551020408163265,0.9827433950364982,1.0,12/40,15.35%,NOP56;FARSA;TBRG4;PA2G4;SRM;NPM1;MYBBP1A;MCM4;NIP7;TFB2M;MRTO4;WDR43
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.3645541573581395,0.8282810260067607,0.7169811320754716,0.9840313610915477,1.0,8/35,15.84%,GNA12;SHTN1;LIMK1;RHOJ;CDC42EP4;CDC42EP3;ARHGDIG;PDPN
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.3228504690898883,0.8280410674496194,0.7333333333333333,0.9839578026524013,1.0,21/87,17.86%,UNC5D;PCLO;SOX9;SULT4A1;MMD2;GRIK3;HES1;MAPK8IP2;CLVS2;ANK2;NOVA2;ERC2;GALNT13;RHBDL3;ASTN1;SLC8A2;CTNND2;CACNG5;CELF3;SNCB;UNC13A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5264128856139445,-0.8277903667777756,0.8367346938775511,0.9835872866880471,1.0,2/9,5.38%,ARL6IP5;GSKIP
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5590902506040881,-0.8277863205183925,0.7884615384615384,0.9830383035386553,1.0,1/5,3.85%,ZFP36L1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.513304612584994,0.8277517983981348,0.7659574468085106,0.9839972311281976,1.0,2/7,11.10%,PLXNA4;PLXNA1
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.5154196007597173,-0.8276126568926313,0.6666666666666666,0.9828420531390394,1.0,1/7,3.09%,FERMT1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.41414807952230637,-0.8275865249631379,0.6666666666666666,0.9823114157295333,1.0,1/12,4.65%,PARP1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.3890276817841114,-0.8271566156557529,0.7547169811320755,0.9825770642116316,1.0,6/25,16.10%,LSM1;PRPF8;SLU7;SMNDC1;SRSF10;KHSRP
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.4321614448057365,-0.8270709260789805,0.7115384615384616,0.9821509001811027,1.0,3/12,21.19%,SLC25A33;TFB2M;TEFM
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.41100035620424835,0.8269676687895999,0.6964285714285714,0.9849232470694892,1.0,5/21,12.58%,RAB17;MDGA1;CAMK2B;EPHA4;SLITRK4
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.3011278129108445,-0.8269217643781968,0.9024390243902439,0.9818576810734307,1.0,17/150,14.07%,CDKN2C;TAF9B;BTG1;PPT1;DERL2;MT3;SFRP1;SLC25A33;PSMD10;NDUFS3;SPHK2;PPP2R1A;SMAD3;EI24;CDC42;RACK1;RAB33B
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.4953346500522927,-0.8268156135229442,0.6415094339622641,0.9815302548051723,1.0,1/5,1.97%,CUBN
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.32223466427303926,-0.826814692388882,0.8421052631578947,0.9809845862141673,1.0,9/75,9.32%,FTL;BLOC1S4;SH3GL2;AP4M1;HSPA8;SCAMP3;GOLGA7;CHMP2A;RAB14
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.31386917648890633,-0.8262830493279287,0.82,0.9813939756606204,1.0,19/108,13.65%,SIRT2;SYAP1;EEF1A1;ZFP36L1;SFRP1;ERN1;PDE3A;DUSP3;PDCD5;WNT5A;LIMS1;HAS2;CD44;GAS1;CORO1B;DSTYK;BMP2;SMAD3;RACK1
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.44058964097819925,-0.8261046442696163,0.6724137931034483,0.9812282612571646,1.0,2/12,10.38%,PLIN2;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.39361701686295436,-0.8258981804806095,0.7358490566037735,0.9810512462946362,1.0,6/32,10.98%,CSTB;PPP1R35;TMED2;FICD;RCC2;CST3
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.39038492754028264,-0.8258765427365411,0.7045454545454546,0.9805357696862306,1.0,2/18,1.28%,RHOC;CD151
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.48163016494322053,0.8257930132006996,0.7058823529411765,0.9866108660130755,1.0,1/8,9.10%,TIRAP
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.4646809680805753,0.8254787229561764,0.6976744186046512,0.9865950964221523,1.0,1/9,4.88%,ABCA2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.4612135049656713,-0.8254098304959461,0.5849056603773585,0.9809444931711947,1.0,2/9,11.92%,SLC30A10;YBX1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3253973093235051,0.825361505452134,0.8571428571428571,0.9862252757645478,1.0,20/77,17.71%,PON1;PON3;PLA2G15;ALOX12;GPAM;NAAA;ACSBG2;ACOT11;ADIPOR2;ACSL1;ACSM6;ACSF2;AOAH;CPT1A;PPARG;ACACA;PPARGC1A;SLC27A4;CPT1C;LIPH
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.4620272292495601,0.8251417558507599,0.6666666666666666,0.9861400325035804,1.0,5/12,28.23%,RAB29;SNCA;NSF;VAMP3;KIF16B
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.4659910799917668,-0.8249661532513595,0.6595744680851063,0.9812667553520062,1.0,1/13,1.71%,RAN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.5246455567383407,-0.824785516222576,0.723404255319149,0.9811187669030972,1.0,1/7,1.69%,RANGRF
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5351177633287559,0.8247732598007363,0.7551020408163265,0.9863281810041998,1.0,2/5,34.26%,CDK9;RNF20
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.4223492576987932,-0.8242542936008993,0.7441860465116279,0.9815608415117901,1.0,1/17,0.49%,GPX1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5044002419577263,0.8241932713100062,0.7446808510638298,0.9867624925866039,1.0,2/6,14.16%,UFD1;SEC14L1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.4960904328688605,0.8241505044417027,0.7,0.9863398611709258,1.0,3/7,5.44%,PON1;PON3;ALOX12
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.44271984702805833,0.8239868003435314,0.6607142857142857,0.9861370420260389,1.0,6/13,27.98%,MACF1;DLG4;MYO9A;NTNG1;DVL2;MOV10
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.4401046500642231,0.8239069658443252,0.74,0.9857740328626425,1.0,6/20,12.11%,TESPA1;CD160;PTPRJ;DGKZ;RAB29;CARD11
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.5231200348856626,0.8235264212098306,0.7540983606557377,0.9859565229838564,1.0,3/5,18.10%,PEX16;SERINC1;ANK3
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.4418608468564022,-0.8233986021150865,0.5818181818181818,0.9824088230018416,1.0,2/10,11.92%,SLC30A10;YBX1
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.3790402756519017,-0.8229912739833197,0.6585365853658537,0.9826036902326443,1.0,3/29,9.44%,FERMT1;PLEKHG5;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.3875234811575734,0.8229505228293249,0.7049180327868853,0.986405874675179,1.0,8/27,16.81%,HDAC4;ALK;AZIN2;FMN2;PFKFB1;BANP;NCOR1;PRKAA1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4185170742280029,-0.8229404552866955,0.6444444444444445,0.9821636898994672,1.0,2/23,5.83%,SOX4;ERN1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.3349207425353523,-0.8227766615055008,0.7818181818181819,0.9819184694415278,1.0,17/69,17.02%,PCSK1N;SCG3;ARL4A;PEBP1;SCG5;PARP2;IL12RB2;COIL;RAD17;TLE4;TALDO1;NAA11;CFTR;PSMG1;CLGN;CSNK2A2;GSTM3
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.3654896645836816,-0.8227209062464169,0.7857142857142857,0.9814507861230608,1.0,3/29,8.05%,THY1;FBLN2;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.37956998492524874,-0.8226989462657139,0.6458333333333334,0.9809379601424454,1.0,3/24,12.83%,FXR2;WNT5A;B2M
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.4602270395559628,0.8225148167782903,0.6842105263157895,0.9867212779611749,1.0,2/8,13.03%,ST6GALNAC5;LARGE1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.35550433760756006,-0.8221836013187342,0.7346938775510204,0.9813784115113052,1.0,6/35,12.13%,FARSA;WARS2;QARS1;SARS1;AARS1;GATC
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.4725746007959023,-0.8220651468878687,0.7608695652173914,0.9809745282478866,1.0,6/10,31.08%,HIRA;H3-3A;ASF1A;RBBP4;CABIN1;SUPT16H
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),0.4448248296199694,0.8219137565807811,0.7254901960784313,0.9873244479389027,1.0,4/11,12.96%,CTBP1;AASS;BRCA1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5077237126422665,-0.8215204780225294,0.7017543859649122,0.9815227401190667,1.0,1/8,3.07%,RARRES2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.4405934750321644,0.8214331333796614,0.7692307692307693,0.9875590187776,1.0,2/12,12.58%,SORT1;SOS1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.5025468140023078,0.8212919458767881,0.7083333333333334,0.9872710358635061,1.0,2/5,34.26%,CDK9;RNF20
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.39889604677558976,0.8211344975791793,0.7551020408163265,0.9869940201602948,1.0,5/21,16.39%,PHF19;BRCA1;KMT2A;RIF1;OGT
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.4427651432930282,-0.8211165629409669,0.66,0.9817343190481372,1.0,4/12,27.23%,CST3;IL18;RUNX1;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.47523968610844863,-0.8210725466201715,0.7727272727272727,0.9812739900449124,1.0,2/8,5.99%,CXCL12;VEGFB
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.5304082827230557,-0.8209082301432762,0.7021276595744681,0.9810587986300843,1.0,2/7,13.73%,DUSP3;FGL1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.36466732743009755,-0.8208409450828358,0.6896551724137931,0.9806164133619365,1.0,6/42,12.89%,HSPG2;ALOX5;THBS2;SARS1;VASH1;AMOT
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.4979111946521314,-0.8207152952364841,0.627906976744186,0.9803052203886361,1.0,3/6,14.84%,PDGFRA;LYN;PRKCQ
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.4358833272076114,0.8204692935058202,0.6896551724137931,0.9877501166831993,1.0,2/17,1.82%,PCTP;PITPNA
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.5419318937507411,-0.8203565072149707,0.75,0.9804316951484545,1.0,1/5,6.68%,DNAJA1
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3440619014424564,-0.8202634574291936,0.6730769230769231,0.98004715682457,1.0,8/55,9.25%,GSTP1;THY1;RTRAF;PPIA;GSKIP;QARS1;TAF7;CEP85
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5187372839487918,-0.8199802270031701,0.7045454545454546,0.9799240127201893,1.0,2/5,6.09%,MT3;ASAH1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.4482156754382582,-0.8194817173882569,0.7272727272727273,0.9803793530540627,1.0,1/11,9.08%,PPP1R10
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.3529408748018011,0.8192643264667494,0.7966101694915254,0.9892769157658343,1.0,6/41,10.08%,RAB3A;COL5A1;SYTL4;CAV3;PLSCR4;DYSF
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.4956033377079243,0.8191615266343641,0.6956521739130435,0.9889301272319845,1.0,2/6,2.72%,HEY2;ZFPM2
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.48679264816018103,-0.8191379800746215,0.7209302325581395,0.9804261696450182,1.0,3/8,17.82%,SLC31A1;COX17;ATP7B
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3969614958320314,0.8191146482841829,0.6666666666666666,0.9884986745588931,1.0,1/19,2.23%,SRF
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.3162542805080132,-0.8190936150426035,0.88,0.979974519443369,1.0,9/87,8.52%,S100A10;RHOC;THY1;AGRN;CALM1;SFRP1;CALM3;LIMS1;GBA3
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.34431364254125296,-0.8190636055636191,0.7254901960784313,0.9794724224949288,1.0,14/52,20.09%,ALOX5;ATP5F1A;VEGFB;WNT5A;EMC10;SEMA5A;CAV1;BMP2;VASH1;SCG2;AKT1;TGFBR1;TEK;AIMP1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.4877423976837324,-0.8186675951815743,0.717948717948718,0.9796045257836927,1.0,2/8,14.15%,NLGN2;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4955917302548851,-0.8184836202847544,0.7021276595744681,0.9794367986827001,1.0,1/8,4.39%,WIZ
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.45518892080740053,-0.8184234732593249,0.6739130434782609,0.9789923428158109,1.0,2/11,3.88%,ZFP36L1;MT3
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.5139194988930679,-0.8183545000462731,0.75,0.9785709699952535,1.0,3/5,22.82%,SEC61B;SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.2804137097198724,-0.8183510505266997,0.9387755102040817,0.9780428053621981,1.0,43/318,13.90%,CUL7;HSD17B10;CFL1;THY1;GORASP1;FGD3;KIF25;CFAP61;SURF4;TMED2;PPIA;PTCD2;PARP1;WTIP;CHCHD10;PHB2;SNX11;ARL1;PEX11A;SLC25A33;LMAN2;TMED9;RNF112;BCS1L;CHCHD2;CHMP2A;RAB14;HAX1;NIPSNAP2;AUP1;MCOLN1;WDR73;ODF2;ANK1;CAV1;SAR1B;GORASP2;TMED1;GOLGA8A;ESRRA;CDC42;PARK7;VPS11
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.3947219403839862,-0.8182330639709523,0.6792452830188679,0.9776957655442352,1.0,3/26,9.73%,RBM22;ERN1;NCL
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.4869636681732489,0.8182244643324352,0.7608695652173914,0.9895072948572918,1.0,1/8,5.18%,ERBIN
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.5311325117472574,0.8181833395672549,0.7307692307692307,0.9885072011945758,1.0,2/5,26.90%,CPSF6;NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.5311325117472574,0.8181833395672549,0.7307692307692307,0.9885072011945758,1.0,2/5,26.90%,CPSF6;NRDE2
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.3462229127195769,0.8181259192862076,0.7708333333333334,0.9880663073226715,1.0,9/45,16.93%,RAB17;EPS15;WASHC1;CCDC93;VPS52;SNX31;LMTK2;DENND1A;EHD1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5280978802358752,0.81809571891055,0.7755102040816326,0.9876311923123806,1.0,1/5,12.98%,FYCO1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.5279401856508003,0.8180809484490524,0.7166666666666667,0.9871223798316444,1.0,3/6,23.03%,AKAP5;CACNA1D;NF1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4005305792300025,0.8180072412390686,0.8,0.986698837423549,1.0,5/25,12.93%,LRP2;MAP2K5;STAT5B;NOS1;ACVR1C
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.48434900671304365,0.8179239630972952,0.723404255319149,0.9862810457019111,1.0,2/8,5.94%,CTBP1;SPI1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.45530474185250364,0.8172855705263146,0.7719298245614035,0.9869374127989002,1.0,5/14,22.55%,ADGRB3;ACTL6B;B4GALT5;LGI4;ANKS1A
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.38310108784186075,0.8169556479675433,0.782608695652174,0.9869428507439657,1.0,6/24,16.48%,ADAMTS9;JAK1;RHOJ;PDPK1;FGF1;TJP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.45845544099482216,-0.8168902576400424,0.7708333333333334,0.9794129292892992,1.0,1/14,2.79%,TCTA
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.3702083980410252,0.8167780192616875,0.7090909090909091,0.9868109123994465,1.0,8/26,18.11%,GPI;MAN2C1;ENO4;MAN2B2;PFKFB1;GAPDHS;PFKL;LDHA
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.311698819594138,0.8166819489688553,0.8235294117647058,0.9864837335649588,1.0,13/77,12.96%,BCL2L11;IGF1R;NEDD4L;ATP10A;RELN;CAMK2B;SHANK3;TIRAP;BMP7;CAMK1;NRG1;ASAP1;SNCA
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.3816258233044031,-0.8166572163468833,0.7708333333333334,0.9792909475166673,1.0,4/36,11.85%,RPS19;CHMP2A;NUP155;WDR73
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.40882585815038114,0.8166184463711162,0.7391304347826086,0.9860671859375254,1.0,1/19,0.86%,BCL2L11
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.5266622973341804,0.8165392619831178,0.6785714285714286,0.9856827374432166,1.0,3/6,40.55%,USP15;USP47;USP1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.476018068291102,-0.8164406457501374,0.6666666666666666,0.9786420582802831,1.0,3/8,11.79%,ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.476018068291102,-0.8164406457501374,0.6666666666666666,0.9786420582802831,1.0,3/8,11.79%,ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.5141306769794116,-0.8163139983503885,0.7592592592592593,0.9784194247964595,1.0,2/7,16.14%,LYN;IL18
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.43955848283071197,-0.8162239771561234,0.82,0.9780283346308533,1.0,5/19,18.44%,ATXN7L3;RNF8;PAF1;CDC73;UBE2N
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.5383854435479726,0.8161389120115955,0.717391304347826,0.9858575439664358,1.0,2/5,15.57%,FOXP1;BCL6
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.5134286150997474,0.8161137494690175,0.7321428571428571,0.9853682382632555,1.0,2/5,12.64%,NLRC5;NLRP12
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.4729394529003352,-0.8159228498714631,0.75,0.9779355489710667,1.0,1/9,3.29%,NT5E
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.39438337201858076,0.8157514155460192,0.723404255319149,0.9854692963075642,1.0,8/21,21.50%,KCNIP1;NOS1;ANK2;DPP6;DPP10;ANK3;CACNA1D;KCNAB2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.48254942524322086,0.8157094732978543,0.7692307692307693,0.9850123080289881,1.0,1/9,7.38%,VCL
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.5056698445871314,0.8156497740140068,0.7719298245614035,0.9845347687516357,1.0,2/6,29.24%,RYK;NR4A2
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.34725054205109873,-0.8155728014308206,0.7872340425531915,0.9780057640205486,1.0,12/54,13.07%,SIRT2;RARRES2;SYAP1;ZFP36L1;ALOX5;SFRP1;WNT5A;BMP2;YAP1;PTPRQ;LRP3;SMAD3
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3626704463322716,-0.8146352489546966,0.75,0.9790583738412916,1.0,9/35,15.46%,UBE2D4;STUB1;RNF126;TRAF5;RNF8;PELI1;RNF168;PRPF19;UBE2S
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3584111708050028,0.8141747549452705,0.803921568627451,0.9865552449595986,1.0,4/37,8.32%,POM121;SLC2A6;POM121C;NUP93
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.31413687762824377,0.8138134792099216,0.92,0.9866712127137669,1.0,22/114,14.04%,LIFR;ADGRL2;KITLG;SHROOM3;TENM3;PRTG;GULP1;PARD3;FBLIM1;TEAD1;SH3PXD2B;COL4A5;ROR1;HES1;PTPRG;RBFOX2;GJA1;IL6ST;CD59;MID1;NAV2;ALDH7A1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3929588669131465,-0.8136949949017468,0.7555555555555555,0.9801434964057371,1.0,6/22,16.51%,ATXN7L3;RING1;RNF168;CUL4B;PAF1;CDC73
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.48248807878939326,-0.81323309295889,0.6428571428571429,0.9799449076846396,1.0,4/9,19.41%,REC8;SYCE1;P3H4;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.48248807878939326,-0.81323309295889,0.6428571428571429,0.9799449076846396,1.0,4/9,19.41%,REC8;SYCE1;P3H4;TEX11
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.36865780608876514,-0.8131590950865852,0.7454545454545455,0.9795096659029172,1.0,10/50,15.21%,BTG1;VEGFB;WNT5A;EMC10;HIPK1;SEMA5A;GRN;ZNF304;STIM1;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.3803438835262285,-0.8129218290753929,0.7058823529411765,0.97943322177227,1.0,8/24,18.75%,SFRP1;RNF6;DDX5;PARK7;RNF14;AR;H3-3A;KDM5D
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.27918015785126943,0.8126763017618382,0.9347826086956522,0.9882104149798577,1.0,33/265,14.29%,FOXO1;RFC4;BCL2L11;FBXO31;BRAT1;PAK1;FOXP1;GADD45A;WRN;PSEN1;UBR5;FMN2;RAD18;BCL2L2;RAD9A;BRCA1;HELB;DDB2;FBXO6;BABAM2;MAPK12;RPA1;ATM;ZRANB3;MOAP1;TP53BP1;TAF1;SMC5;STK11;POLQ;BARD1;MASTL;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.2932845543969173,0.8126221955319299,0.9649122807017544,0.9877374334271183,1.0,24/154,12.55%,SOX9;KITLG;SRF;TIAM1;RIPOR2;ASXL2;LMO3;MMD2;SLC6A6;GCNT2;CDS1;ZBTB16;NRCAM;RANBP3L;MMD;WDFY2;ZHX3;MAPK12;BMP7;CAMK1;SIN3A;GJA1;IL6ST;IL6R
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5276700790989571,0.8123386702125343,0.717391304347826,0.9876899349886266,1.0,1/5,6.13%,UBR5
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.5009561291604876,0.8117967183253807,0.6792452830188679,0.9881668669707143,1.0,2/6,22.28%,NOP53;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.3952805448775402,-0.8115899683783951,0.7,0.9813769151634805,1.0,1/20,0.92%,FBLN5
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.5143752802272412,-0.8109089898066973,0.7560975609756098,0.9821440265895153,1.0,2/7,11.08%,SRI;GRK2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.3660327860693009,-0.8106253158745678,0.6792452830188679,0.982138934581313,1.0,10/37,14.20%,NCSTN;GAPDH;APH1A;TIMP4;PSME3;PSMB9;PRELID1;FURIN;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.30370050170425844,0.8102663382605889,0.8214285714285714,0.9903308839848902,1.0,26/109,18.72%,YWHAH;SAE1;AKT2;ARIH2;NMT1;PSEN1;UBR5;AKAP5;TCAF1;BCAS3;C2CD5;RAB29;B3GAT3;PCNT;CAMK1;CEP131;SEC16A;UBE2D3;PPP1R13B;CEP290;MYO1C;TP63;ITGB1BP1;ANK3;USP36;DMAP1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.4426875007140431,-0.8100451896423642,0.6938775510204082,0.9826813309200985,1.0,2/11,15.29%,PTCD2;SRPK1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4027084259912064,0.8100293046340602,0.7446808510638298,0.9902034994524515,1.0,5/18,15.95%,PTPRC;SRCIN1;DMTN;SEMA4D;PRKCZ
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34860782399334983,0.8099773969431852,0.8301886792452831,0.9897202463181104,1.0,4/40,4.79%,YWHAH;SAE1;ARIH2;NMT1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3663146918340088,0.8096937355835981,0.75,0.9897189066467166,1.0,9/27,21.39%,STMN2;TBCD;TTBK2;SNCA;ATXN7;CAMSAP2;NAV3;TAOK1;CLASP1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.5294911402317395,-0.8096211061852085,0.723404255319149,0.9828937085026962,1.0,1/6,16.80%,GRAMD4
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3288928593031591,-0.8094673958050137,0.8571428571428571,0.9826426755845145,1.0,7/64,13.51%,POLR2L;GAPDH;UBE2L6;IRF3;POLR2K;ISG15;POLR2E
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.46498651424522996,0.8090214741552865,0.7254901960784313,0.9903033022258717,1.0,3/12,16.84%,SLC25A18;GPD2;PPARGC1A
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.33493971473003054,-0.8089383175148104,0.7692307692307693,0.983133714409483,1.0,8/62,9.16%,PPT1;ATF4;SLC30A10;MT3;PTPRZ1;SET;SIGMAR1;NGF
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.4525525999023282,0.8086715254650142,0.6730769230769231,0.9904427803707064,1.0,3/11,10.08%,RAB3A;SYTL4;DYSF
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.4305963468891005,0.8082084857332597,0.7,0.9908328698630079,1.0,6/14,29.52%,RORA;PDK2;FOXK2;PRKN;GNB3;FOXK1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.4456403563914173,-0.8081468230949528,0.7647058823529411,0.9839754054825662,1.0,3/9,15.57%,PRMT1;PARK7;PRMT5
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.4707331370745185,0.8081405457215606,0.7291666666666666,0.9904602203556693,1.0,2/8,8.68%,ABCA2;RORA
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.4312070651574004,0.807771373535307,0.7755102040816326,0.990615047110567,1.0,4/17,14.59%,ANGPTL4;RAB20;CEBPD;RDH12
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.4492262938729936,-0.8077281223003899,0.7678571428571429,0.984197759529114,1.0,2/13,5.20%,PKIB;NABP2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4841805766343909,-0.8077091821885798,0.782608695652174,0.9836904202439336,1.0,3/7,28.09%,DHODH;CMPK1;CAD
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.5159058772839502,0.8073927255966764,0.7872340425531915,0.9907488453778486,1.0,2/6,21.93%,FYCO1;MAPT
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.3774933521253418,0.8071547442175723,0.7551020408163265,0.9907208969668737,1.0,4/32,3.57%,SLC39A14;GPI;G6PC2;SORD
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.5245113509586576,0.8069684670295713,0.7450980392156863,0.9904585170039982,1.0,2/5,37.66%,GNB3;PANK2
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.4803854991641482,0.8068720842848707,0.7291666666666666,0.9901391343752447,1.0,2/9,12.35%,SLC29A2;SLC25A19
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.34511472803985077,0.8067240171970266,0.8085106382978723,0.9898252965805315,1.0,4/36,12.29%,EFNA5;ADCY5;TRIM46;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4601451767649663,-0.8064854024586167,0.68,0.9853652323188722,1.0,3/9,23.35%,LAMTOR5;PARK7;DDRGK1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.4960717799995614,0.8059277709777768,0.7115384615384616,0.9905573814696009,1.0,3/6,27.75%,PTPRT;NFKB1;ST3GAL6
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.411487882962198,0.805834905343816,0.6938775510204082,0.9902280575734427,1.0,4/18,11.72%,CLDN12;LAMA2;VCL;GJA1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.40119008965440195,-0.8054658362418429,0.7441860465116279,0.9865153703422648,1.0,5/15,19.05%,VPS35;MFF;FIS1;RALBP1;MUL1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.3901030698005777,0.8053322358554732,0.8113207547169812,0.9905694197559285,1.0,9/26,24.45%,KCNN3;KCNMB4;NOS1;ANK2;KCNQ1;ANK3;PDZK1;KCNJ16;KCNMA1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.470981742413357,0.8052185287989221,0.6274509803921569,0.9902664076423738,1.0,2/7,16.42%,NRG1;ENG
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.44851562520817867,0.8052053093376692,0.6595744680851063,0.9897508911572434,1.0,1/12,6.24%,CECR2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.38103354792796107,-0.8046701446185794,0.68,0.9873473815705518,1.0,4/24,13.03%,HES5;HIPK1;ULK3;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5260616183460064,-0.8045090154139576,0.8,0.9870672405548091,1.0,1/6,3.84%,PIH1D1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.3434392029105882,0.8044636928520259,0.7931034482758621,0.99044475574349,1.0,7/38,12.61%,FUT2;ABCA2;B3GNT5;SMPD4;GLB1;PGAP1;ESYT1
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.4062658204714975,0.8042390782342218,0.7358490566037735,0.990282297154214,1.0,4/17,13.59%,RANGAP1;TAF3;BBS4;BARD1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.30091745671835124,0.8041887307071593,0.8620689655172413,0.9898297837744885,1.0,11/90,7.00%,PIP4K2C;KIAA1217;GCLC;ARHGEF17;PARM1;GPRC5C;CDC42BPB;CMTM4;FKBP9;CADPS2;CDS1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.414509251292966,-0.8041594891980063,0.7169811320754716,0.98720944913564,1.0,2/11,4.89%,ICMT;AGBL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.5371923878713916,-0.8037252481668496,0.8048780487804879,0.987301551547089,1.0,2/7,13.60%,SPHK2;LAMP1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.4633892951356765,-0.8037157902853023,0.6888888888888889,0.986249097505592,1.0,3/10,11.59%,ALKBH2;MPG;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.4633892951356765,-0.8037157902853023,0.6888888888888889,0.986249097505592,1.0,3/10,11.59%,ALKBH2;MPG;ASCC2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.38711894125909696,-0.8035691012066475,0.8723404255319149,0.9859647675430566,1.0,3/24,7.50%,UBL5;PDCD5;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.4680130365575547,0.8032431397984483,0.7169811320754716,0.9907918571754185,1.0,1/8,3.71%,RNF157
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.4453972556386169,-0.8030310769485326,0.6666666666666666,0.9864837865628417,1.0,2/11,2.92%,HSD17B10;TSPO
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.36581003456471034,0.8030198906128532,0.8333333333333334,0.9906450042924713,1.0,3/26,5.13%,TRPC4;HEPHL1;SLC30A9
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.471682153310102,0.8029949997160712,0.6976744186046512,0.9901412736032127,1.0,2/8,11.11%,PRELP;GLB1
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.45416028880624104,-0.8026600326029629,0.6808510638297872,0.9865815675220377,1.0,1/8,1.74%,AGRN
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.4562222034693134,0.8026336588546412,0.8,0.9903103914645295,1.0,2/12,4.88%,SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.46610765280111405,-0.8026057247730789,0.7073170731707317,0.9861647451836387,1.0,2/8,5.19%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.30442508023703807,-0.8025900910533604,0.9016393442622951,0.985665434293636,1.0,19/92,16.47%,UBB;RPS27A;UBC;RTKN2;PPIA;MALT1;UBA52;WNT5A;TRAF5;CLU;NPM1;IKBKB;CAV1;LAMTOR5;PRKCQ;PRDX3;IL18;DHX33;FLOT1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.3779186258210538,0.8024682636162512,0.7755102040816326,0.9900399720192659,1.0,1/19,2.41%,TRPC4
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.3451968664805483,-0.8023932685113683,0.7735849056603774,0.9854540279304739,1.0,8/44,16.45%,PPT1;HSPA8;FBXO44;NEU4;NGLY1;PRPF19;CUL4B;VCP
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.3886164564755792,0.8022303253052689,0.7083333333333334,0.9898421651014241,1.0,3/23,3.88%,YWHAH;CACNG2;SCN8A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3434524372397989,-0.8020837022486561,0.8909090909090909,0.985535583510137,1.0,11/49,16.47%,CD151;SNX17;STON2;SYT11;SMPD1;RAB5B;CLIP3;AP2S1;LRP1;SNX12;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4184555727458753,0.8018718143764386,0.7441860465116279,0.9900524806486809,1.0,5/20,21.82%,BMP8A;BMP7;GDF11;ENG;SMAD4
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.5028042116792935,0.8014960331762616,0.78,0.9901387164573977,1.0,2/7,12.24%,LOXL3;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.40780286612068983,-0.8014128714758043,0.7083333333333334,0.9860973175554995,1.0,5/16,16.62%,PPIA;NOL3;NONO;PARK7;AKT1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.4873110354566932,0.8013635521128224,0.64,0.9898947484728952,1.0,1/7,9.60%,DUSP1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.32480547318313224,0.8010121005762617,0.9230769230769231,0.9899294235906047,1.0,4/53,7.72%,AHR;IRF2;SYNGR2;RAB20
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3312955878437839,-0.8009364720072769,0.8867924528301887,0.9864377531198549,1.0,13/73,12.61%,BTC;HSPG2;AMOTL2;RTKN2;COL12A1;IL20RA;S100A16;LRIG3;COL4A4;LAMA5;ADCY6;PTPRF;YAP1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.39218457371487836,0.8009177614816286,0.7450980392156863,0.9895879242410467,1.0,5/17,21.96%,USP30;CHCHD3;GDAP1;MIGA2;MFN1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4275530037025238,0.8008655491372038,0.7592592592592593,0.9891643869934729,1.0,2/12,3.80%,ALG6;DPAGT1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.415871406339973,0.8007311138228903,0.7446808510638298,0.9888751216439173,1.0,4/20,6.69%,SRF;FOS;SPI1;TEAD1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.30247142021531537,-0.8006154688589863,0.8571428571428571,0.9863642451826689,1.0,17/80,16.89%,RHOC;FERMT1;PIH1D1;PARP1;PSMC3;BRK1;STUB1;CLU;ISG15;GTF2H2;RACK1;PARK7;PSMC4;DHX33;CUL4B;VCP;BAX
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.5308722287648112,0.8004303627542728,0.7608695652173914,0.9888948270917035,1.0,2/5,22.28%,ERC1;DAB2IP
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.29947560909183807,-0.7999772853834025,0.8913043478260869,0.9871120134971113,1.0,21/101,16.25%,OLIG2;TCEAL7;PDGFD;HES5;SEMA5B;SYNDIG1;PTPRZ1;SHC3;DOK5;PTN;SPRY1;NCAN;BRINP1;TMEM35A;NOVA1;FAT3;CADM3;EFS;TSPAN11;LY6H;PTPN5
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.33253615055089136,0.7995418677932601,0.8461538461538461,0.9897937480282941,1.0,18/50,28.79%,BAIAP2;PAK2;SHC2;SULF1;DOCK1;PIK3CA;DAB2IP;NCK2;PRKD2;PIK3R1;MAPK11;VEGFD;ITGAV;HSPB1;MAPKAPK2;VAV2;PTK2B;FLT1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.3577750815079198,-0.7991392552228899,0.82,0.9879636374096622,1.0,6/30,13.20%,ALOX5;ATRAID;WNT5A;PTN;BMP2;ISG15
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.479393774903015,0.799116230874911,0.7380952380952381,0.9899362864710434,1.0,1/5,11.96%,PDE9A
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.46615157764832504,-0.7987684045782597,0.6341463414634146,0.9881591953958783,1.0,2/7,5.19%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5259279837323051,-0.7986440909286234,0.803921568627451,0.9878813277409404,1.0,2/5,9.95%,THY1;CD44
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.4348674104471616,-0.7985899282739216,0.7735849056603774,0.9874057747336491,1.0,4/13,11.79%,SGPP1;ASAH1;SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.43764547499684814,0.7981828350173228,0.6851851851851852,0.9911573040877233,1.0,3/14,11.89%,SLC22A4;GJA1;ABCA8
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.4751570198409192,-0.7981349280327455,0.7592592592592593,0.9875408546724881,1.0,2/11,6.29%,RARRES2;P2RX4
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4731626936681663,-0.7980843244821644,0.7843137254901961,0.9870714882220097,1.0,2/10,10.38%,SOAT1;SCARB1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.49643919553863425,-0.7979118726943273,0.7884615384615384,0.9868112718626447,1.0,1/5,8.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.3904206240598241,0.7978898899059347,0.7884615384615384,0.9911552349890189,1.0,6/24,17.95%,AKT2;CALCOCO2;C2CD5;FYCO1;PPARGC1A;STX18
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.40846723313154465,-0.7976021534582162,0.8181818181818182,0.9867543815788035,1.0,4/19,8.83%,TSPO;LRRC8D;VDAC2;ABCG2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.40805705641640794,0.7973716270380624,0.7884615384615384,0.9915174645182548,1.0,5/16,15.84%,SLC25A18;SLC13A3;GJA1;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.49497143493888984,0.7973446978326427,0.75,0.991063923156976,1.0,4/7,23.02%,SNCA;BCL2;TF;ACO1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.46541521901730765,-0.7972557828536501,0.7777777777777778,0.9862131966438938,1.0,1/11,3.85%,ZFP36L1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.46541521901730765,-0.7972557828536501,0.7777777777777778,0.9862131966438938,1.0,1/11,3.85%,ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.3198449266790825,0.7970085418648241,0.8545454545454545,0.9911541662677638,1.0,8/56,11.72%,IGF1R;STAT6;OXTR;GRB10;ADIPOR2;ACSL1;PRDM16;GJA1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.4149708940896204,-0.7969792358222012,0.7380952380952381,0.9861621966269796,1.0,5/17,11.25%,ACTG1;ACTB;LIN7C;LAMA5;SOX8
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.382166018202822,-0.7968698253256097,0.8333333333333334,0.9857826897817482,1.0,3/29,5.83%,SOX4;LRRC8D;ERN1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.45908237263327,-0.7967899704325792,0.6521739130434783,0.985381696224825,1.0,2/8,17.81%,BRK1;CYFIP1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.4155313328649884,-0.7965486700570269,0.7708333333333334,0.9851561765980514,1.0,4/15,13.09%,ALDH1L2;DHFR;DHFR2;PM20D2
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.49037906207435156,-0.7965116629878842,0.8048780487804879,0.984668469691013,1.0,1/6,9.26%,RFWD3
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.3810052717189183,0.7960307492087887,0.7592592592592593,0.9921766768485045,1.0,7/17,21.39%,STMN2;TTBK2;ATXN7;CAMSAP2;NAV3;TAOK1;CLASP1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.36773544533248076,0.7958448029503428,0.8409090909090909,0.9919590314186096,1.0,4/26,7.28%,MAN2C1;FUT2;ST6GALNAC5;MAN2B2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.38990425210780255,-0.7957356596980546,0.8,0.9854872592231133,1.0,1/20,3.29%,NT5E
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.4592198924627804,-0.7957324467367541,0.7391304347826086,0.9849671274383631,1.0,2/9,7.11%,CCT5;CCT3
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.48044300755546154,-0.7953220655959994,0.7586206896551724,0.9851626148393936,1.0,2/8,8.95%,PIWIL2;PTN
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.45582465750617207,-0.7952794975153467,0.7543859649122807,0.9846813994359265,1.0,1/13,3.26%,LSM1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.315306390307232,-0.7951235665053772,0.8888888888888888,0.9844078989514328,1.0,13/73,11.92%,CALR;GAPDH;CSTB;PCIF1;DHFR;RPL13A;FXR2;EDNRB;ATRAID;NCL;CST3;EIF4A3;YBX1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.3945537172218403,0.7948339186093579,0.6666666666666666,0.9930107549376295,1.0,4/18,12.29%,NEDD4L;SLC4A4;KLHL3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.5201441496681132,0.7948110703443843,0.8,0.99254227433887,1.0,1/6,1.69%,SOX9
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.44716783509294694,0.794612616293016,0.8125,0.9923554520978999,1.0,1/9,5.05%,PTPRJ
prerank,MSigDB_Hallmark_2020__Complement,0.31138752063213293,0.7943550748761331,0.8222222222222222,0.9922505768373875,1.0,17/116,13.68%,GCA;PCLO;ZFPM2;IRF2;DGKG;PSEN1;RBSN;L3MBTL4;DOCK4;GNB4;CA2;PHEX;CD59;GPD2;HPCAL4;PREP;MAFF
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.38503164527684475,0.7942908222963069,0.8076923076923077,0.9918138685575003,1.0,5/21,18.06%,GADD45A;MAP2K5;PPARG;ANGPT2;ITGB1BP1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.40523157015644184,-0.793917996174812,0.7307692307692307,0.9859549207562758,1.0,1/12,5.38%,SYNDIG1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.4448359427043362,-0.7936768412194473,0.8048780487804879,0.9858880158391615,1.0,1/7,6.51%,PIK3C2G
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.44088065823031297,0.7935079122546475,0.7636363636363637,0.9926179230205754,1.0,3/13,8.89%,MEIS2;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.5048350865170554,-0.7933811317628894,0.7192982456140351,0.9858592900552476,1.0,1/6,3.03%,SLC7A10
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3130966004235243,0.7931918844695234,0.8269230769230769,0.9925538868098674,1.0,10/79,9.14%,FAM107A;EFNA5;RAC3;PAK1;BAIAP2;PHLDB2;PAK2;CYLD;RHOBTB2;ARHGAP17
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.47324003112365753,0.7931868720651424,0.7346938775510204,0.9920412214714539,1.0,3/8,25.69%,ZC3H14;CDK9;NELFE
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.4680397958703759,0.7927650292387695,0.7692307692307693,0.9921813990755551,1.0,2/6,8.74%,EFNA1;EPHA4
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.4525441176674877,0.7922897365357537,0.6842105263157895,0.9925710122530084,1.0,2/9,10.18%,DYSF;NMI
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4538535656547892,-0.7921571816294256,0.7111111111111111,0.9874629268093269,1.0,1/10,4.90%,RIOK2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.4443230580376436,-0.7920189279099479,0.7358490566037735,0.987166922513778,1.0,3/9,21.19%,SLC25A33;TFB2M;TEFM
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.4951198662045198,0.7919762111939108,0.7647058823529411,0.9926445868488228,1.0,1/7,0.77%,FOXO1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.39924486878872445,-0.7916771066504384,0.8235294117647058,0.9871756109604333,1.0,2/18,4.32%,CHRNA4;SYT11
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.44829378209738907,-0.7915869227171429,0.6744186046511628,0.9867931539961188,1.0,2/13,7.25%,MT3;CADM4
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.37674874398947883,0.7913682493014172,0.7903225806451613,0.9931454936824086,1.0,2/28,0.77%,HEY2;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.37059416398696043,0.7911167679917397,0.8333333333333334,0.9930050995895674,1.0,2/23,2.72%,FOXO1;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.5153896574190783,0.7909480582535177,0.7659574468085106,0.9927021984400018,1.0,2/6,15.95%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.5107583971703891,-0.7908499261142884,0.7627118644067796,0.9874807272485433,1.0,3/7,10.75%,CRAT;PCCB;OXSM
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5158865750562749,-0.7906777128474601,0.7555555555555555,0.9872341811840972,1.0,2/6,5.75%,NLGN2;CHCHD10
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.2955170508450618,0.7901539405926431,0.8958333333333334,0.993532511623646,1.0,7/99,6.59%,MGAT4C;ALG6;DPAGT1;FUT2;TRAK1;B3GNT5;GCNT2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.43336172108710536,0.7901453792863179,0.75,0.9930417789762332,1.0,2/13,11.22%,NEIL2;NEIL1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.40408664710799447,-0.789651076074763,0.72,0.9885662264711959,1.0,4/17,14.25%,GMPR2;DGUOK;PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.41068355908235565,0.789488776859567,0.8153846153846154,0.9935361042109786,1.0,3/15,10.17%,SLC6A6;SLC1A4;SLC22A4
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.3934532564842035,-0.7891365862103368,0.8260869565217391,0.988959038164954,1.0,3/20,5.00%,MAP1S;CAMSAP3;MID1IP1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.40876584399016264,0.7886015655837295,0.6923076923076923,0.9945574415831905,1.0,1/7,6.45%,RYR2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.40509407170734246,0.7884384230470464,0.8035714285714286,0.9943001483492846,1.0,7/14,26.82%,PROX1;APPL2;FZD9;KDM2B;TAFA1;NAP1L1;SLC16A2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.38309130147911824,-0.7883277257775145,0.75,0.9896981910210747,1.0,2/18,5.20%,PKIB;NABP2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.336145094424518,-0.7881209564516152,0.851063829787234,0.9895159763549802,1.0,5/39,7.01%,GSTP1;PPIA;ARL6IP5;SEMA4C;QARS1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.49443142677784424,-0.7880602902088316,0.7543859649122807,0.9891228727245573,1.0,2/6,13.92%,VPS35;PRNP
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.4862759868095835,-0.7878009166194095,0.8,0.9890818012073569,1.0,2/8,11.64%,RHOG;RHOBTB1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.32339419343801545,-0.7877741249702747,0.8653846153846154,0.9886190556898139,1.0,11/84,12.75%,ELOB;TSPAN4;NIFK;ST13;HES5;CHCHD10;TUBGCP4;GPAA1;MAGI1;YAP1;PPP2R1A
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.3944013827091806,0.787527005508312,0.803921568627451,0.9953149636105819,1.0,6/16,22.38%,NLRC5;JAK1;PARP9;PPARG;PIAS1;PARP14
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.2958375597683736,0.7872479244964946,0.96,0.9952044142230463,1.0,21/117,13.27%,WNT7A;SHTN1;RAB3A;LRP2;RAB10;PAK1;BAIAP2;CNTNAP1;PARD3;DOCK7;NRCAM;SHANK3;CNTNAP2;DLG4;MAPK8IP2;SGK1;BMP7;SPTBN4;TNIK;SLITRK4;LMTK2
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.5035340861777874,-0.7871967587310479,0.7777777777777778,0.9890754411326043,1.0,1/6,2.24%,CALM1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.41353521102972335,-0.7871926304099874,0.813953488372093,0.9885645787299145,1.0,3/19,11.48%,ALOX5;APOD;CHID1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.3948853182386856,0.7871828722247534,0.8125,0.9948105157142306,1.0,5/20,14.93%,SYNPO2;LIMK1;SHANK3;ASAP3;TSC1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.4165813577187515,-0.787131631958078,0.7391304347826086,0.9881136338368646,1.0,5/14,20.72%,DDX54;DDX5;NCOA4;AR;TADA3
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.4090923162889153,0.787011622521081,0.8448275862068966,0.9945789203396201,1.0,4/21,18.09%,FBXL17;BHLHE40;PER1;CRTC1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.3919527938309995,-0.7868721714143522,0.7111111111111111,0.9881055736860351,1.0,1/15,4.32%,SYT11
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5071176708735894,0.7868501507179902,0.7551020408163265,0.9943323947485257,1.0,2/6,8.12%,ATG7;ATG5
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.495841867653032,0.7866767693591948,0.6491228070175439,0.9941215020853932,1.0,2/5,20.50%,MACROH2A1;NOP53
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.4753037795164999,0.786451715601564,0.7391304347826086,0.9933873461525096,1.0,3/5,32.10%,MAGI2;IQGAP1;MYO1E
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.4753037795164999,0.786451715601564,0.7391304347826086,0.9933873461525096,1.0,3/5,32.10%,MAGI2;IQGAP1;MYO1E
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.3045281337088565,-0.7863803044580473,0.8125,0.9884749898477141,1.0,8/66,10.77%,PRDX5;IDH1;RBP1;IDI1;FADS1;PEX11A;ABCA6;PIPOX
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.40342550874968075,0.7862387750324165,0.78,0.9931924065228298,1.0,5/16,13.07%,ENPP2;PLA2G15;ABHD12B;SMPD4;ABHD12
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.39524324955118784,0.7860712892388838,0.6862745098039216,0.9929220145624981,1.0,3/21,6.09%,PYGB;PHKG1;PYGL
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.4581602067335095,-0.7853514340774294,0.7391304347826086,0.9896793988537228,1.0,2/10,7.11%,CCT5;CCT3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.5034908562788636,-0.7853195593371605,0.723404255319149,0.9891964960346074,1.0,1/6,12.32%,FNTA
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.3821423197565294,0.785196284997966,0.82,0.9938667743061335,1.0,6/26,16.51%,ACACB;MCEE;ACOT11;ACSM6;ACSF2;ACACA
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.46447834351546236,-0.7851581641503756,0.7222222222222222,0.9889294566846277,1.0,1/9,3.15%,TMBIM6
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.5080297494799298,-0.7846586586120943,0.7884615384615384,0.9892869012891452,1.0,1/5,5.28%,ATCAY
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.5016768553162209,0.7845314546260325,0.9069767441860465,0.9943369535197967,1.0,3/5,20.91%,NTRK3;AGT;ZDHHC17
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.3120245381661815,0.7844989778776428,0.8653846153846154,0.9938800662504815,1.0,7/61,11.74%,BCL2L11;SYNPO2;PRKCA;LIMK1;TIRAP;BMP7;NRG1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.4670078459689566,-0.7844221118912872,0.7551020408163265,0.9892298461950936,1.0,1/11,3.66%,SNCAIP
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.3582623200916176,-0.7841581521683904,0.9,0.9892051034827147,1.0,3/31,7.95%,CALM1;PDGFD;CALM3
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.30832575248128813,0.7841517150099215,0.9259259259259259,0.9939370337431457,1.0,10/69,12.96%,PAK1;NTRK3;RPTOR;DOCK7;SPTBN4;CAMK1;DMTN;MTCP1;NOS1;SNCA
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.363528619315862,0.7839910037490246,0.8461538461538461,0.9936619237691807,1.0,4/27,7.89%,NEDD4L;ABCA2;CAV3;RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.5221987701409823,0.7838947684133643,0.7608695652173914,0.9933066488213548,1.0,1/5,8.74%,EPHA4
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4580194037608416,-0.7837710760512442,0.7391304347826086,0.9892932111924609,1.0,1/12,3.19%,POLR2G
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5023292634837391,0.7834833193650055,0.8,0.9934291536635675,1.0,2/7,12.77%,CDKN2A;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.3157395622464026,-0.7830832244042709,0.8947368421052632,0.989810808577035,1.0,11/65,9.39%,ROMO1;RAB1B;MT3;CD63;PAX8;DHRS4;CBR1;DCXR;CHCHD2;ATAD1;ACLY
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.3794130037314862,0.7830579526125623,0.8536585365853658,0.9936168294308761,1.0,5/22,16.62%,PHLDB2;PAK2;SHANK3;TJP1;PPFIA1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.36191525161381344,0.7829488919017665,0.72,0.9932571048097637,1.0,3/23,8.97%,SOX9;ZBTB16;NBR1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.411108360782944,-0.7825384537015247,0.7674418604651163,0.9901883224039586,1.0,4/12,14.93%,SLC30A10;SRI;EPB41;STIM1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.43333397329476664,-0.782527580382698,0.7727272727272727,0.989696448381789,1.0,2/8,21.60%,CX3CL1;ZNF335
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.40987295361258264,-0.7825023674034879,0.8409090909090909,0.9891997280691628,1.0,5/12,23.37%,SEMA5A;YAP1;SCG2;TEK;PPARA
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.37150397365880283,0.7824473170356946,0.8260869565217391,0.9934446762122463,1.0,3/26,4.11%,SEMA3A;SEMA4B;PLXNA4
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.4112886168571262,0.7823365162293843,0.7777777777777778,0.9930653486512558,1.0,5/20,25.84%,ADIPOR2;PRKAA2;PRKAG2;MITF;SIRT5
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.326885286662942,0.7822309342078178,0.875,0.9927666106206526,1.0,7/55,8.47%,MCCC1;ASPA;GLDC;DDO;CARNS1;AUH;AASS
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.44407383015552704,0.7819940178685266,0.7333333333333333,0.992658557332619,1.0,1/11,4.41%,NLRC4
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.41832005920874016,0.7818946040902155,0.76,0.9922952376613698,1.0,1/16,1.62%,TUFT1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.45911164814661604,-0.7818488168017071,0.7636363636363637,0.9899091982716213,1.0,3/10,16.51%,RNF8;PAF1;CDC73
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.38270772839482775,-0.7816317904040162,0.8043478260869565,0.9897984990957732,1.0,7/18,15.53%,ZNF488;HES5;PTPRZ1;EIF2B2;SOX8;EIF2B1;SOX10
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.3794505078436082,0.781540371394845,0.7916666666666666,0.9923877295870426,1.0,3/22,5.44%,ACSS3;FAR2;ALOX12
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.4833717927763304,-0.7813333937443001,0.7446808510638298,0.9898056802023684,1.0,1/5,24.75%,SUPV3L1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.37190553587242065,-0.7812498809802931,0.7659574468085106,0.9894436943306205,1.0,7/30,15.65%,SIRT2;ATRAID;TIMP4;CST3;TIMP2;TIMP1;SNX12
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.4643127620687114,0.7811389299546502,0.7735849056603774,0.9924901313808269,1.0,2/9,4.88%,SEC14L2;ABCA2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.3581963258941159,0.7811209614757662,0.8,0.9920124620545069,1.0,9/34,20.38%,FOXP1;RXRA;SPI1;RARA;PIK3CD;CSF1;PPARG;SRP54;CDK4
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.3886682669198901,0.7809689188979272,0.8260869565217391,0.9917701473769504,1.0,2/16,3.31%,AKT2;SORBS1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.4580940662136969,0.7809452579653222,0.7297297297297297,0.991288339516949,1.0,1/6,7.92%,RABGGTB
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.33827143673932664,-0.7808457472628093,0.8064516129032258,0.9895205686795998,1.0,6/43,14.28%,KDSR;SGPP1;SPHK2;SPTLC1;SAMD8;CERS2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),0.5059221413576802,0.7807707554440966,0.8032786885245902,0.9910416501299042,1.0,1/5,16.42%,ENG
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.4795577152744971,-0.7807316075215317,0.8076923076923077,0.9891751431271191,1.0,1/5,9.68%,POLR1A
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.5019546725059002,-0.7796578856447582,0.7631578947368421,0.990336455584729,1.0,1/5,10.12%,ATP5F1D
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.4775751305034482,-0.779572551527188,0.6938775510204082,0.9899696089232463,1.0,1/6,3.09%,FERMT1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.40517699983878436,-0.7795683191304746,0.7916666666666666,0.9894697396577571,1.0,4/16,16.24%,MAP7D3;KIF18B;STMN4;STMN1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.34397473509915705,0.7795652539813578,0.9230769230769231,0.9925265695505949,1.0,11/34,18.11%,GPI;NR4A3;ENO4;SLC16A3;PDHA1;PFKFB1;ME2;GAPDHS;PFKL;ME3;LDHA
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.34324674988767023,0.77906638846058,0.8113207547169812,0.9928430261256649,1.0,4/38,8.32%,POM121;SLC2A6;POM121C;NUP93
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.34088798631070777,0.7787624626584051,0.8260869565217391,0.9922992497018153,1.0,5/37,11.04%,FABP3;ABCA2;CAV3;RORA;TMEM97
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.34088798631070777,0.7787624626584051,0.8260869565217391,0.9922992497018153,1.0,5/37,11.04%,FABP3;ABCA2;CAV3;RORA;TMEM97
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.3876065531751897,-0.778701690645378,0.8292682926829268,0.9902557448596092,1.0,4/21,9.19%,ARL6IP5;SLC1A6;PRAF2;SLC7A8
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.3835115294936554,-0.7778211691336554,0.7872340425531915,0.9910675849410442,1.0,5/17,27.06%,CHMP2A;TARDBP;NSFL1C;TOR1B;CHMP7
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.4685800484961283,0.7778173676941821,0.7454545454545455,0.9931829825480003,1.0,1/8,7.89%,RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.3818017371679353,-0.7771791991569081,0.7592592592592593,0.991553580271196,1.0,4/19,10.96%,SEMA5B;SEMA4F;SEMA4C;SEMA5A
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.5051382180824714,-0.7770210157547821,0.627906976744186,0.9911923796167009,1.0,1/6,4.39%,WIZ
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.3810175936193766,-0.7768856975520122,0.7857142857142857,0.990927356369693,1.0,2/16,3.65%,ZNF488;HES5
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.5069850855838495,0.7766709689549114,0.7758620689655172,0.9945137273650012,1.0,1/5,12.77%,PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3835844954158232,0.7764979513073443,0.8837209302325582,0.9942861724156892,1.0,6/24,16.37%,OTUD7B;RIPK1;RORA;NLRP12;PER1;TLE1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.4701163444988504,0.7763168699530234,0.7647058823529411,0.9935733577941429,1.0,5/7,37.15%,STAT3;TNRC6B;AGO2;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.4701163444988504,0.7763168699530234,0.7647058823529411,0.9935733577941429,1.0,5/7,37.15%,STAT3;TNRC6B;AGO2;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.375255177553846,0.7759781362792765,0.8245614035087719,0.9935601949466931,1.0,7/31,19.87%,SPIRE1;FMN2;SHLD2;PARP9;RIF1;DTX3L;MMS19
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.4408914827165487,0.7759686648876676,0.7555555555555555,0.9930605576882492,1.0,3/8,13.30%,OR3A2;ADCY3;BBS4
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.39382108017750406,0.7759414757971977,0.7446808510638298,0.9920578450133096,1.0,2/17,4.79%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.39382108017750406,0.7759414757971977,0.7446808510638298,0.9920578450133096,1.0,2/17,4.79%,YWHAH;NMT1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.3893989203417447,-0.7753527059798095,0.723404255319149,0.9927638366857977,1.0,3/20,7.30%,FTL;MT3;CYBRD1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3912576698743732,-0.7753029971245383,0.7674418604651163,0.9923228182240866,1.0,3/23,10.50%,USP51;NUDT16L1;KMT5B
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.33211651385672486,-0.775136128856197,0.8333333333333334,0.9921426456445394,1.0,5/42,11.23%,UBB;MAP1S;NGF;DBNL;EPB41L3
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.3324823110708034,-0.7749018996300495,0.8333333333333334,0.9919520373904723,1.0,7/44,9.95%,MT2A;GAPDH;RPL13A;IRF3;WNT5A;HLA-B;CD44
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.3858299007996856,0.7746235596355064,0.7755102040816326,0.9935076770543317,1.0,3/14,16.11%,PDPK1;AKT3;PPARG
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.5239653816950546,0.7741669463812766,0.8181818181818182,0.9936580660499201,1.0,1/5,8.07%,LOXL3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.3290714219574052,0.7741062462566382,0.8666666666666667,0.993243821738484,1.0,10/58,14.29%,RMI1;MMS22L;WRN;RNF138;BRCA1;RPA1;LIG3;SMC5;POLQ;XRCC3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.4173040109685319,0.7739683483666756,0.7115384615384616,0.9929339275957115,1.0,4/11,19.44%,CPEB3;CPEB4;CPEB1;CPEB2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.32021957464080925,0.7739391044165854,0.9074074074074074,0.9924808964231977,1.0,6/72,4.70%,IGF2BP3;DAPK1;IGF2BP2;ZNF540;PUS7;RTN1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4508733687050275,-0.7738995017500008,0.7659574468085106,0.9931683883706551,1.0,1/8,0.97%,DNAAF2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.42066668703320625,-0.7730466115065605,0.7674418604651163,0.9940439087175669,1.0,4/10,23.37%,APOD;CHID1;ABCD2;PPARA
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.335028501639619,0.7729577067127721,0.8727272727272727,0.9935461540797638,1.0,5/42,11.49%,POM121;SLC2A6;POM121C;NUP93;PRDM16
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.301100321615399,0.7724275515386403,0.9821428571428571,0.9937949749456318,1.0,12/77,12.31%,NUAK1;CHST3;SRPX;TENM3;ARHGEF17;FKBP9;TEAD1;COL4A5;GPR176;PTPRU;RBFOX2;MID1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.3032624960188389,0.7722369496874223,0.873015873015873,0.9935051849744849,1.0,10/67,13.68%,CMTR1;IRF2;TMEM140;NCOA7;NMI;PROCR;TENT5A;PARP9;CSF1;STAT2
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.41586360859807436,-0.7716268646040302,0.75,0.9952356998162509,1.0,4/11,11.28%,DLD;AADAT;PIPOX;PHYKPL
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.41586360859807436,-0.7716268646040302,0.75,0.9952356998162509,1.0,4/11,11.28%,DLD;AADAT;PIPOX;PHYKPL
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.44327240535921203,0.7715508541163381,0.72,0.994143765203974,1.0,3/9,17.95%,PGAP1;SCFD1;STX18
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3570463281770715,0.7714473085566648,0.8478260869565217,0.9937702121977334,1.0,7/29,12.64%,LRRC19;SASH1;TRIM44;PTP4A3;CD27;NMI;NLRP12
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.38114416061461315,0.7714230018157228,0.7021276595744681,0.9933082673200186,1.0,5/25,11.58%,FABP3;CAV3;GPAM;AGMO;LMF1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.5251015812236978,-0.771201849300658,0.8,0.995414812919789,1.0,1/5,4.49%,JMJD6
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4159712437986757,0.7707693994452788,0.7222222222222222,0.9937290997541718,1.0,4/14,8.20%,EPS15;HIP1;SGIP1;FCHO1
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.30605014739525405,0.7706973520384536,0.9215686274509803,0.9933169075644143,1.0,11/70,13.25%,ITPR1;TRPC4;SLC24A2;RYR3;PSEN1;RYR2;ATP2B2;NALCN;CACNG8;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3220323169735307,0.7704878743577038,0.8727272727272727,0.9931513380637856,1.0,9/54,10.29%,PKIG;PTPRJ;PRKAR1B;GADD45A;CAV3;CDKN2A;PRKAR2A;DUSP1;BMP7
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.42084300073171105,0.7702819419241242,0.7868852459016393,0.9929613269587498,1.0,1/12,0.61%,AKR1C2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.38217168961962983,-0.7700356420813078,0.7045454545454546,0.9966050495350823,1.0,2/14,6.11%,PPIA;NOL3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.31900678844151914,0.7700268298651762,0.8936170212765957,0.9929141636550549,1.0,12/54,22.74%,CRIM1;LRP2;VWC2L;SULF1;CHRD;UBE2D3;PPARG;AGT;SMAD5;SMAD4;DAB2IP;TRIM33
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.48807212324152194,-0.7696801481001275,0.7755102040816326,0.9966403838417366,1.0,1/6,23.31%,ERCC8
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.43065077895318665,0.7694833563313563,0.8163265306122449,0.9931571340927012,1.0,2/13,8.51%,DCAKD;PANK4
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.36467889718655766,-0.769067759286798,0.8461538461538461,0.9971411435922101,1.0,3/26,9.28%,GCNT4;GXYLT2;C1GALT1C1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.32997536839441366,-0.7687985167237192,0.8333333333333334,0.9970545726291437,1.0,9/31,16.67%,ASCL1;WNT3;WNT5A;LYN;RXRB;BRINP1;TMEM161A;WNT7B;CDKN2D
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.3359399650967454,-0.7686319982075812,0.7391304347826086,0.9967197485647113,1.0,11/36,16.73%,ASAH1;SMPD1;GBA3;GM2A;NEU1;NEU4;ST6GALNAC3;SUMF2;B4GALT6;NEU3;SMPD3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.31333149036352276,0.7685135712581006,0.8305084745762712,0.9941861393973451,1.0,8/53,12.96%,PAK1;NTRK3;RPTOR;DOCK7;CAMK1;MTCP1;NOS1;SNCA
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.4715997240061369,-0.7684815188051465,0.7446808510638298,0.9963747075443717,1.0,2/7,14.33%,RNF8;RNF168
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.32575939949946403,0.7683912993001982,0.9056603773584906,0.9938486369611342,1.0,11/49,16.20%,EFNA5;MACF1;PLET1;EMP2;CDKN2A;VCL;CDK6;PLEKHA2;CSF1;TSC1;DAPK3
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.3177947010383537,-0.7680864553854356,0.8958333333333334,0.9965050813361568,1.0,2/52,3.84%,RRAGA;PIH1D1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.3174273600528104,0.7678233426100588,0.8979591836734694,0.9942184139659441,1.0,11/69,13.88%,ZNF385B;ITPR1;BCL2L11;BCL2L2;BRCA1;ZNF622;ATM;SCN2A;MOAP1;STK11;MAP3K5
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.5001219514186197,0.7678182883767289,0.8222222222222222,0.9937242151803543,1.0,1/5,7.05%,TCAF1
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.42642607403915533,-0.7676238636837989,0.8076923076923077,0.9967724893812359,1.0,2/11,10.25%,LARP7;IFITM3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.40552687429712786,0.7676015491362177,0.782608695652174,0.9934659226591754,1.0,5/17,16.81%,SEC14L2;ABCA2;FGF1;SREBF1;PRKAA1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.37327537183761017,-0.7671646592075768,0.8181818181818182,0.9970238030367478,1.0,6/21,16.62%,MT3;PPIA;WNT5A;PARK7;IL18;AKT1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.450826677474905,0.7669842608345898,0.7272727272727273,0.9939774910091917,1.0,2/6,10.18%,DYSF;NMI
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.41481726834104243,0.7665305471505071,0.8,0.9941308855492478,1.0,1/10,5.35%,SLIT3
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.2606956848214804,0.7664601541811366,1.0,0.9937454552261414,1.0,57/236,23.23%,HEY2;IGF2BP3;AEBP2;DAPK1;IGF2BP2;ZNF540;PHF19;PUS7;KAT2B;FOXP1;PSEN1;SPI1;SUZ12;AGO1;CPEB3;NLRP12;TAF1;PARP9;CCDC3;PRKAA2;ZNF148;OVOL2;NUDT12;SYNCRIP;GIGYF2;TSC1;WWP2;NCOR1;AGO4;DAPK3;ENG;ADAM10;PRKAA1;SAMD4B;EIF2AK3;ATP2B1;PTBP1;MACROH2A1;LARP1;PICALM;SAMD4A;SFMBT2;ROBO1;TNRC6C;TNRC6A;MAPT;ENC1;SLC24A3;SHMT1;PARP14;APOE;CNOT7;NFKB1;FBXW7;PC;RIDA;SETDB1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.35479214204220605,0.7663377564770054,0.7567567567567568,0.9934093564961022,1.0,11/32,21.64%,NUAK1;NIM1K;PRKAA2;CPEB4;PRKAA1;MTMR3;EIF2AK3;SIK2;FOXO3;BRSK1;PRKAG2
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.4854310801953856,-0.7656911755218762,0.7659574468085106,0.9987399971017616,1.0,2/5,25.20%,DDIT3;RELA
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.4977501756807853,-0.7654802975395089,0.7631578947368421,0.9986160423956483,1.0,2/6,9.01%,CXCL12;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.4189276969610827,-0.7652720723544858,0.8043478260869565,0.9983816529801606,1.0,1/14,3.19%,POLR2G
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.500452177152429,-0.7649068804791654,0.717391304347826,0.9983895638053651,1.0,2/5,10.95%,SFRP1;ADCY6
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.37706127658000277,0.7644167192314132,0.8571428571428571,0.9957446855208855,1.0,9/27,22.83%,CRLF1;HES1;IL6ST;IL6R;PARP9;STAT3;ERBB4;PARP14;CNOT7
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.4376152869340578,-0.7643008579366789,0.7857142857142857,0.9987814068668054,1.0,1/10,14.69%,LRP1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.43445852966847304,0.7642385458232216,0.6444444444444445,0.9954959368470946,1.0,3/11,19.54%,CCP110;MAP4;LIMK2
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.3267049293105354,-0.7641617230130741,0.8666666666666667,0.998494725960358,1.0,7/38,15.25%,ERN1;DXO;NUDT16L1;DDX5;RNH1;RC3H1;MRTO4
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.4361781172043784,-0.7640979328012713,0.7446808510638298,0.9980507174383743,1.0,2/11,14.28%,ALOX5;CERS2
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3676196139825039,0.7640783654833242,0.803921568627451,0.9952278880558356,1.0,3/21,7.38%,EFNA5;MACF1;VCL
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.3679120583959212,0.764049147048778,0.8157894736842105,0.9947647162134767,1.0,2/24,6.68%,BAG5;LIMK1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.383711843906672,0.763985094427296,0.7735849056603774,0.9943508304222634,1.0,4/23,11.05%,DOCK11;RIPOR2;BCAS3;TENM2
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.48298688944767554,-0.763795743972275,0.7380952380952381,0.997932748973654,1.0,1/7,4.39%,WIZ
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.3737372185260661,0.7636198832091966,0.8636363636363636,0.994381428495767,1.0,9/24,18.10%,GCNT2;DENND6A;JAK1;BMP7;PTPRU;ADAM19;PIEZO1;TJP1;ANK3
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.4376473161235198,0.7631535729971978,0.7450980392156863,0.9945144227261272,1.0,1/9,7.41%,SH3PXD2B
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.4440306116421691,0.7628862873956265,0.7708333333333334,0.994364532614059,1.0,1/10,8.60%,BRCA1
prerank,PanglaoDB_Augmented_2021__Monocytes,0.35479436533321723,0.7623205431262816,0.8571428571428571,0.9946825614227405,1.0,4/33,10.08%,PTPRC;SPI1;NAAA;DYSF
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.33966291891288664,0.7620842348316348,0.8076923076923077,0.9944889053634325,1.0,7/39,13.37%,RFC4;WRN;NEIL2;RPA1;LIG3;NEIL1;POLQ
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.43223750925328525,0.7616499097867674,0.8153846153846154,0.9946605231051362,1.0,1/8,0.61%,AKR1C2
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.36221991642804097,0.7615753419717108,0.8545454545454545,0.9942238046749445,1.0,2/18,9.13%,SYT1;DLG4
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.459405377620289,0.7613539658939824,0.7619047619047619,0.9940355287937442,1.0,2/5,13.30%,ADCY3;BBS4
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.32858814319406815,0.7613437212831474,0.8775510204081632,0.9935509506422516,1.0,5/48,10.58%,ADAMTS9;YJEFN3;CD160;AGO1;SULF1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.4565815791449366,0.7610987631338674,0.7916666666666666,0.9924349772700499,1.0,4/8,29.10%,KIF5A;HSPB1;DLG2;KIF5C
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.4565815791449366,0.7610987631338674,0.7916666666666666,0.9924349772700499,1.0,4/8,29.10%,KIF5A;HSPB1;DLG2;KIF5C
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.4565815791449366,0.7610987631338674,0.7916666666666666,0.9924349772700499,1.0,4/8,29.10%,KIF5A;HSPB1;DLG2;KIF5C
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.47743314934434444,0.7608852344295103,0.8431372549019608,0.9922626088360077,1.0,3/8,12.72%,RYR3;P2RY12;TAF1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.3749861129548965,0.7607572344351101,0.7551020408163265,0.9919401101002155,1.0,4/15,12.96%,FOXP1;DYSF;NMI;SNCA
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),-0.44047882987952236,-0.7607134734142199,0.7659574468085106,1.0,1.0,2/8,13.66%,RAB1B;RAP2C
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.3015662272436379,0.7606766685527852,0.9365079365079365,0.9915500867905416,1.0,18/77,19.50%,IGF2BP3;DAPK1;IGF2BP2;ZNF540;PUS7;FTO;CPEB3;SYNCRIP;GIGYF2;TSC1;CPEB4;CPEB1;DAPK3;SAMD4B;EIF2AK3;LARP1;CPEB2;SAMD4A
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.3995722483881257,0.7604225899396739,0.7608695652173914,0.9913299768624821,1.0,2/14,7.57%,EPS15;SORT1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.42712763038659607,-0.7603742824190981,0.75,1.0,1.0,1/9,5.20%,NABP2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.45704148416880813,0.7601988754941977,0.8076923076923077,0.9911827033464676,1.0,3/7,18.10%,PRKCA;JAK1;ANK3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.4967254706666111,-0.7601941919573468,0.7142857142857143,1.0,1.0,1/5,16.47%,FLOT1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.38087958323003646,-0.7599680050325921,0.7959183673469388,1.0,1.0,4/22,18.40%,SLC27A6;ACOX1;TECR;ABCD2
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.4697866214996236,-0.7595860783048936,0.7454545454545455,1.0,1.0,1/6,7.89%,ADAT2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.40805757868169273,0.7594740094026061,0.8076923076923077,0.9917662387120016,1.0,3/17,4.91%,MYRF;NKX6-2;PARD3
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.47592676508925924,-0.7590178212519519,0.7959183673469388,1.0,1.0,2/5,11.99%,NLRP1;CAPN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.3265529165887934,0.75897882694079,0.9111111111111111,0.9919767911892698,1.0,3/45,3.77%,AKR1C2;AKT2;RAB10
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.3629050347147461,0.7589751899202903,0.8125,0.9914861993044086,1.0,2/24,4.62%,PPIE;VAPB
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.303324656121726,0.7589285497735072,0.9230769230769231,0.9910540722641447,1.0,6/83,10.94%,EFHC1;SGO2;RANGAP1;XPO1;TNKS;PCNT
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.4507629970144996,0.7589020789214914,0.8148148148148148,0.9905837381040751,1.0,1/8,7.78%,NAA16
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.3948035467123288,-0.7588173948953059,0.75,1.0,1.0,7/16,27.41%,PIF1;CENPV;SMG5;SETMAR;XRCC5;UPF1;SMG6
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.2811175750044792,0.7581888541216985,0.9814814814814815,0.9911033789799765,1.0,15/120,14.11%,PTPRC;PTPRB;PTPRR;PTPRJ;DUSP4;PLPP4;SSH2;DUSP1;PTPRU;PTPRG;TAB1;DUSP8;STK11;FBXW11;PTPN13
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.4656408205670335,-0.7578314111376794,0.7631578947368421,1.0,1.0,2/8,8.50%,PARP1;PARP2
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.4189868128552605,-0.7571945143494497,0.8048780487804879,1.0,1.0,3/9,9.01%,CXCL12;APOD;TNFRSF14
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.3570373010007374,-0.7570483537966928,0.782608695652174,1.0,1.0,10/31,17.27%,MMP2;CD44;FURIN;CAPN1;TIMP2;CTSL;CTSK;TIMP1;FLOT1;MMP16
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.3570373010007374,-0.7570483537966928,0.782608695652174,1.0,1.0,10/31,17.27%,MMP2;CD44;FURIN;CAPN1;TIMP2;CTSL;CTSK;TIMP1;FLOT1;MMP16
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3524147153122532,-0.7567792759197463,0.8297872340425532,1.0,1.0,5/26,15.71%,PKIB;NABP2;PPP1R10;PRKCQ;HNRNPA2B1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.28807746134070855,0.7563536130319173,0.9464285714285714,0.9933448526912857,1.0,15/69,18.10%,YWHAH;AKT2;SORBS1;NMT1;AKAP5;TCAF1;C2CD5;PDPK1;PRKCE;DPP10;PPP1R13B;MYO1C;TP63;ITGB1BP1;ANK3
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.4625189516281744,0.756241179919097,0.75,0.9930042816861078,1.0,5/7,34.88%,ZCCHC3;ANKRD17;PUM2;PUM1;USP15
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.43887770645384927,-0.7562375307917719,0.72,1.0,1.0,2/6,12.20%,PTN;PTPRF
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3626100690313641,-0.7561683972889477,0.8490566037735849,1.0,1.0,5/19,13.33%,SVIL;MAP10;GIPC1;CENPV;CDC42
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.36310137552720845,-0.7558056479564588,0.8035714285714286,1.0,1.0,5/24,6.28%,MT3;SEMA5B;SEMA4F;RNF6;SEMA4C
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3586459785007884,0.7552548021932819,0.7608695652173914,0.9939316382152691,1.0,6/29,15.32%,EME2;MMS22L;WRN;ZRANB3;PRIMPOL;DONSON
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.41356182877144154,-0.7549862167031339,0.7631578947368421,1.0,1.0,3/12,23.66%,IRF3;HSPD1;RIPK2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.3794317650597049,0.754734548913663,0.8548387096774194,0.9942318232253241,1.0,3/16,13.03%,TMTC2;TMTC4;LARGE1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.4570549856927949,-0.7546811421540996,0.782608695652174,1.0,1.0,4/6,25.03%,APOD;CABP1;CHP1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.4570549856927949,-0.7546811421540996,0.782608695652174,1.0,1.0,4/6,25.03%,APOD;CABP1;CHP1;RAB23
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2902179587613477,0.7544721692801664,0.9454545454545454,0.9940791032705129,1.0,16/70,17.59%,EGLN3;DAPK1;ST18;NLRC4;HIP1;RIPK1;BCL2L13;NLRP12;ACVR1C;SNCA;MAP3K5;CASP8AP2;CFLAR;PPARG;SENP1;EIF2AK3
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.3933954612931766,-0.7542730280241089,0.8125,1.0,1.0,1/17,1.71%,RAN
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.31829106981534633,0.7541054068301978,0.88,0.9939842851555635,1.0,6/44,13.60%,PIP4K2C;CALCOCO2;PIP4K2A;FYCO1;BNIP3L;PRKAA2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.36171514665357096,0.7537915363954938,0.8181818181818182,0.9939953859204312,1.0,8/24,21.97%,RAB10;MACF1;GOLPH3L;RAB31;SEC16A;ANK3;NSF;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.4469580396359697,-0.7535805034124012,0.8043478260869565,1.0,1.0,1/7,0.32%,GPR17
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.42857977296582794,0.7533376231287956,0.7647058823529411,0.9941074413793264,1.0,5/10,29.33%,NOS1;ANK3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.4632556526200218,-0.7532701715618542,0.7916666666666666,1.0,1.0,3/5,23.35%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.4632556526200218,-0.7532701715618542,0.7916666666666666,1.0,1.0,3/5,23.35%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.4632556526200218,-0.7532701715618542,0.7916666666666666,1.0,1.0,3/5,23.35%,UFL1;UFC1;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.34391423330201804,0.7532568161579025,0.8431372549019608,0.9937244178228756,1.0,6/26,16.04%,UBR5;HELB;TP53BP1;SHLD2;POLQ;RIF1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.36170845382421923,-0.7531503505600746,0.8571428571428571,1.0,1.0,3/14,15.71%,PARP1;SMG5;HNRNPA2B1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.3626369708055088,0.7530276869693409,0.8909090909090909,0.9935963382467036,1.0,8/17,22.44%,GPI;ENO4;PFKFB1;GAPDHS;PFKL;LDHA;ENO1;HK1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4426821248485737,-0.7527226262602141,0.8333333333333334,1.0,1.0,2/12,8.32%,SURF4;TMED9
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.4234065062034377,0.7526931786298297,0.7777777777777778,0.993641213360955,1.0,3/10,13.36%,BCL2L11;MOAP1;BNIP3L
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3809227458130521,-0.7526868998805546,0.8679245283018868,1.0,1.0,7/19,16.89%,ATF4;SELENOK;ERN1;AIFM1;QRICH1;TRIB3;BAX
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.4582111438352252,0.752638246067165,0.7291666666666666,0.993187006104271,1.0,3/7,22.84%,CSF1;AGT;NFKB1
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.46213398506135406,-0.7526000690361219,0.803921568627451,1.0,1.0,1/6,2.95%,ROMO1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.34442065864697397,-0.7524928383973285,0.8292682926829268,1.0,1.0,3/22,11.20%,CDKN2C;CDK2AP2;BRD7
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.48033089675442775,0.7524556276667796,0.7407407407407407,0.9929730491263189,1.0,1/5,17.98%,PKD2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3844468172118138,-0.7523755332075709,0.8333333333333334,0.9999966576966548,1.0,3/14,12.24%,TIPRL;PPP1R11;IKBKB
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.4630917819604809,-0.7523639528692229,0.7058823529411765,0.9994967806790384,1.0,3/6,15.53%,EDNRB;SOX8;SOX10
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.4331408596094101,-0.7520558536185433,0.7959183673469388,0.9993489131644782,1.0,1/9,6.65%,SELENOS
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.4721949752348672,-0.7519952232238419,0.7254901960784313,0.9989221995060938,1.0,2/6,14.33%,RNF8;RNF168
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.46751711415503555,-0.7519196357982256,0.7333333333333333,0.9979978034405954,1.0,3/5,33.79%,RYR1;CAV2;SKI
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.46751711415503555,-0.7519196357982256,0.7333333333333333,0.9979978034405954,1.0,3/5,33.79%,RYR1;CAV2;SKI
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.37352758052422413,-0.7519132330328269,0.7619047619047619,0.997495033766318,1.0,3/17,10.35%,TIPRL;PPP1R11;YWHAB
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.44219606664314515,0.751680412690445,0.8214285714285714,0.9935406814100154,1.0,1/9,2.76%,AKT2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.32078648062679777,-0.7516448442545505,0.8596491228070176,0.9973485464554261,1.0,6/35,13.20%,ALOX5;ATRAID;PTN;TXLNG;BMP2;ISG15
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.34374840844858306,0.7513657253715852,0.875,0.9935040422076862,1.0,9/32,22.76%,DGKG;GPAM;DGKZ;LIPH;DGKD;GPD1L;ABHD8;GPAT4;PLA2G12A
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.34530407692686843,0.7513030702302523,0.7903225806451613,0.9931274169839828,1.0,7/30,13.39%,MEF2D;LAMA2;CHD2;CAV3;MAPK12;LARGE1;SGCA
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.4754064013736338,0.7512873929855268,0.8367346938775511,0.9926650001124696,1.0,1/6,7.75%,KLC1
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.36342718574744165,-0.7509475550451901,0.8421052631578947,0.9977587931952634,1.0,2/16,5.21%,FABP7;FABP5
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.5000152897144937,-0.7506772051013793,0.7142857142857143,0.9976277735421392,1.0,1/5,13.37%,BAHD1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.41133712405328726,0.7503720895583369,0.851063829787234,0.993375202397147,1.0,6/16,26.08%,CSF1;PPARG;AGT;NFKB1;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.41865680474077666,0.7502519839308135,0.7924528301886793,0.9930565771305533,1.0,3/11,16.84%,NR4A3;PPARG;PPARGC1A
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.4661629075732552,-0.7502034287262535,0.7142857142857143,0.9978727186576963,1.0,3/5,19.65%,EPHB3;SOD1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.35303885329222195,-0.7499204776236338,0.8431372549019608,0.9978241064010079,1.0,3/20,5.92%,CAMSAP3;MID1IP1;LIMA1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.43147175434245644,0.7498675973236123,0.8367346938775511,0.9930393829319278,1.0,2/8,7.28%,MAN2C1;MAN2B2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.33599702127121966,-0.7497351429338944,0.8627450980392157,0.9975852436170992,1.0,11/35,18.46%,RPS7;MAGEF1;RPL23;RPL11;UFL1;CLU;RAD23A;UBQLN4;RPL5;CSNK2A2;COMMD1
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.5078900377381147,0.7494338551002084,0.8070175438596491,0.9931798576872296,1.0,1/5,6.83%,CRACD
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.42698041827118943,0.7490245862215381,0.7755102040816326,0.9931435200472548,1.0,2/11,12.55%,FOXP1;IL6R
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.4603306420675055,0.7490054625018888,0.7843137254901961,0.9926776773774482,1.0,1/5,21.36%,ENO1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.42032522696205393,0.7489117277095908,0.7884615384615384,0.9923315479883202,1.0,5/12,31.74%,CPSF6;IWS1;NRDE2;SETD2;NUP153
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.44394312994031737,-0.7487834205312522,0.7804878048780488,0.998426155891937,1.0,1/10,5.20%,NABP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3435923631306573,-0.7487512481533193,0.8444444444444444,0.9979560178191856,1.0,10/36,17.95%,RANGRF;RHOG;CLIP3;EPB41;LRP1;ZDHHC8;AKT1;GNAI1;NUMA1;WNK3
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.37663182000733725,0.7483126109367215,0.8620689655172413,0.9927867829965963,1.0,3/20,10.66%,RAC3;RHOJ;P2RY12
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.4212818098107563,-0.7482478851877467,0.8269230769230769,0.9981077453316581,1.0,5/10,24.14%,TRIM35;TRIM28;TRIM13;TRIM5;PML
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.46479750786286333,-0.7474016940555744,0.8333333333333334,0.9986083588674357,1.0,2/5,6.65%,CXCL12;SELENOS
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4022857413019569,-0.7473076654277229,0.7857142857142857,0.9982670946832887,1.0,5/10,25.68%,SAR1B;TMEM30A;INSIG1;CD81;GCC2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.3263338121245375,-0.746855694794156,0.8518518518518519,0.9983722885328921,1.0,9/52,15.42%,KDSR;SGPP1;ASAH1;SMPD1;SPHK2;SPTLC1;SAMD8;CERS2;B4GALT6
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3289293071582362,0.7468404310704221,0.8833333333333333,0.9943424488041636,1.0,6/42,10.22%,FBXO31;EME2;RAD9A;BRCA1;BABAM2;ATM
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.4540746101783577,0.7468011277514331,0.7735849056603774,0.9939055101501207,1.0,2/6,9.08%,CAV3;MLIP
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.45895810173695023,-0.7465484904776349,0.8076923076923077,0.998338996504746,1.0,1/5,14.69%,LRP1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.28944269780116316,0.7461046419396872,0.9361702127659575,0.9943735964160811,1.0,27/82,26.64%,NPHP4;CEP135;CCP110;HAUS2;TTBK2;PCNT;HAUS5;TUBA4A;CEP41;CEP131;TMEM216;CSNK1D;CEP290;ACTR1A;HAUS6;ALMS1;CC2D2A;AHI1;CLASP1;C2CD3;CEP70;TCTN1;SFI1;CNTRL;CEP250;RAB3IP;MARK4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.38460728283503476,0.7459926266441692,0.8269230769230769,0.9940465188576204,1.0,4/15,19.60%,STN1;GNL3L;TENT4B;EXOSC10
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.29379658420403204,-0.7459361416332151,0.9545454545454546,0.9987053039181905,1.0,15/72,15.07%,SQLE;TM7SF2;RARRES2;MID1IP1;SC5D;IDI1;PMVK;EDF1;HMGCS1;CAV1;HDAC3;CERS2;DHCR7;SIN3B;FDPS
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.3439366311908457,0.7454736316704881,0.8297872340425532,0.9942810166069335,1.0,9/31,22.76%,DGKG;GPAM;DGKZ;LIPH;DGKD;GPD1L;ABHD8;GPAT4;PLA2G12A
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.3346262003550756,-0.7453748238969528,0.8723404255319149,0.9988715618493007,1.0,2/37,3.62%,RPL10;PCIF1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.4254183783697001,0.7453157646035846,0.8653846153846154,0.994020859670028,1.0,2/10,15.64%,CPEB3;CPEB1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.4507554017447502,0.745290655892714,0.7872340425531915,0.9935803876418158,1.0,3/9,11.15%,SYT1;RYR2;KCNMB4
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.36598101821926526,-0.7448862926483975,0.7692307692307693,0.9989301856299824,1.0,3/18,11.68%,MT3;COQ10A;SDHAF4
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.35725805769353847,0.7447844008330945,0.8571428571428571,0.9937767742023054,1.0,12/29,24.33%,SPI1;ZNF16;STAT5B;CDK6;ANKRD54;STAT3;ACVR1B;ABCB10;FOXO3;FAM210B;ZFPM1;MAPK11
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.37510849568717375,-0.7447207363909442,0.8913043478260869,0.9986358181609654,1.0,2/16,7.95%,CALM1;CALM3
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.47305358618942484,0.7444877078477411,0.8596491228070176,0.9936738979864067,1.0,3/5,21.82%,PGAP1;PIGU;PIGK
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.38786924370671216,0.7444184775515549,0.8070175438596491,0.9932437255911604,1.0,1/12,3.58%,ENOX2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.3891980596552003,0.7442461101842118,0.8333333333333334,0.9929941882281714,1.0,4/12,11.68%,TMCC2;PSEN1;APH1B;ADAM19
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.49777921149631765,0.7441303325021869,0.8571428571428571,0.9926927499490558,1.0,4/5,36.89%,ATG14;AMBRA1;GPS2;BECN1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.39107016155580543,0.7436748368401609,0.825,0.9928417110971275,1.0,2/10,12.09%,PDPK1;AKT3
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.42479680557302263,0.7436259673883323,0.82,0.9924127755606362,1.0,3/9,16.14%,PTPRJ;SNCA;CBLB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.33930312217099345,-0.743604967612155,0.84,0.9996351850541552,1.0,4/23,10.35%,BAD;CHCHD10;YWHAQ;YWHAB
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.2994753687488078,0.7434522134632329,0.9016393442622951,0.9921309902886819,1.0,14/79,16.11%,CALCB;PRKAR1B;ADCY5;TYRO3;PRKAR2A;GPR176;RORA;ADCY3;CD247;MVK;NLRP12;PLK2;AOAH;PPARG
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3884908846531635,0.743383311597441,0.8823529411764706,0.9917453938081049,1.0,11/23,28.79%,WDR91;WASHC1;P2RY12;WDR81;DAB2IP;IRS1;PIK3R1;FGF2;ATG14;PTK2B;FLT1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.3885953811729802,0.7430190793180834,0.8653846153846154,0.9917384745595687,1.0,3/14,10.01%,VSIR;APH1B;MAPK12
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.4113120826004025,0.7429790755212642,0.7659574468085106,0.9912919961054758,1.0,4/8,30.22%,STX1B;GRIPAP1;ARHGAP44;STX3
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.36715818786545834,-0.7429229536350928,0.8545454545454545,1.0,1.0,6/26,11.25%,SEMA5B;SEMA4F;SEMA4C;FN1;SEMA5A;SOX8
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.41146138536769383,0.7426035075334256,0.803921568627451,0.991242784608782,1.0,2/10,5.98%,ABCA2;ST6GALNAC5
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3865658435115537,-0.7424500956190068,0.8695652173913043,1.0,1.0,3/13,19.98%,IFI6;RHBDF1;RBPJ
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.35244843715333857,-0.7424407191400723,0.8461538461538461,0.9996614377780534,1.0,1/24,1.12%,PPT1
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.4516319241306884,-0.7423883047724436,0.8181818181818182,0.9992807015084971,1.0,1/6,4.05%,BRPF3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.4226434497371381,0.74235754005841,0.7931034482758621,0.9910897377958732,1.0,1/8,2.31%,ST18
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.4243498833647245,0.7421154950391977,0.8070175438596491,0.9908896420997764,1.0,3/11,21.41%,TRNT1;INTS6;ERI1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.47055864798929736,-0.74180567533393,0.76,0.9995429044756997,1.0,3/5,25.20%,RC3H1;HRAS;RELA
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.303174633752303,0.7417571182892928,0.8867924528301887,0.990845413432024,1.0,5/58,8.30%,AKR1C2;SOX9;VCL;LOXL3;PROX1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.4197191241543275,-0.7413647127555377,0.8076923076923077,0.9996621263753087,1.0,2/8,12.58%,HES5;BMP2
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.2843190198342948,0.7412791976568169,0.9682539682539683,0.990947395995594,1.0,19/81,19.95%,ACACB;NLRC4;KCNC2;HCN1;RYR3;AQP4;STEAP4;CARD11;TP53BP1;POLQ;ACACA;APPL2;EHD1;RNF213;PKD2;SAMHD1;CBY1;HPRT1;NACC2
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.3766527546852367,0.7409080849059307,0.8,0.9909738747528668,1.0,2/18,13.96%,TTN;NCAPH2
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.4006396359478195,-0.740799417868669,0.8260869565217391,0.9998423649465589,1.0,2/13,6.17%,FERMT1;S100A16
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.3202271602892007,-0.7406006129927025,0.9333333333333333,0.999625242415459,1.0,2/32,3.65%,SALL2;HES5
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.34833149759131665,0.7403671922118802,0.8888888888888888,0.9911228028124659,1.0,8/24,21.82%,CAV3;SSH2;SHANK3;TJP1;ARFGEF1;PIK3CA;CLASP1;SMAD4
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.3855197629117907,0.7403567402697537,0.8214285714285714,0.9906500916517039,1.0,4/19,13.69%,RACGAP1;SLC6A6;SLC25A19;SLC13A4
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.42945456458934417,-0.7403531697299994,0.76,0.999464320697502,1.0,1/8,6.11%,PHB2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.41245572567288974,0.7403272983241413,0.8181818181818182,0.9902060718827315,1.0,2/13,9.60%,PPP2R2C;DUSP1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.27233818693784695,-0.7398938340656077,0.975609756097561,0.9997308681896877,1.0,17/105,18.52%,JUN;CFL1;PLEKHG5;RHOG;RASSF1;SHC3;BRK1;DBNL;ZNF304;RAP2C;PARK7;RAPGEF3;RIT1;USP28;CYFIP1;TRIM28;RAP2A
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.3504996045591754,0.7396114071554757,0.8125,0.9906561956763175,1.0,4/21,14.48%,PRELP;ST3GAL1;GLB1;B4GALT5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.3198065788625023,0.7394958049639175,0.8604651162790697,0.990301928751914,1.0,6/30,22.28%,RIPOR2;ARHGAP24;SYNGAP1;ARHGAP35;ABL2;DAB2IP
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.45607314168302493,0.7389652419277212,0.8260869565217391,0.9905542052890426,1.0,1/5,8.84%,HABP4
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.4401373434019792,0.7386801205007445,0.7872340425531915,0.9904774501740652,1.0,2/7,14.34%,KMT2C;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.41052079136888897,-0.7381776154320704,0.8297872340425532,1.0,1.0,3/11,9.01%,CXCL12;WNT5A;TNFRSF14
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.3811227541005043,0.737750518343565,0.8524590163934426,0.9911378417941267,1.0,5/20,15.86%,SRF;SPI1;CDKN2A;SMC5;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4725730736498367,-0.7375400302480657,0.8269230769230769,1.0,1.0,1/6,3.88%,MT3
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.27660980182253586,0.7374835203893376,1.0,0.991028032834804,1.0,25/121,17.64%,RFC4;NUAK1;RMI1;ING5;WRN;PIP4P1;RAD9A;TAF3;BRCA1;PIP4K2A;RPA1;SGK1;ATM;PDPK1;TAF1;STK11;BARD1;PRKAA2;BANP;TAF15;MAPKAPK5;PPP1R13B;PRKAA1;PPP2R5C;TP63
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.44970176150959884,0.7374062822455288,0.8269230769230769,0.9906556765462836,1.0,1/5,8.73%,STAT5B
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.4625345836887081,-0.7373738025039207,0.8125,1.0,1.0,1/6,3.84%,PIH1D1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.4097514755729318,0.7371330763382906,0.8333333333333334,0.9904805724887236,1.0,3/12,12.94%,PLA2G15;GPAM;SERAC1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.3584533848877318,-0.7365647056376845,0.8703703703703703,1.0,1.0,4/18,16.65%,RAB1B;RAP2C;RAPGEF3;MSN
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.40150791260447427,-0.7363968962522773,0.7631578947368421,1.0,1.0,1/9,9.26%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.32630613748686804,0.7363959707440144,0.8113207547169812,0.990961638535685,1.0,9/43,14.87%,DOCK5;NEDD9;RAC3;EMP2;CDK6;PLEKHA2;DMTN;CSF1;ARHGEF7
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3702349504956626,-0.7363014722943417,0.8292682926829268,1.0,1.0,2/17,9.23%,RIOK2;ANAPC11
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.32209488289070265,-0.7362411431025975,0.8958333333333334,1.0,1.0,9/27,21.19%,RPS19;CACTIN;GRN;ISG15;USP18;MUL1;LYAR;OAS3;TRAFD1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.332793470001619,0.7360875467097521,0.8805970149253731,0.9908755418928212,1.0,4/35,12.77%,IGF1R;PITPNM2;KCNH1;PIK3CD
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.4708703455172838,-0.7360379875367177,0.7954545454545454,1.0,1.0,4/5,29.47%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.4708703455172838,-0.7360379875367177,0.7954545454545454,1.0,1.0,4/5,29.47%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.4867612944649768,0.7359763284738317,0.8125,0.9905461031396139,1.0,2/5,22.95%,PPARG;PNPLA2
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.47725783034306507,0.7358278669749815,0.8392857142857143,0.9902263377916952,1.0,4/6,26.59%,GLDC;SHMT1;RIDA;GLYAT
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.30053621011641257,0.735735099593521,0.9833333333333333,0.9898741411036809,1.0,9/68,13.41%,PON1;TIAM1;PSEN1;HES1;RARA;STK3;HMBOX1;TAF1;PARP9
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.46079608901017877,-0.7356811185064905,0.8536585365853658,1.0,1.0,4/6,29.47%,B3GALT2;B4GALT3;GAL3ST1;UGT8
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.405059940466416,-0.7350006480226035,0.7818181818181819,1.0,1.0,1/9,2.58%,ACTB
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.37184954644166845,-0.734849329532752,0.8775510204081632,1.0,1.0,2/15,3.85%,LRRC8D;ZFP36L1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.3744792605482208,-0.7346258749681245,0.8392857142857143,1.0,1.0,5/22,10.25%,GAPDH;RPL13A;WNT5A;SHFL;IFITM3
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.46426682266477326,-0.7345351971039624,0.7894736842105263,0.9996207482259339,1.0,1/6,10.12%,ATP5F1D
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.4478821303299485,-0.7344596124380507,0.78,0.9992187276058502,1.0,1/7,4.65%,PARP1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.41262144384996513,-0.7340699598074765,0.8222222222222222,0.999205714663493,1.0,2/11,7.11%,CCT5;CCT3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.43880837384597426,-0.7340326775163643,0.875,0.9987488060058829,1.0,6/10,33.70%,TALDO1;PGM2;PGLS;RPIA;DERA;TKT
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.39105638328652376,-0.7340203750118716,0.8,0.9982772214885317,1.0,5/13,15.55%,SIRT2;RAD17;IKBKB;PGAM1;SMG5
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.36503715599761993,-0.7339257818490583,0.8636363636363636,0.9979572846353185,1.0,6/20,16.24%,CFL1;KIF18B;TWF1;STMN4;DSTN;STMN1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.42872819125701167,0.7337096699427086,0.813953488372093,0.9918969402996263,1.0,1/8,7.98%,RIPK1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.37412795513683494,-0.7335023612426441,0.8292682926829268,0.9979751396081795,1.0,1/12,5.67%,WTIP
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.49051071005577257,0.7334871419151419,0.8181818181818182,0.9917265011071333,1.0,1/6,3.49%,UBASH3B
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.3381429070775682,0.7332422988017578,0.8163265306122449,0.9915655648981695,1.0,3/29,3.13%,SLC39A14;GPI;G6PC2
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.35567078018352627,-0.7332032526560411,0.8867924528301887,0.9978117352047681,1.0,8/24,19.97%,WNT5A;CDC37;CACTIN;HSP90AB1;ISG15;USP18;MUL1;OAS3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.421983353653577,0.7327993652977783,0.8181818181818182,0.9916335060019512,1.0,5/10,20.38%,RXRA;SPI1;RARA;SRP54;CDK4
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.42972498003521015,-0.7326868696691523,0.8478260869565217,0.9979604766998464,1.0,2/9,6.93%,PIWIL2;HENMT1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.36193039280564265,0.732478625137497,0.86,0.9915614142301564,1.0,9/24,19.49%,GPR18;HTR2C;GNA14;P2RY12;GRM1;FPR3;HOMER1;LPAR1;AGT
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.38992704782739207,-0.7324732747665343,0.803921568627451,0.9977469445182182,1.0,2/15,7.67%,ATF4;SARS1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.3727328344581174,-0.7317841355834845,0.8292682926829268,0.9980262758713839,1.0,3/17,15.77%,WTIP;NEK8;MOB3B
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.31398018704012204,-0.7309823938364779,0.9574468085106383,0.9985163668789093,1.0,2/45,5.23%,GPR17;TNFAIP1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.3872072818189974,-0.7303926590840526,0.7380952380952381,0.9987598918442466,1.0,9/22,16.62%,CSTB;TIMP4;CST3;GAS1;TIMP2;PRNP;TIMP1;SNX12;AKT1
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.432132446266301,0.7302813102613968,0.8392857142857143,0.9938537221484649,1.0,5/11,22.27%,KCNB2;TPM1;DAPK3;ENO1;PPP1R12B
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.3702877435018208,-0.7300759522459622,0.8181818181818182,0.9986517999237595,1.0,3/14,12.23%,ACTG1;PTN;GRN
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.46819204475876086,-0.7298530004117939,0.7368421052631579,0.9985137105544444,1.0,1/5,0.41%,CHRNA4
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.43105986849560834,-0.7295081275609785,0.8536585365853658,0.9983958155191177,1.0,1/8,1.59%,CALR
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.41665903115360536,-0.7288127034282471,0.8245614035087719,0.9986940581753407,1.0,2/10,9.95%,THY1;CD44
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.44108594831237147,-0.7286908248996782,0.7708333333333334,0.9983357167737029,1.0,2/7,20.62%,CAV1;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.36272010169207625,-0.7285163620908114,0.9047619047619048,0.9980578444614864,1.0,2/22,10.10%,WTIP;DDX5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3973972351772933,0.7281891868636801,0.8913043478260869,0.9959107862568648,1.0,5/16,16.04%,HELB;TP53BP1;SHLD2;POLQ;RIF1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.3441958741853056,0.7276723627038695,0.8444444444444444,0.9961069767125098,1.0,6/19,23.65%,PHLDB2;PAK2;TJP1;PPFIA1;CLASP1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.4701391920570137,0.7274925766406174,0.9069767441860465,0.995827995870329,1.0,1/7,0.70%,APOLD1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3825464052377662,-0.7267277236203847,0.8166666666666667,0.9999073548186814,1.0,4/15,10.96%,SEMA5B;SEMA4F;SEMA4C;SEMA5A
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.304292090906346,0.726568822553188,0.9583333333333334,0.9963545078295476,1.0,15/61,21.33%,CHRM3;AKT2;RABGGTB;ST3GAL1;PHEX;PIGH;FBXO11;WWP2;UBE2D3;PPP4R2;MCRS1;MMP15;ABL2;PLOD2;LCMT1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.4217290309895797,0.7264480561933964,0.7454545454545455,0.996071022464519,1.0,3/10,13.14%,CAMK1D;IL6R;MTUS1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.4720666895921942,-0.7258986947524159,0.8125,1.0,1.0,1/5,4.65%,PARP1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.4203874659733183,0.7258108498339851,0.8421052631578947,0.9962760634758783,1.0,1/7,9.16%,HES1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.38645181071819773,-0.7258085755905713,0.8125,1.0,1.0,5/17,21.14%,EFNA2;HNF4G;CFTR;GNAI1;PLS1
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4299055576909795,0.7257573585053774,0.9074074074074074,0.9958580973005925,1.0,2/8,12.96%,PTPRJ;SNCA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.46782874380950334,-0.7257432806296894,0.8157894736842105,0.9997327525454693,1.0,1/6,1.82%,BAD
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.3448183315488561,-0.7257367494006777,0.9375,0.9992450780320324,1.0,2/20,8.11%,PARP1;PIF1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.45859343281681353,0.7251430077102496,0.8518518518518519,0.9960444620338426,1.0,2/5,15.57%,FOXP1;BCL6
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.33829143187904975,-0.724533650706918,0.9444444444444444,1.0,1.0,7/32,11.25%,PEF1;SEMA5B;SEMA4F;SEMA4C;KLHL12;SEMA5A;SOX8
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.4229349654455489,0.7242603131322793,0.717391304347826,0.9966392720786207,1.0,5/7,23.20%,FOXP1;CDK6;CSF1;ACIN1;IL34
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.3223385601318501,0.724016201686904,0.8679245283018868,0.9964305842405197,1.0,6/42,10.56%,HEY2;KAT2B;PSEN1;HES1;APH1B;TRAF7
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.3951565846822525,0.7238926937707874,0.8166666666666667,0.9961246748937278,1.0,1/8,1.77%,RAB17
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.4138557224428647,-0.7238704457928464,0.8103448275862069,1.0,1.0,2/12,6.86%,RARRES2;CPA1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.42027781713901957,-0.7236133293111461,0.7735849056603774,1.0,1.0,3/9,13.89%,GPR37L1;PYCR1;PARK7
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.40032435881698475,-0.7232518502111522,0.8181818181818182,1.0,1.0,2/12,16.26%,UBQLN2;NEU3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.4547780205256621,-0.7232164966290415,0.7804878048780488,0.9998285685983549,1.0,4/7,27.86%,STARD13;RBPJ;RHOB;RHOA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.38558417693254116,-0.7232060337030071,0.8260869565217391,0.9993572125282436,1.0,2/13,7.95%,CALM1;CALM3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.36525932438962083,-0.7228558944920763,0.7804878048780488,0.9992497235450263,1.0,7/21,27.41%,PIF1;PPP1R10;SMG5;PML;XRCC5;UPF1;SMG6
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.42553892423902395,0.7227615996070179,0.9387755102040817,0.9970849097817706,1.0,2/12,8.47%,NNMT;AASS
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.38353089213775465,0.7225309473092604,0.8,0.9968484997186271,1.0,2/15,14.31%,NUP93;TMEM43
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.4149072474355131,0.722529286565205,0.8043478260869565,0.9963760596713671,1.0,1/6,5.44%,ALOX12
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.41894433936423897,0.7225208794603006,0.8,0.9959040672224465,1.0,5/10,23.78%,DGKG;ADGRV1;DGKD;GPD1L;ULK4
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.42416710788774714,0.7222658655328967,0.8823529411764706,0.9957287166776126,1.0,2/12,10.72%,FOXP1;CBFB
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.38524310099151776,-0.7222084902193596,0.84,0.9994757165281203,1.0,3/12,21.60%,PTN;CX3CL1;ZNF335
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.4109637308834322,0.7221840483648208,0.8367346938775511,0.9953453685998409,1.0,4/11,16.85%,FABP3;ACSL1;PPARG;SLC27A4
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.4841955761448446,-0.7221581842908813,0.84,0.9990499789065901,1.0,1/5,14.42%,ENTR1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.4363805255754356,0.7220506206565113,0.8148148148148148,0.9950502328799223,1.0,1/7,12.24%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.32458676296397193,0.7219739383371325,0.95,0.9946537036582926,1.0,6/33,15.66%,PCTP;DOCK7;ACOT11;STK11;NOVA2;ABHD6
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3394827486051324,0.7219003393586161,0.82,0.994248310633403,1.0,3/28,8.17%,EFNA5;MACF1;ZRANB1
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.4156379084709984,0.721882306621954,0.7674418604651163,0.9937878952132367,1.0,1/6,5.40%,MCEE
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.32098109599509606,0.721843712330881,0.8771929824561403,0.9933417593634452,1.0,4/36,4.91%,MYRF;SCN8A;CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.2618477770811926,0.7212524781158758,1.0,0.9935326051254865,1.0,15/106,13.10%,FAM107A;RAB17;BAG5;GFAP;HIP1;RPTOR;SGK1;TMEM97;NRG3;RUFY2;CAMK2D;RAP1B;SLITRK4;BBS10;STK11
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3360700365703322,-0.72001138456248,0.8717948717948718,1.0,1.0,1/23,0.47%,CDKN2C
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.29901704328397266,-0.7193161274875535,0.975,1.0,1.0,13/63,12.61%,BAD;CDH3;SFRP1;VEGFB;WNT5A;EMC10;PTN;MST1;SEMA5A;GRN;ZNF304;BMP2;YAP1
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.3865273511803018,0.7190828153111579,0.8431372549019608,0.9956873786217976,1.0,1/10,6.47%,TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.353966292124961,-0.7190622562416186,0.8518518518518519,1.0,1.0,1/23,2.03%,LZTS1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.3253154004284841,-0.719019405790408,0.9555555555555556,1.0,1.0,4/49,6.29%,ATP6V0A4;TIMM8B;TIMM13;P2RX4
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3137593827119429,-0.7187309856136243,0.9318181818181818,1.0,1.0,11/52,18.55%,RANGRF;ACTB;RHOG;CLIP3;LRP1;TMBIM1;ZDHHC8;AKT1;AR;WNK3;PPP2R5A
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.3670900010749558,0.7186438878387391,0.7708333333333334,0.9957110358400707,1.0,3/17,14.48%,PRELP;ST3GAL1;B4GALT5
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.4373056213999723,0.7185317726341339,0.8604651162790697,0.9949065311238079,1.0,2/7,5.89%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.4373056213999723,0.7185317726341339,0.8604651162790697,0.9949065311238079,1.0,2/7,5.89%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.36339586793465345,-0.7180868918988996,0.7924528301886793,1.0,1.0,3/15,19.34%,ERP29;SNX12;RHBDF1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3698848198912449,0.7177202864341755,0.9259259259259259,0.9952940725645102,1.0,2/15,11.69%,BCL2L2;MOAP1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.39250805018530044,0.7176652023010186,0.8085106382978723,0.9948762959486112,1.0,3/11,9.16%,OPALIN;DAAM2;HES1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3409362307806135,0.717550031318851,0.8275862068965517,0.9945692540208267,1.0,10/21,30.80%,PSEN1;NCS1;HOMER1;BRSK1;ULK4;DISC1;NTNG1;ZNF804A;CAMK2G;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.3755329764174801,-0.7174793699583032,0.8627450980392157,1.0,1.0,2/23,4.11%,RANGRF;CD63
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.39893784461651427,-0.7170236057849246,0.7916666666666666,1.0,1.0,3/8,21.45%,UNC119B;LRP1;ZDHHC3
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.44616360219340434,-0.7167647007857337,0.8095238095238095,1.0,1.0,1/7,8.37%,LYN
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.3091612616908578,-0.716444315366803,0.9142857142857143,1.0,1.0,5/46,7.95%,HSD17B10;KRT10;KIF25;FARSA;CRYZ
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.33670673012598973,-0.716190669876789,0.8695652173913043,1.0,1.0,1/20,2.21%,PPIB
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.37889595688673183,0.7155948627712129,0.8333333333333334,0.9962936711909102,1.0,3/12,16.65%,MAPK12;NRG1;MBNL1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.4161119560829375,0.7155427297554341,0.8095238095238095,0.9958714205609841,1.0,2/10,11.93%,PRKG1;TPM1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.4330537168052388,-0.7154831544334556,0.8363636363636363,1.0,1.0,2/8,23.34%,PARK7;P4HB
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.2454172418896976,-0.7154318257546065,1.0,1.0,1.0,21/164,16.67%,CCND1;CDKN2C;SSNA1;TUBA1A;PHLDA1;TUBG1;CTDP1;TUBB4B;CHMP2A;PRKAR2B;GSPT1;ODF2;PPP2R1A;PPP1CB;HAUS8;UBE2S;DCTN3;DYNLL1;CUL4B;OPTN;CDKN2D
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.46645749784146573,-0.7152338741343688,0.8367346938775511,1.0,1.0,2/5,7.28%,LRRC8D;SLC1A6
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.41193252904675526,-0.7150397834618849,0.8076923076923077,0.9999563426843605,1.0,1/7,3.88%,MT3
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.45303855516159564,-0.7149093361025931,0.8333333333333334,0.9996076815052568,1.0,2/7,9.67%,LDLR;HSP90AB1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4108405758865425,0.71483525393549,0.75,0.9961336391789746,1.0,6/9,29.33%,MBOAT2;PLAAT3;PLA2G12A;LPCAT3;PNPLA8;LPCAT4
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.31664929005494813,0.7144993755016337,0.9555555555555556,0.9960560303394638,1.0,10/31,22.90%,ABCA2;PLA2G15;SMPD4;CERS5;CERS6;AGK;CERK;FA2H;TLCD3B;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.3831683524247411,-0.7143466137833664,0.8235294117647058,0.9998710037132428,1.0,2/14,8.93%,CD63;ATAD1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.4428548246698983,-0.7140494901382741,0.8076923076923077,0.9997051392050771,1.0,2/6,14.73%,KMT2B;SETD1A
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.39926546195631674,-0.7140487443244938,0.8490566037735849,0.9992240491477118,1.0,2/12,10.27%,RARRES2;MST1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.40141575358812176,-0.7138353299430382,0.8297872340425532,0.9989404428290537,1.0,1/8,5.12%,PAX8
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.2734638644527965,0.7137708705248402,1.0,0.9962766351870873,1.0,20/94,18.10%,UNC13C;CBLN2;PCDHB5;PSEN1;NRCAM;SHANK3;RAB29;APBB2;SNCA;CACNB4;SLC8A2;FARP1;PPFIA1;CTNND2;RYK;SLC6A1;SNCB;LRFN4;UNC13A;ANK3
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3600146278422919,-0.7135969552482334,0.8813559322033898,0.9987260333815823,1.0,2/19,6.51%,CALM1;HPCA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.3316567539249427,0.713237308506818,0.9464285714285714,0.9964236789939845,1.0,7/18,28.60%,RTN1;PICALM;APOE;FLOT2;RTN2;NTRK2;BIN1
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.427003785822342,0.7125679165051806,0.8222222222222222,0.9967447192233279,1.0,2/8,10.22%,RIPK1;ATM
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.4373904063856092,0.7124361422116684,0.7777777777777778,0.9964196314566797,1.0,3/5,21.93%,PRKAA2;PRKAA1;MAPT
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.3440118374207158,-0.7123940684974942,0.8888888888888888,0.9996239284105225,1.0,2/21,5.44%,MYH3;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.3197062988314525,-0.7123829167881759,0.8181818181818182,0.9991487200696992,1.0,4/29,12.58%,ASCL1;NGF;BRINP1;BMP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.38161358214084856,0.712006251642734,0.8125,0.9964107432485422,1.0,4/15,19.61%,CD160;PDPK1;AKR1C3;PDCD4
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.3406545685861528,-0.7119697130852439,0.9090909090909091,0.9992196511860568,1.0,1/15,2.82%,SVIL
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2716460299199397,0.7118727300309966,0.9841269841269841,0.9960998443633174,1.0,19/130,14.29%,RMI1;EME2;MMS22L;WRN;EYA1;RNF138;XRCC4;BRCA1;BABAM2;RPA1;ATM;LIG3;TP53BP1;SMC5;PIAS4;POLQ;PARP9;BARD1;XRCC3
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.383998783367148,0.7115946195943041,0.8163265306122449,0.995940175281138,1.0,3/10,30.01%,IRF1;UBE2K;PYHIN1
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.38868192317486966,-0.7115942364257207,0.8846153846153846,0.9991431030573442,1.0,5/15,18.91%,SFRP1;RNH1;VASH1;BMPER;ADGRA2
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.35606967533864137,-0.7115256327170628,0.8666666666666667,0.9987621247135897,1.0,1/16,3.84%,PIH1D1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.37920481874809153,0.7114943153182268,0.8,0.9955612108531983,1.0,4/14,12.96%,CAV3;PXK;NOS1;SNCA
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.28452326172506903,0.711159720744749,0.96,0.9954613480363742,1.0,12/71,12.71%,ZMYND8;DUSP22;PTPRJ;TCAF1;VCL;EPHA4;SULF1;SRGAP3;PTPRU;CHRD;TPM1;MAGI2
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.41384636119823437,0.7111582266719845,0.8666666666666667,0.9949961791821516,1.0,3/8,12.44%,FBLIM1;PIEZO1;RAP1B
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.4702490807917421,0.7110461149560721,0.8235294117647058,0.994613621319514,1.0,1/6,19.94%,KDM2B
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.36907901947815264,-0.7107995445019664,0.8863636363636364,0.9991080428480337,1.0,4/19,11.23%,PIH1D1;WBP2;BRD7;SPHK2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.33597169082125905,0.7107866596549386,0.8947368421052632,0.9944276394315595,1.0,6/29,12.04%,SLC25A18;SLC38A9;SLC6A6;SLC7A11;SLC22A4;SFXN3
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.36652785109105096,-0.7102531951462963,0.8,0.9992720837134419,1.0,4/13,27.86%,CHMP2A;CHMP5;CHMP7;RHOA
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.3097724423839364,0.7101818485497157,0.9807692307692307,0.9945200580947469,1.0,9/50,13.33%,PTPRR;SOX9;ERBIN;PRKCA;NRG4;PDPK1;NRG1;SOS1;NRG2
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.31675995725090833,-0.7100099900936041,0.9056603773584906,0.9991024755590947,1.0,7/40,18.68%,RPS19;MAPK13;WNT5A;GRN;IL18;ZP3;CX3CL1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.43501736794447887,-0.709815582047851,0.8536585365853658,0.9988987161728631,1.0,1/7,10.12%,DHODH
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.35192795886333805,-0.7096250935506676,0.8947368421052632,0.9985971597830159,1.0,1/19,3.65%,HES5
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.45244054900911634,0.7095496890148278,0.8461538461538461,0.9947172468714149,1.0,2/8,12.13%,RIPOR2;PADI2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3062147387114965,-0.7095103323010292,1.0,0.9982714055446261,1.0,5/51,10.21%,ATP6V0A4;TIMM8B;TIMM13;MKKS;USH2A
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.41149738313680173,0.7092462887850445,0.8269230769230769,0.9945497041687262,1.0,1/9,6.64%,MID2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.3892337126689885,0.7088418340176916,0.8421052631578947,0.9944916309343997,1.0,3/12,16.04%,TP53BP1;SHLD2;RIF1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.40096105588991765,-0.7086774961454649,0.8163265306122449,0.9987046746069183,1.0,3/7,23.37%,LRP1;NR1H2;PPARA
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.39458036842383293,0.7085161876781064,0.8181818181818182,0.9943380071886534,1.0,3/11,16.04%,TP53BP1;SHLD2;RIF1
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.42605398191160304,-0.7084034382945118,0.7872340425531915,0.9985259575773896,1.0,2/7,14.69%,UNC119B;LRP1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.3250213121550351,-0.7081054341075275,0.8809523809523809,0.9982496064398046,1.0,7/37,16.61%,ACTB;SMARCA5;CHD3;RNF8;MTA2;ACTL6A;ACTR8
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.3903126977161257,0.7079989720481437,0.9482758620689655,0.9944439038956671,1.0,2/15,8.84%,RPS6KB2;HABP4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.34570745639580513,0.7078823265445552,0.9285714285714286,0.9940903173390382,1.0,2/24,4.05%,NR4A3;FOXP1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.453202596156013,-0.7077862058012251,0.7884615384615384,0.9980859409571379,1.0,1/5,9.50%,HAX1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.40232050466445485,0.7071173236278762,0.86,0.9943826269076053,1.0,5/11,28.45%,SLC8A1;ANK2;CACNA1D;HCN2;CACNB2
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.3758819291013126,0.707010493392992,0.9347826086956522,0.9940430300066313,1.0,3/14,13.67%,UBASH3B;PRXL2A;CSF1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.3834165708388455,-0.7065840480108524,0.8095238095238095,0.9988360339561704,1.0,1/9,5.99%,VEGFB
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.37461651035261134,-0.7063696004436187,0.88,0.9986234124769773,1.0,4/13,14.20%,TIMP4;FURIN;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.4964484548649475,0.705203188710299,0.84,0.9949900715139097,1.0,2/5,22.38%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.4964484548649475,0.705203188710299,0.84,0.9949900715139097,1.0,2/5,22.38%,PPARG;PARP14
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.30414251332968717,0.7048087543855739,0.9803921568627451,0.9950227656333189,1.0,5/43,10.58%,SOX9;KLF9;TGFBR3;CDK6;SULF1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.4229502396512647,-0.704746531196315,0.86,0.9998362213053924,1.0,1/6,13.07%,SMAD3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.3048954618903791,-0.7045808484900632,0.94,0.999559904227817,1.0,5/36,12.75%,BRPF3;NPM2;RAD17;DSCC1;PPP2R1A
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.35350383980302325,-0.7043283867273233,0.8163265306122449,0.9993472417934649,1.0,1/21,3.68%,NME3
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.4077451325678816,-0.7042789137315298,0.8846153846153846,0.9979459860106318,1.0,2/10,17.89%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4077451325678816,-0.7042789137315298,0.8846153846153846,0.9979459860106318,1.0,2/10,17.89%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4077451325678816,-0.7042789137315298,0.8846153846153846,0.9979459860106318,1.0,2/10,17.89%,GNPNAT1;UAP1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.3461238329393802,0.7042454089030752,0.92,0.9951915004041834,1.0,7/23,13.33%,PTPRR;ERBIN;PRKCA;NRG4;NRG1;SOS1;NRG2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.4067934907524483,-0.7040070584597957,0.84,0.9977101599611999,1.0,1/9,1.10%,RHOC
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.3686114163372197,-0.7036591702434328,0.8867924528301887,0.9977372509873916,1.0,5/14,16.47%,ASAH1;CDC37;STUB1;PELI1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.3807723724868842,0.7034686384030072,0.8888888888888888,0.9955414224910456,1.0,3/12,13.59%,RANGAP1;SUFU;BARD1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.3688157296350983,0.7029032855499439,0.8636363636363636,0.9956599139192216,1.0,3/16,13.17%,SLIT3;TGFBR3;CATSPERG
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.3043535795455658,0.7021840785318468,0.9791666666666666,0.9959005891796758,1.0,10/35,21.93%,FOS;SLC6A6;RIPK1;SNCA;MAP3K5;AKR1C3;GRIN2B;PICALM;EFNB2;MAPT
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.3018248922524037,-0.7008470017020112,0.8775510204081632,1.0,1.0,3/31,10.20%,PCGF2;CBX5;RING1
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.47590884867039057,0.7007518491405347,0.851063829787234,0.9968518270346645,1.0,1/5,4.82%,TIMP3
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.4007642624421059,0.7003207192403876,0.8888888888888888,0.9968383164082654,1.0,5/11,29.27%,RAB11FIP5;PTPRN;RAB11FIP2;PTPRN2;CAMK2G
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.4473256501182033,-0.7002362665631625,0.8333333333333334,1.0,1.0,5/5,55.29%,TTPA;PLEKHA3;GLTP;CERT1;PLEKHA8
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.3091893494787963,-0.6998324328647697,0.9038461538461539,1.0,1.0,8/35,15.14%,GABARAPL2;PHB2;MAP1LC3A;FUNDC2;WDR45B;FIS1;CTSK;MAP1LC3B2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.35075961992985694,0.6997260350096037,0.8301886792452831,0.997023834970376,1.0,3/24,10.89%,DIP2B;KIAA0319;TRIM46
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.3311761766110056,-0.6996571203893588,0.8775510204081632,0.9999817600986607,1.0,10/30,19.69%,APEX1;PARP1;ADPRS;MPG;TDG;POLG;POLD3;POLD2;RFC5;RFC3
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.37484117683531076,-0.6988673279395894,0.86,1.0,1.0,1/14,1.92%,ATF4
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.35467748314762226,0.6980416998060222,0.8448275862068966,0.9983077884071808,1.0,3/21,15.35%,BRD4;CDK12;CDK13
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.42938353054692757,0.6979442959673927,0.8448275862068966,0.9979140337643955,1.0,3/7,24.50%,PROX1;AGTPBP1;OPHN1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.42212023598611814,-0.6977868137290543,0.9,1.0,1.0,4/8,21.91%,MICALL1;FNBP1L;BIN3;WHAMM
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.39660586629878647,-0.6977625162932027,0.8409090909090909,1.0,1.0,1/11,11.97%,PCYT2
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.34697461157440546,-0.697568877574407,0.8421052631578947,1.0,1.0,3/16,10.65%,RHOG;BRK1;DBNL
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.34964539684034596,-0.6975401611504863,0.8333333333333334,0.9998932869308454,1.0,1/21,0.60%,SALL2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.4611539114487213,0.6974977420457219,0.8545454545454545,0.9979542592898567,1.0,4/7,38.39%,AKAP13;PDE4D;RAPGEF2;ADCY9
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.3406342187104192,0.6971968324742058,0.9180327868852459,0.9978228871673999,1.0,3/20,13.03%,TMTC2;TMTC4;LARGE1
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.40403926892544373,0.696938410788401,0.8125,0.9976104083731842,1.0,1/9,1.93%,WNT7A
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.32082788661525535,0.6962696209221073,0.8928571428571429,0.9978311416382155,1.0,2/28,8.68%,AKT2;RORA
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.36951729382510634,0.69599345464558,0.8723404255319149,0.9976684485759632,1.0,2/15,4.88%,YJEFN3;ABCA2
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.3507910456200638,-0.6957550707225416,0.9183673469387755,1.0,1.0,7/21,15.42%,ASAH1;SMPD1;SPTLC1;SAMD8;ST6GALNAC3;CERS2;B4GALT6
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.4250307031291255,-0.695601314972172,0.8085106382978723,1.0,1.0,1/5,17.68%,SLC7A1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3416930793472296,-0.6953968555950342,0.8867924528301887,1.0,1.0,1/27,1.34%,PMEPA1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.3711666491386658,0.6950129683896917,0.9130434782608695,0.9982539718695812,1.0,2/16,14.09%,PKP2;DSC2
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.3807199420822303,-0.6947617707390731,0.7777777777777778,1.0,1.0,5/11,18.32%,RFK;PPAT;IMPDH2;LHPP;PFAS
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.4465126493313152,0.6945883695320264,0.9365079365079365,0.9982038425781418,1.0,3/5,23.29%,SLC22A4;PDZK1;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3998009923492274,0.6942532810686922,0.8813559322033898,0.9980952299281863,1.0,4/13,18.78%,SHLD2;PARP9;RIF1;DTX3L
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.3472412100686717,0.6941752338703183,0.9019607843137255,0.9977167053265964,1.0,2/19,7.59%,PLA2G15;NAAA
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.35440957262362965,0.6939772048239738,0.8793103448275862,0.9974509823246265,1.0,7/21,19.89%,SOX9;ATM;RORB;ADNP2;PTK7;ABL2;EPHA3
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.3868057123735788,0.6938816744659139,0.8653846153846154,0.9971090707687466,1.0,4/13,17.75%,MYO1H;MYO7A;MYO1C;MYO6
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.3269304524871447,0.6938429680522389,0.9166666666666666,0.9967090517154832,1.0,1/26,1.69%,SOX9
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3967453261386464,0.6936914406643551,0.8936170212765957,0.9963722873042686,1.0,2/11,15.69%,RIPK1;NCOR1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.34265083430748844,-0.6936800829369723,0.9038461538461539,1.0,1.0,5/27,13.40%,CFL1;ZBED3;RAB14;TLE6;TDG
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.34101208650257153,0.6936011737851437,0.9310344827586207,0.9960088930953495,1.0,1/16,4.70%,RTN1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.370135453671688,0.6932448678778609,0.8909090909090909,0.9958791982932723,1.0,2/14,9.97%,RAC3;RHOJ
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.40601037550581637,0.6931175062811408,0.7636363636363637,0.9955253354031098,1.0,2/7,11.50%,DHDDS;MVK
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.37772195499118877,0.6930719798700102,0.8043478260869565,0.9951045418843775,1.0,4/9,34.31%,GTPBP3;TRMT9B;ELP3;ELP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3482328459670806,0.6929976675362102,0.8727272727272727,0.9947244688996547,1.0,3/21,7.42%,BAIAP2;NTRK3;BCAS3
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.4775809854572254,0.6929339904315167,0.9183673469387755,0.9942954689590157,1.0,1/5,2.48%,LMBR1L
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.396039177805086,0.6927399792864969,0.8490566037735849,0.9940728281210516,1.0,2/7,31.20%,ATRX;RTF2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.4108998135013302,0.6927306025780005,0.890625,0.9931763419164613,1.0,2/10,12.44%,TNIK;RAP1B
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.4108998135013302,0.6927306025780005,0.890625,0.9931763419164613,1.0,2/10,12.44%,TNIK;RAP1B
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.37429486241078125,-0.6926971145286639,0.9375,1.0,1.0,2/12,12.43%,DPM2;PIGF
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4315818559557428,-0.6926807070679744,0.7755102040816326,1.0,1.0,3/7,22.71%,RNF8;RNF168;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.37885995599412925,-0.6925612824957067,0.8478260869565217,1.0,1.0,5/13,15.32%,RPS7;RPL23;RPL11;PARK7;RPL5
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.40210345369880984,-0.6924313278229125,0.8148148148148148,1.0,1.0,2/9,21.03%,BTN3A3;JAG1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.2820015168842153,-0.6919429903930827,1.0,1.0,1.0,13/75,12.75%,ATF4;ALDH1L2;DBI;DHFR;PLAAT1;ACSM5;SMPD1;DHFR2;NIT1;PCCB;OXSM;AEBP1;PPP2R1A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.32672531175737096,0.6913879712568726,0.9245283018867925,0.9940500062715031,1.0,17/33,32.50%,RELN;EPHA4;TPST1;FER;ABL2;EPHA3;ABI2;ERBB4;ABL1;INSR;PTK2B;FLT1;DDR2;EGFR;JAK2;PTK2;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.28679233982246916,-0.6913055411183203,0.9583333333333334,1.0,1.0,10/44,19.90%,VEGFB;WNT5A;EMC10;ITGA4;SEMA5A;BMP2;SCG2;AKT1;TGFBR1;TEK
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3616010407445152,0.6909383973926584,0.9038461538461539,0.9940021888975544,1.0,4/16,23.22%,MID2;HS3ST5;TRIM62;CIITA
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.48460480086578,0.6903033783703172,0.8958333333333334,0.9941733124994828,1.0,1/5,4.41%,NLRC4
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3726184773041642,-0.6901131218840697,0.9056603773584906,1.0,1.0,1/10,4.31%,ZNF830
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.4515742077189101,-0.6898932806163985,0.8461538461538461,1.0,1.0,1/6,10.21%,USH2A
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.346830836700745,0.6898251834346241,0.8771929824561403,0.9941969264903827,1.0,1/24,1.34%,PCTP
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.36369011217904545,-0.6898165159386257,0.8461538461538461,1.0,1.0,4/18,20.51%,BRK1;CDC42;CYFIP1;AKIRIN1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.4108182684799592,0.689787985475429,0.86,0.9937920506169987,1.0,3/8,15.82%,EFNA1;EPHA4;NELL1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.38697302066502404,0.6897000032120323,0.8793103448275862,0.9934455395914774,1.0,4/11,19.89%,NRCAM;EPHA4;ARHGAP35;EPHA3
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.42790642066707485,0.6893657474507751,0.7857142857142857,0.9933401382410822,1.0,2/6,8.30%,WNT7A;PROX1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.40572373823937324,-0.689363674778614,0.8723404255319149,1.0,1.0,6/11,23.35%,PHB2;NPM1;PAF1;CDC73;EZH2;DDRGK1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.40021647285463113,0.6893585037896743,0.825,0.992896092973367,1.0,2/7,12.52%,MRRF;MCTS1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.33774740993210894,0.6884854849884445,0.9411764705882353,0.9931697194535734,1.0,2/19,6.00%,SLC24A2;GRIK3
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.4133607198421246,0.6881836161217694,0.8653846153846154,0.9930913060861458,1.0,1/6,2.58%,ALK
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.31507157500908883,-0.688024250905227,0.8269230769230769,1.0,1.0,2/25,7.31%,CLTB;CANX
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.34787946775673256,-0.6880004143858107,0.86,1.0,1.0,2/13,3.91%,SQLE;PPIA
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.33326569244385446,-0.6878899235541347,0.9387755102040817,1.0,1.0,3/21,14.07%,PDGFRA;FUZ;RAB33B
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.3322339820765509,0.6873655216736038,0.8979591836734694,0.9933601434501663,1.0,6/24,13.68%,STAT4;STAT6;ERBIN;STAT5B;EIF2B4;STAT2
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.35818267128948655,0.6864953684315329,0.8596491228070176,0.9938333896655889,1.0,5/12,22.61%,OXTR;NRG1;ARHGAP35;ERBB4;GPAT4
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.3523270906831185,0.6864890932519856,0.88,0.9933856831339261,1.0,5/15,16.99%,FUT2;AGMO;SERINC1;AGK;CERK
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.41707132964362376,-0.6862486935360708,0.9,1.0,1.0,2/9,6.90%,GABARAPL2;MAP1LC3A
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.41707132964362376,-0.6862486935360708,0.9,1.0,1.0,2/9,6.90%,GABARAPL2;MAP1LC3A
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.32149356919593414,0.6855872867163909,0.8653846153846154,0.9937206940345189,1.0,4/17,12.29%,PSEN1;RAP1GDS1;PACS2;CAMK2D
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.4310295065311671,0.685451519644563,0.8518518518518519,0.9934245051542665,1.0,1/9,3.37%,TENM3
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.34276960255800915,0.6854463337920972,0.8809523809523809,0.9929909173428758,1.0,5/15,22.97%,AKT2;P2RY12;CCDC25;SPOCK2;PPM1F
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4332307441225295,-0.68525546493192,0.8490566037735849,1.0,1.0,3/8,14.28%,PTN;GRN;CERS2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.3692591053062394,0.6852249540463977,0.8363636363636363,0.9927485955613076,1.0,5/17,19.53%,HIP1;DOK1;DGKD;AGT;BCAR3
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.29682915720973924,-0.6849557684001162,0.9298245614035088,1.0,1.0,8/46,13.80%,PARP1;ATCAY;RAB14;HSP90AB1;STX6;UFL1;RACK1;RSL1D1
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.39666863858270585,-0.6849522365095617,0.86,1.0,1.0,2/9,16.11%,ADAT2;URM1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.3579631652716877,-0.6849086928949357,0.9347826086956522,1.0,1.0,4/16,16.38%,RING1;RNF8;RNF168;CUL4B
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.4309750472169086,0.6848786455003358,0.9107142857142857,0.9925552993845245,1.0,2/5,25.73%,ACTN4;MITF
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.35908773303975433,-0.6847509818859262,0.8979591836734694,1.0,1.0,2/15,5.55%,KRT10;FARSA
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.4016159503476045,0.6847322043308637,0.8653846153846154,0.9922779162585617,1.0,1/8,6.83%,CRACD
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.2662547881490182,-0.6845990489915686,1.0,0.9999853948861163,1.0,21/100,17.74%,GSTP1;SFRP1;H2AZ1;WNT3;SELENOS;WNT5A;CACTIN;LYN;ADCY6;SPHK2;BRINP1;NCOA4;CFTR;WNT7B;PAF1;CDC73;MSN;AR;GNAI1;RUVBL2;SSTR1
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.40752935052997885,-0.6843686762185442,0.8536585365853658,0.9997431259732191,1.0,2/7,17.95%,WNK2;WNK3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.3702863515426292,-0.684287999251256,0.84,0.9993672249309873,1.0,2/10,15.65%,DNAJA1;SNX12
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.41757009177633303,0.6833046874210016,0.8703703703703703,0.9931222956419745,1.0,1/9,2.90%,BAG5
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.3961858668895265,0.6832467437614679,0.9,0.9927164126116329,1.0,1/10,1.93%,WNT7A
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.44142510198951657,-0.6829422708671671,0.8979591836734694,1.0,1.0,1/5,7.53%,SRI
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.39690287822681125,0.6824392677498122,0.9056603773584906,0.992957506923567,1.0,3/9,15.91%,NRCAM;EPHA4;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.42283236001835084,0.6823683272738708,0.8695652173913043,0.992591907612617,1.0,3/6,18.77%,PHF19;OGT;MACROH2A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.4260719439983076,-0.6822239971510835,0.8703703703703703,1.0,1.0,2/6,28.45%,HLA-F;CUEDC2
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.36308003735565797,-0.6818337297976734,0.8958333333333334,1.0,1.0,3/14,14.00%,TMBIM6;RPS13;RPS26
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.27160843245993854,0.681679305793077,0.9833333333333333,0.9927089449713556,1.0,11/70,15.76%,RMI1;MMS22L;WRN;RNF138;BRCA1;RPA1;LIG3;SMC5;POLQ;XRCC3;CDC7
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.3585959440573945,-0.6815571074567567,0.9565217391304348,1.0,1.0,2/15,6.09%,SYNE2;MYO1D
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.33735429291648633,-0.6812814069180868,0.9137931034482759,0.9999063500954176,1.0,3/28,7.53%,CHRNA4;GNA11;SRI
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.3417331719993212,-0.6804484616932883,0.8958333333333334,1.0,1.0,5/16,17.39%,GAPDH;TPI1;PGAM1;ADPGK;PKM
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.30479167039367877,-0.6803899009977159,0.8913043478260869,0.999819191472021,1.0,5/35,15.65%,SYT11;ARL6IP5;FER1L5;RACK1;SNX12
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.2915282166538803,-0.6802168874765875,0.9183673469387755,0.9994875195498762,1.0,3/32,10.20%,PCGF2;CBX5;RING1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3596420039085534,-0.6801051362912653,0.8979591836734694,0.9992037625380099,1.0,1/14,5.44%,PDGFRA
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.4297804194246844,-0.6800772318315503,0.8333333333333334,0.998763240721813,1.0,2/5,13.40%,ALKBH2;TDG
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.4429198043803172,0.6800567320999374,0.8913043478260869,0.9936175612644665,1.0,4/6,37.38%,AKR1C3;SIRT5;DGKQ;H6PD
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.40897249486223586,-0.678208918897794,0.8431372549019608,0.9999925647914528,1.0,4/10,14.09%,MAGT1;NIPA2;MMGT1;NIPA1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),0.29773229115564603,0.6780745612611777,0.9333333333333333,0.9948922837142001,1.0,8/37,18.60%,TYRO3;TIRAP;NMI;PARP9;IRF1;APPL2;POLR3G;SAMHD1
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.38828126855353085,0.6780614980623518,0.9302325581395349,0.9944425132423582,1.0,2/11,10.93%,EPHA4;SPTBN4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.28164511616473226,-0.6778435120544009,1.0,0.9998706052547736,1.0,6/58,12.15%,GSTP1;PDGFD;SMPD1;LYN;SPRY1;UCHL1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.34721839733063253,0.677563836372926,0.9387755102040817,0.9943774130001171,1.0,1/17,6.24%,CECR2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.3673175102272923,0.6774887829079644,0.8653846153846154,0.9939768445045342,1.0,2/14,5.05%,NR4A3;PTPRJ
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.292406890326773,0.6772846389154547,0.9565217391304348,0.993709022794105,1.0,6/50,10.28%,NEDD4L;ARIH2;UBR5;RNF152;HACE1;KLHL3
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3180291633645365,-0.6772748888207862,0.9583333333333334,0.9995462821876029,1.0,3/26,8.54%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3180291633645365,-0.6772748888207862,0.9583333333333334,0.9995462821876029,1.0,3/26,8.54%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.3895898235157332,0.6769664240018216,0.8775510204081632,0.9935781790027268,1.0,1/11,4.56%,TRAK1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.451864467315212,-0.6765112107576721,0.8541666666666666,0.9998424712318515,1.0,2/5,18.40%,ACOX1;ABCD2
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.43890668308764924,-0.6764229426955335,0.8611111111111112,0.99944083992758,1.0,1/8,1.82%,BAD
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.4628894420571005,-0.6755817279711139,0.8648648648648649,0.9998980658407176,1.0,2/5,36.09%,DCLRE1A;DCLRE1C
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.25651868094630853,0.6749700370018485,1.0,0.994814198512901,1.0,4/105,6.06%,EFHC1;SGO2;RANGAP1;XPO1
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.427243879002698,0.6748960406319492,0.8269230769230769,0.9944582241648282,1.0,1/6,3.43%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.43969099363901,0.6748407030968516,0.8541666666666666,0.9940937608949683,1.0,1/5,10.72%,CBFB
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3096903443446474,-0.6747573430029268,0.9607843137254902,1.0,1.0,4/28,11.97%,LPCAT1;FADS1;TPI1;PCYT2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.43405100454613404,-0.6746418891063022,0.8596491228070176,0.9994294707384369,1.0,1/5,3.65%,HES5
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.43405100454613404,-0.6746418891063022,0.8596491228070176,0.9994294707384369,1.0,1/5,3.65%,HES5
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.32028017502996486,0.6734230724838962,0.94,0.9948435591086495,1.0,7/25,20.35%,MKLN1;DLG4;ARRB2;MAGI2;ARRB1;ATXN2;AHI1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.32600430677985853,0.6731729255884561,0.9122807017543859,0.9946420844093509,1.0,7/24,15.32%,RAD9A;FBXO6;CDC5L;ATM;TP53BP1;CLOCK;DONSON
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.2393426238394547,0.6730629546248865,1.0,0.9942780304687283,1.0,15/151,12.77%,PTPRC;STAT6;FOXP1;RAB1A;RIPK1;BRCA1;RORA;TIRAP;RFTN1;SULF1;RARA;IL6ST;CARD11;IL6R;PIK3CD
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.43936925102197855,-0.6721123845053529,0.9230769230769231,1.0,1.0,2/5,27.63%,DHX33;EIF2AK2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.3305183782409077,-0.671236659888335,0.9130434782608695,1.0,1.0,7/21,19.46%,SYAP1;TIPRL;EIF4EBP2;AKT1;NPRL3;MEAK7;MLST8
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3878736878373596,-0.6709710712055535,0.8518518518518519,1.0,1.0,2/9,10.38%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.391156217655562,-0.6708557370763603,0.8627450980392157,1.0,1.0,2/11,6.43%,THY1;DUSP3
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.3300082269942952,0.6706438111849302,0.8863636363636364,0.9959456977096651,1.0,6/16,19.49%,CAV3;KCNMB4;TPM1;CAMK2D;KCNQ1;AGT
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4078794614199105,-0.6703986772899525,0.86,1.0,1.0,4/8,31.78%,MAD2L2;RPS27L;ING4;KAT5
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.3765501530021631,0.6703272756871537,0.9111111111111111,0.9958275038169506,1.0,2/8,8.80%,RBM15;OXSR1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.32019974245302824,-0.6693804109518956,0.9787234042553191,1.0,1.0,3/30,9.50%,UBL5;TOMM7;HAX1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.3714141857476378,0.6679506572669925,0.8823529411764706,0.9976247657474582,1.0,5/9,21.99%,RBSN;SORT1;GAK;ANKFY1;CCDC91
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.30801911259936116,0.6666870304387558,0.9344262295081968,0.9982084885713123,1.0,3/32,5.32%,ACACB;HCN1;RYR3
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.4110515828495981,0.6662032011521958,0.8703703703703703,0.9972465102004952,1.0,1/5,17.92%,UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.4110515828495981,0.6662032011521958,0.8703703703703703,0.9972465102004952,1.0,1/5,17.92%,UHRF1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.4110515828495981,0.6662032011521958,0.8703703703703703,0.9972465102004952,1.0,1/5,17.92%,UHRF1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),0.3623589403950447,0.6660768594421305,0.8571428571428571,0.9968913606867223,1.0,4/12,22.58%,RB1CC1;UBA5;ULK2;ATG2B
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.36974684094038035,0.665890518531506,0.847457627118644,0.9965978661985075,1.0,3/12,16.04%,TP53BP1;SHLD2;RIF1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.2646120205758989,-0.6656833110700913,0.975,1.0,1.0,16/81,19.25%,RHOC;PIH1D1;HSPA8;BRK1;CLU;SAR1B;CDC42;RACK1;PARK7;ANKRA2;HSPA5;VCP;BAX;SUMO1;RAF1;SLF2
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.4358330356698592,0.6653106614036355,0.8461538461538461,0.9966768689325136,1.0,2/6,8.72%,AHCYL1;CA2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.29822328189624653,-0.6644975988607024,0.9361702127659575,1.0,1.0,8/35,17.95%,RANGRF;RHOG;CLIP3;RACK1;LRP1;ZDHHC8;AKT1;WNK3
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2646147194068686,0.6641288056735387,1.0,0.9972329228081467,1.0,4/63,7.75%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.44829877690856423,-0.6640241383041702,0.8666666666666667,1.0,1.0,1/5,5.18%,E2F4
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.4140957013658723,-0.6637934693628221,0.8214285714285714,1.0,1.0,3/6,28.58%,MCM4;MCM7;MCM3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.3072042738946039,-0.6637859220825235,0.8888888888888888,1.0,1.0,5/21,19.05%,VPS35;MFF;FIS1;RALBP1;MUL1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.3335909776622652,-0.6634344278096667,0.9459459459459459,1.0,1.0,1/10,6.34%,TIPARP
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.3652674495844033,0.6629950139022932,0.9,0.9976878468411743,1.0,3/15,17.43%,THRAP3;DAZAP1;CELF3
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.4027917013624789,-0.6624246145910311,0.8333333333333334,1.0,1.0,2/7,8.05%,CD63;LIMS1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.4149075517327906,-0.6620091258249274,0.8775510204081632,1.0,1.0,1/7,3.58%,EEF1A1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.3724796223924754,-0.6612712254499834,0.84,1.0,1.0,3/11,27.06%,CHMP2A;CHMP5;CHMP7
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3846380011622023,0.6609822001728419,0.8076923076923077,0.9988508461804253,1.0,4/11,21.48%,SPTBN4;B4GALT5;ARHGAP35;MYCBP2
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.39282846564061025,0.6607386224658447,0.9056603773584906,0.998592102788594,1.0,3/9,26.08%,PPARG;NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.27613580958853406,-0.6605727868925753,0.98,1.0,1.0,12/49,16.89%,BAD;BEX3;NGF;NLRP1;AIFM1;MTCH1;CASP9;SMAD3;RACK1;VCP;PDCD2;BAX
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.3566303096221,-0.6603568018464708,0.8863636363636364,1.0,1.0,2/10,14.24%,LYN;RC3H1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.43178646827918965,0.6598103862380068,0.9310344827586207,0.9988404455491994,1.0,2/5,13.25%,RYR2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.28368553715557787,0.6593751434431897,1.0,0.9987610049470551,1.0,11/46,24.53%,NPAS2;RIPK1;NMI;NLRP12;SNCA;POLR3G;AGT;PDCD4;POLR3B;NFKBIA;NFKBIZ
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.3467815156171988,-0.6588642209809742,0.9024390243902439,1.0,1.0,2/18,8.24%,THY1;RCC2
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.3445372387538151,-0.6586097685136367,0.8367346938775511,1.0,1.0,4/10,18.52%,CAMSAP3;CDC42;MSN;RAP2A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.2918376079178831,-0.6584957348921393,0.9615384615384616,1.0,1.0,5/31,12.83%,MT2A;IRF3;HLA-B;CD44;B2M
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3754919690286883,-0.6580664432670716,0.9130434782608695,1.0,1.0,3/10,21.03%,BTN3A3;IL18;JAG1
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.38044808521752316,-0.6576095337149154,0.8372093023255814,1.0,1.0,4/12,14.20%,CD63;LIMS1;SLC2A10;TIMP1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.294165034312584,0.6566277716978479,0.96,1.0,1.0,4/32,14.53%,DND1;FTO;CPEB3;GIGYF2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.31591290020662344,0.6563239734587724,0.9629629629629629,1.0,1.0,8/20,29.33%,TCAF1;ANK2;ANK3;DMD;PDZK1;SLC6A9;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.3281197118649173,-0.6562785981719119,0.9111111111111111,1.0,1.0,5/22,12.89%,AMOTL2;DCHS1;YWHAB;YAP1;AMOT
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3189136409568444,-0.655458640215147,0.8775510204081632,1.0,1.0,2/21,10.50%,PARP1;KMT5B
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.3009448816228801,0.6554246525400581,1.0,1.0,1.0,11/29,23.03%,EPHA7;FOS;SNCA;MAP3K5;SRPK2;GRIN2B;PICALM;FOXO3;EFNB2;MAPT;NF1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.40324154244936156,-0.6554217710537247,0.8867924528301887,1.0,1.0,3/7,21.90%,GTF2H2;CHTOP;MSH3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3234654950548497,0.654732186564296,0.8518518518518519,1.0,1.0,2/16,11.19%,ADSS2;AK3
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.34393176490350236,-0.6544276846365433,0.9074074074074074,1.0,1.0,1/12,3.16%,S100A1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.2759712414811434,-0.6542236014355157,1.0,1.0,1.0,8/58,13.92%,UBB;VPS35;WNT5A;SIGMAR1;CLU;ZNF746;PARK7;PRNP
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.3790916322139678,0.6540166411026689,0.8909090909090909,1.0,1.0,3/9,25.85%,SIN3A;ATRX;MIER1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.2884744726820041,0.6538738736255512,0.9807692307692307,1.0,1.0,9/29,22.80%,BAG5;GFAP;RAP1B;BBS10;TJP1;AGT;TRAF2;DAB2IP;APOE
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.3414724717930363,-0.653162947684464,0.8679245283018868,1.0,1.0,4/16,14.69%,RHOG;SCARB1;RHOBTB1;LRP1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.3769829305341744,0.6527562817156319,0.8863636363636364,1.0,1.0,6/11,23.20%,CAMK1D;MPP1;CSF1;MAPK3;MAPK1;IL34
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.3421288250803446,0.6522502662301403,0.9107142857142857,1.0,1.0,2/13,10.96%,PHLDB2;KNG1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.32008353694332053,-0.6515869589547685,0.9591836734693877,1.0,1.0,5/17,18.40%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.380008756435868,0.6513968936545003,0.7962962962962963,1.0,1.0,2/9,11.37%,ALOX12;PRKG1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.3550055462789463,-0.6513012641888614,0.9272727272727272,1.0,1.0,1/15,2.36%,VEPH1
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.377357227341777,-0.6511795973472294,0.9090909090909091,1.0,1.0,1/8,9.16%,NGF
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.3784177531402413,0.650764604361434,0.86,1.0,1.0,1/8,10.29%,BMP7
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.35530049771707806,-0.6506737465061647,0.9130434782608695,1.0,1.0,1/10,7.65%,SLC25A30
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.35530049771707806,-0.6506737465061647,0.9130434782608695,1.0,1.0,1/10,7.65%,SLC25A30
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.3899791177270147,-0.6506064103932999,0.9574468085106383,1.0,1.0,3/9,14.93%,ISCU;PARK7;STIM1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3005436320211393,-0.6505380308853936,0.9534883720930233,1.0,1.0,7/27,14.28%,ASAH1;SLC25A15;SMPD1;FURIN;SPTLC1;SAMD8;CERS2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.3672139816873254,-0.6503270107239871,0.8936170212765957,1.0,1.0,3/10,22.52%,SAR1B;TMEM30A;CD81
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.3905497118147267,-0.6502769977359215,0.8695652173913043,1.0,1.0,3/8,18.68%,CLU;GRN;CX3CL1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.41387090018091255,0.6499079178882582,0.8888888888888888,1.0,1.0,2/6,24.16%,ADARB2;APOBEC2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.31584527278147106,-0.6497838054164159,0.9830508474576272,1.0,1.0,7/27,15.07%,LPCAT1;IDI1;FADS1;SPHK2;PCYT2;SAMD8;FDPS
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.34807709535298287,0.6496769071712221,0.9433962264150944,1.0,1.0,2/15,5.89%,GCLC;CHAC2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.3964860302315805,0.6486479087117843,0.8928571428571429,1.0,1.0,5/8,39.77%,DNAJB1;HSPA2;DNAJB6;DNAJA4;SACS
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.30905909320010094,0.6485894682755581,0.8723404255319149,1.0,1.0,6/24,23.31%,CENATAC;CEP131;XRCC3;PLK2;ALMS1;C10ORF90
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.3424280594064528,0.6484166010603014,0.9090909090909091,1.0,1.0,4/15,19.37%,MRAP;AP2M1;PPFIA1;PICALM
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.3589275322921431,0.6482290399516243,0.9215686274509803,1.0,1.0,3/13,11.74%,TCOF1;FBXL17;NRG1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3087547399363836,0.6477054997367291,0.9444444444444444,0.999987354268113,1.0,2/21,10.97%,WRN;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.3143593809237201,0.6473600184769724,0.9615384615384616,0.999730400929362,1.0,9/26,29.83%,KCNN3;KCNMB4;ANK2;KCNQ1;KCNJ16;KCNMA1;KCNMB3;DLG1;GABBR2
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.36671309344588626,0.6473523332605912,0.9272727272727272,0.9993004465200945,1.0,1/9,6.23%,ADSS2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2620431977079241,0.6469373038041037,1.0,0.99916090261772,1.0,4/65,7.75%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2552872187332722,0.6468181843744393,1.0,0.9988008111284451,1.0,4/66,7.75%,RACGAP1;KIF3C;OSBPL1A;KLC1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.35291971988843485,0.6467761607399803,0.9574468085106383,0.9983804887188105,1.0,2/12,13.67%,FOXP1;CSF1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.3665739751753775,0.6467182380915507,0.8703703703703703,0.997977830341508,1.0,5/10,38.28%,SCFD1;MTM1;SMCR8;CHMP4B;LRRK2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.3595348958060001,-0.6464518910723592,0.8813559322033898,1.0,1.0,1/12,3.57%,MYH3
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.3595348958060001,-0.6464518910723592,0.8813559322033898,1.0,1.0,1/12,3.57%,MYH3
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.27339705967691386,-0.6462424903940068,1.0,1.0,1.0,5/43,8.83%,SLC35B4;LRRC8D;SLC25A24;SLC25A4;ABCG2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.29812351416349736,-0.6457167765026007,0.9591836734693877,1.0,1.0,4/40,7.02%,RPL10;PCIF1;VPS35;EDNRB
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.25911857212057354,-0.6456878101091215,1.0,1.0,1.0,14/56,21.88%,SMC1A;TUBGCP4;MZT1;GOLGA8A;HDAC3;HAUS8;GOLGA8B;NUMA1;KIF3B;BCCIP;GOLGA2;STARD9;MAP9;TOGARAM2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.3054305840006992,-0.6451615377183423,0.9565217391304348,1.0,1.0,2/19,8.01%,RPS19;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.39692140488676253,-0.6450941200637489,0.8958333333333334,1.0,1.0,2/9,6.43%,THY1;DUSP3
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.38701749473043057,-0.6446909899946883,0.9183673469387755,1.0,1.0,1/10,2.08%,MPDU1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.38701749473043057,-0.6446909899946883,0.9183673469387755,1.0,1.0,1/10,2.08%,MPDU1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.3398014878209918,0.6446187895049648,0.8813559322033898,0.9991181772352232,1.0,2/13,7.02%,CAV3;PLPP4
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.36020017041119995,-0.6445571844563773,0.896551724137931,1.0,1.0,1/13,3.65%,HES5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.4393998736580049,0.6445238056840752,0.9245283018867925,0.9987544218742155,1.0,1/5,1.93%,WNT7A
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.4125025080740699,-0.6442509526695089,0.875,1.0,1.0,1/5,10.63%,CFAP100
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.3183795634544976,0.6439458536046238,0.9491525423728814,0.9986672969139391,1.0,5/26,20.50%,PTPRJ;ARRB2;MAGI2;PPP2R5C;NOP53
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.34247282426772546,0.6436556809295629,1.0,0.998437839926547,1.0,3/16,19.25%,WASHC1;DCUN1D2;ITCH
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.29361723087419445,0.6435710470625537,0.9454545454545454,0.9980619258295196,1.0,1/30,1.79%,RACGAP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.351418756823836,-0.6433047076474051,0.9148936170212766,1.0,1.0,6/12,20.31%,CHCHD10;SLC25A5;BAX;MUL1;ZNF205;ACAA2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3386194959600458,0.6427066463954427,0.9074074074074074,0.9982942812036797,1.0,3/13,31.20%,ATRX;ATP2B4;RTF2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3653704886276601,0.6425798860723869,0.8888888888888888,0.9979704784751563,1.0,3/13,8.61%,SLC39A14;SLC30A9;SLC39A11
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.423829798206783,0.6425614284299191,0.9019607843137255,0.997125656672344,1.0,4/5,27.46%,SLC16A10;CRYM;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.423829798206783,0.6425614284299191,0.9019607843137255,0.997125656672344,1.0,4/5,27.46%,SLC16A10;CRYM;SLC16A2;SLC7A5
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.3972442584389271,0.642472659614887,0.8979591836734694,0.996742539971881,1.0,2/6,17.98%,BMP7;PKD2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.37378511329456376,0.6420619760605953,0.8823529411764706,0.9965447519930055,1.0,1/8,7.72%,RAB20
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3713080702093666,0.6418651380110693,0.9183673469387755,0.9962181310109768,1.0,3/9,33.96%,CIITA;RGCC;LARP6
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.2990695474976973,-0.6414395515811309,0.9782608695652174,1.0,1.0,3/29,8.54%,PRICKLE1;SEMA4C;FUZ
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.35409108613100276,0.641417837300571,0.9787234042553191,0.9960895210945692,1.0,1/13,5.63%,PSEN1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.3618257126408352,-0.6413144822130035,0.9230769230769231,1.0,1.0,2/12,10.38%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.3951489651829257,-0.6408314771388317,0.9,1.0,1.0,3/7,21.45%,MCM4;MUS81;MCM7
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.35561749464237147,-0.6403436534806501,0.86,1.0,1.0,3/11,16.51%,ZFP36L1;PAF1;CDC73
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3493315746423358,-0.6403010609763317,0.95,1.0,1.0,1/11,3.65%,HES5
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3217972898861686,-0.6394008255224601,0.9423076923076923,1.0,1.0,2/16,8.54%,PDGFRA;FUZ
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.3354975613036258,-0.6393757166997788,0.9,1.0,1.0,4/15,16.89%,ATF4;GRN;PRNP;BAX
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.32758615483064246,-0.6391494636700527,0.9433962264150944,1.0,1.0,2/23,4.32%,SNCAIP;SYT11
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.3401624190147359,-0.6387658174782861,0.9636363636363636,1.0,1.0,1/13,2.96%,GABARAPL2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.29173098658809954,0.6387434759147441,0.9807692307692307,0.997473376083993,1.0,5/29,17.47%,SYBU;NEFL;FBXW11;KIF1B;DST
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.3250640821321148,-0.6386663016520971,0.96,1.0,1.0,4/15,22.35%,KPNA2;KPNA4;KPNA1;RGPD1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.33543398470973507,-0.6385279506032022,0.9,1.0,1.0,4/15,20.35%,CACTIN;LYN;GRAMD4;NFKBIL1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3241868699124977,0.6381968886679593,0.8888888888888888,0.9974173352963042,1.0,4/23,13.98%,TENM3;PVR;TENM2;CADM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.31411785695301614,0.6374099790993496,0.9302325581395349,0.9975459289853925,1.0,3/14,16.59%,TYRO3;IRF1;APPL2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.38782336302372256,0.6372272898149955,0.9230769230769231,0.9971981314285452,1.0,3/8,27.74%,TAMM41;LCLAT1;PNPLA8
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.42294775119218825,0.6370636789770665,0.9411764705882353,0.9968506390911425,1.0,1/5,6.80%,SLC16A10
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3622954423906842,-0.6368355762508603,0.8823529411764706,0.999920157281857,1.0,1/10,9.23%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3622954423906842,-0.6368355762508603,0.8823529411764706,0.999920157281857,1.0,1/10,9.23%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3622954423906842,-0.6368355762508603,0.8823529411764706,0.999920157281857,1.0,1/10,9.23%,ANAPC11
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.3653195971649195,-0.6362662219146519,0.9069767441860465,0.9998298171572055,1.0,4/11,20.94%,FADS1;ACOX1;ACOT8;FADS2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.35196084125615823,-0.6353688122620154,0.8913043478260869,0.9999739604185005,1.0,3/9,20.15%,CST3;LRP1;DDR1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.4246844859130277,0.6352944808794061,0.8478260869565217,0.9976395150644616,1.0,2/5,26.56%,UBE2K;PRKN
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.2809279043973149,0.6351815276363678,0.9629629629629629,0.9972792784490343,1.0,3/37,9.48%,ADAMTS9;RIPK1;FBXO6
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.369609766883877,-0.6347596855385264,0.9183673469387755,0.9999296178287423,1.0,1/6,7.53%,SRI
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.3420509311772174,-0.6338835806182138,0.9361702127659575,1.0,1.0,3/16,12.55%,MYBBP1A;CAV1;ZNF304
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.3142529997455826,-0.6336450245274009,0.9615384615384616,0.9998548217321432,1.0,5/17,16.47%,CDC37;SLC25A4;STUB1;PELI1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.28902172861955444,0.6331767777818835,0.9629629629629629,0.9980929748461572,1.0,3/29,8.60%,ABCA2;PROX1;BRCA1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3127222444484199,-0.6330283071732857,0.9591836734693877,0.9997922405739218,1.0,3/17,9.16%,BAG3;DELE1;NGF
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.3978824686860271,0.6329904378443546,0.9038461538461539,0.9977713877756651,1.0,1/5,3.01%,PHF19
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.4088244836502919,-0.6328756384165354,0.8518518518518519,0.9994637372119217,1.0,1/6,10.14%,DCHS1
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.3276990363446339,0.6326526657560904,0.9375,0.997565629456072,1.0,6/15,27.23%,BORA;ANKRD53;CLTC;RNF4;SENP6;TACC3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3937845855433061,0.6326496203780484,0.9166666666666666,0.9971290580646253,1.0,1/5,17.89%,STAT3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.3658041295961311,0.6322284557174831,0.9166666666666666,0.9969451396451653,1.0,2/8,17.89%,PRKCZ;STAT3
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.4243152300582585,0.6319632584302931,0.8688524590163934,0.9966929994975487,1.0,1/5,9.02%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.40331797502152533,0.6318049313309638,0.8867924528301887,0.996381271158194,1.0,1/5,3.76%,LRP2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.37636604171356014,0.6313384371086026,0.84,0.9962278117049467,1.0,1/6,15.85%,AGK
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.35876927650166124,-0.6310708868548225,0.9565217391304348,1.0,1.0,1/11,3.57%,MYH3
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.4013990306227037,0.6310548647520294,0.9019607843137255,0.9959336320017295,1.0,2/5,28.76%,ASH1L;SETD2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3660666181985879,-0.6309537541222338,0.8936170212765957,1.0,1.0,4/10,13.89%,GPR37L1;PYCR1;RACK1;PARK7
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.34860690266794764,-0.630629857037456,0.9655172413793104,0.9997256628711891,1.0,10/10,65.17%,RRAGD;LARS1;SESN3;EIF2AK4;SESN2;SESN1;GCN1;RRAGB;MTOR;IMPACT
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3586296120906719,0.6304279121571147,0.9615384615384616,0.9959682256314938,1.0,1/12,6.23%,ADSS2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.36301736218164454,0.6298867305178396,0.9038461538461539,0.9954575914957271,1.0,1/10,11.59%,ELOVL2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.36301736218164454,0.6298867305178396,0.9038461538461539,0.9954575914957271,1.0,1/10,11.59%,ELOVL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.3175028679694481,-0.6291592762917606,0.9285714285714286,0.9997061900258808,1.0,5/18,23.34%,PARP1;GTF2H2;CUL4B;GTF2H1;GTF2H5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.3175028679694481,-0.6291592762917606,0.9285714285714286,0.9997061900258808,1.0,5/18,23.34%,PARP1;GTF2H2;CUL4B;GTF2H1;GTF2H5
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.2917962240219593,0.6284766262260412,0.9696969696969697,0.9959184342827277,1.0,9/28,21.51%,BRCA1;BABAM2;ATM;DONSON;CHFR;CDC14B;NOP53;TAOK1;BRSK1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.3751324110255002,-0.6282404201957376,0.9298245614035088,0.9999365776573272,1.0,3/9,21.90%,IFIT1;CHTOP;MSH3
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.34632696584639716,-0.6271648376858775,0.813953488372093,1.0,1.0,4/11,26.79%,CAV1;EXOC7;TRIM5;TRIM25
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.30192443614659636,-0.6269543427995093,0.94,0.9998072755756819,1.0,2/20,9.09%,PIF1;DACH1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.29772133219088515,0.626683028812318,0.9454545454545454,0.9965662720019911,1.0,2/21,11.26%,TULP3;SUFU
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.38211583548186445,-0.6263856557469009,0.9,0.9997312924858321,1.0,1/8,1.92%,ATF4
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.36041376976508693,0.6251048987559172,0.9636363636363636,0.9970688020558158,1.0,1/13,1.21%,TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.2503564928425606,0.6244786121711863,1.0,0.9970134497446485,1.0,16/63,24.53%,PRKCA;SASH1;RIPK1;NMI;P2RY12;NLRP12;SNCA;ZCCHC3;POLR3G;AGT;PDCD4;POLR3B;PPM1F;ANKRD17;NFKBIA;NFKBIZ
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.34197406053943036,-0.6237034736489621,0.9038461538461539,1.0,1.0,2/12,10.38%,LDLR;SCARB1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.33955855696708404,-0.6235194199593092,0.8846153846153846,1.0,1.0,1/8,11.60%,FURIN
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.30085332174684076,0.622698316761332,0.9827586206896551,0.9977577946144817,1.0,3/25,9.25%,PRKX;EMP2;PTP4A3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.30773739994403804,0.6225833762263985,1.0,0.9973875722140676,1.0,3/22,13.17%,ABCA2;PAQR7;CATSPERG
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.2815243662934457,-0.6223716269978607,0.98,1.0,1.0,3/29,8.82%,PPP4C;USP51;FIGNL1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3221968855543053,0.6223172966110575,0.9148936170212766,0.997128165337411,1.0,3/14,19.81%,RIPOR2;ARHGAP35;ABL2
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.29735918787008536,-0.6220243778829506,0.96,1.0,1.0,5/22,18.40%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.40453009954617025,0.6219918700660956,0.8979591836734694,0.9968052653350227,1.0,1/5,4.82%,TIMP3
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.28502695543188916,-0.6210044793729782,1.0,1.0,1.0,5/24,18.40%,ATAD1;ACBD5;FIS1;PEX13;ABCD2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.3235623688935986,0.620915323266539,1.0,0.9970728483894765,1.0,2/16,13.13%,IHO1;SYCE2
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.4169144707365238,-0.6205258234102891,0.8979591836734694,1.0,1.0,1/5,4.74%,MALT1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.31631284950950683,-0.6204171863118363,0.9607843137254902,0.9999207095576533,1.0,2/18,13.57%,SMDT1;FIS1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.36586866847138266,0.6203748931596449,0.9148936170212766,0.9965255119239962,1.0,2/6,16.64%,OXSR1;ADAM10
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.36586866847138266,0.6203748931596449,0.9148936170212766,0.9965255119239962,1.0,2/6,16.64%,OXSR1;ADAM10
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.3250614271482996,-0.6199129233552667,0.9565217391304348,0.9997903320131101,1.0,4/14,12.99%,PDGFRA;WNT5A;FUZ;SLC2A10
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.2783524535935358,0.6198967717067329,1.0,0.9963984983314479,1.0,6/31,18.78%,RAD18;UBE3D;UBE2D3;UHRF1;OBI1;DTX3L
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.3763929483256406,-0.6195665675096134,0.9512195121951219,0.999559988752497,1.0,4/8,16.73%,SMPDL3A;SMPD1;SAMD8;SMPD3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.32971613535260746,0.6190515367001646,0.9090909090909091,0.9964241879556104,1.0,1/14,4.45%,NTRK3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.3563771272456674,0.6188789520597723,0.95,0.9961024328935758,1.0,2/12,18.43%,PUDP;UCK1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.40646371102296597,-0.618763544118834,0.9230769230769231,0.9996526971111066,1.0,1/7,12.75%,PPP2R1A
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.3583657893470058,0.618480373531517,0.8947368421052632,0.9958995372925927,1.0,2/6,16.59%,GRB10;APPL2
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.35525152677195976,0.6182045059424776,0.9622641509433962,0.9957095170014475,1.0,1/11,8.70%,DDB2
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.36700544577081445,0.6177194134405695,0.9433962264150944,0.995587362930958,1.0,1/8,7.79%,PVR
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.2780472455226735,-0.617496767375305,0.9777777777777777,1.0,1.0,7/34,17.77%,RPS19;LYN;SLC25A5;UFL1;HSPA9;PRDX3;RPS14
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.2773964381124132,-0.6173117457490386,0.9836065573770492,0.9997242893737724,1.0,1/24,4.30%,MAP1S
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.35586585283911687,0.6171736052413288,0.9148936170212766,0.9955033803039036,1.0,3/12,14.49%,SLC39A14;SLC39A11;SLC39A13
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.29721958560018746,-0.6158736574265352,0.9782608695652174,1.0,1.0,3/15,16.65%,VPS11;SNX12;MSN
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.30831623366052674,-0.6149563680074028,0.8863636363636364,1.0,1.0,2/18,7.94%,PDGFRA;ARL1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.26947096120078656,-0.6149168637376582,1.0,0.9997021334247324,1.0,6/41,16.45%,GPC4;PARP1;HSP90AB1;GPC1;RAB11B;VCP
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.39831819438040594,-0.6148953295636959,0.9795918367346939,0.9992684656622028,1.0,2/6,22.31%,BHMT;ADI1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.3360693573988054,-0.6144593869352725,0.9807692307692307,0.9991434293326275,1.0,2/12,12.55%,CAV1;ZNF304
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.3585082648049417,-0.6130853311301365,0.9795918367346939,0.9994716082040718,1.0,2/9,19.48%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.35723292709342586,0.6126525276270106,0.9375,0.997520635220733,1.0,4/11,22.28%,TIRAP;APPL2;NR1D1;DAB2IP
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.324603820679196,-0.6122181717620346,0.9230769230769231,0.9995639866225314,1.0,2/10,13.16%,PORCN;WDR45B
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.3265833863642713,-0.6120928024319262,0.9318181818181818,0.99874846495616,1.0,1/7,8.36%,SIGMAR1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.3265833863642713,-0.6120928024319262,0.9318181818181818,0.99874846495616,1.0,1/7,8.36%,SIGMAR1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.319126570479033,-0.6106690861287805,1.0,0.9990310080593738,1.0,3/17,16.95%,HAX1;PARK7;CSNK2A2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.2844680390624413,-0.6104721010856736,0.9787234042553191,0.9986984398030981,1.0,6/36,12.86%,LRP10;MAPK13;OSTF1;ISG20;LITAF;CDC42SE1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.39068609857949704,-0.6103894772437969,0.9545454545454546,0.99828934125937,1.0,3/7,19.90%,SEMA5A;SCG2;TEK
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.27986755096028926,0.6103113575611635,0.9423076923076923,0.9982345784662908,1.0,5/30,14.96%,B3GNT5;ST6GALNAC5;LARGE1;PIGH;MPPE1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.2835022848592211,0.6101104909100342,0.96,0.9979214624539818,1.0,5/32,11.84%,USP30;ATG7;RB1CC1;ATG5;MAP1LC3B
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.34030098580393414,-0.6098169821219871,0.9375,0.9981245245811804,1.0,1/12,4.19%,PHF1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.35780555620238574,0.6096713322032549,0.8979591836734694,0.99734668634168,1.0,2/8,28.21%,SREBF1;ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.35780555620238574,0.6096713322032549,0.8979591836734694,0.99734668634168,1.0,2/8,28.21%,SREBF1;ARHGEF10L
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.3231760840492698,-0.609394492081682,0.9777777777777777,0.9975606472554814,1.0,4/15,17.39%,GAPDH;TPI1;PGAM1;PKM
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.3231760840492698,-0.609394492081682,0.9777777777777777,0.9975606472554814,1.0,4/15,17.39%,GAPDH;TPI1;PGAM1;PKM
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.24050685768213254,0.6092544958993165,1.0,0.9971904461445554,1.0,15/80,17.13%,TIAM1;GNA14;RPTOR;ITPR2;PRKAR2A;RIPK1;MAPK10;MKNK1;PRKAA2;STAT2;AP2M1;UBE2D3;ACACA;IRAK4;MAP2K3
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.3342860412733111,0.6085253596182986,0.875,0.9971439763271703,1.0,2/11,10.48%,DND1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.33932072565150384,0.6078460210848579,0.9245283018867925,0.9970722569803371,1.0,2/8,16.59%,GRB10;APPL2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3223487564271246,0.6078149246795878,0.9583333333333334,0.9966677631619943,1.0,6/12,23.20%,PRKCA;RIPK1;CSF1;ACIN1;TRAF6;IL34
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3485345312315141,0.607556285163329,0.9245283018867925,0.9963689004571403,1.0,1/8,4.88%,ABCA2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.3403589071559677,-0.6074669617484011,0.8823529411764706,0.9981497205924398,1.0,1/7,8.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.38826549760419116,0.6067020848786235,0.8867924528301887,0.9963439119447989,1.0,2/5,15.57%,FOXP1;BCL6
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.292720809747467,0.6064613143880234,1.0,0.9960075768675769,1.0,6/29,17.64%,ZHX3;BMP7;IL6ST;IL6R;NELL1;TP63
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.35110004536132317,-0.6060748163863318,0.8979591836734694,0.9984046018575833,1.0,3/10,13.33%,CD44;TWF1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.3756983844858143,-0.6052927918973808,0.9615384615384616,0.998411367490053,1.0,1/6,23.11%,SETMAR
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.25203769646249913,0.6052422392716638,1.0,0.9961594117156439,1.0,7/53,13.21%,KIAA0319;NUP93;BMP8A;BMP7;SULF1;STK11;GDF11
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.36671888756614424,0.6048282928607557,0.9056603773584906,0.9959705873170727,1.0,2/6,21.73%,CNST;ACSL3
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.3790129704465047,-0.6040216896750208,0.9423076923076923,0.9986478888516798,1.0,2/8,13.45%,GINS3;MCM4
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.3982950969689383,-0.6038908554749275,0.8958333333333334,0.9982807801077094,1.0,1/5,16.45%,VCP
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.32113530742591817,-0.6036646543690339,0.9555555555555556,0.9979590058013885,1.0,4/15,16.62%,CHCHD10;MORC3;HSPA5;AKT1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.3007632162275315,0.6035121401814351,0.9666666666666667,0.9962693862568565,1.0,6/25,23.65%,ENPP2;ARHGEF7;PIK3CA;CARMIL1;ABI2;PIK3R1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.3600743602096109,-0.6032131879063862,0.9433962264150944,0.9978264803469585,1.0,2/7,12.61%,WBP2;YAP1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.36653148776707295,0.6031768753023429,0.9607843137254902,0.9960764764440976,1.0,1/9,4.05%,FOXP1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.38026563337826375,0.6030469932400729,0.9655172413793104,0.9957115881363735,1.0,3/6,26.67%,PLAAT3;PLA2G12A;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.30529200976194637,-0.6018167115004694,0.9259259259259259,0.9981168096820127,1.0,2/18,10.59%,SPRY1;CGNL1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.31215260500376507,0.6006891426658901,0.9423076923076923,0.9964843559638198,1.0,3/20,16.84%,NNMT;OGT;PPARGC1A
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.320052860121423,0.6002293977617295,0.9166666666666666,0.9962748221285063,1.0,2/12,14.98%,RIPOR2;PAG1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.2901692847750122,-0.5998275552086714,0.9767441860465116,0.9987440273193334,1.0,5/15,21.05%,MFF;FIS1;MUL1;SLC25A46;MTFR1L
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.38498127246459424,0.5995572918966774,0.9583333333333334,0.996124173377132,1.0,3/5,24.82%,ANK2;CACNA1D;KCNA5
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.24892050495845888,-0.5991364555270614,1.0,0.998624811668894,1.0,15/64,20.38%,SSNA1;TUBA1A;TUBG1;TUBB4B;PRKAR2B;NPM1;ODF2;PPP2R1A;HAUS8;DCTN3;DYNLL1;DCTN2;YWHAE;TUBB;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.3990099369587617,-0.5971601762997,0.9038461538461539,0.9992332911094923,1.0,3/5,23.37%,MKKS;NENF;PPARA
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.3102602921804879,0.596530157799259,0.9649122807017544,0.9971849793663126,1.0,4/16,18.18%,GULP1;RHOBTB2;XKR6;DOCK1
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.37674749737693713,-0.5961838829114492,0.9038461538461539,0.9993474106778018,1.0,3/5,23.88%,PARK7;PRDX3;RAB6A
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.38812941715295923,-0.5959709136920054,0.9038461538461539,0.9990037191828272,1.0,3/6,18.68%,FRRS1L;PRNP;CX3CL1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.37402836152893865,0.5955670705326502,0.9259259259259259,0.9972686895485996,1.0,4/6,40.16%,PRMT7;PCGF3;PCGF5;DNMT3A
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.3672877817284846,0.593467305570827,0.9,0.9978297424685518,1.0,1/6,8.60%,BRCA1
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.4056823045206485,-0.5933122915977095,0.9591836734693877,0.9996964556307303,1.0,1/5,5.32%,PLAAT1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.34670682443728806,0.593243753850515,0.9487179487179487,0.9974903134972536,1.0,2/9,15.62%,HABP4;SRPK2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.3052635969618669,0.5927388182526784,0.9821428571428571,0.9972515973905287,1.0,2/15,14.53%,FTO;GIGYF2
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.3259531854256348,-0.5926092759188196,0.9230769230769231,0.9995591502248946,1.0,3/7,24.02%,PLAT;DDR1;AAMP
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.3412948944568532,-0.5925648947952685,0.9423076923076923,0.999148595225627,1.0,2/9,13.65%,TENM4;RACK1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.3216151498052747,-0.5924480640574148,0.9615384615384616,0.9987921535526046,1.0,3/13,22.36%,EIF4EBP2;PAIP2;TPR
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.3024938100546033,0.5923441238598808,0.9482758620689655,0.9970089031062864,1.0,5/17,31.81%,SPP1;COL5A2;ITGAV;VAV2;PTK2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.32626679442430273,-0.5922011618795179,0.9615384615384616,0.9984942317746236,1.0,2/8,13.09%,HAS2;HDAC3
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.34468905084222184,0.5914543199228405,0.9245283018867925,0.99703398003894,1.0,1/7,5.82%,ETF1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.3198002318257369,-0.5913254088614203,0.9555555555555556,0.9985009109210633,1.0,2/10,13.89%,RFK;PARK7
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.35926895886554505,0.5909996179813948,0.8928571428571429,0.9968709852990613,1.0,2/7,15.56%,PLEKHA4;CSNK1D
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.3948759271553889,0.5909302835406319,0.9411764705882353,0.9964575033819302,1.0,2/5,16.42%,CAMK2D;ENG
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.3055243318952574,-0.5897735183496821,0.9649122807017544,0.9987357398907211,1.0,6/18,18.85%,NGF;SOX8;GPC1;SOX10;GSTM3;ERBB3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.2804228775764128,0.5895482846992174,0.9591836734693877,0.9967374784718871,1.0,4/23,17.92%,KMT2C;KMT2A;OGT;KDM6A
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.3101747804552036,-0.5875222931774098,0.9166666666666666,0.9992923252205732,1.0,4/15,22.13%,CHMP2A;NPM1;CHMP5;NAT10
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3042930083503555,0.5866783415710609,0.9661016949152542,0.9975806425090613,1.0,4/15,22.83%,NLRC5;STAT2;SAMHD1;CNOT7
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.3221398404217536,0.5852338362876922,0.9444444444444444,0.9978473839718224,1.0,2/10,18.50%,BMP7;NR3C2
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.31084989592792517,-0.5851551074521595,0.9767441860465116,1.0,1.0,4/10,19.90%,ERN1;SEMA5A;BMPER;TEK
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.3815277492074573,0.5849187590520232,0.9322033898305084,0.9975426105823525,1.0,1/5,9.45%,CCP110
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.27122406026573614,0.5847914720357972,1.0,0.9971589012945598,1.0,11/31,30.27%,PIP4K2C;PIP4K2A;SCFD1;MTMR3;TBC1D12;PIP4K2B;RAB3GAP1;RAB5A;C9ORF72;PIKFYVE;MTM1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3241405012477795,-0.5836898321758482,0.86,1.0,1.0,3/10,15.21%,PIH1D1;SPHK2;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.34849071592815284,-0.5831627083197035,0.9433962264150944,0.9999186285454147,1.0,2/9,17.73%,MADCAM1;ZP3
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.36769091241400664,0.5827396315635516,0.8666666666666667,0.9976504683765244,1.0,1/5,27.56%,ABCC3
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.3555878830399177,-0.5826530177732798,0.9622641509433962,0.9997505776040204,1.0,1/6,4.89%,AGBL1
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.36649903509363313,-0.5825368396465137,0.8958333333333334,0.9993595758831318,1.0,2/6,26.27%,HIF1AN;TMEM100
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.37042638220247437,-0.5823355228250959,0.9024390243902439,0.9990313547732501,1.0,1/7,9.16%,NGF
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.28265713595109976,-0.5820499638620282,0.972972972972973,0.9987034194457889,1.0,8/28,21.22%,UBE2L6;IRF3;CACTIN;ISG15;OTUD5;PIN1;HAVCR2;PCBP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.30700962208938043,-0.580668647019463,1.0,0.9989416967155184,1.0,1/17,5.44%,PDGFRA
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.34733287355399917,-0.5804609699287653,0.9655172413793104,0.9986274482158788,1.0,1/7,9.77%,ALDH4A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.33541034074156867,0.5794135931226366,0.9512195121951219,0.9985747401475401,1.0,2/7,16.64%,OXSR1;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.364380994773601,-0.5792642730681525,0.8448275862068966,0.9987230794884622,1.0,3/7,21.03%,TGFBR2;TGFBR1;JAG1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.3436639070655328,-0.5792393477409062,0.9615384615384616,0.9983157426337947,1.0,2/9,19.24%,BMP2;SOD1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.3560651284054624,0.5786258743898399,0.9393939393939394,0.9984908086192866,1.0,2/6,24.13%,APOE;ABL1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.30800943562935973,-0.5781328639320159,0.9411764705882353,0.9983491489557295,1.0,2/11,9.67%,CDC37;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3083924521846344,0.5776905640361091,0.9827586206896551,0.9984485595915716,1.0,5/10,29.33%,ANK3;DMD;ACTN4;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.36842494089834515,-0.5768286971485228,0.9183673469387755,0.9980380908195076,1.0,5/5,63.18%,AGPS;GNPAT;FAR1;DHRS7B;PEX7
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.36842494089834515,-0.5768286971485228,0.9183673469387755,0.9980380908195076,1.0,5/5,63.18%,AGPS;GNPAT;FAR1;DHRS7B;PEX7
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.36291097155522717,-0.5755172227735975,0.8653846153846154,0.9982226220735931,1.0,6/6,63.73%,CTCF;RAD21;DDX11;RB1;CTNNB1;WAPL
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.3381733561201168,0.5730329822330315,0.9591836734693877,0.9998912284805985,1.0,1/8,6.09%,PYGL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.291042309528995,0.5728022089873628,0.9803921568627451,0.999594808317568,1.0,3/18,9.10%,RAB1A;RIPK1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.26499874353106284,0.5717587098920951,1.0,0.9995687669767868,1.0,10/32,29.83%,KCNN3;KCNMB4;ANK2;KCNQ1;KCNJ16;KCNMA1;KCNMB3;ATP1B1;WNK1;GABBR2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.3612438655064275,0.5709166695667103,0.9245283018867925,0.9994139728342569,1.0,2/6,15.95%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.26265808741109553,-0.570588363851807,0.9803921568627451,0.9997969199794744,1.0,6/26,16.51%,LARP7;RNF8;RNF168;WDR43;EAF1;CDC73
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.33434507273545566,0.57042294983166,0.9166666666666666,0.9991638081002471,1.0,2/8,16.99%,KCND3;KCNQ1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.28004106344777874,0.5702558199595611,0.9824561403508771,0.9987768892423011,1.0,3/19,13.60%,BRCA1;ADIPOR2;PRKAA2
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.2956771770577999,-0.5689281976484879,0.9423076923076923,1.0,1.0,2/15,7.02%,CAP1;EDNRB
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.3698133082295284,-0.568827515220276,0.94,0.9997602287345513,1.0,1/6,10.64%,NUP155
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.33066468711087393,-0.5687886275639004,0.9361702127659575,0.9993361144413068,1.0,1/6,16.44%,ALDH1A2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.322269192818731,-0.5678363388748952,0.9433962264150944,0.9992271082816355,1.0,2/13,15.55%,PPP1R16A;SMG5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.355734064192744,0.5668444747159828,0.9622641509433962,0.9997676807482061,1.0,1/6,9.59%,RFTN1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.30473221510437015,-0.566477845265048,0.9772727272727273,0.999322024883486,1.0,4/17,18.37%,NABP2;DACH1;SMG5;PARP4
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.2864726351827219,-0.5662094128297367,0.9767441860465116,0.9990093788502508,1.0,1/16,3.88%,NLGN2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.33899460954161587,0.5649514731340665,0.9791666666666666,1.0,1.0,1/7,13.02%,PRIMPOL
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.35618257760335115,0.5639901577301099,0.9473684210526315,1.0,1.0,2/6,15.59%,ARRB2;KLRD1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.36420509145922086,0.5639384288557562,1.0,0.9995984124797015,1.0,2/7,19.44%,CPEB3;CPEB2
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3752816062674611,0.5616326320908398,0.9791666666666666,1.0,1.0,2/5,15.19%,ARRB2;ARRB1
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.36107264711061393,-0.561266860921746,0.9795918367346939,1.0,1.0,1/7,7.41%,EDF1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.3524781958467126,0.561049013996999,0.9107142857142857,0.9998487419751745,1.0,1/6,8.71%,NMNAT2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.2598829778609719,0.5606047183321711,1.0,0.9996116550768732,1.0,2/28,6.59%,TIAM1;GCNT2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.35247410209670166,-0.560597154207479,0.9512195121951219,1.0,1.0,6/9,30.20%,B2M;HLA-F;ERAP1;HLA-A;TAP1;ERAP2
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.28380734895069204,0.5605153482468189,0.9629629629629629,0.9992217201676433,1.0,7/15,33.28%,ARRB1;WWP2;FBXW7;LFNG;EGFR;TSPAN15;HEY1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.3425882660209281,-0.5600242649110498,0.9298245614035088,1.0,1.0,1/8,8.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.292969400413648,0.559597587015193,0.9824561403508771,0.9991628912294309,1.0,2/19,6.17%,MYLK;GRIN1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.3755397538582947,0.5591873127130527,0.9622641509433962,0.9988850655491982,1.0,2/5,15.95%,RARA;PRKCZ
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.3163331088746453,-0.5591024626587184,0.9545454545454546,1.0,1.0,3/11,21.94%,ELMOD2;PCBP2;C1QBP
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.3643766731814261,-0.5585294772265303,0.8888888888888888,0.9999428388910139,1.0,1/5,11.77%,NPM1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.34541024874841386,0.5574662391265077,0.92,0.9990701697739925,1.0,2/8,25.05%,PPARG;TTC39B
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.3175388146469138,0.556984956212965,0.9411764705882353,0.9988173947786948,1.0,2/8,16.42%,NLRP12;ENG
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.2953261993665257,-0.556544433081324,0.9433962264150944,1.0,1.0,2/13,13.07%,BMP2;SMAD3
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.27959345908345035,0.5563983388826734,0.96,0.9985565778424549,1.0,3/19,17.98%,PAK1;ENG;PKD2
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.2851988167583749,0.5548917961390833,1.0,0.9986095551431318,1.0,3/20,17.43%,THRAP3;DAZAP1;CELF3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.28503709398279636,-0.5539967174360297,0.9777777777777777,1.0,1.0,2/22,6.09%,MID1IP1;ASAH1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.2784360691187311,0.5537959291404796,0.9615384615384616,0.9985181395695131,1.0,8/23,24.13%,STMN2;GAS2L1;PRUNE1;CAMSAP2;CLASP1;MAPT;MAP1B;ABL1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.27622584961582886,0.553753166549552,0.9622641509433962,0.9981052465819856,1.0,2/15,14.26%,RAP1B;COL18A1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.2894614215241599,-0.553527798367239,1.0,1.0,1.0,5/23,20.51%,BRK1;TWF1;CDC42;CYFIP1;AKIRIN1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.3101609543096191,0.5516567790510705,0.8490566037735849,0.998467403848797,1.0,1/10,8.25%,UFD1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.34847813238770686,-0.5514869940894558,0.8913043478260869,1.0,1.0,5/5,65.17%,NCK1;EIF2AK4;DDX3X;EIF4G1;IMPACT
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.3264810365532238,0.5510371181566596,0.9433962264150944,0.9981866888553538,1.0,4/11,29.72%,PRDM16;SETDB1;LOXL2;EZH1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.3269914447630542,0.5506019410961859,0.9166666666666666,0.9978979757843391,1.0,3/9,16.99%,GJA1;ANK2;KCNQ1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.2845856423123629,0.5503060711021831,1.0,0.9975724658832212,1.0,5/18,23.93%,CCDC57;RANBP9;CSNK1D;CLASP1;TUBG2
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.32071164715249073,-0.5496392666407176,0.9361702127659575,0.9996909400385331,1.0,4/11,22.36%,KNTC1;BUB3;MAD2L2;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.32071164715249073,-0.5496392666407176,0.9361702127659575,0.9996909400385331,1.0,4/11,22.36%,KNTC1;BUB3;MAD2L2;TPR
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.32071164715249073,-0.5496392666407176,0.9361702127659575,0.9996909400385331,1.0,4/11,22.36%,KNTC1;BUB3;MAD2L2;TPR
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.32071164715249073,-0.5496392666407176,0.9361702127659575,0.9996909400385331,1.0,4/11,22.36%,KNTC1;BUB3;MAD2L2;TPR
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.31223206206455867,-0.5492363511880336,1.0,0.9993932246234236,1.0,1/10,6.29%,P2RX4
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.349946526705059,0.5487595722004434,0.9433962264150944,0.9976544980249547,1.0,2/6,17.37%,CPT1A;CPT1C
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.3238098217580173,-0.5486760526281513,0.8888888888888888,0.9991573732866382,1.0,2/6,28.09%,NIT2;CAD
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.2925039931554553,0.547562872988517,0.9807692307692307,0.9975349688352811,1.0,10/17,33.73%,AGO1;AGO4;TNRC6C;TNRC6A;CNOT7;NRDE2;MOV10;TNRC6B;AGO2;AGO3
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.3378233272364579,-0.5440608532283526,0.9811320754716981,0.9997195277920655,1.0,2/7,14.30%,SLC25A4;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.3378233272364579,-0.5440608532283526,0.9811320754716981,0.9997195277920655,1.0,2/7,14.30%,SLC25A4;PELI1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.34433190806821135,-0.5439502600947964,0.88,0.9993080432957024,1.0,1/5,12.48%,BEND3
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.3059934971260814,-0.542066972343749,0.94,0.999617369468962,1.0,4/15,25.09%,RPF1;MPHOSPH6;URB1;C1D
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.33563672007804224,-0.5420064593056318,0.9069767441860465,0.9992062816824254,1.0,5/7,30.20%,B2M;ERAP1;HLA-A;TAP1;ERAP2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.3118894682344936,-0.5417687575231778,1.0,0.9988877209403462,1.0,1/11,6.29%,P2RX4
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.3338796213062786,0.540749169095769,0.9245283018867925,0.9992487601704063,1.0,3/6,30.85%,GDF11;MEST;JAK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.35571444842805255,0.5404361561941747,0.9555555555555556,0.9988944693629086,1.0,4/6,23.20%,CSF1;MAPK3;MAPK1;IL34
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.336483607412409,-0.5393296653759301,0.95,0.9991705052828159,1.0,1/6,8.19%,SLC25A33
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.3371457590725949,0.5373460686381124,0.92,0.9993290019718879,1.0,5/8,26.54%,ALDH7A1;SMOX;CHDH;SLC44A1;DMGDH
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.29816408108402037,0.5372251036621412,1.0,0.9989503439831171,1.0,1/12,7.89%,RAB11FIP5
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.2621526604661273,0.5370080506108967,1.0,0.9986089350344869,1.0,3/25,14.12%,RPTOR;RAP1GAP2;AP2M1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.3127384865609333,-0.5358993239084325,0.9387755102040817,0.9998959837905007,1.0,2/8,14.25%,PPAT;PRPSAP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.33897006042341427,0.534838439372764,0.9615384615384616,0.9987805294227224,1.0,2/7,23.53%,CAMK2D;PRKD2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.34562608326746547,0.5347080863557324,0.9038461538461539,0.9983943779693433,1.0,3/7,16.84%,ALOX12;ADIPOR2;PPARGC1A
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.29113325444993915,0.5341463083763011,0.9827586206896551,0.9981642855346636,1.0,3/14,19.85%,NMNAT2;MTHFD1;HPRT1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.354201610056631,-0.533653315438433,0.9615384615384616,1.0,1.0,3/5,34.01%,ZDHHC5;SLC15A2;BIRC2
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.3099855695175887,0.5335697329936976,0.9787234042553191,0.9979016133515777,1.0,2/10,19.81%,DLG4;ATXN2
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.3085836452862568,0.5335073246531817,0.9622641509433962,0.9975081257039335,1.0,4/8,27.46%,RARA;PRKCZ;ZFPM1;SLC7A5
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.3475497629694425,-0.532950603504002,0.9272727272727272,0.9999034806271545,1.0,1/5,5.88%,C12ORF57
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.30443778332819493,-0.5324513223881695,0.9245283018867925,0.9996072023567807,1.0,3/11,19.50%,CDC42;TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.3029579503418217,0.5300221037607443,0.9629629629629629,0.9980768569620437,1.0,4/9,29.04%,TRIM44;IL7;IFIH1;MAVS
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.3155989063770044,-0.5282919114588247,0.9615384615384616,1.0,1.0,8/8,68.47%,RUNX1;TGFB1;HDAC2;CREB3L1;TGFB3;SUCO;LARP6;RGCC
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3039967791060284,0.5252077104163133,0.9615384615384616,0.9989519695587041,1.0,2/8,18.06%,MAP2K5;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.3566188607085804,-0.5233629014577368,0.9791666666666666,1.0,1.0,1/5,13.07%,SMAD3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.29398979742752107,0.5217037129365599,1.0,0.9994460057952052,1.0,5/11,31.54%,SUFU;PKD2;NFKBIA;PKD1;KEAP1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.2919035887959974,0.5195583008830625,0.9814814814814815,0.9995062996737046,1.0,3/13,18.58%,CAMTA1;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.279395470933467,0.5185834656595614,0.9607843137254902,0.9992927609420441,1.0,3/9,32.66%,NTNG1;FLRT2;PXDN
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.3497602650484654,-0.5168350122919365,0.9761904761904762,1.0,1.0,4/8,26.00%,PTN;IL17D;PURB;RUNX1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.3219601540684265,-0.5162230692922297,0.9555555555555556,1.0,1.0,1/7,13.90%,VPS11
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.3149575709505209,0.5154908308751589,0.9761904761904762,0.9996063132858543,1.0,3/8,30.80%,SNCA;PRKN;IL1RAPL1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.3261222606441889,-0.5150122294157969,0.9583333333333334,1.0,1.0,1/6,16.08%,PEX13
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.26485598872920413,-0.5146967336698398,0.9761904761904762,1.0,1.0,4/14,19.05%,CAV1;IFIT1;FLOT1;MUL1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.3151789749561147,0.5139191149913733,0.9807692307692307,0.9994990662516428,1.0,3/7,25.38%,ARHGAP21;COPG1;STK25
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.3108467181214668,-0.5128735503830125,0.9318181818181818,1.0,1.0,2/5,24.12%,PRMT1;LDB1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.333121122796403,-0.512414162211647,0.9056603773584906,1.0,1.0,3/5,23.14%,SCARB2;TMEM30A;ATP8A2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.31350806868764436,-0.5096278582349498,0.9787234042553191,1.0,1.0,3/7,24.85%,ZDHHC8;PRKACA;BMP1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.2770931159776311,-0.5093104527786946,0.9818181818181818,1.0,1.0,1/11,10.90%,COQ10A
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.2770931159776311,-0.5093104527786946,0.9818181818181818,1.0,1.0,1/11,10.90%,COQ10A
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.3545492768950145,-0.5090019602678397,1.0,1.0,1.0,2/5,30.32%,RBPJ;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.3210146212481042,0.5088005696729753,0.9767441860465116,1.0,1.0,3/7,28.47%,ADCK1;PRKN;HUWE1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.2200431296898441,0.5072764016384992,1.0,1.0,1.0,11/32,29.04%,TIRAP;TOMM70;IRF1;TRAF3;POLR3G;POLR3B;TRIM56;PTPN11;TBK1;IFIH1;MAVS
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.2931248881132244,-0.5067065376141233,0.9555555555555556,1.0,1.0,2/6,24.12%,PRMT1;LDB1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.29757574849129775,0.5057351236938457,0.9807692307692307,1.0,1.0,1/7,16.42%,ENG
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.2551801189261896,-0.5047175781821811,1.0,1.0,1.0,5/19,25.83%,CHMP2A;NUMA1;CHMP5;TPR;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.34217633220147137,-0.5042129598838448,1.0,1.0,1.0,1/5,6.29%,P2RX4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.2885192218535808,0.5030894812719442,1.0,1.0,1.0,2/10,19.02%,ACVR1C;ACVR1B
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.33886563344097453,0.500818289797755,0.9361702127659575,1.0,1.0,2/5,26.08%,NFKBIA;ITGAV
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.2602411423358139,0.49918115529425916,1.0,1.0,1.0,2/18,12.55%,TIRAP;IL6R
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.319323010497341,-0.4989871490811875,0.9591836734693877,1.0,1.0,2/7,19.65%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.26318137284307963,0.4981831968848675,1.0,0.9999477077563274,1.0,10/19,32.50%,DGKZ;P2RY12;IRS1;EEF1A2;FGF2;ATG14;PTK2B;FLT1;PTK2;PDGFRB
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.22960122459943375,-0.49666865746034566,1.0,1.0,1.0,7/24,24.29%,IRF3;ISG15;FLOT1;POLR3D;OAS3;RIPK2;HSP90AA1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.3304528194845837,0.49634040016044856,0.9795918367346939,0.9998691608109163,1.0,1/5,18.06%,ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.28602163859804186,-0.4961214550494157,0.9782608695652174,1.0,1.0,2/9,12.78%,CAV1;UBQLN2
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.2937901440130773,0.495857390234497,0.9777777777777777,0.9995425558865498,1.0,3/7,21.93%,PRKAA2;PRKAA1;MAPT
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.2669188810744959,-0.49523570658329635,1.0,1.0,1.0,4/14,25.83%,CHMP2A;CHMP5;TPR;HSPA1A
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.29301326136202827,0.4928295866016252,0.9818181818181818,0.9997732515198179,1.0,3/7,28.93%,LIMK2;CLASP1;DLG1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.3322861195898126,-0.4925870496761252,0.9803921568627451,1.0,1.0,2/5,19.65%,TGFBR2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.2777961859909493,-0.4913348889298238,0.9622641509433962,1.0,1.0,2/6,20.16%,CNOT1;NBDY
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),0.3332519545285268,0.48929324622663173,0.9298245614035088,0.9999549847463846,1.0,1/5,9.59%,RFTN1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.30904344802170985,-0.48885064084568275,0.9245283018867925,1.0,1.0,5/6,37.49%,METTL4;MTRES1;ALKBH1;MTG2;NSUN3
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.30917458097313943,0.48651683627131004,0.9545454545454546,0.9996195343372234,1.0,2/6,28.76%,IWS1;SETD2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.30917458097313943,0.48651683627131004,0.9545454545454546,0.9996195343372234,1.0,2/6,28.76%,IWS1;SETD2
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.2824677341381918,-0.4863231406972718,0.9821428571428571,1.0,1.0,2/7,18.26%,ACHE;DAGLA
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.2869791039949408,0.48593209042909097,0.9473684210526315,0.9993140069944391,1.0,2/8,26.64%,CEP250;MARK4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.3167140165826009,-0.48178598724540983,1.0,1.0,1.0,1/6,16.45%,VCP
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.2872481880252855,-0.4807065659710768,0.9821428571428571,1.0,1.0,3/5,28.54%,HRAS;RELA;ZSWIM8
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.3186408868073832,0.4804753775375779,0.9591836734693877,0.9998202262970896,1.0,2/5,28.73%,C17ORF75;WDR11
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.25776550619070626,-0.47744929064176905,1.0,1.0,1.0,2/9,26.61%,ACADS;ETFB
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.2996896704595833,-0.477366024009578,1.0,1.0,1.0,7/7,70.05%,RPS27L;ING4;KAT5;TP53;SP100;RPS6KA6;HIPK2
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.2570915254539414,-0.47515172927750216,1.0,1.0,1.0,3/11,21.60%,BEND3;SETD1A;ZNF335
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.28084823407713905,-0.47260801741982933,1.0,1.0,1.0,7/7,71.94%,EPB41L4B;PTEN;MAP4K4;IQSEC1;MTOR;ADAM9;MAPRE2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.3137652171978297,-0.47012373971191995,0.9811320754716981,1.0,1.0,2/5,27.40%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.3137652171978297,-0.47012373971191995,0.9811320754716981,1.0,1.0,2/5,27.40%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.3137652171978297,-0.47012373971191995,0.9811320754716981,1.0,1.0,2/5,27.40%,SOD1;ERLIN2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.24494205889109738,0.47008880339695347,1.0,1.0,1.0,3/17,16.93%,SLC19A1;PDPN;ABCB9
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.2764671765169321,0.4690516601428161,1.0,1.0,1.0,2/9,15.00%,RAP1B;PLK2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.31992600953101713,0.4679421380274142,0.9824561403508771,1.0,1.0,1/5,19.85%,HPRT1
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.27489487726944783,-0.4676087551359564,0.9736842105263158,0.9992379357150238,1.0,1/6,16.65%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.27489487726944783,-0.4676087551359564,0.9736842105263158,0.9992379357150238,1.0,1/6,16.65%,MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.27489487726944783,-0.4676087551359564,0.9736842105263158,0.9992379357150238,1.0,1/6,16.65%,MSN
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.2911293526570373,-0.466659769112747,0.9807692307692307,0.9989723114208693,1.0,1/8,19.01%,SNAPC5
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.2554730943704423,0.46653520348227284,1.0,1.0,1.0,2/10,16.99%,KCND3;KCNQ1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.29183598079054307,0.46515519657388527,0.9777777777777777,1.0,1.0,6/6,70.83%,ABCC3;ABCC1;ABCC11;ABCC4;SLCO3A1;ABCC10
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),0.28592537864794976,0.4641123028810077,0.9583333333333334,0.9999589059128734,1.0,6/6,71.42%,NUF2;CENPC;POGZ;CENPT;CENPH;MIS12
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.25033458065635894,-0.45941377401162725,1.0,0.9997934459807503,1.0,1/12,10.90%,COQ10A
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.25147713364726654,-0.4589771325492327,1.0,0.9994674738157591,1.0,2/11,15.42%,HSP90AB1;B4GALT6
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.2853871158392435,-0.4568168390873842,0.9791666666666666,0.9993787170059362,1.0,5/5,71.48%,CTCF;KDM1B;MECP2;DNMT3A;PRMT7
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.276398495760769,0.4553022013210268,1.0,1.0,1.0,1/9,11.79%,PACS2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.2640637181786109,0.45447091515599175,0.9821428571428571,1.0,1.0,3/7,34.44%,NAF1;NRDE2;ZCCHC17
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.2805119566421175,0.4512720138142985,1.0,1.0,1.0,2/9,25.30%,AP2M1;CLTC
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.2805119566421175,0.4512720138142985,1.0,1.0,1.0,2/9,25.30%,AP2M1;CLTC
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.2140605340959313,-0.4488507022115773,1.0,0.9999962529696699,1.0,6/27,22.36%,CHMP2A;GNAI1;NUMA1;CHMP5;MAP9;TPR
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.24063089236994625,-0.44859111624352643,0.9787234042553191,0.9996060406479992,1.0,3/12,23.37%,SCARB1;NR1H2;PPARA
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.2620746746833488,0.445219545541132,0.9795918367346939,1.0,1.0,2/8,25.93%,TRAF6;NFAT5
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.29832468110133137,-0.4445198551928208,1.0,0.9996980462507343,1.0,1/5,10.12%,DHODH
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.20179931043692179,0.44238475494062285,1.0,1.0,1.0,5/25,27.04%,RPA1;CDC7;ORC2;ORC3;ORC4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.29308905326297463,0.4418984054761708,1.0,0.9998817248678618,1.0,2/5,32.38%,RAB3GAP1;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.28082748429996307,-0.43569346692907424,1.0,1.0,1.0,6/6,71.94%,EPB41L4B;MAP4K4;IQSEC1;MTOR;ADAM9;MAPRE2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.2744408015442949,0.4346878902015421,0.9565217391304348,1.0,1.0,3/7,34.52%,SESTD1;BIN1;PLN
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.2651239370208812,-0.429416265977726,1.0,1.0,1.0,2/9,16.45%,PRELID1;VCP
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.2721631205673759,0.4200388623878449,1.0,1.0,1.0,5/5,72.79%,BMPR1B;BMPR2;INPPL1;MEF2C;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.25348225622011133,0.4192598365762181,0.98,1.0,1.0,1/6,21.67%,EFNB2
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.26119402985074625,-0.41668437785517126,1.0,1.0,1.0,7/7,73.90%,ERCC8;APLF;TDP1;LIG4;ERCC6;SIRT1;APTX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.2719330577882451,-0.4149518535659207,1.0,1.0,1.0,1/6,18.14%,H3-3A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.2719330577882451,-0.4149518535659207,1.0,1.0,1.0,1/6,18.14%,H3-3A
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.25016978194025663,0.4128663921930953,1.0,1.0,1.0,1/8,22.63%,PDK2
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.25016978194025663,0.4128663921930953,1.0,1.0,1.0,1/8,22.63%,PDK2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.26682923224709965,0.4108318194699489,1.0,1.0,1.0,8/8,73.33%,BMPR1B;BMPR2;FGFR2;LRP5;SFRP4;SKI;FGFR3;LRP6
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.2558757440732544,0.40557965176929667,1.0,0.9999458306454557,1.0,4/6,36.42%,PDZK1;STK39;ANO6;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.20052228724157978,-0.4033597105916537,1.0,1.0,1.0,7/24,27.15%,BMP2;AKT1;JAG1;MAD2L2;PPARA;PLG;GTPBP4
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.20247594564593402,-0.40267940900547516,1.0,1.0,1.0,6/16,26.47%,PRELID1;SOD1;CLPTM1;RUNX1;SPINK5;METTL3
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.23889269681946662,0.4002820279683153,1.0,0.9998360103366768,1.0,2/8,31.20%,ATRX;RTF2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.24911347517730512,0.39834573900383524,1.0,0.9995734920369171,1.0,5/5,75.10%,ATP8B1;PODXL;PLD1;FSCN1;RAP1GAP
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.23542451784526713,-0.3951071350361333,1.0,1.0,1.0,8/8,76.48%,SOD1;WWC2;WWC1;PTEN;LATS1;WWC3;DUSP9;DUSP6
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.23441193853427894,-0.3898352299357256,1.0,1.0,1.0,5/5,76.57%,DPM3;DPY19L2;DPY19L3;DPY19L1;DPY19L4
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.23441193853427894,-0.3898352299357256,1.0,1.0,1.0,5/5,76.57%,DPM3;DPY19L2;DPY19L3;DPY19L1;DPY19L4
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.23236054673069817,-0.38774668769242104,1.0,1.0,1.0,6/6,76.78%,MORC2;RESF1;MPHOSPH8;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.23237771538347862,-0.3843229799446358,1.0,0.9998371681052487,1.0,7/7,76.78%,MORC2;RESF1;MPHOSPH8;TOP2B;TASOR;INPP5K;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.2359962324828914,0.3687785426562731,1.0,1.0,1.0,1/5,19.02%,ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.23984887017908613,0.3656887369782052,1.0,0.9999731141780843,1.0,2/5,27.21%,ARFGEF1;ALG10B
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.2175548182057701,0.36417414441816537,1.0,0.9995823578309915,1.0,1/8,16.93%,EHD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.2297916358800059,-0.355000797571174,1.0,1.0,1.0,7/7,77.04%,MAD2L2;PLG;NOTCH1;VEGFA;NEXMIF;RGCC;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.18770322199231454,-0.31298634016760946,1.0,1.0,1.0,9/9,81.25%,NUMA1;ETV4;MED1;NCOA3;SFRP4;MACROH2A2;PRKCH;TRIM16;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.18768935195448164,-0.3096488246936719,1.0,0.9999957243579054,1.0,8/8,81.25%,NUMA1;ETV4;MED1;NCOA3;MACROH2A2;PRKCH;TRIM16;MACROH2A1
